,filename,label,label_predict,score,precision_5,precision_10,precision_15
0,Clin_Oral_Investig-4-1-2238785.txt,bew||basic structur||index||bew score sum||gener dental practition||surfac||gdp||basic eros wear examin||develop||eros tooth wear||score||research||level score||studi||condit||sever||eros||system||tooth wear||highest score||epidemiolog||sextant||indic||manag||examin||level||eros wear||diagnosi,2||3||refer 1||3 1 depart||1 criteria||score 2||1 11 12||studi||2 risk level||UK 2 depart||3 16||5||surfac textur 2||springer-verlag 2008 introduct 1 4||5 14 9 12 2 19,28965.0||17044.0||16864.5||16861.333||15937.0||15535.5||13983.0||12015.0||11857.667||10778.333||10497.5||10364.0||10050.333||9785.2||9697.333,0.0,0.1,0.06666666666666667
1,J_Interv_Card_Electrophysiol-4-1-2292475.txt,recurr rate||arrhythmia||flutter||pain||similar rate||atrial fibril||lower requir||group||acut success||cryo group||recurr flutter||isthmu conduct||studi||bidirect block||recurr||time||success||pain score||signific||conduct||atrial flutter||patient||ecg||ablat||isthmu length||cathet curv||isthmu line||line||cryothermi||fibril||cathet ablat||procedur||isthmu||block||cryotherapi||bidirect isthmu block||applic||radiofrequ,1||2||3||3 3||type 1||success 1||1 demograph||2 NS||patient||4 patient||4||human type 1||studi||2 procedur data||ablat data 2,31046.0||28965.0||17044.0||17044.0||16987.0||15830.5||15622.5||14817.0||13567.0||13252.0||12937.0||12734.333||12015.0||11774.333||11392.333,0.0,0.1,0.13333333333333333
2,J_Mol_Biol-2-1-2279256.txt,substrat||blast||bind||potenti||gmer||product||antigen||dtdp||posit||deoxythymidin diphosph||lipopolysaccharid||function||phosphat||cofactor||bind pocket||protein||reaction||2||studi||pdb||wbmg||side chain||sdr||wbmh||mutat||catalyt site||gene||mutant||ump||residu||protein function||site||case||activ site||present time||wbmf||triad||structur,1||2||2 2 2||1 1 depart||2 fig. 2||jking01@uoguelph.ca 1 2||1 40||tabl 2||35 fig. 2 2||2 fig. 5||4||o-antigen biosynthesi introduct 1 2||studi||1 E. coli||1 B. bronchiseptica,31046.0||28965.0||28965.0||21528.667||20968.667||20004.333||16598.0||16290.5||16225.25||14768.333||12937.0||12303.2||12015.0||11220.333||10807.333,0.2,0.1,0.13333333333333333
3,Neurochem_Res-3-1-1832150.txt,defici||coq10||skin fibroblast||patient||studi||level||form||diseas||cerebellar ataxia,1 1||1||10 1||3||refer 1||patient||4||fig. 1 10 10||studi||lancet 1 368:70||5||ataxia-ocular apraxia 1||6||2006||1 2006 368 70 82 10.1016,31046.0||31046.0||19014.0||17044.0||16864.5||13567.0||12937.0||12496.5||12015.0||10519.667||10364.0||10350.333||9074.0||8371.0||7862.833,0.0,0.2,0.13333333333333333
4,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-1779626.txt,matrix||tissu engin||sampl||method||articular cartilag||maci||type II collagen||implant||distribut||number||cell||maci procedur||tissu||chondrocyt||ultrastructur analys||cell viabil||membran||phenotyp express,1||2||tabl 1 2||6 3 2||2 7||3||refer 1||6 2 type||4||cell||studi||6 3 2 knee 22||cell viabil analysi 2||1 knee 54||itali 2 institut,31046.0||28965.0||21209.0||18361.0||17981.0||17044.0||16864.5||13655.667||12937.0||12627.0||12015.0||11759.0||11593.5||10910.667||10203.333,0.0,0.1,0.06666666666666667
5,Histochem_Cell_Biol-3-1-2137945.txt,retent||mechan||rna motion||key||rapid||nuclear architectur||nuclear motion||transcript||nucleu||sequestr||rna||molecul||target||nuclear bodi||cajal bodi||interact||protein||dynam properti||nuclear environ||bodi||bind site||releas||gene||distinct structur element||motion||nuclear compart||transcript factor||diffus||dynam natur||method||dynam||site||cell||nucleolu||intranuclear traffick||fundament question||chromatin,1||2||3 fig. 3||1 2006 2004 2006 2004||cell||studi||2006||2006 2004 2006||2006 2007||2007 2007||2007||5 time||2006 1999 2000 2004 2006 2002||cell biolog||live cell,31046.0||28965.0||13021.333||12788.4||12627.0||12015.0||8371.0||8273.0||7829.0||7287.0||7287.0||7152.5||7095.667||7089.5||6547.0,0.2,0.1,0.06666666666666667
6,Vision_Res-2-1-2386851.txt,respons||nois||model||detect||ja||low threshold||finger error||compress transduct||contrast discrimin||varianc||sensori threshold||estim||stimulu||mjm||ratio||uncertainti||fit||sigma-to-mean ratio||paramet valu||contrast||valu||sensat varianc||observ||intrins uncertainti||discrimin||pedest||pedest contrast||trial||increment||data||threshold||second-respons accuraci||visual signal||first-choic accuraci||result||function,1||1 2 2||2||2 2 σ||tabl 1||3||fig. 2||2 method||1 probabl||2 gener||1 δ||NP 1||1 ε||ψ 1||Ψ 1,31046.0||29658.667||28965.0||19355.333||17331.0||17044.0||16970.5||16318.5||15852.0||15811.0||15592.0||15574.0||15573.0||15550.0||15548.0,0.0,0.0,0.0
7,J_Gastrointest_Surg-3-1-1852383.txt,biliari||Rh nonident||BC risk factor||donor||risk factor||neg liver graft||case||incid||liver transplant||chi-squar test||abo-incompat blood group||studi||biliari complic||patient||graft||arteri thrombosi||bc||result||group,1||2||refer 1||tumor 1||1 tabl 1 demograph||figur 1||etiolog 1||4 1 depart||neg 2||patient||studi||spain 2 depart||5||6||nonident 3,31046.0||28965.0||16864.5||16847.5||16476.75||16123.5||15602.0||15492.333||15012.0||13567.0||12015.0||10519.667||10364.0||9074.0||8527.0,0.0,0.1,0.13333333333333333
8,J_Med_Internet_Res-2-2-1761853.txt,health inform||care||servic||product||peopl||internet||ethic||health,1||2003 1||feb 2||patient||2000 2 1 e2 http://www.jmir.org/2000/1/e2/ 10.2196||educ patient||scientif studi||2000||health||diseas||treatment||data||health care||health inform||control,31046.0||19348.5||14598.5||13567.0||10996.667||7251.0||6207.0||5903.0||5601.0||5149.0||5012.0||4969.0||4689.0||4520.5||4404.0,0.0,0.1,0.13333333333333333
9,Bioprocess_Biosyst_Eng-2-2-1705492.txt,oxid deamin||princip compon||part||model||amino acid metabol||run||medium||ly kinet||variabl||liver cell bioreactor||asp||perform||bioreactor||high||kinet||amino acid||valu||system||activ||primari human liver cell||differenti equat system||liver||cell||data||model paramet,1 1||1||2||2 2 2.1||1 10||1 8||tabl 1||0 1 2258 1||3||refer 1||tabl 2||suppl 1||9 2 4||1 2.1||Ai 1,31046.0||31046.0||28965.0||19411.667||19014.0||18600.0||17331.0||17049.75||17044.0||16864.5||16290.5||15942.0||15764.667||15675.5||15528.0,0.0,0.0,0.0
10,Behav_Genet-4-1-2226023.txt,gestat||herit||effect||environment factor||birth weight||varianc||order||influenc||placenta||gestat age||chorion||twin||covari||insert||birth||studi||time||increas||growth||cord insert||placent factor||matern factor||week||regress||qtl||unadjust model||covari matrix||weight||chanc||separ placenta||umbil cord,1||1 2||2||1 2 time||1 2 3 3 2002||1 3 2000||time 1||1 model||3||statist analysi 2 2||J. 1 2 derom||gestat 1||6.688 1||7.403 1||4,31046.0||30005.5||28965.0||21317.333||20231.2||17997.667||17493.5||17468.5||17044.0||16049.0||15956.5||15634.0||15524.5||15523.5||12937.0,0.0,0.0,0.0
11,Biotechnol_Lett-3-1-2151841.txt,increas||substrat||pdi||bip||heterolog protein||activ||protein fold||overexpress||unfold protein respons||molecular chaperon||cell||protein||gene||chaperon system||upr||holdas||target||chaperon,1||2||1 fig. 1||1 2007||2007 4 2003 1||4 2004 2005 2||2007 3 9 2||1 2004 2004 2004||4||cell||protein phosphatas 1||1 2004 1990 2004||1 saccharomyc cerevisia||ER cis-tran 2||x-box bind protein 1,31046.0||28965.0||22356.0||19166.5||14730.25||14673.75||14672.0||13819.25||12937.0||12627.0||12527.667||12152.25||10441.0||9828.667||9626.75,0.0,0.1,0.06666666666666667
12,Eur_J_Epidemiol-4-1-2190786.txt,urin sampl||biolog sampl||parent||biobank||tube||pregnanc||blood||develop||research||process||birth||equal dna concentr||young adulthood||plate||studi||dna||medic ethic committe||children||fetal life||erasmu medic center||mother||genet determin||partner||biolog specimen||laboratori||child,1||2 2||2||2007 introduct 1 2 1 2||3||refer 1||2 14||1 31||2 fig. 2 distribut||7 hofman albert 2 1||1 fig. 1 design data collect||studi||4 3 cape verdian 4 2||type 2 diabet||netherland 2 depart,31046.0||28965.0||28965.0||21434.5||17044.0||16864.5||16631.0||16599.5||16117.25||13441.2||12341.333||12015.0||11984.667||11461.333||11205.0,0.0,0.0,0.06666666666666667
13,Diabetologia-3-1-1914278.txt,sex||endotheli glycocalyx||vascular vulner||imag analyst||diabet||intima-media thick||hyaluronan||present studi||age||control||diabet mellitu||cimt||carotid arteri||patient||type 1 diabet||hyaluronidas||subject||glycocalyx||arteri wall||plasma hyaluronan level||plasma hyaluronan,1||1 1c 2||type 1||refer 1||1 demograph||2 3 gort||99 2||m.nieuwdorp@amc.uva.nl 1 2 holleman||2 univari||2 vink||2 kontush||patient||control fig. 1||S. G. 2 1 depart||type 1 diabet patient,31046.0||20047.0||16987.0||16864.5||15622.5||15337.0||15013.5||15004.25||14541.0||14502.5||14483.0||13567.0||13475.333||13279.6||12508.0,0.0,0.0,0.06666666666666667
14,Mol_Immunol-1-5-2080686.txt,increas||model||ab||endogen light chain||genet background||activ||MZ||FO||cell||mice||sle||igg||level||autoab||Tg||light chain||margin zone,1||2||fig. 1||tabl 1||3||fig. 2||1 Li||l.fossati@imperial.ac.uk 1||2 materi||2 murakami||tabl 1 fig. 3||cell||studi||tabl 1 splenic||fig. 3,31046.0||28965.0||18011.0||17331.0||17044.0||16970.5||15819.5||15524.0||15325.0||14505.5||14170.5||12627.0||12015.0||11563.667||11010.0,0.0,0.0,0.06666666666666667
15,Arch_Orthop_Trauma_Surg-3-1-2111040.txt,complic rate||total hip replac||dynam hip screw||complic||outcom||full weight bear||minimum age||primari||group||revis rate||influenc||dh||trochanter femor fractur||treatment group||studi||arthroplasti||time||intern fixat||fractur||age||hip||treatment||primari arthroplasti||comorbid||patient||risk||proxim femor nail||rel risk||multipl regress analysi||hip screw||mortal||year||mortal risk,1||2||treatment 1 2||2 10||1 year||3||fig. 2||1 refer||refer 1||2 tabl 3||age 2||49-69-6705220 f.geiger@friedrichsheim.d 1 2||mortal 2||24 19 1 fig. 1||marienburgstrass 2,31046.0||28965.0||21674.333||17973.5||17151.0||17044.0||16970.5||16864.5||16864.5||16541.667||16265.0||15003.25||14879.0||14731.6||14483.0,0.0,0.0,0.0
16,Pediatr_Nephrol-4-1-2275772.txt,hypertens||reduct||chronic inflamm||effect||renal replac therapi||therapeut strategi||normal rang||ra||factor||renal function||ckd patient||addit role||measur||renal diseas progress||proteinuria||progress||studi||antiproteinur||increas||ace inhibitor||children||treatment||ckd||kidney function||patient||risk||low-protein diet||antihypertens agent||prevent||anemia||blood pressur||trial||oxid stress||chronic kidney diseas||adult||efficaci||renal failur,2||3||suppl 1||chronic kidney diseas 1 2||patient||4||studi||type 2 diabet||statin refer 1||normotens type 2||5||3 year||ckd stage 2||suppl 3||2005,28965.0||17044.0||15942.0||13623.6||13567.0||12937.0||12015.0||11461.333||11273.667||10639.0||10364.0||10150.0||10128.0||8941.0||8716.0,0.2,0.2,0.13333333333333333
17,Histochem_Cell_Biol-3-1-2137947.txt,cancer||nucleolar structur||bind||mitot phosphoryl||rrna||depend||transcript||assembl||ribosom biogenesi||molecul||nuclear bodi||factor||sequenc||compon||rdna transcript||process||protein||nucleolar assembl||studi||nucleolar compon||nuclear receptor||ribosom||author||nuclear function compartment||activ||viru||dfc||nuclear export||biogenesi||nucleolar protein||rdna transcript machineri||rdna||dynam||complex||ribosom protein||cell||nucleolar machineri||nucleolu||upstream bind factor||cancer cell||pnb||local||cell cycl||norc,1||2||2 2 2 fig. 2||2000 2||hiv 1||2 2006 2006 2002||cell||cancer 1992 1994 2 1 1997||studi||2 place jussieu||cancer cell||franc 2 grupo||2005||cell function||cell factor,31046.0||28965.0||24167.2||17434.0||15689.0||13191.0||12627.0||12430.167||12015.0||9870.333||9851.5||9726.333||8716.0||8604.0||8535.5,0.0,0.2,0.2
18,Arch_Microbiol-3-1-2111041.txt,mass rang||glycerol||compon||speci||bacteria||isom||fraction||lipid||diabol acid||data||abil||earth||genu||alkyl chain||group,1||2||fig. 1||1 2 5 6 4 4||3||M. 2 1 depart||1 thermotogal||2 3 column||2 FA||2 thermotogal||1 2 5 6 thermotoga maritima||4||cell||1 3 thermotoga F.||studi,31046.0||28965.0||18011.0||17553.833||17044.0||16562.75||15538.5||15444.0||14640.5||14498.0||13258.5||12937.0||12627.0||12271.25||12015.0,0.0,0.0,0.0
19,Histochem_Cell_Biol-3-1-1779629.txt,transgen mice||specif||probe||growth plate||hypertroph zone||downstream||fvb mice||long bone||construct||transgen copi||cartilag||bac dna||homolog recombin||high level||dna||integr site||report gene mous||bac||express||hypertroph cartilag||embryo||element||system||lacz activ||activ||gene||hypertroph chondrocyt||enhanc||newborn||primer||founder||offspr||event||growth factor||cell||chondrocyt||vector||genom context,1||2||1 1 materi||1 3 1 fig. 3||fig. 1||1 ml||nco 1||4||4 4 4 4||cell||method 1 materi||tabl 1 materi||studi||bam 32 1||germani 2 depart,31046.0||28965.0||21259.0||20231.2||18011.0||15906.0||15531.5||12937.0||12937.0||12627.0||12134.333||12115.667||12015.0||11094.333||10717.333,0.0,0.1,0.06666666666666667
20,Breast_Cancer_Res_Treat-3-1-2001225.txt,differ||elig patient||random||greater clinic benefit||anastrozol||secondari end point||breast cancer||contralater breast cancer||letrozol||primari object||follow-up||analysi||postmenopaus women||studi||recurr||time||initi therapi||aromatas inhibitor||treatment||contralater breast||ai||lymph node-posit breast cancer||distant metastas||risk||exclus criteria||face trial||therapi||tumor||event||tamoxifen||earli breast cancer||year,1||2||25 1||1 25||3||refer 1||2007 introduct 1 2 3 4||1 month||2 year||suppl 1||anastrozol 1||2 week||3 4||2 cm||3 5,31046.0||28965.0||17172.5||17172.5||17044.0||16864.5||16429.5||16322.0||16110.5||15942.0||15596.0||15100.0||14990.5||14720.5||13704.0,0.0,0.0,0.0
21,Environ_Health_Perspect-114-2-1367850.txt,faro island||specif aspect||current uncertainti||consensu||effect||outcom||prenat exposur||development outcom||report||field||exposur assess||cognit process||review||develop||research||associ||measur||neurolog examin||studi||import||prenat mehg exposur||literatur||age||children||question||exposur||test||neurobehavior test||development effect||matern hair||mehg||outcom measur||mehg exposur||futur research||development rate scale||method||methylmercuri||subject||inform||seychel island||data||psycholog test||assess||year||systemat review||investig||result,1||1 2||2||tabl 1||3||tabl 2||vol 1||2 week||tabl tabl 1||studi||tabl 2 budtz-jorgensen||5||3 mg||12 studi||2006,31046.0||30005.5||28965.0||17331.0||17044.0||16290.5||15610.0||15100.0||12759.333||12015.0||10863.0||10364.0||8944.0||8933.5||8371.0,0.0,0.1,0.06666666666666667
22,Int_J_Hematol-4-1-2276240.txt,multi-centr survey||voriconazol||advers event||clinic evid||ifi||fungal infect||criteria||toxic||clinic trial||diseas||invas fungal infect||treatment||malign hematolog diseas||activ||patient||indic||case||favor respons||prophylaxi||efficaci||antifung||investig,1||2||1 tabl 1||2 tabl 2||3||refer 1||surgeri 1||cn 1||caspofungin 1||2 diarrhea 1 drug fever 1||oral 2||sinu 2||patient||4||5,31046.0||28965.0||21902.667||20515.333||17044.0||16864.5||16358.5||15596.5||15528.0||15501.667||15006.5||14513.5||13567.0||12937.0||10364.0,0.0,0.0,0.06666666666666667
23,Eur_Radiol-2-2-1705545.txt,heart rate||ica||signific stenos||vessel||calcif||low vessel opacif||cad||extens coronari calcif||high preval||popul||coronari arteri||accuraci||score||studi||diagnost accuraci||imag||agatston score||low signal-to-nois ratio||nonenhanc dsct||data acquisit||coronari angiographi||patient||bpm||protocol||imag qualiti||entir heart||interv||dsct||dual-sourc CT||coronari arteri stenosi||diamet||segment||high pre-test probabl||data analysi||motion artifact||excel||heart rate control,1||1 2||2||1 2 3 4||1 1 institut||2 9||3||springer-verlag 2006 2 2||refer 1||segment 1||1 cm||27 2||1 47.4||1 synopsi||2 min,31046.0||30005.5||28965.0||22498.0||21178.333||17178.5||17044.0||16976.25||16864.5||15784.5||15761.0||15688.5||15530.0||15526.0||15117.5,0.0,0.0,0.0
24,Support_Care_Cancer-4-1-2413096.txt,famili member||model||respond||survey||outcom||unmet||death||abil||popul||concept||day-to-day hands-on caregiv||termin ill||area||south australia||peopl||special palli care servic||studi||proport||servic||palli care||patient||valid instrument||individu||support||health omnibu survey||long-term caregiv outcom||inform||data||level||life-limit ill||year||relationship||caregiv,1||2||2 fig. 2||death 1 1||3||refer 1||2 year||death 1||1 spc||1 2 fazeka belinda||patient||3 fig. 3||4||studi||tabl 1 characterist,31046.0||28965.0||20968.667||20961.667||17044.0||16864.5||16110.5||15919.5||15548.5||15004.5||13567.0||13021.333||12937.0||12015.0||11984.333,0.0,0.0,0.13333333333333333
25,Pediatr_Nephrol-3-1-1784542.txt,respons||effect||resist||cardiovascular diseas||dose||report||agent||medic||long-term cohort studi||proteinuria||studi||diseas||lower respons rate||children||treatment||renal diseas||nephrot syndrom||urinari protein excret||sirolimu||kidney function||patient||risk||therapi||fsg||corticosteroid||esrd||kidney||cholesterol||adult||rate,2||3||refer 1||patient||4||cell||studi||angiotensin type 1 receptor||5 6 7||pediatr patient||effect||intern studi||nephrot patient||normotens patient||result,28965.0||17044.0||16864.5||13567.0||12937.0||12627.0||12015.0||9421.0||8811.667||7786.5||6956.0||6876.0||6872.0||6795.5||6080.0,0.2,0.2,0.2
26,J_Gastrointest_Surg-3-1-1852393.txt,multivari analysi||prognost marker||mitogen-activ protein kinas||cd24 express||express||surviv||treatment||cholangiocarcinoma||mapk||cell||data||month||demograph data||protein||patient||studi||radiat||radiat therapi||patient surviv||chemotherapi,1 1 figur 1||1 figur 2||2 2 30||time 1||tabl 1||refer 1||time 2||john.gibbs@roswellpark.org 1 1 depart||grade 1||surviv 2 3||patient||2 12 15||4||2 15 11||cell,23584.75||20404.0||20399.0||17493.5||17331.0||16864.5||16453.0||16146.75||15863.5||15742.0||13567.0||13131.333||12937.0||12864.333||12627.0,0.0,0.0,0.13333333333333333
27,Obes_Surg-4-1-2226018.txt,relev norm group||follow-up assess point||morbid obes||norm group||gener popul||vertic||psychopatholog||signific improv||person||score||follow-up||questionnair||signific differ||studi||neurotic||addit||psychosoci||time||bodi imag||gastroplasti||psychosoci function||psycholog variabl||surgeri||patient||mix result||weight||bariatr surgeri||extrem obes||social anxieti||self-esteem||respect||year,1||2||2 1 depart||25 1||3||refer 1||2 year||2 tabl 2 postop||patient||studi||2 25 26||netherland 2 depart||3 6 12 4 5||studi patient group||2 anxieti 14.3,31046.0||28965.0||20835.0||17172.5||17044.0||16864.5||16110.5||15477.5||13567.0||12015.0||11624.0||11205.0||11054.2||10152.333||9816.333,0.0,0.2,0.13333333333333333
28,Clin_Oral_Investig-3-1-2134843.txt,effect||greater bone loss||single-root teeth||recent statist method||baselin data||surgic periodont therapi||factor||treatment result||influenc||teeth||oral||analysi||studi||ppd||pli||aggress periodont||srp||nonsurg||statist unit||doubl contour||ral-v||baselin||smoke||paramet||patient||therapi||periodont therapi||site||baselin ppd||clinic||ral-v gain||ppd reduct||clinic paramet||interproxim groov||bone loss,1||2||result 1||3||refer 1||3 4||patient||4||tabl 1 studi popul||studi||4 5||5||3 month||49-6221-565074 eickholz@med.uni-frankfurt.d 4 5 1 section||6,31046.0||28965.0||18563.0||17044.0||16864.5||14990.5||13567.0||12937.0||12115.0||12015.0||11650.5||10364.0||9321.0||9204.167||9074.0,0.0,0.2,0.13333333333333333
29,Antonie_Van_Leeuwenhoek-3-1-2140094.txt,extrolit||cultur||speci||aerial hypha||ascospor||cya||uniqu||diam||conidiophor||mea||coloni||promin equatori furrow,1||2||3||2 μm||4||1 fig. 1 aspergillu fumigati number||fig. 2 neosartorya||1 1990 1995 2005||5||31-30-2512097 samson@cbs.knaw.nl 5 1||6||2005||3 μm||2004||1 aspergillu fumigati isol,31046.0||28965.0||17044.0||14648.5||12937.0||11715.667||11322.333||10958.75||10364.0||10353.0||9074.0||8716.0||8688.0||8077.0||8028.25,0.0,0.0,0.0
30,Mar_Biotechnol_(NY)-3-1-2100433.txt,substrat||strength||product||plaqu||plant||surfac||anim||adhes research||marin mussel||tyrosinas||research||marin polychaet||protein||studi||byssu||adhes test||domain||thread||marin mussel adhes||freshwat mussel||varieti||dopa||similar||larg quantiti||natur adhes||repeat||specif identif||repetit motif||spider silk||foot organ||adhes||durabl||attach||quinon||collagen||marin||find||cell||recombin protein||mussel,1||2||1 M.||tabl 1||3||2 M.||3 6||adhes techniqu 2 tabl 2||cell||foot protein 1||studi||figur 1 M.||figur 2 M.||3 M.||adhes 1977 2,31046.0||28965.0||17396.0||17331.0||17044.0||16355.5||13059.0||12652.4||12627.0||12496.0||12015.0||11997.667||11304.0||10395.0||9960.333,0.0,0.1,0.13333333333333333
31,Matern_Child_Health_J-2-2-1592146.txt,intervent||bmi||age||public health concern||women||birth outcom||obes||overweight||prevent studi||activ||nutrit||risk||pregnanc||weight trend||postpartum,1||refer 1||anna-maria am_siegariz@unc.edu 1 3||2006||effect||prevent studi||health 2003||prospect studi||NC north carolina 2 depart||result||health||women health 2003||activ||diseas||treatment,31046.0||16864.5||12023.25||8371.0||6956.0||6741.5||6626.0||6474.0||6417.8||6080.0||5601.0||5273.0||5231.0||5149.0||5012.0,0.0,0.1,0.13333333333333333
32,Breast_Cancer_Res_Treat-3-1-2001224.txt,nation cancer institut||posit immunohistochem analysi||continu hormon treatment||outcom||post-unblind analysi||df||adjuv tamoxifen therapi||hazard ratio||tamoxifen therapi||breast cancer||placebo-control trial||letrozol||analysi||recurr||aromatas inhibitor||benefit||adjuv therapi||median follow-up||treatment||women||patient||clinic benefit||risk||therapi||tumor||placebo||ma.17||trial||safeti||hormon therapi||data||HR statu||tamoxifen||year||efficaci||result,1||2||1 tabl 1 analysi||1 2 4 7 3 7||refer 1||1 suppl||rational 1 3 3 4||patient||4||studi||level 1 evid||trial design 1 fig. 1 ma.17||outcom 2 29||5||3 fig. 3 29,31046.0||28965.0||17598.75||17331.0||16864.5||15942.0||15641.6||13567.0||12937.0||12015.0||11930.333||11746.167||11039.667||10364.0||10333.5,0.0,0.1,0.06666666666666667
33,Exp_Brain_Res-3-1-1914230.txt,trial block||mass||target area||cylind||effect||speed||interperson transfer effect||area||variat||interperson transfer||movement||experiment condit||task constraint||studi||particip||dyad||joint-act coordin||heavi||present studi||task||object||analys||data analys||observ||experi||kinemat paramet||action observ||size||tabl||role||repetit||high speed||actor||experiment task||fitts’ law||trial||coordin||joint action||weight||target region||transfer,1||2||2 2 show||2 result||3||2 year||1 NS||2 role||repetit 1||dyad 1||2 mm||2 fig. 5||2 putting-s||2 fetching-s||tabl 1 result,31046.0||28965.0||20057.0||17522.5||17044.0||16110.5||15857.5||15803.0||15574.5||15529.0||14896.0||14768.333||14485.0||14485.0||13580.667,0.0,0.0,0.0
34,Naunyn_Schmiedebergs_Arch_Pharmacol-4-1-2323035.txt,peptid YY||dipeptidyl peptidas IV||glucagon-lik peptide-1||diabet||cd26||dpp-iv,3||patient||F. 3 1 depart||type 2 diabet||36 2 5 1998||netherland 2 depart||1993 3||36 3||36 2005 3||36 2006 3||2005||36 2002 3||2006||diabet patient||2007,17044.0||13567.0||12881.0||11461.333||11322.0||11205.0||9414.0||9383.5||9161.0||9046.0||8716.0||8608.0||8371.0||8029.0||7287.0,0.0,0.0,0.0
35,Eur_J_Epidemiol-3-1-2071968.txt,cryptosporidiosi||model||speci||water||postcod||variabl||popul||water suppli||analysi||associ||studi||proport||water treatment||signific||agricultur||patient||ill||impact||sourc||independ variabl||inform||case||data||year||signific risk factor||socioeconom statu||result,1||2||16 2 2 2||2 4||3||refer 1||4 2 9 10 2||patient||6 2 C.||studi||5||result cryptosporidium 1 cryptosporidium||tabl 1 cryptosporidium infect||D. 1 chalmer rachel||tabl 2 cryptosporidium parvu,31046.0||28965.0||22711.5||20951.0||17044.0||16864.5||16648.2||13567.0||13351.333||12015.0||10364.0||9312.5||9011.5||8175.5||8161.0,0.0,0.2,0.13333333333333333
36,Pain-2-1-2258319.txt,respons||survey||pain||pt||clinic practic||vignett||practic||advic||health care practition||belief||behaviour||score||associ||questionnair||studi||work||lbp||attitud||hcp||treatment||subscal||activ||patient||clinic guidelin||recommend||practition||practic behaviour||line||UK gp||random sampl||method||return||gp||guidelin recommend||clinic behaviour,1||2||3||tabl 2||patient||3 fig. 1 box-plot||4||studi||tabl 1 characterist||3 result||tabl 2 investig||5||clinic behaviour fig. 1||tabl 3||6,31046.0||28965.0||17044.0||16290.5||13567.0||13266.75||12937.0||12015.0||11984.333||11562.0||11375.667||10364.0||10346.0||10330.0||9074.0,0.2,0.2,0.13333333333333333
37,Exp_Brain_Res-3-1-2048826.txt,monocular arrow||dispar||depth percept||ambigu stimulu||cue||hypothesi||surfac||depth||influenc||signal||slant rivalri stimulu||stimulu||conclus||surfac slant||eye||orient||vergenc||condit||studi||depth cue||perspect||display||slant||direct||present studi||author||altern||saccad||onset||perceptu condit||percept||slant trapezoid||ambigu||slant rectangl||show||trial||data||surfac orient||result,1||1 2||2||3||experi 1||stimuli 2 fig. 2||1 knapen||experi 2||2003 2003 1||1 fig. 1 wheatston stereoscop||4||4 4||studi||experi 1 show||5,31046.0||30005.5||28965.0||17044.0||16535.0||15785.5||15525.5||15494.5||15449.333||13419.2||12937.0||12937.0||12015.0||11770.333||10364.0,0.0,0.0,0.06666666666666667
38,Oecologia-3-1-2039789.txt,respons||main effect||effect||stolon||petiol||resist||measur anova||ramet||competit tray||leaf area loss||plant||herbivor||area||tray||perform||damag||cost||leaf dri mass||competit||studi||defens||time||phenotyp||benefit||total biomass product||adapt plastic hypothesi||clonal plant||express||petiol dri mass||rel biomass alloc||experi||leaf area||induct||leav||dri mass||leaf tissu||leaf||defens induct||asymmetr competit||trait||result||main stolon,1||2||2 2||1 1 depart||sir 1 2||3||3 3||2 5 5||signific 1||1 day||toernooiveld 1||2 cost||studi||netherland 2 institut||5,31046.0||28965.0||28965.0||21528.667||20012.333||17044.0||17044.0||16564.333||16544.0||16489.5||15524.5||14881.0||12015.0||10854.667||10364.0,0.0,0.0,0.06666666666666667
39,Breast_Cancer_Res_Treat-3-1-2001219.txt,respons||postmenopaus||random||effect||metastat diseas||ttf||advers event||superior||breast cancer||orr||letrozol||signific improv||analysi||studi||metastas||progress||diseas||aromatas inhibitor||advanc breast cancer||signific||treatment||post-menopaus women||surviv||earliest date||patient||clinic benefit||therapi||first-lin endocrin therapi||first-lin therapi||trial||endocrin therapi||diseas progress||tamoxifen,1||2||1 year||refer 1||evalu 1||1 57||52 2||2 57||patient||studi||2 53 53||3 month||3 53||2005||53 1 54 54,31046.0||28965.0||17151.0||16864.5||16775.5||16016.5||15052.5||14976.0||13567.0||12015.0||10400.333||9321.0||9081.0||8716.0||8619.5,0.0,0.2,0.13333333333333333
40,Med_Biol_Eng_Comput-3-1-1820753.txt,algorithm||random||scale||potenti||multi-modul sourc||amplitud||scale transform||signal||compon||phase||term||period signal||thorax||sampl||random nois||waveform||sft||electrocardiogram||standard||ecg||heart rate variabl||sourc||inform||spectral analysi||modul,1||1 2||2||2 2||1 4||1 5||1 2 τ||method 1 fig. 1||1 16||3||fig. 2||refer 1||2 17||_{ 1||1 τ,31046.0||30005.5||28965.0||28965.0||21991.5||20705.0||20091.0||17685.0||17498.5||17044.0||16970.5||16864.5||16274.0||15932.0||15654.0,0.0,0.0,0.0
41,Apoptosis-4-1-2217618.txt,integrin||bind||incub||product||proapoptot effect||approach||angiogen endothelium||tumor vasculatur||tumor cell||protein||jurkat cell||apoptosi||tumor tissu||primari amino group||promega||rgdpeg-avidin||activ||trail||experi||subunit||rgdpeg group||complex||cell||result||therapeut protein||ligand||huvec||antitumor activ,1||2||rgdpeg-avidin 2 2 2 fig. 2||3 24 125 2 2 2||3 fig. 1||3||refer 1||1 characterist||23 2||1 μg||lane 1||1 ng||3 3 cell||3 4||4,31046.0||28965.0||20142.833||17936.833||17688.667||17044.0||16864.5||16168.5||15976.5||15725.5||15669.5||15618.0||15571.667||14990.5||12937.0,0.0,0.0,0.0
42,J_Mol_Model-3-1-2039871.txt,parameter||speci||semiempir method||effect||optim||potenti||orbit||atom||geometri||spin-fre energi level||transit metal||high level calcul||group iva||rule||group||refer data||larg formal charg||interatom separ||refer||approxim||accuraci||function||fault||bond||rare ga atom||pm6||attempt||import||error||core-cor interact||transit metal complex||core-cor express||failur||valu||compound||system||element||incorrect structur||potenti sourc||main group||paramet||chemic bond||hydrogen bond||hydrogen||electron state||emphasi||method||heat||complex||weight||data||set||distanc||type||level||water||interact||molybdenum||result||structur,1||1 1||1 2||2||2 2||1 3||2 3 3||1 5||2 5||fig. 1||2 7 3||parenthesi 3 2 2 4||16 1||1 18||1 17,31046.0||31046.0||30005.5||28965.0||28965.0||24045.0||21017.667||20705.0||19664.5||18011.0||17668.667||17588.0||17498.5||17487.5||17314.5,0.0,0.0,0.0
43,Bioinformation-1-10-1896055.txt,number||dataset||probe||mous||annot||organ system||file||analysi||mous embryo||biolog replic||integr analysi||birth defect||sampl||embryo||gene||microarray data||refer collect||compar bioinformat analysi||transcriptom||express data||express profil||seri,1 2||2||2 9||1 differenti||bioinform 1||3 4||figur 2 http://www.genome.ad.jp/kegg/ tabl 1||5 6 7 8 2||studi||system 6 figur 3 2||data analysi 2 19||platform figur 2||6||3 seri||neoplasia 2004 6 1 15068665 figur,30005.5||28965.0||17178.5||16118.5||15556.5||14990.5||12965.8||12310.8||12015.0||11993.6||10483.75||10092.0||9074.0||8801.5||8255.5,0.0,0.0,0.0
44,Osteoporos_Int-3-1-1915640.txt,vitamin||day||osteoporosi||osteocalcin||strength||total||dose||intak||group||non-osteoporot women||postmenopaus women||fractur risk||studi||clinic trial||fnw||femor neck width||age||clinic endpoint||treatment||women||menaquinon||bone||femor neck||dxa-bmd||bmc||placebo||synergist effect||year||result||bone loss,1||2 1||2||2 2||follow-up 1 2 1 2||1 5 1 1 6||2 2 2 intak||result 2 2||0.05 discuss 2 2 2||1 level||3||refer 1||method 2||2 year||2 38,31046.0||30005.5||28965.0||28965.0||24212.8||22515.2||21828.25||21336.667||17993.4||17126.0||17044.0||16864.5||16318.5||16110.5||15279.5,0.0,0.0,0.0
45,Arch_Orthop_Trauma_Surg-3-1-2092411.txt,hind limb||drill time||vivo studi||posit correl||insert time||long time||anim||base plate||tibia||osteocyt||studi||aim||femur||rabbit||time||surgeri||signific||absenc||insert forc||daili practic||bone||experi||drill||distanc||kirschner wire||result,1||2 2||2||3||refer 1||1 kon mosh 1 1 depart||2 mg||patient||3 fig. 3||4||studi||fig. 2 dot||netherland 2 depart||5||2 schuurman arnold,31046.0||28965.0||28965.0||17044.0||16864.5||15941.833||14904.5||13567.0||13021.333||12937.0||12015.0||11414.0||11205.0||10364.0||9683.333,0.0,0.0,0.06666666666666667
46,Virchows_Arch-3-1-1888720.txt,cancer||immunohistochemistri||clinic outcom||multivari analysi||icc||cholangiocarcinoma||liver cirrhosi||studi||antibodi demonstr||apoptosi||tumour cell||valu||express||surviv||neg control||patient||liver fluke infest||high homogen||cell||case||data||immunohistochem||seri,1||2||1 21 2||5 1||6 1||3||refer 1||2 analysi||IV 5 1||patient||4||49-201-7233378 hideo.baba@uk-essen.d 1 1 institut||cell||studi||400 fig. 2,31046.0||28965.0||21097.333||20705.0||20060.0||17044.0||16864.5||16826.0||13900.0||13567.0||12937.0||12707.4||12627.0||12015.0||11398.667,0.0,0.1,0.2
47,Eur_J_Epidemiol-4-1-2190784.txt,sexual risk behaviour||msm||sexual activ homosexu men||hsv transmiss||hsv-2||blood sampl||hiv||hsv-1||knot||associ||decreas||studi||western blot||time||increas||age||sexual partner||independ risk factor||partner||risk||hsv-infect||homosexu contact||risk factor||sexual behaviour||time trend||preval||amsterdam cohort studi||orogenit contact||year||men||calendar year||result,1||2||2 2||time 1 2 2||hsv-2. 2 2||3||type 1||refer 1||1 57||1 1987||1 0.01||lifetim 1||1 461||1 northern||1 615,31046.0||28965.0||28965.0||23229.25||19310.333||17044.0||16987.0||16864.5||16016.5||15948.0||15875.5||15585.0||15582.5||15572.5||15551.0,0.0,0.0,0.0
48,Qual_Life_Res-4-1-2248606.txt,gip-||na||resid||alpha||scale||correl||posit||intern consist||oqol||group||gd||cognit||research||neg||cognit group||neg affect||qualiti||life||question||pa||self-report||depress list||cognit test||depress complaint||item||valid||cognit impair||pgcm||nurs home||pilot studi,1||2||3||refer 1||1 tabl 1 descript||1 36||scale 1||1995 2||inter-relationship 3 2||patient||4||4 4||3 1 heyenda institut||studi||netherland 2 depart,31046.0||28965.0||17044.0||16864.5||16514.5||16384.5||16163.5||15814.5||15337.667||13567.0||12937.0||12937.0||12383.5||12015.0||11205.0,0.0,0.0,0.0
49,Diabetologia-3-1-1914300.txt,cerebrospin fluid||wml||magnet reson imag||sex||brain||effect||intracrani volum||grey matter||atrophi||white matter||larger wml volum||cerebr tissu||leukoaraiosi||associ||volum||type 2 diabet||diabet||studi||particip||control particip||age||analys||wml volum||women||white matter lesion||control||patient||white matter volum||total csf volum||csf||hypercholesterolaemia||segment||smaller volum,2||result 1 2 3||1 2 kappel||fig. 1||3||fig. 2||refer 1||type 2||2 diabet||1 demograph||2 diabet patient||2 volum||patient||20 20 1||4,28965.0||20783.75||20007.667||18011.0||17044.0||16970.5||16864.5||15946.5||15728.0||15622.5||15007.667||14967.0||13567.0||13293.333||12937.0,0.0,0.0,0.06666666666666667
50,Exp_Brain_Res-4-1-2335293.txt,shape||respons||differ||veloc||hand movement||slope||posit||basi||target||averag||order||refer||lumin||latenc||measur||attribut||movement||orient||attribut color||condit||particip||time||visual process||conspicu||chang||systemat differ||finger||subject||line||color||curv,1 1 1||2 2 1||2||respons 1 1 1 1||2 2 fig. 2||3||4 4 2 4||procedur 1||3 2 materi||1 pixel||4||4 4 4 4||31-20-5982572 j.smeets@fbw.vu.nl 2 1 depart||studi||conspicu 3 4 4 4 4,31046.0||29658.667||28965.0||25506.4||22967.75||17044.0||16944.0||16217.5||15898.0||15564.5||12937.0||12937.0||12501.4||12015.0||11469.0,0.0,0.0,0.0
51,Int_Ophthalmol-4-1-2359829.txt,antibiot||organ cultur||medium||bank||hypotherm storag||storag time||evalu||cornea||solut||techniqu||preserv techniqu||tissu||studi||addit||time||endothelium||donor||microbiolog safeti||mandatori||inspect||donor cornea||risk||eye bank||storag||method||corneoscler button,2||refer 1||2008 introduct 1 2 3||patient||4||studi||3 4 5 6 7||1 8 9 7 8||hypotherm storag 2 fig. 2 evalu||netherland 2 tissuebank||6||2005||2006||2004||2003,28965.0||16864.5||16078.8||13567.0||12937.0||12015.0||11283.2||11148.6||10950.5||10374.0||9074.0||8716.0||8371.0||8077.0||7651.0,0.0,0.1,0.06666666666666667
52,Pediatr_Nephrol-3-1-2100430.txt,valvular diseas||hypertens||transplant patient||chronic inflamm||inflamm||high rate||cardiac risk factor||calcif||cardiovascular diseas||death||high preval||abnorm||coronari arteri diseas||dialysi||gener popul||chronic hemodialysi||gener pediatr popul||cardiac morbid||process||cardiac arrest||studi||hyperphosphatemia||import observ||young adult||increas||author||diastol dysfunct||doqi||children||ckd||treatment||ischem heart diseas||cvd||patient||transplant||risk||lvh||renal transplant||anemia||stiff||arteri||esrd||dyslipidemia||data||chronic kidney diseas||mortal||adult||renal failur,1||2 2 42||1 year||3||refer 1||morbid 1 2 3 4 5||2 15||suppl 1||1-513-636-7407 mark.mitsnefes@cchmc.org 1 2 1 divis||2 preval||patient||4||cardiovascular diseas 1||studi||usa 2 divis,31046.0||19805.333||17151.0||17044.0||16864.5||16775.667||16771.0||15942.0||15223.0||14867.5||13567.0||12937.0||12269.0||12015.0||10380.667,0.0,0.0,0.13333333333333333
53,Behav_Genet-4-1-2226022.txt,famili member||model||differ||blood-injuri||genet||spous||herit||sex||effect||varianc||twin correl||factor||influenc||estim||twin||uniqu environment factor||ade model||herit estim||studi||particip||phobia||oldest age group||age||sampl||sibl||women||famili||sex differ||domin||individu||femal||broad-sens herit estim||result||data||fear||non-addit genet effect||assort mate,1||2||1 1 depart||10 1||11 1||2 7||result 2||threshold 2003 2 2||16 2||1 36||23 2||2 33||3 4||2 57||72 2,31046.0||28965.0||21528.667||19014.0||18048.5||17981.0||17522.5||16481.0||16458.0||16384.5||15976.5||15482.0||14990.5||14976.0||14898.5,0.0,0.0,0.0
54,Osteoporos_Int-3-1-1820756.txt,rate||roi||mass||periost expans rate||elderli men||distal radiu||osteoporosi||morpholog basi||spine||distal ulna||abmd||individu slope||area||follow-up||measur||periost expans||decreas||studi||cross-sect data||larg cohort||increas||areal bone miner densiti||bodi||age||hip||signific||baselin||bone||femor neck||bmc||chang||distal forearm||bone miner content||periost apposit||site||men||loss||prospect follow-up||age-rel appar net||bone loss,baselin 2 2 fig. 2||refer 1||1 comparison||bone loss 2 2||0.05 2||szulc@lyon.inserm.fr 1 2 delma||densiti 2||0.02 2||0.03 2||7 0.21 2||studi||investig cohort 1||0.005 NS 2||0.213 0.21 2||0.356 0.31 2,18512.8||16864.5||16349.0||15295.25||15168.0||15008.0||14830.0||14710.5||14707.0||12043.0||12015.0||11059.667||9948.667||9711.667||9709.333,0.0,0.0,0.06666666666666667
55,Breast_Cancer_Res_Treat-3-1-2096638.txt,sporad breast cancer||express||surviv||brca||hereditari invas breast cancer||prolifer||brca1||cell||case||immunohistochemistri||percentag||patient||section||fancd2||breast cancer,1||2||1 2 3||1 1 depart||23 2 2||3||refer 1||tabl 2||1 patient characterist||result 1 fig. 1 exampl||7 1 8||2 neu||patient||4||cell,31046.0||28965.0||25685.0||21528.667||20306.0||17044.0||16864.5||16290.5||15301.333||14778.8||14732.333||14515.0||13567.0||12937.0||12627.0,0.0,0.0,0.13333333333333333
56,Neurosurg_Rev-2-2-1705527.txt,occipit arteri||transoss arteri feeder||jugular bulb||transcondylar approach||davf||arteri feeder||intraoss davf||approach||hypogloss canal||pulsatil tinnitu||foramen magnum||surgeri||treatment||fistula||extens boni drill||obliter||patient||patholog vessel||posterior condylar emissari vein||complet obliter||dural arterioven fistula||pulsatil bruit||region||occipit condyl,1||2||case 1 1 1 fig. 1||1 1 depart||patient 2||case 2 2 2 fig. 2||2 5||1 year||refer 1||1 month||method patient 1||1 summari||1 bien||1 kappu||2 day,31046.0||28965.0||22055.5||21528.667||21266.0||20668.167||19664.5||17151.0||16864.5||16322.0||16095.0||15734.5||15524.0||15523.5||15449.0,0.0,0.0,0.0
57,Antonie_Van_Leeuwenhoek-4-1-2268727.txt,cold-act enzym||sclerotia||growth||malt extract agar||powder wood||temperatur||enzym||activ||natamycin||carrot||applic||hyalina vel fusca||mycelium,1||2||2 3||2 1 depart||3||4||studi||B. 1 stalper||1 mm diamet||1 wösten han||31-30-2513655 r.p.devries@uu.nl 1||2 F. psychrophila||6||3 3 F. psychrophila||2 F. psychrophila A.,31046.0||28965.0||23004.5||20835.0||17044.0||12937.0||12015.0||10798.667||10725.0||10407.0||10349.333||9984.333||9074.0||8769.0||8366.25,0.0,0.0,0.0
58,Clin_Oral_Investig-3-1-2099161.txt,restor treatment||high-cari popul||three-year surviv||oral health||art||materi||oper effect||effect||caviti||primari||evalu||cari||restor||teeth||analysi||dentist||signific differ||studi||cox regress analysi||failur||secondari cari||children||treatment||gross margin defect||perman molar||two-surfac restor||dental treatment||perman dentit||primari dentit||altern treatment strategi||dutch dentist||year||rate||basic oral health care||result,1||2||1 2 fig. 1||3||refer 1||E. 1||1 44||fill surfac 1 2 1 number||2 26||louwesweg 1||2 41||patient||H. A. 2 1 depart||4||studi,31046.0||28965.0||24008.25||17044.0||16864.5||16488.5||16195.5||15906.0||15786.5||15524.5||15253.5||13567.0||13541.2||12937.0||12015.0,0.0,0.0,0.06666666666666667
59,Matern_Child_Health_J-2-2-1592145.txt,disabl||pregnanc,1||2||3||refer 1||llc 2006 1 3 4 5||2 9 28 10.1300||2005||6 7 6||2004||8 6||7||10||2001||13 6 8 11||result,31046.0||28965.0||17044.0||16864.5||13343.5||9206.0||8716.0||8381.667||8077.0||7614.0||6997.0||6982.0||6313.0||6135.25||6080.0,0.0,0.0,0.0
60,J_Gastrointest_Surg-4-1-2231408.txt,lavag fluid||strain||allel type||sampl||specif type||perop lavag fluid||determin||genotyp||analysi||pud||strip||correl||ppu||studi||patient||popul||biopsi||result,1||2||1 4||vaca 1 2||3||refer 1||F. 1||1 ml||4 1 depart||2 frequenc||2 ml||1 spec 4||2 helicobact||8 2 10||patient,31046.0||28965.0||21991.5||20016.0||17044.0||16864.5||15993.0||15906.0||15492.333||14921.0||14865.5||14674.333||14502.0||14033.667||13567.0,0.0,0.0,0.06666666666666667
61,Sleep_Breath-4-1-2270921.txt,model||algorithm||reduct||titrat endpoint||mad||recoveri||outcom||apnea||osa||sleep apnea||clinic cut-off||rdi||mandibular advanc devic||devic||group||sleep medicin physician||correl analysi||dentist||measur||studi||time||cpap therapi||dental sleep medicin specialist||obstruct sleep apnea||upper airway||patient||linear regress||initi treatment option||oral applianc||valid||sleep disord breath||success treatment outcom||posttreat||data||small sampl size||level||sleep medicin||sleep||investig,1||2||2 fig. 2||3||18 1 fig. 1 patient||refer 1||2 correl||patient||3 fig. 3||studi||tabl 1 characterist||5||2 8 9 fig. 8||4 fig. 4||2 patricku john,31046.0||28965.0||20968.667||17044.0||16912.8||16864.5||15281.5||13567.0||13021.333||12015.0||11984.333||10364.0||10328.2||10283.333||9738.0,0.0,0.2,0.13333333333333333
62,Photosynth_Res-3-1-1769344.txt,photosynthesi||effici energi transfer||OG micel||IR spectra||aps-ito||electrod,2 R.||4||81-52-7355226 nango@nitech.ac.jp 1 1 depart||2 3 2004 fig. 4 dot||fig. 3||1 1998 1988 2000||6||2004||2003||2002||discuss 1 R. rubrum rp||2002 1995 2004 2004||2001||result||2000,15409.5||12937.0||12917.8||12050.0||11010.0||10553.5||9074.0||8077.0||7651.0||7057.0||6938.4||6468.75||6313.0||6080.0||5903.0,0.0,0.0,0.0
63,Matern_Child_Health_J-2-2-1592161.txt,intervent||risk reduct||ipc||outcom||commun outreach||program||month||initi home visit||gradi memori hospit||commun develop||pregnanc||concept||reproduct age||magnolia project||infant||follow-up||prenat care||birth||import||vlbw||particip||feto-inf mortal rate||success||reproduct health outcom||subcontractor||care||poor health||clinic servic||women||servic||birth outcom||activ||poor nutrit||preconcept||risk||pregnanc plan||commun||poor birth outcom||famili plan||manag||previou fetal||infant mortal||commun assess||northeast florida healthi start coalit||case manag||deliveri,1||2||3||type 1||refer 1||1 frequenc||date 1||1 million||2 week||3 4||llc 2006 introduct 1 2||patient||4||5||6,31046.0||28965.0||17044.0||16987.0||16864.5||15961.5||15701.0||15588.0||15100.0||14990.5||13995.8||13567.0||12937.0||10364.0||9074.0,0.0,0.0,0.0
64,Diabetologia-4-1-2270365.txt,case-control data||trio||hla||loci||effect||genotyp||joint effect||type 1 diabet||data||gene||supplementari materi||risk||interact||diseas||result||power,1||1 3||1 ctla4 1||result 2 3||tabl 1||2 3 9||3||refer 1||1 diabet||1 iii||1 jo27||E. 1 2 joner||2 rønningen||springer-verlag 2008 introduct 1 2 3||patient,31046.0||24045.0||20706.0||17363.0||17331.0||17133.667||17044.0||16864.5||16768.5||15856.5||15526.0||15486.5||14484.0||13666.333||13567.0,0.0,0.0,0.0
65,Liver_Int-1-_-2156150.txt,rate||respons||hbeag clearanc||intent||hbeag-posit patient||meta-analysi||combin||group||analysi||studi||addit||treatment safeti||primari efficaci measur||lamivudin||heterogen||treatment||monotherapi||patient||trial||quantit meta-analys||biochem respons||nonadult popul||interferon,1||2||2 NL 1||discuss 2 2||fig. 1||3||3 3 3||fig. 2||issu 1||4 1 depart||adult 2||definit 2||2 NL||patient||4,31046.0||28965.0||20051.667||19877.0||18011.0||17044.0||17044.0||16970.5||15848.0||15492.333||15183.0||14728.0||14554.5||13567.0||12937.0,0.0,0.0,0.06666666666666667
66,Histochem_Cell_Biol-4-1-2413111.txt,brb||TJ strand||cancer||paracellular pathway||toxin||inflamm||transmembran protein||mutant form||permeabl||factor||cell polar||barrier dysfunct||protein||evid||barrier||diseas||tight junction||increas||claudin||express||tight junction strand||molecular composit||observ||patient||diabet retinopathi||role||occludin||endotheli cell||tj||integr membran protein||ion select||cell||data||TJ assembl||breast cancer develop||function,2||3 2001 2 2||2006 2||3||1999 2||1 modul||2006 2006 2||claudin 2||2 2007 2002||patient||4||cell||studi||5||4 2002,28965.0||20321.75||18668.0||17044.0||16880.0||15924.5||15235.667||14502.0||14436.333||13567.0||12937.0||12627.0||12015.0||10364.0||9997.0,0.0,0.1,0.13333333333333333
67,Purinergic_Signal-3-4-2072915.txt,adenosin receptor subtyp||adenosin receptor||adenin deriv||affin||adenosin receptor antagonist||deriv||result,1||2||2 2||3 1||2 3 3||1 5||5 1||6 1 3||1 11||2 2 5 5 5||17 1 fig. 1||17 1||3||refer 1||26 1,31046.0||28965.0||28965.0||24045.0||21017.667||20705.0||20705.0||19054.667||18048.5||17804.4||17662.75||17314.5||17044.0||16864.5||16827.0,0.0,0.0,0.0
68,Int_J_Hematol-4-1-2330061.txt,increas||express||defect||stromal cell||cocultur||analysi||cell||anim experi||mice||cfc assay||gene||hematopoiet stem cell||microarray||cdna||hsc,1||2||3||refer 1||1 μg||1 primer||2 NM||4||4 cell||cell||20 13 2||81-29-8369144 miyoshi@brc.riken.jp 1 1 subteam||studi||5||1 hgf ccl2,31046.0||28965.0||17044.0||16864.5||15725.5||15633.5||14619.5||12937.0||12782.0||12627.0||12548.0||12419.2||12015.0||10364.0||10357.333,0.0,0.1,0.06666666666666667
69,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2190783.txt,ground||test condit||posit||implant result||devic||peak contact pressur||medial femor condyl||cartilag||flush implant||contour articular prosthet||implant||stanc posit||condit||studi||knee||full extens||test||articular cartilag defect||contact pressur||sensor||trial||prosthesi||data||osteochondr defect||experiment studi||specimen||articular compon||result,1||2||3 1||2 fig. 2||oper techniqu 2 2 2||3 1 fig. 3||1 year||3||refer 1||3 NS 1||4 NS 1||2 specimen||patient||3 skrbenski gobert 2 1 depart||4,31046.0||28965.0||24045.0||20968.667||17770.4||17527.5||17151.0||17044.0||16864.5||16253.0||14884.0||14608.0||13567.0||13259.167||12937.0,0.0,0.0,0.0
70,Breast_Cancer_Res_Treat-3-1-2096637.txt,calcul||domin mass||mass||underestim||magnet reson imag||detect||correl||non-mass-lik lesion||meta-analysi||addit lesion||high variabl||mri||breast||addit find||foci||studi||literatur||author||lesion||valu||sensit||surgic manag||lesion size||treatment||irregular||ultrasound||patient||size||convent imag||enhanc||chang||tumor||invas lobular carcinoma||dynam curv analysi||find||case||data||small studi||morpholog||seri||mammographi||ilc||result,1||2||2 2||2 2 3 1||1 2 2 0||2 2 1 0||2 2 2 0||1 patient||2 patient||1 denot 1||3 2 2 0||2 5||2 6||2 0 0 1||20 1,31046.0||28965.0||28965.0||26505.0||23767.25||23767.25||23247.0||22306.5||21266.0||20720.667||20266.75||19664.5||19019.5||18049.25||17731.5,0.0,0.0,0.0
71,Antonie_Van_Leeuwenhoek-3-1-2140096.txt,core region||speci||secondari metabol||conserv||dataset||complet genom sequenc||group||sco||sequenc||signal||analysi||protein||studi||present||dna||linear genom||array||gene||chromosom||strain||termin region||region||result,2||3||cell||studi||fig. 3||dna 1995 2||1 mM edta||2 standard deviat||3 S.||2 streptomyc coelicolor||1 streptomyc coelicolor genom||2003||effect||bold 2 S. coelicolor S.||cell divis,28965.0||17044.0||12627.0||12015.0||11010.0||10985.0||10504.333||10345.0||9853.0||9721.0||8081.0||7651.0||6956.0||6886.4||6453.0,0.2,0.1,0.06666666666666667
72,J_Biol_Inorg_Chem-4-1-2359827.txt,pattern||reson||quadrupol split||state||superreduc||line||epr||iii||site||activ||zero-field paramet||fe-protein||electron supplementari materi||citrat||cluster,1||2 2 1||2||2 3||2 fig. 2||5 2||0 1||3||refer 1||1 42||1 57||747 1||1 syn||2 45||2 41,31046.0||29658.667||28965.0||23004.5||20968.667||19664.5||18569.5||17044.0||16864.5||16266.0||16016.5||15543.0||15527.0||15300.0||15253.5,0.0,0.0,0.0
73,Eur_J_Appl_Physiol-3-1-2039775.txt,muscl fibr conduct veloc||veloc||effect||higher valu||posit||variabl||peak frequenc||shift||order||peak||ipl method||motor unit discharg||motor unit||lowest forc level||prolong test||lower||muscl||time||increas||present studi||task||dynam contract||load||upper arm-forearm||activ||declin||experi||mup||paramet||pv||sd-pv||forc||subject||lower valu||initi phase||dynam||skew||posit task||MU activ||within-subject standard deviat||mup frequenc||motor unit potenti||standard deviat||load torqu||level||prolong dynam test||rate||mvc,1||1 2||2 1||2||2 1 3||1 2005||1 2004||result 1||3||3 3||2 min||3 4||4||fig. 1 distribut||studi,31046.0||30005.5||30005.5||28965.0||25685.0||19881.0||19561.5||18563.0||17044.0||17044.0||15117.5||14990.5||12937.0||12528.333||12015.0,0.0,0.0,0.0
74,Diabetologia-3-1-1794136.txt,macrovascular diseas||full adjust||outcom||incomplet covari adjust||variabl||independ predictor||follow-up||type 2 diabet||annual assess||smbg||cardiac death||independ contribut||present studi||western australian data linkag system||baselin||patient||risk||end||community-bas cohort||all-caus mortal||year||rosso||result,1||2||2 patient||3||refer 1||model 2||type 2||mortal 1||patient||4 5 4||stroke model 1||retinopathi model 1||microalbuminuria model 1||neuropathi model 1||microangiopathi model 1,31046.0||28965.0||21266.0||17044.0||16864.5||16428.0||15946.5||15919.5||13567.0||12079.333||11777.667||11674.667||11671.333||11665.0||11652.0,0.0,0.1,0.06666666666666667
75,Evid_Based_Complement_Alternat_Med-4-4-2176145.txt,intervent||day||hypertens||effect||overweight||program||cardiovascular diseas||chronic diseas||review||session||high cholesterol||bodi weight||diabet||studi||health benefit||systol BP||articl||benefit||week||yoga||glucos||subject||weight||type||cholesterol||adult||glucos level||health condit,1||1 11||type 2||discuss fig. 1 figur 1||patient||studi||type 2 diabet||refer 1 jemal||hypertens type 2||studi result||case studi||2007||diabet studi||review studi||hypertens patient,31046.0||18048.5||15946.5||13994.0||13567.0||12015.0||11461.333||11244.0||10797.667||9047.5||7594.0||7287.0||7253.0||7132.5||7033.5,0.0,0.1,0.06666666666666667
76,Extremophiles-4-1-2175526.txt,thermoacidophil||intact polar lipid analysi||dcm layer||compound||analysi||fraction||core lipid||cell||coval bond||major peak||gdgt||glycerol dibiphytanyl glycerol tetraeth||group,1||2||2 2||2 2 3 4||2000 2||3||water 1||4||cell||fig. 1 candidatu||fig. 2 candidatu||netherland 2 depart||2 ml meoh||1 1988 1998 2004 aciduliprofundum||2006,31046.0||28965.0||28965.0||21977.75||17434.0||17044.0||16109.0||12937.0||12627.0||12009.667||11316.0||11205.0||9917.667||8879.4||8371.0,0.0,0.1,0.06666666666666667
77,Eur_J_Nucl_Med_Mol_Imaging-3-1-1998889.txt,reliabl indic||effect||residu tumour||rit||high radiat dose||locoregion rit||tumour||fet uptak||peak||clinic deterior||mri||ratio||analysi||tumour recurr||resect caviti||studi||addit||recurr||surviv time||criterion||highest uptak||blood-brain barrier||present studi||contrast||valu||initi surgeri||normal brain tissu||treatment||intracavitari radioimmunotherapi||malign glioma||baselin||fet||patient||post-therapeut phase||pet||uptak||radiat therapi||tumour-fre statu||sensit tool||threshold||serial fet pet||result,2||2 patient||3||refer 1||2 tatsch klau 1 1 depart||patient||studi||germani 2 depart||01 1 131||02 1 131||1 max max||03 1 131||00 1 131||02 1 188||03 1 188,28965.0||21266.0||17044.0||16864.5||15597.0||13567.0||12015.0||10717.333||10704.667||10682.333||10668.0||10664.0||10662.667||10608.333||10590.0,0.0,0.2,0.13333333333333333
78,Matern_Child_Health_J-2-2-1592246.txt,intervent||pregnanc outcom||effect||primari care||perinat outcom||pregnanc||behavior||matern mortal||unit state||state||infant||matern||prenat care||birth||american academi||evid||age||women||servic||risk||matern complic||preconcept care||primari care provid||profession organ||medicaid||deliveri||health,1||2||refer 1||2 depart||1 risk factor||4||15 1 16 2 17 74||studi||1 23 center||preconcept period 1||exhaust tabl 2||1 cordero josé||2002 fig. 2 percent||2005||3 march,31046.0||28965.0||16864.5||15729.5||12964.0||12937.0||12137.5||12015.0||11886.0||10959.667||10871.0||10353.0||10293.0||8716.0||8598.0,0.0,0.0,0.0
79,Biodegradation-3-1-2151777.txt,substrat||cultur||silica gel||substrat specif||fatti acid||depend||micro-organ||enzym||enzym assay||octylamin||growth||strain bert||activ||carbon||dodecylamin||nitrogen||cell-fre extract||long-chain alkylamin||oxid||oxygen consumpt||strain||alkylamin||cell suspens||ammonium||prepar||biodegrad pathway,1||1 2||1 2 2||2||2 2||1 fig. 1||1 protein||activ 1||3||1 agar||2 oxid||4||cell||studi||1 pseudomona 1992 1999,31046.0||30005.5||29658.667||28965.0||28965.0||22356.0||18667.0||18138.5||17044.0||15536.5||14814.5||12937.0||12627.0||12015.0||9425.25,0.0,0.0,0.0
80,Ann_Surg_Oncol-4-1-2277442.txt,microanatom locat||subcapsular locat||sentinel node||breast cancer||morphometri||ajcc||analysi||sn||invas breast cancer||studi||SN metastas||tumor deposit||breast cancer patient||SN involv||signific predictor||patient||featur||lymph node||tumor-posit axillari SN||itc||diamet||case||penetr depth||lymph node dissect,1||2||result 1 1 2 tabl 1||3||1 23||refer 1||tabl 2||1 90||21 1 11 2 tumor||patient||4||studi||netherland 2 depart||11 3||unknown 1 PR,31046.0||28965.0||21966.5||17044.0||17017.0||16864.5||16290.5||16168.0||14198.4||13567.0||12937.0||12015.0||11205.0||11047.5||10607.0,0.0,0.1,0.13333333333333333
81,Cell_Calcium-1-5-1885971.txt,cell membran||effect||recoveri||mobil||neuron||solut||depth||peak||transient||microelectrod||diffus coeffici||intracellular calcium||buffer||membran||time constant||respons time||casm||experi||size||steady-st level||appar paramet||diffus||tip||calcium||extrus||influx||cell||larg snail neuron||depolaris||result||sequestr,1||1 2||2||2 2||fig. 1 2||app 1 2||1 fig. 3||0 2||fig. 2 fig. 1||3||fig. 3 2||fig. 2||fig. 1 fig. 4 2||2 measur||Ca fig. 1 2,31046.0||30005.5||28965.0||28965.0||21662.333||20040.333||17688.667||17529.0||17490.75||17044.0||16995.0||16970.5||16580.0||16500.5||16299.75,0.0,0.0,0.0
82,Matern_Child_Health_J-2-2-1592151.txt,rate||respons||survey||practic||pregnanc||group||factor||carn||routin care||obstetrician-gynecologist||pcc||posit effect||questionnair||studi||import||folic acid||respons rate||routin exam||care||women||major||patient||issu||preconcept care||folic acid supplement||topic||physician||counsel,1||2 2||2||3||11 2||refer 1||pcc 2||2 6.83||patient||4||studi||tabl 2 percent||5||tabl 5 patient||6,31046.0||28965.0||28965.0||17044.0||17008.0||16864.5||14510.0||14485.0||13567.0||12937.0||12015.0||10918.333||10364.0||9182.333||9074.0,0.0,0.1,0.13333333333333333
83,Bioprocess_Biosyst_Eng-2-2-1705532.txt,rate||heat transfer||steril medium||degre||locat||fluid||effect||cooler||hex||alkalin||abil||side||lower flowrat||flow||steril inlet feed||inlet||hot medium||steam||pressur||outlet||media||process||volum||pressur drop||recycl||design||ferment||resid time||switch||pipe||point||air||loop||gap||valu||temperatur||continu steril||control||valv||media type||spiral heat exchang||util||cool hex||fluid densiti||media compon||heat treatment||system outlet||heat||non-steril side||steril||continu heat treatment||water||process side||acid||min,1 1||1||2 1||2||1 3||2 3||1 2 15||18 2 2||3||3 3||refer 1||2 5 5||1 2 15 67||1 comparison||1 min,31046.0||31046.0||30005.5||28965.0||24045.0||23004.5||21529.333||20619.667||17044.0||17044.0||16864.5||16564.333||16367.5||16349.0||16158.0,0.0,0.0,0.0
84,Histochem_Cell_Biol-4-1-2386527.txt,eukaryot cell||chromatin||nucleu||transcript||arp||form||actin||review||jockusch||protein||structur||non-muscl cell||muscl||cytoplasm||nucleocytoplasm traffick||myosin||activ||gene||role||cell||nuclear actin||larg famili||chromatin remodel||function,1||2||3||arp 1||49-7664-619948 bmj@tu-bs.d 2 1||cell||studi||cyclase-associ protein 2||cell biol fig. 2 2005 blue||germani 2 cell biolog group||3 show||studi protein||3 assembl||2003 2004||michael 1 jockusch brigitt,31046.0||28965.0||17044.0||15532.5||15003.25||12627.0||12015.0||11751.333||9967.5||9742.4||9642.5||9151.5||8666.5||7864.0||7798.5,0.0,0.1,0.06666666666666667
85,Apoptosis-4-1-2311383.txt,respons||nuclear accumul||alveolar type II cell||pka||egfr||camp||phosphoryl||protein||studi||import||sirna||apoptosi||increas||activ||creb||exposur||role||oxid||transcript factor||oxid stress||cell||result||creb activ||protein kinas,1||2 2 2 2 2 2||2||2 2||2 2 2 2||2 2 2 4 3||3 3 2 2||2008 2 2 2||result 2 2||2 2 2 2 16 17||experi 2 2||2 2 stimul||2 2 6 14||c10 cell 2 2||2 2 2 hydrogen peroxid,31046.0||28965.0||28965.0||28965.0||28965.0||23375.2||23004.5||22234.0||21336.667||20565.667||19984.667||19617.0||17825.25||17640.25||17425.6,0.0,0.0,0.0
86,Int_Arch_Occup_Environ_Health-3-1-1915645.txt,ancova||higher level||differ||passiv leisur||recoveri||home||weekend||hypothesi||variabl||gener questionnair||group||high-effort group||report mark||employe||activ leisur activ||measur||studi||particip||higher score||neg affect||time||qualiti||fatigu||workday||sampl||daili basi||hour||analys||activ||partner||experi||worker||associ professor||sleep complaint||diari studi||single-item report mark||support||effort||home activ||job||pleasur||level||respect||relationship||result,1||2||1 1 depart||3||1 fig. 1 overview||research question 1 2||2 df 2 df 2 df||2005 tabl 1||4||studi||31-23-5549377 madelon.vanhooff@tno.nl 1 2 geurt||research question 2||5||tabl 2 activ pattern||6,31046.0||28965.0||21528.667||17044.0||16828.25||16144.25||14557.0||14459.333||12937.0||12015.0||12005.6||11177.0||10364.0||9765.0||9074.0,0.0,0.1,0.06666666666666667
87,Sci_Eng_Ethics-4-1-2413106.txt,short-term||trade-off||addit risk||main object||reactor||plutonium||materi||framework||product||futur||ofc||nuclear wast||uranium||option||plant||fuel cycl||long-term radiolog risk||order||countri||sustain||natur uranium||recycl||fuel||prolifer||analysi||intergener justic||gener||justic||time||benefit||wast||futur gener||valu||iaea||reason||world||risk||present gener||open||period||radiotox||moral discuss||line||cfc||public||nuclear reactor||secur concern||safeti||nea||reprocess||energi||long-term benefit,1||2 2||2||1 5||3||refer 1||1 41 1 fig. 1 radiotox||2 justic||4||wast 6 41 1 fig. 2||netherland 2 faculti||5||futur gener 3 3||6||2005,31046.0||28965.0||28965.0||20705.0||17044.0||16864.5||16611.0||14519.0||12937.0||12622.667||10441.0||10364.0||9406.25||9074.0||8716.0,0.0,0.0,0.0
88,Behav_Genet-4-1-2257994.txt,differ||somat complaint||pi-r abbr||previou report||environment factor||parent||comparison||report||uniqu life event||behavior||pair||concord MZ pair||group||factor||sexual assault||concord||psychopatholog||twin||score||person||OC symptomatolog||concord high pair||alcohol||symptom||studi||genet similar||ocd||futur studi||age||genet factor||valu||life event||monozygot twin||life||anxious-depress||religi obsess||twin pair||discord||between-pair comparison||obsessive-compuls symptom||data||uniqu||OC twin pair||level||discord group,1||2||2005 1||fig. 1||3||2 test||2 diabet||2 drink||2 tabl 2 2002 wave||patient||4||studi||5||6||3 pair,31046.0||28965.0||19881.0||18011.0||17044.0||16085.5||15728.0||14598.0||13758.0||13567.0||12937.0||12015.0||10364.0||9074.0||8805.0,0.0,0.0,0.06666666666666667
89,Breast_Cancer_Res_Treat-3-1-2045691.txt,cup||effect||anastrozol||anastrozol user||comparison||report||breast cancer||group||onh||analysi||eye||studi||optic nerv head||disk margin||eye diseas||age||contour line||tamoxifen-induc effect||women||disk area||visual acuiti||regress line||astrocyt||subject||predict||hrt||data||tamoxifen||adjuv endocrin therapi||year||optic cup||result,1||2||3 1||2 3||2 4 4||2007 introduct 1 2||3||3 3||refer 1||1 fig. 1 graph||30 2||2 year||1 mg||0.242 2||0.210 2,31046.0||28965.0||24045.0||23004.5||18279.667||17149.0||17044.0||17044.0||16864.5||16794.5||16116.0||16110.5||15945.0||14487.0||14484.5,0.0,0.0,0.0
90,Pediatr_Nephrol-3-1-1766479.txt,adult patient||concentr||carnitin||report||administr||drug||iron||studi||increas||children||treatment||dosag||sever side effect||noncompli||periton dialysi||guidelin||pediatr periton dialysi patient||anemia||carnitin supplement||erythropoietin||iron prepar||adult,1||2||ipna 2003 1 2 3||refer 1||100 1||suppl 1||250 2||600 2||patient||4||studi||2 month 100||antibodi 2 3 37 38||3 mg||suppl 3,31046.0||28965.0||16955.2||16864.5||16641.0||15942.0||14620.5||14593.0||13567.0||12937.0||12015.0||10933.0||10141.8||8944.0||8941.0,0.0,0.0,0.06666666666666667
91,Behav_Genet-4-1-2226020.txt,model||genet||effect||sex||phenotyp correl||specif||correl||varianc||variabl||social interact effect||factor||influenc||missing||twin||score||instrument||measur||cbcl||statist analys||matern rate||fit||zygos||clinic diagnos||dsm-iv interview||dsm||age 12||age||present studi||attent problem||children||test||adhd||cprs-r||item||problem||find||statist power||data||present paper||rate||environment influenc||result,1||2||2001 2 2 2 2 2||3 2||1 year||3||1 month||d.i.boomsma@psy.vu.nl 1 1 depart||70 1||66 1||72 1||68 1||77 1||74 1||1 edn,31046.0||28965.0||25189.667||23004.5||17151.0||17044.0||16322.0||16146.75||16096.5||15955.0||15939.0||15923.0||15902.5||15874.5||15641.0,0.0,0.0,0.0
92,Intensive_Care_Med-3-1-2092441.txt,acut lung injuri||mechan||children||criteria||control||cd||high morbid||acut respiratori distress syndrom||incid||mortal||ali||syndrom||studi||admiss||patient||unit||ard||diseas||result,1||2||result 2||refer 1||R. 2||patient||studi||1 baselin patient characterist||netherland 2 depart||1 van woensel||5||congenit heart diseas 1||2005||sepsi 3||B. 1 van rijn,31046.0||28965.0||17522.5||16864.5||15409.5||13567.0||12015.0||11649.25||11205.0||10841.0||10364.0||9563.5||8716.0||8668.5||8470.0,0.0,0.2,0.13333333333333333
93,Arthritis_Res_Ther-5-3-165040.txt,major role||cartilag end-plat||spinal canal||exercis||mechan||pain||nucleu||low||annulu||vertebr bodi||intervertebr disc||matrix||disc||factor||tissu||studi||degener||connect tissu||growth||articular cartilag||gene||patient||proteoglycan||therapi||back pain||collagen||disc degener||nerv||cell||nutrient||nutrient suppli||human||type||loss,1||1 gene||2 year||2 1 univers laboratori||conclus 1 133 1||figur 2||3 4||patient||cell||tabl 1 comparison||studi||tabl figur 1||1 45 46||disc 18 2||disc herniat 1,31046.0||17920.0||16110.5||16102.5||15905.75||15083.0||14990.5||13567.0||12627.0||12104.667||12015.0||11954.333||11335.333||11038.333||10433.333,0.0,0.2,0.2
94,Semin_Immunopathol-3-1-2071951.txt,fluid phase||model||mpgn type II||mbl||bind||cell membran||regul||mpgn||membran attack complex||factor||renal function||therapeut intervent||deposit||format||damag||protein||antibodi||complement||diseas||defici||mutat||activ||patient||membranoprolif glomerulonephr||risk||hemolyt urem syndrom||complex||immun complex||cell||kidney||result||mice||ligand||level||glomerulonephr||inhibit||renal damag,2 2||refer 1||3 4||springer-verlag 2007 introduct 1 2||patient||1 fig. 1 schemat overview||cell||studi||5 7||2006||renal patient||patient manag||affect patient||solubl recombin complement receptor 1||cell membran,28965.0||16864.5||14990.5||14040.0||13567.0||13472.8||12627.0||12015.0||8680.5||8371.0||7708.0||7601.5||7364.0||7100.2||6961.5,0.2,0.2,0.2
95,Appl_Microbiol_Biotechnol-3-1-1914249.txt,substrat||reactor||specif||genet divers||ethanol||sulfate-reduc bacteria||dna||sulfat||gram||electron donor||strain||oligonucleotid probe||full-scal sulfidogen bioreactor||acet||cell||micro-divers||presenc||srb||electron acceptor||singl energi sourc||wastewat,1||2||1 2 fig. 1||1 2 2 1985||1 16||3||1 3 1992||1 μm||2 μm||2 2 1959 1962||4||cell||studi||1 1998 1999 2005 2006||netherland 2 laboratori,31046.0||28965.0||24008.25||22438.25||17498.5||17044.0||16599.333||15689.0||14648.5||14525.25||12937.0||12627.0||12015.0||11432.8||10621.0,0.0,0.0,0.06666666666666667
96,Mcgill_J_Med-11-1-2322923.txt,interstiti nephriti||renal failur||intravascular haemolysi||atn||hypersensit reaction||wasp venom||acut interstiti nephriti||case||rhabdomyolysi||patient||nepal||reaction||acut renal failur||report||direct nephrotox effect||haemolysi||wasp envenom||wasp sting||direct nephrotox||acut tubular necrosi,1||2||4 1||4 2||1 2 1 2 blood count||14 1||8 2||case 1 tabl 1||case 2 fig. 1 tabl 1||3||1 rejsman||patient||studi||4 5 6||5,31046.0||28965.0||21991.5||20951.0||20393.0||17671.5||17559.5||17220.25||17137.0||17044.0||15523.5||13567.0||12015.0||10791.667||10364.0,0.0,0.0,0.06666666666666667
97,Ann_Biomed_Eng-2-2-1705526.txt,model||speci||veloc||wss pattern||effect||pulsatil||tempor variat||flow||ldl||distal region||oxygen||speci transport||coronari arteri||factor||wss||wall motion||medial region||instantan variat||variat||gradual increas||dynam model||mass transport||straight tube model||studi||curvatur||import role||time||futur studi||pulsatil flow effect||flux||wall||motion||dynam curvatur effect||outer||mass transport pattern||arteri||oxygen transport||lad||region||ldl transport||result||coronari arteri motion,1||2||5 2 1||refer 1||15 2 3||1 27||p.g.walker@leeds.ac.uk 1 1 school||1 fruend||1 4 32||9 15 16 2 figur 1||8 2 39||studi||κ figur 2||method comput model 1||5 6,31046.0||28965.0||23458.333||16864.5||16862.0||16729.0||15696.25||15523.5||15391.667||12522.0||12226.333||12015.0||10090.667||9922.25||9719.0,0.0,0.0,0.06666666666666667
98,J_Med_Internet_Res-8-2-1550696.txt,respond||journal articl||actual perform||inform age student||websit||behavior||studi particip||electron health inform||area||health inform compet||research librari||health inform||nutrit supplement||health profession||score||measur||idea||understand plagiar||studi||procedur knowledg||self-report skill level||research skill||particip||plagiar||consum health inform||articl||higher educ||health educ||question||import marker||librarian||internet||sourc||item||consum||rrsa||secondari sourc||search||skill||inform||health topic||case||one-keyword search||data||assess||level||multipl choic||compet||health||document,1||2||studi 1 2 3||tabl 1||3||tabl 2||1 bradley||4||tabl 1 search||studi||1 book refer||health inform tabl 1||multimedia appendix 1||5||1 989 774 2888 ivani1sv@cmich.edu 1,31046.0||28965.0||22267.5||17331.0||17044.0||16290.5||15556.0||12937.0||12149.333||12015.0||11276.0||10925.75||10441.333||10364.0||10361.667,0.0,0.1,0.06666666666666667
99,Purinergic_Signal-3-4-2072918.txt,antipeptid antisera||entpd||antisera||express||member||analys||purinerg||genet immun||ecto-enzym||western-blot analys||cell||immunoprecipit analys||famili||protein||immun||transfect||monoclon antibodi||antibodi||result||purinoceptor,1||2||refer 1||1 μg||1:1600 1||1:2000 1||1:800 1||acknowledg 2 3 4||2007 1 4 7||4||cell||studi||tabl 1 titr||6 5 cell||5,31046.0||28965.0||16864.5||15725.5||15528.0||15527.5||15527.0||14913.75||14566.75||12937.0||12627.0||12015.0||11555.333||10688.333||10364.0,0.0,0.0,0.06666666666666667
100,Sleep_Breath-3-1-1794626.txt,overbit||reduct||random||effect||outcom||apnea||efficaci||mandibular advanc||sleep apnea||benefici respons||group||polysomnographi||loud||ess||signific improv||follow-up||measur||common featur||airway||upper airway resist syndrom||signific differ||sleep studi||success rate||studi||clinic trial||symptom||present||continu posit airway pressur||success||respons rate||author||cpap||treatment||bed partner||upper airway||patient||abnorm anatomi||oral applianc||daytim function||inform||data||clinic||assess||rate||applianc||sleep||investig||result||subject percept,1||2||5 2||1 year||3||refer 1||1 exampl||applianc 1||1 maa||2 form||part 2||2 101||headach 2||patient||4,31046.0||28965.0||19664.5||17151.0||17044.0||16864.5||15896.0||15642.5||15619.5||15038.5||15018.0||14824.0||14664.5||13567.0||12937.0,0.0,0.0,0.06666666666666667
101,Neuropharmacology-2-1-2194164.txt,excitatori postsynapt current||glutamaterg synaps||glutamaterg transmiss||slice||hippocampu||effect||transmitt releas||glutam||high dose||data||concentr||experi||channel||cannabinoid||endocannabinoid||applic||solut,1||1 1||1 1 2||1 2||2||abstract 1 1 1 1 1||2002 1 1 2||1 1 fig. 2||2006 1 1||1 1 1 hájo||2002 1 1||2006 1 2||4 discuss 1 1 1 2||2003 1 2||2007 1 2,31046.0||31046.0||30352.333||30005.5||28965.0||25961.167||24528.5||24008.25||23487.667||23292.75||23049.667||22794.0||22790.167||22554.0||22432.667,0.0,0.0,0.0
102,Anal_Bioanal_Chem-4-1-2324128.txt,column||hydrophil compound||sampl||retent||chromatographi||scx||stationari phase||proteom||analysi||neg charg||post-transl modif||proteom level||hydrophil interact liquid chromatographi||larg rang||separ||enrich||hilic,2||3||refer 1||11 2 11 fig. 2 11||studi||proteom 2002 2 3 10 10.1002||3 peptid||commun 2003 308 1 11 10.1016||2003 2 43 50 10.1021||4 23 4 23||2003||2007||cancer||2001||biochem 1993 218 1 27 10.1111,28965.0||17044.0||16864.5||13009.833||12015.0||10341.5||8837.0||8561.333||8299.6||7962.5||7651.0||7287.0||7076.0||6313.0||6289.5,0.0,0.0,0.0
103,Qual_Life_Res-3-1-2039846.txt,respons||hear aid fit||differ||respond||effect||hear loss||hui||hrqol||practic||popul||aid fit||follow-up visit||group||hear complaint||hear||dutch||person||score||follow-up||measur||cost||questionnair||econom analys||attribut||non-applic||studi||distinct group||test||patient||quality-adjust life year||icer||util||chang||util score||aid user||qali||visit||standard deviat||result||dutch tariff||life score||health,1||2||3||3 3 3||refer 1||0.01 1 2 fig. 1 scatterplot||discuss 1 3 4||l.anteunis@skno.azm.nl 2 1 depart||agreement 2 3||31-88-4455667 janneke.grutters@maastro.nl 1 2 3||patient||4||2005 3||tabl 1 comparison||studi,31046.0||28965.0||17044.0||17044.0||16864.5||16123.833||15682.0||15626.5||15424.333||15411.4||13567.0||12937.0||12880.0||12104.667||12015.0,0.0,0.0,0.13333333333333333
104,J_Biomol_NMR-4-1-2268728.txt,residu||structur restraint||protein data bank||nmr data||nmr structur,3||1 berman helen||2005||2007||protein||1-608-2623759 markley@nmrfam.wisc.edu 1 ulrich eldon||structur 2005||protein research||data||group||1998||model||NJ 08854-8087 usa 3 msd||protein data bank||univers,17044.0||10362.667||8716.0||7287.0||6288.0||6218.2||5625.5||4998.0||4969.0||4875.0||4236.0||3891.0||3869.8||3796.667||3657.0,0.0,0.0,0.06666666666666667
105,Qual_Life_Res-3-1-2062490.txt,erectil dysfunct||refer point||cancer||differ||respond||effect||primari treatment||month||vignett||origin score||score||measur||studi||then-test score||qol||treatment||prostat cancer||local prostat cancer||patient||chang||method||result||respons shift||assess||diagnosi||men||then-test||health,1||1 1 2 2||2||2 4||result 1||3 3||3||refer 1||14 2||2007 introduct 1 2 3 4||1 month||patient||4||studi||1 month post-diagnosi,31046.0||30005.5||28965.0||20951.0||18563.0||17044.0||17044.0||16864.5||16631.0||16429.5||16322.0||13567.0||12937.0||12015.0||10886.0,0.0,0.0,0.13333333333333333
106,Appl_Microbiol_Biotechnol-4-1-2266784.txt,industri product||amino acid||jar fermentor||kikuchi||cultur||signal peptid||heterolog protein||industri scale protein product||secret||product,1||fig. 2||2 C.||2 vvm||method 3||2005||2 C. glutamicum C.||2002||effect||4 5 B. roseum||result||9||data||6 7 M. ammoniaphilum||protein analysi 1970 2002 1997 2002,31046.0||16970.5||15490.0||14484.5||10358.0||8716.0||8268.75||7057.0||6956.0||6161.75||6080.0||5392.0||4969.0||4955.5||4796.5,0.0,0.0,0.0
107,Dysphagia-3-1-1914227.txt,healthi volunt||pharyng residu||differ||deglutit disord||percentag||viscos||solut||refer||analysi||xanthan||bolu||studi||pharyng||head||data collect||increas||temperatur||oral caviti||volunt||amount||substanc||data||marker||water,1||2||2 2||3||llc 2007 1 2||refer 1||MD 2 1 depart||1 millisievert||2 male||patient||3 4 5||6 Pt 1||3 4 14 11 1 12||studi||netherland 2 depart,31046.0||28965.0||28965.0||17044.0||16899.25||16864.5||15820.25||15524.0||14971.5||13567.0||13448.333||13435.667||12704.5||12015.0||11205.0,0.0,0.0,0.06666666666666667
108,Appl_Microbiol_Biotechnol-3-1-2039825.txt,yeast||product||antigen||function antibodi devoid||molecular evolut||egfr||protein||addit||antibodi||light chain||VL domain||antibodi fragment||express||high stabil||advantag||human vh||antigen bind||single-domain||convent antibodi||method||effici||vhh||applic,1||2||3||J. 2 1 institut||1 advantag||2 exampl||springer-verlag 2007 introduct 1 fig. 1||2006||2002 2006 2006 2006||2004 2006 2006 2002||2002 2006 2004 2006||2006 2004 2007 2007 2006 2006||netherland 2 ablynx n.v.||2006 cancer||2002,31046.0||28965.0||17044.0||16310.75||15665.5||14855.5||12876.167||8371.0||8042.5||7969.0||7969.0||7960.667||7781.0||7723.5||7057.0,0.0,0.0,0.0
109,Nutr_J-2-_-293472.txt,intervent||serum lipid||mixtur||effect||meta-analysi||form||serum TC||daidzein||tablet||serum cholesterol||lipid||studi||isoflavon||soy||treatment||phytoestrogen||soy protein||diet||low densiti lipoprotein cholesterol||subject||trial||cholesterol||genistein||isp,1||2||1 1 2 2 6 31||1 trial||2 trial||studi characterist 1||4||women 2002 2||2 yutakfu1@yahoo.com.hk 1 medic centr||studi||3 effect||tabl 1 characterist||figur 1 trial||femal 2 20||2 subgroup analysi,31046.0||28965.0||21874.833||16639.0||15598.5||14784.0||12937.0||12863.0||12799.2||12015.0||12000.0||11984.333||11493.0||11427.667||11288.333,0.0,0.1,0.06666666666666667
110,Neuroradiology-4-1-2275774.txt,cta||ica||brain parenchyma||vessel||contrast medium||CT angiogram||intracrani stent||follow-up||volum||volum dataset||inject||cerebrovascular diseas||imag||invas techniqu||rotat acquisit||patient||act||intraven administr||stent lumen||examin||stent,1||2 2 10 fig. 2||3||refer 1||case 2 3 3 fig. 3||patient||4 4 fig. 4||germani 2 depart||studi result||2007||10||patient complianc||7 8||phantom studi||12,31046.0||19770.6||17044.0||16864.5||14707.667||13567.0||10946.75||10717.333||9047.5||7287.0||6982.0||6901.0||6575.5||6025.5||5852.0,0.0,0.1,0.06666666666666667
111,Eur_Radiol-3-1-2077917.txt,dose-level||stool soften||sixty-on patient||oral contrast agent||moder sensit||prefer||limit bowel prepar||origin raw data||rectum||extens cleans||simul||ctc||repeat CC||contrast||fecal tag||sensit||observ||polyp||colonoscopi||experi||patient||bowel prepar||week||imag qualiti||larg false-posit lesion||dose reduct||segment||stool||CT colonographi||low-dos protocol||result,1||2||1 2 1 2 analysi||2 3 fig. 2||result 2||3||refer 1||1 scale||definit 1||2 day||patient questionnair 1||2 week||protocol 2||2 morpholog||2 colonoscopi,31046.0||28965.0||24941.8||19987.5||17522.5||17044.0||16864.5||16163.5||15768.5||15449.0||15149.333||15100.0||14831.0||14719.0||14524.0,0.0,0.0,0.0
112,Calcif_Tissue_Int-3-1-1914289.txt,igfbp-2 mrna express||brain||endost surfac||probe||shaft||singl period||lamella||group||bone marrow cell||tibia||bone format||studi||increas||mechan load||express||load||control||hybrid||bone||endocort osteocyt||periosteum||section||sham||four-point bend system||rat tibia||endost side||cell||rat||sham-load tibia,1||2||1 1 depart||1 7||1 2 7 25||3||fig. 2||refer 1||1 unit||vivo 1||1 blankenstein||n.bravenboer@vumc.nl 1 2 holzmann||chapter 2||4||cell,31046.0||28965.0||21528.667||19021.5||17576.75||17044.0||16970.5||16864.5||16150.0||15941.0||15526.5||15004.0||14516.0||12937.0||12627.0,0.0,0.0,0.06666666666666667
113,Plant_Cell_Rep-4-1-2413084.txt,respons||metabol pathway||rt-pcr||secondari metabol||regul||anthocyanin biosynthesi||plant||factor||red color||accumul||analysi||lettuc plant||studi||myb transcript factor||lettuc||anthocyanin accumul||express||red pigment||gene||structur protein||transcript factor||repressor||atmyb||leaf color||anthocyanin||result,1||2||4||studi||1 A. tumefacien||2004||cell biolog||effect||441-707 south korea 2 depart||result||2006 arabidopsi 2001 2004||plant cell rep plant cell report||4 fig. 4 arabidopsi myb atmyb60||activ||treatment,31046.0||28965.0||12937.0||12015.0||11535.333||8077.0||7089.5||6956.0||6351.0||6080.0||5835.0||5582.667||5247.333||5231.0||5012.0,0.2,0.2,0.13333333333333333
114,Ann_Biomed_Eng-4-1-2239251.txt,model||leg||pain||vertic sij shear||gluteu mediu||maximum muscl stress||trunk load||ligament||biomechan analysi||pelvic floor||pelvic floor muscl||pelvi||muscl||sij stabil||sacroiliac joint||sij||increas||direct||simul||present studi||slouch||load||simul model||activ||trunk||bone||postur||sij compress||spinal load||coxal bone||sij compress forc||result||shear load||pelvic region||sacrum||pelvic muscl||joint,1 1||1||2||2 2||result 2 2||refer 1||biomechan model equilibrium 1 1 1||part 1||part 2||2 upper||2 summari||2 ventral||2 ilium||http://www.primalpictures.com 2||1 3 M. adductor,31046.0||31046.0||28965.0||28965.0||21336.667||16864.5||16194.167||16058.5||15018.0||14759.5||14694.0||14526.0||14483.5||14483.5||12962.5,0.0,0.0,0.0
115,Ann_Hematol-4-1-2413090.txt,genet materi||monosomi 7||median surviv||monosomi||karyotyp||month||deleteri cytogenet alter||profound||cytogenet find||therapeut strategi||prognost relev||group||delet||clinic manag||multicentr studi||studi||complex abnorm||patient||gene||prognosi||anomali||cytogenet||md||cell||case||ipss||result,1||2 1||2||1 2 3 1 1||1 24 2 1 fig. 2||3 1 15 fig. 1||0 2||3 1 fig. 3||3||refer 1||1 incid||1 3 10 11||2 cytogenet||patient||4,31046.0||30005.5||28965.0||27829.4||21379.0||17737.8||17529.0||17527.5||17044.0||16864.5||15906.5||15030.75||14546.0||13567.0||12937.0,0.0,0.0,0.06666666666666667
116,Graefes_Arch_Clin_Exp_Ophthalmol-3-1-2082068.txt,posit correl||obstruct sleep apnea syndrom||eog channel||intracrani pressur increas||high preval||RI increas||group||factor||polysomnographi||studi||optic nerv perfus defect||nerv fiber layer thick||ocular blood flow||glaucoma||sever||ophthalm arteri||control||visual field defect||patient||sever osa group||iop||risk factor||apnea-hypopnea index||oari||crari||ahi||preval||systol blood veloc||result,1||2||3||fig. 2||refer 1||1 comparison||4 fig. 1||patient||4||studi||fig. 3||5||11 patient||fig. 4||4 glaucoma patient,31046.0||28965.0||17044.0||16970.5||16864.5||16349.0||16319.667||13567.0||12937.0||12015.0||11010.0||10364.0||9309.0||8956.5||8857.333,0.0,0.2,0.13333333333333333
117,J_Med_Internet_Res-5-4-1550575.txt,posit rank||page||link densiti||teenag||teen||number||web||direct relev||correl||posit||simpl web search||search effici||health inform||web-sit characterist checklist||popular search site||studi||characterist||web site||googl||internet||link||user||search engin||search rank||search||site||presenc||smoke cessat||result||search term,1||2||1 4 2 1 0||1 6||3 1 5 3 4||3||1 site||1 click||1 rater||1 o'neil||2 characterist||2 click||2 rater||1 2 0 0 0 resourc||4,31046.0||28965.0||22017.4||20060.0||17687.0||17044.0||16558.0||15544.0||15536.0||15527.0||15128.0||14503.5||14495.5||13116.667||12937.0,0.0,0.0,0.0
118,Clin_Rev_Allergy_Immunol-4-1-2243253.txt,rheumatoid factor||arthriti||sensit||autoantibodi||specif||data||test||patient||studi||ccp2 test||antibodi||RA patient||diseas,1||RA 1 2 3 4 5||refer 1||patient||studi||predict potenti 2||6||2006||4 year||2007||RA patient||2002||scleroderma patient||RA patient group||10 7 7 11 11,31046.0||16884.333||16864.5||13567.0||12015.0||10723.0||9074.0||8371.0||8096.5||7287.0||7258.5||7057.0||6786.0||6464.0||6215.6,0.4,0.2,0.2
119,Pediatr_Nephrol-4-1-2214826.txt,rtx||clinic respons||dose||lupu nephriti||renal function||hemodialysi||sle||sever sle||proteinuria||antibodi||clinic remiss||rituximab||age||sever immunosuppress||children||treatment||multipl cours||patient||therapi||clinic diseas activ||system lupu erythematosu||rituximab therapi||year,1||2||0.01 1 2 2||1 18||1 year||3||refer 1||re-popul 1 fig. 1||1 month||clinic protocol 2 2||rtx 1||2 month||2 week||0.01 2||2 NS,31046.0||28965.0||22420.25||17487.5||17151.0||17044.0||16864.5||16767.5||16322.0||15871.25||15538.0||15281.5||15100.0||14835.0||14817.0,0.0,0.0,0.0
120,Qual_Life_Res-4-1-2238782.txt,respons||model||locat||scale||monoton homogen model||unidimension scale||hrqol||msp||whoqol-bref||grm||exampl||nonparametr irt analysi||estim||research||measur||analysi||questionnair||polytom item||domain||social limit||point||parametr model||item respons theori||grade respons model||monoton||content domain||valu||patient group||mokken model||psycholog well-b||latent variabl||paramet||patient||psycholog||mhm||isrf||dimension||item||method||social health||nonparametr monoton homogen model||case||lower level||data analysi||level||result,1||1 2||2||24 2 1 1 fig. 1||3||refer 1||2 18||tabl 2||2 6 6||1 1.4||29 2||1 δ||1 π||4 1 depart||scale 2,31046.0||30005.5||28965.0||21725.833||17044.0||16864.5||16447.0||16290.5||15704.333||15682.5||15617.5||15592.0||15537.5||15492.333||15123.0,0.0,0.0,0.0
121,J_Digit_Imaging-3-1-2039858.txt,detail||scp emul||net librari||tool||framework||dicom file||dicom file viewer||dataset||project||core||philip||exampl||modal||session||file||dicom||stand-alon tool||associ||script||attribut||import||addit||pac||scu||sop class||scp||imag||emul||valu||system||class definit file||messag||send||test||servic class user||standard||view||dvt||storag||valid||method||sut||command line version||definit file||applic||result,1||2||1 fig 1||2 fig 2||type 1||refer 1||patient||4||type 1 attribut||3 4 5 fig 3||type 2 attribut||zero-length type 2||5||medicin 2007 introduct 1||1-262-369-0900 pnagy@umm.edu 2 1 agfa healthcar,31046.0||28965.0||20721.667||19334.333||16987.0||16864.5||13567.0||12937.0||11510.333||11492.4||10816.667||10631.667||10364.0||10289.75||10035.833,0.0,0.0,0.0
122,Eur_J_Clin_Pharmacol-3-1-1779627.txt,respons||databas||antibiot||system antibiot||number||product||parent||medic||categori||avon longitudin studi||drug||questionnair||medicin||studi||babi||medicin product||age||paracetamol||cohort||children||tick box respons option||data||alspac||health,1||1 2||2||1 4||2 5||result 1||1 9||2 12||1 17||3||refer 1||1 39||1 64||1 170||2 month,31046.0||30005.5||28965.0||21991.5||19664.5||18563.0||18219.0||17408.5||17314.5||17044.0||16864.5||16303.0||15972.0||15646.0||15281.5,0.0,0.0,0.0
123,Childs_Nerv_Syst-4-1-2367395.txt,multipl shunt revis||report||mtv||slit ventricl||shunt||ventricl||small supraorbit craniotomi||supraorbit approach||altern||treatment||tv||patient||hydrocephalu||etv||small ventricl||routin procedur||procedur||case||headach||lamina terminali||supraorbit craniotomi,1||2||2 3||1 year||case 1||refer 1||patient||3 fig. 3||eyebrow incis case 2 2||10 1 23 25||3 day||7 5||527 patient||patient shunt||result,31046.0||28965.0||23004.5||17151.0||17109.5||16864.5||13567.0||13021.333||12240.2||11078.75||9488.5||8680.5||6841.0||6819.0||6080.0,0.0,0.1,0.06666666666666667
124,Matern_Child_Health_J-4-1-2335294.txt,home||wast site||lead||pregnanc||exampl||fish||reproduct risk||chemic||toxic||hobbi||medicin||women||exposur||patient||worker||diet||reproduct toxic||workplac||occup||commun||food||clinician||site||water||environment exposur||health,1||1 2||2||4 1 5||3||fig. 2||refer 1||qualitative’ 1||patient||4||2001 120 1||12 13 fig. 1||1992 3||6||2005,31046.0||30005.5||28965.0||18115.667||17044.0||16970.5||16864.5||15523.5||13567.0||12937.0||12625.333||11534.0||9376.0||9074.0||8716.0,0.0,0.1,0.06666666666666667
125,J_Hum_Genet-2-2-1705471.txt,snp||logist regress analysi||linkag disequilibrium||associ||studi||low statist power||polymorph||sampl||genom variant||control||gene||dopamin D4 receptor||haplotyp analysi||upstream region||data||re-sequenc||variant||schizophrenia||synergist interact||region||result||allel,1||1 1||2||2 2||2 2 fig. 2 drd4||626065 1||patient||1 fig. 1 drd4 box||4||result drd4 1||type 1 diabet||studi||81-48-4677462 takeo@brain.riken.jp 1 6 1 laboratori||1 drd4 marker||3 variant,31046.0||31046.0||28965.0||28965.0||18379.2||15523.5||13567.0||13545.4||12937.0||12383.667||12155.0||12015.0||11985.0||10579.0||8669.5,0.0,0.0,0.06666666666666667
126,Osteoporos_Int-4-1-2267486.txt,intervent||lumbar spine||tool||clinic practic||japan||fractur probabl||previou fractur||clinic risk factor||order||probabl||therapeut intervent||gradient||osteoporosis-rel fractur||equival||present studi||fractur||age||women||femor neck||risk||bone miner densiti||fractur risk assess tool||bmd||data||femor neck bmd||threshold||intervent threshold||hip fractur||intern refer||fractur outcom,fractur 1 fig. 1||refer 1||2 17||suppl 1||femor neck bmd 1 2 1||SD 2||2 orimo||3 4 5 3 6||11 2 16||studi||A. 6 1 depart||1 predict abil||japan 2 depart||fujiwara@rerf.or.jp 1 nakamura||5,17064.0||16864.5||16274.0||15942.0||15363.5||15124.0||14487.0||13292.6||12655.667||12015.0||11531.5||10993.333||10645.333||10390.333||10364.0,0.0,0.0,0.0
127,Pediatr_Radiol-3-1-1891641.txt,veloc||ureter jet||durat||function sphincter||vuj||activ sphincter||group||physiolog condit||sphincter muscl||initi slope||physiolog||signific differ||dual compon||studi||pattern||bladder||age||children||vur||neural compon||observ||normal subject||vesicoureter junction||uti||pregnant women||healthi uret||chang||action||gener anaesthesia||subject||uret||doppler||jet,1||1 2||2||1 2 3||11 1 fig. 1||3||refer 1||squar 1||break 2||9 2 10||patient||3 fig. 3||4||4 4 5||studi,31046.0||30005.5||28965.0||25685.0||18029.75||17044.0||16864.5||15638.0||14521.0||13779.667||13567.0||13021.333||12937.0||12079.333||12015.0,0.0,0.0,0.06666666666666667
128,J_Gastrointest_Surg-3-1-1852382.txt,surgeri||complic||procedur||case||vulner patient||clinic present||patient||tetanu||diffus muscl spasm||gastrointestin procedur,1||2||1 17 1 18||refer 1||hemorrhoid 4 result 1 2||1 jerk||2 month||2 summari||patient||4||5||grade 3||dead discuss 1 clostridium||limb rigid opisthotonu 1||vulner patient,31046.0||28965.0||17401.0||16864.5||15808.2||15526.0||15281.5||14694.0||13567.0||12937.0||10364.0||8862.5||8214.0||7851.5||6846.0,0.0,0.1,0.13333333333333333
129,J_Immunol_Methods-2-1-2225449.txt,method||analysi||cell||primari human macrophag||data||glass coverslip||imag analysi softwar||macrophag||cell line||dapi||binari mask||lp||nuclear,1||2||3||2 μg||2 0.83||4||cell||studi||fig. 2 nuclear||5||7 5 3 csk4||3 pixel||3 csk4||2006||3 data present,31046.0||28965.0||17044.0||14685.0||14565.5||12937.0||12627.0||12015.0||11588.0||10364.0||8602.25||8563.5||8524.0||8371.0||8250.667,0.0,0.1,0.06666666666666667
130,Histochem_Cell_Biol-4-1-2323030.txt,receptor||cancer||bind||mechan||concentr||erbb||anti-canc therapi||ligand bind||erbb2||target||review||endocytosi||endosom sort||ubiquitin||egfr||protein||studi||import||evid||antibodi||plasma membran||endosom||intern||activ||lysosom degrad||degrad||role||caveola||complex||epiderm growth factor receptor||cell||ligand||year||pathway||cbl,1||2 fig. 2||cancer 1||3||ubiquitin 2 2 2007||caveolin 1||2 pathway||cell||studi||3 2006 2006 fig. 3||cancer cell||tabl 1 erbb receptor||PI 3||blegdamsvej 3||2005 2004 2004 2005 2005,31046.0||20968.667||19061.0||17044.0||16336.5||15529.5||15144.5||12627.0||12015.0||11161.2||9851.5||9553.25||8589.5||8523.5||8460.4,0.0,0.2,0.13333333333333333
131,Crit_Care-8-3-468887.txt,low-dos dopamin||gastric intramucos pH||vasopressin||effect||lower gastric phi||agent||flow||group||adrenerg drug||splanchnic haemodynam||cardiac index||phi||epinephrin||studi||cardiac output||increas||red blood cell transfus||fraction splanchnic blood flow||iloprost||patient||inflammatori respons||sepsi||dobutamin||splanchnic oxygen consumpt||blood pressur||shock||data||splanchnic circul||septic shock||microcirculatori blood flow||norepinephrin||min,1||2||2 3||tabl 1||1 3 4 4 5||2 15||2 14||treatment introduct 1 2||tabl 2||2 38||2 51||2 56||2 72||2 gap||2 gradient,31046.0||28965.0||23004.5||17331.0||16865.6||16771.0||16631.0||16580.25||16290.5||15279.5||15045.0||14993.0||14898.5||14618.5||14612.0,0.0,0.0,0.0
132,J_Behav_Health_Serv_Res-4-1-2214828.txt,IP SA||day||residenti SA servic||client||coeffici||popul||state agenc||group||co-occur||MH servic||unit state||state||analysi||studi||addit||mh-onli||mental health servic administr||subclassif||care||servic||opiat||idb||window||individu||inform||record||data||case||medicaid enrol||diagnosi||medicaid||washington state,1||2||health 1||result 1 1 17||1 year||3||refer 1||figur 1||data sourc categori 2 2 2||patient||4||studi||2 11060988 16||medicaid servic 2||2005,31046.0||28965.0||18323.5||17938.75||17151.0||17044.0||16864.5||16123.5||15581.5||13567.0||12937.0||12015.0||10972.333||10135.0||8716.0,0.0,0.0,0.06666666666666667
133,Ann_Biomed_Eng-2-2-1705503.txt,substrat||cultur||fibroblast||effect||concentr||pdgf-ab||prolifer||tissu regener||synthesi||studi||ligament tissu engin||gelatin||increas||two-dimension substrat||express||franc||collagen||growth factor||cell prolifer||cell||collagen synthesi||silicon sheet||type||cell cycl analysi||cultur substrat||result,1||3 2||1 tabl 1||1 figur 1||1 inhibit||1 β||tgf-beta 1||1 tgf-β1||1 pdgf-ab||2 day||1 10 49||cell||1 21 36||studi||cultur condit 2,31046.0||23004.5||21902.667||21097.667||16072.0||15682.0||15535.0||15534.0||15525.5||15449.0||13064.0||12627.0||12016.667||12015.0||10655.333,0.0,0.0,0.13333333333333333
134,Exp_Brain_Res-3-1-1914290.txt,sway-path length||regular cop trajectori||largest lyapunov expon||cognit invest||effect||dual task||postur stabil||intern focu||variabl||order||eye||task difficulti||decreas||particip||center-of-pressur||increas||task||expon||valu||analys||cop||correl dimens||control||amount||regular||local stabil||dimension||postur control||dynam structur||sampl entropi||postur||surrog data||depend variabl||sagitt plane||result||attent||plane||postur sway||cognit dual task||visual depriv,1||2||2 2 2||2 2||2 2006||3||procedur 1||hypothesi 1||1 abbrevi||1 2 roerdink melvyn 1 greven||hypothesi 2||2 asterisk||2 σ||patient||2 2005 2005 2002,31046.0||28965.0||28965.0||28965.0||18668.0||17044.0||16217.5||15726.5||15658.5||15179.0||14686.0||14561.5||14550.5||13567.0||13363.5,0.0,0.0,0.0
135,Eur_Arch_Otorhinolaryngol-4-1-2217622.txt,scala tympani||effect||ear||cochlea||guinea pig||acut||dpoae||pressur||signal||cmdp||decreas||2||inject||pressur increas||diseas||cochlear function||perilymph||chang||CM potenti||ear fluid volum||artifici perilymph||ear pressur,1||1 1||1 2||2 1||2||1 2 4||2 3||1 4||inject 1 1||2 3 4||2 6||1 4 5||fig. 1||1 16||1 17,31046.0||31046.0||30005.5||30005.5||28965.0||24316.0||23004.5||21991.5||20895.333||19648.667||19019.5||18115.667||18011.0||17498.5||17314.5,0.2,0.1,0.06666666666666667
136,Diabetologia-3-1-2039867.txt,insulin resist||model||herit||genet||sex||effect||environment factor||correl||varianc||quantit sex differ||east flander prospect twin survey||pair||lipid metabol||hdl-cholesterol ratio||MZ MC||variat||chorion||twin||covari||twin studi||type 2 diabet||insulin||studi||leptin level||young healthi twin popul||high rang||genet factor||hdl-cholesterol||genet varianc||random intercept model||fat mass||total variat||varianc compon||metabol risk factor||total cholesterol||principl||MZ DC pair||metabol characterist||trait,1||1 2||2||2 2 2||2 2 2 2 2||2 3 2||analysi 1 1||1 2 beunen||2 5||1 5 fig. 1||3 3||3||P. 1 2 8 1 depart||refer 1||1 44,31046.0||30005.5||28965.0||28965.0||28965.0||24991.333||22259.667||20004.0||19664.5||19358.0||17044.0||17044.0||16951.167||16864.5||16195.5,0.0,0.0,0.0
137,Exp_Brain_Res-4-1-2373857.txt,visual modal||systemat bia||respons||cognit resourc||effect||frontal plane||cue||reproduct||sensori motor trace||hypothesi||haptic||horizont||obliqu effect||review||modal||refer||angl||vertic||anisotrop||refer frame||stimulu||process||visual system||orient||spatial orient||studi||condit||error||diagon||obliqu orient||cognit level||task||bodi||gentaz||system||streri||sensori modal||test||gravit cue||subjective-refer frame||percept||frame||paramet||gravit forc||exploratori movement||haptic percept||space||contralater hand||discrimin||haptic modal||hand||haptic discrimin||sagitt plane||hatwel||find||rod||obliqu||adult||product task||plane||result,1||2||3||1986 1||1 averag||grenobl 2||patient||4||studi||mix class 1||5||class 2 anisotropi||franc 2 faculti||5 9 4||5 ipsi 3 7 4,31046.0||28965.0||17044.0||15949.5||15916.5||14485.5||13567.0||12937.0||12015.0||10658.0||10364.0||9874.0||9792.333||9564.333||9475.0,0.0,0.1,0.06666666666666667
138,J_Biol_Inorg_Chem-3-1-2039866.txt,zinc||signal||precipit||complex||spectrum||chemic||attempt||differ fourier map||reaction||calc||bi||sodium pyruv||reaction mixtur||solut||structur,1||1 1 1||2 2 2 1 2||1 2 2 2 2||2 2 2 2 1 2||2 2||2||2 2 2||2 2 2 2 2 2||2 2 2 2||5 2 2 2 2||2 2 2 2 2 Pr||3 2||2 3||2 2 2 35,31046.0||31046.0||29381.2||29381.2||29311.833||28965.0||28965.0||28965.0||28965.0||28965.0||25244.8||24142.0||23004.5||23004.5||22222.5,0.0,0.0,0.0
139,J_Abnorm_Child_Psychol-4-1-2268722.txt,respons||frustrat||cool EF||hyperact||trial delay||prenat smoke||behavior||pregnanc||exampl||order||delay||score||measur||associ||signific differ||conduct problem||studi||affect||particip||inhibitori control||button||task||children||emot||question||comput||low arous||mother||extern behavior||smoke||adhd||computer task||ambigu||prenat||problem||trial||prepot respons||domin hand respons||hot,1||1 1||2||age 1||4||studi||inattent fig. 2||netherland 2 school||2005 2006||studi 2001 2002||2006||2005 2006 1999 2003 2005||cell signal||present studi||2007,31046.0||31046.0||28965.0||17305.5||12937.0||12015.0||11320.333||10604.333||8543.5||8461.667||8371.0||7649.8||7464.0||7377.0||7287.0,0.0,0.1,0.06666666666666667
140,Purinergic_Signal-3-4-2072919.txt,receptor||effect||extracellular space||glutam||ligand-g cation channel||brain||termin||neuron||sympathet nerv||nervou system||neuron activ||channel||nucleotid||p2x receptor||neurotransmitt||subtyp||atp||spinal cord||synapt transmiss||hippocampu||p2i receptor||releas||activ||nerv termin||neurotransmitt releas||adenosin||patholog situat||pharmacolog profil||excitatori amino acid||modul,1||2 1||2||1 4 2||3 1||1 2 6||3 2||4 1||conclus 1 2 3 2||6 1||2 4 3||3 3 1 2 4 receptor||1 2 4 6 11||1 receptor||3,31046.0||30005.5||28965.0||24316.0||24045.0||23028.333||23004.5||21991.5||21442.2||20060.0||19648.667||18423.167||17414.6||17274.5||17044.0,0.0,0.0,0.0
141,Histochem_Cell_Biol-4-1-2248605.txt,escrt||lysosom membran protein||mannos 6-phosphat receptor||receptor||acid phosphatas||cd-mpr||direct pathway||transport vesicl||factor||acid phosphatas activ||compon||electron microscopi||enzym||subdomain||protein||studi||distinct stage||literatur||imag||specif compart||endosom||observ||machineri||endo-lysosom system||transport||gga||tgn||complex||cell||type||cargo||lysosom||function,3||lamp 1||cell||studi||5||endosom 3||3 1985a||2006||earli endosom antigen 1||cell ’s||3 2006 2004 2002 2001 2002b||fig. 5||cell biolog||10||kidney cell,17044.0||15541.5||12627.0||12015.0||10364.0||8579.0||8524.5||8371.0||8298.5||7835.5||7822.0||7670.0||7089.5||6982.0||6962.0,0.4,0.2,0.13333333333333333
142,Environ_Health_Perspect-115-3-1849909.txt,import chemic||respons||skin||mechan||potenti||product||asthma||protect cloth||childhood||factor||isocyan asthma||anim||develop||research||subsequ develop||import||studi||mdi||mdi-ig||health administr||immun respons||host factor||sensit||person protect equip||isocyan||exposur||similar inhal exposur||worker||absorpt||workplac||occup safeti||occup||potenti risk||polyurethan product||subsequ inhal challeng||result||case||set||clinic||human||respiratori exposur||skin absorpt||dermal exposur||health||document,1||2||3||day 1||tabl 2||dilut 1||1 bello||1 ppb||2 day||2 week||2 μg||OO 2||5 1 exposur||2004 tabl 2||day 7 1,31046.0||28965.0||17044.0||16489.5||16290.5||15664.0||15533.5||15532.0||15449.0||15100.0||14685.0||14492.0||14112.333||13552.667||13325.333,0.0,0.0,0.0
143,Childs_Nerv_Syst-3-1-2092440.txt,modern palli care||suffer||pain||parent||termin||medic care||prospect||dutch associ||countri||criteria||ethic debat||studi||end-of-lif decis||babi||intern legisl||qualiti||lesion||life||treatment||sever||meningomyelocel||care||palli care||spina bifida||hopeless||experi||decis||protocol||ethic||intern medic recommend||hydrocephalu||newborn||mmc||sever form||deliber termin||groningen protocol||case||sever physic disabl||level||physician||result,1||2||3||refer 1||1 month||2 year||patient||4||studi||sever brain damag 3 1 5||5||3 day||2005||73 4 5 fig. 4||2006,31046.0||28965.0||17044.0||16864.5||16322.0||16110.5||13567.0||12937.0||12015.0||10517.5||10364.0||9488.5||8716.0||8404.0||8371.0,0.0,0.1,0.06666666666666667
144,Diabetologia-4-1-2170456.txt,durat||baselin recruit||number||month||bmi||follow-up||associ||whr||birth||parou women||diabet||studi||dietari intak||particip||age||analys||children||baselin||diabet mellitu||type 2 diabet mellitu||in-person interview||middle-ag women||risk||breast-feed||physic activ||glucos||trend||case||weight||year,1||2||tabl 1||3||refer 1||model 2||2 5 6||1 Li||0.001 2||hypertens 2||2 yang||4||tabl 2 associ||studi||type 2 diabet,31046.0||28965.0||17331.0||17044.0||16864.5||16428.0||16134.333||15819.5||15055.0||14732.5||14659.5||12937.0||12082.333||12015.0||11461.333,0.0,0.0,0.06666666666666667
145,Int_J_Biol_Sci-3-3-1802012.txt,broad-coverag array||databas||respons||snp||differ||gene express||number||transcript||abil||porcin tissu||cell type||report||est||annot||microarray||group||review||qpcr||sequenc||porcin sequenc||analysi||protein||tissu||increas||author||bioinformat||pig||express||pig gene express||gene||infect||paper||porcin||librari||filament conceptu||transcriptom||unpublish project||serial analysi||method||inform||cell||data||immun||pathway||result,1||1 1||2||2 2 2 2||2 2||31 1 1||3||2 25||usa 2||figur 2||2 mrna||tabl 2 result||cell||studi||tabl 1 largest,31046.0||31046.0||28965.0||28965.0||28965.0||21415.0||17044.0||16132.0||15431.5||15083.0||14694.5||12887.0||12627.0||12015.0||11589.0,0.0,0.0,0.06666666666666667
146,Diabetologia-4-1-2292425.txt,snp||growth||age||children||variat||insulin secret||materi||genotyp||associ||type 2 diabet||birth||variant||gene||studi||region||childhood||popul||type 1 diabet||genet variat,1||2||2 3||4 2||1 2 bouatia-naji||result igf1 1 1||3||type 1||refer 1||1 diabet||1 igf1 3||patient||1 igf1 10||type 1 diabet||studi,31046.0||28965.0||23004.5||20951.0||20004.333||17054.5||17044.0||16987.0||16864.5||16768.5||16045.333||13567.0||12691.333||12155.0||12015.0,0.0,0.0,0.13333333333333333
147,Neuroimage-2-1-2225446.txt,differ||effect||multi-scann data-set||brain||thalamu||grey matter||region volum||imag intens||varianc||group||scanner||analysi||studi||error||diseas||imag||signific||control||test||medial tempor lobe||subject||method||data||calibr||qualiti control||interact||upgrad||result,2||fig. 1||tabl 1||3||fig. 2||1 normal||1 mm||1 AD||scanner 1||2 normal||2 AD||scanner 2||1 7 23||result tabl 1||patient,28965.0||18011.0||17331.0||17044.0||16970.5||16455.0||15936.5||15790.0||15609.5||15414.5||14749.5||14569.0||13677.0||13580.667||13567.0,0.0,0.0,0.0
148,Bioprocess_Biosyst_Eng-2-2-1705473.txt,glutam||balanc metabol control||constant control||tca cycl||ldh||lactat||glutam ferment||oxygen concentr||agit rate||ferment process||strategi||metabol flux||gdh||enzym||condit||lactat overflow||ferment||metabol balanc||lactat product||activ||metabol flux analysi||glutam product||bmc||tca metabol flux||case||lower level||step chang||final stoppag||level||maxim glutam concentr||result,1||2||1 2 4||4 2 2 2 2 5||4 2 2 4||5 2||4 2 1 4 5||constant control 1 2 2||6 1 4||3||refer 1||1 μmol||ldh 1||3 4||control level 1 fig. 1,31046.0||28965.0||24316.0||23193.5||20951.0||19664.5||19249.8||18733.8||17685.667||17044.0||16864.5||15557.0||15539.5||14990.5||14935.6,0.0,0.0,0.0
149,Ann_Hematol-4-1-2226003.txt,thrombosi||coronari heart diseas||anemia||carrier||cardiovascular event||associ||serum ferritin concentr||iron||atherosclerosi||genet marker||cardiovascular diseas||studi||patient||risk||coronari arteri diseas||thrombocytosi,1||2 patient||1 7||refer 1||1 summari||1 3 8 10.1046||patient||studi||39-045-8124626 mfranchini@univr.it 1 4||clinic studi||associ studi||2003||young patient||effect||import studi,31046.0||21266.0||19021.5||16864.5||15734.5||13745.0||13567.0||12015.0||10996.25||8436.5||7840.5||7651.0||7122.5||6956.0||6906.5,0.0,0.2,0.13333333333333333
150,J_Gastrointest_Surg-3-1-1852384.txt,msof||male||complic||cad||death||syndrom||report||logist regress||coronari arteri diseas||morbid obes||bmi||oper||pulmonari embol||leak||age||surgeri||signific||women||obes||obstruct sleep apnea||comorbid||patient||postop small bowel obstruct||risk||incid||roux-en-i gastric bypass||major complic||rygb||procedur||bariatr surgeri||morbid||data||mortal||year||surgeon||periop risk,1||2||result 1 2||2 3 11 2 2||2 3 11 2||http://www.asbs.org 1 2 3||1 year||3||refer 1||2 year||3 4||unknown 1 1 0 0||2 suppl||2 preval||0.01 2,31046.0||28965.0||22030.333||21798.0||20006.25||19264.0||17151.0||17044.0||16864.5||16110.5||14990.5||14940.0||14901.5||14867.5||14835.0,0.0,0.0,0.0
151,Ann_Surg_Oncol-3-1-1914254.txt,cancer||expertis||univers hospit||effect||referr||center||outcom||hospit||death||stage||esophag resect||studi||esophag cancer||data collect||region cancer registri||surgeri||surviv||treatment||oper mortal||select referr||patient||hospit volum||tumor||year||univers||esophag carcinoma||mortal||oper procedur||diagnosi||surgeon,1||2||1 4||2 tabl 2||3||refer 1||1 1.7||2 hospit||result tabl 1||patient||phd j.t.m.plukker@chir.umcg.nl 1 1 depart||4||cell||studi||variabl 2 test,31046.0||28965.0||21991.5||20515.333||17044.0||16864.5||15653.5||15430.0||13580.667||13567.0||12963.0||12937.0||12627.0||12015.0||11223.667,0.0,0.1,0.13333333333333333
152,Tuberculosis_(Edinb)-1-5-1913930.txt,glutamin||strain||glnd||growth||macrophag||mutant||nitrogen metabol||activ||cultur filtrat||control||cell||ammonia||protein||gene||level||glutamin synthetas||nitrogen sourc||virul||extra-cellular GS||delet,1||2||lane 1||4||cell||studi||refer 1 http://www.who.int/tb/publications/global_report/en/index.html||5||figur 2 siga||5 6||fig. 1 M. tuberculosi 7||6||3 mM||lane 3||14 5 6,31046.0||28965.0||15669.5||12937.0||12627.0||12015.0||11243.333||10364.0||10057.333||9719.0||9370.2||9074.0||8722.5||8668.5||7911.667,0.2,0.1,0.06666666666666667
153,Int_J_Biochem_Cell_Biol-2-1-2267855.txt,substrat transport||substrat||one-way anova||model||residu||proton||peptid||pH depend||substrat bind||wild-typ||charg pair||mutant||transport||oocyt,1||2004 2 2 3||4 3 2||3||fig. 2 3||fig. 2||1 μg||1 khz||1 gentamicin||2 materi||fig. 3 3||studi||fig. 4 3||fig. 3||dmeredith@brookes.ac.uk 1 school,31046.0||20762.75||19648.667||17044.0||16995.0||16970.5||15725.5||15551.5||15527.5||15325.0||13021.333||12015.0||11652.333||11010.0||10580.0,0.0,0.0,0.0
154,Arch_Dermatol_Res-3-1-2064945.txt,lesion skin||autoimmun diseas||human BP||model||neutrophil||pathogen effect||pathogen epitop||mast cell degranul||develop||inflammatori cell||blister fluid||diseas||role||eosinophil||experiment BP||find||extracellular matrix protein||autoantibodi||cell||mice||neutrophil infiltr||human||hemidesmosom,1||refer 1||patient||cell||studi||2006||cell respons||32 2 32 41 41 6||bullou pemphigoid antigen 2||2007||7||effect||human BP 1 51 50 57||inflammatori cell||basal cell,31046.0||16864.5||13567.0||12627.0||12015.0||8371.0||7987.5||7584.5||7421.75||7287.0||6997.0||6956.0||6710.167||6513.5||6410.0,0.2,0.1,0.13333333333333333
155,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2367393.txt,edg||optic buttonhol||iol||after-cataract prevent||potenti||pobh||regeneratori lec prolifer||ovd||central posterior capsul||anterior vitrectomi||toric iol||hyaloid||peripher retina||intraocular lens||techniqu||primari posterior capsulorhexi||standard in-the-bag implant||optic rim||retin detach||optic centrat||eye||vitreou entrap||barrier||surgeri||lec||capsular diaphragm||posterior capsul||optic||flare||natur barrier effect||year||optic edg||routin procedur||after-cataract||case||len epitheli cell||ppccc||fibrosi||anterior||posterior capsul opacif,1||2||2 3 8||3||refer 1||2 year||1 mm||eye 2||patient||4||1 complic result||2 indic summari||16 3||5||6,31046.0||28965.0||17387.667||17044.0||16864.5||16110.5||15936.5||14828.0||13567.0||12937.0||12667.667||10573.0||10497.5||10364.0||9074.0,0.0,0.0,0.0
156,Eur_J_Nucl_Med_Mol_Imaging-3-1-1914225.txt,caspas cascad||vivo||model||clinic studi||cell suicid||detect||vulner plaqu||cardiovascular diseas||death||plaqu||apoptot macrophag||target||non-invas detect||strategi||process||apoptosi||imag||lesion||annexin A5||molecular imag||necrot cell||patient||pet||apoptot program||atherosclerot lesion||non-invas imag||cell||case||caspas||environ||result,refer 1||2 hofstra||patient||4||cell||altern method 1 fig. 1 target||netherland 2 depart||fig. 3||L. 1 corsten||31-433-881674 l.hofstra@cardio.unimaas.nl 3 1 depart||P. M. 1 narula||clinic studi||usa 3 depart||27 28 21 22 29 2||effect,16864.5||14488.0||13567.0||12937.0||12627.0||12124.833||11205.0||11010.0||10857.667||10117.2||9200.75||8436.5||7145.333||7093.333||6956.0,0.4,0.2,0.2
157,J_Chem_Ecol-4-1-2266969.txt,thermodesorpt cold trap setup||speci||feed||effect||cucumb||predatori mite||natur enemi||herbivori||volatil||gc-m||emiss||volatil blend||treatment||compound||lima bean||test||cold trap||spider mite||plant speci||multi-speci herbivori||min,"1||1 2||2||analys 1 2 fig. 1||3||1 S.||1 T.||2 S.||2 T.||2 min||2 hr||2 e,e||3 dick marcel 1 1 laboratori||4||studi",31046.0||30005.5||28965.0||19451.8||17044.0||16854.0||16336.0||15813.5||15295.5||15117.5||14511.5||14487.5||13342.667||12937.0||12015.0,0.0,0.0,0.0
158,Intensive_Care_Med-2-2-1315315.txt,databas||model||circumst||equat||outcom||maximum valu||hospit||variabl||logist regress||approach||icu||refer||develop||score||physiolog data||time||hospit discharg||sampl||refer databas||region differ||comput||patient||hospit mortal||icu admiss||ill||goodness-of-fit||sap 3 system||intens care unit||sap 3 score||predict||data||icu level||mortal||final estim||check||prognost model||result,1||2||result 1 2||3||10 2 2 refer||refer 1||part 1||part 2||4 3||patient||4||studi||sap 3 databas 2||part 1 box||4 5 6,31046.0||28965.0||22030.333||17044.0||16898.75||16864.5||16058.5||15018.0||14990.5||13567.0||12937.0||12015.0||11778.0||10917.0||10791.667,0.0,0.1,0.06666666666666667
159,Int_J_Cardiovasc_Imaging-4-1-2373860.txt,mdct||heart rate||circl||phantom||differ||equival mass||calcium score||equival mass score||effect||calcif||calcif densiti||triangl||scanner||cms-index||score||decreas||densiti||agatston score||electron beam CT||cardiac motion||bpm||dsct||smaller slice thick||motion||slice thick||method||dual sourc CT||arteri||motion curv||calcium||volum score||suscept||physic mass||artifici arteri||ebt||ca-scor||64-slice mdct||result,1||2 2||2||1 1 depart||3||3 3 3||refer 1||1 suess||1 4 4 fig. 4||2 phase||2 schmidt||2 zijlstra||4||studi||1 greuter marcel,31046.0||28965.0||28965.0||21528.667||17044.0||17044.0||16864.5||15526.0||14966.6||14954.5||14603.5||14487.0||12937.0||12015.0||10370.0,0.0,0.0,0.0
160,Bioinformation-1-3-1891659.txt,perl||motif||repeat||program||genom||posit||ssrscanner||ssr||microsatellit||time,1||1 2||2||1 2 3 4 5||3||bioinform 1||tabl figur 1||refer 1 levinson||6||2006||6 7 8||divers studi||9||2000 10 62 10645951 3 toth||data,31046.0||30005.5||28965.0||20071.2||17044.0||15556.5||11954.333||11245.0||9074.0||8371.0||7408.333||6198.0||5392.0||5148.5||4969.0,0.0,0.0,0.0
161,Histochem_Cell_Biol-3-1-2137940.txt,apoptot cell||mode||detect||tunel assay result||specif||probe||ssdna antibodi||light microscopi||sentinel||electron microscopi||apoptot cascad||protein||tissu||import||antibodi||apoptosi||varieti||staurosporin||activ||tissu section||dna break||tunel assay||cell death||transmiss electron microscopi||wide varieti||method||necrosi||cytochem techniqu||cell||marker||morpholog||caspas,1||2||3 4 1 depart||cell||studi||fig. 3||caspas 3||2006||cytochem optic microscopi 1||2007 2006||2003||breast cancer cell||caspas 3 activ||total cell||2001 2003 2004,31046.0||28965.0||15880.25||12627.0||12015.0||11010.0||8561.0||8371.0||7933.0||7829.0||7651.0||7469.667||7451.0||7377.5||7347.0,0.2,0.1,0.06666666666666667
162,Pediatr_Radiol-4-1-2292495.txt,thrombu||lumen||complic||subsequ manag||access||contrast medium||malfunct||cathet tip||contrast studi||central||posit||peripher cannula||techniqu||cvc||neck||oper||cathet||studi||inject||clinic team||children||fibrin sheath||tip posit||contrast jet||patient||tunnel||central venou cathet||line||tip||manag||site||initi examin||central venou access devic,"1 2 fig. 1 inset||refer 1||suppl 1||patient||studi||3 fig. 3 inset||2005||adult patient||cancer||2002||paediatr patient||dacron ingrowth cuff fig. 2||1,064 patient||contrast studi||9 10",19211.6||16864.5||15942.0||13567.0||12015.0||9772.25||8716.0||7484.0||7076.0||7057.0||6927.5||6798.2||6784.5||6414.0||6187.0,0.4,0.2,0.2
163,Bioprocess_Biosyst_Eng-2-2-1705518.txt,root||model||cultur||primari metabol pathway||cell build block||tool||organel||medium exchang cultur||concentr||experiment data||secondari metabolit||metabol network||plant cell||time||literatur||amino acid||intracellular concentr||growth||analys||sugar||growth rate||metabol model||intracellular ammonium||root mass||metabol regul||flux||independ pathway||glucos||method||hairi root growth||minim medium||steadi state||cell||nutrient||batch||rate,1||2||2 2||3 1||1 2 3 4 3||2 4||4 2||2 5||3||refer 1||1 C.||2 8 4||2 3 3 solut||_{ 1||28 2,31046.0||28965.0||28965.0||24045.0||21407.2||20951.0||20951.0||19664.5||17044.0||16864.5||16530.5||16018.667||15994.5||15932.0||15707.0,0.0,0.0,0.0
164,Clin_Oral_Investig-4-1-2238781.txt,enamel||wear||primari||area||depth||factor||teeth||score||tissu||studi||dentin||lesion||dental cari||sever||eros||dentit||tooth wear||exposur||paramet||forc||indic||problem||acid||case||diagnosi||relev||loss,1||2||refer 1||1 loss||30 6 1||patient||studi||44 44 1||1 slight eros||iceland 2 depart||involv 2 eros||5||dentin eros 2||2006||2004,31046.0||28965.0||16864.5||16021.0||14462.333||13567.0||12015.0||11245.333||10546.333||10492.667||10423.0||10364.0||9879.333||8371.0||8077.0,0.0,0.1,0.06666666666666667
165,Matern_Child_Health_J-2-2-1592251.txt,feder||prevent care||access||center||program||public health||pregnanc||opportun||approach||state||incom||uninsur||fund||usual sourc||coverag||profession guidelin||children||women||servic||major||preconcept||sourc||health coverag||preconcept care||famili plan||waiver||commun health center||health clinic||medicaid||health,1||2||3||refer 1||tabl 2||1 2 1 dartmouth medic school||april 1||juli 1||1 17 fig. 1 percent||patient||6||2003 7 1 13 30 10.1023||2005||NH usa 2 depart||2006,31046.0||28965.0||17044.0||16864.5||16290.5||15833.0||15583.5||15571.5||14165.0||13567.0||9074.0||8950.0||8716.0||8378.0||8371.0,0.0,0.0,0.0
166,Mol_Biochem_Parasitol-1-5-2075530.txt,involv||PS transloc||cell death||caspas||femal gametocyt||genom dna||caspas activ||stage||caspatag||mosquito||posit||metacaspas||proteas||mosquito bite||ookinet||apoptosi||result||dna fragment,1||2||3||2 materi||fig. 1 plasmodium fig. 1||4||cell||5||P. gallinaceum 2||6||fig. 4||fig. 2 hin hin||posit cell||fig. 3 fig. 3 pbmc1 pbmc1||7,31046.0||28965.0||17044.0||15325.0||14439.0||12937.0||12627.0||10364.0||10322.667||9074.0||8956.5||8499.75||7456.0||7346.667||6997.0,0.0,0.0,0.0
167,Eur_J_Nucl_Med_Mol_Imaging-3-1-1998878.txt,receptor||day||cultur||slower rate||effect||radionuclid therapi||dose rate||irradi||narrow rang||order||delay||nuclear medicin||studi||normal tissu||chamber||cur treatment||exponenti growth||figur||time||cultur dish||low dose||tumour cell||growth||analys||growth delay||radionuclid||exposur||beta particl||rang||irradi chamber||low dose rate||therapi||exposur time||cell||type||intrins radiosensit||dish,1||2||2 2||1 1 fig. 1||5 1||35 2 2 2 block||3||3 3 3||refer 1||1 month||1 week||1 surviv||15 1 25 1 5 6||patient||exposur time 2 fig. 2,31046.0||28965.0||28965.0||24528.5||20705.0||17900.4||17044.0||17044.0||16864.5||16322.0||16140.5||16131.5||14901.0||13567.0||13554.8,0.0,0.0,0.0
168,Int_J_Parasitol-1-5-1906861.txt,respons||receptor||mechan||sever malaria||ec||abil||human serum||surfac||critic factor||vascular endothelium||studi||co-cultur||condit||term||up-regul||increas||endothelium||immun respons||cell apoptosi||express||huvec transcriptom||tnf||biolog process||gene||EC activ||adhes||malaria infect||signific regul||cluster||chang||icam-1||cell||data||presenc||prbc||molecul||huvec||co-cultur experi||result,1||2||factor 1||tabl 1||3||fig. 2||tabl 2||receptor 2||caspas 1||traf 1||2 materi||patient||2003 tabl 2||low fig. 1||cell,31046.0||28965.0||17745.0||17331.0||17044.0||16970.5||16290.5||16234.0||15562.0||15523.5||15325.0||13567.0||13410.667||12667.0||12627.0,0.0,0.0,0.06666666666666667
169,J_Med_Internet_Res-8-4-1794003.txt,databas||neonat medicin||precis||hand search||obstetr||specif||studi particip||combin||geriatr medicin||age-specif search strategi||journal||strategi||mesh term||medicin||term||articl||particip||year 2000||sensit||research assist||medlin||combin term||textword||three-term strategi||clinician||absolut decreas||age-specif search term||adult||exp adult||clinic specialti,1||1 3||tabl 1||3||1 month||tabl 2||1 hayn||preschool 2||msc 2||patient||tabl 1 4 17 4||tabl 1 comparison||studi||canada 1 depart||1 month infant,31046.0||24045.0||17331.0||17044.0||16322.0||16290.5||15554.0||14509.5||14495.0||13567.0||12823.8||12104.667||12015.0||11279.667||11078.0,0.0,0.0,0.0
170,Int_Arch_Occup_Environ_Health-4-1-2175018.txt,differ||complaint||pain||total||treatment control||work-abl||group||averag||order||intens||questionnair||studi||social function||ill percept||qualiti||life||treatment||rsi||patient||percept||person control||ill||work-rel upper extrem musculoskelet disord||upper bodi region||sick-list chronic rsi patient||respect||year||emot role function||health,1||2 3 2||result 1||1 year||tabl 2||patient||4||studi||1 total studi popul||5||tabl 3||2 pain intensiy||6||0.01 3||2005,31046.0||24991.333||18563.0||17151.0||16290.5||13567.0||12937.0||12015.0||11743.0||10364.0||10330.0||10206.667||9074.0||8874.5||8716.0,0.0,0.2,0.13333333333333333
171,Eur_Arch_Otorhinolaryngol-4-1-2358940.txt,phonat||techniqu||surgeri||healthi side||paralysi||procedur||movement||patient||unilater vocal fold paralysi||posit||cricoarytenoid joint||three-dimension comput tomographi||arytenoid cartilag||ventromediocaud part||level||arytenoid||posterior part,2||1 fig. 1||refer 1||patient||springer-verlag 2008 introduct 1 2||studi||evalu case 1 4 fig. 4||tension case 2 5||neck vol. 1||3 8 9 10 fig. 3||3dct 3 6||2004||fig. 5||live patient||effect,28965.0||22356.0||16864.5||13567.0||12990.8||12015.0||11262.333||10641.0||10589.667||9598.667||8709.333||8077.0||7670.0||7017.0||6956.0,0.2,0.1,0.06666666666666667
172,Biochem_Pharmacol-1-5-1920586.txt,herg||effect||potenti||concentr||blockad||short QT syndrom||extern solut||drug||fit||studi||long QT syndrom||doxepin||inactiv||mutat||control||imipramin||current||channel pore||mutant||protocol||data||inhibit||herg channel,1||1 1||2 2||2||fig. 1||3||fig. 2||1 mM||variant 1||herg fig. 1 fig. 1||patient||4||cell||herg fig. 1||studi,31046.0||31046.0||28965.0||28965.0||18011.0||17044.0||16970.5||15723.5||15670.5||14451.2||13567.0||12937.0||12627.0||12078.0||12015.0,0.0,0.0,0.06666666666666667
173,Sci_Eng_Ethics-4-1-2413105.txt,model||feel||high incom||sens||engin ethic||profess||japan||approach||engin||countri||social-contract view||contract||special oblig||profession integr||posit feel||social statu||system||pride||student||code||ethic||implicit contract||view||virtu||high moral standard||notion||problem||implicit social contract||membership-requir view||self-esteem||societi||occup capac,1||2||1 4||2008 1 2||1 10||5 1 6 7 2||3||2 11||3 4||11 2 10||10 6 1 7||4||studi||3 11||5,31046.0||28965.0||21991.5||20684.0||19014.0||17289.2||17044.0||17008.0||14990.5||13666.0||13524.75||12937.0||12015.0||11047.5||10364.0,0.0,0.0,0.0
174,Int_J_Colorectal_Dis-3-1-2039795.txt,micrometastas||tumour cell||result||ihc||number||procedur||colon carcinoma||sln procedur||multi-centr studi||sentinel lymph node||case||patient||studi||posit node||sln||lymph node||lymph node metastas||multi-centr set||aberr lymphat drainag||group,2 result||refer 1||hanzeplein 1||patient||4||31-50-3614873 j.t.m.plukker@chir.umcg.nl 2 1 depart||studi||netherland 2 depart||1 plukker john||5 5||15 patient||2005||patient number||27 patient||patient select,17522.5||16864.5||15529.5||13567.0||12937.0||12501.6||12015.0||11205.0||10433.333||10364.0||9072.0||8716.0||8268.5||7989.5||7665.5,0.2,0.2,0.13333333333333333
175,Neurogenetics-2-2-1513515.txt,snp||differ||caucasian popul||dataset||signific associ||popul||autism||group||largest differ||candid||analysi||associ||studi||addit||ethnic group||sampl||disord||autism patient||autism risk||gene||seizur||caucasian dataset||subunit||gaba receptor subunit||gaba||data||potenti regulatori region||interact||result||allel,1||2 2||2||3||refer 1||suppl 1||2 valu||1 Ma deqiong 1||2 2 gabra4 snp||patient||4||1-919-6840910 mpv@chg.mc.duke.edu 1 1 center||studi||1 martin eden||1 wright harri,31046.0||28965.0||28965.0||17044.0||16864.5||15942.0||15845.0||15556.25||14528.0||13567.0||12937.0||12743.6||12015.0||10481.333||10475.333,0.0,0.0,0.06666666666666667
176,Clin_Oral_Investig-4-1-2238792.txt,reliabl||diseas prevent||oral health||index||cardiovascular diseas||qualiti criteria||oral diseas pattern||non-communic diseas||fill teeth||teeth||countri||criteria||instrument||dental eros||studi||diseas||qualiti||health promot||gold standard||children||eros||oral health promot||world health report||literatur analysi||indic||aspect||valid||method||examin||assess||result,1||2||3||refer 1||tabl 2||1 mm||defect 1||contour 1||part 2||2 mm||contour 2||patient||4||studi||knight twi 2,31046.0||28965.0||17044.0||16864.5||16290.5||15936.5||15844.0||15557.5||15018.0||14896.0||14517.0||13567.0||12937.0||12015.0||9691.0,0.0,0.0,0.06666666666666667
177,J_Fluoresc-4-1-2266787.txt,precis||mixtur||pH 10||concentr||sodium carbon solut||solut||concentr rang||dosag form||drug||analysi||plasma||reaction||pharmaceut prepar||fluoresc intens||experiment paramet||spike human plasma||method||determin||dansyl chlorid||standard deviat||oxm||dilut time||oxamniquin||result,1||1 2||2||26 1 1||2 fig. 2||2 1 depart||1 5||3||refer 1||method 2||27 2||linear 1||scheme 1||1 rizk||2 min,31046.0||30005.5||28965.0||21566.667||20968.667||20835.0||20705.0||17044.0||16864.5||16318.5||15688.5||15676.0||15579.5||15525.5||15117.5,0.0,0.0,0.0
178,Eur_Radiol-2-2-1705542.txt,injuri||labro-ligament complex||therapeut decis||pain athlet shoulder||superior||acut||diagnost work-up||labrum||anterior instabl||arthrographi||ighl||secondari imping||lesion||imag||bicep||common form||diagnost arthroscopi||shoulder disloc||normal anatomi||bankart||tear||complex||athlet||magnet reson||unclear shoulder pain||coron obliqu,2||2 1 2 4||1 2 6||refer 1||lesion 1||1 mnemon||2 37||instabl 2||46 2 11 2 fig. 11a||2 fig. 2a||springer-verlag 2006 introduct 1 5||1 5 9 12 fig. 1a||compar studi||effect||abnorm 4,28965.0||25478.25||23028.333||16864.5||16195.5||15525.5||15371.5||14550.5||11549.667||11328.667||10536.6||9609.667||7344.5||6956.0||6906.0,0.0,0.0,0.0
179,Diabetologia-3-1-2100429.txt,insulin resist||mma||pregnanc||folat||bodi composit||type 2 diabet||matern nutrit variabl||studi||matern nutrit||indian||children||women||mother||nutrit measur||fat mass||size||thci||newborn||adipos||offspr||risk factor,1||2||model 1||3||refer 1||J. 2||tabl 2||2 diabet||1 joshi||1 rege||4||studi||J. 1 joglekar||type 2 diabet||S. 1 fall,31046.0||28965.0||17468.5||17044.0||16864.5||16377.0||16290.5||15728.0||15535.0||15524.5||12937.0||12015.0||11612.667||11461.333||11331.0,0.0,0.0,0.13333333333333333
180,Purinergic_Signal-4-2-2377318.txt,apic surfac||mechan||fluid||medium||flow||atp secret||signal||volum addit control||monocilium||mechan stimul||transient||stimuli||atp||purinerg||releas||assay||epitheli cell||perfus||hypoton challeng||monolay||ionomycin||atp releas||filter||cell||pool,1||2||2 2 2||10 2||9 2||3||refer 1||1 fig. 1 orpk||1 mg||signal 2||polycystin 1||33 2||38 2||2 mg||68 2,31046.0||28965.0||28965.0||17973.5||17178.5||17044.0||16864.5||16770.75||15945.0||15633.0||15524.5||15482.0||15279.5||14904.5||14882.5,0.0,0.0,0.0
181,Diabetologia-4-1-2270364.txt,dna methyl||insulin resist||gene express||islet||insulin secret||GK rat||human diabet islet||beta cell function||usa||insulin releas||type 2 diabet||diabet||studi||sirna||non-diabet donor||express||pgc-1α||pancreat islet||gene||human islet||human||level||oxid phosphoryl,1||2||2 1 depart||refer 1||type 2||2 diabet||donor 1||1 ppargc1a||1 masiello||1 luthman||2 incub||2 ppargc1a||2 marchetti||2 groop||2 lupi,31046.0||28965.0||20835.0||16864.5||15946.5||15728.0||15681.0||15574.5||15525.0||15524.5||14721.5||14534.0||14486.5||14486.5||14484.5,0.0,0.0,0.0
182,Virchows_Arch-4-1-2335297.txt,malign||cancer||descript criteria||microcalcif||initi diagnosi||ductal carcinoma||atypia||median follow-up 160 month||atyp ductal hyperplasia||breast||subsequ cancer||follow-up||carcinoma||lobular neoplasia||studi||adh||lesion||tubular carcinoma||contralater breast||patient||high slide rate||dci||epitheli atypia||case||fea||type||diagnosi||classif||biopsi||flat epitheli atypia,1||2||1 fig. 1||patient 2||2 3 4 fig. 2||3||refer 1||lesion 1||2 mm||2 terminolog||patient||1 march 2004||4||studi||franc 2 depart,31046.0||28965.0||22356.0||21266.0||18577.4||17044.0||16864.5||16195.5||14896.0||14514.5||13567.0||13091.667||12937.0||12015.0||10556.333,0.0,0.0,0.13333333333333333
183,Arch_Orthop_Trauma_Surg-3-1-1914284.txt,cup||differ||resid||posit||abduct||factor||approach||estim||accuraci||total hip arthroplasti||inaccuraci||free hand||signific differ||placement||present studi||hip||safe zone||patient||posterolater approach||acetabular compon||antevers||surgic approach||acetabular cup posit||result||data||perop||surgeon||freehand placement,1||2 3||3||refer 1||patient||4||tabl 2 result||studi||5||springer-verlag 2007 introduct 1 6 7||2005||2004||patient characterist||present studi||10,31046.0||23004.5||17044.0||16864.5||13567.0||12937.0||12887.0||12015.0||10364.0||9551.0||8716.0||8077.0||7429.0||7377.0||6982.0,0.2,0.1,0.13333333333333333
184,Ulster_Med_J-76-3-2075581.txt,pre-op prepar||differ||clinic practic||number||medic literatur||practic||anastomot leakag||relev journal||primari anastomosi||group||elect procedur||infecti complic||anastomosi||studi||evid||author||surgeri||signific||post-op infecti complic||colorect surgeri||patient||infect||small tumour||bowel prepar||rct||randomis||mbp group||mechan bowel prepar||trial||standard practic||rectal carcinoma||small sampl size||rate||mbp||result,1||2||1 15 1||1 15||3||al 1||1 guenaga||2 bucher||patient||signific 1 2 7 9 15||discuss 1 2 7 9 15||4||10 1 9 11||studi||5,31046.0||28965.0||22223.0||17811.5||17044.0||16422.0||15524.0||14489.5||13567.0||13169.833||13113.0||12937.0||12117.75||12015.0||10364.0,0.0,0.1,0.13333333333333333
185,Behav_Genet-4-1-2226021.txt,golden retriev||snp||major role||microsatellit marker||loci||effect||non-aggress golden retriev||behavior inform||owner impress||behavior||strong effect||estim||aggress behavior||analysi||associ||molecular genet studi||studi||dna||haplotyp||aggress||dog||frequenc||linkag analysi||gene||quantit genet analysi||candid gene||allel||serotonin||genotyp||control group||dna sampl||anim model||aggress dog||power,1||2||2 2 htr1a tabl 2||3||number 1||case 2||haplotyp 1||1 htr1a||1 schilder||haplotyp 2||2 htr1a||A. J. 1 1 depart||4||studi||31-20-5983596 l.vandenberg@vumc.nl 1 2 vos-loohui,31046.0||28965.0||18108.4||17044.0||17008.0||16069.0||15620.5||15538.5||15529.5||14580.0||14498.0||14377.4||12937.0||12015.0||12002.8,0.0,0.0,0.06666666666666667
186,Childs_Nerv_Syst-4-1-2413122.txt,meningioma||mutat||analysi||myoepithelioma||marker||patient||year||dna||radiat therapi||loh||tumour,refer 1||C. 2||10 12 1||patient||31-20-5669312 t.j.hulsebos@amc.uva.nl 1 1 depart||netherland 2 depart||1 loh region||histolog find 2||C. J. 1 houben||case report histori 2||3 hulsebo||children 3 year||2007||netherland 3 depart||cancer,16864.5||15490.0||14626.667||13567.0||12917.6||11205.0||10884.333||10429.667||9213.75||9005.5||8524.0||7839.333||7287.0||7231.333||7076.0,0.2,0.1,0.06666666666666667
187,Pediatr_Nephrol-3-1-1989763.txt,feed||ccpd||report||dietari supplement||intak||dialysi||infant||bodi composit||protein||studi||nutrit||fat||import||diseas||appetit||weight gain||increas||growth||age||supplement||children||doqi||acidosi||chronic renal failur||height||patient||common practic guidelin||fat mass||serum albumin||gastrostomi||method||glucos||htsd||crf||level||dialysi dose||eaa||energi||result,1||2||2 2 132||2 10||2 4 5||children 1||3||2 year||suppl 2||sex 2||nutrit 2 2 127||phosphat 2||fals 2||2 sd||10 3 11 2,31046.0||28965.0||19417.667||17973.5||17422.0||17132.0||17044.0||16110.5||14901.5||14885.0||14678.75||14625.5||14580.0||14550.0||14510.5,0.0,0.0,0.0
188,Evid_Based_Complement_Alternat_Med-4-2-1876616.txt,date||pain||effect||outcom||non-malign pain||meta-analysi||chronic||superior||depress||tension-typ headach||group||headach pain||review||colleagu||moyer||conclus||neck||usual care||follow-up assess||condit||evid||spinal manipul||broad array||broad overview||rigor studi design||futur work||futur studi||fibromyalgia||improv||preliminari support||futur clinic trial||treatment||migrain||massag therapi||posit group||waitlist control||patient||relev studi||week||craniosacr therapi||chronic pain||therapi||massag||limit||chronic pain condit||robust support||support||find||cochran collabor||trial||acupunctur||discret pain condit||headach||relax||assess||result,1||2||1 tabl 1||1 8||1 year 1 year||1 year||3||1 month||tabl 2||1 MT||patient||4||tabl tabl 1||method 4 5 tabl 1||studi,31046.0||28965.0||21902.667||18600.0||17151.0||17151.0||17044.0||16322.0||16290.5||15817.5||13567.0||12937.0||12759.333||12327.0||12015.0,0.0,0.0,0.06666666666666667
189,Ann_Biomed_Eng-2-2-1705524.txt,model||effect hepatocyt util ratio||doubl number||medium||percentag||intern oxygen||zone||hepatocyt||flow veloc||oxygen||capillari||shear stress distribut||strategi||mat||amc-bal||simul result||extern oxygen||intern geometri||hepatocyt layer||flow rate||clinic set||increas||mmhg||outflow zone||shear stress||fraction||maxim shear stress||micro model||ga capillari||consumpt||cell distribut||flow field||hepatocyt distribut||inform||cell||case||fluid flow||result,1 1||1||1 2||2 2||2||2 2 2 5 2||2 2 3||2 3 2 2 3||2 2 2 penetr||2 2 2 cell 2 avail||9 2 2||2 4||5 2||2 5||2 ga 2,31046.0||31046.0||30005.5||28965.0||28965.0||25244.8||24991.333||24196.6||21757.5||21640.333||21107.333||20951.0||19664.5||19664.5||19387.333,0.0,0.0,0.0
190,Clin_Rheumatol-4-1-2367392.txt,amyloidosi||tracheobronchomalacia||patient||kidney,1||1 1 depart||refer 1||patient||discuss 2 4 5||case report 1 fig. 1 amyloidosi||netherland 2 depart||31-20-4442138 f.turkstra@janvanbreemen.nl 1 2 rinkel rico||clinic rheumatolog 2008 introduct 1||RA patient||netherland 3 depart||rheumatoid patient||dr. jan van breemenstraat 2||netherland 4 depart||diseas,31046.0||21528.667||16864.5||13567.0||13491.75||12230.0||11205.0||10005.333||7877.8||7258.5||7231.333||6915.5||6176.2||5862.333||5149.0,0.2,0.1,0.06666666666666667
191,Skeletal_Radiol-3-1-2042033.txt,whole-bodi imag||multipl cartilagin exostos||malign diseas||magnet reson imag||spatial resolut||pet-ct||diagnost sensit||scanner||muscl diseas||multipl||ms-ct||bone marrow||mri||introduct||skelet system||excel soft tissu contrast||fat||multipl myeloma||muscl||diseas||bone scintigraphi||diagnost accuraci||imag||system muscl diseas||bodi||lesion||sensit||system||patient||patient posit||tumor||multislic CT||radiographi||high resolut||scintigraphi||examin||case||destruct||assess||muscl dystrophi||skelet metastas||result,1||2 3 4 5||3||refer 1||suppl 1||pat 2||patient||3 fig. 3||studi||5||cancer patient||17 3||iss 2007 introduct 1||patient group||ms-ct 10 26 1 27,31046.0||17327.5||17044.0||16864.5||15942.0||14497.0||13567.0||13021.333||12015.0||10364.0||10321.5||10313.5||9913.0||9221.0||8611.6,0.0,0.1,0.06666666666666667
192,BMC_Bioinformatics-4-_-317283.txt,databas||matrix tabl||larg dataset||tool||keyword||pubm||combin||approach||literatur mine||queri||basic pubm search window||term co-occurr||keyword term||pubmatrix||gene||gene list||tabl||list||pair-wis comparison||proteom approach||data||modifi term||simpl||result||search term,1||figur 1 2||figur 2||3 4 3 4 11 12||tabl 1 exampl||usa 2 nct||1 beckerk@grc.nia.nih.gov hosack dougla||2002||figur 3 gene express result||usa 3 laboratori||2001||result||2000||health||9,31046.0||20404.0||15083.0||11810.833||11802.667||10288.0||7775.75||7057.0||6702.8||6561.333||6313.0||6080.0||5903.0||5601.0||5392.0,0.0,0.0,0.06666666666666667
193,Diabetologia-3-1-1849422.txt,potenti impact||model||nhane iii||survey||number||project||futur||popul||estim||person||score||total number||decreas||diabet||studi||high-risk group||increas||age||proport||risk||hispan commun||individu||older age group||II mortal survey||burden||preval||result||data||nutrit examin survey||mortal||adult||year||substanti number,1||2||2 1 depart||2 time 2 time 2||result 1||J. 1||tabl 1||3||1 number||refer 1||2 diaz||4||model time 2||studi||J. 1 saxena,31046.0||28965.0||20835.0||18955.4||18563.0||17417.5||17331.0||17044.0||17008.0||16864.5||14519.0||12937.0||12265.667||12015.0||11621.667,0.0,0.0,0.06666666666666667
194,Apoptosis-3-1-1914234.txt,cardiomyocyt||effect||hci||incub||concentr||usa||decreas||studi||atp||antibodi||pb||apoptosi||sampl||express||experi||heart failur||nuclear nitrotyrosin residu||nuclear ro product||sah||cell||result,1||1 1||2||2 2 act||2 3 5||fig. 1||1 fig. 3||tabl 1||3||fig. 2||refer 1||2 23||llc 2007 introduct 1 2 3||patient||M. 1 8 9 1 depart,31046.0||31046.0||28965.0||19434.0||18791.0||18011.0||17688.667||17331.0||17044.0||16970.5||16864.5||15976.5||14323.167||13567.0||13313.0,0.0,0.0,0.0
195,Dev_Biol-2-1-2098691.txt,tgf-β||bind||promot element||effect||endoderm element||depend||transcript||downstream||direct effect||endoderm gene express||sox site||anim||sequenc||construct||gfp fluoresc||gastrula||promot||lane||sox17||express||veget||element||network||gene||endoderm differenti||emsa||vegt||endoderm||site||gfp||transgen||region||direct target||result,1||2||2 2||1986 3 3 2 2||1 gene||fig. 2 fig. 1||3||1 promot||1 transgen||1 fragment||xsox17α 1||h.r.woodland@warwick.ac.uk 1||2 unit||2 μl||smad 2,31046.0||28965.0||28965.0||18574.2||17920.0||17490.75||17044.0||15966.5||15744.0||15684.5||15539.0||15524.0||15109.5||14590.5||14488.0,0.0,0.0,0.0
196,Ann_Surg_Oncol-4-1-2234448.txt,fnb specimen||icp-m||hydrochlor acid||sln biopsi procedur||melanoma||primari cutan melanoma||antimoni level||techniqu||ppb||fnb sampl||analysi||studi||true sln||sampl||fine-needl biopsi||patholog assess||standard||ident||lymph node||antimoni||antimoni concentr||patholog||method||procedur||sentinel lymph node||node||region lymph node||level||sln||oper procedur||result,1||2||2 3||1 tabl 2||refer 1||2 3 24||lod 2||patient||3 4 5||surgic oncolog 2008 1 2||dphil 2 6||studi||fac john.thompson@smu.org.au 2 6 1 depart||1 dawson michael||1 scolyer richard,31046.0||28965.0||23004.5||21209.0||16864.5||16428.333||14511.0||13567.0||13448.333||12697.4||12680.0||12015.0||11934.5||10418.667||10400.0,0.0,0.0,0.06666666666666667
197,Eur_J_Pediatr-3-1-2042511.txt,adp||human patholog||platelet||epstein syndrom||dmd||broader clinic phenotyp||platelet function||secret||protein||studi||diseas||gray platelet syndrom||platelet-bas bleed disord||defect||mutat||disord||gene||patient||adhes||platelet research||pathway||metabol diseas||result||function,1||2||1 13 35 1||refer 1||1 syndrom||patient||studi||1 8 9 17||thi||belgium 2 depart||37 32 1 12||irrevers platelet activ 1||2004||rare di 2006 1 10 10.1186||10,31046.0||28965.0||17087.25||16864.5||16332.5||13567.0||12015.0||11543.75||11251.0||10527.333||10217.0||9152.75||8077.0||7967.5||6982.0,0.0,0.2,0.13333333333333333
198,Naunyn_Schmiedebergs_Arch_Pharmacol-2-2-1705472.txt,arrhythmia||effect||cortisol||blockad||cardiac tissu||flow||ang II||synthesi||mineralocorticoid receptor||antagonist||activ||inotropi||cardiac inotropi||heart failur||eplerenon||aldosteron level||cardiac level||glucocorticoid||aldosteron||blood pressur||oxid stress||rat||low level||chai,1||2||3 2||3||patient||angiotensin type 2 receptor||2005b 2005 2004 3||2004 2005 2004||2005 2003 2004 2003 2003||11beta-hydroxysteroid dehydrogenas type 2 activ||2002 2002||2003 2001||10||cell membran||effect,31046.0||28965.0||23004.5||17044.0||13567.0||8900.75||8481.5||8290.0||7949.2||7447.6||7057.0||6982.0||6982.0||6961.5||6956.0,0.0,0.0,0.06666666666666667
199,Diabetologia-3-1-2039861.txt,cardiomyocyt||cd36||insulin resist||basal||high-fat diet||sso||basal phosphoryl||group||diabet cardiomyopathi||vivo cardiac function||phosphoryl||insulin||fat||lfd||lcfa||diabetes-rel heart diseas||increas||cardiac dysfunct||substrat uptak||utilis||high-fat feed||glucos uptak||diet||insulin-resist rat||triacylglycerol||rat||data||contractil dysfunct||myocardi triacylglycerol accumul||lcfa uptak||heart||hfd,1 1 1||1||2||2 2||1 2 5||2 2 15||1 30||3 3||3||fig. 2||9 2 13 2||refer 1||1 boer||cd36 2 24 23 2 2||7 1 8,31046.0||31046.0||28965.0||28965.0||23458.333||20835.667||17156.5||17044.0||17044.0||16970.5||16896.0||16864.5||15577.0||15534.5||14732.333,0.0,0.0,0.0
200,Arch_Dermatol_Res-3-1-1800369.txt,cutan malign||skin cancer pathogenesi||cancer||prognost classif||gene express||immunohistochemistri||classif system||tumour entiti||classif||prognost factor||vascular invas||melanoma||skin cancer||primari melanoma||tumour size||diseas||invas||express||cancer entiti||biomark||molecular marker||malign melanoma||patient||primari tumour||prognosi||squamou cell carcinoma||cell||serum||metastasi||molecul,1||1 1||2||refer 1||malign melanoma 1 1||49-621-3832163 s.ugurel@dkfz.d 1 2 1 depart||44 2||tyrosinas 2||patient||cell||studi||fig. 1 mia||express 3||1 serolog marker||5,31046.0||31046.0||28965.0||16864.5||15790.75||15592.167||15155.0||14490.0||13567.0||12627.0||12015.0||12009.667||10719.5||10585.0||10364.0,0.0,0.2,0.13333333333333333
201,Exp_Brain_Res-4-1-2257995.txt,interhemispher inhibit||fdi||lowest intens||effect||transcrani magnet stimul||corticospin excit||correl||ihi||variabl||motor system||corticospin output||motor hotspot||motor cortex||intens||measur||studi||age||activ condit||activ||mep||older individu||chang||sici||subject||function imag studi||hand||pathway||inhibit||tm,1||2||result 1||fig. 2||2 chang||1 reflect||2 rothwel||S. 2 3 1 sobel depart||2 fig. 1 circl line||studi||chang 2 chang||1 tm measur||C. 1 ward||1 1986 1999 1997||2004 154 1 10 10.1007,31046.0||28965.0||18563.0||16970.5||16025.5||15805.5||14495.5||13704.333||13300.8||12015.0||11712.333||11702.0||11079.0||10060.75||10032.8,0.0,0.1,0.06666666666666667
202,Mycorrhiza-4-1-2245993.txt,signific effect||1-octen-3-ol||collembola||plug||bodi||speci||signific inhibit||effect||aggreg||sawahata||chamber||methyl cinnam||collembolan,2||1 month||2 3 fig. 2 proisotoma||1 fig. 1 proisotoma minuta||studi||cylindr chamber 1||2006||2004||2003||fig. 3 proisotoma||2002||effect||2001||2000||5 nakamori,28965.0||16322.0||15991.8||13418.0||12015.0||10406.0||8371.0||8077.0||7651.0||7343.0||7057.0||6956.0||6313.0||5903.0||5185.0,0.0,0.0,0.06666666666666667
203,J_Chem_Ecol-4-1-2239252.txt,insect||effect||plant||herbivor||prefer||bar-typ plant||plant defens||perform||amino acid level||chemotyp||amino acid||sugar||glucosinol||oviposit||experi||larva||leav||egg||specialist herbivor||bar-typ||generalist||glucosinol concentr||leaf,1||1 1||2||1 1 depart||1 2 4 content||1 M.||3||fig. 2||4||studi||1 M. brassica||1 P. rapa||2 M. brassica||netherland 2 laboratori||3 M.,31046.0||31046.0||28965.0||21528.667||18385.0||17396.0||17044.0||16970.5||12937.0||12015.0||11695.333||11077.667||11001.667||10621.0||10395.0,0.0,0.0,0.0
204,Purinergic_Signal-3-4-2072917.txt,bind||effect||concentr||dna fragment||experiment condit||protein||addit||apoptosi||time||mpp||treatment||activ||cell surviv||cell death||dopaminerg neuron||cell||protect effect||caspase-3||guanosin||molecular mechan||result,1||2||2 2||1 fig. 1||3 6 1||3||fig. 2||refer 1||2 17||kinas 1||post-treat 1||2 μM||tabl 1 effect||elisa 4 2 7 3 4||3 fig. 3,31046.0||28965.0||28965.0||22356.0||19054.667||17044.0||16970.5||16864.5||16274.0||15960.5||15550.0||14595.5||13872.667||13160.0||13021.333,0.0,0.0,0.0
205,Mol_Genet_Genomics-3-1-2129107.txt,inur||strain||growth||express||bind||inulin||extracellular enzym||sucros||unpublish result||inulinolyt enzym||inulinolyt gene||data||protein||transcript||gene||mutant||domain||carbon sourc||invertas||result,1||2||2 fig. 2||1 A.||2 6 5||16 2 6||1 tabl 1 A. niger||4||31-71-5274999 a.f.j.ram@biology.leidenuniv.nl 1 1 institut||cell||supplementari tabl 1||p.o. box 1||3 fig. 6||inur 1 A. niger 2007||2004,31046.0||28965.0||20968.667||17279.0||16134.333||13996.667||13886.6||12937.0||12707.8||12627.0||11818.0||10652.667||10364.667||8431.0||8077.0,0.0,0.0,0.0
206,Bioinformation-1-1-1891626.txt,eukaryot||databas||altern splice||avatar||inform||gene locat||gene||mrna sequenc||est||genom||mrna,1||2||1 2 3||3||figur 1||step 1||bioinform 1||step 2||4 5||refer 1 breitbart||taiwan 2 depart||tabl figur 1 process||6||step 3||2005,31046.0||28965.0||25685.0||17044.0||16123.5||15803.5||15556.5||14763.0||11650.5||11243.333||10501.0||9449.75||9074.0||8802.5||8716.0,0.0,0.0,0.0
207,Arch_Sex_Behav-3-1-2042031.txt,episod||sexual abus||sex||number||outcom||effect||abus characterist||coercion||group||oral sex||hiv||past 3 month||research||sexual behavior||studi||unprotect sex||addit||previou std diagnos||characterist||gender||sexual partner||analys||partner||penetr||demograph||experi||abus||patient||risk||forc||sexual act||limit||sexual risk behavior||adult||std||men,1||2||2 2||1 fig. 1||tabl 1||3||mpcarey@syr.edu 1||patient||studi||usa 2 school||1 carey michael||5||2 demograph characterist||1 tabl 3 sexual risk behavior||2005,31046.0||28965.0||28965.0||22356.0||17331.0||17044.0||15523.5||13567.0||12015.0||10518.333||10409.0||10364.0||10151.667||9562.667||8716.0,0.0,0.2,0.13333333333333333
208,Appl_Microbiol_Biotechnol-4-1-2279157.txt,vivo||differ||express analysi||detect||biolog interpret||quantiti||softwar||statist||approach||techniqu||step||intens||analysi||imag analysi||background||protein||gel||time||pattern||imag||larg amount||statist test||sampl||valu||biolog system||spot||experi||test||statist method||express profil||proteom map||express level||show||method||imag process method||larg number||data||calibr||label||result,1||2||1 2 2003 2007||2 2006 tabl 2||1 current||4||studi||plo biol 2||germani 2 institut||relev protein fig. 2||5 6||1992 1998 1999 2001 1||6||3 2003 fig. 3 protein label||2005,31046.0||28965.0||18737.25||17479.25||16257.0||12937.0||12015.0||11073.667||10367.0||10229.0||9719.0||9619.6||9074.0||8905.5||8716.0,0.0,0.0,0.0
209,Photosynth_Res-4-1-2173912.txt,red alga||width||electron microscopi||pbss||project||array||cyanobacteria||structur||phycobilisom||pb||membran||psii,2||1 1 depart||3 3||3||2 1988||cell||2 1992 2000 2000||25 nm 3 3 fig. 3||aartsma@physics.leidenuniv.nl 2 zhang||1987 1992 3 1999 1996 2||2005||netherland 2 biophys depart||2003||50 nm 3 3 thermosynechococcu||2007,28965.0||21528.667||17044.0||17044.0||14997.0||12627.0||10619.75||9946.5||9832.333||9398.167||8716.0||8421.5||7651.0||7410.6||7287.0,0.0,0.0,0.0
210,Naunyn_Schmiedebergs_Arch_Pharmacol-3-1-2020506.txt,receptor||regul||arf||direct interact||ra||schmidt||actin cytoskeleton||small gtpase||actin organ||enzym||synthesi||protein||plasma membran||phosphoinositid||membran||rho||gtpase||activ||isoform||actin remodel||stimul||pld||phosphatid acid,1||2||springer-verlag 2007 2 2 2 2||2 2000 2 2005 2 2006||3||1 lópez||2 phosphoinositid||2003 2 2001||cell||adp-ribosyl factor 1||yin HL 3 2||A. deusinglaan 1||germani 2 depart||2001 1 2002 2001 2000 2002||s00210-007-0131-4 review 2,31046.0||28965.0||20791.833||18314.167||17044.0||15528.0||14496.5||14309.667||12627.0||11842.667||11556.75||11520.667||10717.333||10614.833||10405.333,0.0,0.0,0.0
211,Biogerontology-4-1-2367389.txt,mous||hif-1α||anim||diet protocol||protein||tissu||skelet muscl||age||express||calor restrict||gene||chang||hypoxia||restrict||mif||liver||hif||prolyl-4-hydroxylas domain||phd||diet-specif||rat||data||calor intak||heart,1||2||3||1 μg||1 mmol||49-551-395895 katschinski@physiol.med.uni-goettingen.d 2 1 institut||studi||hypoxia-induc factor 1||3 express||germani 2 depart||schofield CJ 2||reduc hypoxia-induc factor 1 activ||2006 2006 2006||2006 2005 2007||real time pcr fig. 2 effect,31046.0||28965.0||17044.0||15725.5||15676.5||12291.2||12015.0||11857.0||10719.5||10717.333||9830.667||8475.2||8371.0||8124.667||7550.5,0.0,0.0,0.0
212,J_Abnorm_Child_Psychol-4-1-2277450.txt,differ||anxiou children||inform care||mental health treatment||parent||resourc||percentag||converg valid||diari||group||gener popul||anxieti disord||mental disord||cost||clinic anxieti disord||sever score||studi||school||aim||work||childhood anxieti disord||children||disord||care||treatment||famili||reason||cost diari||discrimin valid||cost-of-il||psycholog problem||method||anxieti||preval||top-down data||data||year||annual societ cost-of-il||gener practition||physic problem||result,1||2||1 2004 2 3 4 5||tabl 1||1 year||3||2 year||2 week||patient||3 1 research centr||4||discrimin valid 2 tabl 2||studi||netherland 2 depart||5,31046.0||28965.0||18072.167||17331.0||17151.0||17044.0||16110.5||15100.0||13567.0||13136.25||12937.0||12565.8||12015.0||11205.0||10364.0,0.0,0.0,0.06666666666666667
213,Eur_J_Appl_Physiol-4-1-2267484.txt,maxim voluntari torqu||day||exercis||dom||voluntari contract||signific recoveri||motor cortex||intens||spinal modul||decreas||studi||muscl||healthi subject||muscl sore||plantar flexor muscl||central fatigu||test||muscl damag||mvt||subject||find||contractil properti||data||evok potenti||walk||result||modul,"1||2||2 2||1 2005||1 year||test 1||fig. 2||potenti 3 1||1 1 motor effici||1 noak||1 puchaux||974-413-2020 contact@sebastienracinais.com 1 2||2 kg||2 cm||4,36 1 fig. 3",31046.0||28965.0||28965.0||19881.0||17151.0||17126.0||16970.5||16624.333||15766.25||15526.0||15523.5||15003.25||14722.0||14720.5||13268.0,0.0,0.0,0.0
214,Biotechnol_Lett-3-1-2045120.txt,cross-link protein crystal||lysozym||molecular dynam||solut||channel||order||analysi||protein||studi||diffus coeffici||pore wall||time||protein crystal||simul||amino acid||transport phenomena||transport||motion||free lysozym||residu||diffus||crystal||water||orthorhomb lysozym crystal||molecul||ara||result,1||2||discuss 2 2||1 2004||10 2||3||14 2||13 2||3 fig. 3||1 1981 2007||1 2000 2005a||studi||2004 2005 2005 3||5||unit atom fig. 2,31046.0||28965.0||19877.0||19561.5||17973.5||17044.0||16631.0||16613.5||13021.333||12920.667||12358.0||12015.0||10638.25||10364.0||8864.5,0.0,0.0,0.06666666666666667
215,Pediatr_Radiol-3-1-1950215.txt,congenit||urorect septum||male||mullerian duct cyst||dorsal aspect||cowperian duct||vcug||diverticulum||urogenit diaphragm||male urethra||present||urethr strictur||embryolog||anterior urethr diverticula||urethra||bladder||patient||valv||anomali||intern sphincter||anterior,"1||1 1 2 fig. 1 2||1 7||refer 1||fig. 2 4||patient||5||fig. 4 4||patient 17||5 6 fig. 5 normal||1,992 patient||7 9 10||histolog studi||histopatholog studi||result",31046.0||26007.333||19021.5||16864.5||15626.0||13567.0||10364.0||10283.333||8575.0||7328.4||6784.0||6457.0||6230.0||6152.5||6080.0,0.0,0.1,0.06666666666666667
216,Mod_Rheumatol-4-1-2279153.txt,respons||diseas durat||retrospect clinic studi||infliximab||demograph factor||clinic respons||discontinu||dose||advers event||japan||factor||low activ||advers reaction||retrospect studi||remiss||eular criteria||studi||rheumatoid arthriti||diseas||secondari insuffici||respons criteria||age||treatment||clinic efficaci||diseas activ||patient||mtx||therapi||crp||RA manag group||younger age||notabl efficaci||infliximab therapi,2||2 result||3||refer 1||patient||statist analysi 1||clinic characterist 1||studi||3 result||tabl 1 baselin characterist||rheumatolog 2008 introduct 1 5||2005||studi group||clinic studi||patient ’s,28965.0||17522.5||17044.0||16864.5||13567.0||12437.333||12398.333||12015.0||11562.0||9161.5||8979.0||8716.0||8445.0||8436.5||8305.5,0.2,0.2,0.13333333333333333
217,Eur_Radiol-3-1-1779628.txt,cancer||local recurr||power gradient system||imag modal||sequenc||accuraci||mri||recent year||neoadjuv therapi||stage||import criterion||studi||rectal tumor||fov||imag||coil system||patient||import anatom landmark||tumor||rectal cancer||local stage||mesorect fatti tissu||rectal carcinoma||eu||mesorect fascia||local excis||crm,2||refer 1||7 1 8 fig. 1||charitéplatz 1||patient||3 4 5||studi||M1 fig. 2||1 tnm classif||5||2 uicc stage||6||28 patient||41 patient||affect patient,28965.0||16864.5||16043.8||15523.5||13567.0||13448.333||12015.0||11327.333||10599.333||10364.0||10052.667||9074.0||8008.0||7554.5||7364.0,0.2,0.2,0.13333333333333333
218,Clin_Rheumatol-3-1-2092406.txt,situat||tool||durat||number||guidanc||group||gener popul||earli arthriti||health profession||follow-up||work disabl||symptom durat||studi||symptom||aim||work||diseas||adapt||proport||workplac adapt||disabl||profession guidanc||chronic arthriti||patient||period||year||arthriti||vocat guidanc||eac||sick leav||statu||job||diagnosi||gener practition||studi entri,1||2||2 1 3 1 3 4||0 0 1 2 0 2||1 year||3||refer 1||demand 1||1 sociodemograph||0.767 1||0.754 1||2 week||patient||4||31-71-5266752 t.p.m.vliet_vlieland@lumc.nl 1 1 depart,31046.0||28965.0||23013.667||17875.833||17151.0||17044.0||16864.5||15620.5||15542.5||15526.0||15525.0||15100.0||13567.0||12937.0||12917.6,0.0,0.0,0.06666666666666667
219,J_Autism_Dev_Disord-4-1-2268726.txt,differ||comprehens||hfa||speed||intellig profil||group||asperg syndrom||perform||diagnost group||piq||peopl||studi||wais-iii profil||hfa group||subtest level||wais-iii||wai iii factor scale||subtest||factor scale||problem||inform||process speed||adult||level,1||2||3||subject 1||1 characterist||1 2.3||2 1 ggz eindhoven||patient||4||studi||netherland 2 depart||tabl 2 viq||5||5 6||6,31046.0||28965.0||17044.0||16465.0||16168.5||15657.0||15017.75||13567.0||12937.0||12015.0||11205.0||10863.333||10364.0||9719.0||9074.0,0.0,0.1,0.06666666666666667
220,Pediatr_Nephrol-4-1-2259258.txt,linkag||npl||loci||total npl||total||pedigre||averag||previou studi||score||studi||evid||haplotyp||vur||children||famili||chromosom 1||linkag analysi||gene||patient||lod||genet linkag||genet heterogen||individu||primari vur||reflux||addit marker||region||maximum lod||complex disord||result,1||2||3||result patient 1||refer 1||famili 1||chromosom 1||1 perrotta silverio 2 1 depart||famili 2||2 2 fig. 2 squar circl||2 1.34||patient||4||studi||rang 1 month,31046.0||28965.0||17044.0||16897.667||16864.5||16458.0||15734.0||15592.833||15417.5||15388.833||14532.5||13567.0||12937.0||12015.0||11378.667,0.0,0.1,0.2
221,Eur_J_Pediatr-4-1-2292481.txt,symptomat asymmetri||month||syndrom||craniosynostosi||review||clinic syndrom||young infant||clinic specialti||torticolli||infant||movement||birth||sign||symptom||studi||literatur||current inform||differenti diagnosi||asymmetri||life||disord||screen||posit prefer||clinic diagnost criteria||case||etiolog||clinic decis||plagiocephali||diagnosi||incid rate,1||M. 1 1 depart||refer 1||1 disord||2 sign||studi||netherland 2 depart||3 year||2 takken tim 1 helder paul||2005||3 7 51||2003||system disord 2 6. craniosynostosi||addit studi||effect,31046.0||17083.0||16864.5||16465.0||14660.5||12015.0||11205.0||10150.0||10037.667||8716.0||8388.667||7651.0||7078.0||6983.5||6956.0,0.0,0.1,0.06666666666666667
222,Arch_Sex_Behav-3-1-1914258.txt,condom||neg influenc||sexual motiv||sex||msm||effect||hiv-posit statu||casual sex encount||varianc||variabl||self-efficaci||behavior||person characterist||step||context||person||neg impact||prosoci tendenc||measur||peopl||plan behavior||consequ||addit||particip||import role||norm-activ theori||riski sexual behavior||person norm||present studi||signific||emot||partner||unprotect anal intercours||steadi||signific increas||item||sexual risk behavior||theori||moral concern||prosoci behavior||determin||subject norm||predict||find||antivir therapi||men||predictor||intent,1||2||3||1 1986||01. 1||behavior 2||8.9 2||88.3 2||57.5 2||01. 2||4||sexual decision-mak 1 1998 fig. 1||studi||2 yr 59 20.1 2||netherland 2 depart,31046.0||28965.0||17044.0||15949.5||15525.0||15259.0||14523.0||14488.5||14486.5||14484.5||12937.0||12016.667||12015.0||11800.4||11205.0,0.0,0.0,0.0
223,Intensive_Care_Med-4-1-2271079.txt,memori||model||hospit||bdi-ii||secondari periton||depress||ptsd||periton||factor||traumat event||icu||abdomin sepsi||develop||major comorbid||follow-up||instrument||questionnair||symptom||studi||median apache-ii score||nomogram||diseas||ptss-10||multivari model||age||stay||patient||sepsi||hospit ward||risk||ies-r||younger age||event||predict||posttraumat stress disord||final model||previou 3 year||initi emerg laparotomi||intens care,1||2||3||refer 1||1 month||2 fig. 2 nomogram||j.reitsma@amc.nl 1||2 week||result 1 fig. 1 flowchart||respons 1 tabl 1 associ||patient||4||studi||netherland 2 depart||ptsd symptom 1,31046.0||28965.0||17044.0||16864.5||16322.0||15730.25||15523.5||15100.0||14630.2||14544.4||13567.0||12937.0||12015.0||11205.0||10770.333,0.0,0.0,0.13333333333333333
224,Eur_Arch_Otorhinolaryngol-4-1-2217621.txt,juvenil onset form||form||cidofovir||prophylact hpv vaccin||adult form||laryng papilloma||hpv||low incid||papilloma||diseas||vaccin||recurr respiratori papillomatosi||lesion||treatment||infect||infect host cell||adequ airway||rrp||suffici clinic follow-up data||risk factor||larg multi-centr collabor clinic trial||year,refer 1||patient||studi||2 33 42||UK 2 depart||44-1223-217559 holger.sudhoff@rub.d 3 1 depart||2005||studi group||40 44 2 49||2006||epidemiolog 26 10 32 1 47||effect||UK 3 depart||respiratori cell||cancer multicent studi,16864.5||13567.0||12015.0||10816.667||10778.333||10117.2||8716.0||8445.0||8406.0||8371.0||7455.333||6956.0||6804.667||6530.5||6412.667,0.0,0.0,0.0
225,Ann_Hematol-2-2-1705486.txt,unexpect effect||bone marrow microenviron||month||erythroid respons||hemoglobin||complet suppress||myelodysplast syndrom||normal||cytogenet respons||md patient||cytogenet remiss||addit chromosom abnorm||cytotox effect||complex karyotyp||clinic trial||lenalidomid||case studi||metaphas||treatment||patient||therapi||transfus independ,1||2||2 3||patient 1||patient 2||5 1||1 9 2 17 1||2004 1||patient 4 1||patient 2 6||3||refer 1||medic patient 3 1||grade 1||patient 3,31046.0||28965.0||23004.5||22306.5||21266.0||20705.0||20006.4||19561.5||19183.333||17202.0||17044.0||16864.5||16223.5||15863.5||15305.5,0.0,0.0,0.0
226,Pflugers_Arch-3-1-1915652.txt,gene express||renal abc transport||effect||product||renal drug transport||tubul cell||ino||lp||aminoguanidin||up-regul||increas||sampl||express||nephrotox||gene||supplementari materi||import efflux pump||proxim tubul||endotoxemia||proxim tubular damag||kidney||rat||renal proxim tubul,1||2||1 1 fig. 1||2 fig. 2||1 1 4 1 fig. 4||5 2||2 3 4||3||refer 1||1 renal||M. 2||pb 1||2 fig. 6||3 3 fig. 3||12 13 2,31046.0||28965.0||24528.5||20968.667||20664.667||19664.5||19648.667||17044.0||16864.5||16447.5||16355.5||15631.5||14338.333||14027.0||13026.333,0.0,0.0,0.0
227,Naunyn_Schmiedebergs_Arch_Pharmacol-3-1-1915621.txt,respons||model||bath fluid||capsaicin||concentr||relax respons||distal coronari arteri||channel||kcl||interest||studi||antagonist||olcegep||vehicl||human coronari arteri||concentr respons curv||cgrp||porcin||arteri||segment||relax,1||1 2 1 2||2||2 2||3 1||37 1 1 1||2 3||1 1 fig. 1 effect||4 2||6 1||1 effect||1 0||2 effect||2 0||3 3,31046.0||30005.5||28965.0||28965.0||24045.0||23729.0||23004.5||21014.0||20951.0||20060.0||19001.0||18569.5||17960.5||17529.0||17044.0,0.0,0.0,0.0
228,Pediatr_Radiol-3-1-1950216.txt,injuri||brain||dwi||spine||abnorm||fat satur||manufactur||tumour||sequenc||mri||addit sequenc||time||imag||contrast||age||children||axial||patient||protocol||slice thick||imag protocol||signal-to-nois||year||diffusion-weight imag||plane,1||2||children 1 2||1 5 fig. 1||1 year||refer 1||1 indic||2 year||vol 2||patient||4||2 age group||studi||contrast medium 1||4 month 3,31046.0||28965.0||21076.333||19358.0||17151.0||16864.5||16688.5||16110.5||14569.5||13567.0||12937.0||12468.333||12015.0||10903.0||10526.333,0.0,0.1,0.06666666666666667
229,J_Abnorm_Child_Psychol-3-1-1915590.txt,model||scale||matern depress||hyperact||parent||low||control variabl||prenat smoke||behavior||group||neg parent||hostil reactiv parent||impuls||parent psychopatholog||associ||high level||high||studi||contrast||sampl||age||physic aggress||children||analys||signific||mother||famili||trajectori||comorbid||smoke||adhd||item||tremblay||problem||earli childhood||co-occurr,1||2||1 fig. 1||1 qlscd 2||3||1996 1||age 2||2 level||cycl 1||no. 1||3 3 4||vol. 1||5 1 depart||mle 2||trajectori 1 2004,31046.0||28965.0||22356.0||20004.333||17044.0||17036.5||16265.0||16085.5||15884.0||15743.5||15675.0||15592.0||14634.667||14486.0||13098.667,0.0,0.0,0.0
230,Surg_Endosc-3-1-2077356.txt,laparoscop procedur||differ||group||laparoscop duhamel||follow-up||aganglionosi||signific differ||rectum||studi||time||cosmet result||adhes obstruct||end point||hospit stay||bowel||postop complic||adhes bowel obstruct||higher enterocol rate||march 1994||enuresi rate||patient||period||open||duhamel||duhamel procedur||enuresi,1||2||1 2 stenosi 0 2||result 1||3||refer 1||C. 1 1 depart||tabl 2||llc 2007 1 3||patient||4||4 4||studi||netherland 2 depart||5,31046.0||28965.0||19059.0||18563.0||17044.0||16864.5||16650.25||16290.5||13919.0||13567.0||12937.0||12937.0||12015.0||11205.0||10364.0,0.0,0.1,0.13333333333333333
231,J_Gastrointest_Surg-3-1-1852386.txt,respons||brdurdli||cancer cell prolifer||local recurr||preoper radiotherapi||clinic down-stag||schedul II||treatment time||clinic assess||prolifer rate||complet respons||radiotherapi||ratio||prolifer||studi||signific growth inhibit||time||author||earli tumor respons||surgeri||valu||treatment||brdurd-label cell||signific||schedul||patient||linear regress||week||regress||spf||resect||interv||tumor||rectal cancer||cell death||cell||rate,1||1 1||2||patient 1 1 1||3 2 1||3||result patient 1||refer 1||1 month||1 week||19 2 2 figur 2 associ||patient||vitro 17 3 1||4||cell,31046.0||31046.0||28965.0||26676.25||25685.0||17044.0||16897.667||16864.5||16322.0||16140.5||15846.0||13567.0||13104.25||12937.0||12627.0,0.0,0.0,0.13333333333333333
232,Purinergic_Signal-4-1-2246000.txt,microgli cell||propag||model||receptor||valu||releas||calcium||site||work||cell||initi||microglia||atp||densiti||calcium wave||diffus substanc||lane||wave||astrocyt||transmiss,1||1 2 1 2||2||2 2||3 1||3 2||7 1 2||4 2||propag 1 2||3 fig. 2 2||5 2||5 3 3 2||2007 2||8 2||result 2,31046.0||30005.5||28965.0||28965.0||24045.0||23004.5||22336.0||20951.0||20029.0||19987.5||19664.5||18354.25||18126.0||17559.5||17522.5,0.0,0.0,0.0
233,J_Abnorm_Child_Psychol-3-1-1915632.txt,social adjust||report||behavior||group||stabil||score||transient||school||social function||gender||nomin||peer||aggress||pattern||boy||adjust||similar||analys||social maladjust||adolesc||bulli||featur||dislik||problemat social behavior||behavior pattern||item||class||depend variabl||find||problem||victim||girl,1||2||result 2||3||T. 2 1 institut||childhood 1||4||4 4||studi||tabl 2 correl||M. E. 1 overbeek geertjan 1||netherland 2 depart||shyness insecur 1||friend tabl 1 intercorrel||T. 1 haselag gerbert,31046.0||28965.0||17522.5||17044.0||15770.0||15769.0||12937.0||12937.0||12015.0||11393.0||11295.833||11205.0||10363.333||8693.5||8169.5,0.0,0.0,0.0
234,J_Chem_Ecol-3-1-1915630.txt,sixth leav||effect||number||total||van loon||butterfli||plant||herbivor||natur enemi||surfac||plant defens||perform||pupal weight||leaf surfac||treatment||leaf surfac extract||glucosinol||oviposit||control||experi||gl||test||cabbag||paper||leav||leaf tissu||butterfli speci||van poeck||egg,1 2 1||2||2 2||3||1 P.||1 brassica||4||netherland 2 centr||5||pieri 1992a 2||1996 22 1 12 10.1007||3 fig. 3 P. rapa||2006 21 3 8 10.1007||2 van loon joop||purifi glucosinol fraction 2,30352.333||28965.0||28965.0||17044.0||16524.0||15670.0||12937.0||10622.667||10364.0||9699.333||9385.6||8250.2||7734.0||7623.5||7418.75,0.0,0.0,0.0
235,Pediatr_Radiol-3-1-1891645.txt,congenit||tracheal||CT protocol||mpr||anatom relationship||dose||high-resolut imag||clinic case||lung||techniqu||airway||compress||time||imag||radiat dose||children||tracheobronchi tree||protocol||scan||inform||case||low-dos protocol,1 1 1||1 1 1 1 1||1||2||1 2 1 2 5||2 3 3||1 2 3 4 5||1 6 1 3 4 5||3||refer 1||5 3||patient||4||tracheobronchi anomali 1 11 1 12||1 imag protocol,31046.0||31046.0||31046.0||28965.0||26077.2||21017.667||20071.2||18585.167||17044.0||16864.5||13704.0||13567.0||12937.0||12189.5||11619.667,0.0,0.0,0.0
236,Appl_Microbiol_Biotechnol-4-1-2271084.txt,microbi commun||reactor||anaerob commun||total bacteria||concentr||probe||lactat||propion||rel abund||methanogen popul||fish||sulfat ratio||ratio||studi||sulfate-reduc bacteria||acetogen bacteria||acetogen||domin microbi commun||methanogen archaea||sulfat||bacteria||activ||methanogen||percentag abund||dgge||effluent||complet oxid||acet||mix anaerob commun||srb||divers||oligonucleotid probe||result,1||1 1||1 2||1 2 2||2||2 2||2 2 2||2 2 2 5||1 2 2 D.||1 fig. 1||1 5||2 1986 2 2 2002 2005||3||1 D.||fig. 2 2 strip,31046.0||31046.0||30005.5||29658.667||28965.0||28965.0||28965.0||24314.75||22647.5||22356.0||20705.0||17253.5||17044.0||16330.0||15740.75,0.0,0.0,0.0
237,Eur_Radiol-4-1-2220024.txt,proxim colon||differ||fluid||effect||total||diagnost perform||dose||group||regimen||score||addit||patient accept||diagnost accuraci||ctc||solid residu||barium||prone||polyp||colonoscopi||patient||bowel prepar||reason||magnesium citrat||residu||data||prepar||statu,1||1 2||2||3 1||1 fig. 1||18 1 2||2 2 fig. 2 arrow||1 3 19||3||refer 1||institut 1||23 2||inconveni 1||2 question||2 mm,31046.0||30005.5||28965.0||24045.0||22356.0||21313.333||18510.4||17134.667||17044.0||16864.5||16244.5||15976.5||15527.0||14911.5||14896.0,0.0,0.0,0.0
238,J_Abnorm_Child_Psychol-3-1-1915605.txt,respons||feedback prefer||higher level||real time||effect||neg evalu outcom||cdi||depress||prefer||score||depress symptom||measur||peopl||neg feedback subsequ||studi||evid||condit||peer||particip||time||failur||success||children||control condit||analys||feedback||subsequ||highest score||social||lowest total score||chang||state mood||contest||find||pre-adolesc children||self-verif||adult||interact||mood||self-verif theori,1||2||time 1||3||time 2||2 1 utrecht univers||vol. 2||4||experiment group 1||1986 1 fig. 1 mediat model||studi||netherland 2 univers||0021-843x.101.2.314 1583225 1||feedback manipul 2||SD 2006 1986 tabl 1,31046.0||28965.0||17493.5||17044.0||16453.0||15992.5||14551.5||12937.0||12359.667||12095.0||12015.0||11592.667||10349.333||9820.667||9033.8,0.0,0.0,0.06666666666666667
239,Mol_Syst_Biol-3-_-1800356.txt,random||proxim promot||transcript||mous||cis-regulatori modul||order||tissue-specif regul||promot sequenc||analysi||vote||background||tissu||promot||genbank||express||signific conserv||bind site||test||balanced-error rate||tcat||enrich||sourc||motif||method||liver||site||inform||result||set||data||human||catalog||top||modul,1||2||factor 1||3||suppl 1||figur 2||2 NM||4||cell||tabl figur 1||tabl 1 abil||tabl 2 transcript||1994 figur 2||factor 3||supplementari section 2,31046.0||28965.0||17745.0||17044.0||15942.0||15083.0||14619.5||12937.0||12627.0||11954.333||11725.0||11161.0||10801.0||10744.0||10211.0,0.0,0.0,0.0
240,Neuropsychol_Rev-3-1-2039835.txt,cognit function||non-pharmacolog intervent||effect||clinic practic||motor||abil||procedur learn||practic||dick||schmidt||review||compon||implicit||perform||research||movement||studi||motor-skil learn||AD patient||practic motor skill||task||feedback||control||patient||amount||recommend||implicit motor-skil learn||train||train program||implicit learn||block||result||rehabilit,2||3||1 summari||patient||4||studi||netherland 2 institut||patient group||6||2005||2006||2006 2004 2005 2006 2002 2006||2004||patient sampl||1997 studi,28965.0||17044.0||15734.5||13567.0||12937.0||12015.0||10854.667||9221.0||9074.0||8716.0||8371.0||8160.5||8077.0||7966.0||7782.0,0.2,0.2,0.13333333333333333
241,Virchows_Arch-3-1-1888717.txt,tissu microarray||metastat site||egfr-posit cell||primari crc||number||correl||core||crc||egfr||slide||studi||metastas||express||concord egfr statu||tissu section||egfr statu||patient||section||reactiv cell||tumor||colorect carcinoma||site||epiderm growth factor receptor||case||tma||result,1||1 1||2||1 1 1 fig. 1||3||1 1 1 19 22 27||refer 1||specimen 2||patient||4||tma 2 tabl 2 comparison||studi||tabl 1 clinic data||method patient characterist 1 28||5,31046.0||31046.0||28965.0||25832.0||17044.0||17007.833||16864.5||14608.0||13567.0||12937.0||12651.4||12015.0||11122.25||10405.0||10364.0,0.0,0.1,0.13333333333333333
242,Environ_Manage-2-2-1705511.txt,habitat||survey||forag||livestock||product||conflict||area||changthang||anim||ladakh||pastor||estim||war||meadow||hanl valley||kiang densiti||eastern ladakh||nomad||livestock popul||studi area||kiang||region||herder||import habitat,1||2 1 1||2||2 2||2 3||1 1 2 fig. 1 chundawat||1 mishra 2001 2 2||3||1 ha||1 0.02||livestock 2 2 chundawat||4||method studi area 2 2 changpa||2 pfister 2004||fitzherbert 2004 2,31046.0||30352.333||28965.0||28965.0||23004.5||21180.833||19061.8||17044.0||16797.5||15751.0||14491.0||12937.0||12469.833||12355.0||12348.333,0.0,0.0,0.0
243,Infect_Genet_Evol-1-5-2080692.txt,tropic diseas||individu||chitin||malaria||analysi||associ||hookworm infect||data||egg||south asia||chitotriosidas||studi||infect||evid||locu||popul||human hookworm infect||allel,2||franco.falcone@nottingham.ac.uk 1||2 materi||studi||chit1 tabl 1||3 result||1 chit1 mutat||1 raiko andrew||2005||1 quinnel rupert J.||tabl 2 chit1 genotyp||chit1 chit1 tabl 2||guinea 1 introduct hollak||2004||2003,28965.0||15524.0||15325.0||12015.0||11563.0||11562.0||10780.333||10382.0||8716.0||8710.5||8260.0||8158.75||8106.0||8077.0||7651.0,0.2,0.1,0.06666666666666667
244,Pediatr_Nephrol-4-1-2413095.txt,CV diseas||snp||gene express||pediatr ckd popul||genet||cardiovascular diseas||popul||ra||function||factor||CV abnorm||renal||gene polymorph||associ||cytokin||human genom||progress||studi||error||haplotyp||polymorph||tissu ra||diseas||increas||ckd||renal diseas||gene||patient||natur||risk||potenti weak||whole-genom associ studi||genotyp||preliminari evid||kidney||data||chronic kidney diseas||atherosclerot CV abnorm||pediatr||allel,1||2||1 gene||1 univers||3||refer 1||1 product||tabl 2||1 73||1 113||tgf-beta 1||1 glossari||1 hyperexpress||2 day||2 allel,31046.0||28965.0||17920.0||17351.5||17044.0||16864.5||16336.5||16290.5||15926.0||15752.5||15535.0||15527.0||15523.5||15449.0||14639.5,0.0,0.0,0.0
245,Exp_Brain_Res-3-1-2039806.txt,motion parallax||monocular||probe||cue||conflict||posit||binocular dispar||combin||surfac||binocular||stimulu||surfac slant||textur||movement||orient||condit||head||particip||slant||inform||trial||weight||textur cue||cue conflict||prior||rotat screen,1||2||2 fig. 2||3||4 4||studi||5||2003 64 1 12 10.1016||6||5 6 6 7||vi 2007 7 1 10 10.1167||2005||analysi 5 5 fig. 5||2004||6 fig. 6,31046.0||28965.0||20968.667||17044.0||12937.0||12015.0||10364.0||10243.6||9074.0||8877.25||8760.167||8716.0||8151.0||8077.0||7708.0,0.0,0.0,0.0
246,Int_J_Colorectal_Dis-4-1-2386752.txt,qualiti||contin||life||signific||post-op complic||score||procedur||fisi||result||rectal tumour||function outcom||patient||faecal contin||studi||seri||tem||local excis||tumour,1||2||result 2 2 1 2||1 patient||3||refer 1||tabl 2||3 4||0.12 2||0.43 2||2 neijenhui||J. R. 2 1 depart||patient||4||studi,31046.0||28965.0||24804.2||22306.5||17044.0||16864.5||16290.5||14990.5||14617.0||14570.0||14483.5||13629.6||13567.0||12937.0||12015.0,0.0,0.0,0.13333333333333333
247,Crit_Care-5-4-37409.txt,patient manag||pda||databas||clinic scenario test||resid||comput commun network||softwar||handheld devic||crossov studi||devic||usa||refer||process||traine||templat||studi||medic refer inform||technolog||benefit||palm devic||care||patient data||comput||medic databas||system||daili note||test||patient||handheld comput||user||studi period||infrar||inform||data||staff||physician||text entri,2 3 4 5 6 7||1 1 intens care unit||patient||4||softwar 1 8||studi||tabl figur 1||method hardwar 1||technolog introduct 1||postgradu year 2||patient data||6||tabl 1 softwar applic||patient inform||patient manag,14230.167||13644.2||13567.0||12937.0||12551.0||12015.0||11954.333||11583.0||11018.333||10745.333||9268.0||9074.0||9053.25||8503.5||7601.5,0.2,0.2,0.26666666666666666
248,Plant_Mol_Biol-4-1-2268730.txt,root||dma secret||Zn defici||rice||plant||zn-defici shoot||barley||analysi||secret||iron||dma||zn-defici rice||ma||shoot||experi||absorpt||ma secret||transport||nicotianamin||zinc||Fe defici||dma synthesi,1||2||5 2 2||5 2||2006 2||3||fig. 2||2 day||62 2||gene express 1 2006 fig. 1||62 5 2||4||81-3-58417514 annaoko@mail.ecc.u-tokyo.ac.jp 1 1 depart||cell||62 62 1 62 2,31046.0||28965.0||22764.667||19664.5||18668.0||17044.0||16970.5||15449.0||14952.5||14104.667||13423.0||12937.0||12917.8||12627.0||12566.2,0.0,0.0,0.0
249,Clin_Oral_Investig-4-1-2238777.txt,effect||sport||enamel||saliva||tooth surfac||wear||clinic examin||surfac||factor||eros agent||chemic||dental eros||enamel surfac||studi||condit||drink||miner content||chemic factor||dentin||progress||import||fluorid||time||increas||salivari flow||eros||behaviour factor||acid drink||consumpt||phosphat content||calcium||protect effect||eros potenti||tooth||soft tissu,1||refer 1||patient||studi||2006 basel karger 1 8||2006||2004||2006 basel karger 1 219||54 60 21 1 53||enamel surfac fig. 2 advanc||effect||irradi cancer patient||5 fig. 5 68||vitro studi||2001,31046.0||16864.5||13567.0||12015.0||9135.2||8371.0||8077.0||7945.8||7630.2||7217.4||6956.0||6921.667||6626.0||6379.5||6313.0,0.2,0.1,0.13333333333333333
250,Diabetologia-3-1-1794135.txt,snp||insulin resist||adiponectin receptor||receptor||effect||report||popul||UK popul||bmi||adiponectin gene||sequenc||analysi||associ||type 2 diabet||associ studi||diabet||studi||evid||haplotyp||quantit trait||polymorph||sir cohort||cohort||control||gene||risk||insulin sensit||genotyp||data||variant||result,1||2||2 1 1 adipor1||3||2 11||refer 1||C. 1||tabl 2||type 2||2 diabet||homogen 1||2 thompson||patient||4||ib1@sanger.ac.uk 1 1 metabol diseas group,31046.0||28965.0||22775.75||17044.0||17008.0||16864.5||16530.5||16290.5||15946.5||15728.0||15629.5||14603.0||13567.0||12937.0||12197.167,0.0,0.0,0.0
251,Eur_Arch_Otorhinolaryngol-3-1-1914267.txt,skin||differ||forearm||strength||split skin graft||frff||forearm disabl||total score||non-donor site||donor site morbid||fasciocutan flap||questionnair||reconstruct||studi||radial forearm flap||wrist||lower arm||object||donor||flap||test||patient||subject self-rat||function result||hand||subject complaint||morbid||cosmet||free radial forearm flap||object function test||function,1||1 2||2||result 1||3||refer 1||1 fig. 1 inclinomet||tabl 2||disabl 1||complaint 1||forearm 1||2 cm||door 2||bike 2||patient,31046.0||30005.5||28965.0||18563.0||17044.0||16864.5||16767.25||16290.5||15745.5||15659.0||15588.5||14720.5||14497.5||14483.0||13567.0,0.0,0.0,0.06666666666666667
252,Mol_Genet_Metab-2-1-2279742.txt,yeast||missens mutat||mixtur||effect||tetram||nativ gel||chemic chaperon||chaperon||rescu||state||catalyt domain||osmolyt||tmao||media||enzym||cb||protein||addit||diseas||dmso||increas||homocystinuria||amino acid||growth||mutat||compound||activ||amount||mutant||chemic chaperon rescu||mutant cb protein||enzym activ||find||data||result||glycerol,1||2||tabl 1||3||fig. 2||warren.kruger@fccc.edu 1||1 2 kožich viktor||fig. 3 fig. 2||4||cell||studi||chaperon set 1||5||chaperon set 2||2 chen xulin,31046.0||28965.0||17331.0||17044.0||16970.5||15524.0||15003.25||13990.25||12937.0||12627.0||12015.0||10895.0||10364.0||10201.333||9859.667,0.0,0.0,0.0
253,Eur_J_Epidemiol-3-1-2071962.txt,model||hypertens||myocardi infarct||cardiovascular event||stroke||cardiovascular diseas||intak||standard deviat increas||sodium||analysi||associ||volum||potassium||potassium intak||cohort||lower quartil||cvd||dietari potassium||risk||dietari data||event||subject||creatinin||posit relationship||blood pressur||urinari sodium||data||mortal||all-caus mortal||salt||relationship,1||2||3 2||result 1||model 1||3||refer 1||model 2||3 1 divis||part 1||1 0.99||1 0.90||1 0.88||1 0.74||1 1.04,31046.0||28965.0||23004.5||18563.0||17468.5||17044.0||16864.5||16428.0||16123.0||16058.5||15642.5||15631.0||15619.0||15610.0||15599.5,0.0,0.0,0.0
254,J_Autism_Dev_Disord-4-1-2335292.txt,differ||daili utensil||symbol||play||durat||asd||month||behavior||opportun||autism||group||play behavior||develop||agreement||toy||studi||time||qualiti||age||object||children||disord||control||book||manipul||attach||development disord||control group||account||level||relationship,1||2||0 2 2 0 2 3||2 8||3||1 characterist||2 correl||3 6||4||studi||5 fig. 1 secur||3 8||netherland 2 depart||1st 2 year||5,31046.0||28965.0||19354.167||17559.5||17044.0||16168.5||15281.5||13059.0||12937.0||12015.0||11618.75||11599.0||11205.0||10761.0||10364.0,0.0,0.1,0.06666666666666667
255,Purinergic_Signal-1-3-2096543.txt,imag||respons||migrat||cell||wound repair||corneal epithelium||atp,1||1 2||2||2 2||3 1||2 3 3 2||3 2||4 2||figur 2 2||5 2||2 3 25 2||3 4 3 2||3 6 2||7 2||5 figur 1 2,31046.0||30005.5||28965.0||28965.0||24045.0||23004.5||23004.5||20951.0||19710.333||19664.5||19568.25||18997.5||18361.0||17981.0||17894.0,0.0,0.0,0.0
256,Biochim_Biophys_Acta-1-5-2212780.txt,light||connexin43||csa||ro product||pharmacolog||mechan||glycogen synthas kinas 3||effect||ampk||gsk3||mitochondri protein||recoveri||vdac||ro format||mediat||product||reperfus||cyclophilin||cardiac myocyt||abil||pore||ro level||mitochondri atp-depend potassium channel||diazoxid||pten||pkg||techniqu||pharmacolog agent||sfa||sur||channel open||reactiv oxygen speci||ant||measur||mct1||respiratori chain inhibitor||volum||phosphoryl||ischaemia||note||decreas||ro||atp||evid||protein||mitochondri permeabl transit pore||mitochondria||apoptosi||membran||cx43||calcium overload||increas||kinas||pkc||cyp||protect||sensit||activ||experi||open||role||respiratori chain||mptp||adenin nucleotid||IP||calcium||complex||oxid stress||data||ischaem precondit||adenin nucleotid translocas||monocarboxyl transport 1||pathway||mitok||surviv kinas cascad||heart,1||2||fig. 1||fig. 2 fig. 1||3||fig. 2||3 2 14||4||cell||fig. 4 figs. 1||fig. 3||monocarboxyl transport 1||5||reperfus injuri 2||2005 1 15 25 16054041,31046.0||28965.0||18011.0||17490.75||17044.0||16970.5||16768.667||12937.0||12627.0||12258.0||11010.0||10667.667||10364.0||10075.333||9527.8,0.0,0.0,0.06666666666666667
257,Appl_Microbiol_Biotechnol-4-1-2266783.txt,organ||substrat||cultur||hydroxyquinol||batch cultur||solid MM||tree||intermedi||peak||enzym||metabolit||reaction||fluorid||phenol||monooxygenas||biodegrad||hydroquinon||hydroxymucon semialdehyd||activ||carbon||degrad||cell-fre extract||reaction mixtur||strain||catechol||benzoquinon||growth substrat||cell||sole sourc||final volum||pathway||high-perform liquid chromatographi||energi||result,1||2||2 2 fig. 2||3||1 mM 3||d.b.janssen@rug.nl 1 1 depart||1 ml||1 mM||2 uptak||2 consumpt||cell||lc-m analysi 1 4||studi||netherland 2 depart||fluorid concentr 1,31046.0||28965.0||22967.75||17044.0||16163.667||16146.75||15906.0||15723.5||14714.5||14624.5||12627.0||12169.5||12015.0||11205.0||10853.667,0.0,0.0,0.06666666666666667
258,Mar_Biotechnol_(NY)-2-2-1475948.txt,induc activ||transgen zebrafish||japanes flounder||tissu||studi||keratin||promot||zebrafish||pattern||express||gene||tumor necrosi factor||liver||site||gfp||induc promot||japanes flounder promot||egg||tissue-specif promot||adult||region||tnf,2||1 embryo||1 minut||2 minut||5 1 gong||4||studi||2 fig. 2.||4 7 1 fig. 4.||2003 1 fig. 3.||2002 fig. 5. 2||2 transgen strain||2005||discuss 1 fig. 1. express||2003,28965.0||15620.0||15588.0||14547.5||13811.333||12937.0||12015.0||11621.333||11363.4||11141.5||10462.25||9968.667||8716.0||8451.4||7651.0,0.0,0.1,0.06666666666666667
259,Virchows_Arch-3-1-1888721.txt,male||distribut||lobular||breast||histolog subtyp||carcinoma||slide||studi||metastas||cutan melanoma||femal counterpart||invas carcinoma||morpholog spectrum||frequenc||larg tertiari center||male breast||patient||period||site||case||data||seri,1||2||1 2 1 depart||result 1 1||fig. 1||refer 1||1 distribut||1 5 7||1 0.13||ste 1||2 carcinoma||2 0.26||patient||4||cell,31046.0||28965.0||23387.75||22724.0||18011.0||16864.5||16304.5||16135.667||15633.0||15528.5||15153.0||14577.0||13567.0||12937.0||12627.0,0.0,0.0,0.06666666666666667
260,J_Gastrointest_Surg-3-1-1852385.txt,diverticular diseas||complic||high rate||perfor diverticul||oper||acut diverticul||elect surgeri||studi||diseas||diverticul||author||surgeri||signific||surgic manag||diseas process||recurr episod||sigmoid diverticul||fistula||patient||attack||resect||colon||procedur||case||data||diagnosi||perfor||surgeon,1 1||2 10||1 13 14 1||refer 1||patient||25 2 9 figur 2||4||1 clinic symptom||classif 10 2||studi||3 11||5||4 12||5 6 7 8||40 patient,31046.0||17973.5||17662.75||16864.5||13567.0||13564.4||12937.0||12369.667||12210.333||12015.0||11047.5||10364.0||9394.5||8147.25||7858.5,0.2,0.2,0.13333333333333333
261,Int_J_Cardiovasc_Imaging-3-1-2121120.txt,perfus deficit||wall motion abnorm||dose||coronari arteri diseas||perfus abnorm||dobutamin stress cmr||mri||follow-up||stress||studi||peak stress||rest||cine||imag||perfus sequenc||cardiac event||patient||cag||wall motion analysi||addit inform||dobutamin||ischemia||normal first-pass perfus||peak-dos dobutamin||segment||examin||perfus imag||lbbb||nwma||min,1||refer 1||1 2 fig. 1 flow chart||1 oudkerk matthij 1 1 depart||1 demograph||hanzeplein 1||bronovolaan 1||ipat 2||patient||1 2 van dijkman paul||studi||netherland 2 depart||C. 1 kuijper||5||patient group,31046.0||16864.5||16185.333||15942.667||15622.5||15529.5||15524.0||14483.5||13567.0||12336.6||12015.0||11205.0||11026.0||10364.0||9221.0,0.0,0.1,0.13333333333333333
262,Domest_Anim_Endocrinol-2-1-2428105.txt,igf||mechan||myometrium||sub-epitheli stroma||uterin horn||postpartum||uterin igf system||tissu||studi||deep endometri stroma||uterin involut||igf-i mrna||postpartum uteru||similar||express||bovin||involut||igf-ii||caruncular tissu||mrna||caruncular stroma||horn||dairi cow||uteru||de||region||se,1||2||tabl 1||3||1 receptor figs. 1||tabl 2||1 cm||figs. 1||2 figs. 3||2 materi||2 week||4||fig. 3 tabl 2 fig. 3||studi||fig. 2 photograph,31046.0||28965.0||17331.0||17044.0||16417.0||16290.5||15761.0||15559.5||15360.667||15325.0||15100.0||12937.0||12770.167||12015.0||11341.667,0.0,0.0,0.06666666666666667
263,FEBS_Lett-1-5-1942071.txt,kinas||pdk1||pkc||present studi||pkd||activ||cell||phosphoryl||depend||agc kinas||cell develop||s6k1||lymphocyt||p90rsk||embryon stem cell||mice||pathway||loss,1||2||fig. 1||2 result||3||fig. 2 fig. 2||fig. 2||kinas 1||d.a.cantrell@dundee.ac.uk 1||2 μg||fig. 1 fig. 1 α||4||cell||ES cell fig. 1||fig. 3,31046.0||28965.0||18011.0||17522.5||17044.0||16970.5||16970.5||15960.5||15525.0||14685.0||14491.0||12937.0||12627.0||12218.25||11010.0,0.0,0.0,0.06666666666666667
264,J_Neurol-3-1-1915650.txt,db||ataxia||reduct||scale||effect||function improv||superior cerebellar peduncl||intent tremor||follow-up||movement||studi||multipl sclerosi||thalamotomi||articl||tremor||treatment||disabl||patient||case report||isoniazid||method||limb||placement site||tremor reduct||trial||tremor amplitud||intent||advers effect,1||2||2 studi||3||refer 1||28 1||examin 1||1 head||1 detail||VL 1||hanzeplein 1||examin 2||62 2||issu 2||3 studi,31046.0||28965.0||20490.0||17044.0||16864.5||16747.5||16201.0||15834.5||15793.5||15567.0||15529.5||15160.5||14952.5||14807.5||14529.5,0.0,0.0,0.0
265,Theor_Appl_Genet-2-2-1544375.txt,blast||databas||speci||number||solanacea||est||annot||unigen set||sequenc||similar chromosom architectur||stage||protein||tissu||tomato||coffe||seed develop||gene famili||seed||famili||librari||cdna||pericarp||set||uniqu||unigen||highli||match||result||function,"1||2||3||2 materi||5 arabidopsi 5 1||4||1-607-2556683 sdt4@cornell.edu 1 1 depart||1 C. canephora tabl 1 characterist||cdna librari 1||5||4 tabl 4||protein 1,182 1 5 126674||6||2002 2003 5||2004",31046.0||28965.0||17044.0||15325.0||13088.25||12937.0||12917.6||11504.167||10487.333||10364.0||9830.0||9540.6||9074.0||8357.333||8077.0,0.0,0.0,0.0
266,Ann_Biomed_Eng-2-2-1705490.txt,actual hemodynam||part||respons||snp||model||hypertens||physiolog variat||snp infus||anim experi||snp-map loop||adapt control||acut||drug interact||drug||anim studi||dbt||cardiac output||hemodynam variabl||averag error||increas||heart failur||hemodynam||acut disturb||acut heart failur||input||setpoint||clinic situat,1||1 1||2 1||2||2 2||1 1 figur 2||1 tabl 2||2 4||1 6||1 7||2 6||1 8||1 14||2 12||tabl 1,31046.0||31046.0||30005.5||28965.0||28965.0||23064.5||21209.0||20951.0||20060.0||19021.5||19019.5||18600.0||17671.5||17408.5||17331.0,0.0,0.0,0.0
267,Skeletal_Radiol-3-1-2042032.txt,magnet reson imag||diagnos||osteoarthr||bone marrow edema||abnorm||group||signific differ||non-acut knee problem||non-acut knee symptom||studi||symptom||young adult||incident find||convent radiograph||knee||loos bodi||prospect studi||radiograph||patient||week||histori||find||radiologist||enchondroma||knee radiograph||articular surfac lesion||year,1||1 1||2||2 1 3 2 2 2||1 1 depart||7 1||fig. 1||3||refer 1||grade 1||1 osteoarthr||2 week||4 3||2 0.3||2 napoleon,31046.0||31046.0||28965.0||27325.0||21528.667||19021.5||18011.0||17044.0||16864.5||15863.5||15589.0||15100.0||14990.5||14698.5||14483.5,0.0,0.0,0.0
268,Purinergic_Signal-2-2-2096640.txt,bacteri clearanc||e-ntpdas||oxid stress||cd39,2||2 2||3||22 2 4 5 2||refer 1||phase 1||1 2 45 P.||ntpdase 1||patient||cell||fig. 1 impact||vitro 69 2 2 70||studi||68 fig. 2||fig. 6 2B 2 4,28965.0||28965.0||17044.0||16882.8||16864.5||15995.0||15912.0||15541.0||13567.0||12627.0||12330.333||12131.2||12015.0||11580.333||11221.6,0.0,0.0,0.0
269,J_Magn_Reson-2-1-2323944.txt,model||nois||excit puls||acquisit sequenc||effect||flip angl||equat||sled||optim||two-pool model||solut||estim||signal||magnet transfer||simul||similar||valu||sensit||experi||paramet||CW variant||test||duti cycl||excit flip angl||consist||human brain||magnet||ramani||standard deviat||data||CW approxim||result,1||1 2||2 1||2||0 1 1||1 tabl 2||ω 1 2||1 cwpe 2||fig. 1||tabl 1 fig. 1||tabl 1||3||fig. 2||experi 1||tabl 2,31046.0||30005.5||30005.5||28965.0||22728.333||21209.0||20020.0||20006.0||18011.0||17671.0||17331.0||17044.0||16970.5||16535.0||16290.5,0.0,0.0,0.0
270,Dev_Genes_Evol-4-1-2292478.txt,famili member||genom sequenc||insect||leg||conserv||ectop express||pcr||tiptop||larval rnai||develop||tsh||protein||addit||head||teashirt||express||member||embryo||milkwe bug||dsrna||trunk||observ||gene||ident||segment||paralog||region||hox gene||rnai||result||function,2||1 2 2 2 fig. 2||1 1 divis||tc-tiotsh 1 2 4||3||1 μg||1786 2||1 2006 anophel||4||1 denel robin||2005 15 1 18 10.1101||6||2005||2004 6||2004,28965.0||25313.667||20790.333||18260.75||17044.0||15725.5||14490.5||13144.0||12937.0||10369.0||9673.4||9074.0||8716.0||8575.5||8077.0,0.0,0.0,0.0
271,Eur_J_Nucl_Med_Mol_Imaging-3-1-1998881.txt,apoptot cell||model||injuri||atn||detect||acut renal failur||anim||analysi||diagnost imag agent||studi||technolog||ddc||apoptosi||acut tubular necrosi||imag||experiment model||outer medulla||cell||rat||kidney||anim model,1||2||3||3 3||3 3 3||refer 1||patient||fig. 5 3 3 3||4||vitro 2 6||cell||aposens aposens aposens 1 2||studi||200 3 5||6,31046.0||28965.0||17044.0||17044.0||17044.0||16864.5||13567.0||13294.4||12937.0||12927.667||12627.0||12031.6||12015.0||9300.667||9074.0,0.0,0.0,0.13333333333333333
272,Plant_Mol_Biol-4-1-2238787.txt,alpha level||replic||medium||stress toler||plant||transcript level||tobacco||stress||western blot analys||relat||increas||inositol polyphosph kinas||wild type||express||seed||toler||treatment||activ||test||gene||atipk2β||abiot stress||transgen||type||continu white light||level||salt||higher plant||result,1||2||2 2 2 2||2 2 2||2 2||240 2 2 2 2||290 2 2||protein determin 2 2 2||3||3 4 1995 3 4 2||1997 4 2||600 2 2 1987||atipk2β 2||4||4 4 4,31046.0||28965.0||28965.0||28965.0||28965.0||23212.6||19372.333||19066.4||17044.0||15265.167||15150.333||14750.25||14516.5||12937.0||12937.0,0.0,0.0,0.0
273,J_Headache_Pain-4-1-2386850.txt,day||europ||differ||popul||neurolog disord||european countri||headach patient||public health perspect||estim||countri||cost||interest||studi||social function||qol||children||tth||life||migrain||disabl||direct cost||partner||patient||impact||year||burden||chronic headach||methodolog||headach||data||preval||work,1||refer 1||1 billion||patient||studi||5||neurol 2005 12 1 27 10.1111||control studi||2004||eurolight steer committe 1||non-econom impact 38 10 9 1||2003||compar studi||2007||10,31046.0||16864.5||15527.0||13567.0||12015.0||10364.0||8267.833||8209.5||8077.0||7899.25||7664.333||7651.0||7344.5||7287.0||6982.0,0.4,0.2,0.13333333333333333
274,Ann_Hematol-4-1-2324127.txt,mapc||circumst||basal medium||cultur||medium||isol||stem cell||multipot adult progenitor cell||germ layer||differenti||differenti potenti||differenti capabl||msc||multi-lineag differenti||present studi||passag||express||pluripot||gene||protocol||cell||marker||adult||adult stem cell,1||1 2 1||2||1 2 3||4 3 2||3||refer 1||mapc 6 2 2||1 2 3 immunofluoresc analysi||2 week||mapc 4 2||1 14 16||3 fig. 3||4||cell,31046.0||30352.333||28965.0||25685.0||19648.667||17044.0||16864.5||16759.75||16362.8||15100.0||13979.0||13098.0||13021.333||12937.0||12627.0,0.0,0.0,0.06666666666666667
275,Eur_J_Pediatr-4-1-2413085.txt,defect||bind||rab protein||membran traffick||brain||activ||human||protein||patient||gene||transport||type||griscelli syndrom||diseas||role||rab||function,2 1||refer 1||2 avp||patient||2 water channel||belgium 2 center||4 5 13 4 5||1 human monogen diseas||2004||acceptor membran 14 32 1||host cell||protein||8||cell biolog method||activ,30005.5||16864.5||14495.0||13567.0||10339.667||10237.333||10172.8||10113.75||8077.0||7778.4||6466.0||6288.0||6154.0||5950.333||5231.0,0.2,0.1,0.2
276,Dig_Dis_Sci-4-1-2413116.txt,fgid||childhood||definit||depress||popul||rape||group||gener popul||assault||function dyspepsia||total score||kind||function gastrointestin disord||GI symptom||questionnair||signific differ||studi||hrql||signific||women||dyspepsia||sexual offenc||non-consult||irrit bowel syndrom||abus||histori||sweden||valid||subject||anxieti||odd ratio||adulthood||ssf||ib,1||1 1 1 1||2||abus 1 1 1 1||abus 1 1 1 1 adult||physic abus 1 1 1 1||abus 1 1 1 1 childhood||emot abus 1 1 1 1||2 tabl 2||abus 1 1 1 adult||sexual abus 1 1 1||3||3 3||refer 1||abus 1 1 adult,31046.0||31046.0||28965.0||24932.4||21010.5||20956.667||20859.0||20831.167||20515.333||19003.4||18866.2||17044.0||17044.0||16864.5||15992.75,0.0,0.0,0.0
277,Pediatr_Nephrol-4-1-2214827.txt,chronic hyperparathyroid||multipl drug therapi||calcium channel antagonist||hypertens||fluid||beta blocker||effect||low sodium dialys||sympathet hyperactiv||ace||renal||drug||import||fluid overload||import factor||increas||children||treatment||renal diseas||ckd||antihypertens therapi||activ||control||patient||risk||antihypertens drug||therapi||antihypertens treatment||pathophysiolog||first-lin therapi||end-organ damag||blood pressur||esrd||chronic kidney diseas||adult,2||2 2 42||3||refer 1||2 bodi||patient||4||studi||5||6||2005||pediatr patient||patient surviv||angiotensin II receptor 1 blocker||7,28965.0||19805.333||17044.0||16864.5||15061.5||13567.0||12937.0||12015.0||10364.0||9074.0||8716.0||7786.5||7392.0||7221.4||6997.0,0.0,0.1,0.06666666666666667
278,Clin_Oral_Investig-4-1-2238780.txt,patholog tooth wear||hypothesi||popul||wear||group||teeth||small proport||clinic experi||attrit||research||progress||term||evid||smith||dentin||age||children||eros||adolesc||tooth wear||abras||data||adult||level,1||2||8 1 2 10 fig. 1||3||refer 1||part 1||patient||25 17 3 1 7||studi||attrit fig. 2||5||3 17 25||UK 2 leicestershir counti||2007||2002,31046.0||28965.0||18194.833||17044.0||16864.5||16058.5||13567.0||12393.8||12015.0||11332.333||10364.0||7975.333||7475.5||7287.0||7057.0,0.0,0.0,0.0
279,Skeletal_Radiol-3-1-1934928.txt,mechan||pain||fat signal||low signal||spine||vertebr bodi||intervertebr disc||osteoclast activ||disc||signal||mri||diseas||increas||imag||cord compress||CT imag||clinic symptom||activ||bone||radiograph||patient||epidur fat||spinal involv||facet||periost apposit||neural dysfunct||vertebra||signal characterist||neural||spinal stenosi,1||2||3||refer 1||enlarg fig. 2 1||patient||fig. 4 3||5 8 4||serial radiograph 2 year||fig. 3 orang||patient demonstr||1999 14 2 192 197 10.1359||result||clinicopatholog studi||12 10 11 12 fig. 12,31046.0||28965.0||17044.0||16864.5||16269.75||13567.0||11652.333||9818.333||8139.75||7383.667||7221.0||6427.833||6080.0||6068.0||5760.833,0.0,0.1,0.06666666666666667
280,Breast_Cancer_Res-5-6-314403.txt,origin data file||gene express||regul||time point||upregul||signal intens||analysi||insert||studi||total rna||cdna microarray||express||rhob||treatment||data analys||epitheli cell||hybrid||cell growth||experi||gene||role||growth inhibit||nmumg cell||cell cycl control||cell||data||pathway||emt||result,1||2||3 1||2 1 16 17 2||factor 1||3||3 3 3 3||1 regul||1 3 hal.moses@vanderbilt.edu 1 depart||tgf-β1-regul gene 1 2||solut 1||chain 1||1 hour||cadherin 1||tgf-β 1,31046.0||28965.0||24045.0||19302.0||17745.0||17044.0||17044.0||16532.0||16326.2||16201.5||15985.5||15712.5||15666.0||15561.0||15551.5,0.0,0.0,0.0
281,Evid_Based_Complement_Alternat_Med-3-4-1697739.txt,psycholog symptom||herbal medicin||effect||product||review||drug||research||studi||clinic trial||symptom||articl||diseas||random clinic trial||treatment||dementia||herb||cognit impair||trial||melissa||formul||systemat review||result,1||2||1 month||issu 1||2 month||issu 2||patient||1 13 14||patient studi||studi||3 ml||clinic studi||2006||tabl tabl 1 phytotherap intervent||santos-neto leopoldo luiz 1,31046.0||28965.0||16322.0||15848.0||15281.5||14807.5||13567.0||13201.667||12791.0||12015.0||8905.0||8436.5||8371.0||7880.8||7762.5,0.0,0.1,0.06666666666666667
282,Diabetologia-4-1-2292422.txt,kir6.2||neonat diabet||sur||mutat||beta cell||effect||insulin secret||atp sensit||function effect||type 2 diabet||block||current||neurolog examin||sulfonylurea therapi||diabet||atp||patient||mgatp||subunit||channel,1||1 1||2||2 2||1 1 2 atp 2||4 2||3||11 50 2 1 fig. 2||29 1 1 fig. 1 atp||refer 1||frances.ashcroft@physiol.ox.ac.uk 1 1 depart||24 2||atp 1||1 mg||50 2,31046.0||31046.0||28965.0||28965.0||24239.2||20951.0||17044.0||16948.667||16926.333||16864.5||16146.75||16120.5||16110.0||15945.0||15827.0,0.0,0.0,0.0
283,Health_Care_Anal-4-1-2226192.txt,ethic committe||nation level||bioethic||context||countri||african countri||research||unesco||interview||social respons||declar||biomed research ethic||intern||univers principl||social||paper||ethic||guidelin||commun||kenya||research project||principl||polici||nation law||univers||bioethic principl||south africa||level||relev||health,1||2 5 1||3||refer 1||http://www.wma.net/e/policy/b3.htm. 1||5 20 1||limit 2 3 4||4||studi||2 thirti interview||5 6||6||6 6||2005||2006,31046.0||23458.333||17044.0||16864.5||15523.5||15275.667||15131.25||12937.0||12015.0||9780.333||9719.0||9074.0||9074.0||8716.0||8371.0,0.0,0.0,0.0
284,Pediatr_Nephrol-3-1-1994209.txt,malform||syndrom||form||approach||signific discoveri||urinari tract||discoveri||develop||renal||clinic diagnosi||studi||diseas||children||defect||disord||mutat||ureter bud||dysplasia||linkag analysi||gene||renal parenchyma||clinic classif||congenit anomali||anatom defect||larg multicentr collabor group||structur variat||clinician||development disord||kidney||human||renal agenesi||classif||trait||gene map,1||2||3||refer 1||2 list||patient||studi||type 2 diabet||39-010-395214 labnefro@ospedale-gaslini.ge.it 3 1 depart||protein 4||25 patient||NY usa 2 depart||fibroblast growth factor receptor 1||angiotensin type 2 receptor gene||2004,31046.0||28965.0||17044.0||16864.5||14698.5||13567.0||12015.0||11461.333||10117.2||9612.5||8433.0||8402.75||8220.6||8079.4||8077.0,0.0,0.1,0.06666666666666667
285,Clin_Oral_Investig-4-1-2238790.txt,root||retent||survey||extent||post||privat practition||materi||zinc phosphat cement||core||high preval||length||clinic crown||factor||restor||questionnair||studi||function time||cement||time||failur||fractur||treatment||resin composit||patient||fractur resist||amalgam||practition||stainless steel||diamet||type||lute||post-retain restor||year||tooth||resin cement||restor materi,1||2||1 15 2||1 1 depart||result 1||3||1 distribut||1 5 4 6 15 2||2 distribut||post 2||2 asmussen||patient||4||studi||0 7 2 9,31046.0||28965.0||21529.333||21528.667||18563.0||17044.0||16304.5||16160.5||15264.0||14654.0||14486.0||13567.0||12937.0||12015.0||11861.75,0.0,0.0,0.13333333333333333
286,Breast_Cancer_Res_Treat-3-1-2137942.txt,statist analysi||number||core||breast cancer||independ predictor||group||total number||invas breast cancer||studi||surviv curv||mast cell||surviv||MC infiltr||mc||patient||prognosi||stroma||tumor||train||good prognosi||cell||case||presenc||ER score||tma||immun cell||result,1||2||2 2||3||fig. 2||refer 1||analysi 2||grade 1||1 detail||lesion 2||grade 2||2 cm||2 summari||patient||1-604-8776089 dhuntsma@bccancer.bc.ca 1 4 1 depart,31046.0||28965.0||28965.0||17044.0||16970.5||16864.5||16826.0||15863.5||15793.5||15155.0||14823.0||14720.5||14694.0||13567.0||12921.167,0.0,0.0,0.06666666666666667
287,Clin_Rheumatol-4-1-2262146.txt,r-chop||rituximab||nhl||arthriti||develop||treatment||pain||lymphoma||knee||synovi fluid||cours||rheumat diseas||tumor lysi syndrom||patient||microbiolog test||diagnosi||chemotherapi||wrist||joint,1 2||M. 1||3||refer 1||F. 1 1 depart||1 week||2 dijkman||patient||4||clinic rheumatolog 2008 introduct 1 2||9 3||netherland 2 depart||5 6 6||A. C. 1 lem||31-20-5124554 f.h.swaneveld@versatel.nl 1 3 van vugt,30005.5||17396.0||17044.0||16864.5||16381.5||16140.5||14494.0||13567.0||12937.0||11392.333||11218.0||11205.0||9504.0||9146.5||8262.0,0.0,0.1,0.06666666666666667
288,Calcif_Tissue_Int-3-1-1914229.txt,date||gprd||effect||osteoporosi||variabl||drug||studi||past||index date||cumul dose||fractur||dutch pharmo record linkag system||β-blocker||pharmo rl||patient||epidemiolog||risk||histori||antihypertens agent||case||data||record||final model||prescript,1||2||2 3||2007 2 1 5||result 1||3||refer 1||tabl 2||P. 1 3 1 divis||januari 1||1 souverein||gprd studi popul 2 1||circl 2||2 leufken||patient,31046.0||28965.0||23004.5||19415.5||18563.0||17044.0||16864.5||16290.5||16283.4||15588.0||15524.0||14765.2||14598.5||14493.0||13567.0,0.0,0.0,0.06666666666666667
289,Purinergic_Signal-3-1-2096770.txt,receptor||migrat||vascular||smc||nucleotid||previou studi||media||prolifer||process||utp||extracellular nucleotid||studi||atp||vascular diseas||nucleotid receptor||endothelium||restenosi||express||intim||releas||activ||smooth muscl cell||earli stage||atherosclerosi||role||cell||function,1||1 2||2||1 1 depart||1 6||6 7 1 2||1 receptor||3||2 6 2 71||refer 1||2 receptor||2 2 72 73 2 receptor||12 14 3 2||BF 2 4||2007 2 receptor,31046.0||30005.5||28965.0||21528.667||20060.0||19020.5||17274.5||17044.0||16954.25||16864.5||16234.0||15339.333||14039.5||13999.667||13251.667,0.0,0.0,0.0
290,Cell_Tissue_Res-4-1-2295254.txt,cardiomyocyt||myocardi infarct||number||incub||stem cell||posit||border-zon||area||infarct||posit effect||prolifer||studi||ami||ecm||asc||increas||adipos tissu||ami phase 2||section||adhes||attach||stem cell therapi||infarct area||cell||fibronectin||heart,1||2 2||2||2 2 fig. 2 2||2 2 fig. 1||asc 2 2 2 2||asc 2 2||1 11 3||J. 1 1 depart||3||3 fig. 3 2||1 day||cell cultur 5 2 2||fibronectin 1||1 ldh,31046.0||28965.0||28965.0||24167.2||23488.0||23186.2||19333.667||17713.667||17093.75||17044.0||17007.25||16489.5||16415.2||15585.0||15539.5,0.0,0.0,0.0
291,Bioprocess_Biosyst_Eng-4-1-2214824.txt,light||led light sourc||distribut||number||scale||sauter||ferment broth||ccd camera||imag analysi softwar||abil||photograph||agit rate||measur||situ measur devic||modular camera system||imag analysi||bubbl size||resolut||condit||ferment||increas||imag||system||larger number||standard||frame||rang||size||bubbl||limit||broth||liquid||agit||pixel||diamet||shroud||camera||envirocam||result,1||2||2 3 3 2 3||histogram 1 2||1.2 2 2||3 2 8||3 3||3||refer 1||part 1||system 2 2 fig. 2 environcam||2 valu||1 pixel||1 envirocam||1 in.,31046.0||28965.0||21812.4||20016.667||19420.667||17387.667||17044.0||17044.0||16864.5||16058.5||15926.167||15845.0||15564.5||15530.5||15528.0,0.0,0.0,0.0
292,Eur_Radiol-3-1-1797072.txt,hypercellular marrow||neoplast marrow||clinic signific||avn||specif question||lymphoma||clinic practic||treatment effect||irradi||normal||long bone||signal intens||sequenc||techniqu||contrast agent||bone marrow||extracompartment tumor growth||allogen transplant||addit||articl||high risk||increas||imag||lesion||contrast||treatment regimen||treatment||uspio||neoplast infiltr||anti-angiogen drug||bone||infiltr||patient||neoplast cell||hematolog malign||therapi||chang||tumor||nhl||diffus||bone marrow cellular||hematopoiet marrow||inform||small molecular gd-chelat||adult||reconvers||cellular,1||2||2 fig. 2||refer 1||irradi 1 44 fig. 1||patient||studi||specif patient||addit patient||patient popul||tumor cell||adult patient||compar studi||effect||lymphoma patient,31046.0||28965.0||20968.667||16864.5||13707.0||13567.0||12015.0||7848.0||7759.5||7675.0||7638.0||7484.0||7344.5||6956.0||6931.0,0.0,0.1,0.06666666666666667
293,In_Vitro_Cell_Dev_Biol_Anim-4-1-2277440.txt,differ||effect||medium||group||scalp cool||doxorubicin concentr||damag||signific differ||decreas||human epiderm keratinocyt||scalp||hair follicl||signific||temperatur||doxorubicin||assay||doxorubicin exposur||control group||cell||drug uptak||keratinocyt||viabil||hair loss||result,1||1 2||2||1 2003 2||1 figur 1||result 1||3||method 2 2 6 cell||0.001 1||figur 2||patient||4||cell||studi||2003,31046.0||30005.5||28965.0||22554.0||21097.667||18563.0||17044.0||16660.6||16095.5||15083.0||13567.0||12937.0||12627.0||12015.0||7651.0,0.0,0.0,0.06666666666666667
294,Pediatr_Nephrol-3-1-1766474.txt,high flux membran||dialysi session||fluid||access||needl||dialys||ultrapur dialys||normal||blood purif||dialysi||ultrafiltr||permeabl||blood||session||hemodialysi||volum||import||membran||hemodiafiltr||adequ||children||mmhg||ultrafiltr rate||continu blood volum||patient||endotoxin||risk||high flux||guidelin||blood volum||weight||urea||newer machin,1||1 2||2||2 2||3 4 4 1||refer 1||1 3 28||1 42||2 year||suppl 1||guidelin 1||1 BW||1 Kt||2 43||guidelin 2,31046.0||30005.5||28965.0||28965.0||18491.0||16864.5||16846.333||16266.0||16110.5||15942.0||15861.5||15592.5||15531.5||15239.0||14821.0,0.0,0.0,0.0
295,Clin_Auton_Res-3-1-1858602.txt,cerebr blood flow||memori||cognit perform||brain||lower limit||clinic practic||tonic brain perfus||group||cortic activ||recent research||perform||cognit||hypotens||cognit deficit||studi||addit||hypotens individu||eeg studi||sampl||test||cognit test||strong evid||limit||blood pressur||deficit||attent||brain perfus||duschek||relationship,1||2||1 studi||refer 1||65 4 2 fig. 2||patient||1 7 3 8 9||3 fig. 3||studi||constitut hypotens 4 1 6||constitut hypotens 1||handbuch teil 1||2005||2006||1 111 mialet JP,31046.0||28965.0||21530.5||16864.5||15367.2||13567.0||13326.6||13021.333||12015.0||10669.0||10444.667||10352.333||8716.0||8371.0||8081.75,0.0,0.1,0.06666666666666667
296,Surg_Endosc-3-1-2169271.txt,number||intermedi||group||novic||GI mentor II simul||endoscopist||represent||studi||particip||time||simul||endoscopi||task||GI mentor II||colonoscopi||novic endoscopist||train||valid||case||data||level||expert,1||2||1 1 depart||1 0||construct valid 1 2 1||12 1||tabl 1||case 1||3||refer 1||9 2 figur 2||modul 1||albinusdreef 2||michelangelolaan 2||1 0 0,31046.0||28965.0||21528.667||18569.5||18514.6||18449.0||17331.0||17109.5||17044.0||16864.5||16130.75||15924.5||14485.5||14483.5||14410.667,0.0,0.0,0.0
297,Sleep_Breath-3-1-1794625.txt,c-flex||central event||satisfact||effect||night||central apnea||potenti||devic||pressur||prefer||apap||score||studi||technician||cpap||treatment||patient||patient prefer||therapi||complianc||standard cpap||airflow||va score||convent cpap||subject||ahi||sleep||expir,1||2||2 2||result 2 2 0. 1||3||springer-verlag 2006 2 2||refer 1||c-flex 1 fig. 1||1 outcom||2 24||1 3 ryan||question 1||2 week||2 83||appendix 2,31046.0||28965.0||28965.0||19013.0||17044.0||16976.25||16864.5||16775.25||16465.0||16120.5||16072.0||15952.0||15100.0||14859.0||14604.0,0.0,0.0,0.0
298,Abdom_Imaging-4-1-2386533.txt,CD patient||contrast medium||vce||detect||magnet reson imag||small bowel||diagnost perform||bowel wall||sequenc||techniqu||accuraci||ultrasonographi||specif valu||follow-up||cross-sect imag||fat||regard||bowel wall enhanc||CT enterographi||diseas||bowel||activ||accur||contrast administr||colon||ibd||optim bowel prepar||patient prepar||inflammatori bowel diseas||termin ileum,1||refer 1||llc 2008 introduct 1 1 2||3 4||patient||4||studi||netherland 2 depart||6||2005||2004||1 fig. 1. vce imag||2003||individu patient||compar studi,31046.0||16864.5||15782.5||14990.5||13567.0||12937.0||12015.0||11205.0||9074.0||8716.0||8077.0||7857.2||7651.0||7600.5||7344.5,0.0,0.0,0.0
299,J_Struct_Funct_Genomics-3-1-1769342.txt,databas||genom sequenc||number||famsbas||structur genom||amino acid sequenc||function||surfac||templat||domain interfac||domain||figur||time||sequenc ident||orf||famili||homolog model||p-loop||hydrophob||solubl protein||interfac||region||year||genom||eukaryot protein||structur,1||2||1 number||studi||top 1999 2||31 1 3.2||28 2 7.1||5||1 aip1 1ixc||3 year||2001 1 136 10.1273||2005 2005 2003||2004 2005 2003 2004 2004 2005||2004||619-0215 japan 2 depart,31046.0||28965.0||17008.0||12015.0||11340.0||11136.667||10515.667||10364.0||10349.333||10150.0||9404.0||8361.0||8219.0||8077.0||7984.25,0.0,0.0,0.0
300,Dig_Dis_Sci-4-1-2292501.txt,effect||total||pathophysiolog mechan||earli satieti||maximum toler volum||function dyspepsia||nutrient drink||median age 40 year||gastric empti||maximum satieti||daili life||studi||symptom||upper abdomin sensat||age||sever||proxim||test||drink test||patient||nutrient drink test||upper abdomin symptom||upper abdomen||pathophysiolog disord||gastric||stomach||rate||relationship,1||2||0 1||1 year||3||fig. 2||refer 1||pain 1||tabl 2||method patient 1||2 test||test 2||1 frequenc||1 ml||2 min,31046.0||28965.0||18569.5||17151.0||17044.0||16970.5||16864.5||16350.0||16290.5||16095.0||16085.5||16085.5||15961.5||15906.0||15117.5,0.0,0.0,0.0
301,Histochem_Cell_Biol-4-1-2413112.txt,day||fibroblast||fsp1||Le hir||cortex||fibrot kidney||tubular cell||tubul||studi||cortic interstitium||myofibroblast||day 1||rer||interstiti space||resid fibroblast||uranyl acet||control||s100a4||uuo||ligatur||distal tubul||proxim tubul||control group||cell||kidney||rat||data||interstitium||uret obstruct||mitot activ||larg popul||fibrosi||uret||morpholog,1||2||1 2 fig. 1||3 1 4 4||3||day 1||1 day||1 list||1 μm||day 2||4||cell||studi||2 μm fig. 6||10 μm fig. 2,31046.0||28965.0||24008.25||18491.0||17044.0||16489.5||16489.5||15739.0||15689.0||15449.0||12937.0||12627.0||12015.0||10836.75||10313.75,0.0,0.1,0.2
302,J_Gastrointest_Surg-3-1-1852377.txt,hepatocellular carcinoma||microvi||number||outcom||df||vascular invas||factor||multivari analysi||analysi||stage||liver transplant||studi||recurr||present studi||microvascular invas||surviv||signific||liver explant||patient||hcc||histolog grade||tumor||liver||poor outcom,1||2||surviv 1 1||3||refer 1||analysi 2||figur 1||3 figur 2||octob 1||patient||result patient characterist 1||4||studi||2 patholog characterist||3 29,31046.0||28965.0||21103.0||17044.0||16864.5||16826.0||16123.5||15736.667||15561.5||13567.0||12996.0||12937.0||12015.0||10444.0||9657.0,0.0,0.1,0.13333333333333333
303,Diabetologia-3-1-1871609.txt,exercis intervent||exercis||effect||plasma glucos||weight loss||group||review||independ effect||follow-up||analysi||type 2 diabet||diabet||studi||particip||moder increas||incid||risk||physic fit||impair glucos toler||igt||prediabet||chang||outcom measur||physic activ||ifg||prevent||individu||signific reduct||cardiovascular fit||glucos||multi-compon lifestyl intervent||control group||trial||level||relev clinic measur,1||2 2||diet 2 2||1 year||3||refer 1||1 unit||2 year||part 1||type 2||1 davi||2 unit||2 exercis||exercis 2||2 bull,31046.0||28965.0||19404.667||17151.0||17044.0||16864.5||16150.0||16110.5||16058.5||15946.5||15723.0||15109.5||14845.0||14845.0||14574.0,0.0,0.0,0.0
304,Qual_Life_Res-4-1-2358934.txt,largest benefit||seiqol||respond||number||global individu qualiti||correl||altern method||pair||feasibl||averag||agreement||score||social judgment theori||import||domain||index score||life domain||qualiti||task||cancer patient||conjoint analysi||life||individu qualiti||patient||scenario||global qualiti||util||valid||individu||method||iqol||weight||aca||level||direct weight||worst option,1||2||3||M. 2||pair 1||inconsist 1||1 noordijk||valid 2||inconsist 2||patient||4||studi||P. M. 3 1 depart||aca refer 1||netherland 2 depart,31046.0||28965.0||17044.0||16355.5||15806.0||15559.0||15523.5||14994.0||14518.5||13567.0||12937.0||12015.0||11266.4||11261.333||11205.0,0.0,0.1,0.06666666666666667
305,Ann_Surg_Oncol-4-1-2373867.txt,sigmoid colon cancer||femal sexual dysfunct||evalu||autonom nerv||dissect||preoper baselin data||preserv||good||oper||studi||intern prostat symptom score||superior hypogastr plexu||pelvic autonom nerv||point likert scale||item score||time||present studi||surgeri||specif sexual problem||patient||surgic procedur||genitourinari function||rectal cancer||femal||erectil function||nerv||success nerve-preserv surgeri||procedur||inferior mesenter plexu||ipss||function,1||2||discuss 1 2 2||23 1 1||54 2 2||3||refer 1||tabl 2||1 demograph||domain patient 1||patient||4||vein thrombosi 1 pneumonia 1||studi||0 2 poor,31046.0||28965.0||22669.25||21693.333||19695.667||17044.0||16864.5||16290.5||15622.5||15244.0||13567.0||12937.0||12549.6||12015.0||11805.333,0.0,0.0,0.13333333333333333
306,J_Comput_Aided_Mol_Des-4-1-2311385.txt,area||requir||goal||recommend||method||special issu||inform||binding-mod predict||statist evalu||data||prepar||test||set||paper||report||practic applic||field||evalu||result||statist report,2||1 11||3||refer 1||1 3 7 10 10||2 8 11||2 4 5 8 10||studi||3 4 9||10 1 7 8 10||gener 1 5 7 10||5 7||4 7 9||5 8 10||prepar 4 5 9,28965.0||18048.5||17044.0||16864.5||13810.2||13390.0||13080.4||12015.0||11791.0||11632.2||11609.2||8680.5||8442.0||7833.333||7357.0,0.0,0.0,0.0
307,Bioprocess_Biosyst_Eng-2-2-1705514.txt,cultur||biomass||product||concentr||manufactur||deviat||process||profil||rel deviat||total biomass||ferment||feedback control||predefin profil||distort||pat||valu||growth rate||control||experi||biomass concentr||procedur||batch-to-batch reproduc||recombin protein||cell||reproduc||result,1||1 2||2||2 2 2||1 fig. 1||low 2 1||2 4 14.60 2||3||refer 1||0.74 2 4 2.00 2 2||_{ 1||1 composit||3.60 3 2||47 2||_{ 2,31046.0||30005.5||28965.0||28965.0||22356.0||20663.333||17717.0||17044.0||16864.5||16676.333||15932.0||15726.5||15342.667||15119.0||14891.5,0.0,0.0,0.0
308,J_Abnorm_Child_Psychol-4-1-2206247.txt,differ||full model||parent||neglect style||adolescence-limit delinqu||posit parent||variabl||behavior||group||neglect parent||develop||research||measur||distinct delinqu trajectori||studi||characterist||pattern||boy||similar||age||sampl||analys||self-report||famili||trajectori||risk||delinqu trajectori||parent style||pittsburgh youth studi||commun||theori||childhood delinqu||style||famili factor||child||data||late adolesc||delinqu||authoritarian||level||demograph variabl,1||2||10 1 2||1 2006||3||1 1 netherland institut||trajectori 1||pp. 1||28.45 1||trajectori 1 6 fig. 1||8 1993 1983 2 3 2||4||trajectori 7 1||studi||netherland 2 depart,31046.0||28965.0||22331.0||19708.5||17044.0||16422.75||15609.5||15584.5||15523.5||15263.0||13911.833||12937.0||12738.667||12015.0||11205.0,0.0,0.0,0.06666666666666667
309,Ann_Biomed_Eng-2-2-1705519.txt,spontan rate||respons||nois||model||dcn||NN stimuli||center||princip cell||spectral notch detector||nois stimuli||experiment data||connect paramet||sound pressur level||sensit analysi||notch||physiolog data||unit||simul||center frequenc||type IV unit||sound local||cat||frequenc||gerbil||inhibitori||type iii||paramet||paramet estim||good fit||notch nois respons||cell||cat type IV unit||rm||rate||inhibit,1 1 1 1||1||2 2||2||15 1 1||18 1 1||3||tabl 2||1 carney||6 18 2 17 2||4||cell||6 2 figur 6||studi||2 conceptu model,31046.0||31046.0||28965.0||28965.0||22223.0||22007.0||17044.0||16290.5||15535.5||14903.2||12937.0||12627.0||12078.5||12015.0||10989.667,0.0,0.0,0.06666666666666667
310,Eur_J_Epidemiol-3-1-2039783.txt,intervent||educ||death||low educ||countri||parent disabl||disadvantag||studi||evid||gener||social polici||earli disabl pension||disabl||epidemiolog||risk||theori||effect intervent||administr databas||polici||child||low parent educ||health||norway,2||2007 1||refer 1||patient||studi||bioethic 3 4 4 5||2001 10 1 49 55 10.1023||2003||2007||observ studi||7||10||effect||studi design||descript studi,28965.0||19166.5||16864.5||13567.0||12015.0||10666.8||7868.833||7651.0||7287.0||7013.5||6997.0||6982.0||6956.0||6575.0||6182.5,0.2,0.1,0.06666666666666667
311,Histochem_Cell_Biol-4-1-2228381.txt,mammalian cell||zuber||erad||chemic chaperon||glucosidas II||edem1||chaperon||nuclear envelop||exampl||copii coat||endomannosidas||ER stress||protein qualiti control||protein||synthet chaperon||myocilin-caus open-angl glaucoma||patholog gain-of-funct mechan||diseas||pathogenesi||gl II||earli secretori pathway||oligosaccharid||protein fold diseas||degrad||golgi apparatu||edem||complex||cell||qualiti control||work||result,1||3 9 2||fig. 2||4||cell||41-44-2554407 zuber61@bluewin.ch 1 1 divis||studi||switzerland 2 depart||insulin 2 gene induc||2005||2006||2004||2005 1999 2005 2006 2005 2006||cell regul||2007,31046.0||17133.667||16970.5||12937.0||12627.0||12474.8||12015.0||10540.0||8969.5||8716.0||8371.0||8077.0||7947.5||7322.5||7287.0,0.2,0.1,0.06666666666666667
312,Arch_Dermatol_Res-2-2-1705513.txt,concomit therapi||cardiovascular event||effect||inflamm||atop dermat||cardiovascular diseas||inflammatori condit||psoriasi patient||popul||methotrex||drug||psoriasi||condit||studi||diseas associ||diseas||synthet antimalari drug||common inflammatori pathway||treatment||psoriasi treatment||comorbid||patient||risk||atherosclerosi||common||lipoprotein||cell||preval||marker||mortal||diagnosi,2||3||refer 1||1 65||decemb 1||2 84||patient||2 barker jonathan 3 1 depart||44 86 2 1 26||cell||type 1 diabet||studi||germani 2 depart||4 12 4||psoriasi suscept 1 gene,28965.0||17044.0||16864.5||16019.5||15580.5||14862.0||13567.0||13273.0||12948.6||12627.0||12155.0||12015.0||10717.333||10575.333||9134.75,0.0,0.2,0.2
313,Calcif_Tissue_Int-3-1-1914224.txt,osteoporosi||independ effect||follow-up||associ||analysi||studi||pcr cycl||promot||haplotyp||fractur||women||vertebr fractur||baselin||risk||bone miner densiti||chang||bmd||colia1||femor neck bmd||year||result||allel,1||2||2 2 2||3||refer 1||2 24||vertebr 1||fragil 1||55 2||91 2||0.14 2||3.2 2||haplotyp 2||2 ng||11.3 2,31046.0||28965.0||28965.0||17044.0||16864.5||16120.5||15754.0||15550.5||15098.0||14891.0||14616.0||14588.0||14580.0||14577.5||14516.5,0.0,0.0,0.0
314,Diabetologia-3-1-1914292.txt,ctgf||differ||diabet milieu||microvascular basement membran||streptozotocin-induc diabet||aminoguanidin treatment||retina||connect tissu growth factor||ccn famili member||protein level||diabet retina||gene express regul||ccn famili||protein||diabet||studi||extracellular matrix||aminoguanidin||increas||age||express||mrna level||famili||advanc glycat end product||extracellular matrix compon||diabet retinopathi||cystein-rich protein 61||mrna||ace inhibit||rat||mice,1||2||3 2||r.schlingemann@amc.uva.nl 1 1||group 1||3||refer 1||2 stitt||diabet rat 1 fig. 1||springer-verlag 2007 introduct 1 2||4||mrna quantif 1 http://www.ncbi.nlm.nih.gov/blast/index.shtml 2||studi||protein-rel protein 2||J. 1 klaassen,31046.0||28965.0||23004.5||20697.667||17960.5||17044.0||16864.5||14491.0||14261.0||14040.0||12937.0||12134.0||12015.0||11752.333||11617.0,0.0,0.0,0.06666666666666667
315,Cell_Tissue_Res-4-1-2386754.txt,day||cultur||differ||gene express||tissue-harvest site||medium||chondrogen differenti||homogen popul||stem cell||variabl||order||osteogen lineag||signific differ||protein||studi||differenti capac||chondrogen||rel target gene express||asc||adipos tissu||donor||frequenc||assay||gene||abdomen||surface-mark express profil||osteogen differenti||fat depot||cell||human||chondrogen differenti potenti||svf||alp activ,1||2 1||2||2006 6 1 1 2||1 2 2006 2006||asc 2006 1 1||protein 2||1 min||1 bmi||2 week||4 3||3 cell||9.20 2||2006 2007 2007 1 3||3 3 fig. 3,31046.0||30005.5||28965.0||21700.4||19188.25||17633.5||17626.5||16158.0||15640.0||15100.0||14990.5||14835.5||14484.5||14207.0||14027.0,0.0,0.0,0.0
316,Crit_Care-8-6-1065076.txt,intens insulin therapi||hyperglycaemia||intens care unit||effect||hyperglycemia||control||tight glucos control||insulin||patient||studi||ill patient||cardiac surgeri||critic ill||metabol,2||1 resid||patient||4||studi||tabl figur 1||tabl 1 featur||critic care 7 2 4 5||5||devo philipp 1 preiser jean-charl 2||3 day||6||belgium 2 clinic director||ill patient||7,28965.0||15694.5||13567.0||12937.0||12015.0||11954.333||11784.667||10632.333||10364.0||10007.5||9488.5||9074.0||8504.75||7037.0||6997.0,0.4,0.2,0.2
317,Mol_Syst_Biol-4-_-2387231.txt,yeast||physic associ||distribut||co-express||correl||comparison||posit||likelihood||ortholog gene||annot||microarray||pair||accuraci||score||analysi||associ||measur||protein||tendenc||mass spectrometri||control||test||gene||cold aceton||human protein||nuclear export||valid||method||ortholog||complex||set||data||human||cce||interact||physic complex,2||2 3||1 4||1 3 4||5 2||inform 1||3||28 1||1 center||inform 2||1 s.d.||2 rang||figur 2||2 μl||prohibitin 2,28965.0||23004.5||21991.5||20342.333||19664.5||17243.0||17044.0||16747.5||16335.0||16202.5||15529.0||15228.5||15083.0||14590.5||14483.0,0.0,0.0,0.0
318,Arch_Dermatol_Res-4-1-2254657.txt,factor||infliximab therapi||treatment||infliximab||ppp||pustulosi||tnf-antagonist||case||gpp||patient||psoriasi||psoriat arthriti||manifest||report||chronic plaque-typ psoriasi||tnf||therapi||indic||pustular skin lesion,1||2||discuss 1 1||fig. 1||2 12||case 1||3||refer 1||case 2||1 descript||patient||5 patient||germani 2 depart||5||case 3,31046.0||28965.0||21264.333||18011.0||17408.5||17109.5||17044.0||16864.5||16069.0||15698.0||13567.0||11965.5||10717.333||10364.0||10108.5,0.0,0.0,0.06666666666666667
319,Cardiovasc_Intervent_Radiol-3-1-2039794.txt,differ||uae||bi||group||score||analysi||studi||fibroid||sexual||bodi imag||qualiti||improv||question||treatment||women||baselin||patient||sexual life||uterin arteri embol||hysterectomi||sexual function,1||2||1 1 depart||1 year||3||fig. 2||refer 1||month 1||2 year||1 58||2 week||part 2||question 2||patient||4,31046.0||28965.0||21528.667||17151.0||17044.0||16970.5||16864.5||16322.0||16110.5||16000.5||15100.0||15018.0||14911.5||13567.0||12937.0,0.0,0.0,0.06666666666666667
320,Immunome_Res-1-_-1312312.txt,databas||on-lin tool||structur approach||hla||tool||number||web||collier de perl||mous IG||annot||immunoinformat||concept||immunogenet||singl chain fragment variabl||analysi||mhc||domain||polymorph||amino acid||chain||amino acid differ||immunoglobulin||gene||section||web resourc||allel||imgt||data||locu||3D structur||structur,1||1 2||2||tabl 1||3||5 2 1 7 13||tabl 2||figur 1||imgt 1||primer-db 1||figur 2||4||studi||web resourc 2 3||5,31046.0||30005.5||28965.0||17331.0||17044.0||16326.8||16290.5||16123.5||15613.5||15525.5||15083.0||12937.0||12015.0||11761.75||10364.0,0.0,0.0,0.0
321,Pediatr_Nephrol-4-1-2259257.txt,csa||latest follow-up||month||renal function||remiss||studi||minimal-chang nephrot syndrom||sdn||biopsy-proven mcn||steroid||treatment||mcn||studi group||csa toxic||nephrotox||chronic renal failur||patient||drop||gfr||long-term treatment||rang 2||control group||glomerular filtrat rate||level||renal biopsi||year||function,1||1 2||2 2 2||2 2 2 2||2 2||2||result 2 2 2 1 1||2 5 12 2 2||2 19 2||3||fig. 2||refer 1||18 20 2 2||rang 2||patient,31046.0||30005.5||28965.0||28965.0||28965.0||28965.0||25844.5||20622.2||20414.667||17044.0||16970.5||16864.5||16569.0||15228.5||13567.0,0.0,0.0,0.13333333333333333
322,J_Mol_Med-3-1-1820750.txt,human inflammatori cardiomyopathi||dilat cardiomyopathi||quantit real-tim pcr analysi||cardiac inflamm||local inflamm||biolog function||therapeut potenti||etiology-rel pathogen pathway||cardiac express profil||apn||dcmi heart||analysi||studi||express||gene||heart failur||gene network||patient||wnt||dcmi||molecular virolog analys||cardiac diseas||cell||human||standard clinic character||microarray analysi||genom express profil||heart,"1||1 1 2 2 2||2||2 2 16 2||studi group 1 1 1||cell 1||2 2 2 a,b||2 fig. 2||1 2 5 17||1 11||fig. 1||1 13||tabl 1||result 1 1 http://www.ncbi.nlm.nih.gov/projects/geo/||3",31046.0||29797.4||28965.0||22711.5||22005.6||21836.5||21734.5||20968.667||18489.5||18048.5||18011.0||17654.0||17331.0||17044.0||17044.0,0.0,0.0,0.0
323,Pediatr_Nephrol-4-1-2275777.txt,secondari damag||effect||long-term outcom||cic||oxybutynin||evalu||nbsd manag||renal function||adequ medic treatment||intraves pressur||follow-up||detrusor muscl||studi||earli diagnosi||bladder||safe urinari contin||children||treatment||long-term experi||standard therapi||intermitt catheter||irrevers renal damag||neurogen bladder||anticholinerg||patient||infect||risk||therapi||contin||intraves instil||manag||detrusor||nbsd||detrusor overact||type||upper||year||urodynam||renal damag,2||1 fig. 1||2 fig. 2||3||neurogen bladder 2 2 2 7||2 predict||patient||4||studi||54 2 55||bladder complianc 2||2004||pediatr 1994 124 1 7 10.1016||2003||10,28965.0||22356.0||20968.667||17044.0||15714.0||15193.0||13567.0||12937.0||12015.0||10451.0||9844.667||8077.0||8067.667||7651.0||6982.0,0.0,0.2,0.13333333333333333
324,Calcif_Tissue_Int-3-1-2039811.txt,differ||total trabecular bone area||raloxifen treatment||effect||bone remodel||number||immunohistochemistri||percentag||correl||postmenopaus osteoporosi||osteocyt apoptosi||group||averag standard deviat||osteocyt||raloxifen||follow-up||empti lacuna||signific differ||studi||apoptot osteocyt||apoptosi||posit osteocyt||women||baselin||test||section||follow-up biopsi||chang||placebo group||placebo||method||cell||year||biopsi,1||2||1 1 1 1 fig. 1||4 2 2 2||2 fig. 2||1 result||refer 1||2 3 tabl 2 associ||1 month||2 year||1.91 2||4.67 2||patient||cell||studi,31046.0||28965.0||26701.0||24958.0||20968.667||18563.0||16864.5||16451.2||16322.0||16110.5||14495.5||14488.5||13567.0||12627.0||12015.0,0.0,0.0,0.13333333333333333
325,Neurosci_Lett-2-1-2271123.txt,app||increas||hippocampu||brain||stress||habitu||elev platform,1||2||fig. 1||3||fig. 2||1 day||c.a.stewart@dundee.ac.uk 1||4||studi||5||6||fig. 2 app protein express||7||10||effect,31046.0||28965.0||18011.0||17044.0||16970.5||16489.5||15524.0||12937.0||12015.0||10364.0||9074.0||8946.8||6997.0||6982.0||6956.0,0.0,0.0,0.0
326,Pediatr_Nephrol-4-1-2335291.txt,cic||high detrusor pressur||approach||pressur||renal function||abdomin approach||cathet||pelvic floor||birth||bladder neck||boy||bladder||age||surgeri||children||peni||stoma||suspens||spina bifida||patient||risk||urinari contin||antimuscarin||dryness||indic||overact||incontin||upper urinari tract||subject||girl||capac||good result||high bladder pressur||year||detrusorectomi||result,1||2||28 1 fig. 1||1 year||3||refer 1||suppl 1||bladder 2 2 21 fig. 2||2 month||patient||3 fig. 3||4||studi||5||3 year,31046.0||28965.0||17379.25||17151.0||17044.0||16864.5||15942.0||15914.333||15281.5||13567.0||13021.333||12937.0||12015.0||10364.0||10150.0,0.0,0.1,0.06666666666666667
327,Clin_Auton_Res-3-1-1797062.txt,recent studi||heart rate||respons||receptor||day||pulmonari vasoconstrict||autonom nervou system||effect||high altitud dweller||acut hypoxia||high altitud||blood||barometr pressur||densiti||point||increas||sensit||control||exposur||respir||heart failur||week||chang||hypoxia||subject||chemoreceptor||blood pressur||pulmonari hypertens||chronic mountain sick||level||baroreflex control||rate||altitud||result||acut exposur,1||2||10 2||3||refer 1||lima 1||maria 2 1 institut||patient||2005||clinic studi||2004||2003||4 week||cm patient||effect,31046.0||28965.0||17973.5||17044.0||16864.5||15545.0||15374.0||13567.0||8716.0||8436.5||8077.0||7651.0||7086.0||7021.5||6956.0,0.0,0.0,0.06666666666666667
328,Pediatr_Nephrol-3-1-2064946.txt,Na||effect||oncot pressur||alter||fluid leakag||edema format||cortic collect duct||capillari||factor||hydrostat pressur||distal nephron||sodium||pan||proteinuria||increas||renal retent||sodium retent||nephrot syndrom||edema||nephrot patient||trans-capillari gradient||patient||ccd||chang||endotheli cell||glucocorticoid||aldosteron||interstitium||rat||high blood pressur,1||2||2 fig. 2||refer 1||2 mg||patient||4||cell||studi||5||franc 2 servic||13 11 13 13 1||day 3||effect||nephrot patient,31046.0||28965.0||20968.667||16864.5||14904.5||13567.0||12937.0||12627.0||12015.0||10364.0||10163.667||9776.6||9488.5||6956.0||6872.0,0.0,0.1,0.2
329,Dev_Genes_Evol-4-1-2292471.txt,cuticl||short germ insect||express||rnai||embryo||conserv||segment||cell||segment groov||gene||class iii||segment polar gene||gene circuit||normal number,1||1 1||1 1 1||2||tc-smo 2 2||3 3 3 3||LG 1||tc-ci 1||2 week||2007 1 4 2002||tc-smo tc-ci 2 2||tc-smo 2||4||cell||tabl 1 summari,31046.0||31046.0||31046.0||28965.0||19322.0||17044.0||15596.0||15545.0||15100.0||14581.75||14502.5||14500.5||12937.0||12627.0||11695.0,0.0,0.0,0.06666666666666667
330,J_Fluoresc-3-1-2064943.txt,nois||time resolut||spfret measur||subpopul||lifetim||total||fret||immobil nucleosom||short-liv unwrap state||bulk experi||fluorophor||process||averag fret effici||dna||trace||donor||valu||excit||acceptor||fret pair||experi||fluoresc intens||fret effici||fluoresc||event||nucleosom||blink||dynam||intact nucleosom||data||label,1||2||2 2 14 2 2||1 12||3||refer 1||13 2||0 2 4||mononucleosom 2 2 16 fig. 2||dot line 2 1||2 set||2 logi||0 fig. 1||data analysi 2 3||3 4 5,31046.0||28965.0||24031.4||18449.0||17044.0||16864.5||16613.5||15998.333||15973.167||15399.25||15208.5||14483.0||14038.333||13916.25||13448.333,0.0,0.0,0.0
331,Ann_Biomed_Eng-2-2-1705502.txt,model||mit||cylind||center||spatial resolut||truncat level||perturb||cnr||regular scheme||resolut||gener||tsvd||figur||magnet induct tomographi||increas||imag||contrast||valu||VU yield||conduct||border||paramet||psf||radiu||regular||snr||regular paramet||chang||imag reconstruct||homogen cylind||method||case||data||voltag||coil,1||2||2 2||3 2||2 5||10 1||0 1||1 2 26 figur 2||tabl 1||3||refer 1||tabl 2||6 7 2||4||0 figur 1,31046.0||28965.0||28965.0||23004.5||19664.5||19014.0||18569.5||18557.0||17331.0||17044.0||16864.5||16290.5||15012.0||12937.0||12780.0,0.0,0.0,0.0
332,Calcif_Tissue_Int-3-1-2151961.txt,differ||activ men||lifestyl||spine||popul||analysi||associ||signific differ||studi||polymorph||particip||bodi height||bodi||age||bone||gene||fat mass||bone miner densiti||peak bone mass||low-dens lipoprotein receptor-rel protein 5||subject||bmd||genotyp||data||studi popul||bodi mass||men,1||2||2 3||21 2 2||1 4 1 depart||fig. 1||3||refer 1||1 subject||covari 1 3||58 1||1 bathum||1 4 andersen||2 nielsen||2 peeter,31046.0||28965.0||23004.5||20403.667||19380.75||18011.0||17044.0||16864.5||16465.0||16086.667||16000.5||15524.0||14691.0||14535.5||14498.0,0.0,0.0,0.0
333,Mol_Neurobiol-3-1-2039784.txt,model||receptor||cn||injuri||cultur||cn injuri||effect||brain||central nervou system||death||abil||neuron||report||chemokin express||patholog condit||vitro||protein||studi||synapt transmiss||cell function||express||cn cell||releas||activ||neurotox||microglia||astrocyt||role||cell interact||neuroprotect activ||cell||chemokin||pathway||interact||electrophysiolog properti,1||2||2 activ||3||type 1||refer 1||receptor 2||2 pathway||patient||cell||protein 2 inhibit||studi||cell-deriv factor 1||neuroglia 1995 2||antoniu deusinglaan 1,31046.0||28965.0||17098.0||17044.0||16987.0||16864.5||16234.0||15144.5||13567.0||12627.0||12117.0||12015.0||11841.333||10543.667||10354.333,0.0,0.1,0.13333333333333333
334,Anal_Bioanal_Chem-3-1-1839866.txt,substrat||enhanc factor||potenti||surfac||gold||seira||approach||self-assembl monolay||techniqu||interact||protein||signal enhanc||studi||metal||membran||electrod||function studi||metal electrod||immobil||enhanc||film||method||properti||acid,1||2||1 2 2 3||1 2 3||1 2 4||1 4||substrat 2 2 2||refer 1||1 min||1 2 11 12 13||1 4 Cl||6 12 1 3 5||4||33 2 14 14 fig. 2||studi,31046.0||28965.0||26505.0||25685.0||24316.0||21991.5||21846.25||16864.5||16158.0||15035.2||14685.333||14676.0||12937.0||12249.833||12015.0,0.0,0.0,0.06666666666666667
335,Pediatr_Nephrol-4-1-2335295.txt,mesangi prolifer degre||iga-n||differ||outcom||long-term outcom||japanes children||group||multivari analysi||late group||renal surviv||focal mesangi prolifer||follow-up||analysi||proteinuria||studi||baselin characterist||diseas||sever iga-n||time||mild iga-n||present studi||children||appar diseas onset||treatment||signific||mesangi prolifer||sever mesangi cell prolifer||initi renal biopsi||time period||patient||rct||studi period||end-stag renal diseas||year||corticosteroid||diagnosi||signific factor||result,1||2 2||2||4 1 2 1 2||1 4||1 1 depart||2 4||1 treatment||group 1||3||refer 1||1 139||1 361||2 day||0.67 2,31046.0||28965.0||28965.0||26591.8||21991.5||21528.667||20951.0||18029.0||17960.5||17044.0||16864.5||15678.5||15597.0||15449.0||14546.5,0.0,0.0,0.0
336,Exp_Brain_Res-3-1-1914235.txt,flexion||instruct||differ||rhythmic movement||cycl durat||effect||time correct||extens||emg activ||depend||electromyographi||bimanu coordin||kinemat||antiphas coordin||signal||effer signal||left||phase||coordin pattern||analysi||phase entrain||movement||emg||kinesthet track||success half-cycl||measur||half-cycl||correct||condit||muscl||time||pattern||emg amplitud||ecr||valu||bilater muscl activ||peak flexion||activ||control||time error||neural control signal||rel phase||method||limb||error correct||hand||afference-bas interact||trial||coordin||rhythmic bimanu coordin||tempor relat||coher||cycl||result,1||2||1 2 7 2 fig. 7||2 7||3||fig. 2||FC 1||HC 3 2||FC 3 2005b 2 2||2 cm||emg 2||kinemat 5 1||4||5||5 5 5,31046.0||28965.0||17991.0||17981.0||17044.0||16970.5||15624.5||15421.667||15053.2||14720.5||14528.0||13826.333||12937.0||10364.0||10364.0,0.0,0.0,0.0
337,J_Mol_Model-4-1-2386531.txt,model||speci||survey||bond length||sulfur||optim||geometri||atom||solid state||weak interact||inter-r distanc||organ solid||good accuraci||form||artifact||higher accuraci||ion||partial charg||fault||acet group||bond||gradient||pm6||unit cell||organ compound||strong bond||densiti||error||period boundari condit||unpair electron||unit||polymorph||paramet optim||distort||valu||compound||turn||carbon group||miner||forc||hydrogen bond||good approxim||solid||train||electrostat potenti||method||proton||dabco||net charg||eid||charg||distanc||crystal||type||ice||molecul||silic||energi||result,1||1 1||1 2 2||2||2 2||2 2 3 2 2 2||3 2 2 2||2 3 2||2 4 2 2||2 2 7 2 2||82.8 2 2 2 2 2||2 2 4||2 4 2||3 2||2 3,31046.0||31046.0||29658.667||28965.0||28965.0||26978.167||25984.75||24991.333||24958.0||24571.4||24138.833||23622.333||23622.333||23004.5||23004.5,0.0,0.0,0.0
338,J_Mol_Biol-2-1-2267215.txt,cam||mammalian cell||acid box||weak interact||Ig||fn3||previou peptid studi||cell surfac||interact||protein||domain||pb||fibronectin type 3||dissoci constant||bind site||immunoglobulin||conform||tb||neural cell adhes molecul||spr||fgfr||peptid||cell||ncam||tris-buff salin||fibroblast growth factor receptor||structur,"1||1 1 1||1 2||2||1 2 1 2 37||4 2||1 1 1 unit cell dimens||3||fig. 4 1 2 fn3||9,10,12 1||fgfr1 interact 1 2||1 2 2vkw 2vkx||47 6 1 2 fn3||purif 2 4||cell",31046.0||31046.0||30005.5||28965.0||24360.0||20951.0||17888.0||17044.0||15589.6||15523.5||15511.75||15003.25||14076.4||14026.667||12627.0,0.0,0.0,0.06666666666666667
339,Bioinformation-2-1-2139994.txt,hypothet protein||databas||sequenc||approach||polar side chain||network||protein||gene||amino acid residu||function,2 3 4||refer 1||materi 1||supplementari materi data 1||8 5||2005 15 1759 16339374 2 yamasaki||7||protein||5 figur 1a 6||data||gene||function||disord protein||protein famili||potenti protein,19648.667||16864.5||16365.5||9623.0||8259.0||7047.833||6997.0||6288.0||5166.75||4969.0||4794.0||4581.0||4086.0||4079.0||4035.5,0.0,0.1,0.2
340,Int_J_Cardiovasc_Imaging-3-1-2121119.txt,mass||differ||LA contractil||hcm||lav||group||aa-sv||ventricular||measur||studi||left atrial volum||eject fraction||la-k||LA conduit||atrial volum||control||LA size||patient||hypertroph cardiomyopathi||aei||lad||wall thick||function,1||2||2 1 2 3||1 fig. 1||result 1||3||13 3 3 2 fig. 2||mitral regurgit 2 2 2 12||I. 1 2 neme||1 2 soliman osama||patient||31104635498 f.j.tencate@erasmusc.nl 1 1 depart||1 3 geleijns marcel||studi||tabl 1 baselin,31046.0||28965.0||26505.0||22356.0||18563.0||17044.0||16876.0||15469.833||15149.0||15006.75||13567.0||12917.6||12041.0||12015.0||11785.0,0.0,0.0,0.13333333333333333
341,Qual_Life_Res-3-1-1915610.txt,gener popul sampl||respons||shannon approach||differ||reliabl||respond||distribut||rel inform||number||hui||shannon||classif system||health statu||popul||categori||gener popul survey||frequenc distribut||instrument||measur||total number||permut||absolut||system||common dimens||health classif system||formal measur||problem||inform||level||health state||classif||discriminatori power||health,1||1 1 1||2||2 2 2 1.30||fig. 1||3||fig. 2||refer 1||level 2||3. 2||max 2||patient||instrument 6 1||4||studi,31046.0||31046.0||28965.0||21745.25||18011.0||17044.0||16970.5||16864.5||16085.5||14929.0||14722.0||13567.0||13516.667||12937.0||12015.0,0.0,0.0,0.0
342,J_Biol_Inorg_Chem-3-1-1915625.txt,substrat||heme||model||dft calcul||experiment structur||cytochrom p450 2d6||spin equilibrium||experiment data||water molecul||enzym||t309v||sampl||rel destabil||spectroscop data||supplementari materi||heme moieti||experiment observ||wild-typ||activ site||water||result||structur,1||1 1||2||2 fig. 2||1 5||1 7||3||refer 1||posit 1||dft calcul 1 1||posit 2||1 π||4||sampl 1 mW||1 sodium dithionit,31046.0||31046.0||28965.0||20968.667||20705.0||19021.5||17044.0||16864.5||16665.5||15775.75||15625.0||15537.5||12937.0||11140.0||10474.333,0.0,0.0,0.0
343,J_Biol_Inorg_Chem-4-1-2359831.txt,band||polyacrylamid gel electrophoresi||odn||solut||platinum||odn II||copper complex||clear sequenc select||smear||fragment||condit||dna||dna cleavag||gel||strand cleavag||sampl||adduct||sequence-select cleavag||copper||major groov||nucleobas||cleavag||close proxim||result,1||1 2 1 1||1 2||1 2 2||2||1 4 2 1 2||1 2 2 3 15 1||1 7 1||6 1 2 6 1 2||1 2 7 2 4 2||1 2 3 2 2 27||cleavag 1 2 1||method 1 2||2 4||cytotox 1 2,31046.0||30525.75||30005.5||29658.667||28965.0||26591.8||23607.167||23029.667||23028.333||22979.167||22899.5||22805.0||21227.667||20951.0||20044.0,0.0,0.0,0.0
344,J_Hum_Genet-3-1-1915643.txt,snp||plasma homocystein||plasma folat concentr||children||risk factor||effect||mother||spina bifida||studi||risk||pediatr control||TT genotyp||femal control,1||2||patient||31-20-4440305 h.blom@vumc.nl 1 4 1 laboratori||studi||netherland 2 depart||1 r01 ns050249-01a1||6||M. 1 heil sandra||heijer martin 2 3 blom henk||2003||cell signal||present studi||netherland 3 depart||10,31046.0||28965.0||13567.0||12628.833||12015.0||11205.0||10355.667||9074.0||8703.25||7741.167||7651.0||7464.0||7377.0||7231.333||6982.0,0.2,0.1,0.06666666666666667
345,Cancer_Chemother_Pharmacol-4-1-2270367.txt,concurr chemoradiotherapi schedul||correl||dose||cisplatin||format||analysi||wbc||total number||normal tissu||studi||infus||sampl||tumor tissu||treatment||schedul||adduct||dna adduct||AG adduct||buccal cell||patient||tumor||cell||radiat||level||cervic cancer,1||2||1 fig. 1||method 2 2 2 32||tabl 1||fig. 2||refer 1||C. 2 1 depart||2 hart||patient||cell||studi||netherland 2 depart||LD 2 6 19||cervix 40 2,31046.0||28965.0||22356.0||18551.8||17331.0||16970.5||16864.5||16130.0||14523.5||13567.0||12627.0||12015.0||11205.0||10386.25||10380.0,0.0,0.1,0.2
346,Neurosci_Lett-1-5-1885995.txt,cbf-1||notch||sub-nuclear bodi,1||2||3||4||cell||5||6||presenilin 1 express hum||2000 260 1 8 11010805||cell biol||7||10||fig. 2 icd icd icd||protein||8,31046.0||28965.0||17044.0||12937.0||12627.0||10364.0||9074.0||9015.75||8660.0||8411.0||6997.0||6982.0||6851.2||6288.0||6154.0,0.0,0.0,0.0
347,Biochim_Biophys_Acta-2-1-2258317.txt,cam||calmodulin||bind||vitro evid||detect||calcineurin||specif||dephosphoryl||nc||CN||protein||studi||calcineurin activ||nfat-gfp||sampl||analys||cytosol||gst||control||activ||assay||pierc||nfat||bind buffer||neuron calcium sensor||CN activ||calcium||cell||data||sd||sd dissoci buffer||interact||bovin brain cytosol||result,1||2||2 2||3 2||fig. 1 2||fig. 2 2||fig. 1 fig. 1 2||assay 2 2||fig. 2 fig. 2 2||fig. 1 fig. 1 fig. 1||fig. 1||3||fig. 3 2||fig. 2 fig. 2||fig. 2,31046.0||28965.0||28965.0||23004.5||21662.333||20968.667||20201.8||19548.667||19369.4||18011.0||18011.0||17044.0||16995.0||16970.5||16970.5,0.0,0.0,0.0
348,Cell_Tissue_Res-4-1-2386751.txt,uterin tissu||ed||skin||day||differ||obstetr complic||complic||abnorm||pregnanc||elastin||postpartum hemorrhag||tnx||signific differ||present||age||elast fiber||ed patient||patient||ehlers-danlo syndrom||complet defici||collagen||vagin plug||uterin connect tissu||mice||human||uteru||type||tenascin-x,1||2 1 1||2||patient 1||2 fig. 2||partu 1 1||partu 1 3||age 1 4||patient 3||2 pregnanc||histochemistri 2||patient||4||cell||studi,31046.0||30352.333||28965.0||22306.5||20968.667||20698.333||16031.0||15849.333||15305.5||14944.0||14502.0||13567.0||12937.0||12627.0||12015.0,0.0,0.0,0.06666666666666667
349,Glycoconj_J-4-1-2413117.txt,calcul||molecular shape||model||isotrop||random coil||cross-peak||polym||anisotrop model||experiment data||coupl||analysi||na-domain||time||simul||sampl||valu||amid||polysaccharid||central residu||experi||octasaccharid||heparin||oligosaccharid||tabl||consist||nmr relax||diffus||dynam||nmr||data||molecul||result,1||1 2 1||2 1||2||2 2||2 3||1 1 15||2 1 15||1 3 2 3 4||2 4||1 1 15 1 13||2 calc 1||1 4 fig. 1||1 1 15 4||5 2,31046.0||30352.333||30005.5||28965.0||28965.0||23004.5||22223.0||21529.333||21407.2||20951.0||20395.4||20014.333||20001.25||19901.5||19664.5,0.0,0.0,0.0
350,Mol_Biochem_Parasitol-1-5-1885993.txt,conserv||specif||protein phosphatas||analysi||protein||ppef||amino acid||lmppef||myristoyl||s-gfp||phosphatas||ef-hand||gene||high confid||ef-hand domain||rdgc||motif||data||tbppef||parasit||result,1||1 1 2||2||3 3 2||2 1 3 ser||fig. 1||7 2||fig. 1 3||2 2 2 stiboglucon resist||tabl 1||3||3 3||fig. 2||tabl 2||1 mg,31046.0||30352.333||28965.0||21017.667||19288.75||18011.0||17981.0||17688.667||17528.2||17331.0||17044.0||17044.0||16970.5||16290.5||15945.0,0.0,0.0,0.0
351,J_Mol_Biol-1-5-1950483.txt,simul||afm||mechan stabil||fnfn10||atom forc microscopi||tnfn3||fibronectin type iii,1||1 13||1 18||refer 1||jc162@cam.ac.uk 1||figur 2||figur 2 5||unfold extracellular matrix 1 2 3||10 figur 1 10||5||5 5||figur 3||6||20 21 5 4 4||8 6 4 9,31046.0||17654.0||17487.5||16864.5||15526.0||15083.0||13510.0||13034.333||11552.75||10364.0||10364.0||9122.5||9074.0||8787.2||8389.25,0.0,0.0,0.0
352,J_Insect_Sci-1-_-355886.txt,day||pupa||concentr||yolk format||monarch||long day condit||metamorphosi||protein||present||condit||lepidopteran||short day condit||sampl||v-mth||m-mth||hexamerin||fat bodi||cecropia||mth||whole-bodi extract||femal pupa||adult develop||post-eclos egg format||femal||support||hemolymph||egg||reserv||immunodiffus||arh||extract,1||2||result 1||method 1||3||discuss 1||figur 1||1 hr||figur 2||4||studi||tabl figur 1||fig. 3||5||figur 3,31046.0||28965.0||18563.0||17359.0||17044.0||16373.5||16123.5||15552.0||15083.0||12937.0||12015.0||11954.333||11010.0||10364.0||9122.5,0.0,0.0,0.0
353,Eur_J_Nucl_Med_Mol_Imaging-4-1-2100432.txt,nois||differ||male||sex||brain||auditori process||rcbf||auditori stimul||analysi||studi||condit||stimuli||gender||pac||contrast||white nois||activ||music||baselin||spm||attent result||auditori||pet||sex differ||primari auditori cortex||femal group||prefront cortex||subject||prefront region||data||region||men||result,1 1||1||2||2 2||3||2 fig. 3||refer 1||1 overview||2 region||M. 3 1 depart||4||studi||result music versu nois 1 1||femal group 4 1 fig. 4||netherland 2 depart,31046.0||31046.0||28965.0||28965.0||17044.0||16995.0||16864.5||15645.5||15272.5||13582.5||12937.0||12015.0||11558.333||11278.667||11205.0,0.0,0.0,0.06666666666666667
354,Mol_Cell_Biochem-4-1-2226060.txt,day||cultur||effect||medium||incub||calcif||statin||concentr||plaqu||ascorb acid||combin||amlodipin||calcium antagonist||growth medium||prolifer||vitro||vsmc||studi||highest concentr||apoptosi||dexamethason||calcif medium||vascular smooth muscl cell||atorvastatin||atherosclerosi||calcium deposit||ca||vascular calcif||calcium||cell||immunofluoresc imag||level||vsmc cultur||result,1||2||result 1 fig. 1||3||fig. 2||refer 1||1 mmol||vsmc 21 2 2||2008 introduct 1 2 4||concentr 2||2 concentr||albinusdreef 2||3 4 cell||patient||4,31046.0||28965.0||18287.0||17044.0||16970.5||16864.5||15676.5||15312.75||15257.4||15162.0||15162.0||14485.5||14202.667||13567.0||12937.0,0.0,0.0,0.0
355,Arch_Orthop_Trauma_Surg-4-1-2225998.txt,x-ray||distal radiu||reduct result||radial inclin||side||distal radiu fractur||techniqu||tradit measur techniqu||measur||volar angul||radiu fractur||templat||studi||distal radial fractur||improv||AO fractur type||observ||patient||radiu||normal valu||direct measur||radial length||reproduc||classif||result,1||2||3||refer 1||1 fig. 1 anatom||patient||C. 3 1 depart||lidström 2 fig. 2 normal||4||studi||4 5||netherland 2 depart||E. 1 gosl||5||6,31046.0||28965.0||17044.0||16864.5||16835.25||13567.0||13149.75||12955.0||12937.0||12015.0||11650.5||11205.0||10994.0||10364.0||9074.0,0.0,0.2,0.13333333333333333
356,Clin_Rheumatol-4-1-2367388.txt,intervent||effect||number||clinic characterist||blood||step||studi||stabl non-steroid anti-inflammatori drug||diseas activ score||rheumatoid arthriti||antioxid||benefici effect||treatment||clinic symptom||antioxid intervent||patient||non-signific increas||period||oxid stress||marker||open pilot studi||da||clinic paramet,1 2 fig. 1 clinic condit||refer 1||C. 1 1 depart||2 dijkman||patient||4||studi||2003 2 5 10.1186||netherland 2 depart||3 month||diseas activ score fig. 2||patient 4 fig. 4 marker||2 123 129 10.1016||control studi||present studi,17122.833||16864.5||16650.25||14494.0||13567.0||12937.0||12015.0||11787.75||11205.0||9321.0||9285.4||9016.6||8889.5||8209.5||7377.0,0.2,0.2,0.13333333333333333
357,Eur_J_Nucl_Med_Mol_Imaging-4-1-2275773.txt,roi||respons||salivari gland function||treatment-induc annexin uptak||differ||effect||dose||abil||spect||tumour||earli apoptosi||normal tissu||studi||apoptosi||parotid gland||submandibular gland||imag||annexin||radiat dose||convent gamma camera||baselin||patient||primari tumour||lymph node||protocol||scintigraphi||radiat||hnscc||tumour-specif apoptot respons,1||2||method 2 2||result 1 99m 1 fig. 1||3||refer 1||tabl 1 patient||2 verheij marcel 1 1 depart||day 2||patient||4||studi||patient fig. 3||netherland 2 depart||cisplatin administr 1,31046.0||28965.0||20534.0||17375.5||17044.0||16864.5||16076.333||15604.5||15449.0||13567.0||12937.0||12015.0||11862.333||11205.0||10582.0,0.0,0.1,0.13333333333333333
358,J_Gastrointest_Surg-3-1-1852381.txt,biliari fistula||approach||skin||fistula tract||jejun loop||biliari surgeri||tract||hepat arteri thrombosi||biliari cutan fistula||anastomosi||liver||procedur||liver transplant||patient||oper procedur||biliari drainag||biliari ductal system,1||refer 1||discuss 2 3||figur 2||patient||1-313-9169147 maboulj5@hfhs.org 1 1 divis||6||4 figur 4||patient ’s||alimentari tract 2007 introduct 1||surgic procedur 3 figur 3||well-select patient||MI 48202-2689 usa 2 divis||result||patient ’s biliari,31046.0||16864.5||15903.333||15083.0||13567.0||12474.6||9074.0||9025.0||8305.5||8025.4||7541.2||6785.5||6282.8||6080.0||5568.333,0.2,0.1,0.06666666666666667
359,Urol_Res-3-1-2082064.txt,extracorpor shock wave lithotripsi||eswl||statist analysi||entonox||va score||effect||pain||analgesia||procedur||inhal entonox||pain relief||signific differ||pethidin||patient||studi||va||stone||air||group,1||2||2 2||result 1||0 2 1 number||3||refer 1||1 mg||2 min||2 78||2 height||1 fig. 1 va score||patient||4||1 demograph data,31046.0||28965.0||28965.0||18563.0||17268.5||17044.0||16864.5||15945.0||15117.5||14864.0||14602.5||13865.8||13567.0||12937.0||12071.333,0.0,0.0,0.06666666666666667
360,Soc_Psychiatry_Psychiatr_Epidemiol-2-2-1764204.txt,differ||psychiatr disord||major depress||lifetim||major depress disord||tarapaca||popul||servic util||countri||analysi||drug||interview||studi||span wide geograph area||district||bio bio||disord||region differ||mental health||mental health servic||servic||socio-demograph differ||chile||alcohol abus||conclus region differ||household||data||region||substanc abus disord||rate||drug abus||popul center,2||result 1 2||tabl 1||3||refer 1||volum 1||SE 2||2 df||4||studi||chile 2 dept.||2003||atyp psychosi 2 df||tabl 2 lifetim preval rate||2002,28965.0||22030.333||17331.0||17044.0||16864.5||16007.5||14771.0||14557.0||12937.0||12015.0||9675.333||7651.0||7341.5||7213.0||7057.0,0.0,0.1,0.06666666666666667
361,Eur_Biophys_J-3-1-2082062.txt,distribut||number||agm||posit||sequenc||peak||afm measur||repeat number||measur||nucleosom posit||fragment||nucleosom array||dna||atom forc microscopi||gel||alpha-satellit dna||reconstitut||internucleosom distanc||fraction||afm||array||kinetochor protein bind||main phase||chromatin condens||liquid||nucleosom||centromer||site||largest fragment||histon||result||chromatin,1||2||3 2||1 fig. 1||1 lane 2||3||1 min||free 1||r-eco 1||2 μm||lane 2||2 Hz||4||studi||background subtract 1,31046.0||28965.0||23004.5||22356.0||20101.333||17044.0||16158.0||15789.0||15523.5||14648.5||14629.0||14575.5||12937.0||12015.0||10518.667,0.0,0.0,0.0
362,J_Headache_Pain-4-1-2276243.txt,cluster headach||model||genet||mechan||headach pathogenesi||primari||typic migrain||suscept loci||behaviour||genet repertoir||epigenet||studi||diseas||clinic featur||mutat||disord||infanc||migrain||fhm||famili||attack||featur||autosom domin||risk||chromosom||epigenet mechan||primari headach||chronic headach||genet variat,1||2||1 diseas 1 2||3||refer 1||allel 1||2 prothrombot||patient||studi||hypocretin receptor 2 gene||2005||2006||2004||chromosom 1 microsatellit marker||27 patient,31046.0||28965.0||24051.5||17044.0||16864.5||15680.0||14485.0||13567.0||12015.0||9317.25||8716.0||8371.0||8077.0||8042.5||7989.5,0.0,0.1,0.06666666666666667
363,Health_Care_Anal-4-1-2362137.txt,intervent||neurologist||nation registri||pam||target group||databas||drug interferon-beta||effect||clinic practic||hcib||variabl||clear protocol||order||workshop||medic advisor||develop||criteria||drug||argument polici analysi||cost||target popul||clinic trial||multipl sclerosi||specif recommend||central pre-utilis approv||particip||long-term effect||treatment||patient||guidelin||ministri||interferon-beta||nation databas||theori||polici develop process||reimburs request||polici||actor||problem||interact polici develop||data||interact process||reimburs||central committe||health,1||2||3||refer 1||issu 1||1 view||interpret frame 1 2||patient||4||studi||5||3 year||patient data||6||netherland 2 doornenkampseweg 24,31046.0||28965.0||17044.0||16864.5||15848.0||15844.0||15199.75||13567.0||12937.0||12015.0||10364.0||10150.0||9268.0||9074.0||8599.5,0.0,0.1,0.06666666666666667
364,Rheumatol_Int-3-1-2134974.txt,autoimmun diseas||autoimmun disord||number||month||vascul||report||cell-direct biolog therapi||follow-up||refractori||small pilot studi||sle||studi||antibodi||clinic remiss||diseas||infus||rituximab||improv||treatment||thrombocytopen purpura||potenti util||patient||clinic benefit||therapi||autoimmun||biolog therapi||inadequ respons||cell deplet therapi||cell||trial||case||system lupu erythematosu||rituximab therapi||result||pilot studi,1||2||3||11 2||refer 1||15 2||16 2||18 2||1 month||25 2||1 mg||2 26||1 summari||infus 1||27 2,31046.0||28965.0||17044.0||17008.0||16864.5||16771.0||16458.0||16447.0||16322.0||16132.0||15945.0||15786.5||15734.5||15711.0||15688.5,0.0,0.0,0.0
365,Pediatr_Nephrol-4-1-2259254.txt,insulin resist||complic||protein degrad||kidney diseas||protein||insulin||condit||muscl||growth||ckd||muscl atrophi||muscl mass||acidosi||activ||degrad||muscl wast||glucocorticoid||cell||uremia||chronic kidney diseas||caspase-3||loss||result||metabol acidosi,3||refer 1||1 evid||patient||cell||studi||3 4 level||10 3 10||2 metabol acidosi||7 2 60 61||cell protein||ckd 3||acidosi 3||caspas 3||2004,17044.0||16864.5||16292.5||13567.0||12627.0||12015.0||11062.333||10336.0||10039.0||9613.25||9457.5||8644.0||8565.0||8561.0||8077.0,0.2,0.1,0.06666666666666667
366,Dig_Dis_Sci-3-1-1914298.txt,false-neg test||optim diagnost accuraci||exercis||chronic gastrointestin ischemia||low cost||lactat||consecut period||target||exercis test||measur||decreas||studi||exercis intens||gastric ischemia||exercis tonometri||test||paramet||patient||period||exercis level||roch diagnost||tonometri||anaerob threshold||optim exercis test||rapid serial lactat||gastric exercis tonometri||target HR||diagnosi||superior mesenter arteri||low level,1||2||3 2||method 3 1||1 test||3||1 fig. 1 relationship||refer 1||1 max||1 algorithm||max 2||wielingenlaan 2||llc 2007 introduct 1 2 3||patient||4,31046.0||28965.0||23004.5||17254.0||17126.0||17044.0||17025.75||16864.5||15762.5||15629.5||14722.0||14483.0||14323.167||13567.0||12937.0,0.0,0.0,0.06666666666666667
367,Pediatr_Radiol-4-1-2367394.txt,locat||metastat diseas||rhabdomyosarcoma||epssg protocol||work-up||chemotherapi||tumour||intergroup rhabdomyosarcoma studi group||group||order||rm||paediatr oncologist||mri||follow-up||malign tumour||BP tumour||studi||rare tumour||soft-tissu sarcoma||present||diseas||bone scintigraphi||transfus||imag||alveolar histolog||surgeri||children||treatment||bone||patient||pet||primari tumour||protocol||prognosi||case report||child||site||cell||primari site||diagnosi||seri||biopsi,1||3 1||2 12||refer 1||1 28||1 2 fig. 1 embryon rm||patient||1 june 2005||springer-verlag 2008 introduct 1 2||cell||studi||M. 6 1 depart||3 8 fig. 3||netherland 2 depart||5,31046.0||24045.0||17408.5||16864.5||16747.5||16208.667||13567.0||13298.0||12990.8||12627.0||12015.0||11590.0||11304.5||11205.0||10364.0,0.0,0.2,0.2
368,Anal_Bioanal_Chem-4-1-2262919.txt,small size||bind||target||recognit||electr signal||signal||electr doubl layer||nacl solut||protein||antibodi||deby screen length||electrochem aptam sensor||nanoscal sensor||carbon nanotub||sensit||fet||detect limit||sensor||recognit element||aptam||high sensit,1||1 2||2||1 16||3||refer 1||1 fig. 1 mip||tabl 2||1 μm||1 nm||2 80||4||3 1 μM sandwich||4 10||2005,31046.0||30005.5||28965.0||17498.5||17044.0||16864.5||16770.75||16290.5||15689.0||15659.0||15071.5||12937.0||12081.5||9959.5||8716.0,0.0,0.0,0.0
369,Mol_Immunol-1-5-1995235.txt,motil||spermatozoa||mous||cd59a||cd59b||abund express||protein||tissu||studi||testi||specif role||mac||blood cell||analys||blood contamin||gene||perfus||absent||role||mrna||primer||acrosom||liver||amplif||result,1||1 20||tabl 1||fig. 2||2006 fig. 1 fig. 1||1 μM||1 sommer||2 materi||2 μl||2004 tabl 1||2004 tabl 2||4||studi||1998 2 3 6 mead||tabl 1 primer,31046.0||17731.5||17331.0||16970.5||16083.0||15636.0||15542.0||15325.0||14590.5||14246.333||13552.667||12937.0||12015.0||11867.6||11627.667,0.0,0.0,0.06666666666666667
370,J_Headache_Pain-4-1-2386847.txt,heart rate||cerebr blood flow||effect||region cerebr blood flow||mca||cerebr arteri||rcbf||decreas||studi||infus||time||increas||present studi||signific||treatment||migrain||volunt||cgrp||patient||chang||placebo||arteri||blood pressur||min,1 1||1 2||2||2 2||2 2 2||2 correct 2||12 1||fig. 1||2 7||tabl 1||A. 1||3||refer 1||2 20||2 18,31046.0||30005.5||28965.0||28965.0||28965.0||19534.333||18449.0||18011.0||17981.0||17331.0||17279.0||17044.0||16864.5||16691.0||16447.0,0.0,0.0,0.0
371,Diabetologia-4-1-2362135.txt,vascular function||type 2 diabet mellitu,1||1 1 1||2 2||2||1 fig. 1||editor 1 2 3||J. 1||3||refer 1||e.s.stroes@amc.uva.nl 1 1 depart||2 level||type 2||1 vergeer||1 birjmohun||patient,31046.0||31046.0||28965.0||28965.0||22356.0||19286.0||17417.5||17044.0||16864.5||16146.75||16085.5||15946.5||15523.5||15523.5||13567.0,0.0,0.0,0.0
372,Matern_Child_Health_J-2-2-1592152.txt,organ||genet||poor pregnanc outcom||outcom||decad||health statu||fetal alcohol syndrom||reproduct||perinat outcom||pregnanc||american colleg||nation organ||health care profession||preconcept health||medic||unit state||main perinat prevent strategi||medicin||health care||acog||import||nurs||profession||condit||diseas||famili physician||preconcept assess||current statu||committe||object||specif type||medic condit||preconcept screen||care||screen||women||servic||dime birth defect foundat||preconcept||standard||patient||histori||risk||guidelin||profession practic guidelin||reproduct awar||commit||prevent||effort||perinat period||preconcept health servic||folic acid||counsel||health,1||2||3||refer 1||1 suggest||1 month||p. 2||llc 2006 introduct 1 2||patient||2 curti michel 3 1 depart||4||5||3 month||part 1 1022 7 10.1016||2005,31046.0||28965.0||17044.0||16864.5||16389.0||16322.0||14507.5||13995.8||13567.0||13278.0||12937.0||10364.0||9321.0||8980.2||8716.0,0.0,0.1,0.06666666666666667
373,Eur_J_Appl_Physiol-3-1-1914240.txt,twitch interpol||differ||rsemg||minor influenc||neural drive||triplet||angl||conclus||voluntari torqu||emg||high level||high contract intens||contract||studi||muscl||rest||increas||present studi||torqu||knee angl||herzog||forc||experiment day||voluntari activ||subject||contract intens||maxim VA||subject popul||data||muscl length||relationship||surfac emg signal||mvc,1||1 1||1 2 2||2||2 3 fig. 2||fig. 1||J. 1||2001 1 2 3 1997||3||subject 1||D. 1||2 valu||1 khz||31-20-5988529 a.dehaan@fbw.vu.nl 1 2 1 institut||2 3 4 fig. 4,31046.0||31046.0||29658.667||28965.0||19987.5||18011.0||17417.5||17383.4||17044.0||16465.0||16330.0||15845.0||15551.5||15418.0||15371.8,0.0,0.0,0.0
374,Eur_Radiol-2-2-1766021.txt,malign||harmon imag||detect||calcif||tissu harmon imag||breast tumour||tumour||combin||chi||vascularis||spatial compound||mri||breast||malign tumour||speckl reduct imag||thi||CM enhanc||tissu||studi||vacuum biopsi||imag||lesion||contrast||breast ultrasound||tumour vascularis||bolu inject||small tumour||patient||fundament mode||focal breast lesion||mammography-dens breast||digit imag||case||level||sri||biopsi,1||2||2 1 fig. 2||1 0||group 1||level 1||3||group 2||refer 1||1 cm||49-6331-515640 2 1 depart||2 comparison||sri 2||differenti 1 33 fig. 1||tabl 1 result,31046.0||28965.0||23488.0||18569.5||17960.5||17126.0||17044.0||16920.0||16864.5||15761.0||15626.5||15308.5||14498.0||14051.6||13580.667,0.0,0.0,0.0
375,Pflugers_Arch-3-1-1839769.txt,neg shift||arrhythmia||verp||tdr||effect||conduct time||stimulu||criteria||hypokalemia correl||critic interv||refractori||condit||hypokalem heart||map||experiment result||repolar||action potenti||clinic observ||arrhythmogen||hypokalemia||membran potenti||refractori period||heart,1||1 1||2||refractori 2 2 2||clh11@cam.ac.uk 1 1||1 11||fig. 1||3||refer 1||schedul 1||1 khz||47 2||3 4||patient||3 4 3 4 90,31046.0||31046.0||28965.0||21754.5||20698.667||18048.5||18011.0||17044.0||16864.5||15600.0||15551.5||15119.0||14990.5||13567.0||12250.4,0.0,0.0,0.0
376,Purinergic_Signal-4-1-2245999.txt,receptor||adenosin receptor||effect||specif||adenylyl cyclas||grk||terminu||arrestin||phosphoryl||protein||agonist exposur||studi||addit||desensit||lipid raft||amino acid||intern||caveola||stimul||gpcr||adenosin||cell||human||level||result||function,1||1 1||1 1 1 1 41||1 1 1 1 58||1 1 42 1||44 1 1 1||3 2||1 1 depart||3 3 2||5 1||1 3 3 3||1 1 9 1 57||45 2 2||physiolog studi 1 1||1 9 9 1,31046.0||31046.0||25145.2||25027.8||23656.0||23620.75||23004.5||21528.667||21017.667||20705.0||20544.5||19903.4||19855.0||18715.75||18219.0,0.0,0.0,0.0
377,Invest_New_Drugs-3-1-1915607.txt,termin elimin phase||pseudopharmacokinet paramet||long half-lif||recoveri||dose||mobil phase||metabol||high concentr||bile duct||typic radio-trac studi||administr||ixabepilon||epothilon||auc||urin||drug||acceler mass spectrometri||plasma||studi||sampl||total volum||total radioact||patient||faecal excret||radioact||tra||mass balanc studi||pharmacokinet,1||2||patient 1||patient 2||3||refer 1||patient 1 14 14 1||2 14||2 3 max tabl 1 14||patient||patient 4||4||result 14 2 fig. 2 14||14 14 14 1 2 blocker||studi,31046.0||28965.0||22306.5||21266.0||17044.0||16864.5||16850.6||16631.0||14241.167||13567.0||13252.0||12937.0||12930.0||12165.167||12015.0,0.0,0.1,0.13333333333333333
378,J_Comput_Aided_Mol_Des-4-1-2270916.txt,decoy||model||number||dataset||atom||comparison||target||area||engin||perform||properti bia||measur||rmsd||dpi||resolut||studi||decoy set||error||metric||pose predict||atom posit||comput||compound||virtual screen||ligand-bas tool||nomin resolut||paper||conform reproduct||enrich||robust comparison||simpl molecular properti||predict||data||properti||ligand||coordin error||applic||crystallograph||purpos||result||structur,1||2||3 2||4 2||3 3||3||refer 1||2 18||1 comparison||free 1||2 resolut||4 3 3 fig. 3 4||11 8 1 10||studi||model 1 fig. 1 fit atom,31046.0||28965.0||23004.5||20951.0||17044.0||17044.0||16864.5||16447.0||16349.0||15789.0||14651.0||13663.667||12308.25||12015.0||11952.5,0.0,0.0,0.06666666666666667
379,Plant_Mol_Biol-3-1-2039854.txt,mpss||number||arabidopsi||rice||plant||orient group||annot||intergen distanc||pair||categori||evolutionari relev||express platform||well-defin goslim categori||orient||coexpress||import||domain||microsynteni||MA express data||occurr||coexpress pair||inparanoid||similar||signific fraction||analys||function categori||fraction||adjac pair||well-defin categori||gene||local microsynteni||neighbor||chromosom||cluster||local coexpress domain||list||MA data||rank number||biolog background||distanc||goslim||coexpress domain||result,2||1 2004 2 2 2000 2||1 fig. 1 distribut||3||chromosom 1||1 descript||4||2 3 nap jan-pet||netherland 2 laboratori||biol 2002 1 5 10.1186||5||3 2005 2006 2004 2006||gene 2004 4 2005 4||6||3 orient,28965.0||21986.833||17157.75||17044.0||15734.0||15698.0||12937.0||11504.25||10621.0||10566.6||10364.0||10115.8||9492.2||9074.0||8783.0,0.0,0.0,0.0
380,Med_Oncol-4-1-2386844.txt,cancer||effect||incub||brdu incorpor||fir||medic treatment||tumor growth||heat shock protein||basal express level||prolifer||protein||reaction||sirna||present studi||growth||express||hsp||gene||patient||cell||level||cancer cell||low level||result,1||2||1 4 2 2||2 2 11 2 2||refer 1||1 character||2 day||6 2 3 4 13||cell cultur 2||patient||4||cell||data analysi 2 12||growth 4 3||5,31046.0||28965.0||25478.25||24182.2||16864.5||15941.5||15449.0||14456.4||14249.0||13567.0||12937.0||12627.0||11118.25||10629.667||10364.0,0.0,0.1,0.13333333333333333
381,Cancer_Causes_Control-3-1-1914283.txt,day||cancer||cohort studi||smoker||endometri cancer||bmi||estim||analysi||associ||follow-up||alcohol consumpt||alcohol||never-smok||studi||netherland||subcohort member||age||cohort||multivari||women||exposur||endometri cancer risk||smoke||cigarett||risk||cigarett smoke||endometri carcinogenesi||hrt||prospect data||data||prospect cohort studi||year||menopaus,"1 1||1||2||2 2||1 1 depart||24 2 2||1 year||3 3||refer 1||patient||studi||82 5,837 1||169 10,330 1||187 11,872 1||1 schouten leo",31046.0||31046.0||28965.0||28965.0||21528.667||20402.0||17151.0||17044.0||16864.5||13567.0||12015.0||10592.333||10444.333||10433.0||10369.333,0.0,0.0,0.06666666666666667
382,J_Gastrointest_Surg-3-1-1852387.txt,model||veloc||mild AP||leukocyt||intravit microscopi||platelet||sever AP||anim||acut pancreat||inflammatori tissu infiltr||platelet function||inflammatori cell||studi||tissu damag||sever||thromboxan||activ||pancrea||inflammatori respons||perfus failur||mild||method||microcircul||endothelium interact||platelet activ||result||function,1||2 2 1 2 1 2||1 9||2 result||3||refer 1||1 werner jen 1 1 depart||histopatholog 1||figur 2||2 cycl||cell||studi||1 serum paramet||germani 2 depart||2004,31046.0||29658.667||18219.0||17522.5||17044.0||16864.5||15952.167||15668.0||15083.0||14843.5||12627.0||12015.0||10946.333||10717.333||8077.0,0.0,0.0,0.06666666666666667
383,Environ_Manage-4-1-2233706.txt,hell canyon||model||sediment||valley characterist||aerial photograph||spatial comparison||coincident influenc||comparison||downstream||ecolog investig||flow||multipl reach||snake||approach||strategi||research||riparian ecosystem||studi||compar studi||similar||analys||research strategi||veget||natur variat||river dam||histori||natur||landscap||impact||river||dam||snake river||data||ecolog consequ,1||2 1 2||2||2 2||result 1 2||4 2||group 1||5 1 5||3||5 1 2 2000 2005||3 1 depart||1995 1||tempor comparison 1 1||locat 1||4 3,31046.0||29658.667||28965.0||28965.0||22030.333||20951.0||17960.5||17258.0||17044.0||16998.8||16861.333||16855.0||16059.0||15957.0||14990.5,0.0,0.0,0.0
384,Aesthetic_Plast_Surg-4-1-2175019.txt,materi||liposuct aspir||aspir fat||lipoinject||convent lipoinject||breast||volum||tissu||inject||studi||asc||increas||adipos tissu||cosmet breast augment||patient||breast augment||cal||augment||cell||case||postop atrophi||result,1||2||1 patient||2 patient||2 fig. 2||2 group||refer 1||discuss 3 1 3||2 month||2 week||1 21 fig. 1 scheme||patient||4||cell||1 patient data no.,31046.0||28965.0||22306.5||21266.0||20968.667||16920.0||16864.5||16708.75||15281.5||15100.0||14092.4||13567.0||12937.0||12627.0||12505.75,0.0,0.0,0.13333333333333333
385,Eur_J_Pediatr-3-1-2151776.txt,cultur||laboratori techniqu||laboratori diagnosi||pertussi control||pcr||review||strategi||countri||infant||diseas||increas||univers immun||adolesc||infect||vaccin strategi||incid||ill||newborn||pertussi||case||childhood diseas||immun||adult||diagnosi,1||2||5 2||1 9||tabl 1||age 1||refer 1||day 1||maximum 1||1 mo||day 2||2 dose||maximum 2||2 mo||4,31046.0||28965.0||19664.5||18219.0||17331.0||17305.5||16864.5||16489.5||15759.5||15581.0||15449.0||15036.5||14719.0||14540.5||12937.0,0.0,0.0,0.0
386,Eur_J_Epidemiol-4-1-2249618.txt,intervent||absolut contraind||day||myocardi infarct||beta-block||statin||hospit||MI admiss||popul||medic||discharg||aspirin||indic drug||full multivari model||studi||admiss||odd||ace inhibitor||secondari prevent||care||arb||patient||non-acut care hospit||acut MI||sick fund||copay||health care system||year||prescript,1||1 1||2||2 3 4||2 3 3 4||3||refer 1||covari 2||0.001 2 4||patient||4||2008 introduct 1 3 4||fig. 1 proport||studi||myocardi infarct 1,31046.0||31046.0||28965.0||19648.667||18997.5||17044.0||16864.5||14567.5||14349.0||13567.0||12937.0||12873.2||12136.0||12015.0||10633.0,0.0,0.1,0.13333333333333333
387,Diabetologia-3-1-1820754.txt,citrat synthas activ||oxid capac||type 2 diabet||electron transport||insulin||studi||skelet muscl||evid||muscl||healthi subject||mitochondria||increas||complex iii||electron transport capac||present studi||control||parallel electron input||respir||patient||uncoupl state||subject||content||oxid phosphoryl||biopsi||result,1||1 1||1 2||1 2 2 2 2||2||2 2 2 2||2 2||2 fig. 2 2 2||2 10 2 2 2 4||1 2 2 flux||2max 2 2 2||1 2 flux||2 2 flux||2 3 36 2 3||result 2,31046.0||31046.0||30005.5||29381.2||28965.0||28965.0||28965.0||24167.2||22629.833||22273.75||21732.75||20043.333||19349.667||18748.2||17522.5,0.0,0.0,0.0
388,Rev_Endocr_Metab_Disord-3-1-1894829.txt,monogen diabet||resist||guidanc||syndrom||lower part||gck||young age||insulin||diabet||present||modi||young adult||low dose||clinic featur||age||children||treatment||pndm||famili||test||gene||patient||featur||kir6.2||neonat diabet||glucos||type||diagnosi||sulfonylurea||result,1||2||annabelleslingerland@hetnet.nl 1 2 1 institut||treatment 1||3||type 1||refer 1||type 2||1 featur||2 diabet||3 4||pndm 2||2 upperpart||llc 2006 introduct 1 2||patient,31046.0||28965.0||18500.2||18029.0||17044.0||16987.0||16864.5||15946.5||15869.0||15728.0||14990.5||14487.5||14483.0||13995.8||13567.0,0.0,0.0,0.06666666666666667
389,Pediatr_Nephrol-3-1-1805046.txt,cognit function||memori||standard score||cognit perform||hypertens||pediatr ckd popul||IQ score||gener popul||analysi||memori score||studi||diseas||particip||age||sampl||attent score||ckd||children||sever||onset||test||cognit test||patient||rang||neurocognit deficit||mild||anemia||risk factor||cognit impair||find||esrd||standard deviat||chronic kidney diseas||attent||level||age-bas standard score||clinic variabl||function,1||2 1||1 2||2||1 2 3||3||number 1||refer 1||1 HD||8 12 2 12 2||2 week||2 relationship||anemia 2||ipna 2007 introduct 1 2||patient,31046.0||30005.5||30005.5||28965.0||25685.0||17044.0||17008.0||16864.5||15607.5||15157.6||15100.0||15000.0||14589.0||13733.2||13567.0,0.0,0.0,0.06666666666666667
390,Soc_Psychiatry_Psychiatr_Epidemiol-2-2-1764203.txt,model||differ||medic problem||counti hospit||hospit||variabl||polytom logist regress model||group||medic||factor||diagnost characterist||adher||criteria||legal statu||voluntari||analysi||research||studi||symptom||psychot symptom||data collect||compulsori||time||clinic factor||treatment||inv-vol||patient||non-convert||commit||individu||inv-inv||data||assess||voluntari statu||outpati follow-up||treatment engag,1||2||55 2 2||patient 2 17 2||result 1||3||refer 1||discharg 3 2||full-tim 2||patient||4||studi||fig. 2 percentag||discharg 1 fig. 1 averag length||conclus 3,31046.0||28965.0||19720.333||18770.0||18563.0||17044.0||16864.5||15405.667||14493.0||13567.0||12937.0||12015.0||11486.667||11441.667||9117.5,0.0,0.1,0.13333333333333333
391,J_Struct_Biol-1-5-2048824.txt,edg||ultrathin section||incub||chromatin||onm||ER tubul||assembl||membran protein||vesicl||junction||stage iii oocyt||scan electron microscopi||nuclear envelop||nuclear pore complex||format||protein||tubul||antibodi||curvatur||pb||membran||egg extract||larg ER vesicl||specif region||npc||sampl||npc protein||nuclear assembl reaction||NE assembl||oocyt||nuclei||larg sac||ER membran||structur,1||2||2 3||2006 2||3||fig. 2||1 abbrevi||2 min||figur 2||2 nm||2 goldberg||tem 4 2||ne fig. 2 fig. 2||4||1999 fig. 2,31046.0||28965.0||23004.5||18668.0||17044.0||16970.5||15658.5||15117.5||15083.0||14618.5||14556.5||13976.333||13578.2||12937.0||12912.0,0.0,0.0,0.0
392,Soc_Sci_Med-2-1-2430159.txt,research capac||govern depart||uganda||practic||research consult||limit research capac||report||agenc||sub-saharan africa||interviewe||institut consult||local capac||research||salari||univers staff||contract||senior social scientist||donor||global econom inequ||academ research||ngo||global economi||institut||senior||low univers salari||social scienc capac||consult||northern||research programm||individu||depart||east africa||africa||social scientist||problem||find||health-rel research||staff||overhead||health,1||2||1 sampl||1f 2||method tabl 1||studi||1f 1 director||5||2005||research 1m 1m 1||2006||1 2003 africa world press||2004||2003||north american 2 director,31046.0||28965.0||16705.5||14485.5||12778.0||12015.0||10375.0||10364.0||8716.0||8693.0||8371.0||8132.0||8077.0||7651.0||7613.75,0.0,0.0,0.0
393,Surg_Endosc-4-1-2292804.txt,differ||cylind||goal-ori movement||resid||path length||group||novic||retract||phase||perform||analysi||movement||signific differ||studi||import||normal path length||point||task||experi||basic mi skill||motion analysi||mi perform||object assess||train||mi||shortest path||method particip||assess||expert||plane||import measur||result,1||2||3||refer 1||task 2 fig. 2||mekelweg 2||patient||studi||netherland 2 depart||data analysi 18 2||2005||2006||2003||experi 6 6 5 fig. 6||present studi,31046.0||28965.0||17044.0||16864.5||15935.0||14484.5||13567.0||12015.0||11205.0||10637.5||8716.0||8371.0||7651.0||7431.0||7377.0,0.0,0.1,0.06666666666666667
394,Eur_J_Pediatr-3-1-2039787.txt,effect||outcom||sequela||parent||health statu||lung function||review||paediatr intens care unit||studi||follow-up research||qol||qualiti||post-traumat stress disord||children||intens care treatment||treatment||life||famili||origin ill||patient||psycholog sequela||survivor||aspect||support||measur tool||neuro-cognit sequela||health||function,1||1 2||2||studi 1 2 3||12 2||3||refer 1||18 2||rang 1||1 mild||picu 1||1 patient characterist||2 patient characterist||patient||4,31046.0||30005.5||28965.0||22267.5||17408.5||17044.0||16864.5||16447.0||16269.0||15691.5||15560.5||15301.333||14607.667||13567.0||12937.0,0.0,0.0,0.06666666666666667
395,Purinergic_Signal-2-3-2096647.txt,concentr||fura-2 microfluorometri||ach||atp,1||1 2||2||2 4 2||1 fig. 2||tabl 1 2||2006 2||fig. 1||3||refer 1||30 2||increas 2||1 ml||50 2||29 2,31046.0||30005.5||28965.0||23622.333||21662.333||21209.0||18668.0||18011.0||17044.0||16864.5||16116.0||16084.5||15906.0||15827.0||15617.5,0.0,0.0,0.0
396,BMC_Genomics-5-_-375527.txt,statist signific||statist analysi||gene express||refseq||concentr||correl||tfb||matrix||approach||sequenc||promot sequenc||score||analysi||measur||promot||signific||bind site||z-transform||pwm||gene||chromosom||cluster||transcript factor||list||regulatori region||cgi||set||threshold||human||human promot||match||result,1||1 2||2||1 2 3||2 3||23 1 1||4 2||tabl 1||3||3 3 3||tabl 2||figur 1||24 2||41 2 3||file 1,31046.0||30005.5||28965.0||25685.0||23004.5||21693.333||20951.0||17331.0||17044.0||17044.0||16290.5||16123.5||16120.5||15850.333||15634.5,0.0,0.0,0.0
397,Intensive_Care_Med-3-1-1915596.txt,intervent||day||differ||reduct||number||demand cxr||abnorm||icu||physician||studi||import||elimin||mortal rate||readmiss rate||lo||icu patient||daili routin cxr||patient||daili routin||chest radiograph||daili routin chest radiograph||chang||find||result||case||data||cxr||clinic indic,1||2||3||refer 1||1 month||phase 1||phase 2||patient||1 march 2004||1 septemb 2004||4||result studi popul 1||31-20-5669111 m.j.schultz@amc.uva.nl 1 6 1 depart||studi||demand cxr 2 3,31046.0||28965.0||17044.0||16864.5||16322.0||15995.0||14954.5||13567.0||13091.667||13069.333||12937.0||12731.0||12277.167||12015.0||11570.0,0.0,0.1,0.13333333333333333
398,Bioinformation-1-5-1891680.txt,pmsearch||transcript factor||server||sequenc||motif||pfm||web server||user||sequenc motif||promot,1||2||1 2 3||3||bioinform 1||4||studi||tabl figur 1||5||4 5 6 7||2006||user interfac figur 1||methodolog 4 6 9||result||function,31046.0||28965.0||25685.0||17044.0||15556.5||12937.0||12015.0||11954.333||10364.0||9843.0||8371.0||8317.5||6928.0||6080.0||4581.0,0.0,0.0,0.0
399,Mod_Rheumatol-4-1-2275302.txt,vivo||gene transfer||adenoviru||fibroblast||effect||inflamm||gene therapi||strategi||retrovir vector||system deliveri||cytokin||system administr||inject||rheumatoid arthriti||plasmid dna||increas||success||express||treatment||gene transfer vector||aav||pannu format||deliveri strategi||patient||angiogenesi||therapi||arthriti||transgen||cell||mice||destruct||anim model||vector||efficaci||deliveri||joint,1||refer 1||2 function||1 summari||interleukin 1||2002 4 1 10 2 10.1186||patient||rheumatolog 2008 introduct 1 2 3||cell||helper type 1||matrix metalloproteinas 1||growth factor beta 1||2 148 58 10.1016||solubl vegf receptor 1||2004 104 1 51 9 10.1016,31046.0||16864.5||16773.0||15734.5||15546.5||14526.333||13567.0||13423.333||12627.0||11327.333||10554.333||9464.5||8984.0||8714.5||8661.5,0.0,0.2,0.13333333333333333
400,Clin_Exp_Metastasis-4-1-2413104.txt,healthi volunt||cancer||differenti express||human serum||group||protein marker||elisa||carcinogenesi||tumor cell||protein||tissu||studi||antibodi||serum level||npc||sampl||express||signific||saa||biomark||patient||identif||npc patient||confirm elisa||nasopharyng carcinoma||potenti biomark||find||serum||maldi-tof-m identif,1||1 2||2||1 3||1 5||1 10||3||fig. 2||refer 1||2008 introduct 1 2||patient||6 3||4||cell||studi,31046.0||30005.5||28965.0||24045.0||20705.0||19014.0||17044.0||16970.5||16864.5||15837.5||13567.0||13059.0||12937.0||12627.0||12015.0,0.0,0.0,0.13333333333333333
401,Pediatr_Nephrol-3-1-1794138.txt,pathophysiolog||podocyt||injuri||podocin||tubulointerstiti||nephrot syndrom||anim model||nephrin,1 1 1 7 8||1 5||fkaskel@aecom.yu.edu 2 1 divis||studi||plo biol 2||6||2005||1 27 28 9 29||2006||2004||6 10||slit diaphragm protein refer 1||effect||plasma cell||10 6 9 11,21257.8||20705.0||15073.0||12015.0||11073.667||9074.0||8716.0||8713.8||8371.0||8077.0||8028.0||8020.2||6956.0||6653.5||6624.75,0.0,0.0,0.0
402,Virus_Res-2-1-2194287.txt,effect||replicon||death||semliki forest viru||vlp||rna||construct||ire||protein||studi||similar result||apoptosi||sfv||egfp||express||replicon vector||releas||viru||viru replic||infect||alphavirus||bcl-2||cell death||cell||data||protect effect||vector||high-level express||result,1||2||fig. 2 fig. 2||fig. 2||noorus 1||2006 6 2||2 materi||fig. 2 fig. 2 fig. 3||3 cell||2 liljestrom||fig. 2 5 cell||2004 23 1||2 1 6 8294493 reed||4||cell,31046.0||28965.0||16970.5||16970.5||15523.5||15470.0||15325.0||14983.667||14835.5||14491.0||14233.0||14037.0||13829.4||12937.0||12627.0,0.0,0.0,0.06666666666666667
403,J_Headache_Pain-4-1-2245992.txt,neuromuscular junction||singl fiber emg||cerebellum||cerebellar function||neuromuscular transmiss||migrain||horizont deviat||mcd||movement||aura||horizont plane||patient||studi||nmj||cerebellar||median valu||channel||function,1||12 1 fig. 1||refer 1||suppl 1||patient||3 fig. 3||2000 85 1||13 14 2||studi||2 10 fig. 2 experiment setup||3 day||2 247 254 10.1016||2005||2006||2004,31046.0||18230.0||16864.5||15942.0||13567.0||13021.333||12592.333||12508.0||12015.0||11850.333||9488.5||8760.0||8716.0||8371.0||8077.0,0.2,0.2,0.13333333333333333
404,Cancer_Causes_Control-2-2-1764866.txt,cancer||calor restrict||transient||human||cancer risk||risk,refer 1||2006 1 5 6||9 10 2||studi||cell 2003 2 327 333 10.1046||2006||3 5 34 36||cancer||effect||prospect studi||anim studi||9 10||result||famin studi||cancer risk cancer,16864.5||14713.75||13779.667||12015.0||8380.833||8371.0||7729.75||7076.0||6956.0||6474.0||6454.5||6187.0||6080.0||6020.0||5851.333,0.0,0.1,0.06666666666666667
405,Protein_Expr_Purif-1-5-1885977.txt,tap||tag||site||purif||yfp||mc||gfp||cell||protein||gene||vector||yellow fluoresc protein||tandem affin purif,1||2||2 2||4 2 4||fig. 1||3||p.schaap@dundee.ac.uk 1||4 3||2 abbrevi||4||cell||3 time||1 mM imidazol||1 mM dtt||1 mM mg-acet,31046.0||28965.0||28965.0||18279.667||18011.0||17044.0||15524.0||14990.5||14618.0||12937.0||12627.0||10492.5||10490.667||10488.0||10482.667,0.0,0.0,0.06666666666666667
406,Eur_Arch_Psychiatry_Clin_Neurosci-2-2-1705499.txt,rate||skin||psychiatr||compuls buy||effect||posit result||specif subtyp||report||behavior||impuls||patholog gambl||studi||addit||intermitt explos disord||evid||current knowledg||kleptomania||treatment||pharmacolog option||comorbid||patient||double-blind trial||internet||double-blind||pyromania||impuls control disord||internet addict||preval||icd||impuls disord||efficaci||result,1||2||1 1 compuls||3||refer 1||dermatolog patient 2||patient||studi||report number 2||adult popul 1||1 28 simeon||1 preval estim||1 month 3.2||adult popul 2||2 ocd rate,31046.0||28965.0||20720.667||17044.0||16864.5||14209.0||13567.0||12015.0||11679.667||11410.0||11170.0||11002.0||10951.667||10716.333||10529.667,0.0,0.2,0.13333333333333333
407,Photosynth_Res-3-1-2117334.txt,donor side||light||acceptor side||uv-b||increas||fluoresc||PS II||photosynthesi||chlorophyl||effect||damag||electron transfer||photosystem II||uv-b irradi||level||irradi||plant||uv-b radiat||function,1||2||1 2 1 laboratori||1 5||1 2 1993||1 2003||fig. 1||1 fig. 2 effect||3||3 3||1 2 5 5 fig. 4||photosynthesi 2005 2||1 1995 2000 2005||fig. 3||netherland 2 embrapa-cerrado,31046.0||28965.0||22949.75||20705.0||20598.333||19348.5||18011.0||17985.75||17044.0||17044.0||16442.0||12589.667||12082.25||11010.0||10374.0,0.0,0.0,0.0
408,Crit_Care-8-1-420054.txt,cardiopulmonari resuscit||intervent||clinic practic||hospit||advers event||report||treatment limit decis||opportun||group||medic||approach||icu||earlier applic||develop||team||process||measur||cardiac arrest||import||error||evid||admiss||increas||literatur||outreach||chain||care||medic emerg team||ward||treatment||emerg||acut pain team||servic||patient||risk||earlier recognit||outreach care||suboptim care||capac||critic care||staff||critic ill,2||concern 2||patient||studi||tabl tabl 1 variabl||aust 2003 179 1 3 o'dea||hospit patient||patient outcom||patient condit||2003||UK 2 nurs consult||individu patient||surgic patient||ill patient||patient safeti,28965.0||14692.0||13567.0||12015.0||9944.5||9343.333||7731.0||7725.5||7706.5||7651.0||7623.0||7600.5||7297.5||7037.0||6998.5,0.2,0.1,0.06666666666666667
409,Oecologia-4-1-2311384.txt,competit advantag||speci||differ||mixtur||effect||product||concentr||water tabl||hollow||posit effect||competit||studi||bog||competit abil||bulk densiti||water level||global warm||evapor||increas||growth||valu||treatment||height increment||temperatur||experi||height||cover chang||biomass product||northern||site||signific interact||water||greenhous||northern site,1||1 1||2||2 4 2 2||2 fig. 2 1||1 7||1 10||1 8||1 17||1 19||1 22||3||1 23||2 19||1 cm,31046.0||31046.0||28965.0||24958.0||23488.0||19021.5||19014.0||18600.0||17314.5||17180.0||17114.5||17044.0||17017.0||16139.5||15761.0,0.0,0.0,0.0
410,Immunogenetics-3-1-1914291.txt,haplotyp||sequenc||cynomolgu macaqu||clone||region configur||loci||chines origin||rhesu macaqu||evolut||gene||vertebr speci||indian rhesu macaqu||macaqu||polymorph||allel,1||2||3 3 4 1||1 min||1 μl||mamu-a2 1||0513 3 2||2 min||mamu-a1 2||mamu-a 2 5||studi||7001 3 2 A1||1301 2 4 A1||mamu-a mafa-a 1||tabl 3,31046.0||28965.0||19517.75||16158.0||15631.0||15526.5||15337.667||15117.5||14492.0||13118.333||12015.0||11554.25||10534.25||10362.333||10330.0,0.0,0.0,0.0
411,Exp_Brain_Res-4-1-2214825.txt,visual inform||model||grip||visual context||effect||grip select||motor plan||grip plan||target object||target||illus||strategi||grip type||movement||orient||studi||present||switch point||particip||initi postur||clockwis||grasp||time||task||object||experi||percept||frame||sequenti object manipul task||action||visual illus||end postur||postur||trial||rod||result||rod orient||start postur||plan||end,1||2||color 1 2||3||apparatu 1 fig. 1||type 2||2 direct||2000 1992 2 fig. 2||4||method particip 1||studi||grip type 1||grip type 2||netherland 2 faculti||5,31046.0||28965.0||20066.333||17044.0||16799.25||15946.5||15005.0||14103.4||12937.0||12236.0||12015.0||11342.0||10648.333||10441.0||10364.0,0.0,0.0,0.06666666666666667
412,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2292476.txt,vergenc adapt||prism,2||refer 1||12 1 5||patient||2006||2003||2002||7 7||effect||elderli patient||8 9 8 8 9 10||placebo-control clinic studi||16 8 9||treatment||clinic,28965.0||16864.5||15754.0||13567.0||8371.0||7651.0||7057.0||6997.0||6956.0||6942.5||6038.0||5674.667||5165.667||5012.0||4858.0,0.0,0.0,0.0
413,Diabetologia-4-1-2170457.txt,obes particip||glycerol uptak||beta-adrenerg stimul||abdomin sat||abdomin subcutan adipos tissu||lipolysi||blood||glycerol||obes individu||adipos vein||import||unit||infus||particip||time||adipos tissu||present studi||mainten||vivo whole-bodi||tag||releas||obes||net uptak||insulin concentr||lipolyt respons||sat||neg net flux||isotop enrich||result||min,1||1 2||2||3 2||2 2 5||2 5||2 5 2 5||2 5 fig. 1 2 5||3||3 3||fig. 2||refer 1||E. 1 1 depart||type 2||1 art,31046.0||30005.5||28965.0||23004.5||22764.667||19664.5||19664.5||19113.333||17044.0||17044.0||16970.5||16864.5||16629.25||15946.5||15596.5,0.0,0.0,0.0
414,J_Gastrointest_Surg-3-1-1852380.txt,hilar bile duct cancer||subphren arteri||pancreat head||major surgeri||vascular reconstruct||superselect tae distal||spa||outcom||re-laparotomi||hemorrhag||cha||hemostasi||hepat inflow||complet hemostasi||success outcom||gda||tae||major hepatectomi||surgeri||sma||pseudoaneurysm||ligat||patient||pha||hepat failur||rha||gastroduoden arteri||case||angiographi||tae proxim||massiv arteri hemorrhag||hepat arteri,1||2||1 2 3||patient 1||patient 2||1 2 figur 1 arrow||result 1||refer 1||1 detail||patient 3||patient||4||studi||bleed outcom 1||1 baselin characterist,31046.0||28965.0||25685.0||22306.5||21266.0||18587.8||18563.0||16864.5||15793.5||15305.5||13567.0||12937.0||12015.0||11048.333||11010.0,0.0,0.0,0.06666666666666667
415,Environ_Manage-3-1-1914239.txt,requir||addition||impact assess||materi||project develop||project||current modal||argument||resourc||oper entiti||tinto||rule||resourc tenur||develop||cameroon||sustain||cost||commun capac||nation fund||institut arrang||capac requir||studi||figur||commun forest||carbon sequestr||reforest||design oper entiti||emiss||cdm implement||legal entiti||activ||ngo||carbon||bimbia||environment impact||forest||impact||cdm||commun||implement||manag||timber exploit||environment servic||skill||capac||inform||commun manag||case||clean develop mechan project||plan||sustain develop||clean develop mechan||biodivers,1||2||1 4 2||3||1 appli||1 ivey||1 295ha||2 centr||bimbia 2||A. 2 1 intern institut||studi||context method 1||project scenario 1||annex 1 countri||non-annex 1 countri,31046.0||28965.0||24316.0||17044.0||16027.0||15524.0||15523.5||14856.0||14503.5||13340.6||12015.0||11666.667||10652.0||10474.333||10472.333,0.0,0.0,0.06666666666666667
416,Behav_Genet-4-1-2257997.txt,motor speed||genet underpin||effect||famili vulner||motor||non-affect sibl||genet basi||speed||variabl||abnorm||group||accuraci||motor output||measur||studi||tendenc||addit||motor time||extern cue||time||task||age||famili suscept||endophenotyp||famili resembl||sibl||disord||children||screen||control||compar problem||famili||adhd||subject||find||deficit||proband||motor task||pac interview,1||2 1 1||2||3 1||7 1 1 1 24 1||1 115 3 1 2||1 1 depart||4 2||10 1||2 22 4 1 3||3||1 distribut||62 1||02 1||03 1,31046.0||30352.333||28965.0||24045.0||22409.5||21710.4||21528.667||20951.0||19014.0||18635.0||17044.0||16304.5||15993.0||15811.0||15783.5,0.0,0.0,0.0
417,Virchows_Arch-3-1-2063564.txt,tumor||intraduct papillari mucin neoplasm||ipmn||intraduct tumor||grade||recent year||carcinoma||outcom||ipmn subtyp||pancrea||case||patient||type||intraduct papillary-mucin neoplasm||recurr||prognosi||posit margin||invas||ductal adenocarcinoma,1||2||3 1 4||3||suppl 1||patient||4||1 incid data||3 year||49-431-5973462 guenterkloeppel@path.uni-kiel.d 3 1 institut||patient group||1 23 51 52||6||incid period 2 number||28 patient,31046.0||28965.0||20342.333||17044.0||15942.0||13567.0||12937.0||12260.667||10150.0||9907.0||9221.0||9074.75||9074.0||8453.0||8008.0,0.0,0.1,0.06666666666666667
418,Invert_Neurosci-4-1-2413115.txt,backbon carbonyl||insect||ion channel||molecular basi||vertebr nachr||crystal structur||insect nachr||protein||import role||ligand-bind site||bind site||imi||hydrogen bond||subunit||residu||neonicotinoid||crystal||nitro group||interact||nicotin acetylcholin receptor||achbp||ctd||structur,2||3||posit 1||2004 3 2003 1||1 Ls||4||studi||5||neonicotinoid Ls 1 2002||1 Ls Ls 5 fig. 5||3 Ls||2006||2004||679-5148 japan 2 depart||2007,28965.0||17044.0||16665.5||15954.5||15544.5||12937.0||12015.0||10364.0||9544.75||9472.667||8543.5||8371.0||8077.0||7984.25||7287.0,0.0,0.0,0.0
419,Hernia-4-1-2231409.txt,differ||oper time||complic||tacker||group||techniqu||oper||mesh fixat techniqu||fixat techniqu||insert||studi||recurr||puh||time||ta||studi group||hernia||lrvih||straightforward repair||fixat||laparoscop repair||crown||method||standard techniqu||incision hernia,2||refer 1||1 day||1 min||patient||4||studi||6||springer-verlag 2008 introduct 1||studi group||2003||54 patient||84 patient||7||138 patient,28965.0||16864.5||16489.5||16158.0||13567.0||12937.0||12015.0||9074.0||8997.25||8445.0||7651.0||7362.0||7163.0||6997.0||6906.0,0.0,0.2,0.13333333333333333
420,J_Mol_Med-3-1-1820751.txt,noonan syndrom||costello syndrom||short statur||clinic phenotyp||k-ra||disord||mutat||ra pathway||ns-like featur||germlin||protein||gene||syndrom||gtp||patient||pathway||jmml||human cancer||ra||result,refer 1||mathildenstrass 1||patient||cell||type 1 neurofibromatosi||germani 2 institut||5||49-761-2704514 christian.kratz@uniklinik-freiburg.d 1||neurofibromatosi type 1 ra||2006 dec 3||2006||2002||10||effect||CS patient,16864.5||15523.5||13567.0||12627.0||11330.0||10367.0||10364.0||10349.333||8517.5||8483.667||8371.0||7057.0||6982.0||6956.0||6952.0,0.2,0.1,0.06666666666666667
421,Eur_J_Pediatr-4-1-2413082.txt,tubercul pericard||tuberculosi||diagnosi||pericardi fluid||pericard,1 1||1 year||3||refer 1||patient||4||g.vanwell@vumc.nl 4 1 depart||31-503-612478 r.bolt@sfg.nl 1 2 rammeloo luka||mycobacterium tuberculosi 2 6||4 month||netherland 3 depart||discuss 6 5||netherland 2 st. franciscu gasthui||netherland 4 depart||addit 4 month,31046.0||17151.0||17044.0||16864.5||13567.0||12937.0||11619.5||10006.5||9540.75||7267.5||7231.333||7046.333||6267.0||5862.333||5495.667,0.0,0.0,0.0
422,Biochem_Pharmacol-2-1-2279149.txt,substrat||model||spectrum||three-dimension structur||mous||breast cancer||peak||protein||reaction||studi||nat||inter-domain loop||steroid||express||compound||assay||activ||inhibitor||arylamin||recombin protein||activ site||tamoxifen||structur,1||2||fig. 2 2||fig. 1||15 1||tabl 1||3||fig. 2||1 mg||peak 1||2 materi||fig. 6 1||peak 2||2 wash||n-acetyltransferas 2,31046.0||28965.0||20968.667||18011.0||17811.5||17331.0||17044.0||16970.5||15945.0||15768.0||15325.0||15032.0||14727.5||14647.0||14494.5,0.0,0.0,0.0
423,Eur_Arch_Otorhinolaryngol-4-1-2254469.txt,standard endoscopi protocol||clinic studi||naso-gastr tube||ill patient||popul||evalu||fee||icu||oral diet||studi||pharyng||clinic sign||deglutit||aspir||fee find||oral feed||diagnost protocol||acut symptom||patient||decis||risk||ventil||liquid bolu||percutan endoscop gastrostomi||rapid evalu||find||swallow||procedur||compensatori treatment procedur||examin||silent aspir||tracheotomi||assess||endoscop assess,1||2||2 2 3||1 2 3 4||refer 1||1 symptom||patient||4||1 januari 2002||2 septemb 2006||studi||tabl 2 rout||5||6||springer-verlag 2008 introduct 1,31046.0||28965.0||24991.333||22498.0||16864.5||16125.5||13567.0||12937.0||12744.333||12473.667||12015.0||10910.667||10364.0||9074.0||8997.25,0.0,0.1,0.13333333333333333
424,Pediatr_Radiol-4-1-2292492.txt,tumor||imag||delay||children||carcinoid||neuroendocrin tumor||detect||pancrea||carcinoid crisi||anatom||gep-net||patient||present||diagnosi||function imag||diseas||imag find,1||refer 1||2 year||1 cm||patient||springer-verlag 2008 introduct 1 2||hepat net 1||2004||pediatr patient||midgut hindgut 3 4||5 year||6 7 17 fig. 6||IA 52242 usa 2 depart||clinicopatholog studi||approach 5,31046.0||16864.5||16110.5||15761.0||13567.0||12990.8||10597.333||8077.0||7786.5||7497.5||6810.0||6740.8||6696.2||6068.0||5967.0,0.2,0.1,0.06666666666666667
425,Exp_Brain_Res-3-1-2137946.txt,visual inform||extern focu||sway||effect||cerebr palsi||cop trajectori||time seri||analysi||eye||measur||condit||opposit effect||present studi||sampl||task||posturogram||children||control||EC condit||visual depriv||function task||amount||regular||function context||visual feedback||neural control mechan||postur control||sampl entropi||data||attent||sen||postur sway||concurr visual feedback||result,1||2 1 1||2||tabl 1||hypothesi 1||hypothesi 2||2 http://www.physionet.org/||patient||1 1 research institut move||2006 2002 2 2000||s.f.donker@uu.nl 1 2 ledebt annick||TD children 1||netherland 2 depart||standard error 1||5,31046.0||30352.333||28965.0||17331.0||15726.5||14686.0||14483.0||13567.0||13502.0||12574.0||12003.0||11482.333||11205.0||11170.0||10364.0,0.0,0.0,0.0
426,Pediatr_Nephrol-3-1-2064942.txt,acei||receptor||injuri||mechan||effect||initi injuri||spironolacton||cardiovascular diseas||abil||interstiti fibrosi||angiotensin||low birth weight||key role||low nephron number||angiotensin type 1 receptor||glomerulosclerosi||progress||proteinuria||diseas||increas||podocyt||genet factor||ckd||mutat||renal diseas||experiment model||glomerulu||activ||patient||regress||therapi||glomerular hypertens||action||sclerosi||fsg||tubulointerstiti fibrosi||angiotensin receptor blocker||growth factor||aldosteron||cell||kidney||mice||human||fibrosi||macrophag||result||function,1||2||2 suppl 2||3||type 1||refer 1||2 receptor||ipna 2007 introduct 1 2||patient||cell||type 1 diabet||studi||2 receptor antagonist||4 4 6 7||5,31046.0||28965.0||19589.333||17044.0||16987.0||16864.5||16234.0||13733.2||13567.0||12627.0||12155.0||12015.0||10913.667||10486.25||10364.0,0.0,0.2,0.13333333333333333
427,Appl_Microbiol_Biotechnol-3-1-1914237.txt,discrimin phylogenet relationship||transcriptom||strain||orf||aflp||solvent-toler bacteria||absenc||function categori||relationship||high-dens oligonucleotid microarray||intergen region||pseudomonad||cog||gene||studi||absent||microarray||fragment dna||genomotyp||function,2||2 3 2 pseudomona 2||3||method 2 2 P.||4||studi||2 pseudomona P.||mascherod weg 1||2 hallsworth john||tabl 1 pseudomona strain||M. 1 mar astrid||netherland 2 wageningen univers||http://www.ncbi.nlm.nih.gov/sutils/coxik.cgi?gi=266 3||function studi||2004,28965.0||20818.2||17044.0||15901.0||12937.0||12015.0||10373.0||10351.333||9738.333||8828.25||8733.25||8724.5||8523.0||8298.0||8077.0,0.0,0.1,0.06666666666666667
428,Crit_Care-9-1-1065088.txt,sever case||core temperatur||effect||dose||group||administr||convent method||studi||treatment||temperatur||patient||relev studi||heat stroke||dantrolen||cool||bodi temperatur||heat||result||case||hyperthermia||convent cool||rate||exert heat stroke||eh,2||3||1 2 3 15 22||2 mg||patient 8 12 2||patient||4||studi||26 26 2||tabl 2 summari||tabl tabl 1 summari||6||3 mg||1 46 15 17 17 15||israel 2 heller institut,28965.0||17044.0||16963.0||14904.5||13634.5||13567.0||12937.0||12015.0||11393.667||11001.333||9675.25||9074.0||8944.0||8115.167||7624.75,0.0,0.2,0.13333333333333333
429,Eur_Radiol-3-1-2077918.txt,vessel wall calcif||pad||peripher CT angiographi||contrast media||scanner||review||techniqu||peripher vascular diseas||resolut||bolu||import||extens calcif||diagnost cost||contrast arriv||time||imag||tomographi||patient||imag qualiti||tabl||enhanc||acquisit||data||level||peripher arteri||CT angiographi,2||G. 1 2 3 1 depart||paramet 1 fig. 1||3||refer 1||1 84||2 94||calcif 2||thrombo-embol 2||patient||4||studi||4 1 5 fig. 4a||netherland 2 depart||1 total tree,28965.0||18637.667||17046.25||17044.0||16864.5||15902.5||14895.5||14646.0||14483.5||13567.0||12937.0||12015.0||11873.8||11205.0||11148.333,0.0,0.1,0.06666666666666667
430,Eur_J_Pediatr-4-1-2254659.txt,organ||bodi||liver biopsi||day||method||mri||iron overload||magnet reson imag||liver||ferritin serum ferritin||deferasirox||patient||lic||therapi||chelat,2 4||2 3 12||3||refer 1||1 comparison||1 8 fig. 1 blue||patient||iron level 1||20 min 2||fig. 3||5||7 9 1 9 10 11||phase 3 studi||6||3 night,20951.0||17287.0||17044.0||16864.5||16349.0||14709.6||13567.0||11573.667||11550.667||11010.0||10364.0||10143.333||10001.0||9074.0||8576.5,0.0,0.1,0.06666666666666667
431,Clin_Auton_Res-3-1-1797061.txt,respons||cutan||injuri||vessel||autonom nervou system||experiment anim||paravertebr chain||short burst||natur activ||transmiss||tail arteri||signal||discharg||spinal transect||muscl||increas||ongo||preganglion input||ganglia||autonom dysreflexia||perivascular nerv||activ||postganglion neuron||vascular bed||spinal cord injuri||vasoconstrict||sympathet ganglia||sympathet nervou system||arteri||nerv||neurovascular transmiss||segment||input||vasoconstrictor pathway||axon,1||2||25 1||3||refer 1||1 Hz||5 12 29 6 7 2||37 3||11 18 11 38 2||2006||gate 1 barker street||fig. 3 diagram||effect||inflammatori cell||4 29 14,31046.0||28965.0||17172.5||17044.0||16864.5||15616.0||10587.0||9411.0||8918.0||8371.0||7829.75||7357.667||6956.0||6513.5||6501.333,0.0,0.0,0.0
432,J_Autism_Dev_Disord-4-1-2226079.txt,permeabl||pdd||children||ratio||urin||serotonin||hyperserotonemia||test||patient||studi||sat||intestin permeabl||platelet||autism||blood sampl,1||2||J. 1 1 depart||3||result patient 1||1 characterist||2 indic||patient||4||studi||netherland 2 depart||5||6||2005||method patient,31046.0||28965.0||17093.75||17044.0||16897.667||16168.5||15648.0||13567.0||12937.0||12015.0||11205.0||10364.0||9074.0||8716.0||8619.5,0.0,0.2,0.13333333333333333
433,J_Gastrointest_Surg-3-1-1852389.txt,renal vein||left gonad||length||left renal vein||involv||renal function||venou resect||oper||superior border||follow-up||interposit graft||reconstruct||primari end-to-end anastomosi||addit choic||patient||graft||resect||creatinin level||superior mesenter vein||pancreaticoduodenectomi||portal vein||smv||periop morbid||vein||eu||pancreat cancer||superior mesenter arteri,1||1 1 figur 1||2 2 figur 2||refer 1||patient||3 3 figur 3||4 4 4 figur 4||5||addit patient||patient select||cancer||effect||result||12||9,31046.0||23584.75||22024.0||16864.5||13567.0||13083.25||10589.8||10364.0||7759.5||7665.5||7076.0||6956.0||6080.0||5852.0||5392.0,0.2,0.1,0.06666666666666667
434,Exp_Neurol-2-1-2288636.txt,rate||stimul||tap||db||stn||frequenc||variat||anova||effect||synchron||perform||normal limit||movement||updr motor score||parkinsonian patient||patient||side||variabl||excess synchron||precis frequenc,2||fig. 1||3||fig. 2||day 1||1 mg||p.brown@ion.ucl.ac.uk 1||itrel 2||2007 tabl 1||fig. 2 effect||patient||4||studi||5||tabl 1 clinic detail,28965.0||18011.0||17044.0||16970.5||16489.5||15945.0||15524.0||14483.0||13983.0||13632.333||13567.0||12937.0||12015.0||10364.0||10015.25,0.0,0.0,0.06666666666666667
435,Surg_Endosc-3-1-2169269.txt,day||overnight infus||devic||group||pre-hydr||oper||bolu||studi||infus||urin output||donor||hour||ldn||pneumoperitoneum||crcl||patient||anesthesia||induct||earli graft function||kidney extract||periop fluid manag||kidney||data analysi||fluid regimen,2||result 2 1 1 1||1 tabl 1||1 1 depart||group 1||1 year||3 3||3||group 2||refer 1||1 month||2 discuss||femal 2||2 mg||patient,28965.0||25636.6||21902.667||21528.667||17960.5||17151.0||17044.0||17044.0||16920.0||16864.5||16322.0||15333.0||14933.0||14904.5||13567.0,0.0,0.0,0.06666666666666667
436,Immunogenetics-3-1-1914236.txt,snp||genet associ||celiac diseas||sampl||express||analysi||famili||gene||studi||dutch popul||appli biosystem||result,1||2||desmoglein 1||1 poell jo 1 van||studi||fig. 2 spink||method patient materi 2001 1||netherland 2 depart||1 spink haplotyp||2 spink tabl 2 spink4 snp||31-50-3617230 m.c.wapenaar@medgen.umcg.nl 1 2 monsuur alienk||6||asterisk 1 spink4 4 arrow point||netherland 3 depart||612 patient,31046.0||28965.0||15570.0||12715.8||12015.0||11326.333||11256.6||11205.0||10426.333||10296.333||10003.0||9074.0||7627.667||7231.333||6812.0,0.2,0.1,0.06666666666666667
437,Exp_Brain_Res-4-1-2373863.txt,shape||vogel||neural represent||convex||aftereffect||stimulu||magnitud||tactil||represent||process||mechanoreceptor||studi||condit||curvatur||adapt||experi||explor mode||touch||finger||subject||hand||result||concav||level||transfer||singl finger,1||1 1||2||analysi 1||experi 1||experi 2||2 subject||1 1933 1996 1997 fig. 1||studi||result 2 fig. 2 error bar||experi 3||experi 4||present studi||7||10,31046.0||31046.0||28965.0||17866.5||16535.0||15494.5||15424.5||12278.5||12015.0||11728.0||9534.0||7480.5||7377.0||6997.0||6982.0,0.0,0.1,0.06666666666666667
438,Clin_Rheumatol-3-1-2039777.txt,jia||function abil||childhood health assess questionnair||measur||questionnair||studi||intern reliabl||median diseas durat||present studi||children||rom||chaq||diseas activ||individu item||patient||item||final score||rheumat diseas||level||jafa||spearman correl coeffici||perform test,1||2||3||1 fig. 1 frequenc||refer 1||0.01 discuss 1 1||1 jafa||2 0.52||m.a.vanrossum@amc.uva.nl 2||patient||4||7 κ 1||t.p.m.vliet-vlieland@lumc.nl 3 1 depart||studi||netherland 2 depart,31046.0||28965.0||17044.0||16986.25||16864.5||16124.5||15535.5||14571.5||14483.0||13567.0||12937.0||12716.333||12646.25||12015.0||11205.0,0.0,0.1,0.13333333333333333
439,Ann_Hematol-4-1-2174523.txt,episod||meta-analysi||variabl||anteced||vted||factor||associ||long travel||studi||hospit patient||relat||methodolog qualiti||heterogen||bia||author||potenti bias||control||patient||transport||dvt||venou thromboembol||case||data||travel||plane||systemat review||result,1||2||3||refer 1||springer-verlag 2008 introduct 1 2 3||patient||1 fig. 1 forest plot||4||studi||3 result||previou 2 year||1 princip characterist||2 11 15 18 19||6||control patient,31046.0||28965.0||17044.0||16864.5||13666.333||13567.0||13493.6||12937.0||12015.0||11562.0||10891.0||10824.0||9167.2||9074.0||8985.5,0.0,0.2,0.13333333333333333
440,Bioinformation-1-7-1891696.txt,cell signal||blast||databas||sequenc||hyperlink||dcse||tool||enzym||protein interact||inform||cell||biolog commun||web databas,1||bioinform 1||methodolog 2 3 4||cell||figur 1 5 6 7||refer 1 persidi||access figur 2 figur 3 4||2006||cell signal||7||protein||8||cell signal enzym||diseas||data,31046.0||15556.5||14813.75||12627.0||11736.4||11243.333||10429.333||8371.0||7464.0||6997.0||6288.0||6154.0||5255.0||5149.0||4969.0,0.2,0.2,0.13333333333333333
441,Breast_Cancer_Res_Treat-3-1-2001222.txt,heart diseas||effect||anastrozol||cardioprotect effect||exemestan||advers event||breast cancer||endometri cancer||letrozol||co-morbid||signific decreas||joint symptom||disadvantag||signific differ||postmenopaus women||studi||life-threaten event||aromatas inhibitor||increas||fractur||adjuv therapi||treatment||ai||women||vagin dryness||hot flash||bone||patient||incid||risk||placebo||event||lower incid||trial||nation surgic adjuv breast||safeti||tamoxifen||earli breast cancer||year||result||bone loss,1||2||1 year||year 1||3||refer 1||year 2||2 year||part 1||suppl 1||suppl 2||2 years’||studi big 1||5 Pt 1||patient,31046.0||28965.0||17151.0||17151.0||17044.0||16864.5||16110.5||16110.5||16058.5||15942.0||14901.5||14496.5||14373.333||13865.667||13567.0,0.0,0.0,0.06666666666666667
442,Doc_Ophthalmol-4-1-2235911.txt,light||frame frequenc||local amplitud||retina||report||normal||artifact||commerci system||electr nois||area||signal||stimulu||measur||mferg respons||trace||time||clinic multifoc electroretinographi||waveform||element||mferg||array||patient||mferg trace||reliabl mferg record||frame||size||fixat||clinic electrophysiolog||procedur||record||data||region||iscev guidelin||display||record time||result,1||2||1 3||contrast 2 2||3||3 3 4 fig. 3||patient||7 1 depart||multifoc electroretinographi 1 fig. 1||springer-verlag 2008 introduct 1 2||ground electrod 1 3||103 element 2 fig. 2 diagram||5 3 5 5 fig. 5||5||1 3 fig. A4 weak signal,31046.0||28965.0||24045.0||19581.0||17044.0||13809.0||13567.0||13512.333||13429.4||12990.8||12092.5||10665.833||10579.333||10364.0||9259.667,0.0,0.1,0.06666666666666667
443,Behav_Genet-4-1-2292426.txt,model||herit||homosexu||differ||genet||homophobia categori||sex||effect||total||homophobia score||twin pair correl||varianc||pair||influenc||estim||twin||score||contribut||twin studi||questionnair||studi||item score||attitud||sampl||signific||hlq||non-heterosexu||item||homophobia||individu||femal||gay men||data||threshold||environment influenc||result,1||1 2||2||2 2||3 2||5 1 fig. 1||3||statist 1||2 number||1 percentag||2 δd.f||homophobia categori 0 1 2 3||6 score 2||twin pair correl 3 1 2||2003 2 test,31046.0||30005.5||28965.0||28965.0||23004.5||19358.0||17044.0||16312.5||15967.5||15782.5||14483.0||13968.833||13381.667||13297.833||13274.0,0.0,0.0,0.0
444,Cancer_Causes_Control-2-2-1764867.txt,liquor||ovarian cancer||day||daili glass||cancer||cohort studi||california||report||censu block group||intak||median famili incom||breast cancer||daili intak||estrogen||associ||decil||rel||alcohol||alcohol consumpt||drink||time||age||cohort||analys||alcohol beverag||wine intak||women||baselin||beer||consumpt||risk||non-drink||year||drink pattern||california teacher studi cohort||wine,"1||2||result 1 2||3||refer 1||2 year||1 d.f.||1 2 purdi david||volum 2||2 43,674||2005 574 1||4||studi||trend tabl 1||1 lee valeri",31046.0||28965.0||22030.333||17044.0||16864.5||16110.5||15524.0||15042.5||14967.0||14483.0||13270.333||12937.0||12015.0||11814.0||10606.667,0.0,0.0,0.0
445,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-2082652.txt,arteri embol||sensori loss||aclr||literatur review||complic||anterior cruciat ligament reconstruct||pseudoaneurysm||poplit arteri||knee||poplit arteri occlus||embolectomi||case||reconstruct||foot||graft||vascular repair||occlus||vascular complic,1||1 fig. 1 4||3||refer 1||1 3 6 9||A. G. M. 2 1 depart||discuss 4 5 4||6 7 7 6||netherland 2 kliniek viasana||31-40-8888609 r.janssen@mmc.nl 1 sala||2007||4 week||conclus 4||8||5 week,31046.0||20001.25||17044.0||16864.5||15639.0||11832.333||9484.75||8035.5||7781.0||7768.75||7287.0||7086.0||7064.0||6154.0||5799.5,0.0,0.0,0.0
446,Neurochem_Res-3-1-1832151.txt,date||intramembran cleavag||aspartyl proteas activ||calsenilin||interact protein||molecular clamp||compon||gamma secretas||cell surfac||enzym||fragment||protein||studi||evid||gener||beta amyloid||insect cell||nicastrin||secretas||substrat competit||activ||strong evid||role||app||transmembran domain||bind partner||presenilin||lrp||amyloid precursor protein||complex||pathway||interact||result||function,1||1 1 2||1 2||2||1 3 1 1 ε||fig. 2||refer 1||40 1||1 interact||defect 1||chromosom 1||presenilin 1||notch 1||1 ps2||presenilin 2,31046.0||30352.333||30005.5||28965.0||22056.4||16970.5||16864.5||16598.0||16528.5||15844.0||15734.0||15579.0||15571.0||15527.5||14538.5,0.0,0.0,0.0
447,Osteoporos_Int-2-2-1705543.txt,date||model||differ||effect||osteoporosi||clinic practic||month||alendron||health plan||nonvertebr fractur||baselin characterist||bisphosphon||primari analysi||hip||fractur||cohort||risedron||patient||incid||therapi||method||risk factor||trial||data||hip fractur||conclus patient||result,1||2||5 1||12 1||1 year||3||refer 1||1 identif||2 comparison||analys 2||CI 2||patient||4||1 health plan||26 2 3 4 12 14,31046.0||28965.0||20705.0||18449.0||17151.0||17044.0||16864.5||15935.5||15308.5||15095.5||14880.5||13567.0||12937.0||12405.333||11950.5,0.0,0.0,0.06666666666666667
448,Purinergic_Signal-4-2-2377322.txt,bath solut||respons||acetylcholin||exercis||human muscl||effect||motor nerv||solut||extracellular atp||depolar||tissu||purin||atp||muscl||membran||human plasma||releas||bodi exercis||serendip||identif||perfus||activ skelet muscl||hypoxia||substanc||potassium channel||procedur||cell||erythrocyt||human erythrocyt||stimulatori effect||heart,1||1 fig. 1||1 6||1 19||3 fig. 2||refer 1||1 6 17||patient||cell||studi||situ 1 vagusstoff||6||267067a0 404573 1 16||cell function||frog musculatur 1 23,31046.0||22356.0||20060.0||17180.0||16995.0||16864.5||14567.667||13567.0||12627.0||12015.0||10457.667||9074.0||8749.75||8604.0||8532.5,0.0,0.1,0.06666666666666667
449,Pediatr_Nephrol-3-1-1915616.txt,receptor||toxin||effect||temperatur shift||specif receptor||supernat||cytotox effect||monocyt||target cell||antibodi||hu||stx||vero cell||protein synthesi||temperatur||experi||hemolyt urem syndrom||chang||coincub||shiga-lik toxin||cell||renal endothelium||transfer||huvec,2||target cell 1 2 fig. 1||3||refer 1||1 125||2 day||toxin 2||patient||4||cell||studi||0.01 fig. 2||ipna 2007 introduct 1 2 escherichia||6 3 6 5||shiga toxin 1,28965.0||18337.833||17044.0||16864.5||15726.0||15449.0||14579.5||13567.0||12937.0||12627.0||12015.0||11548.667||11490.5||11389.0||10428.0,0.0,0.1,0.06666666666666667
450,Int_Urogynecol_J_Pelvic_Floor_Dysfunct-3-1-2062491.txt,urinari symptom||sui||stress urinari incontin||syndrom||depress||biomed factor||pregnanc||factor||urg urinari incontin||gener popul||over-act bladder syndrom||associ||questionnair||studi||symptom||clinic depress||epidemiolog studi depress scale||analys||urogenit symptom||women||oab||univari analysi||signific increas||ces-d||preval||data||urinari incontin||higher rate||uui||year||healthi nullipar women||deliveri,1||2||result 2 2||1 year||refer 1||1 week||2 tabl 1 incid||2 univari||studi||1 year post-partum||3 month||2005||present studi||scientif literatur plo med 2005 2||10,31046.0||28965.0||21336.667||17151.0||16864.5||16140.5||16098.5||14541.0||12015.0||11437.0||9321.0||8716.0||7377.0||7071.333||6982.0,0.0,0.1,0.06666666666666667
451,Pflugers_Arch-3-1-2082651.txt,heart rate||br||murin heart||quinidin||effect||arrhythmogenesi||solut||extrasystol stimul||full agreement||pharmacolog condit||analysi||drug||ventricl||parallel||studi||condit||point||bcl||treatment||arrhythm activ||repolar||flecainid||data||restitut curv||arrhythmogen||critic DI||heart,1||2 1 2||2||1 2 1 2 fig. 1||1 2 6 2||3 2 3 2 3 2||1 2 2 scn5a||1 2 scn5a||3 4 2||2 6||3||1 23||refer 1||5 2 6||44-1223-333840 clh11@cam.ac.uk 1 3 1,31046.0||29658.667||28965.0||26007.333||24512.5||23004.5||22267.5||20035.0||19648.667||19019.5||17044.0||17017.0||16864.5||16134.333||15828.2,0.0,0.0,0.0
452,Pediatr_Nephrol-3-1-1989764.txt,cognit function||effect||group deficit||nervou system||popul||dialysi||kidney diseas||develop||mri||infant||cognit||cognit deficit||studi||diseas||literatur||age||ckd||children||frequenc||control||kidney transplant||transplant||esrd||deficit||data||chronic kidney diseas||attent||norm popul||function,1||2||1 year||3||refer 1||3 1 divis||pp 1||patient||age 1 child||studi||neuropsycholog find 1||9 children 1 year||5||2 duquett peter||2 hooper stephen,31046.0||28965.0||17151.0||17044.0||16864.5||16123.0||15890.0||13567.0||12034.0||12015.0||11037.667||10728.0||10364.0||9745.0||9689.0,0.0,0.1,0.06666666666666667
453,Crit_Care-8-2-420020.txt,recruit||model||posit end-expiratori pressur||injuri||sigh||effect||lung injuri||oxygen||high intrathorac pressur||lung||strategi||acut lung injuri||volum||ali||studi||bacteri transloc||benefit||alveolar unit||increas||overdistens||cyclic collaps||alveolar flood||acut respiratori distress syndrom||low tidal volum||arteri oxygen||patient||peep||prone posit||alveolar collaps||low peep||lung infect||mechan stress||human||ard||recruit maneuv||rm||investig||mechan ventil,1||2 2||2||figur 2 2 2||1 hour||part 2||patient||4||studi||tabl 1 descript||recruit maneuv 15 16 2 1||32 33 2 2 34 35||1 min anesthet||tabl figur 1 16||1 min ard patient 31,31046.0||28965.0||28965.0||22024.0||15666.0||15018.0||13567.0||12937.0||12015.0||11670.667||11499.333||10984.0||10784.0||9953.5||9621.8,0.0,0.2,0.13333333333333333
454,Breast_Cancer_Res_Treat-3-1-2092407.txt,nuclear size||benign tissu||breast cancer||morphometri||shape factor form _ AR||area||benign breast diseas||case-control studi||nuclear perimet||associ||form _ nci||longest axi||subsequ develop||multivari analys||famili histori||breast tumor tissu||bbd||analys||shape factor||women||control||nuclear morphometr featur||patient||featur||histori||risk||form _ AR||subject||risk factor||longest nuclear axi||hyperplasia||case||perimet||diagnosi||nuclear area,1||2||3 2 2||0 2 2||0 1||result 1||3||refer 1||2 year||4 1 depart||0.25 2||patient||4||cell||studi,31046.0||28965.0||24991.333||21341.0||18569.5||18563.0||17044.0||16864.5||16110.5||15492.333||14651.5||13567.0||12937.0||12627.0||12015.0,0.0,0.0,0.06666666666666667
455,Immunogenetics-2-2-1592254.txt,receptor||product||lrc-encod receptor||sequenc||lrc||analysi||evolut||catfish||evid||domain||uniqu composit||membran||zflitr||kir||genom segment||cyt||igsf receptor||detail sequenc analys||member||fcrl||lilr||inhibitori||iplitr||common origin||famili||sequenc analysi||gene||ident||Ig domain||chir||immun receptor||content||support||iplitr sequenc||cell||polymorph differ||teleost||molecul||function signific,box 1||pcr 1||2 identif||1-601-9841708 mwilson@microbio.umsmed.edu 1 1 depart||cell||1 miller norman||1 wilson melani||1 quiniou sylvi||7 3 xenopu 3||margin 4 3 4 fig. 4||switzerland 3||3 clem||3 fcrl3||2006||39216-4505 usa 2 institut,15840.0||15682.5||14895.0||12917.6||12627.0||10499.333||10453.333||10350.667||10350.25||10181.5||8602.5||8532.0||8522.5||8371.0||8076.75,0.2,0.1,0.06666666666666667
456,Ann_Surg_Oncol-4-1-2190340.txt,malign cell||cytolog||locat||materi||needl||metastat melanoma||number||axillari node||posit||difficulti||melanoma||histopatholog evalu||factor||primari lesion||fine needl biopsi||accuraci||follow-up||verif||studi||aspir||diagnost accuraci||diseas statu||lesion||failur||sampl||sensit||clinic materi||test||patient||lymph node||needl pass||patholog||site||clinic follow-up||procedur||larg number||cell||case||clinic||cytopathologist||diagnosi||false-neg result||result||fnb,1||2||1 4 6||refer 1||method patient 1 tabl 1||1 fig||cytodiagnosi 2 tabl 2||fnb procedur 2 2||4 2 tabl 4||patient||4||cell||3 tabl 3||studi||1 4 6 thompson john,31046.0||28965.0||17685.667||16864.5||16589.4||15559.5||15387.5||14848.75||14613.75||13567.0||12937.0||12627.0||12568.0||12015.0||10709.2,0.0,0.1,0.2
457,J_Mol_Model-3-1-2039870.txt,classic electrostat attract||ccsd||combin||refer data||vertic separ||larg basi set||lda||densiti||term||homo-bas stack||dna||densiti function||densiti function theori||interact energi||dft||hydrogen bond||base||twist angl||data||π-π stack interact||energi||result||function,1||1 1||1 2||2||1 2 3 1||1 3||1 4||1 2 12||36 1 1||1 5||1 fig. 3||3||refer 1||refer data 2 2 fig. 2||1 46,31046.0||31046.0||30005.5||28965.0||27025.25||24045.0||21991.5||21954.333||21271.667||20705.0||17688.667||17044.0||16864.5||16587.167||16185.5,0.0,0.0,0.0
458,Pediatr_Nephrol-3-1-1805045.txt,recurr rate||nativ kidney||report||plasmapheresi||factor||regimen||recipi||remiss||induct therapi||graft surviv||recurr||allograft surviv rate||diseas||pediatr renal allograft recipi||patient||graft||transplant||incid||risk||cyclosporin||pre-op PP||nativ kidney nephrectomi||fsg||esrd||clinic recurr||subsequ report||rate||LD graft,1||2||2 2 lancet 3||3||refer 1||patient||4||2 14 14 4||studi||4 5 5||5||4 6 7||3 month||6||3 mg,31046.0||28965.0||18871.5||17044.0||16864.5||13567.0||12937.0||12624.0||12015.0||11221.667||10364.0||9669.333||9321.0||9074.0||8944.0,0.0,0.1,0.06666666666666667
459,Neuroradiology-2-2-1592467.txt,respons||outcom||chemotherapi||glioma||tumour||pf||factor||grade II oligoastrocytoma||pcv chemosensit||mri||prognost signific||volum||studi||chemosensit||patient||primari tumour||oligodendrogli tumour||oligodendroglioma||pcv||genotyp||astrocyt glioma||data||intraobserv variabl||loss||seri||rcbv,1||2||0.238 1 1||8 2||3||3 3||11 2||4 23 4 1 4 2||refer 1||14 2||2 5 5||tabl 2||test 1 4 p53 1||1 rcbv||3 3 3 fig. 3,31046.0||28965.0||20699.333||17559.5||17044.0||17044.0||17008.0||16968.333||16864.5||16631.0||16564.333||16290.5||15706.0||15544.0||14630.4,0.0,0.0,0.0
460,Emerg_Radiol-3-1-1914302.txt,atl||injuri||lumbar spine||adjunct||physic examin||chest||spine||trauma||evalu||radiolog||thorac||diagnost imag||primari survey||life-threaten injuri||manual||abdomin CT||fast||imag||fractur||treatment||care||trauma care||radiograph||patient||abdomen||pulmonari contus||convent radiographi||chest radiograph||indic||line||pelvic radiograph||radiologist||pneumothorax||clinic decis rule||emerg measur||advanc trauma life support,1||1 2||2||1 21||3||refer 1||1 26 28 1||1 29||thorax 1||3 4||chicago 2||patient||1 31 34||primari survey 1||1 13 14 15,31046.0||30005.5||28965.0||17163.5||17044.0||16864.5||16787.25||16658.0||15555.0||14990.5||14573.0||13567.0||11662.333||11198.667||11045.5,0.0,0.0,0.06666666666666667
461,Oecologia-4-1-2270366.txt,model||mass||fecund||speci||scale||number||reproduct||slope||correl||plant||variabl||averag||intercept||anim||bodi size||heterotherm||studi||present||reproduct paramet||empir evid||author||terrestri habitat||expon||adult size||seed||allometr scale||cold-blood vertebr||regress||reproduct event||offspr||annual cycl||weight||egg||present paper||mammal,1||2 1||1 2||2||2 2||4 1 1||1 1 2007||4 1||1 4||1 1 κ||1 6||2 5||1 3 5||1 2007||10 1,31046.0||30005.5||30005.5||28965.0||28965.0||25009.667||23126.333||21991.5||21991.5||20732.667||20060.0||19664.5||19484.667||19166.5||19014.0,0.0,0.0,0.0
462,Int_J_Hematol-4-1-2276242.txt,nktcl||malign lymphoma||tumor suppressor gene||lmp1||lymphoma||western countri||japan||nasal lymphoma||gene mutat||develop||korea||pesticid||studi||ebv||diseas||mutat||frequenc||c-kit gene||china||gene||patient||epidemiolog||risk factor||epidemiolog studi||find||cell||case||latin american countri||p53 gene,1||2||3||refer 1||3 1 depart||tap 1||1 ebv||hematolog 2008 1 2 3 4||subtyp 2||17 2 1 18 23||patient||1 14 15 16 fig. 1||4||cell||studi,31046.0||28965.0||17044.0||16864.5||16861.333||15576.5||15530.0||15360.5||14612.5||14102.2||13567.0||13315.5||12937.0||12627.0||12015.0,0.0,0.0,0.2
463,Anal_Bioanal_Chem-4-1-2045123.txt,yeast||primer||cell wall disrupt||antagonist||yeast androgen bioassay||yegfp||recombin yeast cell||yeast cell||compound||yeast cultur||transform||assay||progesteron||estradiol||testosteron||androgen||paper||pcr||cell line,1||2||3||refer 1||_{ 1||2 cyc1||A. P. 1 1 rikilt||4||2 50 concentr||netherland 2 ira||5||boldenon 1 50 50||2006||R. 1 hamer astrid||M. 2 nielen michel,31046.0||28965.0||17044.0||16864.5||15932.0||14494.5||13521.6||12937.0||11004.333||10374.333||10364.0||9107.0||8371.0||8230.75||8202.25,0.0,0.0,0.0
464,Fam_Cancer-4-1-2253650.txt,cancer||lobular breast cancer||mutat||women||breast||mutat carrier||predict genet test||case||dgc||famili||lobular carcinoma||gene||syndrom||studi||potenti role||risk||loss||lbc||prophylact gastrectomi,2||refer 1||1-604-8776089 dhuntsma@bccancer.bc.ca 1 2 1 depart||patient||studi||10 studi||2004 1 13 24 10.1634||mutat result 6 cdh1 1 10||2004||cancer 2003 2 208 215 10.1002||22 studi||cancer 2002 2 199 204 10.1002||genet studi||2007||cancer,28965.0||16864.5||15592.5||13567.0||12015.0||9498.5||9336.4||9086.667||8077.0||7634.0||7599.0||7535.833||7361.0||7287.0||7076.0,0.2,0.1,0.13333333333333333
465,Anal_Bioanal_Chem-4-1-2287204.txt,light||terminolog||model||gross||effect||daili||dilut water||concentr||dpf||exampl||group||flow-through system||order||anim||sexual differenti||water qualiti||develop||analysi||statist analys||gonad||treatment group||studi||increas||treatment||observ||environment chamber||neg control||experi||exposur||test||acclim||frog||femal||procedur||mix sex||biolog variabl||complet||water||metamorphosi||tadpol||tank||result,1||1 1||1 2||1 2 2 2||1 2 2 2 2||2||2 2 2 2||1 1 fig. 1||1 3||1 2 fig. 2||1 4||1 3 3||1 5||1 25||3,31046.0||31046.0||30005.5||29485.25||29381.2||28965.0||28965.0||24528.5||24045.0||23488.0||21991.5||21711.333||20705.0||17172.5||17044.0,0.0,0.0,0.0
466,Plant_Mol_Biol-3-1-2140092.txt,transit||axillari bud||smallest polypeptid||prb||dormancy-to-growth transit||transcript||plant||retinoblastoma-rel protein||amino acid sequenc||protein level||signal||molecular mass||phosphoryl||protein||hp-form||similar||observ||pea||dormanc||experi||gene||cdna||cell||intact plant||cell cycl||result,1||2||3||1 unit||1 mg||1 cm||lane 1||1 10.6||1 13.9||3 4||dephosphoryl 2||4||4 4 4||cell||1 1 populu tremula populu,31046.0||28965.0||17044.0||16150.0||15945.0||15761.0||15669.5||15552.0||15547.5||14990.5||14507.5||12937.0||12937.0||12627.0||12430.0,0.0,0.0,0.06666666666666667
467,J_Chem_Ecol-4-1-2292484.txt,gland||differ||effect||number||young leav||comparison||jasmon acid||plant||monoterpen||herbivori||accumul||true leav||total foliag||damag||individu leaf||studi||higher concentr||increas||analys||treatment||anova||signific||control||cotton||terpenoid aldehyd||terpenoid||induct||total terpenoid||leav||sesquiterpen||gland number||data||mechan injuri||level||mechan damag||leaf||simul herbivori,1||2||2 2||1 4 4 1 2 3||1 4||2 4||2 2 section||3||0.05 1||vol. 1||3 4||2 morpholog||leav 2||4||experi 1 treatment,31046.0||28965.0||28965.0||22329.167||21991.5||20951.0||19602.0||17044.0||16208.5||15592.0||14990.5||14719.0||14693.0||12937.0||12694.0,0.0,0.0,0.0
468,J_Med_Internet_Res-5-4-1550574.txt,phone number||databas||model||electron patient record||number||object-ori approach||eav model||data type||medic informat||form||field||medic event||exampl||completely-gener physic schema||approach||clinic inform||flexibl||attribut||logic schema||design||gener eav tabl||queri||web page||domain||gener||larg clinic repositori||clinic event||literatur||valu||physic layout||object||system||convent relat databas system||metadata||patient||tabl||user||eav||schema||class||complex||larg number||gener design||convent design||record||simpl eav schema||type||physic schema||applic,1||1 1||1 2||2||method 1 2||1 influenza 1||2 1 influenza||tabl 1||3||tabl 2||1 million||juli 1||2 record||2 attribut||2 queri,31046.0||31046.0||30005.5||28965.0||21227.667||20735.333||20041.667||17331.0||17044.0||16290.5||15588.0||15571.5||14930.0||14761.0||14657.0,0.0,0.0,0.0
469,Neuroimage-2-1-2387200.txt,fraction anisotropi||seed region||differ||multipl linear regress||dti||white matter||abnorm||psychosi||white matter pathway||splenium||group||group differ||probabl||cortex||fiber||tract||mri||studi||gender||focal abnorm||pdf||age||control||interhemispher connect||patient||FA||diffus process||subject||method||threshold||specif cortic region||voxel||region||genu||corpu callosum||schizophrenia||pico||result||first-episod psychosi,2||2 patient||tabl 1||3 3||tabl 2||2 test||figs. 1||1 lithium||2 df||2 FE patient||1 month 7 patient durat 1||5 month 1 patient||2003 tabl 1||2 month 6 patient durat 2||patient,28965.0||21266.0||17331.0||17044.0||16290.5||16085.5||15559.5||15546.0||14557.0||14204.0||14144.5||14143.75||14104.333||13797.0||13567.0,0.0,0.0,0.06666666666666667
470,Eur_J_Nucl_Med_Mol_Imaging-3-1-2121116.txt,kurtosi||good correl||crt implant||correl||higher valu||phase analysi||substanti LV dyssynchroni||phase histogram||gate spect||analysi||interventricular dyssynchroni||studi||gmp||crt||LV dyssynchroni||patient||heart failur||tri-plan tissu doppler imag||LV segment||histogram bandwidth||inform||tdi||cardiac cycl||assess||gate myocardi perfus spect,1||2||5 1 2||refer 1||albinusdreef 2||patient||result studi popul 1||studi||netherland 2 depart||3.79 NS 1||1 stokkel marcel||5||2 baselin characterist||3 fig. 3 correl||6,31046.0||28965.0||23458.333||16864.5||14485.5||13567.0||12731.0||12015.0||11205.0||10573.333||10369.333||10364.0||10316.333||10165.5||9074.0,0.0,0.2,0.13333333333333333
471,Int_J_Cardiovasc_Imaging-3-1-2121118.txt,nccm patient||aortic diamet||blood pressur data||conclus||diastol heart failur||nccm||noncompact||aortic distens||control||systol||patient||studi||aortic elast||aortic stiff||wall||result||gender-match control,1||2||3||group 2||refer 1||2007 introduct 1 2 3 4||3 4||3 1 fig. 1 SD DD||patient||result patient popul 1||3 4 fig. 3||4||studi||method studi popul 3 9 1||5,31046.0||28965.0||17044.0||16920.0||16864.5||16429.5||14990.5||14264.0||13567.0||13119.0||13000.25||12937.0||12015.0||11825.333||10364.0,0.0,0.1,0.13333333333333333
472,Osteoporos_Int-4-1-2267483.txt,treatment complianc||treatment benefit||pharmo-rl||osteoporosi||mpr||poorer complianc||medic||bisphosphon therapi||categori||maxim treatment benefit||osteoporot fractur||follow-up||drug||analysi||femal user||bisphosphon||fractur||women||patient||risk||interv||complianc||low complianc||studi period||hormon replac therapi||user||data||year||result,1||2||result 1||refer 1||1 fig. 1 complianc||2 time||2 fig. 2 half||patient||studi patient||studi||1 januari 1999||1 gener characterist||A. 1 olson||5||2 million resid,31046.0||28965.0||18563.0||16864.5||16825.75||16453.0||15780.75||13567.0||12791.0||12015.0||11990.333||11664.667||11552.333||10364.0||9812.667,0.0,0.1,0.06666666666666667
473,Virchows_Arch-3-1-2039779.txt,affer loop||differ||number||index||photograph||comparison||lower number||apoptot rate||crypt||investig||prolifer||signific differ||studi||apoptosi||cell kinet||semiquantit||increas||adenoma||apoptot index||tissu section||ileal mucosa||patient||rang||section||method||fap||cell prolifer||cell||famili adenomat polyposi||restor proctocolectomi||pouch||biopsi||tissu area,1||2 2 2 fig. 2 2||1 fig. 1||1 patient||2 5||M. 1 1 depart||3||refer 1||1 carcinoma||fig. 7 0 1 2||mib 1||3 patient||D. 2||patient||result patient characterist 1,31046.0||24966.833||22356.0||22306.5||19664.5||17083.0||17044.0||16864.5||16193.5||15615.4||15525.0||15305.5||15289.5||13567.0||12996.0,0.0,0.0,0.06666666666666667
474,Eur_J_Appl_Physiol-3-1-1914221.txt,norm valu||complaint||rehabilit program||ltx||percentag||sedentari person||gener popul||bodi composit||liver transplant||fit||cross-sect studi||studi||isokinet strength||fatigu||present studi||life||sever||liver transplant recipi||test||patient||neuromuscular fit||deficit||level||year||relationship,1||2 2||2||2 3||1 1 depart||1 2 3 agent||1 time||2 2 1979 1999||1 ffm||2 peak||2 1974||2 ffm||2 6mwd||patient||studi,31046.0||28965.0||28965.0||23004.5||21528.667||19408.0||17493.5||15768.75||15531.0||14727.5||14582.0||14490.5||14487.0||13567.0||12015.0,0.0,0.0,0.13333333333333333
475,Histochem_Cell_Biol-4-1-2413113.txt,microtubul||gap junction||migrat||brain||cell||cell adhes||interact||protein||connexon||adheren junction||form||adhes||brain tissu||heart||hemichannel,beta 1||cell||beta 3||disc larg homolog 1||cell respons||2006 2002 2003||cell biolog||endotheli cell||cell adhes||cell movement||cell migrat||adjac cell||crest cell||cell interior||lps-prime cell,15753.0||12627.0||8752.0||8165.25||7987.5||7693.0||7089.5||6691.5||6618.0||6610.5||6440.0||6387.0||6329.0||6323.0||6314.0,0.2,0.2,0.13333333333333333
476,Appl_Psychophysiol_Biofeedback-4-1-2259255.txt,cocain||alpha-theta biofeedback||sud||effect||alpha||scale||neurotherapi||depend||eeg characterist||biofeedback||frontal||heroin addict||function brain activ||chronic||report||heroin user||behavior||amplitud||clinic outcom||mix substanc abus||eeg biofeedback||group||acut||mental rehears||approach||state||techniqu||alpha activ||criteria||eeg abnorm||cognit||research||drug||alcohol||studi||condit||evid||increas||clinic research||theta band||quantit eeg||genet factor||slow-beta coher||neurofeedback||frequenc||disord||treatment||activ||control||erp||abus||patient||section||therapi||kulkoski||beta||stimul||qeeg alter||femal||qeeg techniqu||subject||eeg coher||qeeg||theta||find||problem||function connect||cortic area||data||low-voltag background activ||delta activ||alpha-theta train||classif||alpha absolut power||abstin||result||power,1||2||3||level 2||1 rflp||vol. 2||patient||4||trude003@maroon.tc.umn.edu 3 1 depart||studi||efficaci level 1||5||urocortin 1 neurocircuit||level 3||patient group,31046.0||28965.0||17044.0||16085.5||15529.5||14551.5||13567.0||12937.0||12646.25||12015.0||11624.667||10364.0||10349.333||10125.0||9221.0,0.0,0.2,0.13333333333333333
477,Intensive_Care_Med-2-2-1315314.txt,model||europ||project||outcom||hospit||sap 3 studi||origin counterpart||variabl||icu||vital statu||countri||perform||studi||admiss||cohort||sap 3 databas||hospit stay||system||patient||northern europ||risk adjust system||chronic condit||icu admiss||intens care unit||esm||sap II paramet||data||risk adjust||region||sap II||intens care,1||2 1||1 2||2||patient 1 1||6 2 1||2 3||3||refer 1||day 1||part 1||part 2||soft 2||patient||studi,31046.0||30005.5||30005.5||28965.0||25219.667||23028.333||23004.5||17044.0||16864.5||16489.5||16058.5||15018.0||14588.5||13567.0||12015.0,0.0,0.0,0.13333333333333333
478,Calcif_Tissue_Int-4-1-2268729.txt,mechan adapt||differ||bone structur||structur paramet||effect||osteoporosi||time point||group||anim||ovx||measur||studi||bisphosphon||time||age||valu||anova||ultim displac||control||late treatment||bone||test||cortic thick profil||zol||mechan properti||earli||cortic thick||rat||singl inject||standard deviat||late zol||percentag chang||absolut valu||result,1||1 1 2||2||3||refer 1||1 1 eindhoven univers||2 0.088||patient||4||cell||llc 2008 1 3 4 6||studi||M. 1 gasser||2 14 16 5 7||b.v.rietbergen@tue.nl 1 huisk,31046.0||30352.333||28965.0||17044.0||16864.5||16451.25||14488.0||13567.0||12937.0||12627.0||12073.5||12015.0||11601.667||10914.8||10350.333,0.0,0.0,0.06666666666666667
479,Ann_Surg_Oncol-4-1-2277454.txt,surgic resect||medic intervent||ebrt||fasciotomi||sever symptom||neg impact||extrem||tissu||normal tissu||studi||object||sever||daili activ||grade||late effect||soft tissu sarcoma||patient||treatment procedur||major therapeut intervent||long-term morbid||perfus||st||tumor||item||ilp||irrevers function damag||limb||manag||radiat,1 1||1||2||1 3||2 3||1 4||1 1 axillari||2 6||2 7||2 8||result 2||3||3 3||refer 1||fibrosi 1 3,31046.0||31046.0||28965.0||24045.0||23004.5||21991.5||20739.333||19019.5||17981.0||17559.5||17522.5||17044.0||17044.0||16864.5||16125.333,0.0,0.0,0.0
480,Eur_J_Epidemiol-3-1-2071965.txt,linkag||date||differ||doubl count||hospit||hospit admiss||nation hospit discharg regist||discharg||ratio||studi||hospit morbid data||admiss||ami||gender||acut myocardi infarct||time||cohort||recurr case||declin||patient||hospit mortal||postal code||epidemiolog||incid||regist||event||trend||data||hospit regist||case||mortal||men||recurr event||result,1||2||30 2 1 1||1 1 0||2 1 0||1 year||3||refer 1||1 incid||39 2||patient||1 risk differ||4||studi||30 1 0 0,31046.0||28965.0||23581.0||22728.333||22034.667||17151.0||17044.0||16864.5||15906.5||15262.5||13567.0||13290.0||12937.0||12015.0||11624.75,0.0,0.0,0.13333333333333333
481,Neurochem_Res-4-1-2270371.txt,rostral||incub||white matter||neuron||adult rat||transect injuri||anim||stain||caudal stump||antibodi||cord||western blot||spinal cord||ventral horn||present studi||dpo||gdnf||gdnf protein||hindlimb||rostral stump||cell||rat||level||injuri site,1||2||1 tabl 1||3 3 2 2 fig. 2||4 2 4 4 2||3||refer 1||1 ml||2 day||2 week||2 mm||4||llc 2008 introduct 1 2||cell||studi,31046.0||28965.0||21902.667||20993.167||19348.2||17044.0||16864.5||15906.0||15449.0||15100.0||14896.0||12937.0||12729.8||12627.0||12015.0,0.0,0.0,0.06666666666666667
482,J_Struct_Funct_Genomics-3-1-2140095.txt,famili member||target area||metabol enzym||number||specif||sgc||reductas||protein character||dehydrogenas||target||approach||oxford||develop||purifi protein sampl||enzym||wide scientif audienc||protein||import||domain||gener||diseas||data collect||drug develop||scientif commun||success||ligand screen||compound||structur determin||method||class||inhibitor||determin||inform||nmr||case||data||human||crystal||ligand||protein structur||pdz||wide structur rang||protein kinas||structur,1||2||1 3||3||refer 1||14 2||dna 1||phase 1||50 2||T. 1 sundström michael 1 1||46 2 3||4||cell||studi||1 core protocol,31046.0||28965.0||24045.0||17044.0||16864.5||16631.0||16186.0||15995.0||15827.0||15816.833||15778.0||12937.0||12627.0||12015.0||10750.333,0.0,0.0,0.0
483,Eur_Arch_Otorhinolaryngol-4-1-2279158.txt,laser surgeri||maximum phonat time||differ||laser cordectomi||voic qualiti||group||grab||radiotherapi||vocal emiss||score||spectrogram||studi||voic||qualiti||surgeri||life||treatment||signific||laser||patient||vocal||voic handicap index||dysphonia||inform||fundament frequenc||perceptu analysi,1||2 2||2||2 2 3||tabl 2 2||0 1 2 3 total||3||refer 1||2 2 10 11 12||3 4||2 laser||0 tabl 1||patient||4||studi,31046.0||28965.0||28965.0||24991.333||20515.333||17055.2||17044.0||16864.5||15163.0||14990.5||14594.5||13585.0||13567.0||12937.0||12015.0,0.0,0.0,0.13333333333333333
484,Environ_Health_Perspect-115-3-1849945.txt,cognit function||cumul lead dose||health effect||higher level||effect||outcom||blood lead||dose||report||lead||review||blood||cognit||analysi||associ||measur||symptom||evid||relat||neurobehavior test score||past||manual dexter||increas||author||age||chronic effect||exposur||bone||current||current exposur||test||worker||occup||sourc||cumul exposur||consist||stronger predictor||acut effect||psychiatr symptom||adult||level||function,1||2||1 2 stoke||2000 2||25 1||3||tabl 1 tabl 2||1 visit||127 1||2 visit||4 5 1 divis||patient||4||studi||2 3 schwartz brian,31046.0||28965.0||20010.333||17434.0||17172.5||17044.0||16810.75||15722.5||15716.5||14682.0||13656.5||13567.0||12937.0||12015.0||11554.5,0.0,0.0,0.0
485,Cancer_Causes_Control-3-1-2039842.txt,day||cancer||total fat||lack||subcohort||intak||linol acid||studi||addit||fat||rectal tumor||subcohort member||express||mutat||patient||epidemiolog||risk||tabl||colon||tumor||rectal cancer||netherland cohort studi||case||colon tumor||polyunsatur fat||type||result,1||2||1 1 depart||24 1 fig. 1||refer 1||apc 2||patient||mlh1 express analysi 2 2||4||studi||mp.weijenberg@epid.unimaas.nl 1 lüchtenborg margreet 2||1999 443 1||2 apc apc apc 2||30 31 2||apc apc 1,31046.0||28965.0||21528.667||17586.0||16864.5||14540.5||13567.0||13405.0||12937.0||12015.0||12003.4||11990.667||11655.6||11461.667||10426.0,0.0,0.2,0.13333333333333333
486,Arch_Dermatol_Res-3-1-1950346.txt,receptor||skin||day||psoriasi patient||pasi 50 respond||analysi||total number||psoriasi||lesion||express||treatment||pathogenesi||baselin||patient||chronic plaqu psoriasi||pasi||placebo group||placebo||single-stain section||ccr5||non-lesion skin||cell||data||result,1||2||1 1 depart||3||number 1||type 1||fig. 2||refer 1||site 1||number 2||1 cm||2 week||0.001 2||patient||4,31046.0||28965.0||21528.667||17044.0||17008.0||16987.0||16970.5||16864.5||16558.0||15967.5||15761.0||15100.0||15055.0||13567.0||12937.0,0.0,0.0,0.06666666666666667
487,World_J_Urol-3-1-1913171.txt,tumour sampl||day||superfici bladder cancer||inflamm||posit||chemotherapi||tumour||group||bladder cancer||p53||decreas||local microwav||studi||thermo-chemotherapi||haemorrhag||high-grad urotheli cell carcinoma||increas||bladder||sampl||treatment||temperatur||activ||patient||transit cell carcinoma||bladder tumour||studi thermo-chemotherapi||cystectomi||mmc||cell||hyperthermia||human||prolifer activ||result,1||2||11 2 2 2 2||7 2 2||result 1||treatment 1||group 1||3||group 2||refer 1||haemorrhag 1||1 hulsbergen||2 day||1 patient detail||hyperthermia 2,31046.0||28965.0||24182.2||21642.333||18563.0||18029.0||17960.5||17044.0||16920.0||16864.5||15566.5||15524.0||15449.0||15051.333||14522.0,0.0,0.0,0.0
488,Behav_Genet-4-1-2257998.txt,model||genet design||exact simul||distribut||effect||number||suffici summari statist||mont carlo||varianc||summari statist||genotyp valu||sampl size||group||probabl||transform||DZ twin||analysi||design||raw data||suffici statist||studi||time||simul||effect size||paramet||fals hypothesi||power studi||qtl||method||power calcul||data||case||power,1||1 1||2 1||2||1 2 1 2 0 2||1 3 2||1 2 3 2002||0 0 1 1||1 0||2 0 2 0||2 0||3||2 1 0 1988||tabl 1 illustr 1||illustr 1,31046.0||31046.0||30005.5||28965.0||25846.667||25685.0||21028.0||18569.5||18569.5||17529.0||17529.0||17044.0||16783.25||16483.5||15636.0,0.0,0.0,0.0
489,Plant_Mol_Biol-4-1-2295253.txt,day||germin||seed germin||seedl develop||compon||develop||media||analysi||aba||similar time window||studi||import||phenotyp||sugar||seed||treatment||control||abscis acid||stratif||experi||gene||mutant||role||glucose-arrest seedl||aba insensit||arrest||result,1||2001 2||M. 1 1 depart||1 exp||synthas 1||1 gin||aba2-1 1||2 exp||4||cell||studi||31-10-5292410 bas.dekkers@deruiterseeds.com 1 2 schuurman||1995 5 1 4 bruggink||5||gin 1 2003 abi4,31046.0||17639.0||17083.0||16072.0||15643.0||15560.0||15534.5||15031.5||12937.0||12627.0||12015.0||12004.8||11403.0||10364.0||9712.5,0.0,0.0,0.06666666666666667
490,Sleep_Breath-4-1-2194800.txt,cognit function||day||hypertens||effect||obstruct sleep apnea syndrom||sleepi||clinic global impress||daili live||advers event||adjunct treatment||score||analysi||studi||armodafinil||wake||fatigu||signific amount||treatment||baselin||test||patient||wake test||therapi||episod secondari memori||placebo group||residu ES||placebo||final visit||visit||ncpap||ncpap-adher patient||long-term memori,1||2||0 1||activ 1||3||fig. 2||refer 1||1 month||stage 1||2 week||stage 2||1 patient demograph||toler 2||wake 2||patient,31046.0||28965.0||18569.5||18138.5||17044.0||16970.5||16864.5||16322.0||16110.5||15100.0||15070.0||14937.333||14692.5||14501.5||13567.0,0.0,0.0,0.06666666666666667
491,Exp_Appl_Acarol-3-1-2039815.txt,speci||base frequenc homogen||access||dataset||evolutionari relationship||posit||sequenc||variat||analysi||coi||studi||dna||nuclear||pattern||reproduct parasit||genbank||sampl||phylogeograph pattern||tetranychid mite||tetranychida||gene||identif||spider mite||mitochondri coi phylogeni||paup||phylogenet analysi||speci delin||host plant||select sweep||barcod||dna sequenc||mite||result||taxa||genu||parasit||host plant associ,2 xie||1 1994 2006 2006 3||1 2 T2 netherland aalsmeer||1 2 T1 unknown unknown||studi||tabl 1 overview||1 2 us1 unit state tucson||5||aug-05 3 4||2007 45 1 10 10.1111||2005||2006||2004||2003 2004||2007 2003 2004,14523.5||13413.8||12479.8||12203.2||12015.0||11635.667||10468.167||10364.0||9994.0||9596.4||8716.0||8371.0||8077.0||7864.0||7671.667,0.2,0.1,0.06666666666666667
492,Neuropsychologia-2-1-2265793.txt,memori||word||recal||relat inform||asd||comparison||difficulti||abil||recognit||group||categori||perform||process||studi||condit||evid||particip||asd particip||pattern||task||hippocampu||environment support||effect size||relat memori||asd group||item||list||individu||support||autism spectrum disord||inform||data||level,1||2||fig. 2||tabl 2||2 show||figs. 1||small 2||2 error||patient||4||tabl 1 age||studi||3 result||2 comparison individu||tabl 3,31046.0||28965.0||16970.5||16290.5||15603.0||15559.5||15106.0||14867.0||13567.0||12937.0||12742.333||12015.0||11562.0||10750.333||10330.0,0.0,0.0,0.06666666666666667
493,Eur_J_Epidemiol-4-1-2413078.txt,earlier life condit||countri||pension||german pension scheme||migrant background||inform||migrant||data||pension insur||mortal||death||studi||host popul||popul||migrant mortal||death rate||immigr||germani||foreign,1||1 1||2||1 6 1 2 7||3||refer 1||1 comparison||1 8 fig. 1 14 5||1 1 max planck institut||studi||4 8 9 3 10 3||2 life expect||1475-9276-3-4 15193155 1 11||2005||5 10,31046.0||31046.0||28965.0||21425.6||17044.0||16864.5||16349.0||14647.167||12804.8||12015.0||10925.5||10473.667||9024.75||8716.0||8673.0,0.0,0.1,0.06666666666666667
494,Cardiovasc_Intervent_Radiol-3-1-2062488.txt,varic bleed||collater vein||large-diamet vessel||devic||varic||amplatz vascular plug||embol||cathet||emerg procedur||placement||transjugular intrahepat portosystem shunt||intervent radiolog||portal vein collater||avp||patient||creation||portal vein||avp devic||tip||liver||procedur||esophag varic||closur,1||2||1 1 depart||1 2 fig. 1 portal||3||llc 2007 1 2||refer 1||3 4||2 cm||patient||4||1 year maximum||netherland 2 depart||5||3 day,31046.0||28965.0||21528.667||19230.2||17044.0||16899.25||16864.5||14990.5||14720.5||13567.0||12937.0||11591.667||11205.0||10364.0||9488.5,0.0,0.1,0.06666666666666667
495,J_Gastrointest_Surg-3-1-1852372.txt,ambulatori pH||healthi volunt||biliari reflux||esophagu||group||measur||simultan bile||studi||healthi control||bile||gender-match control||time||bile reflux||age||valu||meal||upper gastrointestin diseas||bilirubin absorb||patient||period||barrett||refer valu||esophag manometri||reflux||acid reflux||data||age 51 year||stomach||lower esophag sphincter||acid||intragastr pH||result,1||2||result 1||3||refer 1||1 week||2 tabl 2 median||patient||4||bile monitor 3 3 2||49-221-478-5076 elfriede.bollschweiler@uk-koeln.d 2 1 depart||14 17 1 figur 1 posit||1 demograph data||studi||3 result,31046.0||28965.0||18563.0||17044.0||16864.5||16140.5||15534.0||13567.0||12937.0||12798.8||12501.4||12243.0||12071.333||12015.0||11562.0,0.0,0.1,0.13333333333333333
496,Immunol_Lett-2-1-2430030.txt,cytokin product||murin||neutrophil||respons||sampl||apc||express||cell||antigen present||antigen||class II||present||macrophag||rel pauciti,1||2||3||s.culshaw@dental.gla.ac.uk 1||2 materi||fig. 2 fig. 3||4||cell||fig. 3 fig. 2 3 323||1 3 polystyren flask||studi||fig. 2 323||339 fig. 2||1 brewer jame||5,31046.0||28965.0||17044.0||15524.0||15325.0||13990.25||12937.0||12627.0||12195.833||12037.5||12015.0||11370.333||11369.667||10397.0||10364.0,0.0,0.1,0.06666666666666667
497,Matern_Child_Health_J-2-2-1592249.txt,survey||primari care||popul||pregnanc||preconcept health||vast major||studi||import||annual exam||preconcept healthcar||time||primari care practic||women||patient||risk||knowledg||preconcept care||risk factor||inform||data||physician||annual well-woman exam||famili medicin practic||deliveri,1||result 1 2 2 1||3 1||fig. 1||2 9||3||refer 1||patient||4||type 1 diabet||studi||2 year 13.5||tabl 2 concept histori||2006||tabl 4,31046.0||25220.4||24045.0||18011.0||17178.5||17044.0||16864.5||13567.0||12937.0||12155.0||12015.0||10765.0||8455.25||8371.0||8276.5,0.0,0.1,0.13333333333333333
498,Pflugers_Arch-4-1-2226063.txt,cardiomyocyt||intact ctni||day||cultur||integrin||ldh activ||medium||incub||ldh||viabl cardiomyocyt||integrin stimul||studi||propidium iodid||ctni||releas||assay||control||activ||control cardiomyocyt||chemiluminesc||necrosi||cell||level||integrin function,1||2||2 2||3||fig. 2||refer 1||1 ml||patient||4||cell||ctni 1 2 grgd grgd||studi||3 2 grgd grgd||5||3 day,31046.0||28965.0||28965.0||17044.0||16970.5||16864.5||15906.0||13567.0||12937.0||12627.0||12023.6||12015.0||11520.25||10364.0||9488.5,0.0,0.1,0.13333333333333333
499,Int_J_Cardiovasc_Imaging-3-1-2121121.txt,heart failur,2007 1 2 3||refer 1||patient||4||studi||5 6||2007||age group||medic treatment||model||2007 keyword left||henri dunantstreet 5||individu treatment||increas||clinic statu,21085.5||16864.5||13567.0||12937.0||12015.0||9719.0||7287.0||4220.0||4124.5||3891.0||3496.0||3480.333||3323.0||3204.0||3031.5,0.0,0.0,0.0
500,Apoptosis-4-1-2423419.txt,icad protein||cancer||dff||ectop express||transcript||report||transcript regul||function import||dna fragment||construct||myc-bind site||studi||promot||icad||apoptosi||express||activ||gene||express level||myc||site||cell||region||human cancer||result,1||3||refer 1||1 min||2 min||2 incub||patient||4||81-3-5285-1161 tesuzuki@nih.go.jp 1 1 depart||cell||studi||4 2 icad 17||japan 2 depart||6||method cell,31046.0||17044.0||16864.5||16158.0||15117.5||14721.5||13567.0||12937.0||12917.6||12627.0||12015.0||11392.75||10645.333||9074.0||8149.5,0.0,0.1,0.13333333333333333
501,Mar_Drugs-5-4-2365694.txt,blue green alga||organ||florida red tide||florida||healthcar provid||toxin||center||futur hab outreach||public health personnel||educ materi||evalu||red tide||caller||person||health profession||hab||interview||ciguatera fish poison||studi||particip||ciguatoxin||outreach||hotlin||system||major||poison inform specialist||cyanobacteria||educ outreach materi||coastal manag||marin||inform||brevetoxin||pilot studi,1||2||tabl 1||3||tabl 2||2 particip||sept 2||patient||1 6 karenia||studi||tabl 1 demograph||http://www.start1.com/ figur 1||5||tabl 3||6,31046.0||28965.0||17331.0||17044.0||16290.5||15477.5||14485.0||13567.0||13374.667||12015.0||11620.333||10749.333||10364.0||10330.0||9074.0,0.0,0.1,0.06666666666666667
502,Health_Care_Anal-4-1-2244696.txt,welfar||time orient||prioritarian||choic||patern||social depriv||futur||greater orient||evalu||gain||inequ||research||peopl||decreas||studi||aim||discuss||utilitarian||particip||autonomi||greater social depriv||egalitarian||benefit||public health approach||valu||dilemma||screen||futur orient||health inequ||lower expect||psycholog||paper||screen uptak||present orient||uptak||inform choic||impact||posit outcom||ethic cost||individu||expect||result,1||2||1 1 1 1 fig. 1||1 5||result 1||1 associ||refer 1||1 1 psycholog depart||51 1||2 type||vol. 1||patient||4||studi||type 2 diabet,31046.0||28965.0||26701.0||20705.0||18563.0||17356.0||16864.5||16412.75||16085.5||15946.5||15592.0||13567.0||12937.0||12015.0||11461.333,0.0,0.0,0.06666666666666667
503,Eur_Radiol-3-1-2039780.txt,magnet reson imag||signal intens||mri||pseudocapsul||renal arteri stenosi||studi||higher sensit||adc||fat||oncocytoma||angiomyolipoma||imag||lesion||malign lesion||opposed-phas imag||patient||potenti kidney donor||renal arteri||enhanc||renal imag||tumor||renal lesion||case||kidney||renal cell carcinoma||function,1||1 30||refer 1||10 1 11 fig. 1||TE 1||2 31||TE 2||patient||30 1 31 2 32||studi||perfus 1 67||6||3 66||2005||TR 3,31046.0||17156.5||16864.5||15820.2||15638.0||15559.0||14597.5||13567.0||13524.6||12015.0||10775.333||9074.0||8954.0||8716.0||8643.5,0.0,0.2,0.13333333333333333
504,Exp_Brain_Res-3-1-1914280.txt,light||stream||rhythm||captur||auditori stream||locat||effect||auditori stimuli||jnd||sequenc||intersensori pair||frequenc||av-interv||intersensori||tone||tempor ventriloqu||intersensori interact||experi||auditori||visual toj task||central loudspeak||auditori group||soa||flanker||sound,1||2||stimuli 2 1||method 1||3||frequenc 1 fig. 1||experi 1||tabl 2||exp 1||1964 1||exp. 1||experi 2||exp 2||vol 2||exp. 2,31046.0||28965.0||20082.333||17359.0||17044.0||16986.25||16535.0||16290.5||16072.0||15569.0||15526.0||15494.5||15031.5||14569.5||14485.5,0.0,0.0,0.0
505,Angiogenesis-4-1-2268731.txt,cancer||nf-κb||effect||mediat||angiogenesi inhibitor||report||agent||direct effect||addit||apoptosi||growth||express||treatment||activ||angiogenesi||role||endotheli cell||inhibitor||growth factor||cell||pathway||inhibit,1||2||3||refer 1||2 fig. 2 model||1 2 griffioen arjan||4||cell||studi||netherland 2 depart||31-43-3876613 aw.griffioen@path.unimaas.nl 1 1 angiogenesi laboratori||commun 2007 355 1 5 10.1016||2006||tumor cell||2007,31046.0||28965.0||17044.0||16864.5||16699.25||15006.75||12937.0||12627.0||12015.0||11205.0||10506.0||9388.833||8371.0||7638.0||7287.0,0.0,0.1,0.06666666666666667
506,Qual_Life_Res-4-1-2238779.txt,respons||reliabl||clinic condit||similar symptom||health statu||gener health statu measur||intern consist||nyha||follow-up interview||follow-up||measur||symptom||studi||clinic trial||empir evid||similar clinic manifest||diseas||time||clinic chang||analys||patient||heart failur||psychometr properti||baselin assess||valid||kccq||anemia||kccq score||statu||assess||disease-specif measur,2||3||fig. 2||refer 1||formula 1||0.001 2||part 2||patient||result patient characterist 1||studi||fig. 1 kccq||tabl 1 baselin||construct valid 1||1-816-9325613 spertusj@umkc.edu 1 2 jone philip||3 month,28965.0||17044.0||16970.5||16864.5||15548.0||15055.0||15018.0||13567.0||12996.0||12015.0||12014.333||11785.0||10854.0||10084.167||9321.0,0.0,0.2,0.13333333333333333
507,J_Abnorm_Child_Psychol-4-1-1915634.txt,continu||panic disord||rcad data||scale||obsess compuls disord||correl||varianc||anxieti dimens||gad||previou studi||homotyp||gener anxieti disord||symptom||studi||item score||ocd||sad||sampl||taxonomi||disord||adolesc||commun sampl||anxieti construct||young adolesc||soph||previou work||social phobia||anxieti||self-report questionnair||type||futur soph||girl,1||2||1 1 depart||3||1 predictor||wave 1||1 sad||1 gad||1 soph||1988 2||2 1988||wave 2||2 soph||4||studi,31046.0||28965.0||21528.667||17044.0||15740.5||15616.5||15537.0||15535.5||15534.5||14997.0||14997.0||14576.0||14494.0||12937.0||12015.0,0.0,0.0,0.06666666666666667
508,Purinergic_Signal-4-2-2377325.txt,respons||effect||glutam||rpe||photoreceptor||rpe cell||light-sensit signal||ectoenzym activ||signal||epinephrin||evid||stimuli||membran||microenviron||cftr||releas||transport||space||role||consist||stimul||adenosin||atp releas||agonist||cell||rod||subretin space||level,2||photoreceptor 2 18 2 2||refer 1||30 2||50 2||31 2||subretin space 1 2 3||48 2||2 53||2008 introduct 1 fig. 1||cell||2 23 2 24 7 25||58 43 2||6||2004,28965.0||18179.8||16864.5||16116.0||15827.0||15559.0||15485.4||15146.0||15041.5||14081.4||12627.0||12415.0||10477.667||9074.0||8077.0,0.0,0.0,0.06666666666666667
509,Neuroimage-2-1-2330063.txt,memori||correl||tractographi||side||connect||epilepsi||memori function||left||volum||studi||hippocamp atrophi||parahippocamp gyru||age||hippocamp volum||structur connect||visual cue||control||test||tle||patient||white matter tract||seizur||signific correl||medial tempor lobe||tractographi analysi||signific interact||voxel,1||2||3||tabl 2||1 moran||1 wieser||2 37||figs. 2||fig. 3 fig. 2||patient||13 34 cp 1 2||2004 fig. 2 fig. 3||studi||tabl 1 clinic data||2004 http://www.psycholog fig. 1,31046.0||28965.0||17044.0||16290.5||15544.0||15531.0||15371.5||14519.0||13990.25||13567.0||13220.2||12807.6||12015.0||11122.25||11025.0,0.0,0.1,0.13333333333333333
510,Eur_J_Epidemiol-3-1-1914270.txt,mdct||mass||differ||calcium score||agatston||cac||coronari arteri||score||measur||volum||random select||studi||error||relat||particip||absolut||ebct||epidemiolog||slice thick||subject||method||risk factor||cardiovascular risk factor||calcium||scan||find||coronari arteri calcif||reproduc||technic variabl||cholesterol||level||coronari calcium measur||result||measur protocol,1||2||2 2||result 1||refer 1||2 2 13 14||2007 introduct 1 2 3 4||1 grobbe||2 1 juliu center||2 characterist||2 bartelink||patient||fig. 2 relat||sabour siamak 1 3||studi,31046.0||28965.0||28965.0||18563.0||16864.5||16622.25||16429.5||15546.5||15414.25||15128.0||14488.0||13567.0||12103.333||12023.0||12015.0,0.0,0.0,0.06666666666666667
511,Eur_Arch_Otorhinolaryngol-3-1-2099162.txt,palatin tonsil||tumour cell||adenocarcinoma||rout||primari adenocarcinoma||metastat tumour||case||common origin||oesophagu||patient||metastas||head||metastasi||neck region||tonsil||tumour,1 1 depart||refer 1||patient||netherland 2 depart||9 2 10 6 6 9||2 mooi wolter||6||2005||ulcer fig. 2 biopsi||discuss 4||netherland 3 depart||cancer||cell carcinoma||10||tumour cell,21528.667||16864.5||13567.0||11205.0||10813.167||9667.667||9074.0||8716.0||8713.25||7319.0||7231.333||7076.0||6984.0||6982.0||6687.0,0.2,0.1,0.13333333333333333
512,Int_J_Hematol-4-1-2276241.txt,genet||11q23 abnorm||karyotyp||advers risk group||prognost factor||categori||cytogenet risk group||analysi||fab||acut myeloid leukemia||subtyp||mpo||mld||age||clinic featur||myeloperoxidas||surviv||aml||patient||normal karyotyp||year||acut leukemia||mld phenotyp||data||diagnosi||classif||result,2||1 2 1 4 mpo||3||fig. 2||refer 1||5 1 0.2||5 3||patient||clinic characterist 3 1||4||1 patient characterist age||7 2 0.3||studi||tabl 2 number||result patient characterist 1 9 9,28965.0||20800.4||17044.0||16970.5||16864.5||13985.333||13704.0||13567.0||13559.75||12937.0||12367.25||12131.333||12015.0||11850.333||10461.333,0.0,0.1,0.06666666666666667
513,J_Affect_Disord-1-5-1894757.txt,psycholog symptom||maximum score||postnat year||outcom||month||social support||difficulti||depress||pregnanc||pakistan||infant growth||factor||depress disord||countri||infant||persist||birth||studi||earli identif||rural sub-district||postnat depress||life event||children||ladi health worker||women||mother||depress women||postnat period||prospect studi||famili||item||event||subject||trimest||debt||prolong depress||preval rate||year||persist depress,1||2||fig. 1||tabl 1||3||2 measur||tabl 2||difficulti 1||law 1||1 newborn||2 month||4||tabl 1 comparison||studi||5,31046.0||28965.0||18011.0||17331.0||17044.0||16500.5||16290.5||15629.0||15606.5||15595.5||15281.5||12937.0||12104.667||12015.0||10364.0,0.0,0.0,0.06666666666666667
514,Virchows_Arch-3-1-1888719.txt,consensu confer||clinic behavior||enet guidelin||consensu||neuroendocrin tumor||digest tumor||classif||ki-67 index||session||confer||mitot index||stage iiib||stage||propos||endocrin||net||particip||system||grade||pancrea||patient||foregut||guidelin||tumor||tnm||prognost assess,1||2||1 2 3||4 2 2 2||2 G2 2||3||refer 1||node 11 1 2 3||part 1||1 propos||size 2||novemb 2||2 alhman||patient||4,31046.0||28965.0||25685.0||24958.0||19319.0||17044.0||16864.5||16565.4||16058.5||15709.0||15066.5||14525.5||14484.0||13567.0||12937.0,0.0,0.0,0.06666666666666667
515,Neurogenetics-4-1-2238789.txt,complet list||biolog associ||express||lewi bodi||substantia nigra||number||drug||cell||data||probe||iter analysi||neurodegener||gene||studi||diseas||SI _ figur _||interact||link||microarray,1||2||3||gene 2 fig. 2||refer 1||2 diabet||1 log2||patient||cell||studi||1 gene ontolog||4 10||2 http://www.morphonom.net/ng/esm/r/si_references_2.rtf acknowledg||4 4 5 fig. 4 11||patient data,31046.0||28965.0||17044.0||16925.0||16864.5||15728.0||15527.0||13567.0||12627.0||12015.0||11954.667||9959.5||9892.0||9867.0||9268.0,0.0,0.2,0.13333333333333333
516,Ann_Surg_Oncol-3-1-2077912.txt,malign||pancreat endocrin tumor||locat||seer databas||durat||small insulinoma||tumor site||islet cell carcinoma||prognost factor||neoplasm||group||multivari analysi||studi||head||diseas||time||registri||diagnosi||age||surviv||seer stage||seer 9 registri||islet cell||pancrea||patient||epidemiolog||distant metastas||uncertain malign potenti||tumor||seer 17 registri||seer program||duoden gastrinoma||preval||data||seer||pancreat cancer||year,1||2||3||refer 1||2 year||2 test||2 fig||patient||patient characterist 2 1 tabl 2.||4||4 4||studi patient||studi||MD 4 1 depart||1 tabl 1.,31046.0||28965.0||17044.0||16864.5||16110.5||16085.5||14519.0||13567.0||13234.667||12937.0||12937.0||12791.0||12015.0||11813.25||11600.333,0.0,0.1,0.13333333333333333
517,Histochem_Cell_Biol-4-1-2228376.txt,molecular machin||reticulon||subcompart||plc||rough endoplasm reticulum||ser||bax||chaperon||ER subcompart||metabol||smooth domain||microtubul||enzym||associ||lipid||smooth endoplasm reticulum||analysi||protein||studi||ER fraction||plasma membran||domain||membran||smooth ER||fraction||rough||protein complex||ER protein||membran traffic||proteom||cell||data||marker||pathway||transit endoplasm reticulum||function,1 1 1||1||2||3 2||1 assess||2003 2006 2||4||cell||studi||1-514-3435755 jacques.paiement@umontreal.ca 2 1 département||calcium-handl protein 2||2006 2005||reticulon 3||2006 2004 2005||2006 2006 2005 2003,31046.0||31046.0||28965.0||23004.5||17002.0||14995.667||12937.0||12627.0||12015.0||12003.8||11751.333||8543.5||8527.0||8388.0||8277.25,0.0,0.2,0.13333333333333333
518,Med_Biol_Eng_Comput-3-1-2039845.txt,respons||thermocoupl||sampl rate||intratrach climat||vivo measur||respons characterist||leakag test||order||signal||step||cathet||humid||measur||decreas||hme||characterist||airway climat explor||time||air||increas||valu||respons time||frequenc||temperatur||system||overshoot||transport||central canal||total assembl||sampl cathet||tip||heat||calibr||sensor hous,1||2||2 3||6 2 2||2 3 fig. 2||1 year||3||refer 1||1 cm||H. 2||line 2||2 cm||2 hilger||f.hilgers@nki.nl 1 5 6 1 depart||patient,31046.0||28965.0||23004.5||22334.667||19987.5||17151.0||17044.0||16864.5||15761.0||15327.0||15125.0||14720.5||14488.0||14004.167||13567.0,0.0,0.0,0.0
519,J_Med_Internet_Res-8-3-2018828.txt,organ||day||internet searcher||survey||web||total||smoker||popul||estim||effect relaps prevent intervent||peopl||queri||studi||time onlin||particip||time||treatment||servic||smoke||reason||internet||quitnet||readi||search engin||onlin||individu||search||cessat||inform||data||year||rate||result,1||2 2||2||4 2 2||tabl 1 2 2||2 4||1 month 2||3||1 week||januari 1||appendix 2||patient||4||recruit result generaliz 2 2||tabl 1 comparison,31046.0||28965.0||28965.0||23622.333||23148.0||20951.0||20536.333||17044.0||16140.5||15588.0||14604.0||13567.0||12937.0||12890.8||12104.667,0.0,0.0,0.0
520,Virchows_Arch-4-1-2329727.txt,sdf1||colorect carcinogenesi||normal colon tissu||antigen retriev||surfac||area||CA IX||surfac epithelium||carcinoma||normal colon||tissu||pimonidazol||hif-1||cytoplasm||adenoma||express||akt||epitheli cell||activ||sdf-1||mtor||hypoxia||hypox cell||mammalian target||cell||presenc||normal mucosa||colorect mucosa,1||1 2||2||4 2||immunohistochemistri 1 2 3||factor 1||system 1||3||refer 1||ga.meijer@vumc.nl 1 1 depart||transport 1||2 number||1 detail||1 2 fijneman remond||patient,31046.0||30005.5||28965.0||20951.0||19299.5||17745.0||17365.0||17044.0||16864.5||16146.75||16000.5||15967.5||15793.5||15003.75||13567.0,0.0,0.0,0.0
521,Pediatr_Radiol-4-1-2292499.txt,postinfecti hydrocephalu||fluid||complic||subdur effus||brain||earli abscess||flow||evalu||infant||central nervou system infect||subarachnoid space||ventricl||studi||extra-axi fluid collect||import role||children||patient||brain sulci||bacteri mening||csf||neurolog find||sonographi||ventricul||find||mening||diagnosi||doppler,2 1 depart||refer 1||1 week||patient||springer-verlag 2008 introduct 1 2 4||studi||fig. 2 arrowhead||38039 turkey 2 depart||effect||initi studi||patholog studi||follow-up studi||baselin studi||2001||neurosonograph studi,20835.0||16864.5||16140.5||13567.0||12981.833||12015.0||11375.667||7873.0||6956.0||6675.5||6545.5||6528.5||6354.0||6313.0||6008.0,0.2,0.2,0.13333333333333333
522,Immunome_Res-1-_-1289288.txt,databas||bind||number||protein antigen||concentr||major histocompat complex||tcr||entri||sequenc||quantit specif data||mhc molecul||specif allel||experiment condit||mhc||protein||antibodi||vaccin||antijen||kinet||valu||blast search||peptid interact||system||archiv||immun system||databas system||link||epitop||method||peptid||complex||cell||data||immun||search method||interact||experiment method,1||1 2||2 1||2||tabl 1||1 21||2 8 2 7 5||50 2||jenpep 1||1 irini.doytchinova@jenner.ac.uk||class 1 class 2||2 2 microglobulin complex||4||24 2 12||cell,31046.0||30005.5||30005.5||28965.0||17331.0||17163.5||16289.0||15827.0||15525.5||15523.5||15307.25||14895.0||12937.0||12697.667||12627.0,0.0,0.0,0.06666666666666667
523,Eur_Arch_Otorhinolaryngol-3-1-2099165.txt,boy||lingual arteri||blood||mass||day||pseudoaneurysm||embolis||vessel wall||case||carotid arteri||posttonsillectomi haemorrhag||patient||fossa,1 1 depart||1 2 3 fig. 1 pseudoaneurysm||refer 1||2 3 4 5 6||2 week||patient||fig. 2 arteriographi||netherland 2 depart||5||right-anterior side fig. 3 2||springer-verlag 2008 introduct 1||4 day||7||unstabl patient||5 day,21528.667||18855.667||16864.5||15676.8||15100.0||13567.0||11316.333||11205.0||10364.0||10350.6||8997.25||7435.0||6997.0||6809.5||6148.5,0.0,0.1,0.06666666666666667
524,J_Med_Internet_Res-7-1-1550637.txt,databas||potenti||definit||medic informat||field||concept||order||journal||ehealth||research||analysi||broad rang||term||clinic data||articl||literatur||taxonomi||care||mesh||system||major||medlin||patient||alli health literatur||internet||medic subject head||telemedicin||scientif abstract||scientif||patient care||consum||gener theme||servic manag||hand||public||inform||commun technolog||organiz factor||broader literatur||clinic||topic||applic||medic informat literatur||research literatur,1||2||2 12||tabl 1||3||1 institut||provid 2||definit 1||biotechnolog 2||visn 2||patient||feb 1 2005||4||tabl 2 12||figur 2 number,31046.0||28965.0||17408.5||17331.0||17044.0||16244.5||15802.5||15768.5||14585.5||14483.0||13567.0||13331.333||12937.0||12811.0||11045.333,0.0,0.0,0.06666666666666667
525,Matern_Child_Health_J-2-2-1592139.txt,intervent||effect||outcom||program||health care provid||financi return||health plan||pregnanc||evalu||preconcept visit||cost||prenat care||birth||diabet||studi||perspect||birth defect||case studi||advers pregnanc outcom||health outcom||benefit||analys||care||women||servic||econom burden||public health program||preconcept||econom evalu||cost-benefit analysi||invest||preconcept care||individu||busi case||case||data||investig||result,1||3 3||refer 1||llc 2006 introduct 1 2||patient||type 1 diabet||studi||5||1 sotnikov sergey||25 3 3 25||41 3||2005||2006||2003||case studi,31046.0||17044.0||16864.5||13995.8||13567.0||12155.0||12015.0||10364.0||10350.0||10171.5||9293.0||8716.0||8371.0||7651.0||7594.0,0.0,0.1,0.13333333333333333
526,J_Neurol-3-1-1915612.txt,day||differ||whiplash||pain||effect||number||total||central nervou system||neck||neck pain||intens||va intens||signific differ||studi||muscl||btx||improv||treatment||whiplash syndrom||botulinum toxin||baselin||cervic rang||patient||week||central mechan||chronic pain||placebo group||placebo||placebo-control clinic trial||chronic whiplash syndrom||total pain||trial||va,1||2 1||2||2 2||1 1 1 3||3 2||2 3||2 4 1 4 2 3||1 2 3 7||4 0 0 2 1 2||7 2||1 year||3||refer 1||1 36,31046.0||30005.5||28965.0||28965.0||27545.5||23004.5||23004.5||21982.333||21013.0||19016.5||17981.0||17151.0||17044.0||16864.5||16384.5,0.0,0.0,0.0
527,J_Abnorm_Child_Psychol-3-1-1915644.txt,model||parent-child attach||effect guidanc||parent||mediat||variabl||behavior||factor||influenc||develop||complet longitudin model||score||infant||high level||research||questionnair||studi||domain||characterist||primari caregiv||qualiti||present studi||cognit abil||children||contextu characterist||longitudin model||signific||life||extern behavior||stress life event||famili||test||toddlerhood||low se||tempera||risk||high-risk sampl||earli predictor||attach||parent-child interact||problem||strang situat||predict||earlier find||lower level||ego-resili||teacher||assess||year||interact||se||predictor||path analysi||result||caregiv,1||2||2 2||2 2 df||fig. 2||1 tabl 1 intercorrel||SD 1||2 df||A. 3 1 depart||4||fig. 1 child||studi||netherland 2 depart||5||s0021963099005855 11039688 1,31046.0||28965.0||28965.0||19359.667||16970.5||16428.75||16164.5||14557.0||13524.0||12937.0||12504.333||12015.0||11205.0||10364.0||10349.333,0.0,0.0,0.06666666666666667
528,Behav_Genet-3-1-1914301.txt,respons||model||underestim||herit||genet||normal distribut||ceil effect||distribut||framework||number||effect||correl||varianc||non-shar environment varianc||varianc decomposit||approach||estim||twin||score||analysi||measur||irt||item respons theori||handl||simul||attent problem||classic test theori||latent variabl||paramet||varianc compon||item||individu||mcmc||data||measur error||sum score||trait||result||sum,1||2||1 1 depart||3||1998 2004 2004 1 1||age 2||2 1997||1 SD||σ 2||method 2004 2||4||1 fig 1 β paramet||1 simul result||2 2004 2006c||studi,31046.0||28965.0||21528.667||17044.0||16496.4||16265.0||16257.0||16164.5||14550.5||13571.333||12937.0||12720.0||12538.667||12351.0||12015.0,0.0,0.0,0.0
529,Purinergic_Signal-3-4-2072924.txt,kinet||singl channel||model,1||2||2007 1 2 3||4 2||1 receptor||1 3 receptor||refer 1||4 3||2 purinoceptor||2 25 2 26 9 4||1 9 10 12||studi||2007 2 4 7 receptor||4 5 6||pannexin 1 channel,31046.0||28965.0||21085.5||20951.0||17274.5||17197.667||16864.5||14990.5||14522.0||13694.333||12318.0||12015.0||11937.8||10791.667||10644.0,0.0,0.0,0.0
530,Biogerontology-3-1-2040177.txt,residu varianc||herit||effect||sex||index||correl||popul||group||biolog age||oss measur||analysi||measur||chuvashia||present studi||age||genet factor||sampl||age adjust||signific||parsimoni model||women||biomark||famili||gene||livshit||oss||individu||BA index||skelet||MG genotyp||segreg analysi||rate||investig||major gene,1||1 1||1 1 1 1||1 1 1 2||1 1 1 2 2 2||1 2 2 2 1 1||2 2 2||2||6 2 1 1||1 2 2 1 1995 3||result 1||2003 2||2007 2||1 1999||3,31046.0||31046.0||31046.0||30525.75||30005.5||30005.5||28965.0||28965.0||25032.75||23288.333||18563.0||18308.0||18126.0||17920.5||17044.0,0.0,0.0,0.0
531,Purinergic_Signal-3-4-2072912.txt,adenin receptor,1||2||1 achromobact achromobact 1 1||7 2||3||3 3 3||refer 1||1 summari||1 μg||contamin 1||2 ml||vitek 2||cell cultur 2||40-228-732567 christa.mueller@uni-bonn.d 1 3 1 univers||patient,31046.0||28965.0||18636.8||17981.0||17044.0||17044.0||16864.5||15734.5||15725.5||15631.5||14865.5||14485.0||14249.0||13799.167||13567.0,0.0,0.0,0.0
532,Surg_Radiol_Anat-3-1-1820760.txt,clavicl||sublux||area||angl||extern rotat||ratio||obstetr brachial plexu palsi||shoulder||muscl||width||deform||children||brachial plexu||superior trunk outlet||intern||paramet||height||patient||rotat||view||acromion||contralater side||scapula visibl||scapula,1||2||2 2||2 fig. 2||result 1||3||refer 1||2 2 16 16||shear grade 1 2||0.51 2||patient||3 fig. 3||4||tabl 1 detail||5,31046.0||28965.0||28965.0||20968.667||18563.0||17044.0||16864.5||16458.0||15202.75||14560.0||13567.0||13021.333||12937.0||11734.333||10364.0,0.0,0.0,0.06666666666666667
533,Bioinformation-2-2-2174421.txt,page||databas||categori||molecular biolog databas||global search||list||link||categori list||access||keyword||number||molecular biolog||data||entri||year 2005||javascript||user,1 2 3 4||figur 2||530016 2 depart||2006||4 depart||530003 3 depart||protein||result||year 2005||year 2004||biolog databas babu padavala ajay 1||data||function||time||research,22498.0||15083.0||10487.333||8371.0||7715.5||6514.0||6288.0||6080.0||5986.0||5666.5||5608.833||4969.0||4581.0||3941.0||3708.0,0.0,0.1,0.13333333333333333
534,Neurochem_Res-3-1-1794624.txt,demyelin||brain||white matter||pad||myelin protein||methyl||deimin||myelin||citrullin mbp||process||protein||studi||multipl sclerosi||dna||import role||apoptosi||increas||up-regul||posit charg||neurolog diseas||amount||data||arginyl residu||histon||mbp||citrullin||result||structur,2||1 fig. 1||refer 1||pad 2||patient||2 fig. 2 deimin pathway||studi||4 5||pad 2 gene||6 7 9 1 10 11||pad 2 regul||pad 2 promot||pad 2 enzym||pad 2 cluster||pad 2 label,28965.0||22356.0||16864.5||14564.5||13567.0||12848.8||12015.0||11650.5||11307.667||10757.0||10382.333||10005.333||9988.667||9882.667||9853.0,0.0,0.1,0.06666666666666667
535,Matern_Child_Health_J-2-2-1592147.txt,smoke||pregnanc,1||1 2 3||3 1 offic||suppl. 2||patient||4 5 4 6||http://www.ntrjournal.org/pregnancy.html. refer 1||2 barker diann||6||2004||als7@cdc.gov 1 melvin cathi||2003||2 s112 melvin CL||2 s217 s238 10.1080||2002,31046.0||25685.0||16094.333||14487.5||13567.0||11328.0||11243.333||9680.667||9074.0||8077.0||7764.25||7651.0||7339.75||7308.0||7057.0,0.0,0.0,0.0
536,Virchows_Arch-3-1-2082069.txt,tumor||lesion||paratesticular structur||true neoplasia||cyst||case||leydig cell||sertoli cell||neoplasia||structur||diagnosi||ectop tissu||testicular||benign mimick||testi||pseudotumor||mesotheli hyperplasia,2||fig. 1||refer 1||2 case||1 montironi||patient||34-93-4169730 falgaba@fundacio-puigvert. 1 2 mikuz||spain 2 depart||1 macroscop mimick||3 case||8 1 patholog section||2 microscop mimick||fig. 4||testicular inflammatory-react lesion 2 3 12||3 boccon-gibod,28965.0||18011.0||16864.5||16069.0||15525.0||13567.0||12003.2||10519.667||10377.333||10108.5||9788.0||9771.333||8956.5||8891.833||8523.5,0.0,0.0,0.0
537,Dev_Biol-1-5-2082130.txt,polaris||adjac cell||requir||wing||lack||core polar protein||development||stronger phenotyp||core||factor||cell polar||signal||clone||trichom||local coordin||protein||tissu||failur||polar||asymmetri||activ||rotat||intercellular commun||commun||planar polar||distal cell edg||localis||complex||cell||transgen||apf||interact||result||function,1||2||3||fig. 2||1 lawrenc||dsh 1||1 perrimon||1 fig. 5||figs. 2||cell||fz fig. 1||supplementari fig. 2||fig. 2 stbm||fig. 2 fig. 2 fz stbm||fig. 2 gubb,31046.0||28965.0||17044.0||16970.5||15598.0||15557.0||15528.5||15462.0||14519.0||12627.0||12051.667||11577.667||11370.667||11364.333||11317.667,0.0,0.1,0.06666666666666667
538,Mol_Genet_Genomics-4-1-2413074.txt,cell wall||alpha-amylas||group||sequenc||amyr||maltos||enzym||analysi||protein||agdb||present||studi||aspergilli||glucan||starch||homologu||glucoamylas||similar||express||member||famili||gene||fungi||phylogenet analysi||strain||starch-bind domain||presenc||transfer||result||function,1||1 2||2||2007 1||1 A.||1 3 A.||3||tabl 2 1 access||1 2 bootstrap valu||2 identif||2005 fig. 1 A.||studi||supplementari tabl 1||31-71-5274999 a.f.j.ram@biology.leidenuniv.nl 1 1 clusiu laboratori||1 kb upstream,31046.0||30005.5||28965.0||19166.5||17279.0||17200.667||17044.0||16213.75||15694.25||14895.0||12062.5||12015.0||11818.0||10473.333||10437.0,0.0,0.0,0.06666666666666667
539,Biochim_Biophys_Acta-2-1-2225445.txt,whole-cel extract||dna-pk||thymu||nuclear extract||immunoprecipit||thymic epitheli cell||phosphoryl||protein||Ku 80||domain||antibodi||phd finger||air||kinas||panel||express||mutat||activ||apec||gene||posit control||phd||site||cell||chromatin,1||2 2||2 2 2||2||3||fig. 2||2 materi||vivo fig. 2 fig. 2||4||cell||studi||fig. 3||5||2004 32 1 10 14704337||6,31046.0||28965.0||28965.0||28965.0||17044.0||16970.5||15325.0||13743.6||12937.0||12627.0||12015.0||11010.0||10364.0||9659.6||9074.0,0.0,0.1,0.06666666666666667
540,Ann_Biomed_Eng-2-2-1705476.txt,captur||detect||filament||specif||pathogen||posit||solut||peak||chamber||antibodi||time||laser||simpl bar code system||pathogen detect||viru||fara||test||decis tree||reaction chamber||strain||fluoresc||captur antibodi||level||region||classif,1||1 1 1 1||1 2||2||1 figur 2||1 11||10 2||13 1||result 2||level 1||3||type 1||refer 1||level 2||1 block,31046.0||31046.0||30005.5||28965.0||20404.0||18048.5||17973.5||17654.0||17522.5||17126.0||17044.0||16987.0||16864.5||16085.5||15829.0,0.0,0.0,0.0
541,Neuroradiology-3-1-2151779.txt,aneurysm||hour||logist regress analysi||min||anterior cerebr arteri||procedur time||support devic||vessel||intracrani aneurysm||angiograph run||diagnost angiograph run||procedur||patient||time||logist||coil||predictor||devic||occurr,1||2 1 depart||refer 1||patient||result 1 fig. 1 procedur time||15-min time period 1 2||4||1 procedur time||studi||netherland 2 depart||springer-verlag 2008 introduct 1 3||3 year||2 odd ratio||6||method patient,31046.0||20835.0||16864.5||13567.0||13079.667||13013.0||12937.0||12125.333||12015.0||11205.0||10606.6||10150.0||10012.667||9074.0||8619.5,0.2,0.1,0.06666666666666667
542,BMC_Fam_Pract-4-_-169167.txt,day||primari care||access||routin||number||mind||primari care organis||practic||elect appoint||appoint||approach||develop||organis||measur||numer data||questionnair||term||articl||time||literatur||appoint data||care||compat system||patient||definit problem||method||clinician||search||broad approach||data||survey techniqu||demand,1||1 2 3 5||day 1||patient||tabl 1 comparison||studi||UK 2 depart||5||tabl 2 patient survey instrument||gener practic 6 1 10 11||6||patient care||figur 1 aro score||6 7||appoint system data 1 summaris,31046.0||21854.75||16489.5||13567.0||12104.667||12015.0||10778.333||10364.0||9502.0||9379.833||9074.0||8672.0||8591.75||8035.5||7961.4,0.2,0.1,0.06666666666666667
543,Matern_Child_Health_J-2-2-1592157.txt,intervent||hiv transmiss||effect||outcom||insur||percentag||behavior||pregnanc||opportun||preconcept period||hiv||factor||state||unit state||infant health||birth||brfss||alcohol consumpt||alcohol||major health risk||birth defect||advers pregnanc outcom||women||hiv test||preconcept||risk||indic||preconcept care||risk factor||inform||data||folic acid||health||current smoke,2||result 1 2||2 8||3 3||3||refer 1||1 comparison||1 serv||4 4||statist method 1||studi||5||2 health risk indic||6||2005,28965.0||22030.333||17559.5||17044.0||17044.0||16864.5||16349.0||15654.5||12937.0||12099.0||12015.0||10364.0||10074.75||9074.0||8716.0,0.0,0.0,0.0
544,Virchows_Arch-3-1-2151131.txt,cancer||target||human diseas||group||approach||develop||mirna express||oligonucleotid||differenti||human genom||protein||normal tissu||microrna||apoptosi||author||express||pathogenesi||gene||human protein||role||mirna||dna sequenc||cell prolifer||cell||case||antisens therapi||malign transform||function,1 1||2||3||refer 1||2 20||patient||cell||studi||cancer cell||human cancer cell cancer||2007||cell growth||cancer||differenti cell||parkinson patient,31046.0||28965.0||17044.0||16864.5||16691.0||13567.0||12627.0||12015.0||9851.5||7752.0||7287.0||7267.5||7076.0||6909.0||6883.5,0.0,0.1,0.13333333333333333
545,J_Membr_Biol-2-2-1764598.txt,synapt ribbon||mechan||number||exocytosi||hair cell||capacit measur||mous||function pool||vesicl||channel||compon||hair cell exocytosi||synapt bodi||protein||studi||neurotransmitt||auditori nerv fiber||ribbon||evid||immumoact||hair cell synaps||increas||synapt transmiss||molecular dissect||releas||system||synapt relev||activ zone||synaps||calcium||find||larg number||cell||pool||ribbon synaps||rate||sound,1||2||2004 1||2005 2||2004 2||2001 2||2000 2||2005 2 figur 2||1 size||1 3 lenzi||1 edmond||1 beutner||1 schnee||1 safieddin||1 shnerson,31046.0||28965.0||19561.5||18840.5||18521.0||17639.0||17434.0||16961.75||16107.0||16035.0||15537.5||15531.5||15528.5||15527.0||15525.0,0.0,0.0,0.0
546,Biochem_Biophys_Res_Commun-1-5-1899526.txt,valu||sensit||anion||cell||data||experi||channel||human atrial cardiomyocyt||myocyt||atrial myocyt||chlorid current||drug-contain solut||heart||solut,1||1 2 2||2||2 2 2 2 2||1 2 3 4 3||tabl 1 2||2 4||0.5 2 2||8 1||fig. 1 fig. 1||fig. 1||fig. 1 fig. 2||tabl 1 tabl 1 tabl 1||3||fig. 2,31046.0||29658.667||28965.0||28965.0||21407.2||21209.0||20951.0||19568.0||18600.0||18011.0||18011.0||17490.75||17331.0||17044.0||16970.5,0.0,0.0,0.0
547,Eur_Arch_Otorhinolaryngol-4-1-2279156.txt,phpt||parathyroidectomi||forget||improv||surgeri||treatment||success parathyroidectomi||asymptomat primari hyperparathyroid||subject symptom||prospect studi||questionnair||concentr||asymptomat phpt||patient||symptom||subject neuropsycholog symptom||depress||medic observ||result,2||0 1 2||1 5||1 year||1 case||refer 1||2 comparison||suppl 2||method 1 fig. 1 pt||patient||4||patient 25 6 17 2||patient 25 10 10 5 2||patient 25 17 6 2 uneasi||improv gener health 1 year,28965.0||22034.667||20705.0||17151.0||17109.5||16864.5||15308.5||14901.5||14172.2||13567.0||12937.0||11697.6||11693.167||9748.833||8883.8,0.0,0.1,0.06666666666666667
548,Oecologia-4-1-2373415.txt,swan||fulltofta bay||speci||water depth||treatment||tuber||distribut||graze intens||ramet||plot||plant||intermedi depth||veget commun,1||2||2 2||1 5||5 2||nl 2 1 limnolog||2 2 P. pectinatu||4||studi||5 4||1 5 P. perfoliatu||5||P. pectinatu 2||4 fig. 4||sweden 2 centr,31046.0||28965.0||28965.0||20705.0||19664.5||15009.75||15002.5||12937.0||12015.0||11650.5||10871.5||10364.0||10348.333||10283.333||9950.0,0.0,0.0,0.0
549,Eur_J_Appl_Physiol-4-1-2225999.txt,heart rate||respons||food intak||cortisol||amylas||satieti||orosensori stimul||hip circumfer||session||measur||sensori rate||relat||cortisol level||increas||food intak regul||lf-to-hf ratio||hunger||full||oral activ||food||waist-to-hip ratio||subject||blood pressur||eat||human||level||desir||min,2||result 2 1 1||fig. 2||1 kg||63 2||263 fig. 1||studi||1 anthropometr valu||fig. 3||saliva biochemistri 2||3 month||fig. 4||netherland 2 wageningen UR||effect||protein,28965.0||24284.25||16970.5||15762.5||14963.0||12068.0||12015.0||11269.333||11010.0||9806.0||9321.0||8956.5||7814.25||6956.0||6288.0,0.0,0.0,0.0
550,Eur_J_Pediatr-3-1-1820762.txt,congenit||parent||normal phenotyp||normal plasma||normal individu||polyclon antibodi||adamts13||plasma||studi||condit||antibodi||hu||sampl||mutat||assay||activ||heterozyg carrier||von willebrand factor||patient||vwf||sds-page||ttp||method||thrombot thrombocytopen purpura||immunoblot||result||proteas,1||2||patient 1||1 clinic||3||refer 1||lane 1||patient 3||pregnanc 2||endotheli cell 1||2 zhou wenhua 2||patient||patient 4||1 15 17||4,31046.0||28965.0||22306.5||17952.0||17044.0||16864.5||15669.5||15305.5||14944.0||14809.667||14523.25||13567.0||13252.0||13068.667||12937.0,0.0,0.0,0.06666666666666667
551,J_Gastrointest_Surg-3-1-1852373.txt,tumor||nodal involv||cohort||surviv||lymphadenectomi||number||outcom||analysi||dismal prognosi||stage||node||patient||studi||lymph node||patholog stage||impact,1||1 2||2||node 1 1 2||0.001 1 2||0 2||3||refer 1||0.001 1||esophagogastr 1 figur 1||0.001 1 0.118 1||unknown 1||stage 3 2||1 demograph||2 histolog,31046.0||30005.5||28965.0||22944.5||20385.333||17529.0||17044.0||16864.5||16095.5||15825.0||15812.25||15734.0||15728.0||15622.5||14705.0,0.0,0.0,0.0
552,Histochem_Cell_Biol-4-1-2323033.txt,receptor||cancer||mechan||bind||regul||fusion||alpha-hel bundl||mous||form||placenta||cell fusion||protein||import||membran||express||membran microdomain||syncytin||gene||tumor||macrophag||cell||fusogen||cancer cell||molecul||host cell,1||2||fig. 3 2||syncytin 2||cell||fig. 2 fish||cancer cell||2005||2004||2005 2007 2007||2003||tumor cell||breast cancer cell||tumor cell 2007 2007 2007||2007,31046.0||28965.0||16995.0||14492.5||12627.0||11394.333||9851.5||8716.0||8077.0||7763.333||7651.0||7638.0||7469.667||7427.4||7287.0,0.2,0.2,0.13333333333333333
553,Clin_Rheumatol-3-1-2071969.txt,ear pain||involv||cogan||hear loss||patholog uptak||test||syndrom||pet||large-vessel vascul||white cell||wall,2 3||1 fig. 1||refer 1||patient||A. W. 2 1 depart||studi||4 5||netherland 2 depart||hans.balink@znb.nl 1 bruyn||6||clinic rheumatolog 2007 introduct 1||10||thirteen patient||white cell||red cell,23004.5||22356.0||16864.5||13567.0||13372.8||12015.0||11650.5||11205.0||10352.0||9074.0||8927.0||6982.0||6798.0||6679.5||6588.0,0.0,0.0,0.06666666666666667
554,Curr_Genet-4-1-2413079.txt,vivo||luciferas imag||signal||cultur||luminesc||express||bioluminesc||activ||cell||report||luminesc imag||assay sensit||arginin,1||2||1 6||mühlenberg 1||panel 2||3 4 4||cell||1 2 4 luc luc 1989||studi||r-luc psad 2 3||5||6||2005||g-luc 4 4||4 day,31046.0||28965.0||20060.0||15523.5||14740.5||14306.0||12627.0||12348.667||12015.0||11514.0||10364.0||9074.0||8716.0||8644.667||7435.0,0.0,0.1,0.06666666666666667
555,Matern_Child_Health_J-2-2-1592148.txt,intervent||hypertens||locat||access||effect||servic coordin||program||resourc||preterm birth||internat visit||import opportun||pregnanc||postpartum care||care coordin||chronic hypertens||risk assess||six-week postpartum visit||infant||nutrit risk||research||matern||birth||internat care||import||recurr||health promot||etiolog pathway||children||psychosoci support||women||servic||famili||week||clinic intervent||on-go care||oral health servic||internat period||preconcept care||content||addit support||support||problem||visit||weight problem||folic acid||preterm deliveri||health,1||2||llc 2006 1 2||3||refer 1||3 stress 1||support 1||pregnanc 1||37 3 2||acog 1||aap 1||ama 1||hp2010 1||2 week||epa 2,31046.0||28965.0||17170.25||17044.0||16864.5||16437.0||16410.0||15984.5||15929.0||15547.0||15534.0||15528.5||15525.0||15100.0||14540.0,0.0,0.0,0.0
556,J_Behav_Med-3-1-2080858.txt,suppress||memori||differ||gener approach||scale||feel||self-conceal||emot control||restraint||definit||report||distress||repression-lik concept||concept||traumat event||awar||social situat||person||research||peopl||attempt||other-decept||tendenc||term||studi||defens||self-imag||denial||non-express||repress||neg emot||emot||self-decept||repress memori||posit aspect||act||aspect||social phobia||individu||style||neg feel||divis||alexithymia||find||repressor||empir find||type||level,1||2||1 fig. 1||3||patient||4||studi||2 weinberg ’s||defens 1990 1 1979 2 1990||cancer patient||1 1990 1988 2001||2005||control studi||0021-843x.88.4.369 479459 1 1990||2004,31046.0||28965.0||22356.0||17044.0||13567.0||12937.0||12015.0||10683.667||10569.833||10321.5||9949.25||8716.0||8209.5||8114.25||8077.0,0.0,0.1,0.06666666666666667
557,Eur_J_Epidemiol-4-1-2226058.txt,age||individu||hr||hdl-cholesterol||analys||rotterdam studi||effect||genotyp||lower risk||overweight||chd mortal||normal weight individu||normal weight||mortal||studi||year||risk||relat||particip,1||2||1 4||2 apo 2||3||refer 1||1 apo||0.14 2||2 apo||2 carrier||31-10-4089382 c.vanduijn@erasmusmc.nl 1 1 depart||2 fig. 2 apo genotyp||studi||26 suppl 1||netherland 2 depart,31046.0||28965.0||21991.5||19385.333||17044.0||16864.5||15636.0||14616.0||14595.5||14593.5||12918.0||12712.8||12015.0||11497.333||11205.0,0.0,0.0,0.06666666666666667
558,Clin_Auton_Res-3-1-1914255.txt,leg||doppler ultrasound||superfici femor arteri||blood flow||head-up tilt||posit||tilt angl||blood flow measur||DU measur||angl||techniqu||strain gaug plethysmographi||agreement||venou occlus plethysmographi||measur||vop||studi||increas||cbf||supin posit||superfici femor blood flow||hut||method||subject||reproduc||venou occlus||venou occlus pressur,1||2||fig. 1||refer 1||2 minut||2 3 fig. 2 blood flow||patient||1 25 8||4||1 18 25||3540535 m.hopman@fysiol.umcn.nl 1 1 dept.||studi||5||head-up tilt 2||netherland 2 rehabilit centr,31046.0||28965.0||18011.0||16864.5||14547.5||13823.167||13567.0||13499.667||12937.0||12758.0||12427.6||12015.0||10364.0||9678.667||8002.25,0.0,0.0,0.06666666666666667
559,Plant_Mol_Biol-4-1-2295252.txt,abaxi trichom||light||day||number||arabidopsi||plant||t-dna||averag||order||signific differ||apic domin||success||juvenil||flower||gene||mutant||leaf initi||veget phase chang||plastochron||shoot develop||line||singl mutant||rosett||phase chang||leaf,1||2 2 2||2||3||1 allel||spl15 1||1 19.5||1 transposon||2 mm||2 18.9||2 pla1||supplementari fig. 1||tabl 1 spl9||3 treatment||1 14.3 1.1,31046.0||28965.0||28965.0||17044.0||15680.0||15583.0||15543.0||15527.5||14896.0||14506.0||14484.0||12271.333||11592.333||11028.0||10485.333,0.0,0.0,0.0
560,Environ_Health_Perspect-116-2-2235228.txt,prenat exposur||chi-squar test||meta-analysi||statist||estim||random-effect model||estrogen||sensit analysi||de exposur||associ||testicular cancer||studi||endocrin disrupt||heterogen||time||qualiti||exposur||hypospadia||test||risk||subset||oral contracept||method||public||pharmaceut estrogen||uniti||diethylstilbestrol||cryptorchid||de||summari estim||environ||result,1||2||tabl 1||tabl 2||1 1.10||2 voulvouli nikolao 1 1 centr||2 2.53||1 june 2005||studi||utero tabl 1||cohort studi 2 1.04||5||de 2 1.10||estrogen receptor 1 gene||context 2 egger,31046.0||28965.0||17331.0||16290.5||15572.5||15301.333||14496.5||13298.0||12015.0||11565.333||10430.0||10364.0||10124.667||9912.75||9757.667,0.0,0.1,0.06666666666666667
561,J_Fluoresc-3-1-1915606.txt,light||sec||protein aggreg||aggreg||normal||solut||peak||size exclus chromatographi||experiment autocorrel function||fluoresc correl spectroscopi||room temperatur||measur||protein||buffer||irrevers denatur||time||increas||sampl||sensit||temperatur||experi||experiment setup||fluoresc intens||sensit detect||denatur protein aggreg||focal volum||fluoresc spectroscopi||fluoresc||nile red||heat||dye fluoresc||analyt detect||data analysi,1||1 2||2||2 2||1 2 37||6 2||7 2||8 2||3||refer 1||1 SD||2 25||τ 1||1 τ||1 nM,31046.0||30005.5||28965.0||28965.0||20596.333||19019.5||17981.0||17559.5||17044.0||16864.5||16164.5||16132.0||15654.0||15654.0||15579.0,0.0,0.0,0.0
562,Ann_Biomed_Eng-2-2-1705482.txt,optim clinic protocol||heat rate||injuri||differ||pt||thermal histori||data point||hold||activ energi||total time||total treatment time||clinic thermal therapi protocol||total number||tissu||studi||break point||non-isotherm portion||hold time||time||increas||valu||surviv||treatment||signific||temperatur||signific amount||thermal therapi||cell surviv||rise||drop||tumor||arrheniu paramet||hr||heat||cell||energi sourc||data||applic||hold period||result||min,1||2||1 4||1 figur 1||stage 1 1||1 5||1 6||1 8||2 7||1 15||1 16||tabl 1||3||refer 1||1 31,31046.0||28965.0||21991.5||21097.667||21089.0||20705.0||20060.0||18600.0||17981.0||17811.5||17498.5||17331.0||17044.0||16864.5||16599.5,0.0,0.0,0.0
563,Ann_Surg_Oncol-4-1-2190337.txt,cancer||differ||center||outcom||neoadjuv treatment||hospit||high-volum center||group||multivari analysi||case-mix||volum||stage||tumor stage||esophag resect||studi||clinic data||ptnm stage||diseas||adjust||surviv||treatment||comorbid||patient||resect||lvh||in-hospit mortal||hospit volum||high-volum hospit||import determin||hvh||origin patient file||procedur||data||risk adjust||mortal||result,1||2||4 1 6 1||4 1 2 1 complic||phd 1 1||2 1 14 3||2 1 6 1 stage||5 2 1 0||8 2||3||2 1 1 0 tumor local||refer 1||3 4 tabl 2||9 3 6 1||surviv 2,31046.0||28965.0||21025.75||20974.2||20773.0||20338.0||20261.2||19117.0||17559.5||17044.0||16875.833||16864.5||15640.5||15639.0||15091.0,0.0,0.0,0.0
564,Osteoporos_Int-3-1-1820755.txt,intervent||exercis||differ||balanc train program||firm surfac||unstabl surfac||osteoporosi||exercis program||effect||condit 5||number||fall||program||sensori condit||mobil||group||adher||ctsib||research||eye||studi||clinic data||fractur||improv||signific||women||control||test||patient||final evalu||risk||home-bas exercis program||train||visual conflict||initi evalu||balanc||walk||result,1||2||result 1||1 data||3||2 data||2 group||refer 1||condit 1||condit 2||55-11-30617490 rosamariarp@yahoo.com 1 2 1 divis||2 24.39||patient||4||studi,31046.0||28965.0||18563.0||18007.5||17044.0||16967.0||16920.0||16864.5||16446.0||15405.5||15223.0||14483.0||13567.0||12937.0||12015.0,0.0,0.0,0.13333333333333333
565,Ann_Biomed_Eng-2-2-1764593.txt,model||gene express||speci||bind||low calcium concentr||calcineurin||nucleu||dephosphoryl||target||averag||ikk||factor||oscil||transloc||cytoplasm||nuclear local signal||increas||export||express||oscil frequenc||sensit||system||activ||control||gene transcript||rise||period||experiment result||show||nfat||calcium||complex||calcium concentr||steadi state||cell||data||rate||initi||result,1||2||2 2||1 2 yang||1 10||1 12||1 7 14 2||1 14||8 2||1 22||3||refer 1||2 14||1 32||1 34,31046.0||28965.0||28965.0||20121.667||19014.0||18449.0||17826.25||17671.5||17559.5||17114.5||17044.0||16864.5||16631.0||16619.0||16417.0,0.0,0.0,0.0
566,Sex_Abuse-2-2-1764595.txt,intern consist estim||sexual interest||male||self-report sexual arous||correl||photograph||intern consist||offend||group||adult femal||categori||view time||femal children||auc||sexual offend||research||affin||interest||studi||affin self-report rate||particip||age||children||adolesc||self-report||ppg||femal toddler||prepubesc children||experi||male child victim||letourneau||VT approach||sexual arous||individu||devianc index||procedur||victim||data||assess||adult||rate||sexual attract,1||2||jworling@ican.net 1 2 1||fig. 1||3||1 graph||valid 2||79 2||2 graph||law 2005 1 1 10 gray||4||studi||type 1 error||1 devianc indic||5,31046.0||28965.0||22764.5||18011.0||17044.0||15578.0||14994.0||14833.0||14537.5||13034.0||12937.0||12015.0||11581.0||11136.667||10364.0,0.0,0.0,0.06666666666666667
567,J_Gastrointest_Surg-3-1-1915599.txt,model||rout||effect||anim speci||intestin motil||biliopancreat duct||intestin flora||anim||acut pancreat||pancreat||organ sampl||studi||duoden content||diseas||bacteri transloc||immun respons||mucos barrier function||bacteria||sever||treatment||immun system||treatment strategi||infect||laboratori anim||sever acut pancreat||rat||human||fals posit result||anim model||bacteriolog result||reproduc||earli mortal||experiment studi||result,2||12 15 2 2||refer 1||1 characterist||31-30-2531944 l.m.a.akkermans@umcutrecht.nl 1 2 1 depart||acut pancreat 1 2||h.timmerman@chir.azu.nl 1 2 visser||drs.m.blom@gmail.com 1 2 timmerman||lpvminnen@gmail.com 1 2 blom||h.gooszen@umcutrecht.nl 1 2 akkerman||2 aspect||patient||studi||netherland 2 depart||R. 2 gooszen,28965.0||17089.75||16864.5||16168.5||15592.167||15420.25||15029.75||15010.0||15009.5||15004.75||14753.0||13567.0||12015.0||11205.0||10276.667,0.0,0.0,0.06666666666666667
568,Cancer_Immunol_Immunother-3-1-2150634.txt,respons||pbmc||elispot||assay outcom||choic||survey||intern site||recoveri||panel particip||elispot assay||antigen||cmv||protocol choic||abil||report||dri ice shipment||group||strategi||criteria||perform||intern locat||plate||studi||particip||figur||immun monitor||immun assay||panel||donor||assay||spot||low background||repeat||weak respond||protocol||common sourc||cell recoveri||laboratori||harmon||valid||guidelin||profici panel||cell||valid practic||central lab||serum||immun||result,1||2 1||2||3||suppl 1||1 88||panel 1||reagent 1||panel 2||1 cell recoveri||1 fig. 1 initi guidelin||patient||4||cell||studi,31046.0||30005.5||28965.0||17044.0||15942.0||15886.0||15781.0||15593.0||14740.5||14713.667||13816.2||13567.0||12937.0||12627.0||12015.0,0.0,0.0,0.13333333333333333
569,J_Med_Internet_Res-5-4-1550572.txt,page||survey||web||behavior||factor||person||attempt||school||studi||correct||time||success||health educ||similar||qualit data||question||observ||adolesc||internet||link||comput literaci||issu||content||site||inform||adolesc searcher||adult||topic||answer||result,1||2||tabl 1||3||2 case||1 question||answer 1||1 word||1 hour||2 question||4||tabl tabl 1||discuss 15 1 2 15 15||2 9.5 diabet 1 4.8||studi,31046.0||28965.0||17331.0||17044.0||16069.0||15952.0||15690.5||15670.0||15666.0||14911.5||12937.0||12759.333||12573.833||12547.4||12015.0,0.0,0.0,0.06666666666666667
570,Int_Urogynecol_J_Pelvic_Floor_Dysfunct-4-1-2259253.txt,stress urinari incontin||pad||pregnanc||group||measur||symptom||studi||weight gain||diagnost strength||childbirth||sever||women||test||self-report symptom||incontin||pad test||curv||data||clinic relev||urinari incontin||result,1||2||1 1 depart||2 fig. 2||refer 1||4||discuss 1 18||studi||pad test 1 fig. 1 distribut||1 aarnouds jan||4 fig. 4||fig. 3 distribut||2003||patient histori||2002,31046.0||28965.0||21528.667||20968.667||16864.5||12937.0||12225.333||12015.0||12000.167||10393.333||10283.333||7861.0||7651.0||7173.5||7057.0,0.0,0.1,0.06666666666666667
571,Matern_Child_Health_J-2-2-1592144.txt,access||famili plan servic||percentag||pregnanc||state||facil||care||women||servic||famili||reason||underutil||pregnanc plan||healthi infant||preconcept care||famili plan||method||problem||visit||data||avail||inadequ attent||commun health center||attent||counsel,2||refer 1||studi||famili plan 1||6||2005||birth 3 pregnanc 4 5||2006||limit contracept method 1 14||2004||2002||7 8||result||2000||activ,28965.0||16864.5||12015.0||11161.667||9074.0||8716.0||8376.6||8371.0||8137.8||8077.0||7057.0||6575.5||6080.0||5903.0||5231.0,0.0,0.0,0.0
572,Ann_Biomed_Eng-2-2-1705544.txt,explant||differ||dynam compress||tissu engin bioreactor||incub||abil||usa||pressur||gag||actuat||media||greater PG breakdown||displac control||bioreactor||stress||studi||densiti||compress||breakdown||pressur film||larg load||sampl||menisc tissu||load||system||PG breakdown||mechan stimuli||test||stress level||standard||strain||linear bear||cell death||mechanotransduct||film||physiolog load||meniscectomi||result||load cell||mpa||level||deep zone||meniscu||cycl||displac,1||2||2 2 figur 2||tabl 1||3||tabl 2||1 Hz||18 3 4 2 figur 4||bioreactor 1 μ figur 1||studi||system 5 1 figur 5||9 2 10 3 figur 9||5||tabl 3||system 3 figur 3,31046.0||28965.0||22024.0||17331.0||17044.0||16290.5||15616.0||12835.5||12714.2||12015.0||11331.8||10829.333||10364.0||10330.0||9743.25,0.0,0.1,0.06666666666666667
573,Breast_Cancer_Res_Treat-3-1-2137941.txt,cbc||cancer||age||mutat||treatment||atm||radiotherapi||age 50||women||spectrum||breast tumour||analysi||carrier||variant||patient||studi||missens variant||ubc||breast cancer||tumour,1 2 1 divis||mutat 3 2 1||v410a 2 1 4||refer 1||a1309t 1 1 16||p884 1||r337c 1||s377g 1||m779t 1||l1493v 1||l1555h 1||l1574f 1||m2482i 1||d2625g 1||h2887d 1,22834.0||19580.75||18237.25||16864.5||16511.0||15524.0||15523.5||15523.5||15523.5||15523.5||15523.5||15523.5||15523.5||15523.5||15523.5,0.0,0.0,0.0
574,J_Gastrointest_Surg-3-1-1852388.txt,gland||long-term endocrin||neck||oper||middl pancreatectomi||exocrin pancreat function||main pancreat duct||middl segment pancreatectomi||exocrin function||patient||median pancreatectomi||risk||tumor||distal transect||segment||procedur||low-grad malign tumor||case||benign||mortal||surgeon,1 3||1 6 10 1 3||refer 1||2 3 10 12||patient||1 3 27 31||1 6 1 21 32 34||13 patient||53 patient||older patient||well-select patient||intern studi group||pilot studi||result||5 cm,24045.0||19038.4||16864.5||14710.75||13567.0||13163.75||13071.167||8914.5||7342.5||6962.0||6785.5||6209.0||6111.0||6080.0||5420.0,0.2,0.1,0.06666666666666667
575,BMC_Bioinformatics-4-_-521197.txt,statist signific||organ||model||random sequenc||distribut||number||stop||put gene||length||rb||order||hidden markov model||sequenc||state||probabl||glimmer||perform||score||protein||background state||fals posit||order markov chain||emiss probabl||markov model||orf||similar||signific||raw genom||test||gene||linear regress||tabl||cumul normal distribut||train||challeng||method||start||real gene||set||hmm||model paramet||codon,1||1 1||2||3 2||1 8||tabl 1||3||2 A.||figur 1||order 1||variat 1||varianc 1||11 4 2||1 Mb||order 1 336 2,31046.0||31046.0||28965.0||23004.5||18600.0||17331.0||17044.0||16238.5||16123.5||15950.0||15898.5||15710.0||15651.0||15529.5||15248.0,0.0,0.0,0.0
576,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2413120.txt,exact sig||differ||effect||number||arthroscop view||percentag||comparison||knee joint||group||oper||analysi||loos fibrou tissu||signific differ||studi||turbid||time||qualiti||arthroscopi||frame||view||disturb||arthroscop pump system||result||presenc||type||time-disturb analysi||straightforward arthroscop knee surgeri,1||2||result 1 1 2||1 1 depart||2 fig. 2||3||refer 1||1 match||method 2 4||22.2 2||11 11 1 11 fig. 1||patient||3 fig. 3||4||studi,31046.0||28965.0||24284.25||21528.667||20968.667||17044.0||16864.5||15669.5||15191.333||14505.5||13703.5||13567.0||13021.333||12937.0||12015.0,0.0,0.0,0.06666666666666667
577,J_Comput_Aided_Mol_Des-3-1-2039848.txt,fadrazol||substrat||metyrapon||model||molecular dock||steric fit||helix||backbon atom||molecular dynam||natur substrat||select||crystal structur||substrat bind||protein||hydroxyl distanc||templat structur||amino acid||steroid||similar||inhibitor potenc||hydroxyl||aldosteron synthesi||protein-inhibitor interact||isoform||cyp11b1||cyp11b2||method||inhibitor||carbon atom||aldosteron||cell||hydroxyl group||activ site||region||interact||result||structur,1||2||1 mL 1||1 65 2||3||refer 1||24 2||1 amino||1 mL||55 2||patient||2007 introduct 1||4||cell||2 valid result,31046.0||28965.0||20741.333||20334.667||17044.0||16864.5||16120.5||15739.0||15589.0||15098.0||13567.0||13210.333||12937.0||12627.0||12022.667,0.0,0.0,0.06666666666666667
578,Cogn_Process-4-1-2254470.txt,memori||cognit control||retent||mechan||synchron||relev inform||brain||abil||instanc||neuron||assembl||posterior cortex||automat process||behavior||interdepend function||area||episod buffer||order||cortex||posterior part||represent||process||activ state||recurr connect||stimuli||evid||unit||time||pattern||integr||neural model||task||cell assembl||mainten||simul||sensit||control||activ||pfc||role||prefront cortex||modul||neural pattern||complex||find||inform||input||cell||attent||level||recurr loop||interact||coher||function,1||2||2003 2003 1||2 1993a||2001 2 fig. 2 ipsp||cell||studi||netherland 2 univers||4 4 fig. 4||2005||2006||2000 2000 5 5||2003||5 1999 fig. 5||2005 2001,31046.0||28965.0||15449.333||14487.5||13844.2||12627.0||12015.0||11592.667||10946.75||8716.0||8371.0||8133.5||7651.0||7624.75||7514.5,0.0,0.1,0.06666666666666667
579,Microbes_Infect-2-1-2426737.txt,vesicular traffic||sequenc||function||motif||analysi||intracellular parasit||upstream region||specif||famili||apicomplexa||protein||transcript||gene||cluster||rab gtpase||parasit||rab||express profil,1||2||3||cluster 1||1 tp01||langsley@cochin.inserm.fr 1||meyerhofstrass 1||chromosom 2||2 tp02||4||nuclear protein 1||cell||fig. 3||2 P. falciparum||5,31046.0||28965.0||17044.0||15782.5||15527.5||15524.0||15523.5||14693.5||14485.0||12937.0||12719.0||12627.0||11010.0||10380.333||10364.0,0.0,0.0,0.0
580,Ann_Surg_Oncol-3-1-2039827.txt,treatment cycl||day||total||dose||pcr||endopelv fascia||phase II studi||chemoradi||oxaliplatin||delay||radiotherapi||studi||surgeri||patient||week||resect||dlt||maximum-toler dose||tumor||rectal cancer||capecitabin||local recurr rate||result,1||2||2 2||5 2 2||1 patient||2 patient||toxic 2 2 2 tabl 2||38 2 2||result 2||3||day 1||1 1 medic oncolog||method 2||87 1 3||1 week,31046.0||28965.0||28965.0||22764.667||22306.5||21266.0||19963.667||19841.333||17522.5||17044.0||16489.5||16434.0||16318.5||16298.667||16140.5,0.0,0.0,0.0
581,J_Mol_Med-4-1-2374880.txt,renin inhibitor||receptor||renin receptor||bind||enzymat activ||effect||renin level||vitro studi||renin inhibit||activ||site||activ site||low pH||blockad||tissu||gener||renin||tissu angiotensin gener||prorenin||function,2||2 activ||type 1||refer 1||2 diabet||patient||prorenin 1 3 8 9||renin-induc erk 1||10 10||effect||vitro studi||mesangi cell||2001||kinet studi||human endotheli cell,28965.0||17098.0||16987.0||16864.5||15728.0||13567.0||11947.6||10361.667||6982.0||6956.0||6379.5||6338.5||6313.0||6162.5||5870.667,0.0,0.1,0.13333333333333333
582,Dev_Genes_Evol-4-1-2362136.txt,pattern||innerv pattern||present studi||insect||speci||develop||embryo||limb||decapoda||myogenesi||evolut||studi||muscl format||adult||antibodi||muscl||western blot||hoechst||isopoda||crustacea,1||2||3||1 mg||1 I.||E. spinifron 2 2 fig. 2||1 harzsch||1 uber||stage 2||ischium 2||meru 2||1999 fig. 1||4||studi||germani 2 depart,31046.0||28965.0||17044.0||15945.0||15808.5||15634.333||15526.0||15525.0||15070.0||14486.0||14486.0||13605.667||12937.0||12015.0||10717.333,0.0,0.0,0.06666666666666667
583,Eur_J_Clin_Pharmacol-4-1-2254473.txt,model||antibiot||diagnost workup||pneumonia||hospit||microbi aetiolog||hospit admiss||antimicrobi therapi||atyp pathogen||beta-lactam antibiot||co-morbid||studi||admiss||bacteria||treatment||aetiolog||patient||potenti predictor||caus pathogen||outpati antimicrobi treatment||find||antimicrobi drug||initi treatment||mortal||diagnosi||cap||predictor,1||2||3||refer 1||3 1 depart||1 5 6||1 demograph||august 1||octob 1||1 voorn||result 1 7 14 2||viral 2||ciprofloxacin 2||patient||1 august 2006,31046.0||28965.0||17044.0||16864.5||16861.333||16828.0||15622.5||15567.0||15561.5||15524.0||15477.0||14549.5||14486.0||13567.0||13168.333,0.0,0.0,0.06666666666666667
584,J_Hum_Genet-4-1-2413114.txt,japanes||snp||bmi||genotyp rel risk||sever obes||control||associ||obes||japanes popul||genotyp||sever adult obes||test||gene||power||group,1||2 1||2 2 2 2 1 2||2||2 fto fig. 1||type 2||2 diabet||1.7. 1||2 chi-squar||2 fto||statist analysi 2 2007 2||2 1998 2005||fto 2 2 fto gene||2 2002 2 1998 fto gene||studi,31046.0||30005.5||29311.833||28965.0||16256.5||15946.5||15728.0||15523.5||14519.5||14502.0||14296.6||13972.333||12560.4||12342.667||12015.0,0.0,0.0,0.0
585,J_Mol_Biol-1-5-2291451.txt,oblig||pack||mechan||nucleu||core||tnfn3||Ig||fold||nativ state||contact||interact||protein||cafn2||domain||loop||sheet||mutat||immunoglobulin||mutant||strand||fibronectin type iii||greek key topolog||transit state||fniii||residu||data||layer||structur,1||2||tabl 1||3||1 34||tabl 2||figur 1||1 58||4 tabl 1||figur 2||53 2||4||tabl 2 figur 3||studi||refer 1 baker,31046.0||28965.0||17331.0||17044.0||16417.0||16290.5||16123.5||16000.5||15866.333||15083.0||15041.5||12937.0||12706.5||12015.0||11289.667,0.0,0.0,0.0
586,Clin_Rheumatol-3-1-1847465.txt,rheumatoid arthriti||disabl||fibromyalgia,2 1 centr||refer 1||patient||2005||2006||0200 australia 2 depart||2002||61-2-61250733 janine.walker@anu.edu.au 1 littlejohn geoffrey||result||2000||health||10 11 12 13 14 15||diseas||function||signific effect,20252.667||16864.5||13567.0||8716.0||8371.0||7912.75||7057.0||6211.4||6080.0||5903.0||5601.0||5170.167||5149.0||4581.0||4499.0,0.0,0.0,0.0
587,Eur_Radiol-3-1-1914219.txt,vivo||lumen||vivo studi||coronari plaqu||tissu compon||plaqu||smooth||evalu||contrast media||coronari arteri||cnr||plaqu attenu valu||attenu valu||intracoronari attenu||msct||oil||measur||attenu||studi||germani||increas||imag||valu||contrast materi||coronari angiographi||convolut||snr||noncalcifi plaqu||filter||vivo model||standard deviat||specimen||result,1||2||nico 1 2 1 depart||refer 1||1 mm||6.4 2 fig. 2||similar 2||2 summari||patient||studi||tabl 1 summari||1 fig. 1 CX lad LM||netherland 2 depart||eur radiol 1||4 fig. 4,31046.0||28965.0||18712.6||16864.5||15936.5||15750.5||15042.0||14694.0||13567.0||12015.0||11695.0||11262.0||11205.0||11009.667||10283.333,0.0,0.1,0.06666666666666667
588,Doc_Ophthalmol-3-1-1820752.txt,respons||eog record||dilat pupil||electr potenti||potenti||difficulti||pupil||retina||report||amplitud||clinic eog||refer data||peak||standard method||eog||retin pigment epithelium||ratio||eye||clinic electro-oculographi||present||minimum||electrod||valu||norm data||saccad||pupil dilat||total dark||test||standard||light peak||chang||minimum amplitud||method||subject||light adapt||result||record||data||light rise||type||dark||arden ratio,1||2||2 3||standard 1 8 1 2||3||electrod 1 fig. 1||1 min||eog 2 fig. 2||patient||4||light lumin 2 3||respons 3 fig. 3||4 fig. 4||light phase 2||2006,31046.0||28965.0||23004.5||19781.2||17044.0||16819.5||16158.0||15735.5||13567.0||12937.0||11676.25||10603.0||10283.333||10170.667||8371.0,0.0,0.0,0.0
589,J_Occup_Rehabil-3-1-1915628.txt,intervent||model||pain intens||complaint||femal comput worker||effect||pain||mfb||work-rel neck-should complaint||cinderella-bas myofeedback train||group||factor||myofeedback||analysi||follow-up||studi||shoulder||netherland||improv||signific||work-rel musculoskelet complaint||disabl||myofeedback train||baselin||week||muscl relax||va score||subject||muscl activ||odd ratio||work||neck-should region||EC group||result,1||2||3||refer 1||pictur 1||1 5 1 roessingh research||1 fig. 1 box plot||patient||g.voerman@rrd.nl 1 sandsjö leif 2 3||studi||tabl 1 characterist||disabl 2 fig. 2 box plot||2 201 7 10.1016||2 hermen hermi||pictur 1 myofeedback system,31046.0||28965.0||17044.0||16864.5||15587.0||15235.0||13581.8||13567.0||12844.167||12015.0||11984.333||10698.667||10485.5||9659.667||8720.25,0.0,0.1,0.06666666666666667
590,Bioprocess_Biosyst_Eng-2-2-1705497.txt,algorithm||genet algorithm||design variabl||popul||variabl||softwar tool||experiment effort||process||bit||multi-object experiment optim||gener||optim valu||object||multi-object optim||experi||amount||mop||small popul size||individu||problem||set||experiment design||result,1 1||1||2 1||2||2 2||2 3||1 fig. 1||1 4||4 2||2 4||1 time||3||3 3 3||3 fig. 2||refer 1,31046.0||31046.0||30005.5||28965.0||28965.0||23004.5||22356.0||21991.5||20951.0||20951.0||17493.5||17044.0||17044.0||16995.0||16864.5,0.0,0.0,0.0
591,Breast_Cancer_Res_Treat-3-1-2001220.txt,cancer||tumor biolog||effect||tool||resist||agent||target||breast cancer||breast tumor||combin||combin therapi||letrozol||estrogen||trastuzumab||studi||aromatas inhibitor||growth||adjuv therapi||express||treatment||biomark||patient||gene||therapi||recent advanc||tumor||growth factor||trial||cell||microarray gene||clinic||ER overexpress||tamoxifen||pathway,1||2||2 studi||refer 1||suppl 1||1 summari||pathway 2||2 suppl||patient||2 studi breast cancer||cell||studi||protein 3||cancer patient||3 year,31046.0||28965.0||20490.0||16864.5||15942.0||15734.5||15144.5||14901.5||13567.0||12690.5||12627.0||12015.0||11666.0||10321.5||10150.0,0.0,0.1,0.2
592,J_Mol_Biol-1-5-1885968.txt,differ||hsqc||bind||favour enthalp contribut||free energi||ligand bind||molecular dynam simul||experiment data||entropi||abp||flexibl||analysi||diffus tensor||interact||protein||domain||heteronuclear singl quantum coher||simul||conform entropi||rdc||bind site||paramet||entrop cost||optimis||motion||chang||consist||residu||nmr relax||rotat diffus||dynam||complex||protein dynam||data||ligand||molecul||order paramet||result||structur,1||2 1||2||2 2||8 2||tabl 1||43 1 15 1||3||refer 1||2 measur||tabl 2||2 valu||1 connect||figur 2||2 LZ,31046.0||30005.5||28965.0||28965.0||17559.5||17331.0||17045.5||17044.0||16864.5||16500.5||16290.5||15845.0||15733.5||15083.0||14501.5,0.0,0.0,0.0
593,J_Med_Internet_Res-4-3-1761945.txt,member state||tool||sixti||qualiti criteria||hon||high qualiti servic||privaci||websit||qualiti initi||medic||order||possibl||unit state||state||organis||criteria||european||european union||specif tool||eeurop 2002 action||avid consum||bodi||nation||european council||system||conduct||rate system||eeurop||standard||internet||code||provid||specif aim||guidelin||core set||commun||site develop||site provid||user||action||content||relev profession associ||inform||parti||initi||user guid||label||health,1||2||3||1 set||1 contributor||2 glossari||patient||4||4 5||level 1 tag||websit 1 commiss||6||consult 3||2003||2002,31046.0||28965.0||17044.0||16249.0||15537.0||14486.5||13567.0||12937.0||11650.5||11471.0||10471.333||9074.0||8687.0||7651.0||7057.0,0.0,0.0,0.0
594,Diabetologia-3-1-2039826.txt,macrovascular diseas||regress analys||chronic hyperglycaemia||cognit perform||insulin level||vascular risk factor||brain||vascular event||atrophi||cognit domain||neuropathi||pwml||group||factor||infarct||mri||score||perform||brain mri||associ||type 2 diabet||cognit||insulin||diabet||neuropsycholog examin||sever wml||multivari model||present studi||brain infarct||vascular factor||white matter lesion||control||type 2 diabet mellitu||test||patient||histori||risk factor||sever mri abnorm||larg number||data||cerebr complic||retinopathi,1||2||J. 1||3||refer 1||33 1||1 point||type 2||2 diabet||1 1c||2 mm||1.8 2||patient||4||type 1 diabet,31046.0||28965.0||17417.5||17044.0||16864.5||16522.5||15967.5||15946.5||15728.0||15588.0||14896.0||14608.5||13567.0||12937.0||12155.0,0.0,0.0,0.06666666666666667
595,J_Comp_Physiol_A_Neuroethol_Sens_Neural_Behav_Physiol-4-1-2323032.txt,organ||speci||mechan||nerv fiber||contact membran||ear||spontan otoacoust emiss||mammalian cochlea||spontan emiss||hair cell||tonotop organ||round window||singl auditori filter||hair bundl||basilar papilla||characterist||membran||emiss||similar||frequenc||endolymphat space||narin||auditori system||amphibian papilla||anuran||s-shape extens||amphibian auditori system||frog||frequenc select||vertebr||sacculu||amphibian||otoacoust emiss||tectori curtain||caudal region||tympan membran||tonotop axi||function,1||2||1 2006||2 1981||1 2000b fig. 1 1985||3 2006||studi||netherland 2 school||5||31-50-3611698 r.l.m.schoffelen@rug.nl 1 2 segenhout johann||2 amolop tormotu 2006||2005||1982 2 5 1990 1975 5||1 26 manley GA||2006,31046.0||28965.0||19708.5||14697.0||13573.8||12707.5||12015.0||10604.333||10364.0||10014.167||9334.5||8716.0||8658.0||8538.75||8371.0,0.0,0.0,0.0
596,Cardiovasc_Eng-3-1-2137944.txt,mode||stroke||aai||pulmonari pressur||echocardiographi examin||myocardi energet output||cardiovascular system||ventricl dysfunct||vvi||valu||system||ventricular pace||paramet||patient||heart failur||numer simul||myocardi oxygen consumpt||cardiac rhythm pace||numer model||blood pressur||data||work||myocardi energet||heart,2||3 1||2 2 2 1992 2||2 2 1990 2 2 3||2 4||1 5||http://www.lidco-ir.co.uk/html/clinical/nhp.asp 1 1||3||patient||studi||420-286-584695 marsik@it.cas.cz 2 1 cardiocent||mathemat model 2 fig. 2 scheme||fig. 1 ventricular pressur||ES 3||ED 3,28965.0||24045.0||23513.6||22385.5||20951.0||20705.0||20698.0||17044.0||13567.0||12015.0||12002.8||11163.0||9374.5||8634.0||8605.0,0.0,0.1,0.06666666666666667
597,Eur_J_Pediatr-3-1-1802727.txt,respons||ecn||day||differ||number||group||acut gastroenter||toddler||infant||bodi weight||treatment group||studi||good clinic practic||trial medic||children||treatment||baselin||patient||probiot||present trial||placebo group||gener state||placebo||diarrhoea||bodi temperatur||acut diarrhoea||trial||data||stool||nissl 1917||efficaci||health,1||2||2 2||2 2 fig. 2 diagram||3 year 1||3||treatment 2||refer 1||1 year 1 ml||4 year 1||studi 3||patient||3 fig. 3||4||studi,31046.0||28965.0||28965.0||18384.8||17115.333||17044.0||16988.5||16864.5||16528.5||15746.333||14529.5||13567.0||13021.333||12937.0||12015.0,0.0,0.0,0.13333333333333333
598,Breast_Cancer_Res_Treat-3-1-2092410.txt,famili member||amino acid||uv||cancer||age||brca||specif popul||mutat||protein function||breast||famili||indonesian popul||gene||patient||popul||breast cancer||group,2||3||refer 1||patient fig. 2||exon 1||2 mutat||patient||4||1 22 24||studi||breast cancer gene 1||indonesia 2 depart||brca2 1 brca2||5||29 3,28965.0||17044.0||16864.5||15836.0||15565.5||15116.5||13567.0||12937.0||12501.667||12015.0||11405.5||10500.333||10444.667||10364.0||9657.0,0.0,0.1,0.06666666666666667
599,Eur_J_Appl_Physiol-3-1-2039810.txt,hot condit||skin||exercis||differ||effect||blood flow||power output||perform||energi flow model||decreas||condit||higher cardiac output||increas||present studi||valu||temperatur||time trial exercis||ambient temperatur||perform decrement||climat||muscl temperatur||time trial perform||bodi temperatur||heat||extra blood||trial,1||1 2||2||1 3||3 2||1 fig. 1||2 tabl 2||1 2005||2 2001||3||2 tabl 3||2 1987||jaeger 2||5||6,31046.0||30005.5||28965.0||24045.0||23004.5||22356.0||20515.333||19881.0||17639.0||17044.0||16541.667||14907.5||14488.0||10364.0||9074.0,0.0,0.0,0.0
600,Ann_Surg_Oncol-4-1-2277449.txt,respons||partial respons||heart-lung machin||ihpp procedur||oper time||circuit||concentr||month||simpl procedur||progress diseas||stabl diseas||ihhp||retrograd||blood loss||system melphalan concentr||leakag||studi||progress||time||hepat arteri||surviv||treatment||retrograd outflow||patient||perfus circuit||tumor respons||perfus||portal vein||present seri||isol hepat perfus||hepat metastas||liver||melphalan||bile duct necrosi||hepat toxic||median||pharmacokinet,1||2||tabl 1||refer 1||phd 1 1 depart||1 mg||ihhp 1||2 mg||interleukin 2||patient||4||studi||11 15 1 21||netherland 2 laboratori||phd 1 vermaa maarten MD 1,31046.0||28965.0||17331.0||16864.5||16203.25||15945.0||15529.5||14904.5||14506.0||13567.0||12937.0||12015.0||10988.75||10621.0||10517.833,0.0,0.1,0.13333333333333333
601,Anal_Bioanal_Chem-4-1-2324126.txt,separ||milk hydrolys||hydrophil fraction||total run time||hilic||formic acid||amino acid||complex mixtur||analys||compound||fraction||activ||identif||at-lin assay||column||ace-inhibit||method||total activ||peptid||peptid vpp||larg number||min,1||1 1 1 1 lactobacillu||1 fig. 1||6 1||3||refer 1||1 peptid||4 1 5 7 4||4||1 tran 15||7 8 fig. 7 1||netherland 2 depart||springer-verlag 2008 introduct 1 3||5||31-104-605310 chris-van.platerink@unilever.com 1 2 janssen hans-gerd,31046.0||24839.6||22356.0||20060.0||17044.0||16864.5||15838.0||14856.2||12937.0||12002.0||11234.0||11205.0||10606.6||10364.0||10019.0,0.0,0.0,0.0
602,Rev_Endocr_Metab_Disord-3-1-1894828.txt,noonan syndrom||respons||clinic studi||similar cardiac defect||syndrom||normal rang||costello syndrom||short statur||growth hormon||cytokin||birth||high incid||hormon||leopard syndrom||age||growth||mutat||children||treatment||gene||height||patient||hypertroph cardiomyopathi||factor XI||cfc||short neck||adult||year||cardio-facio-cutan syndrom||function,1||3||refer 1||patient||10 2 ptpn11 gene||3 month||exon 3||clinic studi||30 patient||2006||4 year||ten patient||cell differenti||untreat patient||occasion patient,31046.0||17044.0||16864.5||13567.0||10198.25||9321.0||8564.5||8436.5||8417.0||8371.0||8096.5||6911.5||6909.0||6831.0||6813.0,0.2,0.2,0.13333333333333333
603,Appl_Microbiol_Biotechnol-4-1-2243254.txt,organ||metabol pathway||product||agent||ferment process||process||organ acid||studi||carboxyl acid||ferment||petrochem process||immobil||fumar||product recoveri||fungi||maleic anhydrid||fumar acid||glucos||cell||acid||yield,1||1 1||http://tonto.eia.doe.gov/dnav/pet/xls/pet_pri_wco_k_w.xl 1 2 2||2 2 fixat||2006 2||1 2000||1 1999||1 1997||3 1997 1||1 3 1986||1990 2 fig. 2||2 comparison||cell||1 literatur data||tran fig. 1,31046.0||31046.0||22244.25||19400.333||18668.0||18474.5||17920.5||17297.5||17213.0||16314.333||16078.75||15308.5||12627.0||12209.667||12135.0,0.0,0.0,0.06666666666666667
604,Diabetologia-4-1-2292424.txt,heal||model||daili clinic practic||major amput||outcom||ulcer||older age||neuropathi||pad||variabl||popul||foot ulcer||co-morbid||peripher arteri diseas||sensat||diabet foot diseas||follow-up||diabet||studi||characterist||eurodial studi||analys||treatment||patient||infect||predict model||end-stag renal diseas||year||individu||esrd||prospect data||data||presenc||foot||diabet foot ulcer||non-heal||rate||predictor||result,1||2||1 1 divis||fig. 1||1 year||3||refer 1||1 week||1 apelqvist||3 4||2 71||2 117||2 259||2 563||2 edmond,31046.0||28965.0||20790.333||18011.0||17151.0||17044.0||16864.5||16140.5||15527.5||14990.5||14889.0||14705.0||14567.0||14523.5||14497.0,0.0,0.0,0.0
605,Brain_Struct_Funct-4-1-2226080.txt,day||open field||number||barn maze||box||maze||open arm||total||neuron||experiment group||separ||open field test||group||matern separ||anim||pnd||estim||behaviour||stereolog||total number||volum||signific differ||revers trial||arm||dentat gyru||time||hippocampu||maze test||hole||escap box||test||paramet||section||total distanc||anxieti||trial||mice||distanc||total neuron number,1||2||3||time 2||1 week||vol 1||1 piec||2 day||2 male||2 section||2 overview||2 asphyxi||3 fig. 3||4||1956 2 1991 fig. 2,31046.0||28965.0||17044.0||16453.0||16140.5||15610.0||15543.5||15449.0||14971.5||14920.5||14605.0||14485.0||13021.333||12937.0||12897.0,0.0,0.0,0.0
606,Intensive_Care_Med-4-1-2228379.txt,proxim tubul injuri||refractori shock||short-term effect||day||benefici effect||septic shock patient||urin||MB treatment||product||urinari excret||septic patient||continu infus||studi||patient||supplementari materi||kidney damag||renal tubular injuri marker||septic shock||clinic paramet||renal failur,1||1 1||2||1 fig. 1||3||refer 1||format 3 1||1 mg||patient||4||studi||netherland 2 depart||kidney damag 1||5||2 15 3 16 17 18,31046.0||31046.0||28965.0||22356.0||17044.0||16864.5||16323.333||15945.0||13567.0||12937.0||12015.0||11205.0||10959.667||10364.0||10341.5,0.0,0.1,0.13333333333333333
607,Ann_Surg_Oncol-3-1-1914247.txt,lower limb||vascular reconstruct||complic||ebrt||long-term vascular side effect||amput||month||arteri occlus||vascular complic||ultrasonographi||follow-up||late vascular morbid||median follow-up||treatment||poplit PI||patient||arteri occlus diseas||critic leg ischemia||rang||perfus||resect||st||sarcoma||ilp||year||limb||femor PI||level||limb salvag treatment strategi||object measur,1||2||1 1 axillari||1 1 iliac||2 tabl 2||3||refer 1||2 year||1 fig||2 3 iliac||2 3 poplit||3 4||suppl 2||17 18 1 tabl 1||patient,31046.0||28965.0||20739.333||20715.667||20515.333||17044.0||16864.5||16110.5||15559.5||15354.667||15353.333||14990.5||14901.5||14644.0||13567.0,0.0,0.0,0.06666666666666667
608,Antonie_Van_Leeuwenhoek-3-1-2140093.txt,surfac||amino acid||coverslip||outer surfac||cbpp||primari antibodi||electron microscopi||high accuraci||peptid||immunogold label||cell||immunogold||mycoplasma||igg||lppq||host cell||domain||antibodi||membran||integr membran domain,1||2||2 4 2 4||1 1 divis||3 3 1 3||2 2 product||1 tabl 1 statist analysi||0 1 1998||4||cell||studi||lipoprotein lppq 1||5||switzerland 2 institut||0 1 mycoplasma pneumonia,31046.0||28965.0||20951.0||20790.333||20544.5||19852.333||14394.8||13791.667||12937.0||12627.0||12015.0||10397.333||10364.0||10189.667||9323.5,0.0,0.1,0.06666666666666667
609,Bioinformation-1-10-1896059.txt,gene express||effect||detect||alter||import aspect||cgh array||group||step||analysi||profil||term||diseas||boundari||valu||array||gene||gene express analysi||chromosom||aspect||copi number||method||copi number alter||data||hybridis||region||level||function,1||2||1 2 3||tabl 1||3||1 depart||bioinform 1||fátima 1 dopazo joaquín 1 2||cell||studi||refer 1 kallioniemi||tabl tabl 1 percentag||2007||15 14 4||spain 2 function genom node,31046.0||28965.0||25685.0||17331.0||17044.0||16770.0||15556.5||15177.0||12627.0||12015.0||11245.667||9699.25||7287.0||7270.333||7089.4,0.0,0.0,0.0
610,Mol_Genet_Genomics-2-2-1705487.txt,cell divis||strain||growth||express||osmot stress||rna polymeras II||cell||cell growth||data||presenc||transcript||gene||thiamin||special role||promot||level||stress condit||role||subunit||method strain,1||2||2 fig. 2||3||1 min||2 day||4||cell||3 3 discuss 3 2005||studi||1 rpb4 fig. 1 rpb4 rpb4||44-1223-496802 jurg@sanger.ac.uk 2 1 univers school||14 2004 4 4||2004||3 fig. 3 rpb4 nmt1,31046.0||28965.0||20968.667||17044.0||16158.0||15449.0||12937.0||12627.0||12309.8||12015.0||11219.5||10727.0||9562.0||8077.0||7836.6,0.0,0.1,0.06666666666666667
611,BMC_Bioinformatics-4-_-166134.txt,word||inform extract||keyword||text mine||number||scientif articl||full text articl||order||context||analysi||mesh term||introduct||biolog inform||term||biolog concept||natur text||articl||figur||keyword content||question||mesh||gene||section||method||subject||content||inform||cell||data||abstract||relev||result,1||2||1 3||1 2 3 andrade@embl.d 1 biocomput||2 protein||tabl 2||figur 1||figur 2 6||figur 3 2 19||cell||germani 2 depart||5||cypru 1 5 perez-iratxeta||tabl 1 keyword select||2.20 2.02 1.02 1.99 2 3,31046.0||28965.0||24045.0||18017.5||17626.5||16290.5||16123.5||13080.0||12631.0||12627.0||10717.333||10364.0||10354.0||9448.0||7713.0,0.0,0.1,0.06666666666666667
612,Eur_J_Epidemiol-4-1-2270357.txt,statist signific||part||model||data split||population-bas survey||pain||number||scientif find||variabl||statist||microarray||independ parti||epidemiolog hypothes||hypothesi fish||two-stag analysi||research||analysi||studi||case studi||valu||signific||signific level||smoke||hypothes||independ data set||method||problem||procedur||case||data||set||confound||epidemiolog survey||predictor||marit statu,1||2 1||2||3||refer 1||part 1||0.000 1||0.012 1||0.015 1||2 site||part 2||norway 2||studi||4 5||smaller part 1,31046.0||30005.5||28965.0||17044.0||16864.5||16058.5||15618.5||15559.0||15552.5||15517.5||15018.0||14514.5||12015.0||11650.5||10780.333,0.0,0.0,0.06666666666666667
613,Diabetologia-3-1-1998885.txt,hyperglycaemia||adhes molecul||concentr||urinari albumin excret||plasma thiamin concentr||metabol dysfunct||microvascular complic||type 2 diabet||plasma||diabet||studi||renal dysfunct||diabet complic||metabol control||urinari excret||patient||thiamin||microalbuminuria||link||vascular dysfunct||type 1 diabet||gfr||erythrocyt||marker||level,1||1 2||2||2 2||1 fig. 1||1 2 ahm||1 2 larkin||3||type 1||fig. 2||refer 1||3 1 depart||1 characterist||type 2||2 diabet,31046.0||30005.5||28965.0||28965.0||22356.0||20025.333||20009.667||17044.0||16987.0||16970.5||16864.5||16861.333||16168.5||15946.5||15728.0,0.0,0.0,0.0
614,Dig_Dis_Sci-3-1-1914244.txt,tumor||apr||anu||surviv||treatment||case||margin||patient||local recurr||diagnosi||melanoma||abdominoperin resect||wle||wide local excis,1||1 1 depart||1 1 fig. 1 melanoma||3||refer 1||1 mm||2 cm||patient||netherland 2 depart||W. M. 2||5||mvantriet@hotmail.com 1 giard||1 cm safeti margin||6 17 5||2003,31046.0||21528.667||19708.8||17044.0||16864.5||15936.5||14720.5||13567.0||11205.0||11186.0||10364.0||10349.333||8052.5||7673.667||7651.0,0.0,0.1,0.06666666666666667
615,Ann_Surg_Oncol-4-1-2234450.txt,lymphat||first-tier lymph node||axilla||cadav||anatom analysi||vessel||anterior upper torso||intern thorac arteri||sentinel node biopsi||sentinel node||intern mammari lymphat||pathway||previou studi||sappey||breast||tissu||cross-sect studi||inject||subareolar inject||thin adult cadav||germani||sentinel lymph node biopsi||system||radiograph||superfici lymphat||lymph node||femal||branch||lymph vessel||subareolar plexu||dye||neg sentinel node studi||node||peritumor inject||specimen||result,2||refer 1||1 male||patient||4||studi||5||15 1 fig. 1.||cancer cell||20 21 3 4||6||3 femal||surgic oncolog 2008 1||2007||1970 2 361 91 10.1016,28965.0||16864.5||16012.0||13567.0||12937.0||12015.0||10364.0||10184.5||9851.5||9419.75||9074.0||8972.5||8630.5||7287.0||7168.4,0.0,0.0,0.0
616,Eur_J_Clin_Pharmacol-4-1-2235908.txt,compet||clinic practic||educ||undergradu medic curriculum||practic||core||undergradu student||nierenberg||curriculum||medic student||approach||drug||process||script||futur doctor||teach||diagnost reason||clinic pharmacolog||import||term||diseas||therapeut||valid inform||object||effect approach||treatment||current theori||context-learn||student||experi||patient||reason||essenti skill||knowledg||consult||lectur||analyt reason||skill||inform||pharmacotherapi||clinic clerkship||undergradu teach,1||2||1 18||3||refer 1||suppl 1||box 1||1 24 fig. 1 24||compet 4 1||practic 1 fig. 3||patient||1 13 14||studi||2 33 knowledg||5,31046.0||28965.0||17487.5||17044.0||16864.5||15942.0||15840.0||14724.0||14721.667||13633.75||13567.0||13201.667||12015.0||10521.667||10364.0,0.0,0.0,0.06666666666666667
617,Eur_J_Clin_Pharmacol-3-1-2071964.txt,aspect||meet||agreement||method||pharmacist||tool||cost||daili dosag||associ||pharmacotherapi audit meet||ddd||data||type||studi||ptam||result||group,1||4 2||fig. 1||1 21||level 1||refer 1||ptam 4 5 1 2||tabl 2||level 2||2 23||type 2||guidelin 1||netherland 2||atc 1||patient,31046.0||20951.0||18011.0||17163.5||17126.0||16864.5||16672.6||16290.5||16085.5||15976.5||15946.5||15861.5||15560.5||15534.5||13567.0,0.0,0.0,0.0
618,Breast_Cancer_Res_Treat-4-1-2217623.txt,age||differ||effect||result||case||data||variant||gene||studi||meta-analys||entri||risk||popul||polymorph||breast cancer||estrogen receptor,1||2||1 2 hofman||refer 1||2 20||1 child||2008 introduct 1 2 3||1 pol||1 stricker||xbai 1||2 siem||patient||31-104089406 c.vanduijn@erasmusmc.nl 1 1 depart||G. 1 2 van duijn||studi,31046.0||28965.0||20045.667||16864.5||16691.0||16268.5||16078.8||15558.0||15541.5||15533.5||14483.5||13567.0||12917.8||12551.0||12015.0,0.0,0.0,0.06666666666666667
619,Qual_Life_Res-3-1-1832149.txt,onlin questionnair||random design||differ||reliabl||mode||scale||effect||number||standard paper version||form||feasibl||child health questionnair||secondari school||subgroup||chq-cf||internet administr||questionnair||multi-item scale||studi||chq-cf scale||small effect||sampl||adolesc||effect size||test||internet||paper||chronic condit||item||valid||score differ||internet version||result||answer||health,1||2||2 3||random 2 2||2 differ||1 year||3||refer 1||condit 1||2 condit||2 34||2 child||4||studi||netherland 2 healthactchq,31046.0||28965.0||23004.5||19718.333||17193.5||17151.0||17044.0||16864.5||16446.0||15405.5||15376.5||15228.0||12937.0||12015.0||10374.0,0.0,0.0,0.06666666666666667
620,Biochim_Biophys_Acta-2-1-2323027.txt,translat control||cpeb||bind||regul||meiotic matur||gld2||tail||symplekin||factor||signal||associ||phosphoryl||synthesi||addit||translat repress||cytoplasm polyadenyl||nano||cytoplasm||polyadenyl||maskin||element||translat activ||activ||cpsf||parn||oocyt||mrna||complex||data||polymeras||deadenyl||function,1||2 1||2||5 1||5 2||3||fig. 2||figs. 1||4||cell||5 4 4||studi||fig. 3||2 hybrid system||5,31046.0||30005.5||28965.0||20705.0||19664.5||17044.0||16970.5||15559.5||12937.0||12627.0||12079.333||12015.0||11010.0||10961.667||10364.0,0.0,0.0,0.0
621,Clin_Rev_Allergy_Immunol-3-1-2071970.txt,autoimmun diseas||infliximab||effect||pss patient||promis result||pss||II studi||baff||score||clinic trial||antibodi||infus||rituximab||improv||treatment||biolog agent||patient||therapi||va score||salivari flow rate||trial||cell||result,1||2||2 6||2 12||3||refer 1||2 15||M. 2 1 depart||2 16||2 3 5 6 7||patient||4||cell||14 15 2||studi,31046.0||28965.0||19019.5||17408.5||17044.0||16864.5||16771.0||16562.75||16458.0||14488.8||13567.0||12937.0||12627.0||12613.0||12015.0,0.0,0.0,0.13333333333333333
622,J_Mol_Biol-1-5-1885970.txt,form||contact||peptid hydrolysi||water proton||activ form||water molecul||catalyt domain||triple-hel collagen||enzym||crystal structur||catalyt zinc||domain||extracellular matrix||matrix metalloproteinas||pro-peptid domain||activ||asymmetr unit||linker region||hydrogen bond||hemopexin-lik domain||activ site mutant||residu||collagen||crystal||region||interact||activ enzym||structur,1||2||2 tabl 1||2 3 4 5||3||refer 1||1 depart||introduct 1||2 μl||Å 2||4||figur 2 20||UK 2 depart||matrix metalloproteinas 1||1 aspenlea road,31046.0||28965.0||21209.0||17327.5||17044.0||16864.5||16770.0||16172.0||14590.5||14574.0||12937.0||11527.667||10778.333||10554.333||10389.667,0.0,0.0,0.0
623,J_Med_Internet_Res-7-3-1550662.txt,page||usabl test||basic search form||cancer||survey||health-rel inform||bet||form||websit||averag||free-text search||portal||categori||redesign||health profession||cancer inform product||clinic trial||user input||cancer patient||question||feedback||patient||internet||tabl||guidelin||nci||onlin||cancer inform||summari||onlin survey||specif trial||inform||result||search log||type||abstract||onlin inform||usabl,1||2||2002 2||3||figur 1||1 outlin||patient||7 figur 1||3 6||9 appendix 1||studi||tabl 2 type||tabl 1 mileston||2 sampl scenario||1 wright lawrenc,31046.0||28965.0||18011.0||17044.0||16123.5||15565.0||13567.0||13081.333||13059.0||12227.0||12015.0||11836.333||11558.667||10476.0||10445.333,0.0,0.1,0.06666666666666667
624,Cancer_Immunol_Immunother-3-1-1914259.txt,pbmc||hud||individu||pn||detect||peptid||control||cell||cytokin||antigen||patient||studi||nervou system||Hu antibodi,1||1 1 1||2||1 1 fig. 1||2 fig. 2||2 1 depart||2 7||1 13||refer 1||2 time||2 month||1 2 verjan georg||2 sclc||patient||cell,31046.0||31046.0||28965.0||24528.5||20968.667||20835.0||17981.0||17654.0||16864.5||16453.0||15281.5||15027.25||14487.5||13567.0||12627.0,0.0,0.0,0.13333333333333333
625,Int_J_Colorectal_Dis-4-1-2386753.txt,recurr rate||high transsphincter perian fistula||anal fistula plug||cryptoglandular origin||outcom||fibrin glue||rectal advanc flap||perian fistula||group||altern treatment||follow-up||high transsphincter fistula||high success rate||advanc||sphincter||recurr||sphincter complex||consecut seri||surgeri||treatment||fistula||patient||anal canal||intern open||procedur||advanc flap||previou fistula surgeri||seri||result||closur,1 2||2||3||refer 1||1 characterist||2 characterist||vicryl 2||patient||4||studi||5||3 month||6||13 patient||26 patient,30005.5||28965.0||17044.0||16864.5||16168.5||15128.0||14486.5||13567.0||12937.0||12015.0||10364.0||9321.0||9074.0||8914.5||8087.5,0.0,0.1,0.06666666666666667
626,Diabetologia-4-1-2362134.txt,m-csf||receptor||rankl-independ pathway||cultur||number||mediat||rankl||diabet control||group||osteoclast||dentin slice||studi||addit||particip||resorpt||healthi control||increas||osteoclast format||coverslip||osteolysi||observ||activ||bone||patient||vitro techniqu||excess concentr||control group||presenc||result||opg,1||2||2 fig. 1||3||refer 1||1 mol||1 1 nuffield depart||1 petrova||patient||3 fig. 3||4||studi||5||10 μm fig. 2||L. 2 edmond,31046.0||28965.0||21662.333||17044.0||16864.5||16530.0||16147.25||15524.5||13567.0||13021.333||12937.0||12015.0||10364.0||10313.75||10172.667,0.0,0.1,0.13333333333333333
627,Arch_Dermatol_Res-3-1-1950585.txt,qualiti||fix||signal||sampl||array cgh studi||molecular fix||intens||clinic practic||ratio||genom dna||amplif||skin dna||background intens level||agaros gel||tissu||result||fresh tissu||pre-analyt sampl prepar,1||1 1||1 2||2||2 fig. 2||1 2 3 24||1 6||fig. 1||3||refer 1||1 week||38.73 1 2 3 24||1 spectrophotometr result||studi||2 repres data,31046.0||31046.0||30005.5||28965.0||20968.667||20082.75||20060.0||18011.0||17044.0||16864.5||16140.5||16066.4||12387.0||12015.0||11671.333,0.0,0.0,0.0
628,Crit_Care-9-3-1175868.txt,pulmonari arteri pressur||low cardiac output||cardiovascular drug||effect||dose||catecholamin||report||agent||clinic outcom||advers cardiac event||group||function||amrinon||epinephrin||milrinon||signific differ||studi||lco||cowork||cardiac output||tachycardia||literatur search||increas||low dose||clinic research||author||cpb||signific||patient||paper||map||dobutamin||cardiac surgeri patient||signific increas||pdi||vital organ perfus||signific reduct||cabg||enoximon||trial||pulmonari hypertens||data||levosimendan||low cardiac output syndrom||dopexamin group||cardiac surgeri||investig||min,1||2||2 2||2 2 3||4 1||2 HV 2||result 1||16 17 2 2||recommend 1||dopexamin 2 1 46||figur 2||recommend 2||2 summari||2 hour||dobutamin 2,31046.0||28965.0||28965.0||24991.333||21991.5||19332.667||18563.0||16366.0||16016.5||15344.0||15083.0||14976.0||14694.0||14625.5||14553.5,0.0,0.0,0.0
629,Environ_Health_Perspect-114-9-1570082.txt,model||day||locat||PM estim||concentr||address||approach||unit state||estim||cross-valid||particul air pollut||daili ambient PM||measur||studi||population-bas studi||valu||geocod address||krige||kriging-bas estim approach||semivariogram||spe||cross-valid paramet||spatial correl||weight least-squar method||rang||method||rmss||site||data||geograph inform system||location-specif PM||semivariogram paramet||se||averag PE||result,1||vol 1||vol 2||10 2.5 tabl 1 2||tabl 1 10||4||4 10 3||studi||10 10 3 10 3 3||3 heiss gerardo 3 1 depart||tabl 3 10 3||usa 2 depart||tabl 2 2.5||1 whi institut||5,31046.0||15610.0||14569.5||14209.2||13881.333||12937.0||12321.0||12015.0||12013.0||11274.0||11171.5||11119.0||11006.0||10919.0||10364.0,0.0,0.1,0.06666666666666667
630,Cancer_Causes_Control-4-1-2323031.txt,crc||categori||gener popul||cancer||subject||repres sampl||screen||women||nationwid opinion poll||program||fear||franc||reason||evid||rate||gener practition||mammographi||cancer screen||result||gp,1||1 1||2||1 2 5||3||refer 1||2008 introduct 1 2 3||1 reason||result 1 fig. 1 adher||patient||4||6||2005||edific committe 1 depart||2006,31046.0||31046.0||28965.0||23458.333||17044.0||16864.5||16078.8||15838.5||14671.2||13567.0||12937.0||9074.0||8716.0||8511.25||8371.0,0.0,0.0,0.0
631,Ann_Biomed_Eng-2-2-1705520.txt,respons||day||effect||bioartifici tissu||incub||amplitud||matrix||load curv||mechan condit||step||actin cytoskeleton||cell mechan||decreas||tissu||matrix mechan||condit||studi||cytod||time||increas||frequenc||load||drop||forc||mechan properti||strain||larger rang||collagen||curv||cell||cell stiff||baselin length||hold period,1||2||3 2||rjo@wustl.edu 1 2 1 depart||3||eq. 1||day 2||figur 2||4||cell||studi||1 mg collagen||1 okamoto ruth||5||1 elson elliot,31046.0||28965.0||23004.5||18710.4||17044.0||15524.5||15449.0||15083.0||12937.0||12627.0||12015.0||10723.0||10372.333||10364.0||10358.333,0.0,0.1,0.13333333333333333
632,Doc_Ophthalmol-3-1-1896293.txt,respons||macula||ground||amplitud measur||field||amplitud||refer||perg record||peak||stimulu||small signal||techniqu||compon||lumin||equip||measur||transient perg||time||electrod||checkerboard||amplif system||waveform||frequenc||implicit time||baselin||peak time||standard||patient||pattern electroretinogram||steady-st perg||tempor frequenc||surfac electrod||perg||clinic perg record||clinic electrophysiolog||activ electrod||frame rate,1||1 2||2||3||patient||transient perg 1 fig. 1||i.e. 2 Hz||6||calibr 3||graham.holder@moorfields.nhs.uk 1 brigel mitchel||patient popul||individu patient||2007||4 rev||patient blink,31046.0||30005.5||28965.0||17044.0||13567.0||13473.0||9937.0||9074.0||8633.0||7800.0||7675.0||7600.5||7287.0||7117.5||6802.0,0.2,0.1,0.06666666666666667
633,Int_J_Cardiovasc_Imaging-3-1-2048828.txt,TA function||tricuspid annulu||tad measur||mri||RV function||magnet reson imag||analysi||taf||measur||patient||studi||assess||tad||real-tim three-dimension echocardiographi,1||2||3||refer 1||I. 1 2 neme||2 line||1 2 soliman osama||8.2 2||9.2 2||patient||31-10-4635498 f.j.tencate@erasmusmc.nl 1 1 depart||tabl 1 comparison||studi||netherland 2 depart||1 4 geleijns marcel,31046.0||28965.0||17044.0||16864.5||15149.0||15125.0||15006.75||14534.5||14529.0||13567.0||12918.8||12104.667||12015.0||11205.0||11014.25,0.0,0.1,0.13333333333333333
634,Evid_Based_Complement_Alternat_Med-4-1-1810360.txt,pediatr MT||reduct||effect||pain||outcom||parent||report||popul||statist||field||behavior||trait anxieti||depress||review||session||recipi||research||measur||multiple-dos effect||suffici data||studi||condit||increas||sampl||children||treatment||scientif understand||immun system||massag therapi||therapi||single-dos effect||frequent failur||arthriti pain||anxieti||child||blind||MT research||statist power||data||MT session||adult||mood||result||salivari cortisol,2||2 1 2 univers||15 1||20 1||1 20||tabl 1||15 2||20 2||1 31||1 month||tabl 2||24 2||30 2||1 field||march 1,28965.0||23158.25||17811.5||17731.5||17731.5||17331.0||16771.0||16691.0||16599.5||16322.0||16290.5||16120.5||16116.0||15922.0||15599.0,0.0,0.0,0.0
635,Photosynth_Res-3-1-1769343.txt,fluoresc excit spectra||energi transfer||spectroscop studi||reconstitut||chlorophyl||band||complex||room temperatur||fluoresc excit||chl||absorpt spectra||spectra||protein||molecular detail||peridinin||structur||energi transfer effici||nativ pcp||high effici||pcp,1||1 2||2||2 4||5 1||line 2 1||ic2 2 1||et1 2 1||1 2005||line 2 1 1 0||ic1 2 1 1 0||2 2005||et1 2 1 2005||3||fig. 2,31046.0||30005.5||28965.0||20951.0||20705.0||20432.0||20007.333||20006.0||19881.0||19687.0||19431.8||18840.5||17183.5||17044.0||16970.5,0.0,0.0,0.0
636,Breast_Cancer_Res_Treat-4-1-2217620.txt,cancer||larger tumour||statist probabl valu||prognost factor||breast cancer||tumour||factor||probabl||follow-up||BC patient||tumour size||studi||breast cancer patient||time||age||brca||surviv||treatment||women||grade||obes||patient||BC diagnosi||lymph node||risk||prognosi||role||excess mortal||year||adjuv treatment||node||nodal statu||mortal||diagnosi||classif||socioeconom statu||clinic behaviour,1||2||1 2 1 depart||2004 2||3||refer 1||2 19||1 overview||lumin 1||basal-lik 1||luminal-lik 1||2 mutat||2 cm||2 N0||patient,31046.0||28965.0||23387.75||18521.0||17044.0||16864.5||16139.5||15645.5||15569.5||15525.5||15523.5||15116.5||14720.5||14501.0||13567.0,0.0,0.0,0.06666666666666667
637,Purinergic_Signal-4-2-2377326.txt,atp releas||ogd||maxi-anion channel||cell||arachidon acid||experi||studi||neuron||atp||calibr curv||astrocyt||solut,1||2||1 1 fig. 1||2 2 fig. 2||23 2 2 2||2 23 2 cell||23 2 2 cell||7 2||1 17 3||3||3 3||refer 1||81-564-557735 okada@nips.ac.jp 1 2 1 depart||4 3||3 fig. 3,31046.0||28965.0||24528.5||22967.75||22470.75||18386.25||18386.25||17981.0||17224.333||17044.0||17044.0||16864.5||15592.5||14990.5||13021.333,0.0,0.0,0.0
638,Eur_J_Pediatr-3-1-2042510.txt,logist regress analysi||gestat age categori||respiratori syncyti viru infect||rsv||number||social characterist||control-pati||hospit||season||sever rsv-induc lrti||hospit admiss||factor||infant||birth||rsv infect||studi||condit||birth order||higher likelihood||young children||age||children||strong autocorrel||rsv-induc lrti||control||famili||patient||risk factor||major epidem||case||predictor||bivari analysi,1||2||test 1 2||3||refer 1||patient||7 month 1||1 2 8 11 14 17||4||tabl 1 distribut||studi||1 10 17 19 6||itali 2 section||refer 3||6,31046.0||28965.0||21072.333||17044.0||16864.5||13567.0||13213.667||13182.667||12937.0||12075.0||12015.0||10799.8||10014.333||9863.5||9074.0,0.0,0.1,0.13333333333333333
639,Pediatr_Radiol-4-1-2292494.txt,day||nephrogen system fibrosi||dose||report||group||proinflammatori condit||contrast agent||develop||renal dysfunct||diseas||end-stag renal failur||time||bodi||age||children||ckd||nsf||renal impair||patient||gadolinium-bas contrast agent||kidney failur||renal transplant||risk factor||chronic kidney diseas||gadodiamid exposur||year||contrast-enhanc mri||gadolinium||previou gadolinium exposur||gadodiamid,2||1 year||1 case||refer 1||2 year||26 2||1 fov||2 day||2 month||nsf 2||patient||olseno@gosh.nhs.uk 3 1 radiolog||studi||tabl 2 websit||1 month cn,28965.0||17151.0||17109.5||16864.5||16110.5||15786.5||15541.0||15449.0||15281.5||14503.0||13567.0||12214.5||12015.0||10951.333||10930.333,0.0,0.0,0.06666666666666667
640,Arch_Dermatol_Res-3-1-1839867.txt,skin||subepiderm blister||leukocyt||pathogen||bullou pemphigoid||predomin||pemphigu||igg subclass||intracellular||igg||studi||epidermolysi bullosa acquisita||complement||diseas||acantholysi||activ||patient||autoimmun bullou diseas||bullou system lupu erythematosu||type vii collagen||autoimmun||blister-induc potenti||autoimmun respons||autoantibodi||mice||bullou pemphigoid patient||relev||blister format||subclass,1||2||refer 1||patient||cell||studi||3 50||fig. 4||3 31.||desmoglein 3||73 75 73 2||2007||pemphigu patient||58 73 75 58 2||2001,31046.0||28965.0||16864.5||13567.0||12627.0||12015.0||9866.5||8956.5||8749.5||8569.0||7906.25||7287.0||6889.0||6545.8||6313.0,0.2,0.2,0.13333333333333333
641,Purinergic_Signal-4-2-2377316.txt,concentr||tyrosin phosphoryl||guanylyl cyclas||pharmacolog inhibitor||chemorepel||avoid||enzym||protein||gtp||studi||western blot||messeng pathway||buffer||pkc||control||behavior assay||purin metabol||behavior buffer||tyrosin kinas||inhibitor||calcium||cell||data,1||2||1 1 3||1 3 4 2 2 2||3||refer 1||1 ml||1 mM||arm 1||1 nM||1 2 tetrahymena tetrahymena||solut 2||13 18 21 2 2||4||cell,31046.0||28965.0||26378.667||24653.667||17044.0||16864.5||15906.0||15723.5||15682.5||15579.0||15042.75||14945.0||13880.4||12937.0||12627.0,0.0,0.0,0.06666666666666667
642,Eur_Arch_Psychiatry_Clin_Neurosci-3-1-1800370.txt,differ||brain||ventromedi frontal lobe damag||mental state||abil||tom||fals belief||group||order||behaviour||social situat||brain damag||score||perform||damag||peopl||studi||healthi control||social cognit task||lmpfc||cognit profil||lesion||statement||medial frontal lobe||task||tactic strategi||schizophren||patient||mental retard||signific correl||stori||item||prefront cortex||subject||control group||deficit||frontal lobe lesion||human||schizophrenia||social cognit,1||1 2||2||fig. 1||3||refer 1||2 fig. 2 perform||2 classif||patient||4||studi||test question 2||3 fig. 3 perform||40 3||patient group,31046.0||30005.5||28965.0||18011.0||17044.0||16864.5||16460.5||14824.5||13567.0||12937.0||12015.0||11009.667||10500.0||9597.0||9221.0,0.0,0.1,0.13333333333333333
643,Surg_Endosc-4-1-2292805.txt,respiratori tract||differ||laparoscop approach||insur||hospit||open surgeri||approach||urinari tract||analysi||present||admiss||cholecystectomi||odd||nosocomi infect risk||nosocomi infect||appendectomi||cmi||cardin health||nim||patient||infect||risk||multivari logist regress analys||laparoscop||nim rate||complex||procedur||data||type||hysterectomi||result,1||2||data 1||3||refer 1||issu 1||comorbid 1||llc 2008 1 2||1 drg||patient||3 4 6||4||studi||1 nim rate||5,31046.0||28965.0||18007.5||17044.0||16864.5||15848.0||15658.0||15587.75||15524.0||13567.0||13018.333||12937.0||12015.0||11220.333||10364.0,0.0,0.1,0.06666666666666667
644,Eur_J_Pharmacol-2-1-2258315.txt,anti-fibrot activ||anti-fibrot agent||effect||death||hepatocyt||fucoidan||reactiv oxygen speci||studi||hepat fibrosi||hepat stellat cell||biolog activ||treatment||hepatocyt injuri||cell death||liver||liver fibrosi||cell||serum||mice||fibrosi||result,1||1 activ||3||1 mM||yagi@phs.osaka-u.ac.jp 1||2 materi||fig. 2 4 4||1976 5 2 4||4 4||4||cell||fig. 3 4 4 4||studi||abstract 4 4 4 4||1993 5 2 mosmann,31046.0||18138.5||17044.0||15723.5||15524.0||15325.0||14953.75||13140.75||12937.0||12937.0||12627.0||12166.2||12015.0||10457.0||10279.5,0.0,0.0,0.13333333333333333
645,Pediatr_Radiol-3-1-1950217.txt,reduct||osteoporosi||hip bmd||idiopath short statur||correl||low bmd||matur||normal||lower extrem||normal hormon level||factor||short statur||growth hormon||LS bmd||follow-up||nonambulatori||lean tissu mass||diseas||bone deposit||increas||bone diseas||diagnosi||fractur||improv||children||treatment||low bone mass||patient||height||dxa find||chronic condit||bone miner densiti||oral contracept||therapi||abnorm dxa find||physic activ||normal valu||dxa||peak bone mass||CS therapi||year||signific reduct||bmd||calcium||full bmd recoveri||result||cranial irradi||level||inhal CS||pediatr||bone miner||puberti,2 3 4||1 year||refer 1||3 1 depart||2 year||patient||type 1 diabet||studi||valu 2 year||usa 2 depart||springer-verlag 2007 introduct 1||type 1 diabet mellitu||2005||2004||pediatr patient,19648.667||17151.0||16864.5||16861.333||16110.5||13567.0||12155.0||12015.0||11648.667||11119.0||10308.75||9191.5||8716.0||8077.0||7786.5,0.0,0.1,0.06666666666666667
646,Dig_Dis_Sci-3-1-1914242.txt,terminolog||databas||complic||diagnos||report||endobas iii system||comprehens code system||field||intern classif||group||text-block||central databas||code system||endoscop find||descript||import||diseas||endoscopi||therapeut procedur||hospit inform system||system||comput system||chapter||endoscop term||code||minim standard terminolog||item||find||procedur||classif||investig||get-c||structur,1||2||2 3 4||result 1||refer 1||netherland 2||chapter 1||2 comparison||chapter 2||method 2 5||6 1 depart||patient||studi||3 year||6,31046.0||28965.0||19648.667||18563.0||16864.5||15560.5||15556.5||15308.5||14516.0||14333.667||14204.667||13567.0||12015.0||10150.0||9074.0,0.0,0.0,0.0
647,Ann_Surg_Oncol-4-1-2244700.txt,apoptot cell||cancer||clinic studi||correl||perimembran||cell mitosi||nsclc||prognost signific||overexpress||aurora-a||studi||poor prognosi||postop surviv||present studi||surgeri||neg control slide||section||prognosi||lung cancer||non-small-cel lung cancer||tumor||signific factor||prolif activ||result,1||1 1||2||2 2||3 2||3||refer 1||2 25||patient||phd ftanaka@kuhp.kyoto-u.ac.jp 1 1 depart||4||cell||studi||5||method patient 1 histolog type,31046.0||31046.0||28965.0||28965.0||23004.5||17044.0||16864.5||16132.0||13567.0||12962.8||12937.0||12627.0||12015.0||10364.0||10331.6,0.0,0.0,0.06666666666666667
648,Pharm_World_Sci-3-1-2039831.txt,intervent||placebo control group||differ||pdd||primari care||effect||discontinu||melatonin||group||medic||benzodiazepin||gp||questionnair||daili dose||gener practic||particip||discontinu rate||low dose||qualiti||patient||week||period||user||hypnot||trial||year||bd,1||2||1 21||1 year||3||refer 1||1 characterist||80 1||2 test||2 follow||result 1 fig. 1 select||patient||4||studi||5,31046.0||28965.0||17163.5||17151.0||17044.0||16864.5||16168.5||16112.0||16085.5||15550.5||14982.4||13567.0||12937.0||12015.0||10364.0,0.0,0.0,0.06666666666666667
649,J_Comp_Physiol_A_Neuroethol_Sens_Neural_Behav_Physiol-4-1-2248214.txt,scatter||structur colour||light||wing||singl scale||butterfli||kinoshita||backscatt light||wavelength||multilay structur||pattern||singl butterfli scale||reflect||reflect spectra||colour||diagram||angular reflect||transmiss electron microscopi||butterfli speci||case||angular distribut,2 2 2||2||2 4 2 4||2 1 2 P. rapa||fig. 2||G. 1 1 depart||1 min||column 1||2 D.||2 min||2 stavenga||4 4 6||1 μm U.||m.a.giraldo@rug.nl 1 yoshioka||3 P.,28965.0||28965.0||20951.0||18232.6||16970.5||16454.25||16158.0||15684.5||15289.5||15117.5||14486.0||11649.333||10513.333||10358.333||9523.0,0.0,0.0,0.0
650,Health_Care_Anal-3-1-2045690.txt,organ||respons||reliabl||question reliabl||non-profit organ||choic||tool||web||special toolbar||practic||hon||exampl||polit actor||social commun||state||health profession||non-government organ||term||technolog||diseas||particip||literatur||care||internet technolog||activ||patient||citizen||internet||percept||user||commun||consum||reflex consumer||individu||trust mark||user tool||reflex||actor||skill||site||inform||search||type||medic profession||initi||prescript||health,1||2||4 2 3 1||1 4||1 56 2||12 1 fig. 1||9 1||refer 1||2 fig. 2 http://www.medcircle.org||2 http://www.jmir.org/2000/1/e7/index.htm||2 http://www.jmir.org/2000/2/e13/index.htm||patient||4||2 januari 2005||access 1 49,31046.0||28965.0||22498.0||21991.5||20344.0||18230.0||18219.0||16864.5||15727.0||14483.0||14483.0||13567.0||12937.0||12603.667||11146.0,0.0,0.0,0.06666666666666667
651,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2206250.txt,vitrectomi||suicid bomb||emerg facil||injuri||bomb||ophthalmologist||intra-lenticular foreign bodi||ocular procedur||hospit||trauma||terror||medic treatment||special attent||urgent primari closur||eye||open globe||head||primari closur||ED stay||surgeri||senior surgeon||patient||ocular injuri||attack||mass casualti||surgic procedur||ocular trauma||lacer||victim||type||surgeon||primari repair,1||1 1||2||refer 1||springer-verlag 2008 1 2 3||1 mm||2 mm||patient||4||1 relev data||studi||acuiti 1 17||trauma 2 16||5||6,31046.0||31046.0||28965.0||16864.5||16140.0||15936.5||14896.0||13567.0||12937.0||12234.0||12015.0||11576.667||11072.0||10364.0||9074.0,0.0,0.1,0.06666666666666667
652,Int_J_Cardiovasc_Imaging-4-1-2233708.txt,sequenc paramet||day||element cardiac||repeat catheter||viabl myocardium||artifact||flow||repeat intervent||feasibl||acut||stent posit||cine imag||analysi||studi||dark band||field strength||acut myocardi infarct||cine||imag||cmr||dark band artifact||puls sequenc||system||chronic phase||quantit analysi||imag qualiti||patenc||scan||safeti||cardiovascular magnet reson,1||1 1||2||1 2 1 depart||ave 1 1||prokinet 1 2||prokinet 2 1||result 1||3 3||3||fig. 2||refer 1||2 type||chronic phase 2 1||lekton motion 1 1,31046.0||31046.0||28965.0||23387.75||20703.667||20005.333||20005.333||18563.0||17044.0||17044.0||16970.5||16864.5||15946.5||15654.0||15615.75,0.0,0.0,0.0
653,Eur_Child_Adolesc_Psychiatry-2-2-1705530.txt,genet risk||gestat||coeffici||effect||lbw||birth weight||report||variabl||depress||factor||influenc||depress disord||pre-nat smoke||birth-weight||twin||depress symptom||associ||birth||social class||studi||symptom||regress analysi||age||famili risk||analys||children||mother||standard||parent report||risk||unit increas||child||weight||interact||result,1||2||time 1||refer 1||time 2||twin 1||2 thapar anita 1 1 dept.||1 tabl 2 genet risk||genet regress analysi 2 2||studi||0.05 fig. 1 genet risk||2004||2003||present studi||genet studi,31046.0||28965.0||17493.5||16864.5||16453.0||15807.0||15188.0||13947.2||13177.0||12015.0||8700.4||8077.0||7651.0||7377.0||7361.0,0.0,0.1,0.06666666666666667
654,Diabetologia-3-1-2063563.txt,clamp||glucos||carrier||beta cell||glp-1||insulin secret||plasma glucos||ogtt||insulin sensit||type 2 diabet||data||variant||insulin||gene||risk||hyperglycaem clamp||pancreat beta cell||polymorph||particip||result,1||2 1||2||1 0.43 2||1 0.29 2||refer 1||tcf7l2 gene 1 1||1 40||1 45||1 41||1 47||2 test||1 58||type 2||2 diabet,31046.0||30005.5||28965.0||20062.0||20059.0||16864.5||16736.0||16598.0||16340.5||16294.0||16159.5||16085.5||16000.5||15946.5||15728.0,0.0,0.0,0.0
655,Mol_Biochem_Parasitol-1-5-1906845.txt,polv,1||2||fig. 1||group 1||3||fig. 2||group 2||1 dbl||patient||2003 2 27||4||studi||1 famili member||2003 2 7 12737636||5,31046.0||28965.0||18011.0||17960.5||17044.0||16970.5||16920.0||15523.5||13567.0||13009.333||12937.0||12015.0||11151.0||10903.5||10364.0,0.0,0.0,0.0
656,Clin_Rheumatol-3-1-1820749.txt,spatial summat||respons||inhibitori pathway||electr stimul||mechan||cognit emot sensit||pain||tempor summat||catastroph thought||hyperalgesia||central nervou system||central sensit||hypothesi||cf||chronic fatigu||cognit||musculoskelet pain||multipl spinal segment||studi||stimuli||evid||spinal cord||physiolog mechan||similar||fibromyalgia||sensit||pain complaint||chronic fatigu syndrom||patient||pain process||central mechan||theoret background||knowledg||chronic pain||brain abnorm||central process||wind-up||allodynia||chronic widespread pain||pathway||investig||result||function brain activ,1||2||3||refer 1||patient||studi||belgium 2 divis||2006||2004||pain patient||effect||FM patient||fibromyalgia patient||cf patient||belgium 3 depart,31046.0||28965.0||17044.0||16864.5||13567.0||12015.0||9789.0||8371.0||8077.0||7610.5||6956.0||6906.0||6812.5||6799.5||6553.667,0.2,0.2,0.13333333333333333
657,Theory_Biosci-4-1-2254468.txt,evolutionari biolog||speci||respond||earlier paradigm||cladogram||phylogenet||systemat||tree||popul||graduat student||draw||group||order||biolog||region univers colleg||import||taxon||question||remaind||evolutionari tree||singl student||phylogenet relationship||stem group||modern evolutionari biolog||find||correct answer||taxa||text book||attent||linnean categori||essenti||relationship,1 1||1||2||fig. 1||3 3||400 1||question 2||4||discuss 1997 1||studi||fig. 3||detail 1 1974||2 fig. 2 phylogenet tree drawn||5||norway 2 avdel,31046.0||31046.0||28965.0||18011.0||17044.0||15650.5||14911.5||12937.0||12098.667||12015.0||11010.0||10595.333||10566.333||10364.0||9676.667,0.0,0.0,0.0
658,Arch_Dermatol_Res-3-1-1910889.txt,articl||urticaria||intoler||nsaid||advers reaction||non-steroid anti-inflammatori drug||grade||coxib||drug||public||reaction||studi||symptom||patient||advers event||non-allerg advers event||evalu||predefin evalu sheet,1||2||0 1||3||refer 1||grade 1||1 ctcae||2 nsaid||cyclo-oxygenas 2||0 0 1||double-blind studi 2||patient||4||49-69-63015117 boehncke@em.uni-frankfurt.d 1 1 depart||0 0 valdecoxib 69 2 1,31046.0||28965.0||18569.5||17044.0||16864.5||15863.5||15524.0||14521.5||14484.0||14410.667||13721.333||13567.0||12937.0||12917.6||12172.833,0.0,0.0,0.06666666666666667
659,Histochem_Cell_Biol-4-1-2248607.txt,neuroendocrin tissu||ph||immatur secretori granul||isg||pc||matur||hypothesi||cell type||zymogen granul||vesicl||molecular tool||msg||import issu||hormon process||process||secret||chromogranin||granul||protein||addit||membran||phenotyp||biochem||prohormon convertas||secretori granul||earli biochem approach||observ||assay||neuroendocrin cell||experi||isoform||size||physiolog pH||role||golgi complex||homotyp fusion||tgn||constitutive-lik secret||cell||data||special cell||mice||biochem approach||pathway||secretori pathway,1||2||3||patient||cell||studi||adp-ribosyl factor 1||3 express||2005 2005||cell biol||2006||cell system||cell type||2003||compar studi,31046.0||28965.0||17044.0||13567.0||12627.0||12015.0||11842.667||10719.5||8716.0||8411.0||8371.0||8155.5||7777.5||7651.0||7344.5,0.2,0.1,0.13333333333333333
660,Int_Arch_Occup_Environ_Health-4-1-2413126.txt,offic worker||scale||correl||plaqu||neg correl||ldl||global stress level||factor||employe||healthi lifestyl||stress||earli atherosclerosi||work-rel stress||studi||low decis latitud||chd||carotid arteri||smoke||risk||atherosclerosi||sera||individu||case||presenc||level||work||imt||result,1||2||2 result||3||particip 1||1 characterist||anna 1 6 1 depart||2 gpi||patient||4||studi||physic activ 2||0 3||3 result||method 2 gpi,31046.0||28965.0||17522.5||17044.0||16518.0||16168.5||14736.8||14491.0||13567.0||12937.0||12015.0||11758.0||11568.5||11562.0||10884.667,0.0,0.0,0.06666666666666667
661,Purinergic_Signal-4-2-2377324.txt,intercal cell||Na||purinerg receptor||kinas||stress-activ protein kinas||medium||cotransport||jnk||activ||cell||inhibit||atp||Cl||nkcc||membran||usa,1||1 2||2||2 2||3 2||1 3 3||4 2||2007 1||2 2 19 20 2||12 2||refer 1||13 17 1 2 44 1||17 2||1 μg||1 agonist,31046.0||30005.5||28965.0||28965.0||23004.5||21711.333||20951.0||19166.5||18925.2||17408.5||16864.5||16707.833||16274.0||15725.5||15623.0,0.0,0.0,0.0
662,Matern_Child_Health_J-2-2-1592154.txt,perinat||episod||outcom||health care provid||month||sara||depress||pregnanc||postpartum period||concept||medic||infant||addit||mood disord||melani||treatment||care||mental health||women||earlier treatment||famili||preconcept||histori||risk||year postpartum||counsel,refer 1||1 sara||2 melani||kmounts@pol.net 2 1 wisconsin associ||studi||1 mount kyle||10||effect||health||treatment||health care||prospect studi Br||15||2001 65 9 17 10.1016||well-control intervent studi,16864.5||15532.0||14499.0||12742.4||12015.0||10392.667||6982.0||6956.0||5601.0||5012.0||4689.0||4650.333||4577.0||4410.4||4381.667,0.0,0.1,0.06666666666666667
663,Diabetologia-4-1-2292427.txt,glomerular filtrat barrier||genet risk||hypertens||progress renal impair||hyperglycaemia||metabol pathway||key||diabet patient||diabet popul||permeabl||factor||develop||glomerular endotheli cell||protein||diabet||normal gfb||import||albumin||filtrat rate||diabet complic||diseas||vascular diseas||increas||podocyt||inflammatori cytokin||signific||direct cellular effect||observ||gfb||key player||microalbuminuria||import contributor||podocyt loss||vegf||risk factor||glycocalyx||type||diabet nephropathi||level,2||type 1||refer 1||2 diabet||s.c.satchell@bristol.ac.uk 1||patient||type 1 diabet||studi||type 2 diabet||normotens type 1||E. 2 1 academ renal unit||obes type 2||japanes type 2||5||3 fig. 3 pathway,28965.0||16987.0||16864.5||15728.0||15523.5||13567.0||12155.0||12015.0||11461.333||11332.667||10936.333||10758.333||10695.667||10364.0||10097.0,0.0,0.0,0.0
664,Arch_Dermatol_Res-3-1-1910890.txt,literatur||aspect||evidence-bas guidelin||drug interact||treatment||drug||induct therapi||evalu||therapi||patient||psoriasi||expert||evid||recommend||psoriasi vulgari||unsystemat literatur search||guidelin||therapeut option,1||2||5 1||1 2 evid||3||refer 1||2 year||LE 1||2 evid||2 week||week 2||background 2 3 4||LE 2||2 augustin||patient,31046.0||28965.0||20705.0||20516.667||17044.0||16864.5||16110.5||15649.0||15252.0||15100.0||15100.0||14842.5||14608.5||14488.0||13567.0,0.0,0.0,0.06666666666666667
665,Plant_Cell_Rep-4-1-2413081.txt,explant||poinsettia plant||medium||resist||rna||t-dna||pcp||area||transform||pnmv-deriv hprna construct||ornament||current studi||co-cultiv||poinsettia||genet engin||infect||somat embryogenesi||root induct||ornament plant||line||non-fe plant||poinsettia genom||transgen line||transgen||millenium||somat embryo||pnmv,1||1 1||2||1 1 1994 1||2 strength 2||2003 1||1 2007||3||1 1994||1 min||1 200 21 2||1 cycl||1 600||RI 1||1 kanamycin,31046.0||31046.0||28965.0||23843.75||19421.667||19348.5||19166.5||17044.0||16641.5||16158.0||15946.5||15884.0||15633.5||15561.5||15526.0,0.0,0.0,0.0
666,Clin_Oral_Investig-4-1-2238784.txt,age group||partial record system||occlus||wear||surfac||teeth||criteria||score||measur||dental eros||hard tissu loss||dentin||literatur||sever||eros||system||aetiolog||tooth wear||amount||epidemiolog||indic||method||epidemiolog studi||data||loss,1||2||4 2||1 10||3||refer 1||30 2||2 30||1 mm||grade 1||contour 1||involv 2||2 30 4||2 mm||contour 2,31046.0||28965.0||20951.0||19014.0||17044.0||16864.5||16116.0||16116.0||15936.5||15863.5||15557.5||15365.0||15056.333||14896.0||14517.0,0.0,0.0,0.0
667,Cancer_Immunol_Immunother-4-1-2253649.txt,cancer||differ||hla||number||immunohistochemistri||local recurr||irradi||low||group||clinic impact||msi||studi||surviv||analys||patient||total absenc||prognosi||colon||impact||tumor||rectal cancer||hla express||low express||stromal cell||result,1||2||2 2||2 4 fig. 2||1 1 1 II 2.2||fig. 1||rectal cancer 1 1||refer 1||0.001 1||RT 1||1 0.042 1 0.006 1 0.653||f.m.speetjens@lumc.nl 1||patient||4||31-71-5266750 p.j.k.kuppen@lumc.nl 1 1 depart,31046.0||28965.0||28965.0||18960.75||18933.2||18011.0||17371.75||16864.5||16095.5||15678.5||15545.167||15523.5||13567.0||12937.0||12917.6,0.0,0.0,0.06666666666666667
668,Exp_Appl_Acarol-3-1-2039800.txt,slt||phytoseiida||sri lanka||perianth||predatori mite||coconut palm||cultivar||surfac||adult femal||coconut mite||densiti||coconut fruit||gap||eriophyida||bulb||coconut||size||space||narrow space||mite||dgt||data||infest,"2||1 cm||1 2 sabe mauric||tabl 1 analysi||4 4||studi||fig. 3||1 cm Ø||phytophaga 2004 14 1 7 lesna||2004||3 4 N. baraki||fig. 5||2003||2007||cultivar 2 40,287 5.36",28965.0||15761.0||15012.0||13116.333||12937.0||12015.0||11010.0||10509.667||8404.167||8077.0||7713.75||7670.0||7651.0||7287.0||7253.75,0.0,0.0,0.0
669,Clin_Oral_Investig-4-1-2238791.txt,shape||cup||current diagnost criteria||occlus||wear||current criteria||shallow defect||group||surfac||loss||tissu loss||teeth||criteria||clinic experi||dental eros||studi||characterist||risk group||diseas||incis||lesion||defect||eros||diagnost criteria||tooth wear||exposur||epidemiolog||valid||subject||epidemiolog studi||case||diagnost process||adjac tooth surfac||diagnosi||acid,1||2||3||refer 1||moder 1||eros 1||part 2||2 preval||1 10 8||19 28 2 fig. 2||patient||grade 2 5||4||8 10 8 1||studi,31046.0||28965.0||17044.0||16864.5||15807.5||15792.5||15018.0||14867.5||14727.333||13733.8||13567.0||13336.667||12937.0||12584.0||12015.0,0.0,0.0,0.06666666666666667
670,Ann_Hematol-3-1-1914243.txt,drug resist||breast cancer resist protein||age||express||surviv||CR rate||elderli aml patient||ef||cell||result||aml||major vault protein||patient||studi||event-fre surviv||level||wbc count||secondari aml||mrna,1||2||3||refer 1||1 day||mdr1 3 2||2 mdr1||patient||4||cell||tabl 1 comparison||studi||mdr 1 express||mdr1 bcrp 3 2||netherland 2 depart,31046.0||28965.0||17044.0||16864.5||16489.5||15358.333||14515.5||13567.0||12937.0||12627.0||12104.667||12015.0||11815.333||11538.25||11205.0,0.0,0.2,0.2
671,Int_Arch_Occup_Environ_Health-4-1-2254471.txt,part-tim return||day||differ||dutch situat||episod||durat||psychiatr disord||number||educ||compani||depress||popul||occup health depart||group||employe||elderli employe||depress symptom||industri sector||studi||health care||symptom||social legisl||work||age||sector||absenc||sick-leav||period||higher risk||depress episod||compani size||return||year||men||median,1||2||2 1 depart||1 year||3||result 1 2 df||1 day||age 2||novemb 1||patient||januari 1 2004||tabl 1 number||studi||31-50-4244307 petra.koopmans@arboned.nl 1 2 roelen||netherland 2 depart,31046.0||28965.0||20835.0||17151.0||17044.0||16560.0||16489.5||16265.0||15566.0||13567.0||13084.333||12544.0||12015.0||12002.8||11205.0,0.0,0.0,0.06666666666666667
672,Bioinformation-2-5-2241933.txt,text mine||keyword||annot||analysi||process||associ||gene annot sentenc||protein||structur||studi||term||noun||frequenc||mesh||biomed literatur||sentenc||initi test||gene||list||method||gene express experi||inform||larg number||set||data||abstract||vector||function,1||2||1 2 3 4 5 6||3||figur 1||4||ganapathi jawahar 1 1 centr||2 cancer categori||studi||keyword figur 2 character 19 gene||current studi||cell death||7 8||biomed literatur natarajan jeyakumar 1||protein,31046.0||28965.0||18238.333||17044.0||16123.5||12937.0||12569.8||12224.667||12015.0||6746.167||6741.5||6710.0||6575.5||6382.2||6288.0,0.0,0.1,0.13333333333333333
673,Breast_Cancer_Res_Treat-4-1-2244694.txt,cancer||lifetim||number||menarch||sex hormon||breast cancer risk||breast cancer||shbg||dhea||testosteron||studi||irregular categori||hormon||characterist||sex hormon level||particip||lifetim exposur||age||children||women||androgen||risk||physic activ||androstenedion||risk factor||menstrual cycl||find||trend||reproduct characterist||level||year||fftp||menopaus||cycl||cumul number,1||2||result 1 2 17 2||3||refer 1||2 children||1 17.5||1 16.14||2 week||2 185||2 17.57||M. 1 1 juliu center||1999 1 1 18 21 10.1186||studi||1 lifetim number,31046.0||28965.0||19727.8||17044.0||16864.5||16091.5||15547.0||15524.0||15100.0||14608.0||14484.5||13496.8||12378.0||12015.0||11380.0,0.0,0.0,0.06666666666666667
674,Eur_Child_Adolesc_Psychiatry-2-2-1705537.txt,cognit function||interfer task||gener alert||genet risk||wcst||differ||effect||correl||speed||variabl||group||cognit adjust||genet vulner||select||fwit||schizophren patient||score||perform||analysi||correct trial||rel||studi||correct||first-degre rel||young person||task||tmt||children||sibl||impair||control||test||patient||risk||execut function||indic||subject||cognit impair||cognit flexibl||attent||schizophrenia||proband||genet influenc||result,1||2||school 1 1||3||refer 1||3 4||patient||1998 30 1 1 9 10.1016||26 37 1 2 51||2002 54 1||4||2004 71 2||secondari school 3 1||2002 57 2||2000 46 2,31046.0||28965.0||20928.0||17044.0||16864.5||14990.5||13567.0||13459.667||13104.4||13086.667||12937.0||12618.333||12347.5||12336.333||12064.333,0.0,0.1,0.06666666666666667
675,Cancer_Immunol_Immunother-4-1-2335290.txt,respons||cancer||day||complic||effect||local edema||month||dose||median surviv time||high altitud||order||anim||interleukin-2||conclus||immun reaction||carcinoma||boscc||immunotherapi||inject||metastas||human cancer patient||necrot materi||sarcoid||studi||cure||bladder||treatment||sensit||immun system||therapeut effect||patient||regress||section||system immun||therapi||nasopharyng carcinoma||tumor||sarcoma||local treatment||cell||case||mice||massiv liber||complet regress||immun||applic||local||human patient||result||function,1||1 2||2||2 patient||mesothelioma 1 1||5 1||1 3 1 85||5 2||2 8||3||refer 1||tabl 2||line 1||anim 1||grade 1,31046.0||30005.5||28965.0||21266.0||20705.333||20705.0||19991.0||19664.5||17559.5||17044.0||16864.5||16290.5||16165.5||15970.0||15863.5,0.0,0.0,0.0
676,Biotechnol_Lett-3-1-1914260.txt,potato||asr||dextran||foreign polym||glucansucras||express||starch content||class||tuber||transform||tuber juic||gene||kd-ut||plant||alternan||starch granul||starch||result,1||1 2||1 tabl 1 50||3||1 2001 2003||4||netherland 2 depart||4 4 2000||5||1 2005a 2006 streptococcu||6||1 asr transcript level||2005||3 gerrit||2003,31046.0||30005.5||17099.25||17044.0||15003.333||12937.0||11205.0||10592.333||10364.0||9895.5||9074.0||8794.5||8716.0||8531.0||7651.0,0.0,0.0,0.0
677,Arch_Dermatol_Res-2-2-1705535.txt,respons||arthropathi ae||clinic respons||efalizumab group||ae||group||efalizumab||analysi||psoriasi||studi||clinic trial||open-label extens||increas||efalizumab-tr patient||proport||treatment||efalizumab treatment||psoriat arthriti||patient||chronic plaqu psoriasi||week||incid||routin clinic practic||risk||placebo group||joint diseas||arthropathi||placebo||event||arthriti||long-term treatment||long-term studi||trial||data||previou histori||result,1||1 1||2||1 1 fig. 1||22 1||refer 1||exposur phase 1 1||1 mg||pp 1||re-treat phase 1 1||1 summari||florenc 2 1 depart||result 1 12 13 2||2 mg||2 baselin,31046.0||31046.0||28965.0||24528.5||17114.5||16864.5||15990.75||15945.0||15890.0||15763.0||15734.5||15630.25||15241.0||14904.5||14829.0,0.0,0.0,0.0
678,Cancer_Causes_Control-2-2-1764594.txt,race||prevent servic task forc||feder poverti level||number||program||percentag||ethnic background||mammogram||nation level||popul||breast cancer||estim||state||ethnic||uninsur women||grante||women||servic||elig||cervic cancer earli detect program||nation breast||provid||health insur||mammographi screen||poverti level||poverti||method||screen rate||breast cancer screen||data||year||hispan origin||famili incom,1||2||1 1 divis||result 1||3||1 number||1 fig. 1 note||refer 1||1 state||2 number||appendix 1||appendic 1||step 2||studi||1 coat ralph,31046.0||28965.0||20790.333||18563.0||17044.0||17008.0||16938.75||16864.5||16293.5||15967.5||15644.5||15525.0||14763.0||12015.0||10406.667,0.0,0.0,0.0
679,Pediatr_Nephrol-3-1-1805049.txt,sodium thiosulf||calcif urem arteriolopathi||calcium||calcif||patient||week||acut renal failur||hemolyt urem syndrom||hu||soft tissu,refer 1||ipna 2007 introduct 1 2||patient||1 month show||type 2 diabet||radiotrac activ fig. 2||case report 3 4 5||2004||84101 israel 2 depart||effect||dialysis-depend patient||endotheli cell||8 9 10||12||diseas,16864.5||13733.2||13567.0||11628.333||11461.333||9795.0||9324.4||8077.0||7881.5||6956.0||6784.5||6691.5||6176.0||5852.0||5149.0,0.2,0.1,0.06666666666666667
680,Naturwissenschaften-4-1-2270361.txt,friction||human hair||skin||bodi angl||african ape||young modulu||posit||orangutan||infant carri||area||anim||gorilla||gibbon||infant||densiti||condit||bodi hair||cling||bodi||valu||hair||load||mother||biped||scenario||mechan properti||forc||chang||limit||curv||problem||weight||safeti||ape||human||adult bodi||primat||result,1||1 2||2||1 5||2 line 2||2 1968 2||3||1 refer||1 2 1987 2004 2 1982||μ 1||1 μ||2 squar 2 triangl 2 line||2 appendix||2 μ||2 1968,31046.0||30005.5||28965.0||20705.0||19738.333||19347.0||17044.0||16864.5||16407.5||15610.0||15610.0||14753.333||14604.0||14569.5||14538.0,0.0,0.0,0.0
681,Int_J_Legal_Med-3-1-2039830.txt,clavicl||model||differ||effect||sex||fusion||variabl||CT scan||probabl||complet fusion||ethnic||dri bone specimen||fusion statu||hdi||studi||age||signific||medial epiphysi||age interv||slice thick||individu||femal||method||examin||data||year||socioeconom statu||result,1||2||result 2||model 1||1 1 fig. 1 age distribut||1 number||refer 1||model 2||tabl 2||12 14 2||4||studi||R. 2 schulz ronald 3||6||andrea 3 1 netherland forens institut,31046.0||28965.0||17522.5||17468.5||17207.0||17008.0||16864.5||16428.0||16290.5||13038.0||12937.0||12015.0||9596.4||9074.0||8630.0,0.0,0.0,0.06666666666666667
682,Auton_Neurosci-2-1-2428072.txt,gap junction||lower cell surfac||motoneuron||neuron||adult rat||electr synaps||lamina viii||slice||coupl||vitro studi||room temperatur||studi||import||antibodi||close apposit||import role||spinal cord||cytoplasm||electroton transmiss||express||adult anim||chat||somat motoneuron||rhythmic||cell bodi||cell||optic section||sympathet preganglion||dendrit process||chat-ir cytoplasm||connexin,1||2||fig. 1||1 i.p.||2 materi||2005 fig. 2||fig. 3 fig. 2||4||cell||studi||fig. 3||5||6||fig. 2 repres exampl||cell group,31046.0||28965.0||18011.0||15534.5||15325.0||14219.0||13990.25||12937.0||12627.0||12015.0||11010.0||10364.0||9074.0||8941.75||8751.0,0.0,0.2,0.13333333333333333
683,Ann_Surg_Oncol-3-1-1914273.txt,respons||skin||recurr diseas||amput||month||tumor necrosi factor alpha||limb salvag||radiotherapi||follow-up||diseas||surviv||treatment||resect margin||patholog examin||time period||patient||critic leg ischemia||perfus||resect||distant metastas||isol limb perfus||tumor||sarcoma||ilp||necrosi||limb||patholog fractur||melphalan||adjuv radiotherapi||radiat||late morbid||year||result,1||2||rang 2||limb salvag 2 2 tabl 2||patient||phd h.j.hoekstra@chir.umcg.nl 1 1 divis||studi||netherland 2 depart||5||tabl 3||4 4 fig||result tumor respons 1 fig||3 fig||21 patient||patient 21,31046.0||28965.0||15228.5||15147.5||13567.0||12520.2||12015.0||11205.0||10364.0||10330.0||8649.0||8639.2||8558.5||8424.0||8424.0,0.2,0.1,0.06666666666666667
684,Bioinformation-1-4-1891668.txt,databas||number||medicin plant||record||data||diabet||diamedbas||plant||diseas,1 1 3 2||bioinform 1||4||530016 2 depart||4 5 6 7 8||refer 1 grover JK||2006||10||diabet babu padavala ajay 1||diamedbas alo vera figur 1||12||diseas||data||2006 biomed informat publish group 2006||530045 3 sri venkateswara colleg,27025.25||15556.5||12937.0||10487.333||9105.2||8524.5||8371.0||6982.0||6713.8||6454.8||5852.0||5149.0||4969.0||3791.0||3510.6,0.0,0.0,0.13333333333333333
685,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2413121.txt,day||pain||effect||inflamm||sport activ||recoveri||arthroscop reconstruct||recoveri time||form||follow-up visit||i-on||group||puls electromagnet field||joint reaction||cartilag||biophys stimul||score||cartilag lesion||pemf||signific differ||studi||joint preserv||anterior cruciat ligament||knee pain||nsaid||increas||articular cartilag||function recoveri||treatment||activ||control||patient||placebo group||placebo||chondroprotect||studi design||procedur||ikdc knee examin form||intern knee document committe||result,1||1 2||2||2 fig. 2||result 1||refer 1||2 tabl||1 characterist||2 tabl 2 gener||2 week||patient||3 fig. 3||4||studi||biophys stimul 1 fig. 1 left,31046.0||30005.5||28965.0||20968.667||18563.0||16864.5||16290.5||16168.5||16050.75||15100.0||13567.0||13021.333||12937.0||12015.0||11649.167,0.0,0.0,0.13333333333333333
686,J_Interv_Card_Electrophysiol-4-1-2262917.txt,accessori pathway||magnet navig||robot navig||cathet tip||posit||ablat cathet||result twenti patient||oper||radiat exposur||cathet||left atrium||studi||time||system||steerabl guid cathet||patient||outer sheath||ablat||map||cardiac arrhythmia||forc||robot ablat||effect remot navig||laboratori||artisan||left femor vein||cathet ablat||tip||procedur||remot cathet ablat||artisan control cathet||human||data||sheath,1||2||1 fig. 1||1 5||result 2||method 1||1 year||3||refer 1||tabl 2||1 cm||2 week||2 4 5 fig. 4||patient||4,31046.0||28965.0||22356.0||20705.0||17522.5||17359.0||17151.0||17044.0||16864.5||16290.5||15761.0||15100.0||14035.8||13567.0||12937.0,0.0,0.0,0.06666666666666667
687,Support_Care_Cancer-3-1-2092409.txt,cancer||frustrat||effect||number||recurr diseas||parent||report||variabl||concept||group||factor||pearson correl analys||dutch||studi||parent cancer||tempera dimens||daughter||analys factor analys||adolesc children||pleasur intens||age||life event||children||question||control||adolesc||tempera||inter-item correl||illness-rel variabl||socio-demograph||problem||preval||attent||year||educ level||relationship||eatq-r,1||2||2 4||2 tabl 2||2 5||3||refer 1||1 cronbach||patient||4||studi||1997 1 rotterdam||netherland 2 depart||1 hoekstra harald||5,31046.0||28965.0||20951.0||20515.333||19664.5||17044.0||16864.5||15552.0||13567.0||12937.0||12015.0||11656.0||11205.0||10371.333||10364.0,0.0,0.0,0.06666666666666667
688,Graefes_Arch_Clin_Exp_Ophthalmol-3-1-2082065.txt,critic flicker fusion frequenc||light||peripher motion percept||motion contrast threshold||double-puls resolut||retina||visual function||group||loss||young control||stimulu||contrast sensit||measur||eye||signific differ||studi||arm||sensit||frequenc||age-match control||visual acuiti||test||patient||eccentr||motion||visual field||color percept||subject||dynam process||tempor resolut||threshold||region||motion sensit||result||function,1||2||2 1 fig. 1||1 age||3||refer 1||subject 1||2 2 fig. 3 46 60||patient||2 fig. 2 gabor stimulu||studi||3 8||color percept 1||5||4 2 fig. 4 broken line,31046.0||28965.0||24008.25||17305.5||17044.0||16864.5||16465.0||13804.0||13567.0||12632.0||12015.0||11599.0||10601.667||10364.0||10193.5,0.0,0.1,0.13333333333333333
689,Diabetologia-3-1-2039833.txt,organ||insulin resist||insulin secret||fatti acid||pancreat beta cell||develop||thiazolidinedion||diabet||studi||atp||circul||muscl||mitochondria||metabol syndrom||beta cell damag||adipos tissu||genet factor||adipocyt||releas||type 2 diabet mellitu||patient||ectop triacylglycerol deposit||risk||haart||triacylglycerol||cell||rate||result||lipotox,2 2||refer 1||J. 2 1 depart||type 2||2 diabet||j.a.maassen@lumc.nl 1 2 romijn||5 6 8 2||patient||cell||studi||type 2 diabet||2 30 33||netherland 2 depart||type 2 diabet mellitu||obesity-associ type 2 diabet,28965.0||16864.5||16573.5||15946.5||15728.0||15006.0||13639.25||13567.0||12627.0||12015.0||11461.333||11410.333||11205.0||8671.25||8597.0,0.0,0.3,0.26666666666666666
690,Skeletal_Radiol-3-1-2141652.txt,fluid||detect||blood flow||dorsal aspect||normal||neovascularis||flow||contrast agent||ray||mri||small quantiti||disadvantag||measur||studi||synov||rheumatoid arthriti||connect tissu||increas||author||imag||sensit||eros||ultrasound||bone||small field||patient||view||space||finger||hand||tendon insert||subcutan tissu||proxim recess||small joint||tendon||proxim phalanx||joint,1||2||1 2 1 3 4||techniqu 1 fig. 1||refer 1||2 year||1 mm||2 1 fig. 2 arrowhead arrow||phalanx 1||patient||23 1 24||studi||interphalang joint 1||3 mm||research studi,31046.0||28965.0||24207.6||17043.75||16864.5||16110.5||15936.5||15803.167||15529.5||13567.0||12436.667||12015.0||10544.333||8935.5||7861.5,0.0,0.1,0.13333333333333333
691,Neurochem_Res-4-1-2413118.txt,gene express||rna interfer||specif monoclon antibodi||pcr||PD patholog||DA level||protein||studi||dopamin||ds oligo||express||activ||DA biosynthesi||normal function||specif primer||α-synuclein||cell||data||level||vector||min,2||2 2||2 fig. 2||fig. 1||3||refer 1||1 μl||3 2 edta||2 min||cell viabil 2||lane 1 lane 2 lane 3||4||cell||1 Wu Bo 1 Yu||cell cultur 8 2,28965.0||28965.0||20968.667||18011.0||17044.0||16864.5||15631.0||15358.333||15117.5||13895.667||12989.0||12937.0||12627.0||12518.8||12225.25,0.0,0.0,0.06666666666666667
692,Purinergic_Signal-4-2-2377319.txt,microenviron||receptor||nucleosid||adenosin||atp releas||purinerg||synaps||cyclic nucleotid||releas||cell||ideal||tissu||receptor channel||atp||introductori articl||nucleotid,1||2||refer 1||1 4 3 4 5 6||4||cell||studi||line fluid 2||AL usa 2 depart||2007||cell biolog||2002||epitheli cell||special cell||mammalian cell,31046.0||28965.0||16864.5||15567.0||12937.0||12627.0||12015.0||10227.333||8458.5||7287.0||7089.5||7057.0||6606.5||6521.0||6474.5,0.0,0.1,0.06666666666666667
693,Environ_Manage-3-1-1866215.txt,recruit||sediment||cottonwood||water surfac||speci||nativ||water||number||weed||total||perenni||zone||plant||surfac||total cover||xeric condit||remov||elev||dam construct||time||establish||recruit box model||bare ground||upland||valu||horsetooth reservoir||upland plant commun||veget||dam remov||seedl||exposur||drawdown rate||upland veget||horsetooth site||colorado||veget colon||commun||cover||year||speci rich||dam||site||drawdown||plot,1||1 2||2||3||tabl 2||1 SE||june 1||1 mccune||4||studi||5||2 amlin NM||2 hart DD||2 stanley EH||2 shafroth PB,31046.0||30005.5||28965.0||17044.0||16290.5||15811.5||15589.0||15528.5||12937.0||12015.0||10364.0||9747.333||9745.333||9739.0||9722.0,0.0,0.0,0.0
694,Eur_J_Pediatr-3-1-1914268.txt,school age||brain||outcom||neuropsycholog function||abil||difficulti||normal rang||group||review||area||long-term follow-up||asphyxia||behavior problem||criteria||mild NE||neonat encephalopathi||cognit||moder NE||score||young age||research||read||school||studi||addit||gener||intellig||age||sarnat||children||system||behavior consequ||mild||domain read||futur research||educ achiev||ambigu result||problem||find||result||case||healthi peer||sever NE||inclus criteria||heterogen group||perinat asphyxia||averag rang||function,1||2||group 1||1 year||3||group 2||refer 1||trial 1||1 60||1 SD||stage 1||3 4 1 depart||heidelberglaan 1||2 SD||stage 2,31046.0||28965.0||17960.5||17151.0||17044.0||16920.0||16864.5||16639.0||16297.5||16164.5||16110.5||15880.25||15530.0||15124.0||15070.0,0.0,0.0,0.0
695,Osteoporos_Int-4-1-2267485.txt,model||osteoporosi||death||fractur probabl||clinic risk factor||exampl||probabl||bmi||osteoporot fractur||hazard function||cost-effect||fractur risk||studi||rheumatoid arthriti||death hazard||increas||fractur||age||hip||signific||cohort||absenc||comput||women||prior histori||continu variabl||risk||clinic fractur||clinic spine||valid||bmd||signific interact||data||hip fractur||assess||year,1||2||2 2||2 2 fig. 2 2||3 2||4 1||1 0||result 2||3||2 3 4 6||refer 1||1 fig. 1 input||2 diabet||1 7 8 4 9 1||2 unit,31046.0||28965.0||28965.0||24167.2||23004.5||21991.5||18569.5||17522.5||17044.0||17005.0||16864.5||16812.0||15728.0||15595.333||15109.5,0.0,0.0,0.0
696,Pediatr_Nephrol-3-1-1805050.txt,hypertens||urin microalbumin||ufsk||report||creatinin concentr||group||solitari kidney||renal function||standard method||renal size||ura||studi||abpm||patient group||children||control||unp||diastol BP||patient||size||uak||daytim||blood pressur||kidney||renal size sd||case||serum creatinin level||renal agenesi||BP profil||renal mass||compensatori hypertrophi,1||2||result 1||3||type 1||group 2||refer 1||2 22||0.06 2 1 121.95||0.001 2||26.44 2||patient||studi patient||1 demograph data||studi,31046.0||28965.0||18563.0||17044.0||16987.0||16920.0||16864.5||16074.0||15096.0||15055.0||14483.5||13567.0||12791.0||12071.333||12015.0,0.0,0.0,0.13333333333333333
697,Ann_Biomed_Eng-2-2-1705493.txt,model||vessel||intramyocardi pressur||resist||isobar beat||bottom||ventricular pressur||flow||pressur||low ventricular volum||fiber||volum||outflow decreas||stress||decreas||paramet sensit analysi||nfa||minimum||increas||coronari inflow||paramet||coronari bed||ventricular wall||chang||strain||intramyocardi pump||primari relat||radial wall stress||experiment observ||normal physiolog condit||primari interact||cardiac wall||cycl||limit number,1||2||1 1 depart||19 1 1 1 figur 2||1 8||0 2||3||1 23||refer 1||1 SD||2 kpa||1 8 13||model 9 1 2 6 22||6 3||3 6,31046.0||28965.0||21528.667||21103.0||18600.0||17529.0||17044.0||17017.0||16864.5||16164.5||14487.5||13820.667||13591.833||13059.0||13059.0,0.0,0.0,0.0
698,Appl_Microbiol_Biotechnol-4-1-2243256.txt,substrat||enzym activ||bind||putrescin oxidas||puo||putrescin||substrat specif||spectrum||enzym||amin||room temperatur||substrat bind||polyamin||activ||plate||gene||mutant||oxidas||aromat cage||oxid,1||1 mM||Rh 1||1 Rh||1 Rh Rh Rh 2 2||Rh Rh 2 2 Rh||tabl 2 Rh||1 1983 459||1 Rh Rh||1 Rh glu324leu||2 Rh Rh||Rh tabl 1 Rh||1 1997 ɛ 515||3 Rh||substrat specif Rh 1,31046.0||15723.5||15591.0||15591.0||14897.333||11667.6||10905.667||10567.333||10439.333||10395.0||9745.667||8733.5||8672.75||8590.0||8450.25,0.0,0.0,0.0
699,Skeletal_Radiol-4-1-2257990.txt,high intens||lumbar vertebra||pain||metastat diseas||low signal intens||progress diseas||vertebr bodi||mri||soft tissu mass||adipocyte-lik vacuol chordoid cell||benign notochord cell tumor||bone scintigram||lesion||imag||entir marrow space||notochord vestig||bone||radiograph||patient||surgic procedur||tumor||chordoma||bnct||case||giant notochord rest||diagnosi||advanc imag||biopsi,1||1 2||2||1 3 1||1 2 3||2 patient||method 1||3||fig. 2||refer 1||1 antibodi||2 summari||patient||4 patient||4,31046.0||30005.5||28965.0||26378.667||25685.0||21266.0||17359.0||17044.0||16970.5||16864.5||16187.0||14694.0||13567.0||13252.0||12937.0,0.0,0.0,0.06666666666666667
700,World_J_Urol-4-1-2295251.txt,partial respons||rcc||effect||antigen||target||combin||vegf level||bevacizumab||caix||tumor cell||studi||clinic trial||phase II trial||diseas||g250||bevacizumab treatment||surviv||treatment||patient||monoclon antibodi||therapi||tumor||vegf||trial||renal mass||renal cell carcinoma||result,refer 1||C. 2||2 week||springer-verlag 2008 introduct 1 2 3||patient||cell||studi||netherland 2 444||2 oyen wim||3 mg||2006||4 8 9||A. 4 1 267 experiment urolog||meet proceed part 1||tumor cell,16864.5||15490.0||15100.0||13666.333||13567.0||12627.0||12015.0||10406.333||9662.667||8944.0||8371.0||8161.0||8159.5||8157.25||7638.0,0.2,0.2,0.2
701,J_Biomol_NMR-3-1-1892527.txt,molecular properti||constraint||nmr interact||nmr data||molecular dynam||molecular dynam simul||exampl||averag||order||nmr investig||compon||bond||analysi||molecular align||orient||similar result||dynam behaviour||tensor||membran||quadrupolar interact||simul||pseudo-forc||MD approach||valu||axi||sampl||pgla||system||dipolar coupl||deriv||pyren||molecular re-orient||nmr interact tensor||time averag||heat||experiment error||princip axi||site||inform||case||segment orient||peptid||solid state nmr||data||cholesterol||high degre||molecul||order paramet,1 1||1||2 1 2||2 2 1||2||2 2||3 2 2 2 2 2||2 4 2||3 2||2 4||2 2 20||1 zz 2 yy 2 2||pyren 2 2005 2 2||2 2005||anne.ulrich@ibg.fzk.d 1 2 1 institut,31046.0||31046.0||29658.667||29658.667||28965.0||28965.0||26978.167||23622.333||23004.5||20951.0||20782.333||19664.833||19124.6||18840.5||18500.2,0.0,0.0,0.0
702,Law_Hum_Behav-4-1-2175020.txt,eyewit identif||field studi,2||3||4||studi||5||1-951-7889269 robert.rosenthal@ucr.edu 6 1 depart||2006 2006||2006 2006 2006 2006||2006||futur studi||field studi||laboratori studi||1-617-4953855 dls@wjh.harvard.edu 1 daw robyn||result||illinoi studi,28965.0||17044.0||12937.0||12015.0||10364.0||8523.2||8371.0||8371.0||8371.0||6447.5||6406.5||6378.5||6211.8||6080.0||6033.0,0.0,0.0,0.06666666666666667
703,Plant_Mol_Biol-3-1-1805039.txt,organ||respons||bind protein||promot region||express pattern||rehydr||rice||high-salin||plant||microarray||salin||group||flag leaf||analysi||stress||drought||regulatori element||studi||promot||full-length cdna sequenc||shoot||flag||genom express||express||experi||gene||leav||express profil||cold||motif||high-salin stress||panicl||result,1||2||4 2||t-p 1 2 fig. 1||12-034-323854 xingwang.deng@yale.edu 1 2 3 1||1 gene||3 3 1 fig. 3||3||fig. 2||2 gene||1 week||stage 2||2 kb||4||studi,31046.0||28965.0||20951.0||19208.2||18017.167||17920.0||17430.8||17044.0||16970.5||16879.5||16140.5||15070.0||14573.5||12937.0||12015.0,0.0,0.0,0.06666666666666667
704,Eur_J_Pediatr-4-1-2292480.txt,famili mediterranean fever||amyloidosi||anakinra||treatment||fmf||chest pain||month||attack||patient||colchicin,1||1 5 1||2 4||refer 1||1 mg||2 mg||3 5||patient||itali 2 depart||5||3 month||2006||10||effect||protein,31046.0||24152.0||20951.0||16864.5||15945.0||14904.5||13704.0||13567.0||10553.667||10364.0||9321.0||8371.0||6982.0||6956.0||6288.0,0.0,0.1,0.06666666666666667
705,Eur_J_Pediatr-4-1-2190787.txt,differ||school outcom group||standard test||development disturb||parent||development outcom||school perform||follow-up programm||group||norm score||low birth weight||score||prematur children||follow-up assess||school||studi||age||special assist||development domain||children||test||mild||year||problemat follow-up outcom||problem||motor skill||data||neurolog||assess||school outcom||perinat data||development follow-up||result,1||2 2||1 0||1 30||1 year||3||refer 1||tabl 2||3 4||countri 5 1||result 1 14||4||21 pvl normal 2 2||studi||netherland 2 depart,31046.0||28965.0||18569.5||17156.5||17151.0||17044.0||16864.5||16290.5||14990.5||13926.667||13807.667||12937.0||12623.8||12015.0||11205.0,0.0,0.0,0.06666666666666667
706,Exp_Eye_Res-2-1-2394572.txt,adult mous||subretin inject||photoreceptor cell||onl||effect||number||photoreceptor||dose||retina||mous||normal||disrupt||retin transplant||anim||administr||recipi||eye||olm||studi||cell integr||time||integr||greater number||control||transplant||section||intravitr inject||segment layer||signific increas||aaa administr||outer||find||cell||mice||subretin space||layer||müller cell,1||3||fig. 2||1 week||1 mg||1 μl||2 materi||2 week||2 μm||fig. 1 fig. 3||4||cell||supplementari fig. 1||fig. 1 uga||studi,31046.0||17044.0||16970.5||16140.5||15945.0||15631.0||15325.0||15100.0||14648.5||14510.5||12937.0||12627.0||12271.333||12018.667||12015.0,0.0,0.0,0.13333333333333333
707,Clin_Oral_Investig-2-2-1544376.txt,histolog data||BD valu||differ||respect site||osseointegr||surfac||titanium||anim||direct bone||tibia||rhbmp-2||implant||bmp-a||bone format||germani||dog||present studi||biocoat||week||titanium implant||distanc||mandibl||experiment studi||pilot studi,1||3||springer-verlag 2006 2 2||refer 1||bmp-b 3 1 2 fig. 3||1 mg||1 mm||cell||studi||bone-morphogenet protein 2||2 2 40 18 21 40||1996 30 1 4 10.1002||protein 4||6||BD tibia fig. 2,31046.0||17044.0||16976.25||16864.5||16513.167||15945.0||15936.5||12627.0||12015.0||11752.333||11573.333||10402.0||9612.5||9074.0||8562.0,0.0,0.0,0.0
708,Eur_Arch_Otorhinolaryngol-3-1-2042030.txt,lesion||midlin facial structur||year||rare diseas||complaint||treatment||radiotherapi||imdd||case||progress ulcer||re-irradi||patient||total dose||palat||physic examin||radiat ulcer||local||diseas||biopsi,1||1 3 3 1||1 3 1 4 1 3||2 1 3 4 5||refer 1||1 erythema||discuss 2||case report 1 fig. 1||5 1 depart||2 mucos||patient||netherland 2 depart||grade 1 mucos||grade 1 erythema||springer-verlag 2007 introduct 1,31046.0||24045.0||23360.5||20071.2||16864.5||15528.5||15333.0||14669.0||14634.667||14525.5||13567.0||11205.0||10604.333||10579.333||10308.75,0.0,0.0,0.06666666666666667
709,Plant_Foods_Hum_Nutr-4-1-2413119.txt,liver damag||placebo pretreat||anim||placebo||alt||noni||noni juic||liver||rat||experi||protect effect||ast activ||group,1||fig. 1||refer 1||experi 1||1 mL||experi 2||4 tabl 1 4||4||4 4||ast activ 1 4||studi||2006 376 1 12||2008 4 4 4 4||vitro 5 4 4 4 4||LM examin 2 6,31046.0||18011.0||16864.5||16535.0||15589.0||15494.5||15134.0||12937.0||12937.0||12325.25||12015.0||11347.5||10757.8||10476.0||9953.0,0.0,0.0,0.0
710,J_Gastrointest_Surg-3-1-1852391.txt,logist regress analysi||complic||effect||variabl||logist regress||group||factor||techniqu||oper techniqu||anastomosi||analysi||strictur||studi||odd||gastric bypass||age||gastrojejunostomi||surgeri||signific||obes||patient||peripher neuropathi||rygb||obes patient||gerd||bariatr surgeri||rate,1||2||1 group 2||2 2 antagonist||result 2||1 year||3||refer 1||20 2||2 26||infect 2||2 antagonist||patient||statist method 1||studi,31046.0||28965.0||21628.667||19401.0||17522.5||17151.0||17044.0||16864.5||16691.0||15786.5||15143.5||14619.0||13567.0||12099.0||12015.0,0.0,0.0,0.13333333333333333
711,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2292470.txt,differ||artifici view condit||natur view condit||asthenopia||deviat||phoria||session||eye||measur||comfort prism||noniu line||condit||stimuli||phoria paramet||eso||feedback loop||valu||fixat dispar||observ||test||paramet||interv||fusion contour||line||heterophoria||prism||trial||fusion vergenc||fixat cross||comfort,1||2||2 2 2 2 fig. 2||2 3 4||2 9||3||refer 1||2 cm||patient||4||studi||lang test 1||fig. 3||5||comfort prism 2,31046.0||28965.0||24966.833||19648.667||17178.5||17044.0||16864.5||14720.5||13567.0||12937.0||12015.0||11473.0||11010.0||10364.0||9734.667,0.0,0.0,0.0
712,Histochem_Cell_Biol-4-1-2323029.txt,mechan||direct transfer||organel||subsequ studi||connect||tnt||virus||nanotub||format||intercellular transfer||membran continu||viral transmiss||tissu||plasma membran||mitochondria||tunnel nanotub||similar structur||thin||cell||data||type||transfer||bridg||tnt-like structur,1||2||2004 1||2 2004||fig. 2||1 2008||cargo 1||2006 2006 1 2004||cell||tissu 2007 4 2003 2||5||2002 2002 1981 2008 2||2005||2006||2004,31046.0||28965.0||19561.5||18521.0||16970.5||16543.5||15542.5||13966.25||12627.0||11841.2||10364.0||9109.8||8716.0||8371.0||8077.0,0.0,0.1,0.06666666666666667
713,Oecologia-3-1-2039837.txt,rate||ambient condit||respons||speci||genet group||acclimat||thermal toler||data point||popul||factor||physiolog||measur||north sea group||clam||valu||sensit||temperatur||limit||respir rate||bay||data||season variat||taxa||metabol rate||mussel||specimen,1||2||2 2 2||3||_{ 1||toernooiveld 1||symbol 3 2||_{ 2||2 mytilu||4||studi||black line 1||squar box 1||5||netherland 1 netherland institut,31046.0||28965.0||28965.0||17044.0||15932.0||15524.5||15370.333||14891.5||14555.5||12937.0||12015.0||10909.333||10636.667||10364.0||9200.25,0.0,0.0,0.0
714,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2292474.txt,retina||endogen insulin level||area||peripher area||measur||studi||retin thick||healthi subject||blood glucos level||refract error||hyperglycemia||baselin||optic coher tomographi||diabet retinopathi||chang||blood retina barrier||fovea||subject||maxim hyperglycemia||glucos||procedur||ere||somatostatin||result,2||method 2 2||3 3 3 fig. 2||type 1||refer 1||30 2||1 mm||1 2 polak bettin||result 1 fig. 1 graph||patient||studi||2 3 ringen peter||type 2 diabet||netherland 2 institut||31-20-4441015 ngm.wiemer@vumc.nl 1 2 eekhoff elisabeth,28965.0||20534.0||17014.6||16987.0||16864.5||16116.0||15936.5||15007.25||14651.6||13567.0||12015.0||11569.25||11461.333||10854.667||10008.167,0.0,0.0,0.06666666666666667
715,Purinergic_Signal-4-1-2246001.txt,day||open field||number||sci||function improv||usa||anim||myelin||analysi||prolifer||matur oligodendrocyt||rip||cord||spinal cord||increas||lesion||function recoveri||treatment||section||remyelin||spinal cord injuri||astrocyt||cell prolifer||cell||guanin||rat||brdu||guanosin||oligodendrocyt||endogen progenitor cell,1||2||2 2 2||1 1 1 fig. 1||discuss 1 1 1||2 fig. 2||2 1 depart||3||refer 1||2 week||cell||studi||3 49 3||fig. 3||5 5 5 fig. 5,31046.0||28965.0||28965.0||25832.0||23709.75||20968.667||20835.0||17044.0||16864.5||15100.0||12627.0||12015.0||11750.667||11010.0||9286.4,0.0,0.0,0.06666666666666667
716,Ann_Biomed_Eng-2-2-1705509.txt,depth percept||mode||blood vessel||light sourc||vi||devic||surfac||shutter glass||depth||techniqu||nir||tissu||wavelength rang||infrar rang||superfici artifact||imag||shadow||contrast||crt||visual rang||reflect||percept||enhanc||user||tissu surfac||pixel||stereoscop movi||blood withdraw||inform||camera||result,2||2 figur 2||1 12||refer 1||1 cycl||1 vi||1 nir||1 cate||discuss 2||patient||31-10-408-9445 f.wieringa@erasmusmc.nl 1 2 3 mastik||studi||3 figur 3||2 view BV||6,28965.0||19710.333||18449.0||16864.5||15884.0||15630.5||15542.0||15536.0||15333.0||13567.0||12843.167||12015.0||11763.0||9892.0||9074.0,0.0,0.0,0.0
717,Appl_Microbiol_Biotechnol-3-1-2043089.txt,calcul||potato||plant compon||cyanophycin||materi||potenti||biomass||product||ton||plant||polym||import group||econom||chemic||cost||organ acid||protein||n-function||fossil raw materi||protamylass||ferment||amino acid||advantag||amino acid arginin||cyanophycin product||raw materi||cyanobacteria||larg scale||paper||technic process||biorefineri||agricultur wast stream||bulk chemic||year||large-scal ferment||applic||arginin,1||2||chemic 2 2||2 2006||2 2007||3||plant 2 fig. 2||pH 2||2 econom||2004 1 2005 2007||cell||netherland 2 depart||5||heat 4 3||3 S.,31046.0||28965.0||19494.333||18668.0||18126.0||17044.0||16348.75||14720.5||14616.5||13781.5||12627.0||11205.0||10364.0||10141.667||9853.0,0.0,0.0,0.0
718,Diabetologia-4-1-2170455.txt,diabet particip||retin vessel||individu||retin haemodynam||year||blood flow||blood glucos||measur||type 1 diabet||retinopathi||paramet||diabet||haemodynam measur||studi||patient||level||abnorm||diabet retinopathi||good glycaem control||retin circul,type 1||refer 1||1 characterist||applic 1||1 schaumberg||2 nathan||patient||type 1 diabet||studi||33 type 1||springer-verlag 2008 1||interpret type 1||1c 9 2||well-control type 1||2 1 schepen eye research institut,16987.0||16864.5||16168.5||16072.0||15524.5||14495.5||13567.0||12155.0||12015.0||11991.0||11563.667||11499.667||11495.667||11326.333||10977.0,0.0,0.3,0.2
719,Pharm_World_Sci-3-1-2082655.txt,effect||sens||health care practition||medic||meta-synthesi||encount||understand||research||process||practic concept||studi||particip||pharmaceut care||theme||bodi||control||in-depth interview||interview transcript||chronic ill experi||patient||natur||chronic condit||ill||practition||individu||find||medic experi||pharmaceut care practic,1||2||10 2||method 1||refer 1||2008 introduct 1 1 3||PC 1||2 colleg||patient||studi||1 studies’ method||3 15||1 man 17 women||3 men||2005,31046.0||28965.0||17973.5||17359.0||16864.5||16495.0||15698.5||14720.0||13567.0||12015.0||11573.0||10810.5||9346.75||8876.0||8716.0,0.0,0.2,0.13333333333333333
720,Clin_Auton_Res-2-2-1705534.txt,respons||differ||electr stimul||autonom nervou system||type respons||millisecond||peak latenc||side||amplitud||area||sympathet skin respons||ssr record||record site||compon||latenc||measur||studi||stimuli||ipsilater||stimul||method||subject||magnet||reflex||contralater side||record||type||ssr,1 2||2||1 figur 1||2 9||3||refer 1||2 24||1 norm||2 khz||patient||studi||1997 7 1 4 10.1007||5||13 26 2 19 11||present studi,30005.5||28965.0||21097.667||17178.5||17044.0||16864.5||16120.5||15648.5||14511.0||13567.0||12015.0||11669.8||10364.0||8840.0||7377.0,0.0,0.0,0.06666666666666667
721,Apoptosis-4-1-2257993.txt,mechan||effect||reperfus||y-27632||pten||simul ischemia||atp||cytochalasind||latrunculina||cytoskeleton||apoptosi||wortmannin||treatment||akt||activ||control||neg regul||endotheli cell||jasplakinolid||cell||apoptot nuclei||inhibit||akt activ||rho-kinas,1||2||refer 1||1 groeneveld||3 fig. 3||B. johan 2 1 depart||cell||studi||cell 5||netherland 2 depart||arrow 2 19||5||1 muster rene||31-20-4448255 m.vanderheijden@vumc.nl 1 2 versteilen amanda||method cell cultur 23 2,31046.0||28965.0||16864.5||15531.0||13021.333||12773.0||12627.0||12015.0||11495.5||11205.0||10986.667||10364.0||10355.667||10003.833||9881.4,0.0,0.1,0.06666666666666667
722,J_Plant_Res-3-1-2039807.txt,cell wall||carbohydrate-bind modul||high express||singl cbm||plant||cell type||primari||stem||cell wall structur||tobacco||cellulos||tissu||consequ||acid hydrolysi||membran||sampl||express||polysaccharid||control||prolong juvenil||cell wall modif||cbm||wall||tobacco cell wall||wall loosen||layer||plant develop||xylem cell||result||modul,1||2||1 3||1 4||1 6||2 2 2 2004 2002 2001||1 1998||3 3 3||fig. 2||1 6 6||1 1990||1 tri||tobacco 1||1 1969||1 vancomycin,31046.0||28965.0||24045.0||21991.5||20060.0||18057.0||17641.0||17044.0||16970.5||16398.0||16227.5||15625.5||15624.0||15614.0||15526.0,0.0,0.0,0.0
723,Eur_J_Pediatr-3-1-1914295.txt,fda||effect||pediatr exclus||program||market exclus||patent||wide age rang||usa||medic||order||adult market||pediatr studi||develop||infant||research||drug||industri||medicin||studi||literatur||clinic pharmacolog review||age||children||pharmaceut prepar||patent extens||market||trial||data||pediatr popul||adult||prescript||pediatr,1||2||1 parasitolog 1||1 year||3||refer 1||system 2||prepar 1||step 1||adult 2 3||anti-malari 1||2 characterist||1 2 holl robert||metabol 2||prepar 2,31046.0||28965.0||20705.0||17151.0||17044.0||16864.5||16324.5||15890.5||15803.5||15803.333||15523.5||15128.0||15081.0||15015.5||14850.0,0.0,0.0,0.0
724,Crit_Care-9-1-1065098.txt,oper manag||nurs manag||ethic topic||icu director||resourc alloc||review||icu||director||nurs||regard||profession||articl||difficult decis||literatur||icu physician||dilemma||paper||protocol||ethic||decis||role||issu||ethic challeng||clinic issu||polici||manag||intens care unit||clinician||search||critic care||attent||ethic dilemma||physician||intens care,2 3||result 1 1||8 1||2 0 1 0 3||3 1 0 0 4||patient||2 neil.lazar@uhn.on.ca 1 research associ||tabl 1 distribut||studi||4 5 6 7||tabl figur 1 distribut||1 critic care medicin||canada 2 associ professor||2004||1 rsibbald@saebauld.com lazar neil,23004.5||22724.0||18600.0||17848.2||14642.6||13567.0||13477.2||12075.0||12015.0||9843.0||9356.5||9276.25||8246.0||8077.0||7768.5,0.0,0.0,0.0
725,Bioinformation-1-6-1891690.txt,databas,1 2||1 figur 1 5||2 depart||bioinform 1||3 4||refer 1 köhler||biosilico 2004 2 61 2 merali||tabl tabl 1 list||6||2005||2006||categori figur 1 screen-shot||india 3 depart||diseas||15,30005.5||18414.25||15729.5||15556.5||14990.5||11248.667||11158.667||9677.5||9074.0||8716.0||8371.0||8220.5||6547.667||5149.0||4577.0,0.0,0.0,0.0
726,Ann_Hematol-4-1-2324130.txt,diseas sever||prednison||monoclon gammopathi||clinic respons||gaucher diseas||normal rang||mgu||follow-up||cytokin||decreas||protein||free light chain||studi||multipl myeloma||diseas||serum level||increas||age||cohort||immunoglobulin||patient||rang||risk||parc||gammopathi||ert||risk factor||growth factor||cell||level||flc||result,1||2||1.57 1 1||3||refer 1||1 26||A. 2||1 characterist||2 year||region 2||3 studi||flc level 1 fig. 1||patient||springer-verlag 2008 introduct 1 2||4,31046.0||28965.0||20713.0||17044.0||16864.5||16827.0||16238.5||16168.5||16110.5||15272.5||14529.5||14059.8||13567.0||12990.8||12937.0,0.0,0.0,0.06666666666666667
727,J_Occup_Rehabil-3-1-1915618.txt,pain intens||pain||high intens perform level||univers medic center groningen||variabl||tsk||weak||tampa scale||perform||intens||measur||chronic low back pain||studi||fabq||fear avoid belief questionnair||function capac||sampl||high intens lift||analys||activ||test||patient||regress equat||fce||hand||dynam||clbp||effort||capac||lift||avoid behavior||fear||relationship||result||rehabilit,1||2||2 1 12||studi 1||studi 2||1 3 4 1 center||result 1||1 age||refer 1||1 fig. 1 plot||tabl 2||2 chang||sampl 2||2 sampl||discuss 2,31046.0||28965.0||21954.333||21530.5||20490.0||18739.4||18563.0||17305.5||16864.5||16818.75||16290.5||16025.5||15665.0||15665.0||15333.0,0.0,0.0,0.0
728,Ann_Surg_Oncol-4-1-2234441.txt,statist analysi||cancer||normal liver||immunohistochemistri||differenti hcc||immunoblot analysi||analysi||differenti||liver cirrhosi||noncancer tissu||studi||condit||import||import role||hypoxia-resist hcc line||express||hypox condit||tumor differenti||patient||hcc||tumor||line||rage||hepat||case||level||cancer cell||result,1||2||immunohistochemistri 2 2||3||refer 1||tabl 2||phd 1 1 depart||2 fig||patient||4||cell||studi||cell cultur 2 condit||hcc 1 fig||1 mL isopropanol,31046.0||28965.0||19357.667||17044.0||16864.5||16290.5||16203.25||14519.0||13567.0||12937.0||12627.0||12015.0||11148.25||10400.333||10394.667,0.0,0.1,0.13333333333333333
729,Int_Arch_Occup_Environ_Health-3-1-1915587.txt,icp-m||contamin||locat||effect||materi||hcl||concentr||hospit||initi amount||platinum||surfac||wipe||facil||solvent||drug||intern standard||dutch hospit pharmaci||import||desorpt solvent||surfac contamin||hospit pharmaci||sampl||variabl physic characterist||sensit||cytotox agent||compound||analyt run||pharmaci||clean room||laf hood||cytotox drug||complianc||valid||method||nebulis||procedur||data||threshold||level||result,1||2||2 2||1 3||2 5||1 2002||2 2005||result 1||3||3 3||site 1||1 week||locat 1||1 amount||vol 1,31046.0||28965.0||28965.0||24045.0||19664.5||19051.5||18840.5||18563.0||17044.0||17044.0||16558.0||16140.5||15957.0||15833.0||15610.0,0.0,0.0,0.0
730,Behav_Genet-3-1-1824713.txt,model||genet||england twin||parent||abnorm||normal rang||factor||model test||influenc||environment risk factor||twin||conduct problem||progress||present||time||present studi||age||analys||frequenc||adolesc||marijuana||risk||longitudin studi||substanc||risk factor||problem||inform||liabil||presenc||year||initi||environment influenc||result,1||2||2 2 2||initi progress 2 2 2||time 1||3||time 2||model 2||2 fig. 2 note||2 df||bracket 2 2 df||2 marijuana||1 2001 2003 2003||4||bree mariann 1 1 depart,31046.0||28965.0||28965.0||17840.4||17493.5||17044.0||16453.0||16428.0||15898.25||14557.0||14528.75||14507.0||13165.25||12937.0||12923.2,0.0,0.0,0.0
731,J_Mol_Med-3-1-2121656.txt,hif||brain||stroke||hypoxia||therapeut,1||2 2||2||2 3||4 1 5||7 2||factor 1||3||refer 1||factor 2||cell death fig. 2 1||3 4 5 6 2||springer-verlag 2007 1||cell||studi,31046.0||28965.0||28965.0||23004.5||18115.667||17981.0||17745.0||17044.0||16864.5||16704.5||15681.4||15676.8||13312.333||12627.0||12015.0,0.0,0.0,0.0
732,Oecologia-3-1-1915600.txt,microbi enemi||root||effect||biomass||microorgan||soil biota||factor||multipl||influenc||nematod||top-down control||multitroph interact||soil microorgan||studi||plant perform||inocul||growth||natur ecosystem||control||soil||pot||hodgkin||rooij van der||result||steril||plant commun composit||microarthropod||cook,1||2||1 4 1 depart||2 1 0.858 0.36 1||2 1 1.736 0.191 1||3||experi 1||1 T.||0.001 1||0.01 1||3 1 0.672 0.415 1||0.0001 1||1 par||1 30.49||1 14.13,31046.0||28965.0||19380.75||18244.6||18212.6||17044.0||16535.0||16336.0||16095.5||15875.5||15829.8||15669.0||15550.0||15525.0||15524.0,0.0,0.0,0.0
733,BMC_Struct_Biol-4-_-331416.txt,model||sequenc align||program||probe||mlv||loop region||helic||sequenc||multipl||quest||agreement||fv1||protein||domain||eia||figur||loop||sequenc similar||viru||paramet||gene||ident||murin leukaemia viru||residu||method||signific sequenc similar||region||molecular model||result||structur,1||2||tabl 1||3||tabl 2||2 jstoye@nimr.mrc.ac.uk 1 divis||4||cell||studi||tabl 3 4||5||u.k 2 divis||5 6||29 3||usa 1 18 10.1385,31046.0||28965.0||17331.0||17044.0||16290.5||15072.75||12937.0||12627.0||12015.0||11199.0||10364.0||9750.0||9719.0||9657.0||9223.5,0.0,0.0,0.0
734,Pediatr_Radiol-3-1-1805044.txt,siopel||tumour||hepat vein||involv||pretext stage||criteria||origin pretext system||extrahepat abdomin diseas||metastas||diseas||high risk||primari malign liver tumour||medial section||children||hepatoblastoma||pretext system||patient||revis||risk||portal vein||ascit||extrahepat diseas||risk factor||liver||risk stratif||find||current siopel studi||major branch||pretext||diagnosi||biopsi,2||2 fig. 2||7 2 3||3||refer 1||pretext stage 1 1||1 definit||segment 2||patient||3 4 5||studi||pretext II 1 3 fig. 3||studi siopel 1 eur||black grey 1||blue purpl 2,28965.0||20968.667||17668.667||17044.0||16864.5||15823.75||15768.5||14744.0||13567.0||13448.333||12015.0||11900.0||11124.75||10524.333||9775.0,0.0,0.1,0.06666666666666667
735,Arch_Orthop_Trauma_Surg-4-1-2324129.txt,statist analysi||reduct||disloc calcan fractur||complic||posterior facet||good condit||averag||upper ankl joint||follow-up||studi||averag follow-up time||lower ankl joint||compar result||intern fixat||joint deviat||fractur||surgeri||calcaneu||treatment||zwipp score||surgic techniqu||normal shoe||patient||close reduct||rang||follow-up evalu||view||disturb||lower leg||osteiti||case||clinic||wire||intern fixat techniqu||result||soft tissu,1||1 1||2||2 2||1 patient||2 1 depart||3||2 clinic||refer 1||2 20||18 2||minimum 2||2 degreif||patient||4,31046.0||31046.0||28965.0||28965.0||22306.5||20835.0||17044.0||16911.5||16864.5||16691.0||16447.0||14575.5||14483.0||13567.0||12937.0,0.0,0.0,0.06666666666666667
736,Exp_Brain_Res-4-1-2248215.txt,signific effect||effect||sham condit||pain||magnet stimul||left SI||amplitud||lep||subject pain rate score||peak||compon||yag laser stimul||theta burst stimul||studi||condit||acut pain percept||itb||germani||time||eeg||laser-evok potenti||pain process||tb||low-intens stimuli||stimul||subject pain percept||subject||hand||ctb||main find||primari somatosensori cortex||experiment session||result,1||2||2 2 2 2||2 fig. 2||3||1999 2003 1 fig. 1 mri||studi||germani 2 depart||1 Hz rtm||5||6||signific electrophysiolog 3 4 fig. 3||2005||2005 2005 2005 2006||tabl 1 post hoc analysi,31046.0||28965.0||28965.0||20968.667||17044.0||13384.833||12015.0||10717.333||10413.0||10364.0||9074.0||9030.167||8716.0||8629.75||7948.2,0.0,0.1,0.06666666666666667
737,Placenta-1-5-1895600.txt,cyclooxygenas||glycogen cell||hne||tunel-posit||cell type||mous||fetal endotheli cell||murin placenta||human pregnanc||placenta||gestat age||dual-label||stress||apoptosi||immunoreact||increas||primari antibodi||sampl||express||apoptot index||syncytiotrophoblast||signific increas||ihc||oxid stress||cell||gc||individu cell||co-localis,"1||2 2 2 2 2 2||2||3 2||fig. 1 fig. 1 fig. 1||fig. 1||tabl 1||3||1 mann||gjb2@cam.ac.uk 1||2 materi||patient||4||cell||fig. 1 a,b",31046.0||28965.0||28965.0||23004.5||18011.0||18011.0||17331.0||17044.0||15582.5||15524.0||15325.0||13567.0||12937.0||12627.0||12021.667,0.0,0.0,0.06666666666666667
738,Intensive_Care_Med-3-1-2040486.txt,death||lactat||patholog condit||johann joseph scherer||carl folwarczni||blood||puerper fever||lactic acid||research||condit||muscl||articl||autopsi||observ||patient||leukaemia||demonstr||human blood||scherer||shock||result,refer 1||patient||live patient||result||diseas||11||springer-verlag 2007||7 month||15 17||8 day||16||time||J.||research||sever diseas,16864.5||13567.0||7017.0||6080.0||5149.0||5051.0||4445.5||4297.5||4080.0||4043.5||3951.0||3941.0||3789.0||3708.0||3666.0,0.4,0.2,0.2
739,J_Med_Internet_Res-4-2-1761933.txt,page||locat||access||web site qualiti||web||temporari server problem||medic knowledg||refer||internet archiv||health inform||previou studi||attrit||web page||studi||medic topic||specif health-rel topic||time||url||qualiti||world wide web||site locat||uncertain period||viewer||web content||issu||search engin||address field||health claim||item||content||site||inform||health-rel web site||topic||result,1||2||1 2 1 0 1||8 6 3 2 1||1 1 1 6 0 travel||17 2 1 5 1 expert||3||5 1 0 1 0||1 scher||2 qualiti||4||tabl tabl 1||studi||60 3 1 10 total||robert wilenski 2 3,31046.0||28965.0||25639.2||18456.6||18066.333||17541.333||17044.0||16928.4||15527.0||15467.5||12937.0||12759.333||12015.0||11749.8||11579.5,0.0,0.0,0.06666666666666667
740,Diabetologia-4-1-2235909.txt,oral agent||dose||advers event||target||fast plasma glucos||insulin detemir||type 2 diabet||bodi weight||insulin||studi||detemir||particip||weight gain||present studi||analys||treatment||glycaem control||fpg||meal-tim insulin||insulin glargin||hypoglycaemia||patient||week||glargin||oral glucose-low drug||basal insulin analogu||event||ten-point PG profil||trial||oral glucose-low agent,1||2||1 age||3||refer 1||result particip 1 1 2 1c||type 2||acknowledg 1||safeti measur 1 2 3 4||2 diabet||1 algorithm||2 home||1c 2||2 1c||patient,31046.0||28965.0||17305.5||17044.0||16864.5||16542.833||15946.5||15877.5||15743.0||15728.0||15629.5||14668.5||14547.5||14547.5||13567.0,0.0,0.0,0.06666666666666667
741,J_Mol_Med-4-1-2359832.txt,mdm2||correl||comparison||thyroid carcinoma||form||group||p53||ctrl||ratio||analysi||human tumorigenesi||protein||studi||addit||western blot||mdm4||sampl||express||signific||papillari thyroid carcinoma||ptc||tumor properti||mrna||tumor||mdm4 variant||histopatholog featur||data||presenc||variant||level||human cancer||method tissu sampl,1||1 1||1 2||2||1 3||3 1||1 fig. 1||1 4||2 fig. 2||2 4||13 2 13 3 1||3||11 2||1 27||1 mM,31046.0||31046.0||30005.5||28965.0||24045.0||24045.0||22356.0||21991.5||20968.667||20951.0||17115.8||17044.0||17008.0||16729.0||15723.5,0.0,0.0,0.0
742,Cancer_Causes_Control-2-2-1705485.txt,differ||face||ear||solar ultraviolet radiat||hair cover||hypothesi||melanoma||neck||invas melanoma||scalp||sun exposur||age||solar UV exposur||hair||women||australia||incid||chang||femal||younger women||site||data||rate||incid rate,1 1||1||2||2 2||fig. 1||1 fig. 1 measur||refer 1||1 1 queensland institut||australia 1||5||6||2006||6 7||2003||cancer,31046.0||31046.0||28965.0||28965.0||18011.0||17776.0||16864.5||15885.5||15617.0||10364.0||9074.0||8371.0||8035.5||7651.0||7076.0,0.0,0.0,0.0
743,Childs_Nerv_Syst-3-1-1849423.txt,cerebrospin fluid||brain parenchyma||puls pressur||acut hydrocephalu||intracrani complianc||narrow capacit vessel||chronic hydrocephalu||capillari||subarachnoid space||hydrodynam concept||systol pressur||treatment||systol pressur transmiss||view||hydrocephalu||complianc||csf||patent aqueduct||etv||pathophysiolog||theori||dandi||ventriculostomi||csf pressur||etiolog||normal-pressur hydrocephalu,1 year||refer 1||patient||studi||19 1 5 9 14||patholog studi||result||random clinic studi||health||diseas||treatment||14||model||age||hydrocephalu 9 14 14,17151.0||16864.5||13567.0||12015.0||10882.6||6545.5||6080.0||6032.667||5601.0||5149.0||5012.0||4297.0||3891.0||3565.0||3561.0,0.0,0.0,0.06666666666666667
744,Ann_Surg_Oncol-4-1-2190341.txt,day||center||unresect||group||re-explor||initi oper||oper||initi find||analysi||neoadjuv therapi||studi||diseas||pancreat surgeri||surgeri||distal pancreatectomi||reoper||patient||resect||tumor||case||pancreat cancer||result,1||2||3 2 1||3||3 3 3||refer 1||1 durat||1 fig||3 fig 2||infiltr 1 4||patient||3 6||4||0 1 mortal 0 1 length||1 0 resect,31046.0||28965.0||25685.0||17044.0||17044.0||16864.5||15829.5||15559.5||15360.667||14733.667||13567.0||13059.0||12937.0||12609.667||12594.0,0.0,0.0,0.06666666666666667
745,Plant_Cell_Rep-3-1-1824786.txt,respons||rt-pcr||resist||plant||field||parent materi||transgen wheat||percent fhb sever||wheat||studi||inocul||transgen plant||diseas||fhb||analys||sever||screen||seed||fusarium head blight||field condit||fhb sever||line||signific reduct||transgen wheat line||transgen||chitinas||level||greenhous||result,1||2 2||2||2 1 0 1 2 seed||5 2||protein 1||2 3 2 3 screen||0 1||3||2 1998||1 1992||1 product||muehl003@umn.edu 1 1 depart||1 ml||2 3 line,31046.0||28965.0||28965.0||21059.167||19664.5||18667.0||18621.2||18569.5||17044.0||16600.5||16377.0||16336.5||16146.75||15906.0||15764.667,0.0,0.0,0.0
746,Mol_Immunol-1-5-1994210.txt,thymu||effect||central toler||real-tim pcr||antigen||autoimmun regul||mous||thymic epitheli cell||signal||develop||mtec||studi||air||express||epitheli cell||gene||microarray data||lymph node||air protein||role||normal develop||autoimmun||thymocyt||cell||data||tra||result,1||2||fig. 2 fig. 2||part.peterson@ut.e 1||2 materi||pcr 2||2005 fig. 1 air fig. 1||4||fig. 2 express||cell||studi||syndrom type 1||trefoil factor 1||1 laan martti||1 kisand kai,31046.0||28965.0||16970.5||15525.0||15325.0||14642.0||13519.5||12937.0||12778.667||12627.0||12015.0||11864.333||11833.0||10353.333||10353.0,0.0,0.1,0.13333333333333333
747,Cancer_Causes_Control-2-2-1705538.txt,patient intak form||effect||menopaus statu||menarch||breast cancer risk||mammogram||clinic assess form||factor||current visit||bmi||influenc||previou studi||mammograph breast densiti||posit effect||breast||birth||studi||densiti||cutpoint||continu form||famili histori||multivari model||age||analys||women||breast cancer risk factor||pariti||histori||risk||hormon replac therapi||breast densiti||nhmn record||data||larg popul||posit associ||interact,"1||2||2 6 1 dartmouth||3||refer 1||1 distribut||1 0.29||1 0.30||2 0.22||2 0.58||2 0.70||2 0.61||1,607 2 1,010 2||1,804 2 1,295 2||patient",31046.0||28965.0||17274.25||17044.0||16864.5||16304.5||15606.0||15595.5||14584.0||14566.5||14564.0||14550.5||14484.5||14483.5||13567.0,0.0,0.0,0.0
748,Curr_Eye_Res-1-1-2430176.txt,hematolog disord||macula||effect||short follow-up period||hemodilut||month||venou thrombosi||occlus||grid laser photocoagul||abnorm hematolog factor||group||blood||ilm||eye||visual prognosi||studi||inject||diseas||follow-up period||random clinic trial||brvo||pathogenesi||treatment||signific||improv||final VA||branch retin vein occlus||visual acuiti||patient||initi VA||sheathotomi||neovascular||macular thick||risk factor||laser photocoagul||case||laser treatment||small sampl size||initi,1||2||2 patient||group 1||3||2 3 4 4 4||group 2||1 month||tabl 2||2 year||1 eye||classif 1||2 month||2 line||part 2,31046.0||28965.0||21266.0||17960.5||17044.0||16964.0||16920.0||16322.0||16290.5||16110.5||15868.5||15865.0||15281.5||15125.0||15018.0,0.0,0.0,0.0
749,Ann_Hematol-3-1-2040174.txt,respons||median time||month||dose||chronic||long-term complic||platelet||chronic itp||follow-up||itp||studi||refractori itp||diseas||time||rituximab||treatment||immun thrombocytopen purpura||patient||week||rang||splenectomi||cell||rituximab therapi||result,2||2 studi||2 1 6 18||respons 1||1 year||3||refer 1||phase 1||1 patient characterist||2 month||result 1 9||patient||8 9 2||16 7 2||fig. 2 9,28965.0||20490.0||18253.5||17197.0||17151.0||17044.0||16864.5||15995.0||15301.333||15281.5||14172.667||13567.0||13503.667||13304.333||13111.0,0.0,0.0,0.06666666666666667
750,Photosynth_Res-3-1-1779624.txt,reduct PP||spinach chloroplast||sugar phosphat||intact||octulos||sep||spinach||phosphat||PT enzym||enzym||reaction sequenc||reaction||calvin cycl||pga||non-oxid segment||assay||activ||carbon||leav||method||chloroplast||phosphotransferas reaction||mg chl||photosynthet carbon reduct cycl||rate||label||octulos phosphat||enzym prepar||result,1||1 1||1 2 1||1 2||2 1||2 2 1||2 1 2||2 2||2||2 2 1 fig. 1||3 2 2||2 2 3||2 1 2 1 14||2 3||14 2 2 2 2 3,31046.0||31046.0||30352.333||30005.5||30005.5||29658.667||29658.667||28965.0||28965.0||24999.6||24991.333||24991.333||24863.8||23004.5||22866.833,0.0,0.0,0.0
751,Eur_J_Nutr-2-2-1705483.txt,effect||cereal fraction||microbicid activ||lipid oxid damag||periton leukocyt||chronic diseas||immun function||total polyphenol||natur product||studi||import||healthi subject||diseas||antioxid||immun respons||author||health promot||supplement||health||activ||control||healthi mice||leukocyt function||week||diet||cereal||redox state||diet supplement||oxid stress||gssg||mice||protect effect||macrophag||catechin||polyphenol||immun cell||result||function,2||diet 1 1||extract 2 2||fig. 1||fig. 2||refer 1||17 2||1 week||patient||39449-35 mondelaf@bio.ucm. 1 3 1 dept.||studi||2 week sampl||1 nutrit composit||redox state 2||result immun system respons 1,28965.0||20792.0||19540.333||18011.0||16970.5||16864.5||16274.0||16140.5||13567.0||13197.0||12015.0||10855.0||10617.0||10188.0||8961.2,0.0,0.0,0.06666666666666667
752,Dig_Dis_Sci-3-1-1914226.txt,tumor||gist||constip||rectal gist||signific medic histori||gastrointestin stromal tumor||rectal examin||abdomin pain||calculu||rectal tumor,1||2||3||refer 1||conclus 1 3||eur radiol 2 2||2007 1 3 4 9||patient||fig. 2 arrow||5 low risk 2||5||5 6||10 5||3 o’clock||fig. 3 arrow,31046.0||28965.0||17044.0||16864.5||16427.0||14978.25||14741.2||13567.0||11540.667||11177.5||10364.0||9719.0||8673.0||8525.0||7567.0,0.0,0.0,0.0
753,J_Med_Internet_Res-9-2-1913941.txt,cam||degre||access||nlm||tool||clinic practic||specif||pubm||medic research||open access||session||full text||profession develop||research||interest||medicin||studi||domain||profession||articl||particip||literatur||full-text articl||servic||inform manag||practition||user||limit||chiropractor||public||inform||inform retriev||abstract||altern medicin practition||life scienc||health,1||2||integr 1 2||3||tabl 2||figur 2||2 hour||patient||3 4 5||studi||design tabl 1||canada 1 univers||particip 2 week||articl figur 2||multimedia appendix 1 multimedia appendix 2,31046.0||28965.0||20248.333||17044.0||16290.5||15083.0||14625.5||13567.0||13448.333||12015.0||11932.333||11667.333||10730.0||10584.333||10094.5,0.0,0.1,0.06666666666666667
754,Bioprocess_Biosyst_Eng-2-2-1705536.txt,polyest||extracellular space||medium||batch cultiv||purif||mobil phase||periplasm||protein||cultiv||cytoplasm||rtfh||sec pathway||growth rate||extracellular medium||activ||induct phase||induct||glucos concentr||glucos||hcdc||cell||solubl protein||hydrolas activ||batch||periplasm protein||result,1||1 1||1 2||2 2||2||broth 1 2 1 2 2||1 1 13 1||5 2 1||1 1 set||2 4||1 6||1 2 dcw||1 3 3 4||22 23 2 1 2||1 protein,31046.0||31046.0||30005.5||28965.0||28965.0||24834.5||24350.0||23458.333||21181.333||20951.0||20060.0||20009.667||19517.75||19029.4||18667.0,0.0,0.0,0.0
755,Neurosurg_Rev-4-1-2279160.txt,cranio-vertebr junction||order||approach||clinic applic||surgic treatment||remov||studi||compress||spinal cord||middl turbin||mucosa||soft palat||anatom studi||endonas||endonas approach||muscle-mucos flap||oral caviti||odontoid process||risk||problem||transor approach||procedur||endoscop||case||nasal caviti||applic||hard palat||atla||endoscop dissect||irreduc atlanto-axi disloc,1||1 fig. 1||2 2 3 fig. 2||refer 1||patient||studi||manfr 4 1 depart||5||4 fig. 4||itali 2 servic||part 3||5 6 fig. 5||2004||2003||45 patient,31046.0||22356.0||21783.0||16864.5||13567.0||12015.0||11620.5||10364.0||10283.333||10161.0||9057.5||8694.5||8077.0||7651.0||7601.0,0.0,0.1,0.06666666666666667
756,J_Chem_Ecol-4-1-2373414.txt,efn secret||signal||compound||control||lima bean||voc||heil||odor bind protein||plant||lanolin past,1||2||2006 fig. 1||4||2004 2005 2005||2006||2006 2006||2003||present studi||2007 2001||protein||8||result||germani 3 depar||CP 36821 guanajuato méxico 2 depart,31046.0||28965.0||14797.667||12937.0||8503.0||8371.0||8371.0||7651.0||7377.0||6800.0||6288.0||6154.0||6080.0||5913.0||5293.333,0.0,0.0,0.0
757,Anal_Bioanal_Chem-4-1-2359830.txt,calcul||mass||mercuri||ammonia group||icp-m||methylmercuri biothiol||direct inject||es-m paramet||fragment pattern||organ molecul||ion trap||analyt method||electrospray mass spectrometri||plant||biothiol||form||solut||group||order||signal||mehgci||fragment||figur||biota||nitrogen atom||es-m||compound||cy||plant extract||hplc eluent||standard||molecular ion||methylmercuri||proton||complex||detect condit||inform||electrospray mass spectromet||in-sourc fragment||extract||molecul,1||2 1 1||2||2 2||2 2 2||3 2||2 2 5||2 6 2||1 fig. 2||fig. 7 1 2 2 2||5 2 2 5||6 2 2 6||1 11||fig. 1||fig. 6 2 2,31046.0||30352.333||28965.0||28965.0||28965.0||23004.5||22764.667||22334.667||21662.333||21652.333||19664.5||19019.5||18048.5||18011.0||17995.0,0.0,0.0,0.0
758,Intensive_Care_Med-4-1-2271085.txt,stroke volumeindex||transpulmonari thermodilut||algorithm||tpco||svi||measur||coronari arteri bypass graft||data||patient||studi||bioimped svi||error||bioimped||cardiac output,1||2||1 1 divis||3||refer 1||result 2 1 TD||method 2||patient||4||studi||netherland 2 depart||1 6.4 13.9||5||1 buhr wolfgang||2 0.6 8.8,31046.0||28965.0||20790.333||17044.0||16864.5||16568.5||16318.5||13567.0||12937.0||12015.0||11205.0||10397.0||10364.0||10358.0||9836.333,0.0,0.2,0.13333333333333333
759,Ann_Hematol-4-1-2275303.txt,order||respons||md||panel||risk||treatment||nhae||drug||lenalidomid||vte||myelodysplast syndrom||clinic trial||patient||advers event||neutropenia||abnorm||diseas||therapi||time||recommend,1 2||2||1 2 3||1 3||3||refer 1||1 intern||2 month||11 2 11 3||patient||5 5||neutropenia 1 febril||10 10 3||3 score||3 week,30005.5||28965.0||25685.0||24045.0||17044.0||16864.5||16391.5||15281.5||14027.75||13567.0||10364.0||10357.667||10336.0||9575.0||9139.5,0.0,0.1,0.06666666666666667
760,Ann_Surg_Oncol-3-1-2039838.txt,model||macroscop tumor||day||median surviv||preclin studi||periton carcinomatosi||dose||group||anim||cytoreduct surgeri||heat intraperiton chemotherapi||clinic trial||studi||rit administr||radioimmunotherapi||adjuv therapi||surgeri||surviv||treatment||temperatur||surgic procedur||perfus||mmc||procedur||rat||hipec||toxic||physic condit||result,1||2||follow-up 2 2||tabl 1||3||refer 1||phd 1 1 depart||2 year||1 boerman||3 2 2 treatment group characterist||patient||oper procedur 2 2 11||4||studi||netherland 2 depart,31046.0||28965.0||19657.333||17331.0||17044.0||16864.5||16203.25||16110.5||15527.0||14358.667||13567.0||13044.0||12937.0||12015.0||11205.0,0.0,0.0,0.06666666666666667
761,Surg_Endosc-4-1-2422865.txt,differ||alloc conceal||complic||total||health statu||sic||group||order||techniqu||preoper data||gener short form||oper||score||follow-up||questionnair||studi||randomis trial||gener||minim invas||cholecystectomi||bodi imag||minim invas procedur||surgeri||analys||alloc sequenc||subscal||giqli||test||patient||week||secondari outcom measur||method patient||procedur||symptomat cholecystolithiasi||trial||small-incis cholecystectomi||health,1||2||health 1||result 1 fig. 1||3||refer 1||oper result 1 2||recoveri 1||1 pancreat||bosboomstraat 1||1 epididim||1 patient characterist||2 week||H. M. 1 1 depart||patient,31046.0||28965.0||18323.5||18287.0||17044.0||16864.5||16735.25||15757.0||15735.0||15524.0||15523.5||15301.333||15100.0||14004.2||13567.0,0.0,0.0,0.06666666666666667
762,J_Autism_Dev_Disord-4-1-2268724.txt,respons||social-cognit function||differ||face process||social interact||face recognit||non-target condit||abil||facial express recognit||hypothesi||speed||target||autism||group||signific group differ||accuraci||criteria||FR task||process||complex condit||symptom||pervas development disord||social cognit task||pattern||task||facial express||express||children||disord||emot||affect state||diagnost criteria||cognit capac||accur||emot recognit||identif||attention-demand strategi||individu||anxieti||complex pattern||mcdd||pdd-no||diagnosi||result,1||1 2||2||2 3||1 1 depart||3||2 1992||2 0.06||2 0.74||patient||2 fig. 3 accuraci||studi||3 10||tabl 2 frequenc||5,31046.0||30005.5||28965.0||23004.5||21528.667||17044.0||15336.5||14668.5||14569.5||13567.0||12856.5||12015.0||12013.0||11152.667||10364.0,0.0,0.0,0.0
763,Invest_New_Drugs-3-1-2039853.txt,cancer||maximum dose||dyspnea||effect||home||deep breath||dose||medic supervis||lower mtd||administr||studi||nurs||atp||cardiac disord||infus||disord||patient||reason||lung cancer||pre-termin cancer patient||day care center||presenc||chest discomfort||mtd||side effect||cardiac ischemia||pre-termin cancer,1||2||1 3||1 4||1 1 depart||1 5||3||refer 1||work 1||1 infus||2 40||2 van||intervent 2||patient||4,31046.0||28965.0||24045.0||21991.5||21528.667||20705.0||17044.0||16864.5||16547.0||15711.0||15557.5||15219.5||15045.0||13567.0||12937.0,0.0,0.0,0.06666666666666667
764,Arch_Microbiol-4-1-2270922.txt,mass||cultur||shake flask||system biolog||comparison||variabl||biolog||rel abund||acet concentr||shake flask cultur||analysi||bioreactor||organ acid||protein||flask||control cultiv||cultiv||time||pattern||growth||sampl||system||experi||electron donor||chemostat cultur||laboratori||proteom||peptid||steadi state||cell||optic densiti||batch||acid||result,1||1 2||2 1 2 2 2 1||2||2 2 2 2 600||1 4||control batch 1 2 2 1||3||1 46||flask 1||2 defici||2 dark||2 3.9||triangl 2||flask 2,31046.0||30005.5||29658.667||28965.0||23216.2||21991.5||20755.333||17044.0||16185.5||15547.5||14694.0||14558.5||14547.0||14537.5||14507.0,0.0,0.0,0.0
765,J_Med_Internet_Res-5-4-1550578.txt,nation cancer institut||internet user||cancer||web||specif||difficulti||cancer queri||exampl||health inform||cancer type||breast||gener inform||queri||studi||term||symptom||natur languag process||web site||sampl||specif type||gener public||treatment||question||internet||user||subcategori||search engin||issu||individu||cancer inform||vocabulari||search||site||user question||inform||methodolog||data||type||topic,1||2||tabl 1||tabl 2||1 week||appendix 1||1 cline||patient||sampl figur 1 appendix 1||4||studi||appendix 1 35||queri tabl 2||queri appendix 1||2 search engin,31046.0||28965.0||17331.0||16290.5||16140.5||15644.5||15529.0||13567.0||13180.2||12937.0||12015.0||11094.667||10976.667||10546.0||10503.0,0.0,0.0,0.06666666666666667
766,Histochem_Cell_Biol-4-1-2413109.txt,junction format||bind||specif||adheren junction||molecul||par protein||cell polar||signal||actin cytoskeleton||small gtpase||apico-bas polar||jam||format||associ||protein||membran||tight junction||claudin||recent evid||afadin||protein complex||par3||aj||patj||complex||major multiprotein complex||membran asymmetri||cell||apkc||lgl||interact||local||function,1||2||2 protein||3||desmoglein 1||ctn 2||cell||adhes molecul 1||multi-pdz domain protein 1||2006||adheren junction 1996 2||cell type||2003||individu cell||cell biolog,31046.0||28965.0||17626.5||17044.0||15570.0||14489.5||12627.0||10778.667||9613.75||8371.0||8142.75||7777.5||7651.0||7130.5||7089.5,0.0,0.1,0.06666666666666667
767,Support_Care_Cancer-3-1-2071950.txt,cancer||extent||home||number||end-of-lif care||hospit||death||major concern||medic treatment||research||process||rel||questionnair||interview||symptom||studi||netherland||bereav rel||qualiti||cancer patient||care||incur cancer||life||treatment||institut||major differ||problem||case||set||physician||gener practition||health,1||2||place 1 1 2||result 1 1||1 1 depart||1 week 1||3||refer 1||13 2||life 1||1 characterist||2 test||hospit 2 2 hospic 3 3||1 week 4||49 2,31046.0||28965.0||22925.5||22724.0||21528.667||21109.0||17044.0||16864.5||16613.5||16353.0||16168.5||16085.5||15654.167||15072.667||15064.5,0.0,0.0,0.0
768,Ann_Biomed_Eng-3-1-2040176.txt,cadav||injuri||cervic spine||onboard clock||rollov crash||rollov||lap belt||contact||probabl column injuri||peak||measur||seat belt||studi||acceler||head||time||vehicl||present studi||roof crush||far-sid||neck load||load||test||spinal injuri||atd||roof deform||sensor||passeng atd||dynam||hybrid iii dummi||human spine||crash mode||passeng||data||load cell||driver||camera||suv||atd neck||local peak neck forc||dynam rollov test||passeng car||residu forc magnitud||result,1||2||1 1 figur 1||2 11 2||2 4||atd instrument 2 2 1||method 1||3||1 problem||4 1 depart||1990 2||figur 2||2 Hz||2 figur 4||3 5,31046.0||28965.0||23584.75||20993.667||20951.0||17888.0||17359.0||17044.0||16247.0||15492.333||15187.0||15083.0||14575.5||14367.667||13704.0,0.0,0.0,0.0
769,Purinergic_Signal-3-4-2072925.txt,cn||mechan||glutam||central nervou system||antisens oligonucleotid||neuron||calcium wave||biolog function||patholog condit||approach||purinerg receptor express||develop||embryogenesi||physiolog||process||prolifer||differenti||subtyp||import||atp||specif agonist||antagonist||purinerg receptor||synapt transmiss||express||purinerg||hippocampu||releas||activ||glial cell||earli stage||role||astrocyt||neural stem cell||knockout anim||cell||cell prolifer||rat||pathway||rat hippocampu||result,1||1 2||2 1 2||2||2 56 2||3||refer 1||3 2 receptor||2007 introduct 1 2 3 4||1 128||pharmacolog approach 1 2 2 38||91 2||115 2||196 2||6 1 194 1 195,31046.0||30005.5||29658.667||28965.0||19650.333||17044.0||16864.5||16504.0||16429.5||15693.0||15426.833||14891.0||14708.0||14570.5||14306.2,0.0,0.0,0.0
770,Exp_Cell_Res-1-5-2131725.txt,mitosi||chromosom arm||function||aurora||polo kinas||anaphas||phosphoryl||nhk-1||phosphatas treatment||histon modif||kinas||cyclin||polo||centromer||histon||centromer region||region||chromosom segreg||loss||cell cycl||chromatin,1||2||fig. 1 fig. 1||3||fig. 2 fig. 2||fig. 2||figs. 1 fig. 1||h.ohkura@ed.ac.uk 1||4||cell||supplementari fig. 1 supplementari fig. 1||nhk-1 fig. 2||fig. 3||5||1 nanba yasuaki,31046.0||28965.0||18011.0||17044.0||16970.5||16970.5||16785.25||15524.0||12937.0||12627.0||12271.333||11320.0||11010.0||10364.0||10349.333,0.0,0.0,0.0
771,Matern_Child_Health_J-2-2-1592142.txt,survey||number||fortif||health care provid||educ||dietari supplement||pregnanc||vitamin supplement||awar||birth||ntd||birth defect||folic acid daili||increas||age||supplement||women||consumpt||recommend||knowledg||folic acid consumpt||year||folic acid,1||2||result 1||3||refer 1||2 awar||2 vol||patient||4||studi||5||discuss 3||2005||practic implic 10 1 14 15||2004,31046.0||28965.0||18563.0||17044.0||16864.5||14597.5||14569.5||13567.0||12937.0||12015.0||10364.0||9372.5||8716.0||8190.833||8077.0,0.0,0.0,0.0
772,Glycoconj_J-4-1-2234449.txt,heparin-induc thrombocytopenia||gag||immunoprofil||sulfat||heparinas||lmwh||reactiv||sulodexid||chemic||anticoagul||enzymat digest||heparinoid||nadroparin||danaparoid||antibodi||domain||biolog characterist||specif immunoprofil||enoxaparin,1||1 1||2 2||2||2 fig. 2||2 4||1 2 van||1 7||7 1||0 1||1 0||1 9||2 8||3||type 1,31046.0||31046.0||28965.0||28965.0||20968.667||20951.0||20495.0||19021.5||19021.5||18569.5||18569.5||18219.0||17559.5||17044.0||16987.0,0.0,0.0,0.0
773,J_Mol_Biol-1-5-1892151.txt,substrat||linear fragment||bpli||restrict enzym||concentr||linear product||form||SC||construct||sequenc||reaction rate||type iif categori||enzym||catenan||endonucleas||reaction||condit||singl polypeptid||dna||r-m||cleavag||fll||potassium||double-strand break||test enzym||singl ring||act||OC form||koac||duplex||recognit sequenc||plasmid||site||OC||bcgi||rate||individu circl||copi||restrict endonucleas||baei,1||2||32 1 1||34 2 1||1 figur 2||tabl 1||3||refer 1||32 1||2 tabl 3||1 41||tabl 2||1 42||figur 1 figur 1 figur 1||figur 1 figur 1,31046.0||28965.0||21428.0||20599.667||20404.0||17331.0||17044.0||16864.5||16619.0||16541.667||16294.0||16290.5||16266.0||16123.5||16123.5,0.0,0.0,0.0
774,Cell_Tissue_Res-3-1-2039796.txt,thrombin peptid||bsp||group||soft connect tissu||area||tissu sampl||protein express||bone regener||opn||gap||distract gap||runx2||osteoblast||bone||section||bone sialoprotein||distract||osteoblast differenti||control group||cell||data||adult||osteoblast lineag||osteopontin||distract osteogenesi,2||1 fig. 1||2 1998 2||tabl 1||1 day||1 mmol||immunohistochem procedur 2 2||4 4 3 cell||4||31-20-4448683 a.bronckers@vumc.nl 1 1 depart||cell||studi||runt-rel gene 2||fig. 3||5,28965.0||22356.0||20722.0||17331.0||16489.5||15676.5||14886.0||13886.25||12937.0||12917.6||12627.0||12015.0||11254.0||11010.0||10364.0,0.0,0.0,0.06666666666666667
775,Pediatr_Radiol-2-2-1764599.txt,roi||databas||lumbar spine||osteoporosi||low bmd||clinic pathologist||factor||bodi composit||standard deviat score||numer result||studi||import||densiti||bone age||pediatr dxa||signific chang||interpret||hip||norm data||age||children||bodi||total bodi bmc||height||patient||bmc||dxa result||chang||larger bone||dxa||bmd||radiologist||standard deviat||result,1||1 2 2 2 2||2||1 2 1 depart||1 2 3 4||3||refer 1||2 43||2 min||2 gender||134 2||http://www.bcm.edu/bodycomplab 2||patient||2 43 2 35 21||studi,31046.0||29381.2||28965.0||23387.75||22498.0||17044.0||16864.5||15239.0||15117.5||14727.5||14622.5||14483.0||13567.0||12943.8||12015.0,0.0,0.0,0.13333333333333333
776,Ann_Biomed_Eng-4-1-2413127.txt,load condit||comput head model||part||model||injuri||cerebrum||gray matter||brain||equival stress||geometri||traumat brain injuri||brain injuri||influenc||finit element model||cortex||cerebr cortex||stress||boundari constraint||studi||shear modulu||head||heterogen||brain tissu||time||increas||simul||materi properti||direct||mechan load||injuri criteria||csf||numer model||method||tbi||region||result,1||1 2||2||1 1 2 4||1 3 3||1 5||39 1 2||1 3 5 5||3||refer 1||2 4 10||27 2||2 47||4||2 4 23 9,31046.0||30005.5||28965.0||25998.5||21711.333||20705.0||20523.667||17204.5||17044.0||16864.5||16294.667||15688.5||15119.0||12937.0||12570.5,0.0,0.0,0.0
777,Pediatr_Cardiol-4-1-2267487.txt,kawasaki diseas||hla||comparison||subgroup||associ||hla-b locu||studi||taq dna polymeras||intern control primer||dna||polymorph||diseas||increas||korean children||ethnic group||children||frequenc||gene||patient||signific increas||healthi korean adult||amplif||healthi control group||hla-b||allel,1||2||1 3||25 1||3||refer 1||1 min||final 1||68 1||1 profil||1 μmol||39 2||75 2||56 2||57 2,31046.0||28965.0||24045.0||17172.5||17044.0||16864.5||16158.0||15931.0||15923.0||15872.0||15557.0||15262.5||15006.5||14993.0||14976.0,0.0,0.0,0.0
778,J_Mol_Biol-1-5-2291452.txt,depend||parent||core||tnfn3||intermedi||fold||rate constant||surfac||stabil||chimer protein||parent protein||fnfn10||protein||domain||loop||mutat||strand||role||fniii||residu||backbon||dynam||properti||side-chain dynam||region||fnotnc||exchang,"1||2||tabl 1||1 17||fig. 2 fig. 2||fig. 2||2 1 15 22||posit 1||2 22||2 valu||1 17,18||2 fig. 6||4||cell||studi",31046.0||28965.0||17331.0||17314.5||16970.5||16970.5||16942.75||16665.5||16074.0||15845.0||15528.5||14338.333||12937.0||12627.0||12015.0,0.0,0.0,0.0
779,Atherosclerosis-2-1-2292239.txt,earli time point||magnet reson imag||ldl-c||time point||aortic distens||effect||statin||small number||plaqu||larg arteri stiff||coronari arteri||area||plaqu size||mri||brachial arteri||unselect coronari arteri diseas patient||imag||treatment||atheroma burden||baselin||patient||regress||atherosclerosi||therapi||chang||crp||aorta||carotid||function,1||2||2 2||1 patient||fig. 1||3||fig. 2||tabl 2||robin.choudhury@cardiov.ox.ac.uk 1||11.6 2||patient||4||3 tabl 3||2005 6 1 201||studi,31046.0||28965.0||28965.0||22306.5||18011.0||17044.0||16970.5||16290.5||15524.0||14523.5||13567.0||12937.0||12568.0||12261.25||12015.0,0.0,0.0,0.06666666666666667
780,Eur_J_Nucl_Med_Mol_Imaging-3-1-1914271.txt,imag||contrast agent||molecular imag||effect||total plaqu burden||vessel wall||cardiovascular diseas||clinic arena||studi||specif inform||patient||promis applic||cardiovascular molecular imag||field||therapi,1||2||refer 1||J. 2 1 depart||1 bax||patient||studi||netherland 2 depart||review 31 23 1||well-control type 2 diabet||6 7 fig. 6||effect||result||fig. 7||function effect,31046.0||28965.0||16864.5||16573.5||15562.5||13567.0||12015.0||11205.0||9609.25||8597.25||7530.25||6956.0||6080.0||5986.5||5768.5,0.0,0.2,0.2
781,Ann_Surg_Oncol-4-1-2266786.txt,outcom||dropout rate||olt||milan criteria||patient surviv||biolog||ucsf group||criteria||liver transplant||studi||past 10 year||ddlt||ldlt||transplant||deceas donor liver graft||patient||graft||size||hcc||tumor||morphology-bas stage system||favor preliminari surviv result||select bia||tumor morpholog||liver graft||year||result,1||2||suppl 1||patient||surgic oncolog 2008 1 2 3||5 7 1 fig||studi||itali 2 depart||5||3 cm||phd sglee2@amc.seoul.kr 7 1 depart||patient outcom||patient select||adult patient||44 patient,31046.0||28965.0||15942.0||13567.0||13421.833||12120.0||12015.0||10553.667||10364.0||8760.0||8153.0||7725.5||7665.5||7484.0||7456.0,0.2,0.2,0.13333333333333333
782,Neuropsychologia-2-1-2394569.txt,model||word||superior tempor cortex||posit correl||brain||BA 21||correl||frontal cortex||perisylvian region||BA 37||posterior portion||group||languag||deaf particip||experiment||deaf peopl||hear||addit activ||score||individu differ||associ||experiment condit||fmri||analysi||studi||condit||speech||stimuli||particip||BA 46||gyru||hemispher||hear non-sign||task||deaf nativ signer||activ||deaf children||speechread||identif||nativ signer||cluster||hear adult||skill||sign languag||non-sign||middl||voxel||region||deaf,1||2||tabl 1||3||fig. 2||1 cluster||2 penhun||2006 tabl 1||baselin tabl 2 fig. 1||4||studi||2 activ region||skill tabl 1||fig. 2 calvert||5,31046.0||28965.0||17331.0||17044.0||16970.5||15782.5||14486.0||14344.333||13859.2||12937.0||12015.0||11925.333||11672.333||11325.667||10364.0,0.0,0.0,0.06666666666666667
783,Breast_Cancer_Res_Treat-3-1-2001218.txt,big 1-98||df||distant site||primari||breast cancer||upfront therapi||letrozol||system df||hormone-sensit breast cancer||analysi||prior cancer event||addit||recurr||time||adjuv therapi||treatment||monotherapi||women||patient||risk||signific benefit||primari core analysi||event||trial||clinic||tamoxifen||year||result,1||2||rational 1 2||3||1 23||refer 1||2 18||anastrozol 1||patient||2 express statu cancer||3 year||4 fig. 3 18||patient group||6||2005,31046.0||28965.0||20049.333||17044.0||17017.0||16864.5||16447.0||15596.0||13567.0||10410.25||10150.0||9721.5||9221.0||9074.0||8716.0,0.0,0.1,0.06666666666666667
784,Soc_Psychiatry_Psychiatr_Epidemiol-2-2-1764202.txt,privat psychiatrist||social withdraw||reliabl||referr||prodrom servic||durat||number||posit||psychosi||contact||group||earli psychosi||health profession||prodrom clinic||symptom||studi||import role||untreat psychosi||mental health||help-seek pathway||patient||featur||year||health system||find||psychologist||assess||schizophrenia||gp||pathway,1||2||fig. 1||3||refer 1||2 test||χ 2||patient||4||studi||tabl 2 distribut||help-seek pathway 1||5||result sampl characterist 1||insidi symptom 1 3 20 21,31046.0||28965.0||18011.0||17044.0||16864.5||16085.5||14547.5||13567.0||12937.0||12015.0||11381.333||10797.0||10364.0||10195.5||9499.833,0.0,0.2,0.13333333333333333
785,Ann_Surg_Oncol-4-1-2277451.txt,literatur||cancer||adjuv therapi||manag||oper||surgic volum||servic||outcom||volum||centr||institut||hospit||patient||studi||poor qualiti||surgeon,1||1 1||1 2||2||refer 1||version 1||patient||literatur 3 4 5 1 6||studi||patient group||6||patient 17||1 18 fig. 1. volum||patient outcom||patient knowledg,31046.0||31046.0||30005.5||28965.0||16864.5||15767.5||13567.0||13513.167||12015.0||9221.0||9074.0||8575.0||8211.8||7725.5||7084.0,0.0,0.2,0.13333333333333333
786,Eur_J_Appl_Physiol-4-1-2226001.txt,leg||strength||correl||abil||push-off||measur||daili life||muscl strength||particip||high risk||hand grip strength||healthi older adult||age||knee||leg press apparatu||lower limb strength||leg extens strength||risk||grip strength||non-fal||jump height||subject||obstacl||fall risk||muscl strength measur||capac||trial||faller||account||classif||result,1||2||3||1 0.69||1 jump||1 1 research institut move||legpress max 2 2 3 jump||studi||experi 1 2005a||1 correl coeffici||netherland 2 institut||5||2005c 1 1994 2000||issu 3||2005,31046.0||28965.0||17044.0||15594.5||15540.5||13502.0||12584.833||12015.0||11065.0||10960.667||10854.667||10364.0||9798.5||8847.0||8716.0,0.0,0.0,0.0
787,Osteoporos_Int-3-1-1894753.txt,tanner stage 2||differ||tanner stage||humeru||length||bone mass||area||periost||humer dimens||ratio||avon longitudin studi||measur||humer width||periost growth||studi||narrow age rang||longitudin growth||width||present studi||age||boy||fractur||children||analys||bone||height||bone miner densiti||dxa||humer geometri||method||gender differ||humer AR||scan||find||result||girl||puberti,1||2||2 2 2 fig. 2||2 tabl 2||result 1||tabl 1||children 1||refer 1||2 1 8 9 10||emma.clark@bristol.ac.uk 1||44-117-928-3841 jon.tobias@bristol.ac.uk 2 3 1 commun||age 9.8 year 2 2||4||studi||tanner stage 1,31046.0||28965.0||24167.2||20515.333||18563.0||17331.0||17132.0||16864.5||15707.8||15523.5||13121.833||12966.6||12937.0||12015.0||10759.0,0.0,0.0,0.06666666666666667
788,J_Neurooncol-4-1-2295256.txt,left pariet region||differ||brain||correl||group||delta||state||left hemispher||meg||analysi||lower alpha||rel||higher cognit function||studi||frequenc band||diseas||healthi control||increas||hemispher||lower alpha band||special brain area||neurocognit function||rel power||control||gamma band||patient||neurocognit deficit||state brain activ||tumor||bilater frontocentr meg region||low-grad glioma||diffus||brain tumor patient||theta||lgg||region||result||power,1||2||2 fig. 2||1 fig. 1 distribut||3||3 3||assess 1||refer 1||trial 1||2 tumor||parieto-occipit 1||3 patient||C. 1 6 1 depart||patient||4,31046.0||28965.0||20968.667||17157.75||17044.0||17044.0||17002.0||16864.5||16639.0||15807.0||15523.5||15305.5||15135.0||13567.0||12937.0,0.0,0.0,0.06666666666666667
789,Cardiovasc_Intervent_Radiol-3-1-1914265.txt,sfa||abi||angiograph result||superfici femor arteri||complic||procedur||endovascular treatment||occlud stent||endovascular stent||patient||pier||side||option||occlus||intervent radiolog,1 2||conclus 3 1 2||refer 1||case report 1 2||patient||5||2005||patient ’s||2004||2007||4 cm||result||patient ’s maximum||treatment||patient underw ccd,30005.5||19561.5||16864.5||16572.0||13567.0||10364.0||8716.0||8305.5||8077.0||7287.0||6706.5||6080.0||5694.667||5012.0||4622.333,0.2,0.1,0.06666666666666667
790,J_Gastrointest_Surg-3-1-1852394.txt,tumor||greater omentum||literatur||case||english literatur||hemangiopericytoma||patient||resect,refer 1||figur 2||patient||figur 3||discuss 3 11 12 3 11||analysi||12 case||1998||exp clin cancer||addit treatment||case||report||tumor||therapi||alimentari tract 2007,16864.5||15083.0||13567.0||9122.5||8623.833||4687.0||4512.5||4236.0||3653.0||3482.0||3173.0||3104.0||2649.0||2633.0||2594.333,0.2,0.1,0.2
791,Pediatr_Nephrol-2-2-1764601.txt,popul||focal segment glomerulosclerosi||naprtc||proteinuria||increas||diagnosi||age||children||nephrot syndrom||patient||incid||epidemiolog||risk||fsg||esrd||preval||case||adult||renal biopsi||year||seri,1||2 3||refer 1||histologi 1||2 mutat||patient||children 4 5 6 6 2||2005||1 1925 berlin heidelberg||5 7 10 5 9 11||4 11 12 11||question patient||10||AZ 85013 usa 2 depart||population-bas studi,31046.0||23004.5||16864.5||15525.0||15116.5||13567.0||12272.0||8716.0||8126.0||7525.0||7222.75||7212.5||6982.0||6688.2||6101.5,0.0,0.1,0.06666666666666667
792,Matern_Child_Health_J-2-2-1592159.txt,dental||intervent||oral health||potenti||preterm birth||matern oral health||pregnanc||factor||cari||state||case-control studi||oral||infant||matern||birth||import||diseas||age||children||care||treatment||women||mother||birth outcom||matern periodont diseas||infect||risk||dental servic||data||tooth||deliveri||health,1||2 1 depart||23 2 2 2 23||refer 1||studi||31 2 α||2006||2002 50 1 104 martin||7516 usa 2 depart||kboggess@med.unc.edu 1 edelstein burton||2002||effect||studi design||prospect studi||result,31046.0||20835.0||18574.2||16864.5||12015.0||10509.667||8371.0||8345.4||8340.0||7779.75||7057.0||6956.0||6575.0||6474.0||6080.0,0.0,0.0,0.0
793,Naunyn_Schmiedebergs_Arch_Pharmacol-3-1-1915601.txt,fluoresc microscop||internalis||fluoresc||receptor||hisg-tag||detect method||BM chemiluminesc blot substrat||signal||mechan||cell membran||luminesc signal||detect||sphingosine-1-phosph receptor||non-radioact method||cell||result||protein||antibodi||membran||time,1||1 2||1 3||fig. 2 1||1 receptor||3||day 1||bar 1||fig. 4 1 receptor||7 fig. 6 1||4||cell||experi fig. 5 1||squar 1 receptor||springer-verlag 2007 1 receptor,31046.0||30005.5||24045.0||21662.333||17274.5||17044.0||16489.5||15829.5||13115.5||13023.25||12937.0||12627.0||12102.5||11593.0||10860.0,0.0,0.0,0.06666666666666667
794,J_Behav_Med-4-1-2346512.txt,intervent||effect||pain||cognit behavior therapi||therapist||popul||review||therapist time||chronic diseas||health condit||cbt||research||health problem||studi||condit||time||treatment||disord||patient||internet||psycholog treatment||tradit form||problem||trial||control group||headach||adult||systemat review||result,1||studi 1||2 2003||2 0||2 diabet||intervent 2||post 2||patient||4||studi patient||1 year 18||studi||1 year FU||netherland 2 depart||5 studi,31046.0||21530.5||18308.0||17529.0||15728.0||15045.0||14654.0||13567.0||12937.0||12791.0||12743.667||12015.0||11448.333||11205.0||11189.5,0.0,0.1,0.13333333333333333
795,Eur_Child_Adolesc_Psychiatry-3-1-1914287.txt,infant develop||problem behavior||parent||older children||behavior||dimens||factor||order||social commun||develop||stabil||infant||score||high level||young age||studi||aim||work||princip compon analysi||boy||age||sampl||children||analys||social commun problem||commun sampl||sex differ||item||common||pearson correl||problem||total problem score||data||attent||level||earli age||inhibit||compet||result,1||2||3 1||1 25 2||phd 1 2 1 dept.||3||refer 1||score 1||2 fig. 1 transit||1 common||score 2||13 2 4||4||result frequenc 1||1 28 16 4,31046.0||28965.0||24045.0||21103.333||18265.6||17044.0||16864.5||16576.0||16334.25||16055.5||15535.5||15388.0||12937.0||12667.667||12595.75,0.0,0.0,0.0
796,J_Chem_Ecol-3-1-2039843.txt,access||plant||endogen glucosinol||extract||natur enemi||herbivori||intern standard||pierida||time||sampl||lepidoptera||instar||growth rate||glucosinol||flower||caterpillar||amount||infloresc||gener linear model||mechan homogen||myrosinas||leaf tissu||genotyp||glucosinol concentr||leaf||result,1||2||1 4 1 4||1 1 laboratori||day 1||plant 2||1 2001a||suppl. 1||4||E. 1 3 harvey||studi||netherland 2 depart||A. 2 agerbirk||1 215 263||5,31046.0||28965.0||21991.5||20944.667||16489.5||15727.0||15538.0||15528.0||12937.0||12532.0||12015.0||11205.0||10830.667||10478.0||10364.0,0.0,0.0,0.0
797,Arch_Orthop_Trauma_Surg-4-1-2228384.txt,differ||pain||effect||durat||product||group||delay||statist signific differ||signific differ||inject||studi||hip osteoarthr||hyaluronan||hip||treatment||infiltr||patient||signific pain reduct||hh||tha||hyaluron acid||adant||prepar||viscosupplement||non-op treatment,1||2||2 2||1 fig. 1||2 3 fig. 2||refer 1||1 month||1 characterist||2 year||weligerveld 1||2 evolut||2 mulier||patient||32-16-338824 michiel.mulier@uz.kuleuven.ac.b 2 3 1 depart||treatment group 2,31046.0||28965.0||28965.0||22356.0||19987.5||16864.5||16322.0||16168.5||16110.5||15523.5||14670.5||14483.0||13567.0||13258.5||12950.667,0.0,0.0,0.06666666666666667
798,Dev_Genes_Evol-4-1-2265772.txt,sequenc||express||myohara||worm||ejg||ovari||regener||glutamin synthetas||amino acid ident||annelid,1||2||singl line 2||5||6||cell prolifer||blastem cell||result||taxonom studi||2000||9||data||intens cell prolifer||control||express,31046.0||28965.0||10394.667||10364.0||9074.0||6597.5||6314.0||6080.0||6018.5||5903.0||5392.0||4969.0||4764.333||4404.0||4395.0,0.0,0.0,0.06666666666666667
799,J_Med_Internet_Res-1-1-1761705.txt,citat analysi||internet user||number||resourc||correl||index||sens||websit||evalu||daili visit||averag||medic matrix||webometr||journal||updat||media||measur||studi||articl||medic websit||qualiti||author||sampl||world wide web||system||citat||grade||rate system||qualiti indic||internet||link||impact factor||method||content||inform||result||visit||work||inbound link,1||2||tabl 1||3||figur 1 figur 2||1 goldwein||figur 2||tabl 2 tabl 3||4||studi||tabl figur 1||1 18 http://www.mdcc.com||1 19 http://www.mc.vanderbilt.edu/p||2 22 http://www.wish.org||5,31046.0||28965.0||17331.0||17044.0||15603.25||15524.0||15083.0||13310.25||12937.0||12015.0||11954.333||11658.667||11453.667||10716.333||10364.0,0.0,0.1,0.06666666666666667
800,Angiogenesis-4-1-2268723.txt,cam||host||folkman||day||vessel||effect||blood vessel||vasoprolif respons||blood suppli||factor||develop||tissu||evid||growth||activ||angiogenesi||tumor||endotheli cell||neovascular||judah folkman||antiangiogen activ||cell||mice||molecul,1||2||3||refer 1||1 week||1 mm||blood vessel 1 2||2 day||3 6 3||cell||studi||4 5||1 angiogenesi inhibitor||13 3||3 day,31046.0||28965.0||17044.0||16864.5||16140.5||15936.5||15595.75||15449.0||14387.333||12627.0||12015.0||11650.5||10706.667||10653.0||9488.5,0.0,0.1,0.06666666666666667
801,Diabetologia-4-1-2292421.txt,adipocyt||mitochondria||fatti acid,refer 1||J. 2 4 1 depart||j.a.maassen@lumc.nl 1 2 romijn||2 consumpt||studi||netherland 2 depart||obesity-associ type 2 diabet||2007||netherland 3 depart||addit studi||A. 3 hein||molecular cell biolog||diseas||treatment||beta cell dysfunct,16864.5||15846.2||15006.0||14624.5||12015.0||11205.0||8597.0||7287.0||7231.333||6983.5||6867.333||5293.0||5149.0||5012.0||4523.333,0.0,0.0,0.0
802,Virchows_Arch-3-1-1888722.txt,RP specimen||cancer||number||vanish cancer||core||prostat tissu||step||rp||dna specimen analysi||slide||microsatellit analysi||studi||addit||dna||radic prostatectomi||figur||residu prostat cancer||atyp foci||deeper section||paraffin block||prostat cancer||dna analysi||biopsi core||patient||posit biopsi||ident||section||incid||prostatectomi||case||block||specimen||biopsi||residu cancer,1||2||2 fig. 2||apex 2 1||8 2||3||refer 1||apex 3 1||suppl 1||arrow 1||1 patients’||mid-zon 4 1||3 3 fig. 3||mid-zon 5 1||patient,31046.0||28965.0||20968.667||20008.667||17559.5||17044.0||16864.5||16035.0||15942.0||15863.5||15629.5||14663.0||14027.0||13805.333||13567.0,0.0,0.0,0.06666666666666667
803,J_Med_Internet_Res-7-2-1550646.txt,page||databas||web||ihca||lexisnexi academ databas||pubm||mass media||clinic outcom||review||retract||refer||medic||conclus||media||al paper||queri||studi||articl||notic||case studi||author||health||mesh||citat||scientist||patient||press releas||internet||press report||cochran retract||search||public||cochran collabor||princip conclus||systemat review||result,1||2||review 1 2 3||3||1 depart||1 articl||patient||studi||4 5||1 cochran review||1 20 15331181 10.1016||3 report||6||2005 7 2 e21 background||2005,31046.0||28965.0||19826.25||17044.0||16770.0||16316.5||13567.0||12015.0||11650.5||11151.333||10309.0||10074.0||9074.0||9020.6||8716.0,0.0,0.2,0.13333333333333333
804,J_Chem_Ecol-4-1-2239250.txt,insect||speci||effect||sex||concentr||plant||dri mass determin||popul||herbivor||natur enemi||parasitoid||artifici select||studi||defens||time||mithen||surviv||pieri rapa||specialist||compound||glucosinol||oviposit||GS concentr||glucobrassicin||induct||direct defens||individu||femal||total GS concentr||level||generalist||caterpillar||parasit,1||2||2 1 laboratori||2 2 fig. 8||3||3 fig. 2||2 cm||2 df||2 hr||4||4 4||studi||3 fig. 4||netherland 2 depart||1 P. xylostella,31046.0||28965.0||20251.0||17265.0||17044.0||16995.0||14720.5||14557.0||14511.5||12937.0||12937.0||12015.0||11652.333||11205.0||11038.667,0.0,0.0,0.06666666666666667
805,Intensive_Care_Med-3-1-2039828.txt,oral administr||voriconazol||invas pulmonari aspergillosi||pcr||combin||antifung therapi||combin therapi||fungal infect||chronic obstruct pulmonari diseas||drug||human studi||sign||clinic trial||relat||non-invas diagnost test||treatment||invas diseas||high tropism||patient||breakthrough infect||risk factor||ipa||GM assay||diagnost process||serum||diagnosi,1||2||3||refer 1||day 1||J. 2||B. J. 1 1 depart||patient||1 risk factor||4||2 3 31 33||1 24 26||2 treatment option||netherland 2 depart||2 31 33,31046.0||28965.0||17044.0||16864.5||16489.5||16377.0||13943.6||13567.0||12964.0||12937.0||12540.25||12310.0||11441.667||11205.0||11039.0,0.0,0.1,0.06666666666666667
806,Eur_J_Clin_Pharmacol-4-1-2426926.txt,dacp||ldl-c||concentr||dose||physic examin||advers event||group||blood sampl||stanol||dose group||phase||sitostanol||tablet||stanol-contain product||higher dose||plasma||decreas||studi||time||increas||dasp||treatment||activ||baselin||week||low-dens lipoprotein cholesterol||singl dose||placebo group||placebo||urinalysi||event||plant sterol||subject||fm-vp4||lipoprotein||hypercholesterolemia||safeti||phase 2||cholesterol||level||plant stanol||men||pharmacokinet,1||1 2||2 1||2||2 2||1 1 depart||tabl 1||3||3 3||number 1||refer 1||20 2||day 1||drug 1||phase 1,31046.0||30005.5||30005.5||28965.0||28965.0||21528.667||17331.0||17044.0||17044.0||17008.0||16864.5||16691.0||16489.5||16439.5||15995.0,0.0,0.0,0.0
807,J_Autism_Dev_Disord-4-1-2254472.txt,pdd||effect||number||search task||enhanc stimulu discrimin||target||eye movement||group||visuo-spati task||fixat time||plaist||stimulu discrimin||enhanc abil||analysi||signific differ||particip||search strategi||present studi||control||test||size||superior perform||fixat||subject||control group||reaction time data||high function adult||fixat cross||effect search strategi||stimulu element,1||2||1 fig. 1||2 fig. 2||3||condit 1 condit 2 1996||4||netherland 2 depart||1 adi score||method particip 1997 1994 1||2003||present studi||2002||10||effect,31046.0||28965.0||22356.0||20968.667||17044.0||13346.0||12937.0||11205.0||11053.333||8498.8||7651.0||7377.0||7057.0||6982.0||6956.0,0.0,0.0,0.13333333333333333
808,Neuroimage-2-1-2278232.txt,english||phonolog||left inferior frontal gyru||locat||left ifg||effect||rhyme||smg||bsl sign||group||languag||deaf peopl||phonolog process||greater extent||perform||analysi||pictur||experiment condit||peopl||sign||syntact process||neural system||particip||precentr gyru||hear group||bsl||task||primari school||oral school||activ||superior portion||medial portion||exposur||network||bsl task||non-n signer||neural network||pariet lobe||item||ifg||hear statu||left pariet lobe||phonolog represent||data||adult||region||phonolog awar||deaf,1||2||tabl 1||3||fig. 2||2006 fig. 1||2 stoko||4||studi||fig. 4 3||tabl 1 conrad||fig. 2 macsweeney||fig. 3||fig. 5 3||5,31046.0||28965.0||17331.0||17044.0||16970.5||14797.667||14487.5||12937.0||12015.0||11652.333||11561.0||11324.667||11010.0||10794.667||10364.0,0.0,0.0,0.0
809,Dig_Dis_Sci-3-1-2140097.txt,stenosi||diagnost evalu||acid product||exercis||chronic gastrointestin ischemia||detect||splanchnic stenosi||gastrointestin ischemia||chronic mesenter ischemia||chronic abdomin symptom||signific differ||studi||diagnost accuraci||gold standard||valu||patient group||meal||medic measur system||unreli result||ischemia||cgi||gastric||gastric exercis tonometri||stomach||diagnosi||result,1||1 2||2||2 2 3 4||2 2 16||2 2 valu||3||refer 1||2 level||2 test||2 peak||15 2 2 8 15||5 1 depart||2 patient characterist||2 rais,31046.0||30005.5||28965.0||21977.75||20627.0||20218.333||17044.0||16864.5||16085.5||16085.5||14727.5||14647.6||14634.667||14607.667||14564.0,0.0,0.0,0.0
810,Eur_Radiol-2-2-1705470.txt,vivo||gastric wall layer||magnet reson imag||lymphoma||endolumin RF coil||gastric wall||tumor volum||intermedi||histopatholog stage||signal intens||factor||sequenc||mri||carcinoma||stage||imag techniqu||opposed-phas sequenc||studi||suffici imag||lesion||gastric tumor||sensit||prospect studi||diffuse-typ gastric carcinoma||gastric wall differenti||gastric carcinoma||suffici detail||lymph node||serosa||tumor||coil concept||inform||case||cardia||experiment studi||layer||gastric region,1||1 1 2||1 2||2||2 2||3 2||T1 1 2 1||4 1||15 1||3||refer 1||15 2||sensit 1||4 T2 1 13 1||2 3 4 5 6,31046.0||30352.333||30005.5||28965.0||28965.0||23004.5||22804.5||21991.5||17811.5||17044.0||16864.5||16771.0||16064.5||15904.4||15676.8,0.0,0.0,0.0
811,Eur_J_Appl_Physiol-4-1-2374881.txt,differ||exercis||strength||mobil||health-rel fit compon||larg group||compon||person||studi||muscl strength||muscl||relat||particip||young adult||major muscl group||skin-fold||non-domin side||ambulatori statu||valu||activ||spina bifida||adolesc||test||aerob capac||physic fit||maxim exercis test||hydrocephalu||joint mobil||health-rel physic fit||mmc||result||ankl joint||joint,1||2||2 2||2008 2 2 2 2 2||2 2 pet 2 2||1 1 depart||result 2 2||2 2 β||2 3 2 β||2 2006||2 2001||3||studi 2 1992 2 1978 2||1 min||G. 1,31046.0||28965.0||28965.0||24477.667||23212.2||21528.667||21336.667||19416.0||18823.0||18668.0||17639.0||17044.0||16826.333||16158.0||16138.5,0.0,0.0,0.0
812,J_Autism_Dev_Disord-4-1-2175022.txt,differ||atn||diagnos||asd||gener outpati clinic||group||dutch||clinic experi||score||symptom||studi||domain||autism spectrum quotient||present studi||diagnost protocol||pddno||comorbid||patient||high function autism||mild asd||item||II disord||aq-d||autism spectrum disord||social domain||adult||result,1||2||1 patient||3||disord 1||tabl 2||1 characterist||avoid 1||borderlin 1||hanzeplein 1||3.8. 1||schizoïd 1||agoraphobia 2||patient||4 patient,31046.0||28965.0||22306.5||17044.0||16465.0||16290.5||16168.5||15730.5||15540.5||15529.5||15523.5||15523.5||14489.5||13567.0||13252.0,0.0,0.0,0.06666666666666667
813,Osteoporos_Int-4-1-2277453.txt,bone microarchitectur||risk reduct||effect||osteoporosi||advers event||popul||osteopenia||nonvertebr fractur||analysi||fragil fractur||postmenopaus women||fractur risk||studi||trabecular architectur||fractur||low bone mass||treatment||risedron||women||vertebr fractur||femor neck||patient||risk||placebo||bmd||trial||data||preval vertebr fractur,1||2||1 year||result patient 1||refer 1||2 13||1 month||1 SD||death 2||2 summari||fractur 1 fig. 1 reduct||patient||studi||1 baselin characterist||A. 2 barton,31046.0||28965.0||17151.0||16897.667||16864.5||16613.5||16322.0||16164.5||14879.0||14694.0||13782.4||13567.0||12015.0||11010.0||10839.333,0.0,0.0,0.13333333333333333
814,Surg_Endosc-4-1-2262145.txt,endoscop surgeri||surgic resid||resid||surgic curriculum||competit element||month||curriculum||possibl||score||virtual realiti simul||perform||traine||virtual realiti train||studi||particip||time||simul||task||pgi||paramet||opinion||virtual realiti||train||skill||endoscop procedur||train program||level||train time||mandatori part||result,1||1 11||refer 1||pgi 1||1 broeder||pgi 2||4||1 august 2000||studi||A. 1 rink||1 fig. 1. result||netherland 2 dept.||5||2005||pgi 3,31046.0||18048.5||16864.5||15534.0||15526.5||14493.5||12937.0||12345.667||12015.0||11522.0||10560.25||10388.333||10364.0||8716.0||8533.0,0.0,0.1,0.06666666666666667
815,J_Behav_Med-4-1-2413087.txt,parent alcohol||higher level||effect||parent||environment factor||factor||problem drink||alcohol||alcohol consumpt||drink||addit||regard||time||present studi||children||behavior control||mother||control||adolesc||famili||test||father||wave||longitudin studi||genet suscept||item||support||find||problem||parent problem drink||van der vorst||level||result,1||2||time 1||3||time 2||pe 1||2 glass||2 barn||2 marsh||1 fig 1 longitudin model||4||studi||1 1998 2006 1995||pe tabl 1||netherland 2 depart,31046.0||28965.0||17493.5||17044.0||16453.0||15532.0||14567.0||14519.0||14516.0||13279.4||12937.0||12015.0||11579.25||11560.0||11205.0,0.0,0.0,0.0
816,Cancer_Immunol_Immunother-3-1-2082063.txt,intern posit control||defect express||df||cervic carcinoma patient||signific associ||clinicopatholog paramet||apm compon||tumour||erap1||independ predictor||compon||apm defect||score||cervic carcinoma||tap||express||surviv||down-regul||patient||prognost paramet||antigen process machineri||human carcinoma||erap||independ prognost paramet||normal express||stromal cell||case||apm||loss||cervic cancer,1||1 2||2||3||refer 1||tabl 2||jan 1 1 depart||0.017 1||0.100 1||0.284 1||0.001 2||patient||30 33 37 2 2||4||express fig. 2,31046.0||30005.5||28965.0||17044.0||16864.5||16290.5||16179.5||15544.5||15534.5||15524.5||15055.0||13567.0||12994.8||12937.0||12778.667,0.0,0.0,0.06666666666666667
817,Histochem_Cell_Biol-4-1-2248610.txt,toxin||retrograd traffic||side||retrograd transport||endocytosi||golgi network||protein||ER||golgi cisterna||plasma membran||endosom||stack||shiga toxin||secretori rout||cisterna||earli endosom||compart||golgi apparatu||tgn||traffic||multipl detail||cell||golgi apparatu stack||molecul||secretori pathway||function,"2||1 interact||cell||studi||genom biol 2||32,000 fig. 2||5||shigella dysenteria 1||2000 2006 2008 2006 2007 2||2005||2004||2003||44,000 fig. 3||2007||cell biolog",28965.0||16528.5||12627.0||12015.0||11413.333||11314.0||10364.0||10355.333||10156.333||8716.0||8077.0||7651.0||7340.667||7287.0||7089.5,0.2,0.1,0.06666666666666667
818,J_Neurol-3-1-1915648.txt,effect||hypersomnol||sleepi||dose||medic||gener health||measur||interview||point||present studi||mental health||activ||partner||test||modafinil||patient||percept||rang||period||double-blind placebo-control crossov studi||chang||action||placebo||myoton dystrophi||rand-36||insuffici effect,1||2||2 3 4||3||refer 1||1 point||3 patient||2 point||patient||studi||5 6||3 point||13 patient||19 patient||studi inform,31046.0||28965.0||19648.667||17044.0||16864.5||15967.5||15305.5||14927.0||13567.0||12015.0||9719.0||8966.5||8914.5||8440.5||7727.5,0.0,0.1,0.06666666666666667
819,Ann_Surg_Oncol-3-1-1914276.txt,tissu microarray||differ||woman||PR express||immunohistochemistri||nonattend||group||multivari analysi||PR neg||van nuy classif||biolog marker express||score||studi||interv dci||screen round||express||van nuy||screen||interv group||neu express||patient||chi-squar analysi||suffici paraffin-embed tissu||dci||patholog||screen-detect||two-year interv||mammographi||tma group,1||2||1 4||2 tabl 2||3||refer 1||3 1 depart||immunohistochemistri 1 tabl 1||2 24||1 0.1||1 grade||1 0.2||1 ER||phd 1||2 29,31046.0||28965.0||21991.5||20515.333||17044.0||16864.5||16861.333||16462.75||16120.5||15872.0||15863.5||15796.0||15781.0||15636.5||15617.5,0.0,0.0,0.0
820,Fam_Cancer-3-1-1914241.txt,fifti year||cancer||hospit||hnpcc||tumour||group||crc||lynch syndrom||msi-analysi||criteria||carcinoma||multipl tumour||young age||famili histori||age||microsatellit instabl||famili||patient||colorect cancer||bethesda-guidelin||clinic genet centr||guidelin||method||medic specialist||inform||data||diagnosi||physician,1||2||1 11||2007 introduct 1 2 3||3||refer 1||2 vasen||patient||4||2 tabl 2 diagnost work-up||A. 1 oostindiër||J. 2 kloosterman-boel||M. 2 krijnen||4 5 6||7 8 9 10 1 11,31046.0||28965.0||18048.5||17128.0||17044.0||16864.5||14485.5||13567.0||12937.0||12485.4||11519.667||10918.333||10905.667||10791.667||10270.333,0.0,0.1,0.06666666666666667
821,Osteoporos_Int-3-1-1820757.txt,lipid profil||differ||serum lipid||aorta calcif||cardiovascular event||osteoporosi||cardiovascular diseas||spine||vertebr bodi||serum triglycerid||independ correl||factor||osteoporot fractur||bodi composit||lipid||associ||wrist fractur||signific differ||postmenopaus women||studi||observ studi||hip||fractur||sever||women||vertebr fractur||observ||bone||apob||risk||triglycerid||bone miner densiti||independ contributor||apo polymorph||total cholesterol||bmd||multipl regress model||acut cardiovascular event||bone loss,1||2||1 year||3 3||3||refer 1||1 werg||1 tankó||0.1 2||2 cohort||AC 2||5.0 2||2 christiansen||4||cell,31046.0||28965.0||17151.0||17044.0||17044.0||16864.5||15523.5||15523.5||14831.5||14776.0||14736.5||14579.0||14498.5||12937.0||12627.0,0.0,0.0,0.0
822,Doc_Ophthalmol-3-1-1784540.txt,xlr||hexagon||amplitud||x-link retinoschisi||area||eye||retin dysfunct||stimulu array||studi||time||grey hexagon||averag control subject||valu||mferg||implicit time||control||test||patient||femal||subject||carrier||segment||situ inversu,1||2||16 2 2 2 2||1 3 1 depart||result 1 1 18||3||refer 1||2 20||patient||studi||fig. 3||3 SD||6||1 normal OU 4 53 20||male patient,31046.0||28965.0||23962.2||20407.5||18025.25||17044.0||16864.5||16691.0||13567.0||12015.0||11010.0||9163.5||9074.0||8565.0||7272.5,0.0,0.2,0.13333333333333333
823,Breast_Cancer_Res_Treat-3-1-2001217.txt,effect||anastrozol||advers event||breast cancer||chemotherapi||combin||letrozol||regimen||hormone-sensit breast cancer||patient awar||neoadjuv therapi||detriment effect||recurr||aromatas inhibitor||adjuv||benefit||adjuv therapi||treatment||ai||women||patient||decis||sexual health||risk||tumor||placebo||event||mbc||individu||long-term survivorship||trial||breast cancer continuum||case||tamoxifen||year,1||2||3||refer 1||1 mg||big 1||2 years’||patient||4||studi||2007 introduct 1 5 6||1 safeti profil||2 express statu cancer||5||3 year,31046.0||28965.0||17044.0||16864.5||15945.0||15552.5||14496.5||13567.0||12937.0||12015.0||11813.8||10724.667||10410.25||10364.0||10150.0,0.0,0.1,0.06666666666666667
824,Bioinformation-2-4-2255066.txt,neurolog disord||databas||sequenc||disord||drug||dnd||gene||diseas||entri||neurodegen disord,1 2 3 4 5||cell||refer 1 http://en.wikipedia.org/wiki/neurodegenerative_diseas 2 copped||india 2 depart||content 6 7 figur 1||neurodegen disord gowthaman ragul 1||nerv cell||protein||result||diseas||gene||protein sequenc||research||tabl||relat gene,20071.2||12627.0||12539.4||10521.333||9782.0||6600.8||6551.5||6288.0||6080.0||5149.0||4794.0||3918.5||3708.0||3616.0||3581.5,0.0,0.1,0.13333333333333333
825,Purinergic_Signal-3-4-2072921.txt,purinerg receptor||lesion nigro-striat circuit||receptor||dopamin denerv||express||substantia nigra||rat brain||gray matter||brain||experiment condit||specif||green immunofluoresc||presenc||protein||striatum||atp||rat striatum||protein level||confoc analysi,"1||1 1||1 1 1 1 1 1||2 1||2 2 1||2||2 2||3 1||4 1||5,6,7 1 1||astrocyt 2 1 3||2 2,5 2||2007 1||4 4 1||2007 introduct 1 2 3",31046.0||31046.0||31046.0||30005.5||29658.667||28965.0||28965.0||24045.0||21991.5||20697.667||19335.5||19312.0||19166.5||18973.333||17128.0,0.0,0.0,0.0
826,Oecologia-3-1-1915602.txt,host||root||effect||plant||herbivor||natur enemi||parasitoid||indol glucosinol||develop||harvey||insect cultur||studi||insect herbivor||qualiti||glucosinol||control||foliar herbivori||larva||root tissu||mortal||adult||interact||result||root biomass,1||2||1 1 depart||tabl 1||renn 1||1 2 vet louis||studi||T. rapa 1||netherland 2 laboratori||M. 1 3 harvey jeffrey||2005||2005 2005 2005 2004||2004||2003||effect,31046.0||28965.0||21528.667||17331.0||15529.0||15027.0||12015.0||10952.333||10621.0||10393.8||8716.0||8556.25||8077.0||7651.0||6956.0,0.0,0.1,0.13333333333333333
827,Eur_J_Epidemiol-3-1-2071967.txt,amd||myocardi infarct||osteoporosi||stroke||depress||blood sampl||area||factor||blood||endocrin diseas||anxieti disord||elderli||updat||urin||research||drug||macular degener||associ||measur||studi||particip||diseas||high risk||glaucoma||imag||import inform||optic disc||age||genet factor||object||disord||parkinson diseas||gene||heart failur||dementia||risk||protocol||atherosclerosi||candid gene||alzheim diseas||method||subject||risk factor||determin||grief||examin||larg number||assess||rotterdam studi,1||2||1 3||2007 introduct 1 2||M. 1 1 depart||refer 1||1 ng||1 januari||patient||9 11 1 10||studi||type 2 diabet||netherland 2 depart||1 4 witteman jacquelin||1 krestin gabriel,31046.0||28965.0||24045.0||17149.0||17083.0||16864.5||15618.0||15588.0||13567.0||12117.75||12015.0||11461.333||11205.0||11009.25||10365.333,0.0,0.0,0.06666666666666667
828,FEMS_Microbiol_Ecol-1-_-2121141.txt,model||speci||scale||ecolog hypothes||divers pattern||instanc||cca||varianc||variabl||environment gradient||statist||hypothesi||group||order||approach||techniqu||data matric||variat||row||gradient||measur||environment condit||multivari analys||pca||axe||princip compon analysi||ordin||pattern||ecolog studi||interpret||multivari||object||sampl||ordin diagram||signific||rda||observ||test||tabl||specif rule||cluster||distanc matric||commun||constrain ordin||statist packag||method||rank||microbi ecolog||site||complex||inform||data||set||distanc||canon correspond analysi||origin varianc||cluster analysi||relationship||nmd,1||2||fig. 1||tabl 1||3||fig. 2 tabl 2||fraction 1||fraction 2||2 distanc||2 legendr||tabl 1 fig. 1 avis||1998 tabl 2||studi||1994 tabl 2||tabl 1 usag,31046.0||28965.0||18011.0||17331.0||17044.0||16630.5||15746.5||14706.0||14646.5||14526.5||14137.6||12272.333||12015.0||11606.0||11597.667,0.0,0.0,0.0
829,Biogerontology-4-1-2174522.txt,genet||product||sirtuin||sirtuin activ||nadh level||nadh||metabol||lifespan||nad||accumul||format||protein||alter protein||condit||gener||increas||age||AL condit||benefici effect||glycolysi||dhap||dietari restrict||activ||control||mitochondri||oxid||nad avail||cell||methylglyox||level||pathway||function,1||cell||type 1 diabet||glyoxalas 1 activ||glyoxalas 1 defici||neuron sirt 1 activ||2005||2006||2005 2007 2003||2003 2007 2006 2007 2006||2003||2007||effect||neuron cell||complication-fre patient,31046.0||12627.0||12155.0||12093.333||10490.667||9344.0||8716.0||8371.0||7884.667||7793.4||7651.0||7287.0||6956.0||6862.5||6784.5,0.2,0.1,0.06666666666666667
830,Int_J_Colorectal_Dis-3-1-2134973.txt,constip||defec||defec disord||questionnair||appendico-cecostomi||studi||irrig||qualiti||life||treatment||colon irrig||addit therapi||dgp||patient||amount||abdomin cramp||contin||fecal incontin||colostomi||water||success rate||result||dynam graciloplasti,1||1 1||2||1 2 fig. 1 biotrol||3||refer 1||2 success||28 32 1 5 1 5||sigmoid 2||patient||studi||prolaps 2 0||10 patient||3 fig. 3 success||4 8 9 3 10,31046.0||31046.0||28965.0||19207.0||17044.0||16864.5||14790.0||14576.833||14511.0||13567.0||12015.0||11706.0||10274.5||9919.75||9701.8,0.0,0.1,0.13333333333333333
831,Biochim_Biophys_Acta-1-5-1906864.txt,receptor||excess ldl||effect||incub||particl||foam cell format||ldl||accumul||lipid||decreas||foam cell||studi||import||lactoferrin||crlp||increas||chylomicron remnant||lipid accumul||cmr||top fraction||atherosclerosi||uptak||phagocytosi||oxid||oxid state||lrp||find||cell||cholesterol||apo||macrophag||pathway||result,1||2||fig. 1 fig. 1||3||fig. 2 fig. 2||fig. 2||tabl 2||2 materi||2 min||fig. 2 fig. 3 tabl 2||2 lipid||thp-1 cell 2||patient||4||4 4,31046.0||28965.0||18011.0||17044.0||16970.5||16970.5||16290.5||15325.0||15117.5||14757.0||14721.5||13868.667||13567.0||12937.0||12937.0,0.0,0.0,0.0
832,Neurochem_Int-2-1-2194163.txt,wild type||spontan epsc||synapt transmiss||effect||glutam||drug||control||capsaicin||capsazepin||glutam releas||data||studi||applic||epsc||amplitud,1 1||1||2||fig. 2 1 1 1||2006 1 1 1||fig. 3 1 1 1||fig. 2 1||1 1 ac||2000 1 2 fig. 1||fig. 4 1 1||2006 1||2006 2||2003 2||1997 1||2002 1 1 sasamura,31046.0||31046.0||28965.0||25415.8||25377.25||23031.6||21662.333||20707.667||20387.2||20001.25||19708.5||18668.0||18308.0||17297.5||17288.25,0.0,0.0,0.0
833,Matern_Child_Health_J-2-2-1592247.txt,perform measur||intervent||prioriti||project||program||educ||summit||innov strategi||nation map||public health||preconcept care program||popul||pregnanc||clinic practic strategi||public health practition||strategi||state||unit state||measur||matern||birth||prenat care||health care||public polici||age||women||servic||reproduct health||ppor||preconcept health promot||preconcept||patient||father||jurisdict||risk||provid||state perform measur||indic||issu||preconcept care||nation summit||famili plan||effort||unpublish data||clinic||abstract||folic acid||preconcept risk assess||health||servic provid,1||1 2||2||2 4 2 2 4||3||refer 1||1 state||2 year||2 sampl||2 hour||patient||4||5||fig. 1 state titl||3 month,31046.0||30005.5||28965.0||22553.8||17044.0||16864.5||16293.5||16110.5||15665.0||14625.5||13567.0||12937.0||10364.0||9413.5||9321.0,0.0,0.0,0.06666666666666667
834,Anal_Bioanal_Chem-3-1-1592253.txt,power tool||vivo||biomolecul||bind||real time||optic molecular imag||system biolog||specif||abil||fret||molecular probe||fp||qd||system level||fluoresc protein||omi||protein||tissu||greater tissu penetr||addit||imag||high spatial||system||quantum dot||chang||oct||fluoresc||method||fluoresc probe||dynam||flim||biolog event||cell||shim||red fluoresc||fc||interact||applic,2||refer 1||1 omi||1 9 11 fig. 1||cell||fluoresc protein 2||46 69 2||calcium 97 2||5 28 98 99 2||2005||2006||2004||130 C. elegan 2||2003||2002,28965.0||16864.5||15532.0||15502.2||12627.0||11926.0||10375.0||10241.0||8753.2||8716.0||8371.0||8077.0||7871.5||7651.0||7057.0,0.2,0.1,0.06666666666666667
835,Qual_Life_Res-4-1-2238788.txt,differ||hrqol measur||effect||satisfact||clinic practic||futur||hrqol||experiment group||cld||group||chronic diseas||experiment||gener popul||score||experiment condit||questionnair||liver transplant||studi||computer measur||gener practic||diseas||age||control||patient||consult||implement||checklist||control group||hepatolog||inform||chronic liver diseas||data||mental hrqol||physician||univari analys||result,1||2 1 2 2||2||3 4 1 1 2||1 fig. 1||1 differ||1 year||3||refer 1||fig. 2 patient||2 characterist||1 2 darlington anne-sophi||3 4||patient||4,31046.0||29485.25||28965.0||24207.6||22356.0||18234.0||17151.0||17044.0||16864.5||15836.0||15128.0||15004.75||14990.5||13567.0||12937.0,0.0,0.0,0.06666666666666667
836,Pediatr_Nephrol-3-1-2064944.txt,rrt||earli detect||renal replac therapi||report||popul||dialysi||kidney diseas||unit state||countri||naprtc||pediatr ckd||registri||age||children||ckd||care||major||patient||incid||epidemiolog||end-stag renal diseas||renal transplant||inform||esrd||preval||data||chronic kidney diseas||congenit renal disord||kidney||adult||preval rate,2||1 5 fig. 1||1 8||2 8||refer 1||15 2||age 2||1 week||22 2||childhood 1 4||5 21 2 5 fig. 2||patient||studi||3 10||10 2 17 10,28965.0||19358.0||18600.0||17559.5||16864.5||16771.0||16265.0||16140.5||16074.0||14825.0||14485.833||13567.0||12015.0||12013.0||11628.0,0.0,0.0,0.06666666666666667
837,Ann_Biomed_Eng-2-2-1705491.txt,number||leukocyt||specif||firm adhes||molecul||flow||field||averag||surfac||ldv||interact||studi||flow condit||system||shear stress||view||method||hydrogel||cell||leukocyt adhes||averag number,1||1 1 1||1 2||2||1 2 environ||2 figur 2||refer 1||1 min||4 1 3 figur 3||IL 1||2 integrin||713-348-5154 jwest@rice.edu 1 1 depart||cell||studi||vivo figur 1,31046.0||31046.0||30005.5||28965.0||20339.0||19710.333||16864.5||16158.0||15854.4||15612.5||14527.5||12917.6||12627.0||12015.0||11027.667,0.0,0.0,0.13333333333333333
838,FEBS_Lett-1-5-1964784.txt,egr||thymu||transcript||ap-1||rhoa||divers biolog function||develop||enzym||notch||protein||wild type||express||affymetrix gene||cell develop||pre-tcr||transcript factor||thymocyt||cell||mice||loss||function,1||2||fig. 1 fig. 1||3||fig. 2||figs. 1 fig. 1||delta 1||2 materi||fig. 2 supplementari fig. 1||fig. 2 fig. 2 cd2||4||cell||supplementari fig. 1||supplementari fig. 2||3 result,31046.0||28965.0||18011.0||17044.0||16970.5||16785.25||15620.0||15325.0||14151.0||13578.4||12937.0||12627.0||12271.333||11577.667||11562.0,0.0,0.0,0.06666666666666667
839,Appl_Microbiol_Biotechnol-3-1-1914294.txt,strain||isopren||emiss||methylerythritol phosphat pathway||growth||express||enzym||iptg||product||cell||concentr||gene||studi||amount||pathway||isopren emiss||terpenoid||biosynthesi||function,1||2||1998 1 fig. 1||3||type 2||1 mM||step 2||2 μg||4||31-50-3633000 o.kayser@rug.nl 1 1 depart||cell||studi||1 mM iptg||De deimten 1||1 kayser oliv,31046.0||28965.0||17826.0||17044.0||15946.5||15723.5||14763.0||14685.0||12937.0||12917.6||12627.0||12015.0||10487.0||10456.667||10379.0,0.0,0.0,0.13333333333333333
840,Arch_Orthop_Trauma_Surg-4-1-2413128.txt,conserv treatment||pseudarthrosi||calcan nonunion||fractur||nonunion||subtalar joint||calcaneu||complic||pain||subtalar arthrodesi||case||month||patient||report||trauma||bone graft,1 5 6 4 2 1||3||refer 1||1 summari||patient||4||nonunion 1 year||bone graft 2 6||6||1999 102 1 13 22 10.1007||2007||oper patient||10||current studi||bone graft 3 10,20572.0||17044.0||16864.5||15734.5||13567.0||12937.0||11438.0||10145.25||9074.0||7966.167||7287.0||7208.5||6982.0||6741.5||6642.0,0.2,0.1,0.06666666666666667
841,Biol_Psychol-1-5-2075532.txt,rate||effect||face||attent task||attent bia||amygdala||similar pattern||group||intens||research||individu differ||cognit||signific differ||emot intens||present find||studi||bia||direct||task||facial express||emot||threat-process||eye-mov data||individu||anxieti||manual respons||data||attent||fear||result,1||2||3||number 1||fig. 2||1 tott0006@tc.umn.edu||2 ratcliff||data fig. 2||studi||5||tabl 1 group characterist||2005||3 array||2006||2003,31046.0||28965.0||17044.0||17008.0||16970.5||15523.5||14491.5||12970.0||12015.0||10364.0||10207.0||8716.0||8666.0||8371.0||7651.0,0.0,0.1,0.06666666666666667
842,Planta-3-1-2039816.txt,wilt||speci||petal||petal cell||absciss||program cell death||agaros gel||petal senesc||develop||stage||dapi||remark nuclear morpholog||time||floral life span||increas||sampl||dna content||treatment||flower||ethylen treatment||dna degrad||nuclear condens||dna breakdown||dehydr||flow cytometri||chang||chromatin condens||flower open||cell||result||nuclear diamet||preliminari experi||lower sequenc||nuclei||nuclear area||petal desicc,1||1 1 1 1||2||2 4 2||1 4||3 3 3||2 2 fig. 2 P. yedoensi||2 D.||4||4 4||cell||2 P. yedoensi 2 D.||6 6 3 6||P. yedoensi 1||31-317-475347 wouter.vandoorn@wur.nl 2 1 nation institut,31046.0||31046.0||28965.0||23622.333||21991.5||17044.0||15651.167||15289.5||12937.0||12937.0||12627.0||12316.0||11066.5||11027.333||10467.833,0.0,0.0,0.06666666666666667
843,Planta-4-1-2270920.txt,phloem||leaf cell||speci||distribut||sucros||plant||subcellular compart||sorbitol||common plantain||mesophyl cell||ratio||sugar alcohol||metabolit||myo-inositol||studi||apoplast||activ transport||mannitol||siev tube||non-aqu fraction||sugar||cytosol||celeri||stroma||compart||leav||sourc||sea plantain||peach||vacuol||leaf||sugar alcohol concentr||fructos||subcellular distribut,1||2||1 3||3||1 concentr||1 5.0||1 FW||1 sea||1 3 1996 2007||subcellular volum 2 2 4 6||4||4 4||studi||4 5||4 6,31046.0||28965.0||24045.0||17044.0||16202.5||15619.5||15586.5||15575.5||14601.0||13496.0||12937.0||12937.0||12015.0||11650.5||11005.5,0.0,0.0,0.06666666666666667
844,Osteoporos_Int-3-1-1766477.txt,lumbar spine||osteoporosi||popul||vertebr deform||multipl||mxa||studi||deform||fractur||age||vertebr morphometri||women||vertebr fractur||normal lumbar spine bmd||grade||patient||risk||dxa||bmd||scan||normal bmd||preval||hip fractur||signific risk factor,1||2 2||2||2 2 2||3 1||3||refer 1||2 15||fractur 1||t-score group 2 2||1 mitchel||grade 2||patient||2 fig. 2 present fractur||4 4,31046.0||28965.0||28965.0||28965.0||24045.0||17044.0||16864.5||16771.0||16117.0||15718.5||15594.5||14823.0||13567.0||13366.6||12937.0,0.0,0.0,0.06666666666666667
845,Planta-4-1-2413075.txt,hybrid signal||liquid nitrogen||incub||pepper||pathogen||plant||antifung activ||pme||oxid stress toler||abiot stress respons||molecular mass||growth chamber||protein||inocul||cotyledon||growth||express||treatment||seedl||control||hybrid||pme activ||gene||role||leav||inhibitor||spore||suscept||wild-typ||result,1||2||1 2 2 2 2 solut||1 4||1 3 3||1 8||2004 2||3||1 1 2000 nicotiana||1 min||1 mL||1 trna||1 xcv||1 rifampicin||4,31046.0||28965.0||24638.5||21991.5||21711.333||18600.0||18521.0||17044.0||17008.5||16158.0||15589.0||15578.5||15542.5||15524.0||12937.0,0.0,0.0,0.0
846,Biochim_Biophys_Acta-2-1-2396231.txt,klf express||respons||gene express||effect||cardiac myocyt||polysom||upregul||cell type||endothelin-1||protein||total rna||studi||signific role||apoptosi||increas||express||multipl klf famili member||famili||gene||cardiac myocyt hypertrophi||mrna||transcript factor||krüppel-lik factor||gene promot||cell||oxid stress||data||pathway||klf,1||2||2 2||abstract 2 2 2 2||6 2 2||2 2 fig. 5 2 2||3.4 2 2||fig. 1 fig. 2||tabl 1||tabl 2 fig. 1||3||fig. 2||tabl 2||fraction 1||2 signal,31046.0||28965.0||28965.0||23279.4||22334.667||21866.667||19372.333||17490.75||17331.0||17150.75||17044.0||16970.5||16290.5||15746.5||15633.0,0.0,0.0,0.0
847,Int_J_Cardiovasc_Imaging-4-1-2233707.txt,nccm patient||present studi||subject||control subject||mad||LA function||laef||noncompact||nccm||control||patient||studi||noncompact cardiomyopathi||LV dysfunct||mitral annulu||maa||result,1||2||2 3||data 1 2||2de examin 2 2 2||3||refer 1||1 demograph||1 2 anwar ashraf||patient||4||31-10-4635498 f.j.tencate@erasmusmc.nl 1 1 depart||studi||discuss 1 6 9||2008 introduct 1,31046.0||28965.0||23004.5||21660.0||17655.8||17044.0||16864.5||15622.5||15008.5||13567.0||12937.0||12918.8||12015.0||11803.25||11461.667,0.0,0.1,0.13333333333333333
848,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2226194.txt,anterior femor translat||flexion||condylar contact||differ||spreader||previou report||postop knee kinemat||dynam stair activ||tibial rotat||static knee flexion||group||ligament||techniqu||studi||averag center||posterior cruciat||posterior||signific||stair ascent||control||knee||activ||rotat||stair activ||patient||knee arthroplasti||knee kinemat,1||2||method 1 2 fig. 1||result 1||14 1||3||fig. 2||refer 1||1 patient demograph||2 degre||2 kashif||2 fennema||patient||4||1-352-3927303 banks@ufl.edu 1 4 1 depart,31046.0||28965.0||19941.0||18563.0||17671.5||17044.0||16970.5||16864.5||14937.333||14651.5||14483.0||14483.0||13567.0||12937.0||12920.833,0.0,0.0,0.06666666666666667
849,J_Gastrointest_Surg-3-1-1852375.txt,ocular lesion||surgic resect||ulcer||intestin ulcer||intestin involv||intestin perfor||ileocec resect||symptom||diseas||oral ulcer||lesion||age||reperfor||gastrointestin symptom||patient||resect||year||case||genit ulcer||diagnosi||seri,1||2||method 1 1 2 2||3||refer 1||2 45||2 week||3 4||patient||1 18 19||886-2-86659727 surgery6711@yahoo.com.tw 1 1 divis||2 7 30 5||studi||2 4 11 12 12||1 termin ileum 4,31046.0||28965.0||24738.8||17044.0||16864.5||15300.0||15100.0||14990.5||13567.0||12763.0||12474.6||12398.25||12015.0||11731.4||11076.0,0.0,0.1,0.06666666666666667
850,Purinergic_Signal-4-2-2377323.txt,amilorid||effect||channel||solut||camp||apic||addit||atp||cftr||treatment||releas||activ||apic solut||experi||current||monolay||atp releas||enac||cell||data||chlorid channel,1||2||2 2||2 10 1 1||2 3||6 2||fig. 1||10 2||3||3 3||3 3 3||fig. 2||refer 1||line 1||2 3 5 8,31046.0||28965.0||28965.0||24509.75||23004.5||19019.5||18011.0||17973.5||17044.0||17044.0||17044.0||16970.5||16864.5||16165.5||15631.75,0.0,0.0,0.0
851,Purinergic_Signal-3-3-2096642.txt,host||effect||diarrheal diseas||pathogen||rna||wateri diarrhea||supernat||phosphat||type iii secret||cell surfac||enzym||secret||revers transcript||studi||addit||host cell death||releas||activ||uss chamber||epec||experi||larg releas||infect||amp||strain||zinc||adenosin||method||phosphat releas||inhibitor||minim medium||cell||zinc supplement||host cell,1||2||result 1 1 1||2 2 16||2 2 2 fig. 2 E.||1 effect||2 3 2 incub||fig. 1||24 1||2007 introduct 1 2||3||refer 1||lane 1 lane 2||2 mM||method 2 6,31046.0||28965.0||24804.5||20627.0||20461.167||19001.0||18863.0||18011.0||17161.0||17149.0||17044.0||16864.5||15149.25||14683.0||13903.667,0.0,0.0,0.0
852,Matern_Child_Health_J-2-2-1592243.txt,intervent||nation recommend||survey||practic pattern||pregnanc outcom||health care provid||practic||pregnanc||medic||approach||physician||ntd||studi||age||women||famili||preconcept||patient||preconcept survey||recommend||provid||knowledg||behavior pattern||risk||guidelin||prevent||preconcept care||nation summit||specif preconcept recommend||effort||prepregn plan||folic acid||preconcept counsel||counsel||prepregn survey||key word,1||2||refer 1||4 1 univers||patient||6 Pt 1||6 pt. 1||4||studi||5||mph aprn-bc 1||6||2005||11 studi||2004,31046.0||28965.0||16864.5||15880.0||13567.0||13435.667||13374.333||12937.0||12015.0||10364.0||10354.0||9074.0||8716.0||8533.0||8077.0,0.2,0.2,0.13333333333333333
853,Mol_Immunol-1-5-2075531.txt,respons||potent activ||bind||molecul||human serum||hors||elisa||reqigg||strong respiratori burst||igg||condit||antibodi||half molecul||ehv-1||glycosyl||chain||human igg||nip||pbs-t||residu||glycan||reactiv||pbl||region||fcγr||subclass||equin||amino acid differ,1||2 2 2 2 burton||fig. 2 2||1993 2 2||1987 2 2||tabl 1||1 μg||1997 2 2 molecul||2 materi||1993 2 2 pleass||fig. 2 fig. 2 sheoran||cell||studi||tabl 1 reactiv||tabl 1 morton,31046.0||23184.4||20968.667||19904.667||19593.333||17331.0||15725.5||15540.0||15325.0||14929.75||13580.6||12627.0||12015.0||11645.0||11570.0,0.0,0.0,0.0
854,Matern_Child_Health_J-2-2-1592153.txt,survey||health care provid||practic||variabl||pregnanc||behavior||nonphysician hcp||ntd||folic acid||particip||correct amount||age||hcp||preconcept care visit||care||public health servic||women||practic set||multivitamin||patient||provid||knowledg||prevent||set||level||physician||predictor,1||2||result 1||refer 1||2 factor||patient||6 pt. 1||1 provid type||studi||1 stone cheryl||5||2 fassett elizabeth||6||2005||patient age,31046.0||28965.0||18563.0||16864.5||16704.5||13567.0||13374.333||12204.667||12015.0||10388.667||10364.0||9664.0||9074.0||8716.0||8566.0,0.0,0.1,0.06666666666666667
855,Int_Arch_Occup_Environ_Health-3-1-1915641.txt,model||potenti confound||complaint||heavi physic work||pain||sex||effect||popul||upper extrem||regress model||neck||high||studi||decis author||symptom||musculoskelet co-morbid||time||baselin questionnair||increas||analys||turn||baselin||long period||upper extrem complaint||patient||risk||cox regress model||psychosoci risk factor||style||risk factor||larg size||sick leav||self-report questionnair||sick||work||wildhagen||effect modif,1||2||1 year||3||1 month||scale 1||1 week||2 week||1 week 5||patient||4||1 3 4 bouter lex||studi||respons categori 1||1 month 36,31046.0||28965.0||17151.0||17044.0||16322.0||16163.5||16140.5||15100.0||14215.0||13567.0||12937.0||12211.0||12015.0||11675.667||11455.667,0.0,0.1,0.13333333333333333
856,J_Gastrointest_Surg-3-1-1852390.txt,oper time||complic||number||short gastric vessel divis||convers rate||convers||month||hospit||singl surgeon||length||dilat||oper||decreas||studi||laparoscop nissen fundopl||learn curv||dysphagia||short gastric vessel||time||cohort||stay||reoper||postop dilat rate||patient||wrap||lnf||seventh cohort||laparoscop||curv||fundopl||persist dysphagia||procedur||open fundopl||seri||surgeon||result,1||2||result 1 1||1 1 dysphagia||reoper 1 2||3||number 1||refer 1||1 week||figur 1||1 demograph||2 month||patient satisfact 2||patient||4,31046.0||28965.0||22724.0||20708.667||20020.333||17044.0||17008.0||16864.5||16140.5||16123.5||15622.5||15281.5||14215.667||13567.0||12937.0,0.0,0.0,0.06666666666666667
857,Plant_Mol_Biol-3-1-1805040.txt,main shoot||respons||root||comparison||transcript||rice||plant||report||floral transit||microarray||salin||auxin||stage||stress||agami||protein||tissu||shoot||present studi||valu||express||toler||jasmon||control||growth stage||gene||salt stress||genotyp||data||salt,1||1 2||2||2 2 2||2 2||1 2002 2 1||1 fig. 1||1 1 depart||2005 1||result 1||3||tabl 2||chromosom 1||1 japonica||1 s.e.,31046.0||30005.5||28965.0||28965.0||28965.0||24528.5||22356.0||21528.667||19881.0||18563.0||17044.0||16290.5||15734.0||15540.5||15525.0,0.0,0.0,0.0
858,Intensive_Care_Med-3-1-1915615.txt,lesion||differenti diagnosi||treatment||mri||complet recoveri||coma||case||cell count||patient||week||protein||full recoveri||diseas||csf||lyme diseas,1||2||case 1 fig. 1||case 1||3||refer 1||3 1 depart||2 week||patient||netherland 2 depart||brain 2 month||springer-verlag 2007 case 9 6 2||netherland 3 depart||effect||comatos patient,31046.0||28965.0||17560.25||17109.5||17044.0||16864.5||16861.333||15100.0||13567.0||11205.0||10831.667||9249.167||7231.333||6956.0||6785.0,0.0,0.1,0.06666666666666667
859,Int_Urol_Nephrol-4-1-2268719.txt,serum phosphat||serum magnesium level||valu||hemodialysi||phosphat control||magnesium||sever hypermagnesemia||calcium||serum phosphat level||phosphate-bind||serum||patient||studi||rang||level||magnesium carbon||end-stag renal diseas||group,1||2||3 1||4 2 2||3 2||2 3 3 2||4 1||2 3 3||2 3 3 3||3 3 3 2||3 3 3 3 2||3 3 5 2||3||3 3||3 3 3 3 3 3,31046.0||28965.0||24045.0||23622.333||23004.5||23004.5||21991.5||21017.667||20024.25||20024.25||19428.2||18354.25||17044.0||17044.0||17044.0,0.0,0.0,0.0
860,J_Mol_Biol-2-1-2279226.txt,atp-depend chromatin||result gener||histon tail||nativ page||effect||purif||depend||chromatin||tail||histon acetyl||octam transfer||lysin acetyl||hydrolysi||enzym||full-length||protein||reaction||studi||addit||dna||acetyl||snf2||rsc||increas||octam||amino acid||mutat||control||activ||modif||nucleosom||complex||atp hydrolysi||bromodomain||histon||effici||transfer||rate||rsc complex,1||2||2 2||3||figur 1||lane 1||t.a.owenhughes@dundee.ac.uk 1||figur 2||figur 2 figur 2 figur 2||2 77||2 mM||figur 1 figur 1 24||4||cell||figur 2 effect,31046.0||28965.0||28965.0||17044.0||16123.5||15669.5||15524.0||15083.0||15083.0||14862.0||14683.0||13554.0||12937.0||12627.0||12374.0,0.0,0.0,0.0
861,J_Biomol_NMR-3-1-2048825.txt,constraint||nmr constraint list||number||noesi spectra||atom||total||entri||hpc||contact||file||analysi||total number||distanc inform||spectra||fragment||import||pdb||occurr||pdb entri||nmr structur ensembl||inter-atom distanc||constraint data||residu||sequenc fragment||inform||nmr||set||data||distanc||type||structur,1||2||3||1 sampl||1 overview||1 helix||1983 2||2 overview||2 helix||4||cell||data set 3 2 fig. 3||studi||residu fig. 2||contact type atom 1 atom 2,31046.0||28965.0||17044.0||16705.5||15645.5||15546.5||14762.0||14605.0||14506.0||12937.0||12627.0||12408.333||12015.0||11549.667||10660.833,0.0,0.0,0.0
862,J_Med_Internet_Res-6-3-1550604.txt,page||word||grade level||access||effect||materi||literaci level||web||abil||difficulti||read abil||averag||group||order||health inform||health materi||read||text||health question||studi||weak search strategi||term||think-aloud||particip||rectum cancer||web site||health educ||basic search||health||question||high-school read profici||read level||method subject||googl||experi||internet||health site||lung cancer||answer||search engin||individu||subject||navig||search||site||inform||skill||literaci||level||strong read skill||investig||low literaci||search term,1||2||3 2||5 2||7 2||tabl 1||inform 1||3||1 particip||subject 1||tabl 2||2 case||question 1||1 link||1 kirsch,31046.0||28965.0||23004.5||19664.5||17981.0||17331.0||17243.0||17044.0||16518.0||16465.0||16290.5||16069.0||15952.0||15932.0||15534.0,0.0,0.0,0.0
863,J_Gastrointest_Surg-3-1-1852376.txt,metastat site||extens extrahepat diseas||detect||neoadjuv treatment||nonresect diseas||chemotherapi||patholog find||bevacizumab||abdomin CT||metastas||recurr||high risk||lesion||longer follow-up||sensit||treatment||fdg-pet||patient||neoadjuv chemotherapi||resect||hepat resect||tumor||extrahepat diseas||liver||origin imag find||colorect liver metastas||result,1||1 2||2||2 2||1 cm 1||group 1||0 2 group 1||3||group 2||refer 1||1 month||group 2 patient||1 cm||2 month||2 week,31046.0||30005.5||28965.0||28965.0||20856.0||17960.5||17744.75||17044.0||16920.0||16864.5||16322.0||15802.333||15761.0||15281.5||15100.0,0.0,0.0,0.0
864,Eur_Radiol-3-1-2039819.txt,mdct||coronari arteri||dual-sourc CT||virtual angioscopi||coronari fly-through||high qualiti visualis||post-process||major branch||patient||imag qualiti||major coronari arteri||time||min,1||1 fig. 1 larg||3||refer 1||2 3 fig. 2 visibl||hanzeplein 1||2 min||6 10 2||patient||bypass graft 1 3||studi||discuss 3||3 min||12 13 3||20 patient,31046.0||17062.5||17044.0||16864.5||16021.0||15529.5||15117.5||15007.0||13567.0||12124.25||12015.0||9372.5||9157.0||9052.667||8992.0,0.0,0.1,0.06666666666666667
865,Histochem_Cell_Biol-4-1-2248609.txt,sandvig||clathrin||mechan||toxin||depend||instanc||endocyt mechan||raft||actin||rhoa||endocytosi||protein||plasma membran||membran||cholera toxin||intern||shiga toxin||uptak||role||caveola||ricin||membran lipid||macropinocytosi||complex||cell||dynamin||flotillin,hep 2 cell||2007 1 2007 2001||4||cell||norway 2 depart||2005 2005||2007 2005 2007 2005 2005 2006||2006 2007 2005||2006 2007||2002 2005 2003||2007 2005 2006 2007 2007||cell type||2003 2007 2006 2003 2007||2000 1 161 171 10.1034||2007,13865.333||12983.25||12937.0||12627.0||10507.667||8716.0||8182.167||8124.667||7829.0||7808.0||7789.6||7777.5||7649.4||7524.0||7287.0,0.2,0.1,0.06666666666666667
866,J_Headache_Pain-4-1-2245994.txt,mk-0974||receptor||migrain attack||pain||effect||triptan||acut attack||advers event||trigemin ganglion||coronari blood flow||studi||addit||olcegep||increas||treatment||migrain||cgrp receptor blocker||cgrp||trigemino-cerebrovascular system||action||arteri||cardiovascular side effect||headach||human||side effect||level||relief,1||2||3||refer 1||1 67||patient||4||2001 909 1||studi||pharmacol 2002 434 1||pharmacol 2003 481 2||2 49 53 10.1016||6||pharmacol 2000 397 2||2 112 120 10.1016,31046.0||28965.0||17044.0||16864.5||15964.0||13567.0||12937.0||12468.0||12015.0||9774.75||9400.25||9254.5||9074.0||8965.5||8901.0,0.0,0.1,0.06666666666666667
867,Pediatr_Radiol-4-1-2292491.txt,relaxometri||iron elimin||organ dysfunct||correl||pituitari gland||order||liver biopsi||chelat therapi||mri||place||iron||multipl echo||liver siderosi||studi||time domain||tissu iron||age||thalassaemia||iron overload||signal intens ratio||myocardium||patient||relaxometri method||method||ferritin||pituitari siderosi||liver||relax,1||2||12 2||3||refer 1||patient||4||studi||2006||2007||patient Br||young patient||effect||transfus patient||correl studi,31046.0||28965.0||17408.5||17044.0||16864.5||13567.0||12937.0||12015.0||8371.0||7287.0||7285.0||7122.5||6956.0||6821.0||6806.5,0.0,0.2,0.13333333333333333
868,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-2082657.txt,notch roof||refer line||centr||arthroscop view||posit||double-bundl acl reconstruct||area||tibia||intercondylar notch||tunnel posit||attach geometri||notch||studi||anterior cruciat ligament||femur||attach area||acl||anatom posit||plb||posterolater bundl||landmark||knee||shallow||attach||anteromedi bundl||line||bundl||tibial attach||distanc||arthroscop procedur||amb||tunnel placement||result,2||2 tabl 2||1 6 1 6||tabl 1||3||refer 1||1 SD||surfac 2||4||M. 4 1 research||3 7 3 7||studi||netherland 2 depart||5||tabl 3,28965.0||20515.333||20060.0||17331.0||17044.0||16864.5||16164.5||15056.0||12937.0||12859.25||12020.5||12015.0||11205.0||10364.0||10330.0,0.0,0.0,0.06666666666666667
869,Matern_Child_Health_J-2-2-1592140.txt,effect||health care provid||asthma||dose||pregnanc||concept||medic||medic supervis||isotretinoin||drug||studi||condit||drug administr||fetu||treatment||embryo||women||mother||exposur||chronic condit||risk||addit inform||therapi||individu||preconcept care||inform||plan||folic acid||health||advers effect,1||refer 1||2 week||4||1 7 cdc||studi||1997 396 1||2 47 48||jcragan@cdc.gov 1 friedman||5||updat 2004 46 2||patient ’s||M. 2 holm lewi||2004||3 uhl kathleen 4,31046.0||16864.5||15100.0||12937.0||12705.0||12015.0||11563.333||10521.667||10380.333||10364.0||9684.5||8305.5||8268.0||8077.0||7501.0,0.0,0.1,0.06666666666666667
870,Eur_J_Clin_Pharmacol-3-1-1914304.txt,databas||apd||number||report||factor||adr||drug||associ||studi||hypotherm effect||literatur search||antipsychot||hypothermia||advers drug reaction||patient||risk||ror||case report||intern databas||bodi temperatur||risk factor||case||schizophrenia,1||2||2 patient||result 1||refer 1||1 72||1 1514||43 2||2 characterist||patient||report 3 34 2||3 1 geriatr depart||studi||2 case report||netherland 2 depart,31046.0||28965.0||21266.0||18563.0||16864.5||15939.0||15526.5||15239.0||15128.0||13567.0||12725.25||12680.25||12015.0||11747.333||11205.0,0.0,0.1,0.13333333333333333
871,Eur_J_Nutr-2-2-1705489.txt,substrat||x-ray||model||vivo||lower amount||digest product||small intestin||experiment condit||studi||starch||lower crystallin||sampl||digest||fraction||experi||amount||experiment paramet||method||ham||glucos||dsc||dynam||mechan stress||crystallin||prepar||batch||digest residu,1||2||1 fig. 1||3||refer 1||prepar 1 1 16||1 averag||1 ml||diffract 2 fig. 2||digest residu 2 1||patient||4||studi||dsc 20 1||RS type 2,31046.0||28965.0||22356.0||17044.0||16864.5||16694.5||15916.5||15906.0||15734.0||15240.0||13567.0||12937.0||12015.0||11828.0||10764.333,0.0,0.0,0.06666666666666667
872,Evid_Based_Complement_Alternat_Med-2-4-1297501.txt,random||pain||posit result||palmetto||biofeedback||herbal||practic||chronic||exploratori studi||complementari medicin||studi||symptom||clinic trial||varieti||author||supplement||treatment||pollen extract||patient||trial||acupunctur||data||hyperthermia||chronic prostat||altern medicin||abstract||men,1||1 1||2||2 2||1 3||3 1||3 2||1 1 hyperthermia||2 3 categori 1||2 2 acupunctur||7 1||2 3 3 3 6||tabl 1||3||1 4 4 5,31046.0||31046.0||28965.0||28965.0||24045.0||24045.0||23004.5||20723.667||19422.0||19323.0||19021.5||17834.2||17331.0||17044.0||16821.0,0.0,0.0,0.0
873,J_Abnorm_Child_Psychol-3-1-1915626.txt,social group||classroom social statu||differ||effect||sport||scale||social hierarchi||depress||intermedi||behavior||area||depress problem||depress symptom||high||associ||research||school||studi||gender||domain||nomin||peer||boy||children||trail||adolesc||good learner||achievement-rel domain||girl||problem||result||data||statu||human||relev||earli adolesc||gender differ,1||2||3||statist 1||2 correl||vol. 2||2 σ||patient||4||studi||a.j.oldehinkel@med.umcg.nl 1 2 rosmalen judith||netherland 2 depart||standard deviat 1||bivari associ 2||5,31046.0||28965.0||17044.0||16312.5||15281.5||14551.5||14550.5||13567.0||12937.0||12015.0||12005.8||11205.0||11038.667||10882.667||10364.0,0.0,0.1,0.06666666666666667
874,J_Comput_Aided_Mol_Des-4-1-2270923.txt,decoy||goal||earli enrich||number||independ||extens||correl||varianc||extens quantiti||target||field||exampl||approach||auc||perform||score||cost||measur||design||dud||popular measur||studi||evid||gener||individu error bar||metric||valu||question||screen||compound||system||virtual screen||activ||experi||test||intrins properti||bedroc||method||extens properti||curv||procedur||true posit rare||set||properti||averag properti||experiment design||simpl||result,1||1 2||2 1||2||1 1 4 21 fig. 1||1 differ||tabl 1||3||refer 1||method 2||vol 1||stat 2||decoy 2||3 5||4,31046.0||30005.5||30005.5||28965.0||19055.333||18234.0||17331.0||17044.0||16864.5||16318.5||15610.0||14544.5||14513.0||13704.0||12937.0,0.0,0.0,0.0
875,Exp_Brain_Res-4-1-2315690.txt,visual inform||statist analysi||effect||number||visual monitor||hypothesi||experiment group||sensorimotor impair||target||cerebr palsi||group||begin||experiment||movement||prospect control||signific differ||studi||lah||particip||healthi control||visuomotor control||hemiparet CP||task||object||saccad||control||peak veloc||hemiparesi||affect hand||saccad initi||action||individu||obstacl||hand||landmark region||trial||grasp time||data||respect||end||intermedi fixat,1||2||procedur 1 1 fig. 1||3||section 1||patient||1 particip inform||studi||2 3 moa eye||fig. 3||1985 1968 1||depend variabl 2||5||4 fig. 4||42 3,31046.0||28965.0||19900.6||17044.0||15961.0||13567.0||12158.667||12015.0||11680.0||11010.0||10644.667||10508.0||10364.0||10283.333||9265.0,0.0,0.1,0.06666666666666667
876,Intensive_Care_Med-4-1-2249616.txt,organ||day||random||fluid||effect||surviv sepsi campaign||fluid administr||outcom||recent trial||septic patient||stress ulcer prophylaxi||death||acut renal failur||meta-analysi||popul||report||clinic outcom||renal replac||group||clinic assess||sepsi bundl||icu||strategi||strong||upper GI||earli goal-direct resuscit||pressur||mortal benefit||blood glucos||grade system||decreas||insulin||ali||studi||clinic trial||evid||resuscit||cardiac output||steroid therapi||mortal rate||failur||literatur||ill children||benefit||increas||committe||sepsi syndrom||children||grade||sever sepsi||superior clinic outcom||acut respiratori distress syndrom||patient||infect||sepsi||tidal volum||blood lactat concentr||recommend||peep||protocol||fluid challeng||risk||rct||guidelin||fluid resuscit||sedat||support||dobutamin inotrop therapi||shock||trial||shorter intub time||entir group||continu analysi||mortal||septic shock||rate||antimicrobi resist||blood cultur||critic ill||mechan ventil,1||2||2 2||method 1 2||2 2 peep||method 1||3||2 group||2 factor||1 determin||part 1||1 central||suppl 1||grade 1||issu 1,31046.0||28965.0||28965.0||21227.667||19313.333||17359.0||17044.0||16920.0||16704.5||16597.5||16058.5||15951.5||15942.0||15863.5||15848.0,0.0,0.0,0.0
877,Neurochem_Res-4-1-2226019.txt,amino acid||cultur||vesicular glutam transport||rat cerebr cortex||effect||vglut||glutam||normal morpholog||incub||quantit analysi||peptid||cell||rat||cell cultur||neuron||transport,1||2||1 15 1 1 1||2 fig. 2||6 2||protein 2||3||refer 1||immunoreact 1 fig. 1||3 4 5||4||llc 2008 introduct 1 2||cell||studi||fig. 3,31046.0||28965.0||25752.2||20968.667||19019.5||17626.5||17044.0||16864.5||16790.0||13448.333||12937.0||12729.8||12627.0||12015.0||11010.0,0.0,0.0,0.06666666666666667
878,Int_J_Biochem_Cell_Biol-2-1-2279807.txt,incub||bead||non-transl function||phosphoryl||stabl cell line||rasgap||protein||sh2 domain||shp2||specif antibodi||antibodi||sh3 domain||ciap||protein synthesi function||eef1a1||codon-depend bind||isoform||role||elut protein||bind partner||complex||cell||eef1a2||interact||function,1||2||protein 2 fig. 2||3||1 μg||polymeras 1||2 materi||2005 fig. 2 fig. 2||2003 fig. 1||patient||2006 286 1||4||cell||fig. 2 interact||elong factor 1,31046.0||28965.0||17298.5||17044.0||15725.5||15624.0||15325.0||15319.6||14557.667||13567.0||13200.0||12937.0||12627.0||11984.0||11853.667,0.0,0.0,0.06666666666666667
879,Immunogenetics-4-1-2206249.txt,popul genet||annot data||databas||mhc refer sequenc||qbl||loci||major histocompat complex||popul||annot||major indel||gene annot||cox||sequenc||variat||analysi||founder haplotyp||mhc||human genom||studi||european popul||haplotyp||diseas||mann||popul level||gene||pgf||cluster||segment||haplotyp sequenc||dbb||data||region||mcf,1||method 1 1 1 or2j1 1||hla-drb1 2 2||3||fig. 2||suppl 1||intron 1||1 hart elizabeth 1||2 distribut||trim31 5 2||lauren 1 roger jane 1||type 1 diabet||studi||annot data 2||1 palmer sophi 1 robert ann,31046.0||21310.167||19319.667||17044.0||16970.5||15942.0||15566.0||15549.25||15264.0||13110.667||12460.4||12155.0||12015.0||11377.0||10599.5,0.0,0.0,0.06666666666666667
880,Neuroradiology-3-1-2039855.txt,cranial nerv||clinic condit||complic||outcom||initi angiograph result||occlus||follow-up||circul||addit||aneurysm||treatment||endovascular treatment||institut||patient||incid||basilar arteri||nerv||good angiograph||superior cerebellar arteri||sca||complet||coil||result,1 patient||2 fig. 2||2 1 depart||3||refer 1||method patient 1 fig. 1||2 aneurysm||patient||4||netherland 2 depart||5||complic 3 fig. 3||discuss 3||3 month||6,22306.5||20968.667||20835.0||17044.0||16864.5||16861.4||14621.5||13567.0||12937.0||11205.0||10364.0||9985.25||9372.5||9321.0||9074.0,0.0,0.1,0.06666666666666667
881,Environ_Manage-2-2-1705480.txt,stream||differ||effect||aquat ecosystem||varianc||lake||variabl||spatial scale||water movement||partial redund analysi||total organ carbon||factor||catchment||variat||anc||largest amount||process||water chemistri||variat partit||import||natur variabl||studi||uniqu varianc||landscap posit||rda||stepwis rda||analys||treeless land cover||veget||alpin||arabl land||water chemic variabl||amount||toc||local-scal variabl||water resid time||total phosphoru||alpin treeless area||ecosystem||independ variabl||boreal lake||site||geograph posit||stream chemistri||deposit variabl||region||interact||lake chemistri,1||2||2 2 borcard||combin 2 2 3||3||2003 1 2 wiland||factor 2 3||2 2 fig. 3 sourc||2 valu||1 3.36||1 9.13||1 13.17||4||fig. 1 locat||studi,31046.0||28965.0||19311.333||19087.75||17044.0||16917.75||16817.667||16188.4||15845.0||15529.5||15527.0||15523.5||12937.0||12296.667||12015.0,0.0,0.0,0.06666666666666667
882,Int_J_Hematol-4-1-2330060.txt,respons||express||activ||cell||gene||cell type,3||method 2 11 3 3||4||cell||6||triplic experi fig. 2||cell activ||cell type||cancer||2002||cell cycl||cell lymphoma||cell bioloyg||8||leukocyt sub-popul morgan richard r.morgan@surrey.ac.uk 1,17044.0||14355.2||12937.0||12627.0||9074.0||9007.0||8929.0||7777.5||7076.0||7057.0||6674.5||6461.0||6314.0||6154.0||5268.333,0.2,0.2,0.13333333333333333
883,Eur_J_Appl_Physiol-3-1-1914232.txt,differ||exercis||coeffici||recoveri||function impair||correl||ventilatori threshold||mono-exponenti model||exercis test||chronic heart failur||chf||breath||clinic purpos||studi||rest||recoveri kinet||kinet||respons time||onset||intra-class correl||paramet||onset kinet||patient||test||interv||method||reproduc||threshold,1 1 1||1||2 2||2||1 4||springer-verlag 2007 2 2 2 2||tabl 2 2||2 2 1987||2 2 2005 2001||fig. 1||2 recoveri kinet 2 2||2 2 2 onset kinet||3||2 1996||2 min,31046.0||31046.0||28965.0||28965.0||21991.5||20791.833||20515.333||19593.333||18239.75||18011.0||17534.6||17492.0||17044.0||15996.0||15117.5,0.0,0.0,0.0
884,Eur_J_Nucl_Med_Mol_Imaging-4-1-2275776.txt,differ||nyha classif||durat||mibg||centr||neg correl||independ predictor||delay||variat||ratio||analysi||associ||studi||inject||imag||present studi||paramet||collim||heart failur||patient||prognosi||acquisit paramet||acquisit||subject||result,1||2||result 2||A. 1||3||fig. 2||refer 1||3 1 depart||tabl 2||123 1||patient||4||imag analysi 1 fig. 1 123||studi||tabl 1 123,31046.0||28965.0||17522.5||17279.0||17044.0||16970.5||16864.5||16861.333||16290.5||15742.0||13567.0||12937.0||12551.5||12015.0||11700.0,0.0,0.0,0.13333333333333333
885,Matern_Child_Health_J-2-2-1592155.txt,intervent||pregnanc outcom||program||pregnanc||numer factor||countri||infant||child surviv||matern||promot||declar||safe motherhood initi||health promot||children||care||intern||women||reproduct health||activ||recommend||preconcept care||famili plan||polici||inform||preconcept counsel||safe motherhood||health,1||2||3||refer 1||accord 2 4||3 5||patient||5 8 3||2002 6 2 71 3 10.1023||3 18||2002. p. 1||3 9 3 5 9 10||1985. p. 1||llc 2006 introduct 1||1989. p. 2,31046.0||28965.0||17044.0||16864.5||14223.667||13704.0||13567.0||11187.333||10571.667||10486.5||10374.333||10369.667||10367.667||10253.5||9672.667,0.0,0.0,0.0
886,springeropen-4-1-2200676.txt,molecular function||respons||chronic hypoxia||gene express||mechan||cch||normox||cardiac myocyt||upregul||oxygen||group||independ experi||biolog||oxygen level||unigen number||decreas||differenti||studi||import||zebrafish||increas||adapt||hypox condit||gene||hypertrophi||section||hypoxia||express level||hyperplasia||find||chronic constant hypoxia||heart,1||2||2 2 2 2 concentr||factor 1||3||solubl 1||31-71-527-4999 bagowski@rulbim.leidenuniv.nl 1 2 1 depart||tal 1||2005 2005 2||heart 2||2 heart||2 concentr||metabol 2||section 2||2 2004 2006 2006,31046.0||28965.0||23443.8||17745.0||17044.0||15629.0||15592.167||15524.0||15465.667||15354.0||15354.0||15162.0||15015.5||14920.5||13446.0,0.0,0.0,0.0
887,Pflugers_Arch-3-1-2137943.txt,recoveri||trans-diaphragm approach||respiratori rate||anim||pressur||mct-induc PH||small burst||trans-thorac approach||cathet||diaphragm||ventricl||studi||netherland||cardiac output||time||increas||pulmonari circul||surgeri||mmhg||control||respir||echocardiographi||studi period||pulmonari arteri||procedur||rat||small amount||heart,1||1 1||2||2 1 depart||ventricl 1 1 fig. 1||hypertens 2 2||anaesthesia 2 2||3 3||3||1 23||refer 1||surgeri 1||1 week||diaphragm 1||autopsi 1,31046.0||31046.0||28965.0||20835.0||19645.4||19476.667||19327.333||17044.0||17044.0||17017.0||16864.5||16358.5||16140.5||15552.5||15540.5,0.0,0.0,0.0
888,Extremophiles-4-1-2262144.txt,speci||metabol pathway||prolin||haloarchaea||lysin||enzym gene||folat||step||phosphat||enzym||lipid||synthesi||bacteri enzym||haloarcha genom||isoprenoid||bacteria||threonin||menaquinon||compar genom||gene||spite||dkfp||archaea||altern enzym||pyruv||glucos||isoleucin||complet||pathway||arginin||glycerol,1 2||2||3||2 fixat||plasmid 2||5 2 1986||4||49-89-85783557 oesterhe@biochem.mpg.d 1 1 depart||5||nucleotid 2 purn||4 3 thermoplasma 2005||4 8||6||2006||5 3 2000 2004 2006b,30005.5||28965.0||17044.0||14618.0||14543.0||13394.0||12937.0||12917.6||10364.0||9834.667||9676.75||9545.5||9074.0||8371.0||8290.8,0.0,0.0,0.0
889,J_Neurooncol-4-1-2174521.txt,medulloblastoma growth||copi gain||cell line||larg cell||medulloblastoma||report plasmid||p53||gain||fish||overexpress||studi||transfect||apoptosi||copi number rel||tumor||amplif||cell||isochromosom 17q||data||level||cell cultur||chemotherapeut agent||immunoblot||result||sem,1||2||2 2 wip1 2 2||3 2||2 0 1||4 2||mb27 2 2||0 1||3||3 3||refer 1||2008 introduct 1 2 3||5 0 1||magnesium-depend 1||tp53-0 1,31046.0||28965.0||23231.6||23004.5||22034.667||20951.0||19310.333||18569.5||17044.0||17044.0||16864.5||16078.8||15834.333||15523.5||15523.5,0.0,0.0,0.0
890,Gene-2-1-2270349.txt,intact cybrid||differ||effect||triphenylmethylphosphonium||proton leak||oligomycin||bioenerget differ||atp synthesi||human popul||analysi||mitochondria||ident nuclear dna||nuclear gene||haplogroup||respir||cybrid||cell||bioenerget capac||rate||oxid phosphoryl||result,1||2||2007 2 4 2||fig. 1||3||2005 fig. 1 fig. 1||figs. 1||1 ψ||1 reynafarj||2 materi||patient||cell||1990 fig. 4 figs. 2||0 cell||state 3,31046.0||28965.0||19538.5||18011.0||17044.0||16152.0||15559.5||15550.0||15524.5||15325.0||13567.0||12627.0||9672.0||9360.0||9292.5,0.0,0.0,0.06666666666666667
891,Pediatr_Nephrol-4-1-2335288.txt,hypertens||serum creatinin||renal function||develop||liver transplant||studi||diseas||cardiac transplant||children||ckd||renal diseas||lung transplant||cardiac||transplant||patient||epidemiolog||risk||cyclosporin||gfr||end-stag renal diseas||risk factor||liver||esrd||hematopoiet stem cell transplant||case||chronic kidney diseas||renal insuffici||year||hsct||calcineurin inhibitor,2||1 5||1 year||refer 1||1 percentag||liver 2||patient||studi||ipna 2008 introduct 1 1 19||1 kidney damag||1 month posttranspl||5||2006||6 10||90 2 kidney damag,28965.0||20705.0||17151.0||16864.5||15782.5||15047.0||13567.0||12015.0||11469.167||10959.667||10883.333||10364.0||8371.0||8028.0||8022.0,0.0,0.2,0.13333333333333333
892,Pediatr_Surg_Int-4-1-2248216.txt,IM surgeri||major ccvd||syndrom||intestin malrot||popul||abnorm||associ||studi||correct||time||age||congenit defect||patient||risk||IM patient||ccvd||cardiovascular complic||risk factor||IM diagnosi||morbid||mortal||post-op morbid||high morbid rate||congenit malform,1||2||3||1 type||refer 1||associ 2||defect 1||patient||4||studi||tabl 2 characterist||netherland 2 depart||m.kouwenberg@cukz.umcn.nl 1 severijnen||31-24-3619052 l.kapusta@cukz.umcn.nl 3 1 depart||4 tabl 4,31046.0||28965.0||17044.0||16987.0||16864.5||16315.5||15844.0||13567.0||12937.0||12015.0||11290.667||11205.0||10349.333||10117.2||9830.0,0.0,0.2,0.13333333333333333
893,Pediatr_Nephrol-3-1-1805047.txt,kidney stone||statist analysi||age||valu||children||calcium ion||healthi children||ammonium oxal||kidney stone diseas||urin||subject||adolesc||bri||crystal||studi||adult||risk||healthi subject||result||bonn risk index,1||1 2 2 2 2 2||2||9 2||3||fig. 2||refer 1||0.02 1||3.1 1||0.13 1||2.66 1||y-axi 2||equil 2||patient||3 fig. 3,31046.0||29311.833||28965.0||17178.5||17044.0||16970.5||16864.5||15751.0||15643.5||15633.0||15533.0||14488.0||14483.5||13567.0||13021.333,0.0,0.0,0.0
894,Eur_Arch_Otorhinolaryngol-2-2-1705529.txt,mastoid obliter||meatoplasti||cmof||small meatoplasti||neo-osteogenesi||volum||flap||eac||open caviti problem||mastoidectomi caviti||radic mastoidectomi||patient||studi||periosteum||year||caviti||fascioperiost flap||eac volum,1||2||2 3 fig. 2||3||refer 1||1 week||2 year||10 1 8||patient||4||cell||studi||3 4 fig. 4||5||2005,31046.0||28965.0||19987.5||17044.0||16864.5||16140.5||16110.5||14727.333||13567.0||12937.0||12627.0||12015.0||11973.5||10364.0||8716.0,0.0,0.1,0.13333333333333333
895,Exp_Brain_Res-4-1-2190788.txt,spatial separ||respons||locat||effect||stimulu gener||jnd||pss||tempor recalibr||vroomen||shift||tempor order judgment||particip||present studi||task||gelder||tempor ventriloqu||exposur||short exposur phase||spatial dispar||keetel||visual task||trial||asynchron AV stimulu pair||sound||result||test stimuli,1||2||stimuli 2 1 fig. 1||2 1 fig. 2 v-first||tabl 1||1 show||warandelaan 2||studi||3 min||2005||2006||2004||2003||present studi||2007,31046.0||28965.0||19253.8||18790.6||17331.0||16643.5||14483.5||12015.0||9157.0||8716.0||8371.0||8077.0||7651.0||7377.0||7287.0,0.0,0.0,0.06666666666666667
896,Purinergic_Signal-3-4-2072916.txt,respons||apoptot cell death||day||injuri||effect||recoveri||inflamm||potenti clinic import||sci||anim||myelin||volum||studi||cord||spinal cord||secondari patholog event||apoptosi||present studi||treatment||inflammatori respons||section||spinal cord injuri||microglia||potenti mechan||rat||data||guanosin||secondari injuri||function,1||2||2 1 depart||fig. 1||3 3||fig. 2||refer 1||neurolog function 1 1||day 1||2007 introduct 1 2 3 4||day 2||2 week||4||injuri 38 40 2 2||5 3 6 3 6,31046.0||28965.0||20835.0||18011.0||17044.0||16970.5||16864.5||16809.5||16489.5||16429.5||15449.0||15100.0||12937.0||12550.0||12520.0,0.0,0.0,0.0
897,J_Digit_Imaging-3-1-2039840.txt,word||open sourc||web||search queri||pac integr||index||report warehous||abil||report||solut||phrase||user interfac||binari oper||design||radiolog report||queri||search interfac||technolog||time||system||queri durat||featur||internet||ri||user||search engin||implement||problem||radiologist||inform||wildcard||data||medic context||interfac||result||document,1||2||2 fig 2||3||refer 1||method 1 fig 1||2 5 6||3 4||patient||3 fig 3||report warehous 2||3 year||2005 5||med inform 2005 74 2||6,31046.0||28965.0||19334.333||17044.0||16864.5||16459.25||16134.333||14990.5||13567.0||11387.0||10694.333||10150.0||9540.0||9099.4||9074.0,0.0,0.0,0.0
898,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-1950586.txt,atraumat hip injuri||cam||imping||sport||labral tear||revis arthroscopi||extens OA||soft tissu patholog||acetabular retrovers||order||techniqu||open surgic approach||follow-up||fai||studi||hip arthroscopi||pincer||debrid procedur||time||joint motion||proxim femor neck||hip||arthroscopi||treatment||averag time||activ||osseou abnorm||femor neck||patient||week||acetabular rim||adhes||profession athlet||patholog||arthroscop approach||procedur||hockey player||return||athlet||femoroacetabular imping||microfractur||structur abnorm,1 1||1||2||1 1 2 2 fig. 1||2 patient||7 2||3||refer 1||1 29||art 1 tenni 1 jockey 1||1 golfer||3 patient||patient||studi||7 13 2 28,31046.0||31046.0||28965.0||26007.333||21266.0||17981.0||17044.0||16864.5||16658.0||15548.833||15524.0||15305.5||13567.0||12015.0||10668.25,0.0,0.0,0.13333333333333333
899,Eur_Radiol-4-1-2270369.txt,msct-ca||number||intermedi branch||cca||popul||origin||anatom variant||coronari arteri||signific cad||diagon branch||studi||coronari anomali||complex anatomi||three-dimension imag||visual||variabl number||coronari angiographi||patient||anomali||segment||preval||data||variant||conu branch arteri,1||2||2 3||2 1 depart||result 1||fig. 1||1 25||3||refer 1||2 18||2 24||1 99.8||1 35.2||2 segment||2 49.7,31046.0||28965.0||23004.5||20835.0||18563.0||18011.0||17172.5||17044.0||16864.5||16447.0||16120.5||15532.0||15529.5||14744.0||14492.5,0.0,0.0,0.0
900,Mol_Biochem_Parasitol-1-5-1964783.txt,dextran||endocytosi||major defect||express||defect||effect||rna interfer||pcf||protein||degrad||arf||parasit||lysosom||rnai||knockdown,1||2||fig. 1 fig. 1||3||fig. 2||fig. 2 fig. 2||2 materi||4||cell||studi||fig. 2 35||fluid-phas endocytosi fig. 2 fig. 2||5||fig. 1 T. brucei||6,31046.0||28965.0||18011.0||17044.0||16970.5||16970.5||15325.0||12937.0||12627.0||12015.0||11978.667||11340.0||10364.0||9429.25||9074.0,0.0,0.0,0.0
901,Virchows_Arch-3-1-2039817.txt,tumor||mass||retroperitoneum||mucin cystadenoma||borderlin malign||cyst||case||pancrea||primari retroperiton||foci||cystic mass||mix inflammatori cell||mural nodul,1||2 2 1||2||clinic histori 1 1 fig. 1||refer 1||2 case||2 merku||patholog find 2 fig. 2||4||31-70-3126657 j.merkus@hagaziekenhuis.nl 1 1 depart||12 month 2||netherland 2 depart||TR UD 1||2005||F. R. 1 stoot,31046.0||29658.667||28965.0||17292.0||16864.5||16069.0||14493.5||13172.2||12937.0||12917.6||12138.333||11205.0||10435.667||8716.0||8460.5,0.0,0.0,0.0
902,Matern_Child_Health_J-2-2-1592162.txt,commun||intervent||age||african american||gdm||risk||chw||prevent||complic||women||preconcept care||control||educ||diabet||import||barrier||provid||pregnanc||health insur||health,1||2||1 1 4 7 1||1 1 center||1 5||1 15||3||refer 1||type 2||march 1||llc 2006 introduct 1 1||4||type 1 diabet||studi||8 9 2 3 9 10,31046.0||28965.0||22614.4||21238.667||20705.0||17811.5||17044.0||16864.5||15946.5||15599.0||14412.0||12937.0||12155.0||12015.0||11654.833,0.0,0.0,0.0
903,Int_J_Colorectal_Dis-4-1-2225995.txt,certolizumab pegol||infliximab||effect||phase iii studi||hrqol||ibdq||symptom||certolizumab pegol 400 mg||studi||domain||diseas||improv||analys||treatment||placebo respons rate||life||clinic efficaci||baselin||patient||offici||clinic benefit||placebo||crp||inflammatori bowel diseas||efficaci||cdai score,1||2||1 patient||3||3 3||refer 1||1 fig. 1 studi design||1 baselin||precis 1||week 2||2 week||4 suppl 1||2 proport||precis 2||novemb 2,31046.0||28965.0||22306.5||17044.0||17044.0||16864.5||16043.6||15869.5||15660.5||15100.0||15100.0||14940.333||14675.5||14620.0||14525.5,0.0,0.0,0.0
904,Purinergic_Signal-3-4-2072910.txt,yeast||receptor||intron||adp||express||analys||ortholog||pseudogen||agonist||key residu||specif||evolut||gene||posit||orphan gpcr||nucleotid||group,1 1||1||2||4 1||1 2 12||type 1 1||1 10 1 12 1 12||1 12||2007 2||2007 introduct 1 1||3||refer 1||gpr87 human 1 1||19 2||1 kbp,31046.0||31046.0||28965.0||21991.5||21954.333||21673.333||18637.333||18449.0||18126.0||17669.25||17044.0||16864.5||16581.25||16139.5||15541.0,0.0,0.0,0.0
905,Eur_J_Pediatr-3-1-1914296.txt,surgic treatment||techniqu||submucos tunnel||vur||treatment||vesicoureter reflux||complic||children||patient laparoscopist||reflux||case||experi||laparoscopi||patient||convent laparoscopi||laparoscop techniqu||robot surgeri||open surgeri||robot||group,2||3||refer 1||3 23 24 1 fig. 1||patient||2 10 16||pediatr urolog 1||pediatr urolog 2||patient group||2005||2006||3 18 24||22 3 24||effect||reflux patient,28965.0||17044.0||16864.5||15062.667||13567.0||13299.333||11055.667||10362.0||9221.0||8716.0||8371.0||8083.0||7834.333||6956.0||6932.0,0.2,0.1,0.06666666666666667
906,Neurosurg_Rev-2-2-1564192.txt,logist regress analysi||male||potenti||correl||index||skull base||high prolif potenti||meningioma||multipl||volum||recurr||characterist||time||growth||age||independ risk factor||higher growth rate||edema||patient||low densiti area||tumor||mib-1||radiolog featur||growth potenti||cell,1 1 2||2||1 0 1||3||refer 1||1 characterist||2 year||mib 1||1 4 4 15||result 1 3 11||patient||1 11 19||cell||13 2 15||3 month,30352.333||28965.0||22728.333||17044.0||16864.5||16168.5||16110.5||15525.0||15374.25||14805.25||13567.0||13137.0||12627.0||12601.333||9321.0,0.0,0.0,0.13333333333333333
907,J_Med_Internet_Res-9-2-1913940.txt,host||english||page||indigen group||tuberculosi||french||websit||group||languag||maiz||local languag||order||estim||countri||turkish||peopl||avian flu||nutrit||term||food-rel institut||diseas||hit||onlin health inform||spanish||linguist prefer||global agenc||googl search||url||nation||world wide web||googl||institut||internet||world||human health||immigr||sourc||search engin||food||food agenc||effort||translat||result||higher rate||schizophrenia||human migrat||rate||strong prefer||health,1||2||1 15||tabl 1||3||tabl 2||2 multimedia appendix 2||4||3 tabl 3||studi||tabl 1 overlap||version 2 method||tabl 3||multimedia appendix 2||4 tabl 5,31046.0||28965.0||17811.5||17331.0||17044.0||16290.5||14552.0||12937.0||12568.0||12015.0||11614.333||11042.0||10330.0||9747.667||8972.333,0.0,0.0,0.0
908,Eur_J_Pediatr-3-1-1876255.txt,antibiot||day||episod||effect||month||tube||amoxicillin||acut inflamm||tympanostomi tube insert||virus||viral infect||aom||eustachian tube dysfunct||tympanostomi tube||studi||vaccin||middl ear||antibiot treatment||age||bacteria||treatment||recent prospect studi||eustachian tube||ome||patient||infect||poor long-term prognosi||viral test||dysfunct||acut otiti media||nasopharyng aspir cultur||year||result,1||2||1 54 fig. 1||3||refer 1||2 year||1 guidelin||2 50||2 fig. 2 NP||2 month||2 43||2 week||patient||4||pediatr 2005 164 1 2 10.1007,31046.0||28965.0||17056.25||17044.0||16864.5||16110.5||15861.5||15827.0||15752.0||15281.5||15239.0||15100.0||13567.0||12937.0||12467.833,0.0,0.0,0.06666666666666667
909,Eur_J_Nucl_Med_Mol_Imaging-3-1-1998890.txt,side-effect||final dose||administr||treatment||uptak||follow-up||gep tumour||dose||chi-squar test||patient||octreot||therapi||fsh concentr||progress diseas||tumour,1||1 1 2||2||3||refer 1||suppl 1||grade 1||springer-verlag 2003 introduct 1 2 3||patient||4||studi||12 NE pancrea 1||3 month||result 177 3 0 3||patient group,31046.0||30352.333||28965.0||17044.0||16864.5||15942.0||15863.5||14601.333||13567.0||12937.0||12015.0||9351.0||9321.0||9317.2||9221.0,0.0,0.1,0.06666666666666667
910,Virchows_Arch-3-1-1888716.txt,rna qualiti||transcript||metallothionein||microarray||tumour||group||classic morpholog||follicular variant||studi||benign thyroid tissu||common variant||express microarray studi||lesion||sampl||express||papillari thyroid carcinoma||biomark||ptc||gene||role||cluster||potenti biomark||find||data||variant||molecular patholog||result||function,1||2||2 3 3||protein 1||result 1||3||2 gene||refer 1||23 2 3 fig. 2||transcript 1||metalloproteinas 1||1 smyth||1 cahil||1 sherlock||1 streck,31046.0||28965.0||21017.667||18667.0||18563.0||17044.0||16879.5||16864.5||16587.6||15974.0||15562.5||15546.5||15531.0||15528.0||15523.5,0.0,0.0,0.0
911,Pflugers_Arch-3-1-1950587.txt,respons||gene express||rapid||cardiac myocyt||target||stretch-activ channel||mechan stimul||ventricl||protein||myocyt||stimuli||express||slow inotrop respons||region differ||observ||endo||epi||gene||mrna||stretch||rat||wall thick||heart||transmur differ,1||1 1 fig. 1||1 2 harrison||result 1||2 9||limit 10 2 1||1 min||e.white@leeds.ac.uk 1 1 institut||1 calaghan||2 min||patient||12 8 6 2||tabl 1 comparison||M. 1 white||1 calibr sampl,31046.0||24528.5||20032.0||18563.0||17178.5||17143.0||16158.0||15884.0||15524.0||15117.5||13567.0||12511.25||12104.667||11841.333||11211.0,0.0,0.0,0.0
912,J_Neurol-2-2-1705504.txt,cerebrospin fluid||model||congenit||cellular prolifer||molecular etiolog||brain||molecular genet||multifactori disord||htx rat||form||cellular signal pathway||cytokin||studi||diseas||genet factor||pathogenesi||development mechan||major||gene||csf||hydrocephalu||genet studi||molecular||genet diseas||growth factor||human||genet loci||anim model||locu||aqueduct||function,1||acknowledg 1 1||1 123 fig. 1||refer 1||1 deriv||1 summari||tgf-beta 1||patient||studi||viru type 2||palestinian arab 2||6||1 neurol med chir||patient care||pediatr surg 12 suppl 1,31046.0||20933.667||16876.5||16864.5||15778.0||15734.5||15535.0||13567.0||12015.0||10774.333||9659.333||9074.0||8824.75||8672.0||8276.0,0.0,0.1,0.06666666666666667
913,Pituitary-3-1-1915635.txt,initi surgic treatment||recoveri||month||surgic treatment||non-funct pituitari macroadenoma||visual field recoveri||process||eye||cortisol level||defici||nerv compress||improv||surgeri||defect||treatment||visual outcom||optic chiasm||visual acuiti||visual field defect||patient||pituitari macroadenoma||week||progress improv||transsphenoid surgeri||visual field||data||assess||year,1||1 patient||result 1||fig. 1||A. 1||1 year||M. 1 1 depart||3||refer 1||2 year||1 cm||patient||4 patient||4||tabl 1 patient characterist,31046.0||22306.5||18563.0||18011.0||17279.0||17151.0||17083.0||17044.0||16864.5||16110.5||15761.0||13567.0||13252.0||12937.0||12380.0,0.0,0.0,0.06666666666666667
914,Qual_Life_Res-4-1-2275305.txt,quantit posit||va continuum||indirect method||respond||pain||respons option||health statu||vignett||mobil||equidist||dimens||mild depress||va scale||score||instrument||transform||extrem||respons scale||studi||untransform equidist||descriptor||sever||system||eq-5d||isoform||level descriptor||method||methodolog||five-level version||direct quantif||level||health state||health,1||2||3||refer 1||direct method 1 2||1 3 bonsel||dimens 2||2 isoform||1 fig. 1 diseas vignett||patient||4||2 fig. 2 direct quantif||studi||31-20-6972316 m.f.janssen@amc.uva.nl 1 2 birni||2008 introduct 5 1,31046.0||28965.0||17044.0||16864.5||16182.0||16034.667||14637.0||14574.0||14454.2||13567.0||12937.0||12837.0||12015.0||12005.2||11187.25,0.0,0.0,0.06666666666666667
915,Naturwissenschaften-4-1-2270370.txt,area||non-migr||habitat||non-breed season||coastal||speci||wader||speci diversif||diversif||sub-speci||number||migrant||migratori||studi||ecolog speciat||popul||environ||result,1 1 1 1||1||2||1 fig. 1||1 result||3||studi||2 buehler DM||appendix tabl 2 data||2005||2006||2004||tropic wetland 1 8.547||tropic wetland 1 9.21||inland boreal 1 19.211,31046.0||31046.0||28965.0||22356.0||18563.0||17044.0||12015.0||9865.667||9448.25||8716.0||8371.0||8077.0||7817.25||7817.0||7815.25,0.0,0.1,0.06666666666666667
916,Matern_Child_Health_J-2-2-1592248.txt,intervent||goal||model||clinic practic||outcom||program||ecolog model||pregnanc||behavior||preconcept health||lifespan||preconcept period||step||select panel||research||action step||high risk||public polici||panel||sector||member||care||children||women||partner||famili||preconcept intervent||recommend||provid||knowledg||action||commun||individu||preconcept care||level||strateg plan||focu||purpos||health,1||2||3||refer 1||recommend 1||2 call||4||studi||2 fig. 2 preconcept care pyramid||action recommend 1||preconcept care 1 6 7||preconcept care recommend 1||6||recommend 3||2006,31046.0||28965.0||17044.0||16864.5||16016.5||14600.0||12937.0||12015.0||11238.333||10915.333||10323.4||9133.25||9074.0||9015.5||8371.0,0.0,0.0,0.0
917,Eur_J_Nutr-3-1-1914246.txt,vitamin||calcul||age group||micronutri||model||fortif||product||public health||sensit group||dietari supplement||intak||popul||exempt||group||toler upper intak level||maximum safe amount||european union||msfl||netherland||dutch commod act||risk-assess model||children||ul||dutch polici||maximum fortif level||afl||miner||maximum level||risk||rasmussen||safe addit||dutch model||food||maximum||risk manag||nation survey||level||adult||folic acid||energi||result||maximum amount,1||2||1 1 5 6||1 3 11||children 1||3||refer 1||95 1||box 1||1 maximum||95 2||switzerland 2||2 decemb 2004||studi||0.15 children 1,31046.0||28965.0||20382.5||17713.667||17132.0||17044.0||16864.5||16393.0||15840.0||15759.5||15352.5||14563.0||12385.667||12015.0||11508.667,0.0,0.0,0.0
918,Pediatr_Nephrol-3-1-2100434.txt,ghrelin||effect||GH receptor||rhgh||igfbp displac||resist||renal function||growth hormon||protein||linear growth||age 6 year||axi||growth||growth failur||ckd||treatment||children||transplant||patient||GH resist||insulin-lik growth factor||end-stag renal diseas||glomerular filtrat rate||level||igfbp||final adult height||renal failur,1||2||2 3||introduct 1 2 4||3||refer 1||patient||4||3 7||5||insulin-lik growth factor 1||6||pediatr patient||7||10,31046.0||28965.0||23004.5||18561.5||17044.0||16864.5||13567.0||12937.0||12020.5||10364.0||9378.0||9074.0||7786.5||6997.0||6982.0,0.0,0.1,0.06666666666666667
919,Eur_J_Pediatr-4-1-2234442.txt,cn involv||idursulfas||complic||death||placebo-control trial||enzym replac therapi||gag||clinic phenotyp||infusion-rel reaction||joint contractur||reaction||progress||studi||mucopolysaccharidosi type II||diseas||infus||age||improv||life||sever||treatment||disord||patient||involv result||attenu form||gene||mp II||ert||sever diseas||challeng||earli development mileston||sever airway obstruct||spleen||diagnosi||hunter syndrom||joint,1||2||3||refer 1||diagnosi 1||1 mg||suppl 1||antihistamin 1||2 month||2 preval||patient||studi||mp II 2 8 fig. 2||12 patient||patient group,31046.0||28965.0||17044.0||16864.5||16112.0||15945.0||15942.0||15531.0||15281.5||14867.5||13567.0||12015.0||11729.333||9709.5||9221.0,0.0,0.0,0.13333333333333333
920,Exp_Brain_Res-3-1-1914263.txt,trial block||mass||forearm||static torqu||effect||inerti eigenvector||limb orient||gravit torqu||mass vector||angl||elbow||signal||magnitud||upper arm||rel||orient||condit||error||muscl||line segment||particip||pattern||line segment 1||kinesthesi||torqu||experi||vertic plane||test||percept||manipul||propriocept||space||limb||effort||inform||trial||joint angl||result,1||2||1 2 1 faculti||2 4||3 CM 2 1||7 2||time 1||3||number 1||3 CM 1 fig. 1||experi 1||circl 1||experi 2||2 CM||4,31046.0||28965.0||22814.75||20951.0||19465.75||17981.0||17493.5||17044.0||17008.0||16984.0||16535.0||15639.0||15494.5||14886.5||12937.0,0.0,0.0,0.0
921,Environ_Manage-4-1-2359833.txt,joint ventur||environment state||water govern||polici paper||wastewat treatment||maswsc||privat sector||access||water||privat sector involv||current landscap||construct||capit||develop||capit shortag||contract||urban water govern||particip||infrastructur||maanshan||legal system||local resid||servic||local offici||china||macau||provis||government regul||bot project||invest||public-priv partnership||mwsl||manag||public util||public||servic qualiti||financi risk||govern||water sector||privat||bcg||energi||tariff reform,1||2||1 3||3||2 3 3 fig. 2 distribut||J. 1 Fu tao 2 1||hollandseweg 1||4||shanghai wastewat 3 2||netherland 2 depart||europeanist 2002 8 1||5||6||2005||2005 2006 2005 2005,31046.0||28965.0||24045.0||17044.0||16426.167||15821.667||15523.5||12937.0||11526.5||11205.0||11064.75||10364.0||9074.0||8716.0||8629.75,0.0,0.0,0.0
922,Plant_Mol_Biol-4-1-2268718.txt,organ||pump||number||transport system||specif||depend||diverg||arabidopsi||osmot pressur||rice||plant||channel||ion||anim||categori||nucleosid||gradient||membran transport||protein||environment condit||plasma membran||membran||increas||amino acid||biolog system||prokaryot||bacteria||biolog activ||transport gene||system||control||gene||transport||secondari activ transport||substanc||environment situat||cell||divers,1||2||2 3||3 2||1 2 2005||2003 2 2||2 1 1 fig. 1 number||4 2||1 2 2001 2003||1 2 1999 2002||3||3 3||system 1 2 E.||2 comparison||rice 2 6 6 2,31046.0||28965.0||23004.5||23004.5||22909.0||21860.333||21674.833||20951.0||18493.75||17965.75||17044.0||17044.0||16406.5||15308.5||15284.6,0.0,0.0,0.0
923,Pharm_World_Sci-4-1-2253652.txt,cancer||drug-rel problem||pharmacist||drug regimen||drp||system cancer therapi||health care profession||chemotherapi||complementari treatment option||oncolog pharmaci||oncolog||medic||order||adher||adr||drug||pharmaceut care concept||process||research||analysi||consequ||error||clinic trial||medic error||pharmaceut care||cancer patient||treatment||support medic||system||patient||risk||problem||care process||specif contribut||cancer chemotherapi||physician||interact||prescript||cochran librari||advers effect,1||2||result 1 3||refer 1||2 classif||patient||4||53 54 2||cancer patient||5 6||3 34||patient outcom||8 11 3 12 13||2003||34 2 32 34 36,31046.0||28965.0||18056.667||16864.5||14824.5||13567.0||12937.0||10413.333||10321.5||9719.0||9416.0||7725.5||7672.6||7651.0||7291.2,0.0,0.2,0.13333333333333333
924,Purinergic_Signal-3-4-2072920.txt,role||receptor||p2x||releas||pain||nerv||cell||rat||spinal glial cell||evid||neuron||atp||neuropath pain||phagocytosi||microglia,1||2||2007 introduct 1 2||refer 1||4||cell||neurosci 2004 24 1 7 10.1523||cell type||6 12||2002||7||cell line||effect||microgli cell||12,31046.0||28965.0||17149.0||16864.5||12937.0||12627.0||8416.333||7777.5||7463.0||7057.0||6997.0||6956.0||6956.0||6362.0||5852.0,0.0,0.1,0.06666666666666667
925,J_Gastrointest_Surg-3-1-1852379.txt,diagnost evalu||nation cancer data base||cancer||differ||center||gastrectomi||number||stage IV diseas||outcom||hospit||report||high-volum center||stage IB||gastric surgeri||medic school||gastric adenocarcinoma||studi||gastric cancer||surviv||treatment||signific||ncdb||oper mortal||lymphadenectomi||institut||patient||hospit volum||hospit type||curv||case||data||medic oncolog unit||mortal||type||node||year||chcp||comp,1||2||1 figur 1||2 3 figur 2||0 1 0 1||1 number||refer 1||januari 1||3 4||2 patient characterist||patient||cancer 1 depart||studi||alimentari tract 2007 introduct 1 2||5,31046.0||28965.0||21097.667||19043.75||18569.5||17008.0||16864.5||15588.0||14990.5||14607.667||13567.0||13538.667||12015.0||11515.333||10364.0,0.0,0.0,0.13333333333333333
926,Int_J_Legal_Med-3-1-1794629.txt,intermediate-s size||simpl loci||individu||intermedi allel||dys576||loci||dys643||tabl||dys570||studi||y-str||divers||dys481,1||2||2 5 2 3||2 taq 1||5 7 1 1||result 2 3 10 1||3||2 10 2 10 4||refer 1||1 min||1 μl||1 loci||multiplex 1||44-1223-494919 cts@sanger.ac.uk 1 1||2 variat,31046.0||28965.0||21334.5||20010.667||19863.25||18023.4||17044.0||16966.2||16864.5||16158.0||15631.0||15587.0||15535.0||15523.5||14858.0,0.0,0.0,0.0
927,Purinergic_Signal-4-1-2245998.txt,cardiomyocyt||clinic import||receptor||respons||pyrimidin||hypertens||ectonucleotidas||myocardi infarct||p2i||effect||blood flow||catecholamin||sympathet nerv||platelet||factor||aspirin||human skelet muscl||blood pressur regul||purin||studi||atp||antagonist||increas||vascular tone||p2x||purinerg||releas||similar import||heart failur||angiogenesi||role||pathophysiolog||growth factor||cell prolifer||erythrocyt||human||heart,1||1 2||2||1 6||1 receptor||1 2 4 6 receptor||3||refer 1||13 2||2 receptor||nerv 1||antagonist 1||1 purinoceptor||pannexin 1||medium 2,31046.0||30005.5||28965.0||20060.0||17274.5||17105.0||17044.0||16864.5||16613.5||16234.0||15761.0||15659.5||15562.5||15525.0||14907.5,0.0,0.0,0.0
928,Int_J_Colorectal_Dis-4-1-2225996.txt,intestin epitheli cell||respons||effect||real-tim pcr||iec||combin||secret||cytokin||protein||studi||import role||nuclear factor||respect cytokin||express||induct||role||mrna||cell||chemokin||data||synergist effect||protein secret||strong synergist effect||inflammatori bowel diseas,1||2||3||refer 1||transcript 1||1 ml||1 μg||1 μl||49-551-392063 draddat@gwdg.d 1 2 1 centr||iec 2 fig. 2 5||stimul protocol 2 2 5 cell||patient||4||cell||studi,31046.0||28965.0||17044.0||16864.5||15974.0||15906.0||15725.5||15631.0||15301.0||14658.2||13756.5||13567.0||12937.0||12627.0||12015.0,0.0,0.0,0.13333333333333333
929,Qual_Life_Res-3-1-2039822.txt,respons||reliabl||episod||effect||correl||hrqol||popul||fsq||gener questionnair||construct||otiti media||estim||disease-specif||fsq specif||mcid||function health statu||score||follow-up||paediatr condit||questionnair||aom||regard||gener||nr||children||sensit||subscal||om6||chang score||inter-item correl||sem||chang||valid||nr caregiv||sever diseas||method||hand||function limit||acut otiti media||life questionnair||poor sensit||taiqol||clinic relev||fh||clinic||assess||moder||year||caregiv||health||frequent episod,1||2||1 graph 1||age 1||3||refer 1||score 1||larg 1||1 definit||1 episod||8 8 9 1 2||2 3 n.a||2 characterist||2 week||2 episod,31046.0||28965.0||20734.0||17305.5||17044.0||16864.5||16576.0||16114.0||15768.5||15648.0||15542.2||15365.333||15128.0||15100.0||14607.5,0.0,0.0,0.0
930,Purinergic_Signal-1-2-2096532.txt,carbon monoxid||PC 12 cell||pc12 cell||guanosine-depend neurit outgrowth||ngf||neurit outgrowth||cyclic gmp||nitric oxid synthas||guanosin||heme oxygenas,1||2||figur 2 1||3||refer 1||figur 3 1||1 48||figur 1||2 44||1-905-3833958 mrathbon@mcmaster.ca 1 3 1 depart||4||cell||18 20 2||studi||15 2 environ,31046.0||28965.0||20404.0||17044.0||16864.5||16430.333||16186.5||16123.5||15155.0||13605.5||12937.0||12627.0||12437.0||12015.0||11516.0,0.0,0.0,0.0
931,Naturwissenschaften-3-1-1829419.txt,receptor||number||pollen||bee||behavior||coloni||sequenc||influenc||step||clone||ovariol number||defens respons||studi||ci||express||analys||natur variat||ii||gene||map||cdna||candid gene||qtl||ortholog||behavior genet||marker||serotonin receptor||defens behavior||region||trait,1||2||2 3||repage@asu.edu 2 1 depart||1 annot||2 schlipaliu david 1||2 annot||behavior 2006 1 4||4||studi||3 express||fig. 5 1 marker letter||2005||2006||4 2001 drosophila 2005 4,31046.0||28965.0||23004.5||15626.5||15621.5||15040.75||14581.0||13476.75||12937.0||12015.0||10719.5||9436.0||8716.0||8371.0||8269.8,0.0,0.1,0.06666666666666667
932,Eur_J_Pediatr-3-1-2151774.txt,anorexia patient||pneumomediastinum||chest||pressur||malnutrit||neck||vomit||anorexia nervosa||sign||spontan pneumomediastinum||literatur||disord||adolesc||patient||risk||secondari pneumomediastinum||laryngopharyngoscopi||alveolar wall ruptur||case||subcutan emphysema||alveolar wall,2||patient 1||patient 2||1 2 3 4 1 depart||2 1 fig. 1 coron||refer 1||1 2 4 5 7 8||case 2||2 fig. 2 arrow||1 2 3 4 heggelman ben||1 9 8||patient||studi||netherland 2 depart||case report case 1,28965.0||22306.5||21266.0||20588.667||19226.4||16864.5||16077.167||16069.0||15896.75||15004.167||14197.333||13567.0||12015.0||11205.0||10124.0,0.0,0.0,0.06666666666666667
933,Eur_Radiol-2-2-1766022.txt,biomechan statu||cylind||cartilag repair surgeri||complic||joint effus||earli post-op period||nativ cartilag||variabl||normal||evalu||signal intens||surfac||cartilag repair||sequenc||cartilag||signal||techniqu||smooth contour||complet fill||mri||cartilage-cartilag interfac||tissu||studi||high signal-to-nois ratio||synov||cartilag defect||time||imag||articular cartilag||defect||adjac cartilag||autolog chondrocyt implant||bone||paramet||patient||graft||earli stage||aci||defect fill||repair||high resolut||cartilag repair tissu||delamin||osteochondr autograft||case||joint||structur,1||2 1||2||2 3 4||1 year||3||refer 1||2 year||A. 1 2 szomolanyi||1 marlovit||patient 2 year||springer-verlag 2007 introduct 1 1||patient||4||studi,31046.0||30005.5||28965.0||19648.667||17151.0||17044.0||16864.5||16110.5||15881.0||15525.5||15262.667||14456.2||13567.0||12937.0||12015.0,0.0,0.0,0.13333333333333333
934,Neurosci_Lett-2-1-2330064.txt,p2i||spinal cord||adp,1||2||2 2||1 1 fig. 2 1 1||1 fig. 1 1||13 1 1 1 1 receptor||4 1||fig. 3 1 1||fig. 2 2||2 2 atmospher||1 receptor||3||2 μl||1 12 13||4,31046.0||28965.0||28965.0||26354.167||24528.5||21991.5||21991.5||21028.0||20968.667||19319.333||17274.5||17044.0||14590.5||13720.0||12937.0,0.0,0.0,0.0
935,Virchows_Arch-4-1-2329729.txt,malign||calcif||atyp intraduct epitheli prolifer||core||columnar cell chang||radiolog||classic lobular neoplasia||core biopsi diagnosi||breast||follow-up||carcinoma||lci||risk lesion||lobular neoplasia||studi||pleomorph lci||literatur||lesion||diagnost surgic excis||excis||women||patient||risk||dci||fibrocyst chang||surgic biopsi||core biopsi||site||diagnosi||mammographi||biopsi,1||2||3||refer 1||2 year||1 extent||LN 1||2 lee||2 detail||0.0001 2||2 porter||2 elston||2 hodi||1 5 mm||patient,31046.0||28965.0||17044.0||16864.5||16110.5||15689.0||15584.0||14861.0||14753.0||14628.5||14512.0||14491.5||14484.0||14079.0||13567.0,0.0,0.0,0.06666666666666667
936,J_Biol_Inorg_Chem-3-1-2099460.txt,substrat||serr||heme||band||potenti||coat electrod||heme iron||experiment data||potassium phosphat buffer||solut||state||electrod surfac||activ form||intens||enzym||spectra||protein||studi||buffer||Ag electrod||electrod||cyp||interfaci electr field||supplementari materi||amount||detail structur inform||cell||presenc||activ site||activ enzym||imidazol,1||1 2 1||2 1||2 1 2||2||2 2||34 2 2 2||1 4||1 3 1 3 22||3||refer 1||1 28||1 37||1 materi||1 48,31046.0||30352.333||30005.5||29658.667||28965.0||28965.0||22170.75||21991.5||19872.6||17044.0||16864.5||16747.5||16412.0||16365.5||16186.5,0.0,0.0,0.0
937,J_Mol_Biol-1-5-2098880.txt,adp||constant||muscl fibr||lifetim||concentr||regulatori light chain||amplitud||actin||essenti light chain||actin bind||actomyosin complex||phase||fast||mhc||reaction||studi||fast phase||muscl||rlc||rabbit||light chain||elc||equilibrium||pig||tca||releas||myosin||bovin||isoform||amount||S1||fluoresc||data||presenc||myosin heavi chain||rate||muscl contract,1||1 2||2||2 2||1 12 2||1 tabl 1||2 tabl 2||1 figur 2||1 6||2 scheme 1||1 scheme 2||2 scheme 2||2 6||1 9||1 13,31046.0||30005.5||28965.0||28965.0||21954.333||21902.667||20515.333||20404.0||20060.0||20041.333||20041.333||19347.667||19019.5||18219.0||17654.0,0.0,0.0,0.0
938,Immunogenetics-3-1-1914303.txt,host||rna qualiti||number||transcript||group||lung||analysi||studi||pmn||immun respons||express||signific||host respons||gene||infect||express profil||cell||data||mice||immun||locu||pathway,1||1 1||2||1 2 3||3 1||1 3||2 4||3||3 1 total||1 total||1 day||part 1||1 cm||1 μg||1 fig. 1 B. pertussi,31046.0||31046.0||28965.0||25685.0||24045.0||24045.0||20951.0||17044.0||16739.333||16587.0||16489.5||16058.5||15761.0||15725.5||13724.8,0.0,0.0,0.0
939,Eur_Radiol-4-1-2292493.txt,malign||differ||detect||margin||enhanc kinet||breast cancer||group||mri||rim-enhanc||breast||studi||characterist||brca1||type 3 curv||lesion||age||sporad case||women||enhanc pattern||risk||size||tumor size||dci||brca-mc||carrier||radiologist||control group||case||benign||sharp margin||mammographi||brca2||match,1||2||refer 1||1 1 430 depart||1 cm||1 kok||brca 1||2 mutat||2 obdeijn||2 4 0.194||patient||1 6 0.049||studi||3 3 1.000||netherland 2 depart,31046.0||28965.0||16864.5||16173.25||15761.0||15541.5||15530.5||15116.5||14485.0||13968.0||13567.0||13384.333||12015.0||11374.667||11205.0,0.0,0.0,0.06666666666666667
940,Purinergic_Signal-3-1-2096771.txt,recruit||neutrophil||receptor||migrat||human neutrophil||inflamm||earli recruit||chemotact activ||nucleotid||monocyt||immatur||studi||atp||evid||intracellular calcium||import role||dc||dendrit cell||immun respons||purinerg receptor||releas||activ||chemotaxin||lymphocyt||cell damag||eosinophil||cell||chemokin||human immun cell||immun cell||function,2||2007 introduct 3 3 1 2||type 1||refer 1||45 2||3 4||cell||studi||8 24 25 1 7||1 4 7 22 64 65||6||27 29 33 2||neutrophil 27 28 2||pharmacol 1996 317 2||cell respons,28965.0||17114.0||16987.0||16864.5||15300.0||14990.5||12627.0||12015.0||10154.4||9342.333||9074.0||8911.5||8497.25||8259.0||7987.5,0.0,0.2,0.13333333333333333
941,Evid_Based_Complement_Alternat_Med-4-1-1810371.txt,cup||day||tobacco smoke||effect||chemoprevent effect||smoker||dose||dna damag||anim||regular intak||tobacco||human trial||non-smok||high level||evid||long durat||green tea||exposur||smoke||tea||consumpt||latent period||risk||period||lung cancer||epidemiolog studi||trial||cell||mice||carcinogen||year,1||2||tabl 1||tabl 2||2 50||1 cup||tea 2||patient||4||cell||day 1 year||studi||tabl figur 1||day 2 year||refer 1 ezzati,31046.0||28965.0||17331.0||16290.5||15827.0||15586.0||14531.5||13567.0||12937.0||12627.0||12078.333||12015.0||11954.333||11384.667||11243.333,0.0,0.1,0.06666666666666667
942,FEBS_Lett-1-5-1942070.txt,respons||stress stimuli||pkc||express||surviv||regul||pkd||activ||prolifer||oxid stress||cell||class II histon deacetylas||cell surviv||cell antigen receptor||bcr||data||essenti role||pathway||present report||role,1||2||fig. 2 2 2||fig. 1||3||fig. 2||2 materi||4||cell||fig. 3 fig. 3||fig. 3||1 involv reloc||6 cell||5||6,31046.0||28965.0||22967.75||18011.0||17044.0||16970.5||15325.0||12937.0||12627.0||11010.0||11010.0||10940.667||10850.5||10364.0||9074.0,0.0,0.1,0.06666666666666667
943,Histochem_Cell_Biol-4-1-2413110.txt,receptor||skin||desmoplakin||pv-igg||bind||mechan||desmoglein compens||extracellular||pathogen||dsg||specif epiderm layer||plakoglobin||intermedi filament||adheren junction||junction||pemphigu||compon||desmoglein||egfr||desmosom||protein||epidermi||present||PV pathogenesi||desmosom format||acantholysi||intercellular adhes||cadherin||PV serum||PV patient||epiderm split||cell biologist||junction complex||gene||experi||adhes||stratifi epithelia||plakophilin||rho gtpase||event||tyrosin kinas||dsc||autoantibodi||steric hindranc||cell||mice||desmosom compon||human||keratinocyt||molecul,1||2||2 cell||2 2006||2 2004||2007 2||3||1 regul||1 antibodi||1 mutat||suppl 1||desmoglein 1||dsg 1||plakophilin 1||dsc 1,31046.0||28965.0||20796.0||18668.0||18521.0||18126.0||17044.0||16532.0||16187.0||16157.0||15942.0||15570.0||15541.5||15537.0||15533.5,0.0,0.0,0.0
944,Histochem_Cell_Biol-4-1-2386529.txt,cytoplasm inclus||denk||aggreg||hepatocyt||inclus||mdb||p62||ubiquitin||format||phosphoryl||protein||alcohol||studi||keratin||import||diseas||apoptot protein||omari||toxic memori||zatlouk||patient||degrad||steatohepat||major constitu||type II||liver||unpublish data||oxid stress||mallory-denk bodi||variant||mice||type||mdb format||human||function,1||2||4 2004 1||3||part 1||1 denk||1 zatlouk||sequestosom 1||2 exampl||patient||4||43-316-384329 helmut.denk@meduni-graz.at 1 1 institut||cell||microtubule-associ protein 1||studi,31046.0||28965.0||17353.333||17044.0||16058.5||15535.5||15533.5||15525.5||14855.5||13567.0||12937.0||12707.4||12627.0||12449.333||12015.0,0.0,0.1,0.13333333333333333
945,Eur_J_Nutr-2-2-1705523.txt,intervent||stanol ester||model||effect||group||anim||cholesterol reduct||sesamin||serum cholesterol||atherogen diet||studi||lignan||analys||week||pure sesamin epim||rat||mice||human||cholesterol||triglycerid level||result,1||2 2||2||1 2 3 4 5||group 1||tabl 1||fig. 2||refer 1||intervent 1||3 fig. 3||studi||fig. 1 chemic structur||4 group||cancer||7,31046.0||28965.0||28965.0||20071.2||17960.5||17331.0||16970.5||16864.5||16085.5||13021.333||12015.0||9777.5||8906.0||7076.0||6997.0,0.0,0.0,0.06666666666666667
946,Soc_Psychiatry_Psychiatr_Epidemiol-3-1-2039804.txt,iraq||asylum seeker||center||psychiatr disord||physic health problem||import predictor||group||physic diseas||factor||iraqi asylum seeker||psychopatholog||studi||drug consumpt||pmlp||netherland||lower qualiti||qualiti||life||care||disabl||servic||asylum procedur||medic specialist||visit||preval||post-migr live problem||gener practition||long asylum procedur||health,1||2||group 1||1 2 15 11||variabl 1 12 1||3||group 2||refer 1||2 year||2 month||statist 2||patient||4||studi||2 health servic,31046.0||28965.0||17960.5||17409.75||17361.0||17044.0||16920.0||16864.5||16110.5||15281.5||15272.0||13567.0||12937.0||12015.0||11960.667,0.0,0.0,0.06666666666666667
947,Pflugers_Arch-3-1-1915585.txt,part||number||specif||endotheli glycocalyx||permeabl||blood||two-photon microscopi||compon||glycoprotein||plasma-deriv protein||dermatan sulfat||vascular endothelium||interact||heparan sulfat||membran||vascular diseas||hyaluronan||endothelium||shear stress||glycosaminoglycan chain||proteoglycan||role||endotheli surfac layer||patholog||endotheli cell||delic layer||mechanotransduct||layer||glycocalyx||chondroitin sulfat||cell||molecul||specif protein bind||function,2||3||refer 1||1 characterist||proteoglycan 1||mimecan 35 1 2||2 regul||2 composit||2 fgf||4||decorin 40 1 1 CS||cell||biglycan 40 1 2 CS||type 1 diabet||400 1 3 HS,28965.0||17044.0||16864.5||16168.5||15557.0||15501.75||15491.5||14686.0||14491.5||12937.0||12917.0||12627.0||12500.6||12155.0||12151.25,0.0,0.0,0.06666666666666667
948,Eur_J_Pediatr-3-1-1829443.txt,gtc||state||insulinoma||episod||age 3 year||month||patient||symptom||diagnosi||seizur||confusion state,2||refer 1||patient||1 fig. 1 ictal eeg||studi||5||armenia 2 medic center||4 year||age 3 year||4 day||2001||result||5 month||2000||beta-islet cell tumor,28965.0||16864.5||13567.0||13449.0||12015.0||10364.0||8457.25||8096.5||7955.0||7435.0||6313.0||6080.0||5981.0||5903.0||5092.333,0.2,0.2,0.13333333333333333
949,Trans_R_Soc_Trop_Med_Hyg-1-5-1950430.txt,anaemia||effect||uganda||pregnanc||helminth||hiv||aor||estim||malaria||intens||hiv infect||associ||analysi||studi||import||hookworm||sampl||stool sampl||women||infect||hookworm infect intens||trial||preval||unpublish data||epg||moder||result,1||1 1||1 0.0002 1 0.014 2||1 month||figur 1||2 test||1 319||1 0.025||1 0.049||1 0.060||1 0.127||1 0.980||1 0.966||2 materi||2 88,31046.0||31046.0||18226.2||16322.0||16123.5||16085.5||15602.0||15548.0||15539.5||15530.0||15529.0||15526.0||15525.5||15325.0||14845.5,0.0,0.0,0.0
950,Neuroradiology-3-1-2082066.txt,intern carotid arteri||subarachnoid haemorrhag||cta||distribut||inconclus find||middl cerebr arteri||raw date imag||neuroradiologist||neg||studi||axial imag||aneurysm||surgeri||posterior||treatment||endovascular treatment||patient||vessel loop||risk||sah||find||angiographi||rebleed||rate||diagnost modal||unenhanc CT||ia-dsa||result,1||1 2||2||1 2 3 4||1 patient||24 1 1||1 1 depart||2 fig. 2||2 2 middl||1 0||14 1||25 1||3||refer 1||1 locat,31046.0||30005.5||28965.0||22498.0||22306.5||21789.333||21528.667||20968.667||19416.0||18569.5||17671.5||17172.5||17044.0||16864.5||15957.0,0.0,0.0,0.0
951,Virchows_Arch-4-1-2329733.txt,tma core||cancer||full section||posit||core||agreement||kappa||analysi||slide||tissu||express||paraffin block||two-class||molecular marker||tumor||escc||donor block||squamou cell carcinoma||case||marker||valid studi||moder||tma,1||2 1 depart||1 1 0 2 10||0 1 2 3||1 4 fig. 1||2 1 0 3 10||result 2||refer 1||5 2 1 8 10||1 specif||6. 2 fig. 2||immunohistochemistri 1||2 34||2 overview||patient,31046.0||20835.0||20826.4||20787.0||20001.25||18026.0||17522.5||16864.5||16702.2||16587.5||15939.5||15594.5||15376.5||14605.0||13567.0,0.0,0.0,0.0
952,Pflugers_Arch-4-1-2270919.txt,surfac||order||indent||membran||endocytosi||imag||fluoresc||method||high resolut||flotillin||sscm||topographi||microscopi||cell||pit||topograph imag||fluoresc imag||endocyt pit||high resolut imag||caveola,1||2||sscm 2 2 2 2||2 2 16 5||2 7||3||refer 1||flotillin 1||plasmid 2||sscm 1 6||22 fig. 1||cell||sscm 3 3 3 fig. 3||sicm 1 materi||5,31046.0||28965.0||23173.6||18061.25||17981.0||17044.0||16864.5||15527.5||14543.0||13376.0||13068.333||12627.0||12193.333||10911.667||10364.0,0.0,0.0,0.06666666666666667
953,J_Membr_Biol-3-1-1784061.txt,ionic strength depend||neg charg||concentr||low affin||electrostat charg||channel||solut||surfac||tetraethylammonium||lysin||ionic strength||studi||gallamin block||amino acid||quaternari ammonium ion||vestibul||tea||surfac electrostat||outer vestibul||residu||electrostat potenti||data||block||ionic strength sensit||interact||result||gallamin,1||2||2 2 guid||3||1991 1 3||1 5B||1 taglialatela||figur 2||1972 2||studi||1990 figur 1||hannel 1 long||shaker 1 shaker 5 6||2005||allamin 3,31046.0||28965.0||19415.0||17044.0||16535.333||15527.5||15526.5||15083.0||14577.5||12015.0||11218.667||10547.667||10110.0||8716.0||8522.5,0.0,0.1,0.06666666666666667
954,Naturwissenschaften-3-1-2039849.txt,recruit||model||tandem run||revers tandem||tandem||number||coloni||strategi||scout||ant||emigr||frank||time||fraction||activ||experi||paramet||rang||paper||mallon||pratt||late recruit||nest||social carri,1||1 2||2||result 2||model 1||3||model 2||1 1 paramet descript||2002 2005 1||1 2002 2006||2 frank||4||2 fig. 2 top figur||studi||3 2001,31046.0||30005.5||28965.0||17522.5||17468.5||17044.0||16428.0||15889.75||15606.333||15491.333||14621.0||12937.0||12873.4||12015.0||11678.5,0.0,0.0,0.0
955,Eur_Arch_Otorhinolaryngol-4-1-2217619.txt,lip||closur||object||open||3d-reconstruct||duct||structur||opfo||utricular side||valv||specimen||bast||wall||utriculo-endolymphat valv||endolymph,1||3 2 6||refer 1||3 1 5 10||h.p.wit@med.umcg.nl 1 1 depart||3 4 2 20||system 1 6||2005 209 1||2002 171 1||studi||4 5||netherland 2 laboratori||5||j.h.segenhout@kno.umcg.nl 1 buytaert||2 19 23 10.1016,31046.0||18361.0||16864.5||16359.0||16146.75||15840.75||14601.333||13326.0||12788.667||12015.0||11650.5||10621.0||10364.0||10350.0||10259.5,0.0,0.0,0.0
956,Qual_Life_Res-3-1-1915653.txt,respons||cancer||respons categori||small-cel lung cancer||explan||chemotherapi||strategi||self-present||score||measur||discrep group||interview||bit||studi||present||time||qol||fatigu||question||treatment||patient||discrep||ann||counter-intuit find||conflict find||respons shift||answer||result,1||2||4 2||3||refer 1||3 3 4||3 patient||box 2||4 4 3||patient||1 http://www.mindjet.com fig. 1 note||4||studi||qualit method 1 4||netherland 2 depart,31046.0||28965.0||20951.0||17044.0||16864.5||15675.0||15305.5||14799.5||14306.0||13567.0||13551.2||12937.0||12015.0||11965.5||11205.0,0.0,0.1,0.13333333333333333
957,Plant_Mol_Biol-3-1-1876254.txt,root||nerolidol synthas||petiol||product||transcript||jasmon acid||plant||nerolidol||herbivori||trichom||terpen||linalool emiss||enzym||tomato||protein||amino acid||emiss||spider mite||linalool||cdna||leav||monoterpen synthas||min,1||2||2 2||2002 1 1||3||1 citru||cvanschie@ucsd.edu 1||rschuuri@science.uva.nl 1 1 swammerdam institut||cell||1996 1997 2||2001 3||netherland 2 univers||2 lemts1 5 9||5||2 2004 2000 2006 salvia,31046.0||28965.0||28965.0||23049.667||17044.0||15530.5||15523.5||12707.8||12627.0||11847.0||11678.5||11592.667||11199.25||10364.0||10265.4,0.0,0.0,0.0
958,J_Interv_Card_Electrophysiol-4-1-2292477.txt,long term follow-up||long term outcom||month||atrial fibril||popul||acut success||common type afl||cryoablat||chronic success rate||follow-up||recurr||cavotricuspid isthmu||late recurr||atrial flutter||afl||patient||histori||cti||procedur||data||larg popul||year,1||2||1 year||3||1 fig. 1 percentag||refer 1||1 month||1 characterist||3 patient||patient||31-43-3875104 lm.rodriguez@cardio.unimaas.nl 1 1 depart||studi||6 patient||5||2 14 23 24,31046.0||28965.0||17151.0||17044.0||16896.75||16864.5||16322.0||16168.5||15305.5||13567.0||12917.6||12015.0||11320.5||10364.0||9881.5,0.0,0.1,0.06666666666666667
959,J_Med_Internet_Res-1-suppl1-1761819.txt,web site||visitor||inform||peopl||internet||telemedicin,1 1 univers||sep 1999 19 9 1999 1||result||factor||method||inform||1999 introduct||number||type||UK health commun||medic internet research||med internet||trial||relat work||mechan,21916.333||8236.0||6080.0||4444.0||3672.0||3440.0||3046.5||2970.0||2928.0||2717.0||2610.0||2279.0||2232.0||2208.5||2159.0,0.0,0.1,0.06666666666666667
960,Photosynth_Res-3-1-2117338.txt,plastid||electron densiti||chlorophyl||oxygenas||methylacetamid||backbon carbonyl group||assembl||group||bond||interact||electrostat bond||protein||sidechain||membran||dipol moment||posit charg||lhcp||specif locat||chloroplast develop||light-harvest complex||chl||electron||complex||feig||charg||ligand||water||molecul||dipol,1||1 2||2||2 2||1 1 fig. 1||2 3 2 3||1 3 2 5||2 fig. 2||3 3 2 3||tran 1 2 3||2002 1||3||3 3||1 valu||1 chen min 2 1 school,31046.0||30005.5||28965.0||28965.0||24528.5||23004.5||21854.75||20968.667||20024.25||19359.5||19051.5||17044.0||17044.0||16885.5||15605.333,0.0,0.0,0.0
961,J_Mammary_Gland_Biol_Neoplasia-3-1-1820839.txt,model||cancer||gland||entir gland||person commun||breast cancer||mammari gland||singl transgen||latent growth factor||develop||protect role||breast||mammari epithelium||studi||gene defici||genet alter||transgen model||defici||similar||express||extracellular proteas||transgen mous model||proteas intervent studi||PA system||involut||activ||similar express pattern||stroma||mammari cancer||role||dci||plasminogen||tumor||upar||stromal cell||unpublish data||growth factor||transgen||cell||mice||human||mmp||cancer cell||metastasi||heterogen genet background||proteas,1||2||3||refer 1||matrix-metalloproteinas 1||llc 2007 introduct 1 2||cell||studi||1 PA system||tissu inhibitor 1||cancer cell||figur 3||function studi||3 35 54 3 36||2003,31046.0||28965.0||17044.0||16864.5||15523.5||13779.0||12627.0||12015.0||11835.0||11428.667||9851.5||9122.5||8298.0||7792.6||7651.0,0.0,0.2,0.2
962,Qual_Life_Res-3-1-2039864.txt,vitamin||moder intens||intervent||day||exercis||differ||random||effect||outcom||program||percentag||community-dwel adult||daili live||group differ||group||session||mild cognit impair||possibl||vitamin supplement||intens||measur||studi||cognit declin||physic health||particip||qol||age||random control trial||supplement||analys||activ||baselin||pap||attend||item||subject||mci||signific interact||trial||rate||result,1||2||1 2 3||Z. 1 2 3||particip 15 1 1||1 year||3||refer 1||1 week||1 inclus||patient||4||studi||2 28 29||5,31046.0||28965.0||25685.0||19289.5||17164.75||17151.0||17044.0||16864.5||16140.5||15656.5||13567.0||12937.0||12015.0||11228.0||10364.0,0.0,0.0,0.06666666666666667
963,Eur_J_Pediatr-4-1-2234440.txt,moebiu syndrom||hypogonadotrop hypogonad||hypogonad||patient,2||refer 1||2 ml||patient||present patient||2003||patient ’s famili||15 year||hospit 12||associ||age||8 ml||24||level||case report,28965.0||16864.5||14865.5||13567.0||8153.0||7651.0||6160.333||3916.5||3873.5||3666.0||3565.0||3460.0||3276.0||3206.0||3138.5,0.2,0.1,0.06666666666666667
964,Pediatr_Nephrol-3-1-1766475.txt,dose||intak||normal rang||pth||dialysi||parathyroidectomi||group||phosphat||growth hormon||pth level||sever lesion||parathyroid hormon||growth||children||chronic renal failur||patient||recommend||pediatr patient||renal osteodystrophi||hypercalcemia||upper limit||calcium||normal level||level,1||2||2 3 3||pth 6 3 1 2||refer 1||ipna 2005 2 2||1 frequenc||suppl 1||1 fischbach||2 mmol||2 rönnholm||ipna 2006 introduct 1 2||36 2 5||patient||3 19 2 24,31046.0||28965.0||21017.667||17231.8||16864.5||16679.0||15961.5||15942.0||15542.0||14636.0||14484.5||13950.0||13684.0||13567.0||13149.75,0.0,0.0,0.06666666666666667
965,Eur_J_Clin_Pharmacol-3-1-2039832.txt,literatur||strategi||pharmacokinet profil||regress analysi||renal transplant recipi||limit sampl strategi||auc||tacrolimu||tacrolimu concentr||satisfactori predict||ape||patient||studi||popul||lss||time,1||2||1 2 4||1 2 3 patient||1 4||2 4||2 3 4||2 0||1 year||3||refer 1||7. 0 1 2||0 1 4||2 time||method patient popul 1 1,31046.0||28965.0||24316.0||22655.5||21991.5||20951.0||19648.667||17529.0||17151.0||17044.0||16864.5||16733.75||16692.0||16453.0||16222.8,0.0,0.0,0.0
966,Matern_Child_Health_J-2-2-1592141.txt,radiat therapi||rate||ovarian tissu||cancer||young cancer survivor||treatment||fertil||icsi||women||ovarian failur||radiat||chemotherapi agent||risk||agent||pregnanc||chemotherapi||ovarian stimul,refer 1||llc 2006 introduct 1 2||patient||4||studi||4 5||failur 3 4 5 6||fertil preserv techniqu 1||1 fertil preserv option||breast cancer patient||cancer||7||effect||8||cancer treatment,16864.5||13995.8||13567.0||12937.0||12015.0||11650.5||10083.2||8137.75||7948.0||7783.0||7076.0||6997.0||6956.0||6154.0||6044.0,0.0,0.0,0.06666666666666667
967,Int_J_Parasitol-1-5-1885961.txt,day||reduct||rel humid||rna||group||bm86||analysi||inject||studi||total rna||dsrna||engorg femal||control||oligonucleotid primer||tick||subolesin||gene||larva||femal||method||control group||egg||adult||rnai||result||bm91,2||tabl 2||yalelaan 1||2 materi||2 α||cell||studi||tabl 1 list||tabl 1 bm86||fig. 2 boophilu||tabl 2 subolesin||6||fig. 4||2005||2004,28965.0||16290.5||15525.0||15325.0||14688.0||12627.0||12015.0||11698.0||11574.333||11323.667||10882.0||9074.0||8956.5||8716.0||8077.0,0.0,0.1,0.06666666666666667
968,Matern_Child_Health_J-2-2-1592250.txt,intervent||alcohol-expos pregnanc||age||individu||effect contracept||risk||bing drink||screen||women||high rate||alcohol||fetal alcohol syndrom||alcohol consumpt||assess||level||report||fa||pregnanc||health,2||refer 1||4||studi||1 consult visit||llc 2006 introduct 1||2005||utero 4 5 6 4 www.cdc.gov||2002||10||studi find||georgia 30333 usa 2 depart||summari 4 11||2000||health,28965.0||16864.5||12937.0||12015.0||10591.667||10253.5||8716.0||7558.167||7057.0||6982.0||6947.0||6681.8||6137.0||5903.0||5601.0,0.0,0.0,0.06666666666666667
969,Qual_Life_Res-3-1-2039790.txt,lower distress||cancer||differ||pain||time point||specif||upper GI endoscopi||depress||distress||group||surveil||score||measur||barrett esophagu||symptom||time||pattern||discomfort||endoscopi||potenti determin||signific||baselin||upper gastrointestin endoscopi||patient||reason||cancer surveil test||sedat||anxieti||hospit anxieti||upper gastrointestin||burden||procedur||specif distress||depress score||level||potenti adapt||gener distress,1||2||2 tabl 2||3||hypothes 1||1 2 bac dirk||2 cm||haringvliet 2||6 1 depart||patient||result refer 1||2007 introduct 1||4||psycholog distress 1 fig. 1 differ||studi,31046.0||28965.0||20515.333||17044.0||15634.5||15016.75||14720.5||14483.0||14204.667||13567.0||13269.667||13210.333||12937.0||12296.167||12015.0,0.0,0.1,0.06666666666666667
970,Semin_Immunopathol-4-1-2315689.txt,recruit||brb||integrin||migrat||bind||eau||retin antigen||inflamm||leukocyt||rpe||inflammatori condit||separ anatom site||retina||local microenviron||cystein molecul||bone marrow||retin pigment epithelium||selectin||monocyt||tissu||barrier||immun privileg||leukocyt adhes cascad||tight junction||leukocyt migrat||endothelium||inflam venul||express||lymphocyt||uveiti||adhes||role||endotheli cell||inflammatori site||site||cell||chemokin||molecul||function,1||refer 1||patient||cell||9 137 1||studi||eau 60 86 1 62 2||forrest JV 2||vascular cell adhes molecul 1||3 54||cell function||2006||cxc chemokin receptor 2||cell type||barrier 53 1 4 132 134,31046.0||16864.5||13567.0||12627.0||12252.667||12015.0||10548.333||9734.0||9181.6||9100.5||8604.0||8371.0||8198.75||7777.5||7668.5,0.2,0.1,0.06666666666666667
971,Qual_Life_Res-3-1-2039824.txt,musculoskelet disord||mental||injuri||rtw||pain||outcom||due||month||health statu||intern consist||work limit||depress symptom||score||high level||follow-up||measur||studi||function statu||recurr||wage replac benefit||particip||health outcom||time||disord||disabl||mental health||claim statu||women||baselin||trajectori||multipl outcom measur||worker||limit||rtw statu||complet recoveri||work absenc||return||data||statu||result||health,1||1 2||2||3||fig. 2||refer 1||2 36||2 item||1 fig. 1 recruit procedur||patient||4||studi||tabl 2 comparison||1 child 118||1 month post-injuri,31046.0||30005.5||28965.0||17044.0||16970.5||16864.5||15344.0||14798.5||13776.4||13567.0||12937.0||12015.0||11411.0||10990.0||10887.0,0.0,0.0,0.06666666666666667
972,Oecologia-4-1-2270359.txt,requir||high fibr content||ludwig||constraint||speci||protein concentr||forag||open field||effect||canopi||savanna tree||dom||tree||percentag||grass||season||herbivor||tarangir||linear program model||low nutrient||posit effect||veget zone||larg herbivor||domin grass speci||wildebeest||protein||studi||eleph||qualiti||maximum fibr intak||african savanna||sampl||veget||canopi edg||gener linear model||lower fibr concentr||forag qualiti||open grassland||savanna||nutrient requir||nutrient||larg tree||bush||energi||result,1||2||3||T. 1 1 depart||part 1||1 acacia acacia 1||4||studi||netherland 2 depart||1999 3||1994 2 ithaca||5||result cynodon 1 panicum||6||1995 1994 1969 2,31046.0||28965.0||17044.0||16553.0||16058.5||15533.0||12937.0||12015.0||11205.0||10919.5||10403.0||10364.0||9286.75||9074.0||8512.0,0.0,0.1,0.06666666666666667
973,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2358931.txt,plug||tekscan sensor||surfac measur||effect||full-thick cartilag defect||bottom||contact||group||pressur||cartilag||measur||signific differ||stress||mosaicplasti||osteochondr transplant||weight bear motion||cartilag defect||flush level||defect||knee||bone||transplant||articular cartilag defect||earli osteoarthr||forc||motion||border contact pressur||sensor||stress elev||weight||condyl||surfac congruenc||intact joint surfac,1||2 2||1 result||refer 1||region 1||statist 1||1 pixel||region 2||2 statist||2 techniqu||1 5 fig. 5||3 3 fig. 3||3 9 4 2 16||studi||netherland 2 depart,31046.0||28965.0||18563.0||16864.5||16313.0||16312.5||15564.5||15272.5||15272.0||15036.0||14187.5||14027.0||13657.8||12015.0||11205.0,0.0,0.0,0.0
974,Semin_Immunopathol-4-1-2315691.txt,amd||age-rel macular degener||transgen mice||inflamm||creg||rodent eye||cornea||compon||eye||protein||studi||normal tear||import||diseas||altern||treatment||vascular endotheli growth factor||activ||cfh||uveiti||crri||complement system||complement regulatori protein||inform||anim model||low level||mous model||result,1||refer 1||patient||studi||complement compon 2||mol immunol 2007 44 1||2006||addit studi||effect||amd patient||cell traffic||protein||result||3 123 132 10.1016||2006 82 3 389 394 10.1016,31046.0||16864.5||13567.0||12015.0||10082.333||8502.6||8371.0||6983.5||6956.0||6791.5||6380.0||6288.0||6080.0||5894.0||5355.833,0.2,0.1,0.2
975,Photosynth_Res-3-1-1769345.txt,edg||plastocyanin||sampl||x-ray absorpt spectroscopi||iron centr||complex||measur||data||spectra||structur||energi||iron geometri||electron transfer||cytochrom,1||1 2||2 2 1 2 2 2||2||2 2||1 1998||3||3 fig. 2||1999 2||iii 1||panel 1||1 díaz-quintana antonio 1 1 instituto||0.003 2||2 1.97||1994 fig. 1,31046.0||30005.5||29311.833||28965.0||28965.0||17641.0||17044.0||16995.0||16880.0||15856.5||15781.0||15534.5||14587.5||14499.0||12753.0,0.0,0.0,0.0
976,J_Mol_Biol-1-5-2082129.txt,substrat||mixtur||sfii||cleft||recognit site||hex||concentr||lin||singl dna-bind cleft||linear product||form||separ molecul||dimer||state||wt||activ form||auc||enzym||protein||reaction||fast phase||condit||dna||time||one-sit plasmid||experi||singl exponenti||subunit||duplex||plasmid||site||complex||hexachlorofluorescein||OC||copi,1||2||32 2 2 2 2||3 2||fig. 4 3 2 2||studi 2 2 36||0 2||tabl 1||3||refer 1||1 32||1 34||figur 2||1 figur 4||3 4,31046.0||28965.0||23610.4||23004.5||18577.4||17917.0||17529.0||17331.0||17044.0||16864.5||16619.0||16417.0||15083.0||15061.333||14990.5,0.0,0.0,0.0
977,Eur_J_Clin_Pharmacol-3-1-2071959.txt,bottl||mem cap||electron monitor||form||viral replic||low resourc||botswana||feasibl||regimen||adher||studi||pill intak||monitor||time||failur||treatment||hiv patient||self-report||pill||patient||reason||thirti patient||histori||period||therapi||pilot-studi||haart||antiretrovir medic||method||data||level,1||2||3 2||3||refer 1||1 month||1 death||1 lamivudin||2 week||3 4||2 lamivudin||2 mem||springer-verlag 2007 introduct 1 2||patient||4,31046.0||28965.0||23004.5||17044.0||16864.5||16322.0||15919.5||15549.5||15100.0||14990.5||14509.0||14496.5||14040.0||13567.0||12937.0,0.0,0.0,0.06666666666666667
978,Evid_Based_Complement_Alternat_Med-5-1-2249747.txt,respiratory-rel condit||mechan||chronic smoker||effect||potenti applic||dose||lower respiratori tract||report||review||lung||urin||pulmonari diseas||clinic effect||emphysema patient||studi||condit||antioxid protect||defens||articl||diseas||antioxid||gsh inhal||treatment||patient||minor side effect||inhal gsh||glutathion||sulfit sensit||optim dose||respiratori diseas||method||gsh||potenti concern||oxid stress||upper||side effect||inhal||sulfit,1||1 2||2||3||2 year||patient||4||cell||studi||4 synthas 4 4 4 4||gsh introduct 1||cancer patient||10 patient||2 week gsh||5 6,31046.0||30005.5||28965.0||17044.0||16110.5||13567.0||12937.0||12627.0||12015.0||10820.833||10805.0||10321.5||10274.5||10090.333||9719.0,0.0,0.2,0.13333333333333333
979,Qual_Life_Res-3-1-2039860.txt,differ||unexplain complaint||complaint||refer popul||practic||demograph characterist||depress||popul||group||studi||gener practic||earli identif||dutch colleg||characterist||domain||physic function||dutch nation survey||qualiti||fatigu||life||mental health||descript studi||gener practic popul||patient||consult||chronic consequ||gp||depress group||health,1||2||patient 1||2007 introduct 1 2||refer 1||E. 1 1 depart||studi group 1||1 0 0||patient||3 4 5||studi||patient group 3||netherland 2 depart||1 demograph characterist||5,31046.0||28965.0||22306.5||17149.0||16864.5||16629.25||15978.667||14410.667||13567.0||13448.333||12015.0||11828.667||11205.0||10845.333||10364.0,0.0,0.1,0.13333333333333333
980,Eur_Radiol-3-1-1820761.txt,chronic hypoxia||cancer||vascular||vessel||hypoxia-direct therapi||abil||flow||tumour||oxygen||cu-atsm-pet||blood||techniqu||develop||radiotherapi||reoxygen||clinic translat||tissu||studi||bold-mri||imag||tumour cell||invas techniqu||cancer patient||treatment||lead contend||hypoxia imag||prospect studi||perfus||therapi||chang||hypoxia||method||human applic||cell||presenc||function,1||2||2 2 2 2 18 60||2 15 2 1 16||2 2 13 2 14||3||refer 1||1 comparison||64 1||2 2 40 41||import 3 4 2||11 1 12 fig. 1 4||2 hour||springer-verlag 2007 introduct 1 2||4,31046.0||28965.0||20223.0||19500.8||19090.8||17044.0||16864.5||16349.0||15972.0||15405.5||15186.0||15151.333||14625.5||14040.0||12937.0,0.0,0.0,0.0
981,J_Biomol_NMR-3-1-2039844.txt,align||charg distribut||residu dipolar coupl||variat||bond||ubiquitin||molecular align||protein||dma||dispers||direct||molecular align fluctuat||liquid crystal nmr spectroscopi||rdc||rdc-probe order paramet||addit motion||ensembl||motion||intern fluctuat||net electr dipol moment||dynam||data||bond fluctuat||molecul||rdc-probe dynam||order paramet,1||2 1 2||2||2 fig. 2||2 4||2 NH 2||fig. 1||4 1 2003||3||1 mg||2 valu||viikinkaari 1||LS 2||model 5 2||LS 2 2 α 2006,31046.0||29658.667||28965.0||20968.667||20951.0||19361.667||18011.0||17211.333||17044.0||15945.0||15845.0||15524.0||14583.5||14406.667||13382.8,0.0,0.0,0.0
982,Obes_Surg-4-1-2367390.txt,morbid obes||band||complic||gastric perfor||sever complic||case||gastric band||stomach||patient||perfor||paraesophag hernia,2 3 1 depart||discuss 1 2 4||refer 1||2 day||patient||2 fig. 2 complet atelectasi||netherland 2 depart||1 schutteva herman||simon smitweg 2||netherland 3 depart||obes patient||31-71-5828903 j.vogelaar@rijnland.nl 1 adhin santosh||5 day||6 month||treatment,19887.25||18662.25||16864.5||15449.0||13567.0||12807.4||11205.0||10367.0||9724.667||7231.333||6974.5||6210.0||6148.5||5336.0||5012.0,0.2,0.1,0.06666666666666667
983,Pediatr_Nephrol-3-1-1766478.txt,buffer-fre solut||choic||expertis||fluid||access||complic||dialysi fluid||renal replac therapi||blood flow||hemofiltr||standard time||circuit||renal unit||prefer therapi||acut renal failur||arf||cvvh||solut||ultrafiltr||dialysi||blood||renal function||techniqu||hemodialysi||extracorpor circuit||cathet||volum||glucos solut||multi-organ failur||children||care||patient||good practic||free flow||periton dialysi||therapi||continu supervis||dialysi therapi||guidelin||blood flow rate||intens care unit||extracorpor techniqu||blood pressur||rate||hypoglycemia||clinic circumst,1||2||1 2 3||3||refer 1||suppl 1||2 40||suppl 2||patient||4||recommend 1 6 13||4 5 6||latvia 2 children||3 time||1 cvvh cvvhdf,31046.0||28965.0||25685.0||17044.0||16864.5||15942.0||15557.5||14901.5||13567.0||12937.0||11342.25||10791.667||10729.0||10492.5||10354.333,0.0,0.1,0.06666666666666667
984,Int_J_Cardiovasc_Imaging-3-1-2048827.txt,leaflet||suffici||TV annulu diamet||TV anatomi||inadequ||area||agreement||analysi||measur||normal TV||studi||imag||commissur||cross-sect view||commissur width||patient||standard two-dimension echocardiographi||tricuspid annulu shape||qualit assess||assess||TV leaflet||TV leaflet shape,1||2||2 2||4 2||3||refer 1||1 score||31-10-4635498 f.j.tencate@erasmusmc.nl 1 1||2 normal||area 2||1 2 geleijns marcel||patient||4||1 frowijn rené 1 neme||I. 1 2 mcghie jacki,31046.0||28965.0||28965.0||20951.0||17044.0||16864.5||16576.0||15525.0||15414.5||15081.5||15021.25||13567.0||12937.0||12424.0||12117.4,0.0,0.0,0.06666666666666667
985,Purinergic_Signal-3-4-2072913.txt,retin slice||rat retina||receptor||ectonucleotidas||swelling-inhibitori effect||retin parenchyma||ntpdase||releas||agonist||glutam||enzym||activ||cell||extracellular metabol||A1 receptor||extracellular degrad||neuron||atp||retina||nuclear layer,1||2 2||2||2007 1 1||1 receptor||3||refer 1||4||16 17 1||cell||1 31 32 4||studi||5||5 5 5||6,31046.0||28965.0||28965.0||23126.333||17274.5||17044.0||16864.5||12937.0||12860.0||12627.0||12082.0||12015.0||10364.0||10364.0||9074.0,0.0,0.1,0.06666666666666667
986,Eur_J_Pediatr-4-1-2413080.txt,boy||growth||age||children||dutch||delet size||closur defect||sever growth||wh||growth chart||birth||patient||syndrom||studi||data||weight,refer 1||girl discuss 1 1||1 knoer||1 levtchenko||4 1 depart||2 renier||patient||4||studi||netherland 2 depart||5||6||4 year||31-243616428 t.antonius@cukz.umcn.nl 1 draaisma||netherland 3 depart,16864.5||15999.5||15525.5||15524.0||15492.333||14485.0||13567.0||12937.0||12015.0||11205.0||10364.0||9074.0||8096.5||7762.25||7231.333,0.0,0.2,0.13333333333333333
987,Eur_J_Clin_Pharmacol-4-1-2329724.txt,differ||effect||group||formulari||session||facilit||score||drug||studi||prescrib||gener problem-bas curriculum||treatment||posttest||person formulari||student||patient||train||ration prescrib||patient case||train programm||classic curriculum||skill||univers||case||addit train||result,1||2||result 1 1||1 2 3 4 case||3||refer 1||1 2 fig. 2 PF EF||1 pre||1 groot||1 barn||1 richir||patient||1 fig. 1 PF EF||4||intervent 1 4 8,31046.0||28965.0||22724.0||18633.0||17044.0||16864.5||15717.167||15591.0||15568.0||15559.5||15526.0||13567.0||13483.8||12937.0||12815.5,0.0,0.0,0.06666666666666667
988,Purinergic_Signal-3-4-2072926.txt,bdnf protein||receptor||synapt transmiss||hippocampu||mechan||bdnf function||experiment model||bdnf level||normal bdnf tone||function consequ||bdnf||blockad||striatum||hippocamp slice,refer 1||exon 1||1 domenici||1 minghetti||1 armida||1 pèzzola||2 mice||2 popoli||39-0649387104 patrizia.popoli@iss.it 1 1 depart||R. 1 pepponi||T. 1 martir||L. 1 tebano||itali 2 depart||2005||2006,16864.5||15565.5||15528.0||15524.5||15523.5||15523.5||14920.0||14487.0||12917.6||10967.0||10892.333||10857.333||10553.667||8716.0||8371.0,0.0,0.0,0.0
989,World_J_Urol-3-1-1913182.txt,cancer||random studi||earli detect||activ surveil||detect||number||popul||possibl||strategi||risk assess||prostat||overtreat||radic prostatectomi||nomogram||diseas||time||treatment||screen||prostat cancer||patient||incid||psa||overdiagnosi||earli age||base||invas treatment||procedur||inform||case||mortal||year||men||biopsi||result,1||2||1 5||3||refer 1||2 year||grade 1||psa 1||grade 2||patient||studi||5||6||screen-detect cancer 1 23 24||2005,31046.0||28965.0||20705.0||17044.0||16864.5||16110.5||15863.5||15547.0||14823.0||13567.0||12015.0||10364.0||9074.0||8886.6||8716.0,0.0,0.1,0.06666666666666667
990,Neurogenetics-3-1-1820748.txt,genet studi||muscl||mutat||potassium channel||function effect||mutant crna||famili||clinic||current||transvers||electrophysiolog studi||myokymia||episod ataxia||epilepsi||oocyt,2||2 2||3||type 1||refer 1||1 day||patient||kcna1 dde 2 fig. 2||3 3 fig. 3 xenopu||transmembran segment 2||3 4 7 10 11||1-617-3554697 fuki.hisama@childrens.harvard.edu 4 6 1 depart||laura.ment@yale.edu 2 3 pober barbara||addit famili member 1||episod ataxia type 1,28965.0||28965.0||17044.0||16987.0||16864.5||16489.5||13567.0||12585.6||11284.8||9867.0||9802.2||9258.833||9209.2||8851.25||8568.75,0.0,0.0,0.0
991,Purinergic_Signal-3-4-2072914.txt,receptor||sampl||valu||express||clone||atp releas||p2i receptor||pc12 cell||vesicl exocytosi||nucleotid||camp||exocytosi||cell||protein||nucleotid releas||cyclic amp synthesi||radioact||noradrenalin,1||2||2 2||1 3||3 2||14 1 1||2007 2||12 2||3||refer 1||27 2||29 2||2007 introduct 2 25 1||15 6 4 2||3 3 10,31046.0||28965.0||28965.0||24045.0||23004.5||22129.667||18126.0||17408.5||17044.0||16864.5||15688.5||15617.5||14379.0||13888.25||13690.0,0.0,0.0,0.0
992,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-2042026.txt,pain||loos femor compon||outcom||averag flexion||osteoarthr||bear||averag||compon||oper||score||follow-up||tibial compon||studi||anteromedi pain||knee||radiograph||patient||revis||surviv rate||procedur||case||year||surgeon||result,2||method 1||1 year 3||3||refer 1||1 oxford||2 mm||patient||4||studi||netherland 2 depart||bear 1 revis||bear 1 convers||7 year 10 2 11||3 case,28965.0||17359.0||17115.333||17044.0||16864.5||15752.5||14896.0||13567.0||12937.0||12015.0||11205.0||10461.667||10449.0||10250.2||10108.5,0.0,0.2,0.13333333333333333
993,Purinergic_Signal-3-4-2072911.txt,receptor||site-direct elimin||immunoprecipit||phosphoryl||p2x receptor||protein||reaction||atp||antibodi||pma||germani||pkc||current||sds-page||oocyt||direct pkc-mediat phosphoryl||final concentr||cell||pkc site||immunoblot||result||min,1||1 2 1||2||2 3 2||3 2||2 3||3 3 2||24 2 2||2 3 2 3 X.||2 fig. 2 2 3 X.||2007 3 2||1 receptor||1 3 receptor||3||refer 1,31046.0||30352.333||28965.0||24991.333||23004.5||23004.5||21017.667||20402.0||18441.2||18183.833||17765.333||17274.5||17197.667||17044.0||16864.5,0.0,0.0,0.0
994,Eur_Radiol-3-1-2077913.txt,heart rate||roi||nois||thorac aorta||excel inter-observ agreement||pulmonari trunk||chest||artifact||evalu||coronari arteri||lung||attenu valu||ecg-gating-rel artifact||score||attenu||ventricl||studi||time||imag||data acquisit||patient||bpm||imag qualiti||independ reader||ecg-gat chest examin||dual-sourc CT||acut chest pain||slice thick||acut coronari syndrom||aorta||contrast media protocol||heart||contrast attenu,1||2||1 6||3||refer 1||1 mm||rca 1||1 pairwis||2 mm||2 cm||find 2 3 4 5||patient||4||studi||2 imag find,31046.0||28965.0||20060.0||17044.0||16864.5||15936.5||15538.0||15535.5||14896.0||14720.5||14237.8||13567.0||12937.0||12015.0||11320.0,0.0,0.0,0.13333333333333333
995,Mol_Syst_Biol-3-_-2174632.txt,oncogen stimuli||databas||regulatori loop||regulatori relat||number||alter||downstream||ra||oncogene-sign block||function||biolog||sequenc||gene mutat||analysi||protein||pattern||mutat||surviv||neutral hub||quantit analysi||oncogene-sign collabor||network||gene||map||cancer signal||tumor||event||motif||oncogene-sign rout||cell||set||data||block||node||mutat frequenc||result||tumorigenesi,1||2||3||figur 1||block 1||figur 2||1 5 wang edwin 1 5||tabl 1 effect||patient||4||cell||canada 2 depart||4 figur 3||5||supplementari figur 2,31046.0||28965.0||17044.0||16123.5||15829.0||15083.0||13921.333||13872.667||13567.0||12937.0||12627.0||10586.0||10394.0||10364.0||10319.333,0.0,0.0,0.06666666666666667
996,Mol_Biochem_Parasitol-1-5-1906846.txt,higher level||effect||depend||paba||npp||folat||proton gradient||drug||stage||profil||2||2′||plasma membran||pb||buffer||membran||sdx||assay||intern pH||pyr||uptak||transport||dnp||pH gradient||glucos||exogen folat transport||cell||erythrocyt||nutrient||folin acid||parasit||low level,1||2 2 2||2||1 3||fig. 1||8 2||3||fig. 2||initi 1||1 ml||1 mM||2 materi||fig. 1 fig. 1 P.||tabl 1 effect||fig. 3 3,31046.0||28965.0||28965.0||24045.0||18011.0||17559.5||17044.0||16970.5||16191.0||15906.0||15723.5||15325.0||14809.2||13872.667||13021.333,0.2,0.1,0.06666666666666667
997,J_Comp_Physiol_A_Neuroethol_Sens_Neural_Behav_Physiol-3-1-1915583.txt,palp||host||respons||receptor||speci||concentr||cold receptor||group||behaviour||benzaldehyd||stimuli||evolutionari relict||lepidoptera||sensit||leaf disc||compound||sensilla||adapt speciat||larva||rosacea||host plant||feed respons||cell||record,1||1 2||2||isol 2 2 2||cell 1||2 8 9 2 2||1 11||3||suppl 1||pre-puls 1||2 circl||1 fig. 3 feed||4||cell||2 Y. cagnagellu 2 1996,31046.0||30005.5||28965.0||21926.5||21836.5||19688.2||18048.5||17044.0||15942.0||15523.5||14598.5||13335.5||12937.0||12627.0||12293.6,0.0,0.0,0.06666666666666667
998,Histochem_Cell_Biol-4-1-2386528.txt,cell divis||mitosi||formamid||cancer||number||katanin||aurora kinas||microtubul||centrosom protein||accumul||research||associ||centrosom||sperm||protein||studi||scnt||diseas||plk||numa||mtoc||spindl||duplic||role||centriol||centrosom function||centrosom cycl||cell cycl regul||complex||cell||schatten||cell cycl||result,1||2||2003 2002 2 fig. 1||1 Nu||2 μm||centrin 2||cell||studi||complex fig. 2||cyclin-depend kinas 2||cell cancer||cancer cell||6||4 2006 2007 7||2005,31046.0||28965.0||15939.0||15527.5||14648.5||14485.5||12627.0||12015.0||11861.667||9950.333||9851.5||9851.5||9074.0||8898.0||8716.0,0.0,0.2,0.13333333333333333
999,Anal_Bioanal_Chem-3-1-1820759.txt,analyt result||materi||phenyltin analysi||between-method varianc||tube||solut||certif||uncertainti||upper toluen layer||butyltin||dpht||sampl||organotin||valu||mae||degrad||organotin compound||standard solut||mbt||analyt bias||water||extract||small amount||methanol||result||crm,1||1 1||1 2||2||2 2||1 4||valu 1 2||1 20||1 16 17 1||1 21||1 year||3||refer 1||1 26||1 hcl,31046.0||31046.0||30005.5||28965.0||28965.0||21991.5||20912.0||17731.5||17406.5||17163.5||17151.0||17044.0||16864.5||16827.0||15557.0,0.0,0.0,0.0
1000,Anal_Bioanal_Chem-4-1-2259237.txt,model||number||saal river||biofilm sampl||pc||percentag||Mg content||high sensit||variabl||order||predict abil||dpl||munich||biofilm||supervis method||environment condit||test set||sampl||object||cart||discrimin||method||regress tree||river||leutra river||data||node||water||classif||chemometr||PC 2||result,1||1 2||2 2||2||1 1 1 1 10||1 fig. 1||2 fig. 2||2 1 depart||PC 3 1 1||3||refer 1||PC 1||1 descript||2 week||PC 2,31046.0||30005.5||28965.0||28965.0||26233.2||22356.0||20968.667||20835.0||19871.75||17044.0||16864.5||15698.5||15698.0||15100.0||14658.0,0.0,0.0,0.06666666666666667
1001,Anal_Bioanal_Chem-3-1-1592252.txt,vivo||carcinogen product||product||relev properti||hydroxylamin||rule||group||characterist ion||sulfat product||allyl alcohol||structur inform||metabolit||fragment||drug||biolog effect||bioactiv||sulfat||neg ion mode||compound||mass spectrometri||benzyl alcohol||biolog fate||fragment pathway||method||pharmaceut||structur featur||site||data||sulfat metabolit||type,1||2||4 2 2 2||tabl 1||3||3 3||3 fig. 2||refer 1||rule 1||18 5 1||33 2 scheme 2||4 3||2 carbon||rule 2||chapter 2,31046.0||28965.0||24958.0||17331.0||17044.0||17044.0||16995.0||16864.5||15635.5||15113.0||15010.5||14990.5||14634.5||14595.0||14516.0,0.0,0.0,0.0
1002,Acta_Neuropathol-4-1-2386160.txt,receptor||neuron||epilepsi||patholog condit||dysplast neuron||similar pattern||vegfb||protein||normal tempor cortex||tissu||studi||antibodi||immunoreact||primari antibodi||vegfa||hippocampu||pyramid neuron||express||intract epilepsi||vascular endotheli growth factor||immunocytochemistri||observ||patient||role||dysplast cortex||cell||case||fcd,1||2||immunocytochemistri 2 2||vegfa 2 2 fig. 2||3||refer 1||1 summari||2 vegfa||patient||4||31-20-5669522 e.aronica@amc.uva.nl 1 4 1 depart||cell||studi||vegf receptor 1||1 56 fig. 1 repres immunoblot,31046.0||28965.0||19316.333||18378.6||17044.0||16864.5||15734.5||14493.5||13567.0||12937.0||12920.833||12627.0||12015.0||11548.667||11544.0,0.0,0.1,0.2
1003,Anal_Bioanal_Chem-3-1-2117337.txt,apoglucos oxidas||low flow rate||glucos||acid treatment||filter||system||detector||enzym||microreactor||activ||glucos oxidas||prepar||apogox||applic||devic||flavin adenin dinucleotid||electrochem detect||fad||solut||flow system,1||1 2||2||2 2 1 1 4||2 4 1||1 1 univers||enzym activ 2 2 2||refer 1||1 squar||1 triangl||1 diamond||hanzeplein 1||perform 3 3 1 fig. 3||inject 2||microreactor 1 12 fig. 1,31046.0||30005.5||28965.0||26591.8||24316.0||21916.333||18592.6||16864.5||15638.0||15578.0||15563.5||15529.5||15015.0||14779.5||14585.8,0.0,0.0,0.0
1004,Anal_Bioanal_Chem-4-1-2259236.txt,meaning molecular-level analysi||complex system||mass||organ structur spectroscopi||materi||number||separ||oxygen||ion||peak||bond||ratio||analysi||spectra||structur space||complex mixtur||limit bandwidth||discret analyt volumetr pixel space||isom||complex unknown||nonrepetit complex materi||fticr mass spectra||current inabl||marin||nmr||data||properti||chemic bind||voxel||molecul||chemic structur||function,1||5 2||3||refer 1||14 2||1 2 26 27||seri 1||2 3 gugisch||2 mering||2 frommberg||1 1 gsf research center||4||tabl 1 characterist||2 37 11||5 4,31046.0||19664.5||17044.0||16864.5||16631.0||16257.75||15802.5||15337.333||14484.0||14484.0||13485.0||12937.0||11984.333||11931.333||11650.5,0.0,0.0,0.0
1005,Anal_Bioanal_Chem-3-1-1805043.txt,wastewat treatment||biotransform||hydrochlorothiazid||diclofenac||concentr||ca process||hydraul retent time||averag daili flow||drug||remov||analysi||process||intern standard||attenu||sludg||elimin||membran||membran bioreactor||sampl||treatment||compound||remov effici||mbr||ca effluent||effluent||method||pharmaceut||effluent concentr||primari clarifi||effici||wastewat,1||1 2||2||1 3 3||parenthes 1 2 3 fig. 1||18 1||3||fig. 2||1 month||tabl 2||2 17||2 3 9 11||1 5 biotransform||4||1 19 20,31046.0||30005.5||28965.0||21711.333||18855.667||17487.5||17044.0||16970.5||16322.0||16290.5||16274.0||14113.0||13807.0||12937.0||12925.667,0.0,0.0,0.0
1006,Am_J_Community_Psychol-2-2-1705531.txt,respons||woman||neg social reaction||lifestyl||disclosur||posit||support provid||commun system||rape||rape survivor||neg experi||karen||assault||step||religi commun||interview||reaction||social class||studi||current studi||commun system personnel||social reaction||medic system||friend||legal||mari||legal system||famili||experi||in-person interview||reason||decis||foster care system||natali||survivor||self-blam||sourc||impact||shawna||support||neg reaction||effort||case||silenc||polic||fear||secondari victim||result,1||2||3||4||studi||5||6||pp. 3||4 year||2004||7||10||effect||current studi||futur studi,31046.0||28965.0||17044.0||12937.0||12015.0||10364.0||9074.0||8583.5||8096.5||8077.0||6997.0||6982.0||6956.0||6741.5||6447.5,0.2,0.1,0.13333333333333333
1007,Anal_Bioanal_Chem-4-1-2270354.txt,sampl mass||pc||raman||Cu concentr||sick dog||hair sampl||liver biopsi||chronic hepat||nail||analysi||thumb nail||nail clip||studi||princip compon analysi||melanin||hepat Cu concentr||pca||dog||sampl||hair||Cu determin||Cu liver statu||result||chemometr||inaa||Cu liver level,1||1 1 2||2||1 8||3 1 8||refer 1||1 69m||2 min||3 4||cell||studi||1 fig. 6 top||gender 3 4 5 4||netherland 2 gerx||5,31046.0||30352.333||28965.0||18600.0||18081.333||16864.5||15523.5||15117.5||14990.5||12627.0||12015.0||11339.0||10754.4||10374.0||10364.0,0.0,0.0,0.06666666666666667
1008,Anal_Bioanal_Chem-3-1-1914286.txt,gradient liquid chromatographi||long-capillari monolith column||squar root||bsa||peak capac||mass spectromet||length||similar gradient slope||separ||protein identif||long column||score||analysi||linear flow rate||gradient||protein||flow rate||increas||sampl||digest||column||extern flow cell||mascot||protein identif score||effici||min,1||2||2 2 fig. 2||20 1 1||tabl 1||3||refer 1||2 mascot||10 fig. 1||3 fig. 3||4 3 4 3 buffer||reagent 4 3||1999 857 1 20 10.1016||6||mass spectrometri analysi 2,31046.0||28965.0||22967.75||22169.667||17331.0||17044.0||16864.5||14486.5||14334.667||13021.333||12086.2||10040.333||9214.4||9074.0||8709.0,0.0,0.0,0.0
1009,Anal_Bioanal_Chem-4-1-2226005.txt,ratio measur||precis||interfer||light element||larg variat||isotop fraction||techniqu||variat||ratio||instrument||intens||plasma||extern precis||isotop ratio measur||composit||mc-icp-m||sampl||extern normal||element||mass spectrometri||fraction||standard||ion beam||light mass ratio||high instabl||data||isotop||silic,1||2||26 2 2 2 2 2||2 3||2 2 ɛ||3||refer 1||28 1||1 35||50 2||1 saprolit||44 2||48 2||52 2||1 6 7 4 5,31046.0||28965.0||24572.167||23004.5||19317.0||17044.0||16864.5||16747.5||16520.5||15827.0||15524.0||15155.0||15146.0||15052.5||14083.6,0.0,0.0,0.0
1010,Anal_Bioanal_Chem-4-1-2226000.txt,wash solut||chip||cell||concentr||spectra||studi||dynam monitor||ser||rang||gold nanoparticl,1||1 1||2 2 2||2 6||1 27 6 2||3||1 fig. 1 schemat||1 6 6||2 25||examin 2||1 3 21 fig. 3||1 11 22 23 4 2||4||1482-466410 s.j.haswell@hull.ac.uk 1 1 depart||cell,31046.0||31046.0||28965.0||19019.5||17874.25||17044.0||16779.75||16398.0||16132.0||15160.5||14678.2||14028.333||12937.0||12917.6||12627.0,0.0,0.0,0.06666666666666667
1011,Anal_Bioanal_Chem-4-1-2175028.txt,Rb correct||mc-icpm||precis||interfer||element fraction||la-mc-icpm||high Sr content||mass spectromet||dimer||techniqu||accuraci||isobar interfer||ratio||analysi||Kr correct||la-mc-icpm analys||studi||correct||Sr isotop ratio||geolog materi||sampl||ree||laser||fraction||carbon||tim analys||signific ree content||instrument mass discrimin||spot analysi||method||Sr isotop||marin carbon||mass bia correct||problem||data||Sr isotop analys||sampl materi,1||2||1 1 27 1||1 2 fig. 2||1 12||3||refer 1||1 18 88 2||statist 2||171 2||173 2||168 2||172 2||170 2||166 2,31046.0||28965.0||23887.5||23488.0||18449.0||17044.0||16864.5||16166.5||15272.0||14614.0||14612.0||14610.0||14607.0||14605.5||14603.0,0.0,0.0,0.0
1012,AIDS_Behav-3-1-1847541.txt,men||pilot intervent||effect||practic||sti||hiv||submit||ethnic||cost||foreskin||school||studi||clinic trial||addit||accept||particip||lukobo||medic practition||age||protect||mother||male circumcis||infant circumcis||MC servic||non-circumcis commun||tradit circumcis||signific impact||africa||procedur||circumcis||south africa||bailey||region||unpublish report||non-circumcis ethnic group,1||2||tabl 1||3||2 month||patient||studi||level 3||2 circumcis prefer||2001 1 4 223 231 10.1016||6||2005||2005 2006 2005||2006||2003 2005,31046.0||28965.0||17331.0||17044.0||15281.5||13567.0||12015.0||10125.0||9863.0||9408.333||9074.0||8716.0||8601.0||8371.0||8183.5,0.0,0.1,0.06666666666666667
1013,Acta_Neuropathol-4-1-2270355.txt,dmv||distribut||materi||high likelihood categori||inclus||dlb||vulner nuclei||braak||categor||ep||stage||region distribut||transentorhin region||studi||clinic sign||diseas||cohort||sever||dementia||mild||subject||case||account||result,1||2||3 2||1 2 3 4||1 1 na||1 0||1 year||3||3 3||refer 1||1 applic||1 inclus||yliopistonranta 1||2 applic||2 inclus,31046.0||28965.0||23004.5||22498.0||20710.667||18569.5||17151.0||17044.0||17044.0||16864.5||16072.0||15656.5||15524.0||15031.5||14616.0,0.0,0.0,0.0
1014,Anal_Bioanal_Chem-3-1-1914274.txt,mixtur||mode||detect||protein concentr||optim||effect||concentr||ascorb acid||gradient||pad system||measur||ros-produc||resolut||ro||hplc||condit||flow-rat||bioactiv||on-lin pad system||flow rate||antioxid||increas||individu compound||flow-rat gradient||compound||pro-oxid||system||fia||harm effect||paper||present pad system||off-lin batch format||data||organ modifi||hplc separ||flow inject analysi||paraquat||result||min,1||2||2 2 fig. 2||1 1 fig. 4||3||refer 1||1 tabl 1 initi||discuss 1||1 mg||1 ml||1 mM||2 fig. 5||4||31-205987610 npe.vermeulen@few.vu.nl 1 1 lacdr-divis||studi,31046.0||28965.0||22967.75||20001.25||17044.0||16864.5||16761.0||16373.5||15945.0||15906.0||15723.5||14768.333||12937.0||12419.4||12015.0,0.0,0.0,0.0
1015,Anal_Bioanal_Chem-3-1-1592466.txt,sampl inject||channel dimens||feasibl studi||squar section channel||solut||squar capillari||sampl solut||mix protein sampl||protein||inject||deprotein||f-bsa||cas-chip||system||CE separ||multilay flow||microchannel||pdm||capillary-assembl microchip||small molecul||larg molecul||fluoresc intens profil||pretreat||capillari electrophoresi||microchip||molecul||success separ,1||1 1||6 2||7 2||3 3 3 3||refer 1||1 fig. 4||1 molecul||4||1 26 27||studi||fig. 2 photograph||fig. 3||5||electrophoret separ 1 28,31046.0||31046.0||19019.5||17981.0||17044.0||16864.5||16319.667||15863.5||12937.0||12022.0||12015.0||11341.667||11010.0||10364.0||8600.75,0.0,0.0,0.0
1016,Acta_Neuropathol-4-1-2270353.txt,alpha-synuclein||cell death||express||lewi neurit||synapt plastic||control||overnight||tissu section||sporad PD case||cell||case||protein||section||antibodi||dementia||lewi bodi||ampa receptor||method tissu sampl,1||2||2 1 1 1 fig. 1||1 fig. 2||tabl 1||3||refer 1||1 hour||2 derkac maria 1||log 2||4||cell||studi||2 28 16 3 fig. 4||supplement tabl 1,31046.0||28965.0||26354.167||21662.333||17331.0||17044.0||16864.5||15666.0||15013.75||14557.5||12937.0||12627.0||12015.0||11720.333||11705.333,0.0,0.0,0.06666666666666667
1017,Anal_Bioanal_Chem-4-1-2228378.txt,higher temperatur||oligom||format||dna sequenc||gutingimycin||adduct||product||oligonucleotid||fragment||guanin||electrospray mass spectrometri||trioxacarcin||hplc||dna||capillari exit voltag,1||2 1 1||1 2||1 2 2||2||2 2 1 2 5a||1 2 4 2 4||fig. 1 1 2 3||1 2 2 λ||2 2 2 4a 3||conclus 2 2||2 4a 2||10 1||1 fig. 2 4a 2||tabl 1,31046.0||30352.333||30005.5||29658.667||28965.0||23593.0||22970.0||22615.4||22266.25||20797.0||19707.0||19325.333||19014.0||18799.6||17331.0,0.0,0.0,0.0
1018,Anal_Bioanal_Chem-3-1-1802725.txt,conserv||spectrum||mobil raman spectroscopi||artefact||galleri||analyt challeng||varnish layer||lid||exampl||mobil spectromet||area||techniqu||non-destruct analysi||paint||earli keyboard instrument||pigment||exhibit galleri||analysi||instrument||experiment condit||condit||mar virgin||raman spectroscopi||object||panel||laser||renaiss||museum||textil banner||larg dimens||museum object||work||indian kalighat||investig||antiqu egyptian sarcophagi,1||2||1 2 3||2 3 2 2 3||2 3||3 2||2 fig. 2||1 19 fig. 1||3||refer 1||discuss 1||1 accumul||1 overview||3 4||3 4 fig. 3 4,31046.0||28965.0||25685.0||24196.6||23004.5||23004.5||20968.667||17595.5||17044.0||16864.5||16373.5||15704.5||15645.5||14990.5||12987.6,0.0,0.0,0.0
1019,Acta_Neuropathol-4-1-2386158.txt,gray matter||molecular form||number||specif||specif cellular marker||plaqu||neuron||report||mous||form||area||insult||reactiv oxygen speci||AD patholog||enzym||protein||minor form||evid||antibodi||peroxiredoxin||brain tissu||increas||imag||peroxiredoxin 6||control||tau||control tissu||astrocyt||patholog||human brain||oxid stress||cell||diffus plaqu||region||dens core||low level||goat||gray,1||2||2 2||2 2 3||1 1 depart||17 1||3||refer 1||1 list||2 list||2 gai||patient||4||3 3 16||cell,31046.0||28965.0||28965.0||24991.333||21528.667||17314.5||17044.0||16864.5||15739.0||14698.5||14483.5||13567.0||12937.0||12679.667||12627.0,0.0,0.0,0.06666666666666667
1020,Anal_Bioanal_Chem-3-1-1797063.txt,agr cascad||commun||bacteria||stabil||biofilm format||endoproteas||quorum sens||system||signal diffus||signal concentr||signal product||growth condit||aip||biofilm||import||quorum||studi||molecul||environ,1||2||1 2 vibrio||6 2||3||refer 1||2 21||1 δ||1 phcb||3 4||2 streptococcu||cell||14 1 P.||studi||2 16 P. aeruginosa fig. 1,31046.0||28965.0||20008.667||19019.5||17044.0||16864.5||16123.0||15592.0||15524.0||14990.5||14502.5||12627.0||12448.333||12015.0||11832.167,0.0,0.0,0.06666666666666667
1021,Anal_Bioanal_Chem-2-2-1764597.txt,pcdd||dioxin-lik pcb||mixtur||number||analyt||concentr||calux||dioxin||tempor trend||report||review||order||concentr rang||techniqu||select||polychlorin dibenzofuran||analysi||chemic||tcdd||signific advanc||tef||pcdf||toxic effect||discuss||emiss||sampl||sampl type||compound||furan||mass spectrometri||seri||pcb||dlpcb||congen||toxic equival quantiti||sourc||method||determin||toxic equival factor||data||human||hite||extract||applic||toxic,1 1 1||1||2||1 1 fig. 1||1 4||3||refer 1||1 37||1 141||1 151||envcan 1||1 153 fig. 2 149||3 1 ontario ministri||report ep 1||0.1 0.05 1,31046.0||31046.0||28965.0||24528.5||21991.5||17044.0||16864.5||16412.0||15680.0||15664.0||15523.5||13109.8||12076.5||11398.333||11038.333,0.0,0.0,0.0
1022,Anal_Bioanal_Chem-3-1-1705481.txt,environment monitor||sediment||detect||recoveri||lab||stockholm pop convent||analyt||program||concentr||analyt method||low cost||abil||analyt laboratori||percentag||gpc||review||routin measur||strategi||step||techniqu||countri||solvent||analysi||GC column||lipid||pesticid||blank||organochlorin||electron supplementari materi||air||analyt system||evapor||sampl||ocp||individu congen||analyt standard||pcb||scientist||congen||pop||limit||low environment impact||method||manag||routin pop analysi||data||field blank||water||extract,1||1 2||2||2 4||10 1||7 2||tabl 1||3||refer 1||15 2||review 1||13 2||tabl 2||2 6 5||2 year,31046.0||30005.5||28965.0||20951.0||19014.0||17981.0||17331.0||17044.0||16864.5||16771.0||16648.0||16613.5||16290.5||16134.333||16110.5,0.0,0.0,0.0
1023,Acta_Neuropathol-3-1-2080348.txt,reactiv astrocyt||injuri||dwmg group||neuron loss||gray matter||brain||thalamu||gliosi||globu pallidu||periventricular necrosi||frontal cortex||neg group||group||dwmg||astrocyt hypertrophi||cerebr cortex||infant||purkinj cell||studi||white matter gliosi||age||hippocampu||signific||sever||incid||pvl case||necrosi||prematur infant||basal ganglia||gfap||perinat panencephalopathi||find||cell||case||data||white matter injuri||periventricular leukomalacia||perinat period||gray matter lesion||pvl,1||2||deliveri 1 1 1 1||23 2 2 2||postnat period 1 1 1 1||1 3 1 depart||3||refer 1||sever 2||1 dwmg||1 2 3 billiard saraid||1 2 volp joseph||grade 2||patient||cerebellar hemispher 1 fig. 1,31046.0||28965.0||24900.8||22470.75||20894.833||20407.5||17044.0||16864.5||15574.0||15539.0||15411.4||15023.25||14823.0||13567.0||13450.0,0.0,0.0,0.0
1024,Anal_Bioanal_Chem-3-1-2117333.txt,calibr standard||calcul||retent time shift||higher level||mix solut||recoveri||solid phase||fortif||toluen||solut||matrix||gcb||step||solvent||intern standard||analysi||process||pesticid||adsorpt||inject||inject speed||time||liner||minimum||effici extract||clean-up||sampl||polar||multi-residu analysi||standard||amount||degrad||sourc||ethyl acet||valid||residu||method||set||gpc clean-up||full-scan acquisit||methanol||result||compil,1||1 2||2||1 2 fig. 1||1 1 1 GC||2 4||1 2.5 1||1 5||1 2 44||1 2 GC||1 8 2 4||5 2||1 7||1 10||1 8,31046.0||30005.5||28965.0||24008.25||23380.25||20951.0||20843.0||20705.0||20452.0||20131.333||19775.5||19664.5||19021.5||19014.0||18600.0,0.0,0.0,0.0
1025,AIDS_Behav-2-2-1544374.txt,condom||global aid crisi||effect||program||vision||educ||uganda||report||gpa||iec||behavior chang||review||hiv||strategi||countri||campaign||note||sexual behavior||time||health educ||district||activ||major differ||world health organ||educ campaign||ugandan ministri||ministri||hiv preval||aid||train||prevent||multipl channel||support||africa||inform||plan||level||year||sexual activ||health,1||2||3||1 uganda||fig. 1 sourc||studi||1 1988 1990||district mobil 1||5||1 mill. usd||6||2003 2000 4||2004||usa 2 uganda ministri||2003,31046.0||28965.0||17044.0||15574.0||12338.0||12015.0||11161.333||10460.667||10364.0||10351.0||9074.0||8830.333||8077.0||7779.25||7651.0,0.0,0.0,0.0
1026,Anal_Bioanal_Chem-3-1-2117336.txt,pda||substrat||reactor||gentl flow||aceton||incub||carry-ov||pH optimum||complet digest||capillari||surfac||high concentr||order||on-lin digest||protein digest||high activ||enzym||fragment||liquid chromatographi||protein||netherland||buffer||time||surfac modif||sampl||surfac plasmon reson||spr sensor||immobil||digest||experi||gold-sensor disk||amount||immobil enzym||open-tubular reactor||spr||disk||peptid||water||dextran hydrogel||result,1||1 1||1 2||2||1 3||1 4||22 1 2||protein 1||fig. 1||method 1||1 5 5||3||refer 1||38 1 3||1 solut,31046.0||31046.0||30005.5||28965.0||24045.0||21991.5||21064.667||18667.0||18011.0||17359.0||17258.0||17044.0||16864.5||16561.333||15985.5,0.0,0.0,0.0
1027,Eur_J_Epidemiol-4-1-2190782.txt,date||day||coronari heart diseas||differ||myocardi infarct||hospit||cardiovascular diseas||death||nation hospit discharg regist||diabet men||follow-up||diabet||admiss||netherland||gender||ami||acut myocardi infarct||long-term mortal||surviv||analys||signific||women||diabet mellitu||patient||epidemiolog||risk differ||prognosi||risk||popul regist||inform||mortal||year||result,2||result 1||3||refer 1||2 time||L. 1||1 characterist||2 short||2 reitsma||patient||E. 1 1 juliu center||4||19 2 20||studi||type 2 diabet,28965.0||18563.0||17044.0||16864.5||16453.0||16285.0||16168.5||14734.5||14493.0||13567.0||13133.8||12937.0||12232.0||12015.0||11461.333,0.0,0.1,0.06666666666666667
1028,Pharm_World_Sci-3-1-1805038.txt,dispens||databas||dutch commun pharmaci||number||correl||drug interact||drug combin||ratio||drug||analysi||questionnair||studi||import||netherland||validation-set||system||medic surveil system||pharmaci||patient||risk||advers patient outcom||euron system||medic surveil||determin||case||health care centr,1||1 1||2||result 1||3||1 number||number 1||refer 1||1 erythromycin||1 2 casper peter||formula 2||1 10 11||patient||4||1 28.9 0.61 2 12.8,31046.0||31046.0||28965.0||18563.0||17044.0||17008.0||17008.0||16864.5||15532.5||15072.25||14507.5||14359.667||13567.0||12937.0||12049.6,0.0,0.0,0.06666666666666667
1029,J_Med_Internet_Res-8-2-1550702.txt,pda||rate||male||organiz level||resid||survey||clinic practic||health care provid||present review||patient track||practic||handheld devic||nation sampl||specif task||health care profession||usag pattern||group||review||person||handheld usag rate||health care||studi||characterist||profession||technolog||articl||author||age||health||specialist||care||student||medic resid||patient care||handheld comput||market research firm||medic refer||inform||preval||person digit assist||data||systemat review||year||physician||adopt rate||adopt||organiz task||result,1||2||2002 2||tabl 1||3||2 characterist||2 4 4 9||2 survey||4||result figur 1||studi||3 2001||beng phd 1 3 3 depart||survey appendix 1||1 handheld comput,31046.0||28965.0||18011.0||17331.0||17044.0||15128.0||15057.75||14948.5||12937.0||12775.667||12015.0||11678.5||11309.667||10740.333||10729.0,0.0,0.0,0.06666666666666667
1030,Eur_Arch_Otorhinolaryngol-4-1-2254466.txt,malign||intervent||tumor recurr rate||total||prognost factor||facial nerv||surgic complic||rpa||surgic treatment||follow-up||studi||recurr||multinodular||lesion||pleomorph adenoma||clinic featur||surgeri||multipl lesion||signific||patient||period||risk||tumor||parotidectomi||nerv||case||type||postop radiotherapi||previou oper,1||2||2 3||result 1||3||refer 1||4 1 5 5||1 summari||33.3 1||30.0 1||2 cm||patient||4||22.2 fig. 1||studi,31046.0||28965.0||23004.5||18563.0||17044.0||16864.5||16177.75||15734.5||15558.5||15535.5||14720.5||13567.0||12937.0||12022.667||12015.0,0.0,0.0,0.13333333333333333
1031,Support_Care_Cancer-4-1-2206248.txt,cancer||spous||parent||health statu||report||group||male partner||relationship||score||studi||aim||parent cancer||treatment intens||total problem||recurr||psychosoci||time||qol||age||children||cancer patient||treatment||adolesc||patient||ill||problem||type||diagnosi||signific relationship||physic problem||norm||function,1||2||cancer 1||3||refer 1||1 34 2 35||2 descript||norm 2||qol 2||result particip 1 3||patient||4||studi||netherland 2 depart||colorect cancer 1 year,31046.0||28965.0||19061.0||17044.0||16864.5||15948.5||14657.5||14608.0||14557.5||14040.0||13567.0||12937.0||12015.0||11205.0||10456.0,0.0,0.0,0.13333333333333333
1032,Pediatr_Nephrol-3-1-1915619.txt,linkag||sampl||vur||children||marker||famili||gene||locu||role||result||linkag studi,2||1 1 depart||7 1||result 1||3||refer 1||famili 1||chromosom 1||1 onlin||1 gdnf||patient||studi||C. 1 van||netherland 2 depart||7 7 8 1 onlin,28965.0||21528.667||19021.5||18563.0||17044.0||16864.5||16458.0||15734.0||15732.5||15562.0||13567.0||12015.0||11511.667||11205.0||10322.6,0.0,0.0,0.0
1033,Pediatr_Radiol-4-1-2292498.txt,grade II||ultrasound contrast agent||durat||fundament imag||advers event||levovist||evalu||vcug||modal||contrast agent||posterior urethr valv||administr||urinari tract||vesicoureter reflux||microbubbl||studi||urethra||increas||imag||normal salin||bladder||children||vur||renal pelvi||grade||fundament mode||vu||harmon||reflux diagnosi||low diagnost accuraci||uca||intraves administr||procedur||examin||reflux||kidney||precontrast||cycl||result,1||2||2 3||1 fig. 1||refer 1||suppl 1||1 reflux||2 decemb||4||studi||thi||5||6||2005||2004,31046.0||28965.0||23004.5||22356.0||16864.5||15942.0||15671.5||14540.0||12937.0||12015.0||11251.0||10364.0||9074.0||8716.0||8077.0,0.0,0.1,0.06666666666666667
1034,Eur_Radiol-3-1-2077908.txt,pain||total||total size||associ||decreas||studi||progress||bme||diseas||time||lesion||imag||bone marrow edema-lik||grade||knee||bone||patient||OA||size||multipl joint site||chang||find||womac||cyst||anatom locat,1||1 2||2||result 1 2 1||2 year 2||3||refer 1||2 year||1 watt iain 1 1 depart||2 2 fig. 2a||nex 1||3 3 3 fig. 3||albinusdreef 2||nex 2||2 3 4 6 7 5,31046.0||30005.5||28965.0||24284.25||20395.333||17044.0||16864.5||16110.5||15950.0||15737.75||15525.5||14630.4||14485.5||14485.0||14230.167,0.0,0.0,0.0
1035,Eur_J_Clin_Pharmacol-3-1-2071966.txt,ineffect||effect||clinic practic||discontinu||advers event||antidepress||patient report||drug||spontan report||medicin||previou medic||hcp||treatment||system||experi||advers drug reaction||patient||natur||therapi||impact||issu||problem||inform||sexual problem||side effect||relev,1||2||3||experi 1||1 http://www.meldpuntmedicijnen.nl||2 relev||patient||4||e.r.heerdink@uu.nl 2 1 scienc shop||side effect 2||studi||1 van hulten||patient report system refer 1||appendix box 1||5,31046.0||28965.0||17044.0||16535.0||15524.0||14826.0||13567.0||12937.0||12490.2||12229.0||12015.0||10840.667||10816.8||10641.0||10364.0,0.0,0.1,0.06666666666666667
1036,Pharm_World_Sci-3-1-1915627.txt,daili clinic practic||europ||belgium||number||clinic practic||polypharmaci||atyp||combin||medic||countri||common practic||studi||antipsychot||frequenc||antipsychot agent||antipsychot polypharmaci||anticholinerg||patient||larg number||hospit pharmacist||data||result,1||2||3||1 number||refer 1||1 1 symfora group||part 1||germani 1||2007 introduct 1 2 3 7||31-33-4609553 wj.broekema@symfora.nl 1 2||patient||4||2 12 14 3 7||studi||1 van harten,31046.0||28965.0||17044.0||17008.0||16864.5||16742.25||16058.5||15869.5||15439.5||15003.25||13567.0||12937.0||12631.0||12015.0||10841.333,0.0,0.0,0.13333333333333333
1037,Pediatr_Nephrol-3-1-1805051.txt,iron statu||effect||inflamm||ascorb acid||advers event||erythropoiesis-stimul agent||acut||iron supplement||hemodialysi||vitro studi||esa therapi||iron||studi||hemoglobin level||esa||absolut||increas||iron storag||erythropoiet respons||children||kidney function||patient||therapi||end-stag renal diseas||guidelin||anemia||ferritin||parenter iron prepar||esrd||oxid stress||chronic kidney diseas||intern recommend||intraven iron,2||1 year||3||refer 1||patient||studi||40 1 41||2006||adult patient||compar studi||2002||dialysi patient||effect||ckd patient||hemodialysi patient,28965.0||17151.0||17044.0||16864.5||13567.0||12015.0||11579.333||8371.0||7484.0||7344.5||7057.0||6956.0||6956.0||6905.5||6859.0,0.2,0.2,0.2
1038,Behav_Brain_Res-2-1-2424131.txt,light||choic||disconnect lesion||effect||weber fraction||sham-les group||acbc||group||callosotomi group||behaviour||delay||lamp||linear indiffer function||delay discount||prefer function||phase||signific differ||orbit prefront cortex||lesion||experi||lever||size||callosotomi||reinforc||curv||sucros solut||trial||rat||data||inter-tempor choic||result||opfc,1||1 1||2||2 2 2 2||fig. 1||3||fig. 2||2 method||1 week||2 min||phase 2||4||NJ fig. 1||fig. 1 ɛ||fig. 3,31046.0||31046.0||28965.0||28965.0||18011.0||17044.0||16970.5||16318.5||16140.5||15117.5||14954.5||12937.0||12138.667||12014.333||11010.0,0.0,0.0,0.0
1039,Med_Biol_Eng_Comput-4-1-2329737.txt,vivo||receptor||respons||exercis||myocardi infarct||product||channel||influenc||endotheli dysfunct||flow perturb||adenosine-medi vasodil||coronari circul||decreas||coronari blood flow||vasodil influenc||coronari resist vessel||coronari vasculatur||activ||heart failur||hypertrophi||coronari arteriol||adenosin||dysfunct||vasodil||swine||coronari vasoconstrict||find||parasympathet control||LV dysfunct||myocardi oxygen balanc||heart,1 2 1||2 2||2||1 2 receptor||refer 1||max 2 fig. 2||2 71||2 balanc||patient||23 1 23||tonino PA 2||type 1 receptor mrna||3 week||2005||2006,30352.333||28965.0||28965.0||21171.333||16864.5||15846.25||14889.0||14639.5||13567.0||12340.667||9913.667||9475.25||9139.5||8716.0||8371.0,0.0,0.0,0.0
1040,Bioinformation-2-1-2139988.txt,literatur||databas||inform||medicin plant||diabet||antimicrobi properti||plant,1 2 3 4 5||step 2||diab figur 1||methodolog step 1||step 3||figur 1 momordia charantia||effect treatment||treatment||develop||research||antioxid effect||antimicrobi effect||antidiabet effect||plant control||inform,20071.2||14763.0||10752.0||10638.667||8802.5||8062.25||5984.0||5012.0||3750.0||3708.0||3555.0||3507.0||3484.5||3446.5||3440.0,0.0,0.0,0.06666666666666667
1041,Cult_Med_Psychiatry-2-2-1705533.txt,cultur||muslim world||marriag||lebanon||practic||person commun||jewish man||donat||infertil father||lebanes ivf clinic||ivf||infertil muslim||coupl||third-parti donat||infertil husband||gamet||countri||ayatollah khamanei||recent year||infertil coupl||medic anthropolog||anonym donor||sperm donat||sperm||moral||law||fatwa||regard||technolog||islam||debat||iran||muslim marriag||children||embryo||women||ethnograph research||middl eastern region||scienc||muslim||gamet donat||patient||world||local moral world||adulteri||donor gamet||egg||muslim middl east||global,1||2||minhorn@umich.edu 1 2 1 director||3||march 2||patient||4||2004 2004 2 majli||usa 2 depart||5||6||2005||2005 2006 2004||2006||2004 2004,31046.0||28965.0||18226.2||17044.0||14558.5||13567.0||12937.0||11280.0||11119.0||10364.0||9074.0||8716.0||8388.0||8371.0||8077.0,0.0,0.1,0.06666666666666667
1042,Osteoporos_Int-4-1-2358936.txt,progress deform||lumbar spine||suggest||popul||vertebr deform||group||GC therapi||measur||studi||diseas||increas||deform||fractur||follow-up period||preval deform||progress vertebr deform||hip||age||ictp||women||grade||baselin||bone||patient||multivari logist regress analysi||risk||bone miner densiti||bone turnov||subject||method||bmd||low-norm bmd||gc||bone resorpt||data||sarcoidosi||year,1||2||1 5||1 fig. 1 arrow||refer 1||1 baselin||S. P. 1 1 depart||patient||3 17 3||studi||31-413-381354 caroline@heesen.eu 1 2 drent||netherland 2 depart||C. 1 wolffenbuttel||5||2 bmd variabl,31046.0||28965.0||20705.0||16937.25||16864.5||15869.5||13850.0||13567.0||12557.0||12015.0||12004.2||11205.0||11021.0||10364.0||10238.333,0.0,0.2,0.13333333333333333
1043,Histochem_Cell_Biol-4-1-2386530.txt,motil||mechan||ciliopathi||mous||human diseas||flow||signal||protein||tissu||studi||structur||diseas||electron microscop studi||basal bodi||ciliogenesi||defect||mutat||cilia||ciliari membran||cell biologist||primari cilia||function,1||stchristensen@bio.ku.dk 2 1 depart||2 motil||cell||studi||1 46 satir||NY usa 2 depart||2004 2006 2005||2006||cell signal||2006 2003 1999 2005||biophi biochem cytol 1956 2 4||2007||2007 2007||2007 2007 2007,31046.0||15626.5||14538.0||12627.0||12015.0||10794.0||8402.75||8388.0||8371.0||7464.0||7383.25||7317.333||7287.0||7287.0||7287.0,0.2,0.1,0.06666666666666667
1044,BMC_Med_Educ-4-_-328087.txt,learn||opportun cost||knowledg base||faculti time||web-bas resourc||core||inform explos||knowledg manag||develop||medic school||medic educ||teach||today||educ activ||student||inform manag||knowledg||train||challeng||factual||problem||trend||doctor||pbl||teacher||graduat,1 repstein@hku.hk 1 depart||patient||studi||figur 1 comparison||effect||interview studi||2 princ KJ van mameren||2000||activ||1999||gene||health care||patient awar programm||20||human,16146.75||13567.0||12015.0||11299.667||6956.0||6186.0||6150.0||5903.0||5231.0||4795.0||4794.0||4689.0||4674.667||4417.0||4229.0,0.0,0.0,0.0
1045,J_Med_Internet_Res-4-1-1761926.txt,model||framework||abil||evalu||health care profession||solut||multi-rat kappa||internet-bas diabet manag||more-complet solut||health inform||lifemast||posit effect||diabet||health care||blood glucos level||articl||diseas||technolog||web site||system||inform deliveri||patient||internet||mydiabet||user||commun||manag||search||site||inform||data||level||relev||criterion||highest level||result||document,1||1 1||1 4 1||2 1 1 3 4||3 1||3 2||4 2||3||2 model||tabl 2||1 faculti||novemb 1||2 site||patient||patient patient,31046.0||31046.0||25009.667||24207.6||24045.0||23004.5||20951.0||17044.0||16428.0||16290.5||15624.0||15566.0||15517.5||13567.0||13567.0,0.0,0.0,0.06666666666666667
1046,Int_Arch_Occup_Environ_Health-4-1-2413125.txt,studi popul health promot||older age||abil||variabl||dimens||factor||influenc||score||wai||associ||measur||studi||regard||self-develop||work||higher score||increas||multivari model||oldest age group||age||health||life||mental health||stress life event||psychosoci factor||life style||work abil||stress handl||physic activ||event||determin||result||lower regress coeffici||year||work-rel factor||demand||lack||white-collar worker,"1||1 2||2||result 1||3||1 characterist||1 min||version 2||2 max||5.3 2||2 elder||1,134 2||4||31-10-4638474 a.burdorf@erasmusmc.nl 1 1 depart||A. M. 1",31046.0||30005.5||28965.0||18563.0||17044.0||16168.5||16158.0||14727.0||14722.0||14539.0||14501.5||14483.0||12937.0||12918.0||12768.0,0.0,0.0,0.0
1047,Behav_Processes-2-1-2396234.txt,respons||male||sex||open field||head-dip behaviour||area||anim||valid measur||behaviour||previou studi||research||measur||rodent||studi||time||neophilia||increas||explor||object||head-dip||frequenc||hole||exposur||hole-board||central area||locomot||apparatu||trial||rat||presenc||mice||avers condit||environ||result,"fig. 1||tabl 1||fig. 2||trial 1||2 materi||studi||1,14 tabl 1||fig. 3||5||post hoc fig. 1||2005||2006||2004||3 result 3.1||2003",18011.0||17331.0||16970.5||16639.0||15325.0||12015.0||11556.333||11010.0||10364.0||9103.5||8716.0||8371.0||8077.0||7788.333||7651.0,0.0,0.1,0.06666666666666667
1048,J_Med_Internet_Res-7-3-1550657.txt,buzz index||internet user||common cancer||cancer||month||news media||news coverag||search activ||popul||neoplasm||health inform||media coverag||breast||yahoo||score||interest||studi||term||time period||test||internet||incid||user||search engin||cancer search activ||method||specif cancer type||news||onlin inform||health,1||2||tabl 1||3||1 divis||januari 1||1 million||figur 1 2003||4||1 jansen jim 2 yahoo||studi||tabl 2 spearman||1 million user||5||1 mallon kenneth,31046.0||28965.0||17331.0||17044.0||15662.5||15588.0||15588.0||13299.333||12937.0||12040.0||12015.0||10876.0||10672.0||10364.0||10359.333,0.0,0.0,0.06666666666666667
1049,Lipids-3-1-2039812.txt,intervent||vivo||effect||medium||fatti acid||inflamm||intestin inflamm||concentr||cytokin||fatti acid composit||protein||fish oil||proport||express||isotype-match control antibodi||temperatur||activ||epa||patient||section||ibd||fatti acid incorpor||cell||data||human||caco-2 cell||ara||result,1||2||phospholipid 1 1||1 express||3||fig. 2||refer 1||0.004 1 1 36 fig. 1||2 measur||4 2 fig. 3||1 mg||1 fatti||protocol 2||patient||4,31046.0||28965.0||20706.0||17720.5||17044.0||16970.5||16864.5||16660.0||16500.5||15980.5||15945.0||15636.0||14831.0||13567.0||12937.0,0.0,0.0,0.06666666666666667
1050,Ann_Hematol-3-1-2082654.txt,diagnost||peripher blood||molecular diagnost||detect||cimf||cml||bone marrow||criteria||cel||cytomorpholog||molecular character||mutat||disord||cytogenet||cmpd||neg cmpd||tyrosin kinas||case||allogen hematopoiet stem cell transplant||diagnosi||classif||chronic myelomonocyt leukemia,2||3||refer 1||patient||4||cell||studi||cmpd 1 bcr||5||jak2 1 5 10 bcr||abl fig. 1 bcr||germani 2 stem cell transplant||2005||2006||4 year,28965.0||17044.0||16864.5||13567.0||12937.0||12627.0||12015.0||10384.0||10364.0||9705.2||9150.5||8753.6||8716.0||8371.0||8096.5,0.0,0.0,0.0
1051,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2413124.txt,differ||complic||hospit||pdr||advers event||anti-glaucoma eye drop||group||sampl size||order||factor||retin break||retin detach||analysi||eye||signific differ||studi||intravitr TA inject||diseas||convent ppv group||endophthalm||surgeri||intra-op complic||final examin||visual acuiti||patient||incid||addit surgeri||prolif vitreoretinopathi||event||case||diagnosi||ppv,1||2||1 year||3||refer 1||2 tabl 2 factor||1 month||1 week||patient||tabl 1 diseas||4||3 tabl 3||2 13 13||studi||eye 1 fig. 1 TA ppv,31046.0||28965.0||17151.0||17044.0||16864.5||16497.5||16322.0||16140.5||13567.0||13270.333||12937.0||12568.0||12496.333||12015.0||11362.333,0.0,0.1,0.13333333333333333
1052,J_Neurooncol-3-1-1915654.txt,hemangioblastoma||von hippel-lindau diseas,1||2||J. 1 1||2 refer 1||2 van||patient||netherland 2 depart||31-402-465512 monique.hanse@cze.nl 1 3 vincent||3 month||netherland 3 depart||result||treatment||8 mg||30||molecular analysi,31046.0||28965.0||21960.333||20898.0||15219.5||13567.0||11205.0||9633.0||9321.0||7231.333||6080.0||5012.0||3499.0||3267.0||3193.5,0.0,0.0,0.0
1053,Int_J_Colorectal_Dis-3-1-2077921.txt,artifici bowel sphincter||anal sphincter defect||treatment||implant||system||follow-up||problem||procedur||case||institut||data||dgp||patient||studi||infect||faecal incontin||anal manometri||placement||result,1||2||result 1 2||2 fig. 1||3||refer 1||1 aetiolog||radiotherapi 2||patient||4||31-43-3875473 c.baeten@surgery.azm.nl 1 1 depart||studi||nerv evalu 1||netherland 2 depart||5,31046.0||28965.0||22030.333||21662.333||17044.0||16864.5||15571.0||14619.0||13567.0||12937.0||12917.8||12015.0||11342.333||11205.0||10364.0,0.0,0.1,0.13333333333333333
1054,Dev_Genes_Evol-4-1-2292473.txt,organ||constraint||insect||beeman||insight||breakpoint||transcript||artifact||sequenc||singl imag||analysi||regulatori element||hox cluster||express||element||gene||cluster||hox||complex||homc||data||embryon develop||region||hox gene||result||function,1||1 1 divis||2007 2||studi||1 5 beeman richard||1 denel robin||2006||2005 2007||1 r17 r29 10.1093||3 levin michael 2 brown susan||2003||cell biolog||KS 66506 usa 2 depart||futur studi||result,31046.0||20790.333||18126.0||12015.0||10393.0||10369.0||8371.0||8001.5||7964.5||7805.167||7651.0||7089.5||6720.6||6447.5||6080.0,0.0,0.0,0.06666666666666667
1055,Matern_Child_Health_J-2-2-1592156.txt,cytomegaloviru||educ||cmv||toxoplasmosi||normal immun function||pregnanc||transmiss||birth||diseas||listeria||age||women||viru||infect||risk||pregnant women||food||preconcept care||human||rate||listeriosi,1||1 2 2||2||refer 1||age 1 year||mlynch1@cdc.gov 3 1 center||1 3 4 T. gondii T.||5||effect studi||6||2005||2004||dross3@cdc.gov 1 jone jefferi||jljones@cdc.gov 2 lynch michael||6 9 toxoplasma toxoplasma toxoplasma 2,31046.0||29658.667||28965.0||16864.5||12622.333||12428.75||10719.5||10364.0||9485.5||9074.0||8716.0||8077.0||7871.0||7292.5||7260.5,0.0,0.0,0.0
1056,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2413123.txt,shape||len||precis||refract properti||equival refract index||refract index||endogen insulin level||hartmann-shack aberrometri||hyperop shift||order||ocular paramet||blood glucos||measur||eye||ogtt||ocular refract||studi||increas||healthi human eye||refract error||hyperglycemia||chang||subject||glucos||procedur||higher order aberr,2||result 1 fig. 1||refer 1||subject 1||1 2 polak bettin||patient||2 len 3 fig. 2 len||studi||2 3 ringen peter||netherland 2 institut||31-20-4441015 ngm.wiemer@vumc.nl 1 2 eekhoff elisabeth||11 4 5||0 fig. 3||10 24 29 32 1||3 30 len 4,28965.0||18287.0||16864.5||16465.0||15007.25||13567.0||13355.667||12015.0||11569.25||10854.667||10008.167||9450.667||9371.0||9153.2||8335.0,0.0,0.1,0.06666666666666667
1057,Med_Biol_Eng_Comput-4-1-2329731.txt,nois||algorithm||tool||local deform||matrix remodel||specif cell||techniqu||singl smooth muscl cell||analysi||stage||imag analysi||cross-correl||studi||compact||consecut imag||time||imag||deform||experi||direct CC||coat||method||pixel||matrix element||cell||standard deviat||case||collagen deform||decomposit CC,1||2 1||2 2||2||bottom 2 2||refer 1||1 set||box 1||2 fig. 2 top||cc 1||1 768||2 characterist||2 2 4 fig. 4 top||patient||4,31046.0||30005.5||28965.0||28965.0||19362.0||16864.5||16249.0||15840.0||15791.5||15548.5||15546.0||15128.0||14840.0||13567.0||12937.0,0.0,0.0,0.0
1058,Bioinformation-2-2-2174422.txt,databas||sequenc||centromer||inform||cell||data||protein||entri||teck databas||chromosom||telomer,1 2 3 4 5||cell||refer 1 hiyama||cancer||10||protein||8 9||methodolog 6 7||data||function||control||protein databas||age||inform||2007 biomed informat publish group 2007,20071.2||12627.0||11244.0||7076.0||6982.0||6288.0||5773.0||5460.0||4969.0||4581.0||4404.0||3655.5||3565.0||3440.0||3429.667,0.2,0.3,0.26666666666666666
1059,Ann_Surg_Oncol-3-1-2077910.txt,addit investig||ovarian cancer||cancer||complic||metastat diseas||number||malign find||breast cancer||group||breast||follow-up||signific differ||reconstruct||studi||prophylact surgeri||standard procedur||primari BC||age||mutat||women||famili||institut||mastectomi specimen||mastectomi||decis||histori||risk||fnac||risk carrier||microscop examin||care histolog examin||find||examin||prophylact mastectomi||pm||hereditari BC||data||hereditari breast cancer||pbso||year||relev data,1||2||tabl 1||3||refer 1||tabl 2||PM 1||1 fig||pneumothorax 1||1 complication.||2 mutat||patient||2 patient breast cancer||4||result studi popul 1,31046.0||28965.0||17331.0||17044.0||16864.5||16290.5||15785.0||15559.5||15532.5||15523.5||15116.5||13567.0||13078.5||12937.0||12731.0,0.0,0.0,0.0
1060,Exp_Brain_Res-3-1-2080346.txt,organ||flexion||experiment trial||movement trajectori||present experi||global track behavior||effect||extens||veloc profil||phase space||musculoskelet factor||variabl||form||target||extens excurs||visuo-motor track||phase||feedback signal||analysi||wrist postur||particip||shorter||point||endpoint variabl||maxim extens||wrist||direct||present studi||musculoskelet underpin||peak veloc||stroke patient||harmon||maxim flexion||global kinemat||anchor||dynam||full track trajectori||find||trial||execut||coordin dynam||region||cycl,1||2 2||2||5 1||7 1||1 result||3||tempor 1||tempor 4 1||circl 2||4||1994 1994 1995 1 fig. 1||3 3 fig. 3 rectangl 3||2 1999 1988||4 2005,31046.0||28965.0||28965.0||20705.0||19021.5||18563.0||17044.0||15769.0||14825.0||14598.5||12937.0||12367.667||12195.667||11596.333||10826.5,0.0,0.0,0.0
1061,Appl_Microbiol_Biotechnol-4-1-2270352.txt,biomass||medium||product||total||hydrochlor acid||mol||supernat||lactic acid||hydrolysi||phase||lactic acid product||enzym||process||organ acid||lime||addit||ferment||glucan||monomer sugar||fed-batch phase||polysaccharid||ltw||amount||wheat straw||lime-tr wheat straw||pH control||pretreat||calcium hydroxid||ssf||result,1||1 1||2||2 3 3 3||tabl 1||3||3 3||2 suspens||31-317-475347 ruud.weusthuis@wur.nl 1 1 agrotechnolog||A. 2 visser diana 2||studi||1 B. coagulan||1 bakker robert||1 jansen mickel||fig. 1 schemat represent,31046.0||31046.0||28965.0||20024.25||17331.0||17044.0||17044.0||14526.0||12420.4||12312.2||12015.0||10802.0||10472.667||10378.667||9062.0,0.0,0.0,0.0
1062,Virchows_Arch-4-1-2329735.txt,statist signific||tissu microarray||genet||intestin||emmprin||periton||group||MT case||liver metastasi||venou invas||compon||analysi||high level||carcinoma||studi||invas||present studi||high stage||express||gastric carcinoma||lymph node metastasi||patient||muc2||lymph node||find||case||diffus part||cell adhes||mix type||type||diffus compon||classif||diffus distribut||patholog characterist,1||2||1 fig. 1||0 2 2 0||3||refer 1||3 5 2 8||IV 4 1||patient||2 0 4 9||4||4 3 3 18||studi||tabl 2 comparison||5 fig. 3,31046.0||28965.0||22356.0||17529.0||17044.0||16864.5||15631.75||14757.667||13567.0||13346.75||12937.0||12738.5||12015.0||11411.0||10794.667,0.0,0.1,0.13333333333333333
1063,Clin_Oral_Investig-4-1-2238786.txt,oral health||current diagnost criteria||index||occlus||wear||surfac||factor||basic eros wear examin||develop||criteria||eros tooth wear||research||dental eros||dental clinician||studi||condit||progress||clinic phenomenon||lesion||age||defect||eros||diagnost criteria||tooth wear||exposur||dental practic||tooth morpholog||eros challeng||valid||capabl||preval||case||eros index||intern basi||lesion characterist||diagnosi||loss||tooth||result,1||1 2||2||3||refer 1||http://www.who.int/oral_health/media/en/orh_report03_en.pdf 1||patient||4||studi||norway 2 univers||5||6||compar studi||7||effect,31046.0||30005.5||28965.0||17044.0||16864.5||15523.5||13567.0||12937.0||12015.0||10895.333||10364.0||9074.0||7344.5||6997.0||6956.0,0.0,0.1,0.06666666666666667
1064,Virchows_Arch-4-1-2233709.txt,gastriti||tissu microarray||parafibromin||gastric tumour||cell line||depth||multivari analysi||tumour size||progress||studi||antibodi||invas||adenoma||express||independ prognost factor||pathogenesi||parafibromin express||gastric carcinoma||patient||section||prognosi||tumour tissu||larg tumour||line||surviv rate||metastasi||downregul parafibromin express,1||1 2||2||fig. 1||3||3 3||fig. 2||1 min||cultur 2||carcinoma cell line 1 2||2 relationship||pH 2||patient||4||cell,31046.0||30005.5||28965.0||18011.0||17044.0||17044.0||16970.5||16158.0||15060.0||15052.8||15000.0||14720.5||13567.0||12937.0||12627.0,0.0,0.0,0.06666666666666667
1065,Arch_Dermatol_Res-4-1-2254658.txt,peripher blood||skin||differ||absolut number||moderate-to-sever diseas||percentag||mild psoriasi||total lymphocyt||pasi-scor||blood||ratio||analysi||psoriasi||studi||rel under-represent||diseas||mild diseas||increas||lesion||present studi||normal subject||lymphocyt||patient||subset||mild||subject||moderate-to-sever psoriasi||cell||sever form||result,1||2 3 fig. 2||result 1||fig. 1||3||refer 1||1 demograph||2 week||patient||cell||studi||1 blood withdrawn||fig. 3||21 22 2 10||5,31046.0||19987.5||18563.0||18011.0||17044.0||16864.5||15622.5||15100.0||13567.0||12627.0||12015.0||11024.333||11010.0||10602.75||10364.0,0.0,0.2,0.2
1066,Eur_J_Pediatr-3-1-2151775.txt,effect||secondari case||dose||report||order||administr||surveil||oral||infant||current incid||birth||vkdb||late vkdb||studi||netherland||breastf infant||age||current dutch guidelin||week||incid||newborn||paediatr||case||data||cholestat liver diseas||prophylaxi||netherland paediatr surveil unit,1 1||1||1 1 1||2||1 1 1 3||1 1 1 29||1 1 1 9 1 daili||1 1 depart||springer-verlag 2007 1 1 1||1 year||3||refer 1||1 januari||5 1 4 18||4,31046.0||31046.0||31046.0||28965.0||27545.5||23852.0||21697.833||21528.667||20405.8||17151.0||17044.0||16864.5||15588.0||14569.0||12937.0,0.0,0.0,0.0
1067,J_Neurooncol-4-1-2174520.txt,strategi||glioblastoma||effect||medium||trail||dna-depend protein kinas||activ||flow cytometri||cell||synergist effect||studi||non-chemotherapeut agent||report||agent||lovastatin||apoptosi||combin||dna fragment,2||1 1 fig. 1||2 2 2 fig. 2||3||refer 1||1 min||2008 introduct 1 2 3||0 1 28 0 1||2 min||2 μg||cell cultur 2||4||cell||studi||2007 0 1 arrest,28965.0||24528.5||24167.2||17044.0||16864.5||16158.0||16078.8||15345.4||15117.5||14685.0||14249.0||12937.0||12627.0||12015.0||11134.25,0.0,0.0,0.13333333333333333
1068,Ann_Surg_Oncol-3-1-1914261.txt,melanoma patient surviv||narrow excis biopsi||re-excis specimen||df||melanoma||import confound||group||influenc||primari melanoma||wide excis biopsi group||tumor cell||breslow thick||studi||diagnost biopsi type||invas||age||surviv||re-excis||lymphat invas||primari melanoma site||SN statu||patient||incis biopsi||site||unknown||type||posit margin,1||2||1 patient||1 4||tabl 1||refer 1||2 system||tabl 2||surviv 2 tabl 1||stage 1||0.001 1||1 153||0.004 1||surviv 2||2 mm,31046.0||28965.0||22306.5||21991.5||17331.0||16864.5||16324.5||16290.5||16211.0||16110.5||16095.5||15663.0||15584.5||15091.0||14896.0,0.0,0.0,0.0
1069,Osteoporos_Int-4-1-2277446.txt,day||effect||home||month||dose||bone turnov marker||calcium supplement||group||pth||phosphat||administr||decreas||studi||calcium intak||particip||serum 25||increas||random clinic trial||serum pth||secondari hyperparathyroid||baselin||nurs staff||placebo||monthli administr||calcium||daili administr||level||nurs home||result,1||2 2||2||0 1 2||1 2 wijnhoven||3 tabl 2 0 1 2||refer 1||Dw 1||tabl 1 0 0 2||discuss 2 3 4||2 week||calcium 2||Ca 2||2 lip||patient,31046.0||28965.0||28965.0||22034.667||20005.333||19288.167||16864.5||15533.5||15162.6||15161.75||15100.0||14856.0||14588.5||14521.5||13567.0,0.0,0.0,0.0
1070,Mol_Imaging_Biol-3-1-1915656.txt,rel lesion detect||elig studi||specif||test accuraci||meta-analysi||refer test||transmiss||review||studi||index test||articl||methodolog qualiti||imag||lesion||oncolog patient||fdg||tomographi||sensit||elig||patient||nac imag||AC imag||fr-pet||attenu correct||data||lesion detect||dual-head coincid pet||positron emiss tomographi||systemat review||result,1||2||1 1 depart||3||refer 1||2 tabl||1 cm||conting 2||non-attenuation-correct 2||patient||methodolog qualiti assess 1 2||4||studi||1 methodolog assess||2 qualiti assess,31046.0||28965.0||21528.667||17044.0||16864.5||16290.5||15761.0||14491.5||14483.5||13567.0||13049.6||12937.0||12015.0||11437.667||11297.667,0.0,0.1,0.13333333333333333
1071,J_Biol_Inorg_Chem-3-1-2099461.txt,formaldehyd oxidoreductas||substrat||high concentr||formaldehyd||valu||benzyl viologen||singl broad line||pre-steady-st kinet||enzym||visibl spectrum||data||concentr||wavelength||pre-steady-st data||reaction||electron acceptor||ferredoxin||substituted-enzym mechan,1||2||2 1 2 3||1 10 1||2 5 2||1 21 2||1 6||1 10||1 20||1 13||tabl 1||3||refer 1||1 materi||2 21,31046.0||28965.0||26505.0||23024.667||22764.667||21097.333||20060.0||19014.0||17731.5||17654.0||17331.0||17044.0||16864.5||16365.5||16123.0,0.0,0.0,0.0
1072,Virchows_Arch-3-1-1888718.txt,malign lymphoma||tcrbcl||diagnost algorithm||lymphoma||immunohistochemistri||pcr||liver biopsi||extranod site||studi||anaplast larg cell lymphoma||margin zone lymphoma||pattern||dlbcl||differenti diagnosi||lymphoma cell||frequenc||infiltr pattern||infiltr||addit biopsi||liver||site||entiti||extranod lymphoma||molecular analys||case||diagnosi||classif||biopsi||hepat lymphoma involv,1||1 1 2||2||3 2||1 1 3 1 3 0||1 8 1 6||0 3 3 2 2 3||1 2 7 0 6 1||1 1 0 0 1 0||1 2 4 mzl||1 11||3||4 2 6||refer 1||1 42,31046.0||30352.333||28965.0||23004.5||22219.833||19330.0||19192.5||18870.167||18569.5||18237.75||18048.5||17044.0||16992.0||16864.5||16266.0,0.0,0.0,0.0
1073,Purinergic_Signal-4-2-2377317.txt,major mechan||mechan||concentr||exocytosi||nucleotid||uridin nucleotid||rel abund||udp||cell surfac hydrolysi||hypoton shock||studi||plasma membran||intracellular calcium||releas mechan||Ca||calcium-depend exocytosi||experi||perfus||nucleotid speci||fluoresc||adenosin||cell||uridin triphosph||result||nucleotid releas||hypoton solut,1||2||2 2||1 8 1||fig. 2 2||1 9 10 1||10 2||3||3 1 4 7||refer 1||nucleotid releas 1 1 fig. 1||discuss 1||2008 introduct 1 3 4 1||1 pmol||fura-2 calcium measur 2 2 2,31046.0||28965.0||28965.0||22748.667||20968.667||18616.5||17973.5||17044.0||17006.0||16864.5||16594.833||16373.5||15902.0||15542.0||15281.667,0.0,0.0,0.0
1074,Eur_Arch_Otorhinolaryngol-3-1-1914238.txt,cancer||troubl||pain||tumor site||hrqol||oral tumor||tongu||gener popul||function deficit||teeth||score||singl item||studi||speech||function statu||tongu mobil||qualiti||present studi||treatment||oral caviti||comorbid||patient||major impact||ill||impact||wors score||qlq-h||neck cancer||classif||result||function,1||2||3 2||1 16||3||refer 1||2 35||4 3||2a 2||springer-verlag 2007 introduct 1 2||result sampl descript 1 2||patient||4||studi||tabl 1 characterist,31046.0||28965.0||23004.5||17498.5||17044.0||16864.5||15480.0||14990.5||14505.0||14040.0||13761.2||13567.0||12937.0||12015.0||11984.333,0.0,0.0,0.13333333333333333
1075,Diabetologia-3-1-1975734.txt,vivo||insulin storag||gene therapi||beta cell transcript factor||normal pancrea||hepatocyt||pancreat beta cell||lentivir vector||intraven glucos toler test||group||transduct||anim||vitro||insulin||diabet||studi||transduct effici||express||gene||ins-fur||type 1 diabet||physiolog glucos control||lentivir deliveri||diabet mice||liver||procedur||cell||rat||ffo||partial hepatectomi||long-term transgen express||deliveri,"1||2||2 2 2||3 1 1 5 fig. 1||stz-diabet 2 2 fig. 2||group 1||group 2||refer 1||ann.simpson@uts.edu.au 1 1 depart||experi 1 1 d,e||2 23||1 wei||1 o’brien||insulin-promoter-factor 1||2 min",31046.0||28965.0||28965.0||20920.333||18374.4||17960.5||16920.0||16864.5||16146.75||16032.25||15976.5||15559.5||15552.5||15523.5||15117.5,0.0,0.0,0.0
1076,Environ_Manage-4-1-2242854.txt,stream||differ||scale||land||effect||high flow||total||watersh manag||concentr||correl||varianc||stream size||spatial scale||entir watersh||influenc||first-ord||total nitrogen||downstream water qualiti||water qualiti||downstream reach||previou studi||surfac water chemistri||water chemistri||studi||watersh||sampl||analys||ecoregion||signific predictor||riparian zone||riparian||annual water volum||total phosphoru||site||nutrient||data||relationship||land cover||result,1||2||1 3||3 2||2 3||1 2 1 divis||3||2 valu||2 month||2 2000 2001 fig. 2||4 3||2 horton||chemistri relationship 1 3 3||4||2007 3,31046.0||28965.0||24045.0||23004.5||23004.5||22834.0||17044.0||15845.0||15281.5||15024.4||14990.5||14494.5||13299.0||12937.0||12165.5,0.0,0.0,0.0
1077,Glycoconj_J-4-1-2234451.txt,cell wall||bind||carbohydr microarray||materi||specif||probe||plant||polym||order||hybridoma line||analysi||hierarch cluster||hybridoma supernat||antibodi||sampl||plant cell wall||array||pectic side chain||monoclon antibodi||epitop||agp||glycan||mab||cell,1||2||array 2 2 2 2||analysi 1 1 2 5||box 1 2 3 4 1||3||fig. 2||refer 1||array 2 4 2 4||2 1 fig. 3 probe||2 sampl||45-35322132 willats@my.molbio.ku.dk 1 1||langebrogad 1||4||29 3 2 30,31046.0||28965.0||23229.6||21221.6||20278.667||17044.0||16970.5||16864.5||16818.4||16494.2||15665.0||15523.5||15523.5||12937.0||12886.5,0.0,0.0,0.0
1078,Environ_Manage-3-1-2094719.txt,stone line||wide-scal impact||tool||project||extens||bolivia||bolivian mountain valley||natur resourc manag||practic||rural poverti||cl||particip rate||villag||zimbabw||group||order||rural villag||farmer group||strategi||approach||experiment||develop||institut level||sustain||ex-post evalu||swc practic||project withdraw||particip||farmer contest||local institut||mainten||activ||famili||swc||paper||farmer-to-farm train||knowledg||widespread sustain result||solid foundat||impact||farmer||train||train activ||contest||conserv leader||rural develop||soil manag practic||farmer-bas extens||sustain develop,1||2||3||2 year||volum 1||2 show||2 percentag||documento 2||3 2000 3||2005 1991 2||4||studi||4 2005||3 qualiti||2005 3 show,31046.0||28965.0||17044.0||16110.5||16007.5||15603.0||14742.0||14483.0||13330.333||13065.667||12937.0||12015.0||10826.5||9507.0||9333.667,0.0,0.0,0.0
1079,J_Chem_Ecol-4-1-2373416.txt,polar fraction||hymenoptera||postpharyng gland||femal european beewolv||european beewolf||strohm||unsatur||group||sphecida||secret||alken||crabronida||proport||keton||compound||ppg||hydrocarbon||individu||femal||gc-ftir||chemic composit||type||herzner||extract||function,1||1 1||2||2 fig. 2||ppg 1 1||valu 1||chemic dimorph 2 2||2 df||2001 1998 1||4||studi||germani 2 depart||method sampl 2 2007||ion 1 1400||2 P. triangulum,31046.0||31046.0||28965.0||20968.667||20704.0||16885.5||14623.5||14557.0||13865.0||12937.0||12015.0||10717.333||10572.25||10477.333||10330.667,0.0,0.0,0.0
1080,Photosynth_Res-3-1-1779625.txt,rate||cylind||mixtur||sugar phosphat||filter membran||work-up||octulos||solut||analysi||intern standard||metabolit||present||membran||incorpor||time||mox-tm deriv||valu||sugar||photosynthesi||carbon||experi||dri nitrogen||apparatu||glucos||chloroplast||oxygen electrod||water||extract||label||dephosphoryl step,1||1 2 2 2||2||2 3||1 2 2 evolut||2 2 2001||1 3 13 4 2 1||13 2 2||3 3 3 2||2 5||13 2 2 2 2001||3||13 2||13 2 2 13||1 2 3 13 1980,31046.0||29485.25||28965.0||23004.5||22338.0||21414.333||20883.333||20730.667||20024.25||19664.5||19494.0||17044.0||16613.5||16613.5||16354.2,0.0,0.0,0.0
1081,Transgenic_Res-4-1-2268725.txt,periton lavag||skin||bac||mast cell||cre||transgen mice||cell||eyfp||mice||gene,1||2||3||1 primer||2 mg||49-221-4785949 axel.roers@uni-koeln.d 1 1 depart||cell||mcpt5-cre rosa26 eyfp 2 fig. 2||5||germani 2 faculti||a-mcpt5-cr rosa26-eyfp 2||minim vector fig. 1||2005||cell factor||2004,31046.0||28965.0||17044.0||15633.5||14904.5||12917.6||12627.0||10488.833||10364.0||9953.333||9658.333||9527.75||8716.0||8535.5||8077.0,0.0,0.1,0.06666666666666667
1082,Neurosurg_Rev-3-1-2077911.txt,complet resect||fmm||bone resect||vertebr arteri||difficulti||VA transposit||nerv root||meningioma||approach||dura||lower part||occipit bone||anatomi||studi||head||foramen magnum||spinal cord||craniocerv junction||point||literatur||lesion||surgic strategi||FM meningioma||exposur||patient||resect||FM area||tumor||surgic approach||drill||arteri||branch||nerv||lower cranial nerv||case||VA damag||import vascular structur||rate||atla||skull base surgeon||occipit condyl,1||2||2 fig. 2||3||refer 1||2 15||1 review||100 1||11.80 1||1 3 5 55||suppl 2||vol 2||book 2||patient||process fig. 1,31046.0||28965.0||20968.667||17044.0||16864.5||16771.0||16648.0||16641.0||15524.5||14921.25||14901.5||14569.5||14532.0||13567.0||12652.667,0.0,0.0,0.06666666666666667
1083,Planta-4-1-2270913.txt,author||ethephon||salicyl acid induct||salicyl acid||element||luc||promot||activ||final extens||gfp||region iii||pathogen||plant||rice||report||induct||SA treatment||defens,1||2||1 min||cell||82-31-2991692 djhwang@rda.go.kr 1 1 nation institut||1 mM SA||1 ci ospr10||2 600 xoo||2006||element 1 xoo xanthomona||440-707 south korea 2 depart||2001||activ||1999||analysi,31046.0||28965.0||16158.0||12627.0||10814.333||10700.0||10419.333||9734.667||8371.0||7888.75||6350.8||6313.0||5231.0||4795.0||4687.0,0.0,0.0,0.06666666666666667
1084,Apoptosis-4-1-2423418.txt,hypertonicity-induc cation channel||electron cell||cell shrinkag||shrunken cell||effect||control||process||activ||cation channel||hyperton stress||hicc||experi||cell||avd||hela cell||regulatori volum increas||st||apoptosi||channel||rvi,1||2 1||2 2||2||2 2 2 2||2 2 2 2 2||1 1 fig. 1||2 2 3 3||discuss 2 2||1 2 10 12||1 3 14||refer 1||2 18||3 3 fig. 3||3 5,31046.0||30005.5||28965.0||28965.0||28965.0||28965.0||24528.5||23004.5||19877.0||18211.25||17462.333||16864.5||16447.0||14027.0||13704.0,0.0,0.0,0.0
1085,Anal_Bioanal_Chem-4-1-2413088.txt,cadsv||carbon fibr||potenti||concentr||in-lin||flow||solut||flow system||mercuri film||peak||signal||sampl solut||injection-mould electrochem micro-flow cell||analysi||bife||adsorpt||electrochem detect||electrod||increas||dimethylglyoxim||height||flow cell||film||solut composit||sensor||maximum respons,1||2||4 2||1 1 school||3||refer 1||rang 1||1 mm||chip fabric 1 fig. 1||4||accumul stage 2 fig. 2||cell||1 fielden peter||5||analyt characteris 2,31046.0||28965.0||20951.0||20928.0||17044.0||16864.5||16269.0||15936.5||13426.8||12937.0||12888.8||12627.0||10439.0||10364.0||9794.667,0.0,0.0,0.0
1086,Clin_Oral_Investig-2-2-1705496.txt,test group||light touch sensat||complaint||object evalu||neurosensori dysfunct||month||neurosensori disturb||lower lip||popul||group||physic dysfunct||area||symphysi||sensat||implant||questionnair||orofaci region||studi||trigemin nerv injuri||regard||impress||mental nerv||age 56 year||placement||psychophys test||age||object||surgeri||load||oral caviti||patient||oral implant||nerv||procedur||level||region||lower jaw,1||2||2 4||1 13||1 year||3||refer 1||1 week||1 overview||1 jacob||1 malevez||2 surgeon||patient||4 patient||4,31046.0||28965.0||20951.0||17654.0||17151.0||17044.0||16864.5||16140.5||15645.5||15570.0||15523.5||14615.5||13567.0||13252.0||12937.0,0.0,0.0,0.06666666666666667
1087,Cardiovasc_Intervent_Radiol-4-1-2367387.txt,intervent procedur||statist analysi||dosimet||differ||protect apron||dose||linear relat||person dosimet||transmiss||measur||studi||relat||holder||william||present studi||singl year||lead apron||exposur||addit inform||effect dose||special holder||radiologist||procedur||data||occup exposur||addit dosimet||physician||result,1||2||1 2 3 4||method 1 2 fig. 1||tabl 1||3||fig. 2||refer 1||tabl 2||radiologist 1||2 month||patient||2 1 radiat protect group||studi||netherland 2 depart,31046.0||28965.0||22498.0||19941.0||17331.0||17044.0||16970.5||16864.5||16290.5||15595.5||15281.5||13567.0||13206.8||12015.0||11205.0,0.0,0.0,0.06666666666666667
1088,Matern_Child_Health_J-2-2-1592150.txt,hiv||pregnanc||preconcept care,1||llc 2006 1 2||3||refer 1||4 4||4||1 15 cdc||1 20 cdc||5 6 7||2005||feb 3||utero 4 4||2006||2002||effect,31046.0||17170.25||17044.0||16864.5||12937.0||12937.0||11898.333||11845.0||8811.667||8716.0||8638.0||8636.0||8371.0||7057.0||6956.0,0.0,0.0,0.0
1089,Surg_Endosc-4-1-2358937.txt,anim||stapl line reinforc||surgeri||blood loss||complic||liver||materi||transect||liver resect||substanti liver parenchyma||addit||time||bile leak||devic||routin blood test,1||2||3||refer 1||1 day||2 day||1 fig. 1 schemat illustr||porcin model 2 fig. 2||4||studi||netherland 2 depart||5||2 9 30 32||2 robertu jan-luka||3 day,31046.0||28965.0||17044.0||16864.5||16489.5||15449.0||13469.0||13389.2||12937.0||12015.0||11205.0||10364.0||9954.0||9656.0||9488.5,0.0,0.0,0.0
1090,Behav_Genet-3-1-2039802.txt,differ||genet||apomorphin suscept||thalamu||product||high gnaw score||unsu genom||origin||rat model||variat||low gnaw score||dna||topoisomeras II bind site||epigenet variat||hippocampu||complex phenotyp||ap-pcr analysi||epigenet background||apo-su||wistar rat||epigenet factor||rat||locu||complex disord||ap-pcr product||genom||unsu rat genom,1||2 2||1 min||4||studi||fig. 3||5 5 5||product 3||2005||5 fig. 5||7||1b 4||result||product 5||aph-1b 2005 2001 2006,31046.0||28965.0||16158.0||12937.0||12015.0||11010.0||10364.0||9335.5||8716.0||8568.0||6997.0||6480.5||6080.0||5995.5||5857.5,0.0,0.0,0.0
1091,Neurochem_Res-4-1-2295255.txt,day||brain||olfactori bulb||blood vessel||report||infect mous brain||control mice||nos-2||hippocampu||viru||glial cell||patient||infect||capillari blood vessel||influenza viru||astrocyt||model mous||gfap||mice||level||region||result,1||2||immunohistochemistri 2 2 2 2||3 2 3||nos-1 2 2 2 fig. 2||2 4 2 8||fig. 1||3||refer 1||1 5 7||patient||llc 2008 introduct 1 2 3||4||hplc-uv method 2 3||studi,31046.0||28965.0||23200.6||21017.667||20140.0||19255.25||18011.0||17044.0||16864.5||16135.667||13567.0||13448.833||12937.0||12420.5||12015.0,0.0,0.0,0.06666666666666667
1092,Diabetologia-3-1-1914282.txt,hmw adiponectin||hmw||moder alcohol consumpt||adiponectin||activ||oxid capac||insulin sensit||concentr||alcohol||studi||men||high molecular weight||result,1 2||2||method 2 2||refer 1||15 2||method 2||patient||studi||4 5||tabl 1 1c||type 2 diabet||type 1 0.022||type 1 0.027||type 1 0.084||type 1 0.086,30005.5||28965.0||20534.0||16864.5||16771.0||16318.5||13567.0||12015.0||11650.5||11597.333||11461.333||11337.0||11335.333||11329.333||11329.333,0.0,0.1,0.06666666666666667
1093,Ann_Biomed_Eng-2-2-1705516.txt,circumferenti stretch||leaflet||mechan forc||effect||aortic valv leaflet||sgag||cell morpholog||elastin||circumferenti cyclic stretch||fiber||avl||analysi||bioreactor||rel motion||stretch bioreactor||contractil phenotyp||cyclic stretch||studi||current studi||tissu||sgag content||dmem||imag||express||nativ structur||tissu section||valv interstiti cell||valv||section||aortic valv||forc||valv leaflet||stretch||collagen||valv failur||cell phenotyp||elastin content,1||1 2||2||1 2 25||1 figur 1||1 10||10 2||4 2 5||30 1||refer 1||2 28||1 4′||1-404-894-4243 ajit.yoganathan@bme.gatech.edu 1 4 1||valid 2||red 2,31046.0||30005.5||28965.0||21103.333||21097.667||19014.0||17973.5||17422.0||17156.5||16864.5||15707.0||15525.5||15006.2||14994.0||14757.0,0.0,0.0,0.0
1094,Crit_Care-6-3-137445.txt,ischaem damag||complic||dorsal pedi||temporari occlus||present review||brachial||axillari arteri||report||factor||cathet||studi||radial||arteri cannul||haemodynam monitor||femor arteri||pseudoaneurysm||patient||infect||sepsi||incid||arteri cathet||risk||paper||patient popul||risk factor||arteri||site||case||rate||radial arteri,1||2||1 1 55||1 5||0 1||1 18||3||1 53||42 0 1 0 1||34 1 10 0 2||100 2 14 0 1||197 0 3 3 4 2||patient||4||220 0 1 4 4,31046.0||28965.0||21107.667||20705.0||18569.5||17487.5||17044.0||16082.0||15152.8||14974.8||14527.4||13716.0||13567.0||12937.0||12638.4,0.0,0.0,0.06666666666666667
1095,Sleep_Breath-4-1-2211364.txt,mandibular advanc devic||dgz||treatment||effect treatment option||snore||obstruct sleep apnea||dental sleep medicin||upper airway resist syndrom||sleep-rel breath disord||posit||posit paper||oral applianc||srbd,1||patient||germani 2 offenburg||5 6 7||2005||2006||procedur 3 8||2004||susann praxis@drschwarting.d 1 hueber||2003||individu patient||2002||effect||germani 3 hern||treatment,31046.0||13567.0||9887.0||8811.667||8716.0||8371.0||8195.667||8077.0||7765.25||7651.0||7600.5||7057.0||6956.0||5915.333||5012.0,0.0,0.0,0.06666666666666667
1096,Pharm_World_Sci-3-1-2082656.txt,intervent||respons||freedom||pharmacist||sens||physician behaviour||medic review||factor||behaviour||psycholog reactanc||attempt||studi||clinic care recommend||evid||medic practition||reactanc||treatment regimen||care||treatment||medic regimen||patient||decis||recommend||reactanc theori||intervent strategi||action||decis support system||physician,1||2||2008 1 2||refer 1||patient||3 4 5||4||studi||5||6||patient care||2006||2004||2003||individu patient,31046.0||28965.0||20684.0||16864.5||13567.0||13448.333||12937.0||12015.0||10364.0||9074.0||8672.0||8371.0||8077.0||7651.0||7600.5,0.2,0.2,0.13333333333333333
1097,Int_Urogynecol_J_Pelvic_Floor_Dysfunct-4-1-2335287.txt,symptomat pelvic organ prolaps||complic||pain||sacrospin hysteropexi||valid questionnair||outcom||function outcom||posterior compart||score||symptom||studi||domain||anatom outcom||qualiti||urinari leakag||follow-up period||surgeri||life||bothersom symptom||urogenit symptom||women||effect size||sacrospin ligament||uterovagin prolaps||procedur||sacrospin ligament fixat||standard questionnair||urinari incontin||recurr cystocel||prolaps||pelvic organ prolaps||result||follow-up time,1||2||result 1||3||refer 1||1 day||colporrhaphi 1||1 patient characterist||rang 2||stage 2||2 complic||patient||2 week 5||4||2 week 8,31046.0||28965.0||18563.0||17044.0||16864.5||16489.5||15525.0||15301.333||15228.5||15070.0||14921.0||13567.0||13521.333||12937.0||12118.0,0.0,0.0,0.0
1098,Ann_Surg_Oncol-4-1-2190342.txt,respons||cancer||neoadjuv chemoradi||neoadjuv treatment||paclitaxel||patholog complet tumor regress rate||chemoradi||regimen||radiotherapi||studi||esophag cancer||time||surgeri||tumor regress grade||treatment||surviv||postop complic||patient||tumor||transhiat esophag resect||stage II||trial||mortal,1||2||2 tabl 2||3||refer 1||day 1||phd 1 1 depart||2 26||neoadjuv treatment 2 2||trg 1||failur 1 2 fig||median 2 rang 2||2 middl||result patient characterist 1 tabl 1||patient,31046.0||28965.0||20515.333||17044.0||16864.5||16489.5||16203.25||15786.5||15773.25||15526.0||15270.25||15003.0||14641.5||14441.0||13567.0,0.0,0.0,0.06666666666666667
1099,Sci_Eng_Ethics-4-1-2225997.txt,intens care condit||elderli peopl||injuri||random||inclus||agent||prospect||brain injuri||sever tbi||proxi||countri||european||acut neurolog||studi||clinic trial||pharmacolog trial||good clinic practic||clinic test||time window||time||benefit||direct||clinic research||treatment||pharmacolog neuroprotect agent||patient||acut emerg situat||critic care situat||proxi consent||ethic||consent||defer consent||risk-benefit ratio||short therapeut time window||independ physician||specif ethic issu||tbi||trial||case||sever traumat brain injuri||waiver||signific advers side effect||efficaci||emerg research,2007 introduct 1 2||3||refer 1||40 1||march 1||june 2||patient||3 4 6||fig. 1 43||studi||1 time window||12 3 6||5||6||2005,17149.0||17044.0||16864.5||16598.0||15599.0||14548.5||13567.0||13018.333||12511.667||12015.0||11732.667||10656.667||10364.0||9074.0||8716.0,0.0,0.2,0.13333333333333333
1100,Pathol_Oncol_Res-4-1-2413131.txt,effect||concentr||cell line||combin||oral cancer||cisplatin||oscc||egfr||protein||studi||addit||egfr inhibitor||cisplatin sensit||cisplatin resist||growth||treatment||sensit||oral squamou cell carcinoma||oscc cell growth||cell||pathway||higher express||inhibit||cancer therapi,1||2||1 1 fig. 1||2 fig. 2||3||refer 1||1 min||1 cisplatin||patient||4||cell||studi||2005||clinic studi||p-egfr 3 fig. 3 materi,31046.0||28965.0||24528.5||20968.667||17044.0||16864.5||16158.0||15568.5||13567.0||12937.0||12627.0||12015.0||8716.0||8436.5||8151.4,0.0,0.0,0.13333333333333333
1101,Breast_Cancer_Res_Treat-4-1-2190785.txt,cancer||multivari rate||differ||distribut||high particip rate||breast cancer||group||vital statu||introduct||stage||adequ treatment||social class||studi||diseas||time||socio-econom strata||proport||surviv||screen||women||patient||eindhoven cancer registri||period||screen programm||socio-econom statu||se indic||year||se,1||2 3 4 5||refer 1||statu 1||1 fracheboud||2 roukema||patient||2 3 4 13 19||4||studi||tabl 1 characterist||fig. 2 trend||netherland 2 depart||1 million inhabit||southeastern netherland 2,31046.0||17327.5||16864.5||16125.5||15525.0||14483.5||13567.0||13304.4||12937.0||12015.0||11984.333||11573.667||11205.0||10397.667||10378.667,0.0,0.2,0.13333333333333333
1102,Transgenic_Res-3-1-1829418.txt,model||gland||differ||effect||mous||breast cancer||mammari tumor phenotyp||latenc||analysi||background||studi||ino||pymt||fvb||phenotyp||increas||mammari tumorigenesi||tumor latenc||ino defici||strain||tumor||molecular pathway||data||mice||metastasi||result,1||2||2 2||2003 2 2 fig. 2||tabl 1||1 fig. 4||1 gland||3 3 3 fig. 3||1 6 201||4||densiti 2003 2||1 9 216||studi||1 young dmitri 1 cardiff robert||1 manner cathyryn,31046.0||28965.0||28965.0||19904.4||17331.0||16319.667||15663.5||14630.4||13443.0||12937.0||12437.0||12208.0||12015.0||10519.167||10407.333,0.0,0.0,0.06666666666666667
1103,Pflugers_Arch-3-1-1915642.txt,lipid-droplet densiti||exercis||effect||glycogen||total||plasma ffa oxid||averag||muscl glycogen||con trial||plasma||insulin||cho trial||studi||fat||infus||rest||fiber type||oxid rate||insulin concentr||cho||carbohydr ingest||skelet muscl glycogen||oxid||subject||glucos||adipos tissu lipolysi||find||imtg||con||muscl biopsi||carbohydr||fat oxid||carbohydr supplement,1||1 2 2||2||2 2||2 2 3||1 3||1 13 2 2||13 2 2||1 5||1 6||2 2 34||1 13 2 13 2||C. 1 2 1 depart||1 8||1 13,31046.0||29658.667||28965.0||28965.0||24991.333||24045.0||23309.5||20730.667||20705.0||20060.0||19906.0||19500.0||19113.2||18600.0||17654.0,0.0,0.0,0.0
1104,Mol_Neurobiol-3-1-2039847.txt,vivo||bind||hyperphosphoryl tau||AD lesion||protein aggreg||brain||aggreg||shsp||clearanc||chaperon||amyloid beta-protein||strategi||amateur chaperon||earli develop||tpa||gag||accumul||format||heat shock protein||protein||AD brain||addit||profession||amyloid||hsp||neurodegen diseas||system||activ||tau||transport||apolipoprotein||cell||result||data||mice||human||apo||profession chaperon||level||heparan sulfat proteoglycan||toxic||microgli cell,1||2||M. 1 2||3||refer 1||1 summari||polypeptid 1||2 allel||patient||31-24-3668754 m.verbeek@cukz.umcn.nl 1 1 depart||cell||netherland 2 depart||amyloid beta 1||Aβ fibril 2||2 verbeek marcel,31046.0||28965.0||21252.333||17044.0||16864.5||15734.5||15561.5||14639.5||13567.0||12917.6||12627.0||11205.0||10554.667||9742.0||9685.333,0.0,0.0,0.06666666666666667
1105,Arch_Gynecol_Obstet-2-2-1705528.txt,single-day treatment||day||treatment||onset||genit herp||full outbreak||patient||symptom||progress||recurr||viral replic||recurr genit herp outbreak||patient-initi episod therapi,1||1 effect||3||refer 1||2 15||2 day||patient||viru type 2||5||6||2004||7 6 8||single-day famciclovir clinic trial 2||1 47 55 pue MA||patient complianc,31046.0||19001.0||17044.0||16864.5||16771.0||15449.0||13567.0||10774.333||10364.0||9074.0||8077.0||7408.333||7215.8||6985.4||6901.0,0.0,0.1,0.06666666666666667
1106,Osteoporos_Int-3-1-1766476.txt,intervent||day||injuri||differ||number||intervent program||fall||hospit||activ prevent||group||studi||fewer injuri||comprehens geriatr assess||individu care plan||fall risk factor||fractur||surgeri||convent care||treatment||systemat assess||control||intervent ward||multifactori intervent||intervent group||delirium||prevent||orthoped||control group||hip fractur||multifactori intervent program||rehabilit,1||2||3 2||1 1 depart||1 2 lundström||refer 1||2 test||1 englund||1 borssén||2 37||2 svensson||2 nyberg||patient||4||1 11 0.006,31046.0||28965.0||23004.5||21528.667||20004.667||16864.5||16085.5||15526.5||15524.5||15371.5||14499.0||14487.0||13567.0||12937.0||12065.333,0.0,0.0,0.0
1107,Eur_J_Pediatr-3-1-2151778.txt,minim necrosi||hgv||hcv||group||liver biopsi||studi||antibodi||diseas||follow-up period||children||natur histori||patient||infect||low rate||nosa||hematolog diseas||liver||data||adult||fibrosi||year||biopsi,1||2||2 6 3||group 1||1 1 1 gastric pariet cell||0 2||3||group 2||refer 1||1 characterist||2 year||patient||level group 1||4||antibodi 1 0,31046.0||28965.0||18361.0||17960.5||17718.833||17529.0||17044.0||16920.0||16864.5||16168.5||16110.5||13567.0||13042.333||12937.0||12822.333,0.0,0.0,0.06666666666666667
1108,J_Mol_Med-3-1-2121654.txt,cardiomyocyt||actin||myosin motor domain||phase-contrast imag||effect||peptid||primari cell||cell||cpp||concentr||protein||tat||terminu||primari adult cardiomyocyt||tat cpp,1||2||1 3 3||1 1 waf||control 1 3 2||4 4 2||fig. 2||refer 1||4 fig. 1||1 mW||3 3 3 3 fig. 3||top 2||4||cell||springer-verlag 2007 2,31046.0||28965.0||21711.333||20700.0||20364.75||18279.667||16970.5||16864.5||16319.667||15527.5||15032.667||14612.5||12937.0||12627.0||12618.667,0.0,0.0,0.06666666666666667
1109,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2206251.txt,vitrectomi||antibiot||injuri||vision||decad||trauma||eye trauma||clinic evid||factor||delay||remov||eye||associ||king khale eye specialist hospit||studi||foreign bodi||tertiari care eye hospit||time||endophthalm||age||treatment||iofb||visual outcom||final VA||visual acuiti||visual loss||patient||ocular injuri||risk||nlp||repair||risk factor||ocular trauma||case,1 1||result 1 2 1||2 3||4 1||tabl 1||refer 1||1 4 16||2 present||fig. 2 patient||4.7 1||4 15 2||2 eye||patient||studi||light percept fig. 1 patient,31046.0||24284.25||23004.5||21991.5||17331.0||16864.5||15978.0||15852.0||15836.0||15581.0||15493.0||14828.0||13567.0||12015.0||10152.6,0.0,0.0,0.13333333333333333
1110,Ann_Biomed_Eng-2-2-1705506.txt,leaflet||si||polym||field||remodel||bone marrow||implant||mechan stimul||bioreactor||tissu||studi||evid||myofibroblast||extracellular matrix||scaffold||ecm||decellular||molecular imag||heart valv||fibrin gel||biomark||heart valv tissu||matrix protein||valv||tissu engin||mechan environ||epc||collagen||biodegrad polym||growth factor||cell||properti||human||anim model||adult||applic||endotheli||heart||result||function,1||in-vivo 2 2||fschoen@partners.org 1 2 1 depart||3||26 2||1 145||procollagen 1||patient figur 1||patient||structur 2 185 87 1||cell||studi||stage 2 77||calcif figur 2||in-vivo 2 91,31046.0||19327.333||18710.4||17044.0||15786.5||15668.0||15532.0||15271.333||13567.0||12720.6||12627.0||12015.0||10299.667||10164.333||9944.667,0.0,0.0,0.13333333333333333
1111,Intensive_Care_Med-3-1-1915613.txt,treatment respons||pediatr intens care unit||respons||patient descript studi||effect||parent||explan||pediatr intensivist||acut||approach||antipsychot medic||hypoact||criteria||design||clinic present||studi||present||ill children||picu||children||treatment||medic condit||disord||haloperidol||patient||incid||routin clinic practic||disturb||delirium||dsm-iv criteria||anxieti||intens care unit||risperidon||case||clinic observ||adult||psychiatr consult||diagnost,1||2||result 1||3||refer 1||2 year||suppl 1||G. 1 1 divis||asian 1||discuss 2||gender 2||haloperidol 2||patient||studi||1 year sepsi,31046.0||28965.0||18563.0||17044.0||16864.5||16110.5||15942.0||15900.5||15552.0||15333.0||14727.5||14506.5||13567.0||12015.0||11531.667,0.0,0.0,0.13333333333333333
1112,J_Gastrointest_Surg-3-1-1852374.txt,perman stoma||perman fecal divers||factor||multivari analysi||perian abscess||surgic treatment||small bowel resect||follow-up||abdomin procedur||fecal divers||surgeri||temporari stoma||stoma||fistula||patient||risk||temporari fecal divers||rectal resect||year||fecal incontin||abscess format||case||rectal advanc flap||rate,1||2||tabl 1||3||tabl 2||T. 2 1 depart||CI 2||incontin 2||2 jehl||2 glatzl||2 kasparek||2 meil||patient||0.04 5 2||4,31046.0||28965.0||17331.0||17044.0||16290.5||16032.75||14880.5||14587.5||14486.5||14483.0||14483.0||14483.0||13567.0||13231.0||12937.0,0.0,0.0,0.06666666666666667
1113,Diabetologia-3-1-1914285.txt,tzd||rosi||fatti acid||upregul||cell type||pathway||metabol||lipolysi||analysi||secret||prostaglandin metabol||thiazolidinedion||decreas||protein||insulin||increas||low insulin||adipos tissu||rosiglitazon||lipid accumul||treatment||gene||lipid content||adipokin||chang||matur adipocyt||adipos||secret protein||cell||level||adipocyt||result,1||2||1 2 rene||fig. 1||3||refer 1||1 fig. 1 oro||type 2||glucos 1||member 1||beta 1||dehydrogenas 1||oxidas 1||metalloproteinas 1||1 μmol,31046.0||28965.0||20009.333||18011.0||17044.0||16864.5||16767.25||15946.5||15861.0||15791.5||15753.0||15578.5||15568.5||15562.5||15557.0,0.0,0.0,0.0
1114,Cancer_Immunol_Immunother-3-1-2150627.txt,requir||pbmc||elispot||respons||number||tetram||cmv||percentag||abil||posit||intracellular cytokin||group||order||phase||analysi||pbmc sampl||clinic trial||present||technolog||donor||panel||frequenc||assay||function assay||cimt||standard||protocol||elispot reader||reactiv||cell,1||1 1||2||2 2||fig. 1||3||fig. 2||refer 1||13 2||1 month||1 mg||1 ml||5 5 5 2||2 overview||2 wölfel,31046.0||31046.0||28965.0||28965.0||18011.0||17044.0||16970.5||16864.5||16613.5||16322.0||15945.0||15906.0||15014.25||14605.0||14485.0,0.0,0.0,0.0
1115,Eur_Radiol-3-1-1914269.txt,heart rate||averag decreas||percentu width||attenu profil||coronari arteri||averag spearman coeffici||measur||movement||attenu||studi||increas||imag||CT attenu||CT imag||lumen visibl||highest score||imag qualiti||coronari stent||method||longitudin plane||stent lumen||heart phantom||tempor resolut||stent||cardiac cycl||plane||64-slice mdct||heart||result,1||2||2 2 2 fig. 2||fig. 1||tabl 1||3||refer 1||method 2||tabl 2||hanzeplein 1||2 3 7 8||patient||4||studi||fig. 3,31046.0||28965.0||24167.2||18011.0||17331.0||17044.0||16864.5||16318.5||16290.5||15529.5||14790.0||13567.0||12937.0||12015.0||11010.0,0.0,0.0,0.06666666666666667
1116,Virchows_Arch-4-1-2234444.txt,gynaecolog origin||lymphangioleiomyomatosi||posit||ccst||sugar tumor||actin||lung||term||rapamycin||numer case||present||diseas||clear epithelioid cell||angiomyolipoma||lesion||aml||pulmonari lymphangioleiomyomatosi||pec||gene||featur||patient||mtor||pecoma||tumor||site||normal counterpart||cell||kidney||case||uteru||tsc||epithelioid,1||1 year||3||refer 1||2 function||1 month||39-45-8027136 franco.bonetti@univr.it 1 2 1 depart||chemotherapi 2||fascicl 2||1 fig. 1 renal angiomyolipoma||patient||4||cell||studi||1 year hepat,31046.0||17151.0||17044.0||16864.5||16773.0||16322.0||15592.167||14694.0||14506.5||13806.0||13567.0||12937.0||12627.0||12015.0||11630.333,0.0,0.0,0.13333333333333333
1117,Matern_Child_Health_J-2-2-1592158.txt,art||fertil problem||pregnanc||assist reproduct technolog||factor||addit counsel||multipl||ivf||fertil||twin||infertil||birth||lower birth weight||embryo||treatment||multipl gestat||women||patient||risk||singleton||embryo cultur condit||cycl,1 3||1 1 depart||refer 1||1 2 3 frazier linda||patient||4 4||8 9 10 2||4 4 5 6 7||2005||4 13||patient inform||2006||4 14 14||patient percept||effect,24045.0||21528.667||16864.5||15418.2||13567.0||12937.0||11873.25||10461.8||8716.0||8599.5||8503.5||8371.0||7177.0||7069.0||6956.0,0.2,0.1,0.06666666666666667
1118,Pediatr_Nephrol-4-1-2259256.txt,injuri||anticholinerg medic||cic||abnorm||cerebr palsi||pressur||lower extrem function||renal function||intraves pressur||lower urinari tract||infant||high||myelodysplasia||low pressur||present||condit||sphincter||cord||sacral agenesi||spinal cord||time||increas||lesion||bladder||children||complianc||newborn||incontin||dysfunct||urodynam studi||reflux||detrusor overact||assess||lower extrem||urodynam,2||1 4||9 2||level 1||3||birth 1 3||lesion 1||abrupt 2 2 hypoglycemia||infect 5 1||patient||injuri refer 1||5||3 year||urodynam lesion 2||bladder capac 2,28965.0||21991.5||17178.5||17126.0||17044.0||16235.0||16195.5||14489.25||14244.0||13567.0||11601.667||10364.0||10150.0||10118.0||9894.0,0.0,0.0,0.0
1119,Biochim_Biophys_Acta-2-1-2258316.txt,tauopathi||syk||tau||tyrosin phosphoryl,1||2||2 2||3||patient||fig. 4 fig. 1||4||cell||vitro fig. 1||fig. 2 phosphoryl||fig. 3 fig. 3 fig. 3||casein kinas 1||1 mM dithiothreithiol||5||6,31046.0||28965.0||28965.0||17044.0||13567.0||13483.75||12937.0||12627.0||12255.333||11477.0||11010.0||10643.0||10482.667||10364.0||9074.0,0.0,0.0,0.0
1120,Purinergic_Signal-3-1-2096766.txt,respons||receptor||treg||major defect||effect||vasculatur||ecto-nucleotidas||platelet||function||ecto-enzym||atp||immunoregulatori function||dendrit cell||immun respons||express||lymphocyt||role||adenosin||cell||data||ecto-atpas||cellular immun respons||vascular inflammatori||cd39,1||2||2007 introduct 1 2 3||3 3 3||refer 1||2 14||15 16 2 17 2 2||42 1||pusi 2||cell||triphosph diphosphohydrolas 1||5||low low fig. 1||9 50 3 fig. 3||6,31046.0||28965.0||17128.0||17044.0||16864.5||16631.0||16501.0||16266.0||14484.5||12627.0||10418.667||10364.0||9995.0||9429.0||9074.0,0.0,0.1,0.06666666666666667
1121,J_Gastrointest_Surg-3-1-1915638.txt,stenosi||injuri||complic||center||referr||outcom||bile duct injuri||bile duct||eea||follow-up||leakag||strictur||studi||cholecystectomi||present studi||surgeri||surviv||treatment||data analys||reconstruct surgeri||end-to-end anastomosi||stent therapi||percutan transhepat catheter||patient||addit therapi||present seri||bdi||long-term stricture-fre surviv||procedur||endoscop||stent||duct||data||long-term result||year,1 1||1||2||2 2||2 4||3||refer 1||d.j.gouma@amc.uva.nl 1 1 depart||2 4 symptom||patient||tabl 1 patient characterist||figur 1 refer patient||studi||M. 1 gouma||netherland 2 depart,31046.0||31046.0||28965.0||28965.0||20951.0||17044.0||16864.5||16146.75||14369.0||13567.0||12380.0||12124.25||12015.0||11601.333||11205.0,0.0,0.1,0.13333333333333333
1122,Purinergic_Signal-3-4-2072928.txt,receptor||nac||P2 receptor||injuri||posit cell||mechan||gfap||bbg||activ||process||agonist||cell||rat||data||immunofluoresc||studi||atp||microglia||pakt||microgli cell,"1||2||7 1 1||1 2 29||method materi 2 4 2 2||refer 1||1 2,4,6,12 1 49||1 μl||2 4 receptor||statist analysi 1 fig. 1||3 7 3 3 7||4||cell||studi||7 1 receptor antibodi",31046.0||28965.0||23029.667||20760.333||17531.5||16864.5||15814.25||15631.0||15135.0||14666.8||13025.2||12937.0||12627.0||12015.0||10718.5,0.0,0.0,0.13333333333333333
1123,Ann_Surg_Oncol-3-1-1914262.txt,IM sln||surgic explor||sentinel node||breast cancer||surgic treatment||stage procedur||radiotherapi||primari tumor||inject||metastas||radiotherapeut treatment||time||visual||intern mammari lymph node||patient||visual IM sln||tumor||lymphoscintigraphi||patient IM sln||parastern intercost incis||node||sln||rate||axillari sln,1||2||1 tabl 1||2 tabl 2||3||refer 1||70 1||1 cm||3 patient||2 cm||2 fig||2 albregt||surgic oncolog 2007 1 2 4||patient||4,31046.0||28965.0||21902.667||20515.333||17044.0||16864.5||16096.5||15761.0||15305.5||14720.5||14519.0||14483.0||13611.667||13567.0||12937.0,0.0,0.0,0.06666666666666667
1124,Matern_Child_Health_J-2-2-1592143.txt,outcom||product||health behavior theori||behavior||pregnanc||pcc||research||cost||healthi pregnanc||promot||babi||time||benefit||social market||care||women||servic||patient||provid||consum||market||preconcept care||demand||health,1||2||refer 1||1 theori||2 sampl||patient||4||llc 2006 introduct 1 3||2005||6 7||2002 6 2 75 88 10.1023||fewer patient||30 2 31 32 33 34||result||cost-effect studi,31046.0||28965.0||16864.5||15779.5||15665.0||13567.0||12937.0||11611.6||8716.0||8035.5||7891.167||6838.0||6727.333||6080.0||6057.5,0.0,0.1,0.06666666666666667
1125,Pituitary-3-1-2045692.txt,primari pituitari somatotropinoma||pancreat polypeptid||glucos load||concentr||pituitari gland||report||normal||secretori regular||ghrh||GH secret||ghrh concentr||long-term follow-up||mri||primari tumor||remov||secret||decreas||studi||clinic find||increas||medic therapi||valu||surgeri||treatment||carcinoid||serum ghrh concentr||test||patient||larg bronchial carcinoid||igf-i||repeat CT||tumor||normal valu||acromegali||ectop ghrh-syndrom||examin||case||octreotid||approxim entropi,1||2||patient 1||patient 2||3||refer 1||2 fig. 2 follow-up||patient 3 3||1 deconvolut||patient 3||2 SD||segment 2||no. 2||exon 2||albinusdreef 2,31046.0||28965.0||22306.5||21266.0||17044.0||16864.5||15987.0||15885.0||15531.5||15305.5||15124.0||14744.0||14703.0||14525.0||14485.5,0.0,0.0,0.0
1126,Reprod_Biol_Endocrinol-1-_-153492.txt,structur luteolysi||speci||luteolysi||luteal regress||corpu luteum||process||progesteron||function luteolysi||cell||term||regress||molecular mechan||function,1||5 1||2002 1||2 ctelleri@usd.edu 1 depart||tabl 1 result||1 11 13||2002 1 terminolog||cell||2002 96 2||usa 2 divis||2002 5 4||2002 35 3||3 14 17||6 7||1 jmbowen@uic.edu telleria carlo,31046.0||20705.0||19051.5||15626.5||13580.667||13453.0||12722.333||12627.0||12312.333||10380.667||10119.333||8698.667||8308.0||8035.5||7777.25,0.0,0.1,0.06666666666666667
1127,Qual_Life_Res-3-1-1915604.txt,spous||scale||dutch huntington associ||durat||patient qol||belief||huntington||gener health||coupl||research||studi||consequ||social function||symptom||diseas||ill percept||long durat||higher score||qol||qualiti||life||treatment||analys||mental health||subscal||control||partner||patient||percept||vital||amount||ill||futur research||total motor score||result,1||2||qol 2 3 2||3||1 helder||patient||studi||1 van kempen||ill percept 1||I. 1 snoei||5||2 pearson correl||2 van houwelingen||M. J. 1 weinman||6,31046.0||28965.0||18781.0||17044.0||15530.0||13567.0||12015.0||10846.0||10708.0||10539.333||10364.0||10228.667||10149.0||9649.0||9074.0,0.0,0.2,0.13333333333333333
1128,Pediatr_Nephrol-4-1-2413093.txt,lmx1b||podocyt||slit diaphragm,refer 1||patient||diseas||patella syndrom patient||gene||express||metanephr precursor cell||model system||develop||30||human nephrin gene||human kidney||glomerular diseas||transcript factor||role,16864.5||13567.0||5149.0||5073.667||4794.0||4395.0||4277.0||3787.5||3750.0||3267.0||3013.0||2763.0||2676.5||2673.0||2641.0,0.0,0.0,0.0
1129,Int_J_Cardiovasc_Imaging-3-1-2048829.txt,aortic valv stenosi||non-invas method||aortic stenosi||area||techniqu||tte measur||measur||studi||ava||cardiac catheter||axial view||contrast||signific||sever||avc||patient||valv||aortic regurgit||signific correl||aortic valv||mild||method||contrast allergi||left ventricl||aortic valv area||ebt||moder||tte||result||function,1||2||2 2 2 2 2||2 2||1 1 1 1 fig. 1||3 2 2||2 patient||18 2 2||24 2 25 2 2||3||fig. 2||refer 1||1 observ||hanzeplein 1||2 plane,31046.0||28965.0||28965.0||28965.0||26701.0||24991.333||21266.0||20619.667||18694.0||17044.0||16970.5||16864.5||16529.0||15529.5||14585.0,0.0,0.0,0.0
1130,Eur_J_Clin_Pharmacol-3-1-1914266.txt,day||sever overanticoagul||antibiot||differ||pdr||dose adjust||therapeut rang||inr||measur||phenprocoumon||studi||time||coumarin||signific||patient||risk||consent||user||dose reduct||acenocoumarol||anticoagul clinic||initi||data||clinic||overanticoagul||co-trimoxazol||interact||result||follow-up time,1||1 1||2||2 3||2 4||patient 2 3||0 1||1 13||3||refer 1||0 0 1||patient||4||cell||boer anthoniu 1 1 divis,31046.0||31046.0||28965.0||23004.5||20951.0||19858.667||18569.5||17654.0||17044.0||16864.5||14410.667||13567.0||12937.0||12627.0||12496.0,0.0,0.0,0.06666666666666667
1131,Clin_Auton_Res-3-1-1797060.txt,heart rate||exercis||middl age||coronari arteri calcium||relationship||gxt||slow hrr||cac||presenc||heart rate recoveri||year||atherosclerosi||hrr||particip||cac score||young adult,1||2||2 3||1 1 dept.||result 1||3||refer 1||1 2 carnethon merced||2 minut||2 1.20||patient||4||5 12 2 3 10 9||studi||type 2 diabet,31046.0||28965.0||23004.5||20712.0||18563.0||17044.0||16864.5||15004.75||14547.5||14541.5||13567.0||12937.0||12433.167||12015.0||11461.333,0.0,0.0,0.0
1132,Crit_Care-6-5-130146.txt,clinic condit||random||dic||outcom||congenit defici||hospit||antithrombin iii||meta-analysi||icu||subgroup||dissemin intravascular coagul||drug||atiii||studi||evid||previou rct||observ studi||italian hospit||treatment||patient||sepsi||heparin||rct||indic||italian ministri||intens care unit||find||trial||inform||data||mortal||septic shock,1||1 2||2||result 1||3||figur 2||2 1 7 8 9 10||patient||4||studi||tabl 1 characterist||tabl figur 1||tabl 2 relationship||itali 2 research||defici 180 1,31046.0||30005.5||28965.0||18563.0||17044.0||15083.0||14256.0||13567.0||12937.0||12015.0||11984.333||11954.333||11205.333||10958.333||10586.333,0.0,0.2,0.13333333333333333
1133,Eur_Radiol-4-1-2270358.txt,heart rate||aortic diseas||diagnost evalu||cta||diagnost workup||coronari arteri diseas||stenos||neg predict valu||simultan evalu||heart||invas angiographi||analysi||pulmonari embol||studi||coronari atherosclerosi||diagnost accuraci||imag||cardiologist||coronari arteri segment||cta find||coronari cta||coronari find||contrast materi||equival dose||patient||protocol||dual-sourc CT||acut chest pain||respect valu||find||examin||insuffici contrast opacif||chest pain||dose length product||recent CT technolog||chest pain assess,1||2||1 1 depart||1 13||3||refer 1||2 diagnos||examin 5 1||patient||4||studi||project fig. 2||germani 2 depart||1 becker christoph||1 reiser maximilian,31046.0||28965.0||21528.667||17654.0||17044.0||16864.5||14744.0||14255.333||13567.0||12937.0||12015.0||11584.333||10717.333||10422.0||10364.333,0.0,0.1,0.13333333333333333
1134,Skeletal_Radiol-4-1-2226078.txt,net ablat time||cancer||complic||pain||effect||deploy||tumour ablat||bpi score||combin||pain interfer||pain relief||ideal treatment||studi||metastas||spinal metastas||nsaid||CT guidanc||electrod||lesion||cancer patient||treatment||osseou metastas||patient||week||ablat||radiat therapi||opioid||method||bone metastas||local anaesthesia||procedur||radiopharmaceut therapi||radiofrequ ablat,1||2||1 3||1 tibia 1||1 3 5||2 3 4 fig. 1||method 1||3||refer 1||34 1||1 week||1 cm||2 spine 3||34 2||3 patient,31046.0||28965.0||24045.0||20734.333||19484.667||18993.6||17359.0||17044.0||16864.5||16417.0||16140.5||15761.0||15457.0||15376.5||15305.5,0.0,0.0,0.0
1135,Pediatr_Radiol-3-1-1915603.txt,posit||testicular posit||udt||re-examin||npt||studi||testi||viabl abdomin test||boy||paediatr surgeon||surgeri||children||oper find||test||patient||abdomen||surgic procedur||find||laparoscopi||physician||result,1||2||J. 1 1 depart||3||refer 1||conclus 2||3 4||2 3 5 6 7||springer-verlag 2007 introduct 1 2||1 fig. 1 ultrasound find||patient||4||studi||cohort 14 2||netherland 2 depart,31046.0||28965.0||17093.75||17044.0||16864.5||15078.0||14990.5||14488.8||14040.0||13850.4||13567.0||12937.0||12015.0||11283.0||11205.0,0.0,0.0,0.13333333333333333
1136,Eur_J_Appl_Physiol-4-1-2358938.txt,day||exercis||intrins contractil properti||vibrat train||effect||inact control group||abil||isometr knee extens||group||exercis countermeasur||contract||knee extensor||studi||muscl||characterist||rest||time||train session||increas||rve||frequenc||resist exercis||bed rest||torqu||forc||stimul||individu||subject||maxim||isometr contract||rate||torqu develop||resist vibrat exercis||foa||mvc,1||2||1 2 4 1 institut||F. 1 2 3||3||1 min||1 khz||e.mulder@neuro.umcn.nl 1 2 3 gerrit||2 min||2 week||2 khz||4||H. L. 1 2 rittweg||studi||150 2 1999 1997 fig. 2,31046.0||28965.0||21087.4||19498.75||17044.0||16158.0||15551.5||15414.8||15117.5||15100.0||14511.0||12937.0||12646.2||12015.0||11945.167,0.0,0.0,0.06666666666666667
1137,J_Biol_Inorg_Chem-3-1-1915633.txt,FC epr signal||refin||ecftna||outer entranc||monom||fourfold channel||channel||ferroxidas center||factor||bfr||main-chain||phase||crystal structur||high number||iron||protein||chain ferritin||side chain||similar||huhf||symmetri||electron-dens map||hydrogen bond||glu||side-chain atom||residu||ferritin||site||hyperthermophil microorgan||data||crystal||afftn||pfftn||Fe atom||result||structur,1||1 2||2||6 9 2 3 2||30 1 fig. 1||3||refer 1||1 day||7 7 7 2 1||FC 1||2 month||1 unit cell||4 2 fig. 4||2 2 2 P. furiosu escherichia||vol 2,31046.0||30005.5||28965.0||17888.0||17583.75||17044.0||16864.5||16489.5||16200.4||15624.5||15281.5||14975.667||14953.75||14867.167||14569.5,0.0,0.0,0.0
1138,J_Headache_Pain-4-1-2386848.txt,day||reduct||effect||month||advers event||group||follow-up visit||drug||school||studi||aim||children||frequenc||prevent treatment||migrain||disabl||adolesc||open studi||patient||week||paper||topiram||prophylact treatment||headach frequenc||pediatr migrain||trial||headach||side effect||loss,1||2||refer 1||2 year||springer-verlag 2008 introduct 1 2 3||patient||method 1 9||studi||1 aan classif||5||4 5 6 7 8||6||3 mg||2004||2007,31046.0||28965.0||16864.5||16110.5||13666.333||13567.0||13370.0||12015.0||10582.667||10364.0||9105.2||9074.0||8944.0||8077.0||7287.0,0.0,0.2,0.13333333333333333
1139,Skeletal_Radiol-4-1-2335296.txt,plantar fasciiti||atrophi||adma||inferior calcan nerv||logist regress||order||posterior tibial tendinosi||mri||format||analysi||studi||plantar enthesophyt||initi report||age||ptt dysfunct||patient||calcan spur||calcan spur format||pearson chi-squar analys||nerv||find||abductor digiti minimi atrophi||marker||achil tendinosi||presenc||foot||calcan edema,1||2||1 7||3||refer 1||tabl 2||patient||tabl 1 comparison||studi||muscl fig. 2 adm||studi group||2006||100 patient||pediatr patient||discuss patient,31046.0||28965.0||19021.5||17044.0||16864.5||16290.5||13567.0||12104.667||12015.0||8815.5||8445.0||8371.0||7901.5||7786.5||7634.0,0.0,0.2,0.13333333333333333
1140,J_Neurol-2-2-1705488.txt,medic emerg||heart attack||brain||number||stroke||cours||educ||lesson||session||aid train||measur||peopl||St john ambul||sign||questionnair||teach||symptom||studi||hands-on measur||particip||acut stroke||knowledg||action||train||healtheduc||brain attack||inform||topic||correct descript||stroke awar,1||2 1 depart||refer 1||1 symptom||2 3 5 3 6 8||procedur 1 fig. 1 concept||patient||1 key result||studi||3 6 8||6||germani 2 bavarian divis||4 symptom||observ studi||stroke patient,31046.0||20835.0||16864.5||16125.5||14774.167||13783.4||13567.0||12512.0||12015.0||10757.333||9074.0||7484.5||7071.0||7013.5||6981.5,0.0,0.1,0.06666666666666667
1141,Brain_Struct_Funct-4-1-2248604.txt,outlier||respons||roi||day||effect||oddbal block||posit differenti bold||deh||speech stimulu interact||condit||stimuli||sensori compon||speech||gyru||sensori mechan||contrast||acoust factor||control||activ||bonferroni||standard||test||map||lexic statu||standard-devi pair||oddbal||middl posit||posterior auditori cortex||motion||primari auditori cortex||deviant||subject||block||cognit mechan||middl||anterior||word deviant||function imag||sound||result,1||2||2 1 2 2004||2 2 2006 5 2||3||1 end||panel 1||1 onset||2 end||2 http://www.pstnet.com tabl 2||2 onset||posit 1 2 3 day 787.58||1 http://www.praat.org tabl 1 pitch||6 3||4,31046.0||28965.0||24263.25||21126.0||17044.0||16585.0||15781.0||15650.5||15544.5||15386.75||14610.0||13545.667||13145.4||13059.0||12937.0,0.0,0.0,0.0
1142,Anal_Bioanal_Chem-3-1-1764596.txt,analyt techniqu||analyt||injector||ptv injector||higher bromin compound||instrument method||review||analysi||higher bromin congen||instrument||hrm||studi||inject||on-column inject||molecular weight||increas||author||HR instrument||bromin flame retard||sensit||compound||multipl inject||temperatur||environment sampl||congen||standard||degrad||paper||inject techniqu||isobutan||molecular fragment||column||mass resolut||method||polybromin diphenyl ether||detector||human sampl||commerci standard||work||pbde||octabd congen||result||min,1||2||refer 1||2 μl||springer-verlag 2006 introduct 1 2||4||25 1 25||studi||1 pbde 25||4 Cl 2 calibr||5||2005||3 http://www.bsef.com||2006||2004,31046.0||28965.0||16864.5||14590.5||14256.8||12937.0||12548.0||12015.0||11457.0||10549.25||10364.0||8716.0||8522.5||8371.0||8077.0,0.0,0.1,0.06666666666666667
1143,Anal_Bioanal_Chem-4-1-2287205.txt,mixtur||mode||optim||concentr||fluoresc polar||measur||affin||competit bind curv||wavelength||decreas||coumestrol||hplc||meoh||hr system||FP detect||compound||system||phytoestrogen||assay||fia||gradient hplc system||experi||test compound||fluoresc||hr||on-lin||organ modifi||result||min,1||2||2 fig. 2||1 6||3||refer 1||hplc 14 2 2||microsom incub 2 4 2||2 mL 5||31-205-987610 npe.vermeulen@few.vu.nl 1 1 depart||cell||fig. 1 experiment||2 50 valu||1 mL 40||erα affin 2,31046.0||28965.0||20968.667||20060.0||17044.0||16864.5||15584.25||14273.4||13153.667||12917.8||12627.0||12393.333||11459.667||11109.333||9733.0,0.0,0.0,0.0
1144,Histochem_Cell_Biol-4-1-2386534.txt,schweizer||adenocarcinoma||squamou metaplasia||basal||express pattern||specif||cell type||suprabas layer||epitheli type||moll||diagnost marker||differenti||protein||tissu||keratin||typic intermedi filament protein||diseas||pattern||hair follicl||express||mutat||langbein||hair||epitheli cell||tumor||type II||diagnost applic||cell||case||marker||simpl||layer||function signific,1 1||1||2||2 3||3||basic 1||keratin 1||3 Pt 2||germani 2||vol 2||tabl 1 2006||patient||4 4||4||cell,31046.0||31046.0||28965.0||23004.5||17044.0||15751.0||15675.0||15398.667||14829.0||14569.5||14344.333||13567.0||12937.0||12937.0||12627.0,0.0,0.0,0.06666666666666667
1145,Bioinformation-1-2-1891631.txt,databas||aromat plant||medicin||india||plant||folklor,2||bioinform 1||tabl figur 1||search result figur 1||2005||data||2005 biomed informat publish group 2005||develop||univers||inform||depart||plant||biotechnolog inform system||scienc||web develop,28965.0||15556.5||11954.333||10028.25||8716.0||4969.0||3906.0||3750.0||3657.0||3440.0||2494.0||2489.0||2443.333||2414.0||2189.0,0.0,0.0,0.06666666666666667
1146,Plant_Mol_Biol-3-1-1805041.txt,databas||rice gene||number||correl||import gene||field||experiment data||sequenc||mutant panel databas||insert||phenotyp||seed||natur condit||gene function||function analysi||gene||mutant||nipponbar||phenotyp data||line||long leaf||retrotransposon||insert line||function,1||1 1 1 1 1||1 1 1 1||2||refer 2 2||1 1 2004 2005||fig. 1||3||1 month||1 mg||86 1 3 2 6 neck||phenotyp analysi 2 2 plant||1995 2 2004 2006||studi||45 1 16 1 18 thick,31046.0||31046.0||31046.0||28965.0||20204.333||19721.25||18011.0||17044.0||16322.0||15945.0||14582.167||13121.0||12019.25||12015.0||11996.333,0.0,0.0,0.0
1147,Cell_Tissue_Res-3-1-2071963.txt,mglur antibodi||light||receptor||synapt ribbon||mglur||posit||metabotrop glutam receptor||BC dendrit||retina||cone triad||rod triad||electron microscopi||bipolar cell||BC marker||process||cone||protein||antibodi||electron micrograph||bc||horizont cell||pkc||arrow||spinul||section||goldfish||cell||rod||dendrit||similar posit||outer plexiform layer||rod-driven hc||result||structur,"1||2||2 2||1 2 2 1986||3||immunochem 1||antibodi 2 2005||4||4 4 4 4 4||1 1983 1985 1 d,e||cell||studi||1 LM EM||5||5 5 5 5",31046.0||28965.0||28965.0||22457.25||17044.0||15530.5||13003.0||12937.0||12937.0||12688.2||12627.0||12015.0||10626.667||10364.0||10364.0,0.0,0.0,0.06666666666666667
1148,Diabetologia-4-1-2292420.txt,heart rate||intervent||exercis intervent||exercis||long-term efficaci||differ||resist||month||programm||adher||cost||type 2 diabet||studi||particip||endur type exercis||physic therapist||glycaem control||type 2 diabet mellitu||medic fit programm||patient||physic fit||clinic benefit||brisk walk||physic activ||cardiovascular risk profil||medic fit||blood pressur||min,1||2 1 2||2||3 1 2||3 1||2 2 aggrav||3 3||3||type 1||refer 1||1 3 particip||part 1||type 2||2 diabet||1 stehouw,31046.0||29658.667||28965.0||25685.0||24045.0||19314.333||17044.0||17044.0||16987.0||16864.5||16693.333||16058.5||15946.5||15728.0||15529.0,0.0,0.0,0.0
1149,Eur_J_Nucl_Med_Mol_Imaging-3-1-1914264.txt,respons||model||radionuclid therapi||lymphoma||optim||clinic dosimetri||thyroid carcinoma||dose||abil||individu patient||target||whole-bodi||tumour||estim||radiotherapi||bone marrow||phase||studi||metastas||import||antibodi||prospect trial||dosimetri||solid tumour||radiat dose||treatment||neuro-endocrin tumour||activ||radionuclid||gbq||bone||patient||amount||abl approach||therapi||radiat dosimetri||maximum toler dose||method||mci||cell||data||radiat||toxic||result,1||2||3||refer 1||phase 1||2 trial||1 gbq||4 1 depart||regimen 2 3 4||2 giammaril||2 8 10||86 0 1 3||patient||cell||86 1 3 111,31046.0||28965.0||17044.0||16864.5||15995.0||15598.5||15527.0||15492.333||14782.25||14483.0||14033.667||13740.5||13567.0||12627.0||12333.5,0.0,0.0,0.13333333333333333
1150,Mol_Genet_Genomics-4-1-2270915.txt,respons||acc||valu||express||tobacco||pathogen||transcript||studi||rice||jasmon acid||plant||infect||level||fourth leav||defens,1||2||detail 1 1 1 arabidopsi||3||1 hygromycin||suppl 2||studi||012 2 2 xoo ospr1||1 mM dithiothreitol||5||012 2 ospr1||2 ospr1 actin gene||2007 2006||7.6 fig. 1 pr1 arabidopsi||ospr1 ospr1 2 ospr1,31046.0||28965.0||18851.6||17044.0||15526.5||14901.5||12015.0||11617.2||10485.333||10364.0||9701.0||8539.25||7829.0||7350.8||7333.5,0.0,0.1,0.06666666666666667
1151,Environ_Health_Perspect-113-12-1314901.txt,tobacco industri||commod industri coalit||regul||pesticid regul||phosphin||regulatori agenc||compani||agenc||review||mrl||note||pesticid||industri||case studi||ebdc||member||standard||epa||world health organ||vettorazzi||public interest||coalit||meet||public||methopren||case||ethylen bisdithiocarbam||human||tobacco pesticid||philip morri||document,1||4 1 center||2 overview||1 august 2003||studi||tabl tabl 1 number||2004||case studi||2002||10||anim studi||usa 3 divis||5 januari 2005||2001||result,31046.0||15202.333||14605.0||12928.333||12015.0||10312.0||8077.0||7594.0||7057.0||6982.0||6454.5||6407.0||6403.333||6313.0||6080.0,0.0,0.1,0.06666666666666667
1152,Methods-1-5-1895922.txt,antibiot||number||bacteri strain||concentr||minimum inhibitori concentr||mic||solut||fischer suppli||resazurin method||resazurin||natur product||crude extract||microtitr plate||serial dilut||test materi||compound||assay||bacteri speci||indic||strain||purifi compound||method||antibacteri assay||extract||result,1||2||1 2 3||fig. 1||fig. 1 tabl 1 tabl 2||3||4||fig. 2 structur||studi||3 result||tabl 1 mic||5||1 euonymu europaeu||1 chrysanthemum segetum||1 centaureum erythraea,31046.0||28965.0||25685.0||18011.0||17210.833||17044.0||12937.0||12158.667||12015.0||11562.0||11557.0||10364.0||10355.333||10350.0||10349.667,0.0,0.0,0.0
1153,Clin_Oral_Investig-3-1-1797073.txt,day||enamel||applianc||saliva||studi||fluorid||deminer enamel||duraphat||respect tooth||opposit buccal aspect||sampl||present studi||varnish||oral caviti||volunt||uptak||detect limit||acquisit||site||transfer||enamel sampl||applic||specimen||seri||tooth,1||2||1 2 1 depart||2 3||1 tabl 1||1 2 attin||1 2 buchalla||result 2||3||refer 1||day 1||1 day||1 week||2 19||M. 1 2 yakin,31046.0||28965.0||23387.75||23004.5||21902.667||20012.0||20007.667||17522.5||17044.0||16864.5||16489.5||16489.5||16140.5||16139.5||15939.5,0.0,0.0,0.0
1154,J_Occup_Rehabil-3-1-2039785.txt,pain intens||respond||high effort||comput usag||pain||product||popul||factor||categori||previou research||select||low job satisfact||product due||neck||intens||associ||measur||symptom||studi||dichotom variabl||comput worker||presente||analys||logist regress analys||sick absenc||descript statist||psychosoci load||psychosoci factor||product loss||worker||mous posit||object instrument||mous usag||subject||case||sick leav||studi popul||loss||musculoskelet symptom||result,1||1 2||2||3||refer 1||1 1 tno work||symptom 2 fig. 2||2 index||2 vol||llc 2007 introduct 1 2||product loss 1 tabl 1||3 4 5||4||result product loss 1 fig. 1||studi,31046.0||30005.5||28965.0||17044.0||16864.5||16044.0||16027.75||14934.0||14569.5||13779.0||13666.2||13448.333||12937.0||12628.5||12015.0,0.0,0.0,0.06666666666666667
1155,Eur_J_Clin_Pharmacol-4-1-2426925.txt,healthi volunt||clinic signific||day||pharmacokinet paramet||dose||advers event||artesun||combin||clinic examin||group||administr||auc||phase||ratio||drug||amodiaquin||sampl||treatment||toler||cross-ov studi||volunt||haematolog paramet||patient||uncompl falciparum malaria||healthi normal volunt||malaria patient||main activ metabolit||dihydroartemisinin||pharmacokinet,1||1 2||2||1 1 divis||group 1||tabl 1||3||fig. 2||group 2||refer 1||1 6 7 8 1||1 6 max 1 6||2 ml||http://www.who.int/malaria/docs/treatmentguidelines2006.pdf 2||3 5,31046.0||30005.5||28965.0||20790.333||17960.5||17331.0||17044.0||16970.5||16920.0||16864.5||16863.4||16143.8||14865.5||14483.0||13704.0,0.0,0.0,0.0
1156,Intensive_Care_Med-3-1-1915647.txt,explanatori variabl||differ||effect||outcom||cmv||death||public bia||meta-regress analysi||sensormed ventil||cld||chronic lung diseas||factor||hfv||subgroup||gestat age||infant||analysi||high-frequ ventil||ventil strategi||studi||import||time||rr||lpv||protect ventil strategi||respiratori distress syndrom||patient||random trial||ventil||rrr||rel risk||prematur neonat||risk||depend variabl||public||trial||high lung volum strategi||year||convent mechan ventil||import variabl||result,1||2||3 3 2||4 2 4||fig. 1||3||fig. 2||refer 1||2 3 25||1 covari||patient||4||studi||rel risk 1||1 studi characterist refer,31046.0||28965.0||21017.667||18279.667||18011.0||17044.0||16970.5||16864.5||16436.0||15608.0||13567.0||12937.0||12015.0||11947.0||11758.75,0.0,0.0,0.13333333333333333
1157,Skeletal_Radiol-4-1-2271083.txt,malign||patholog report||spine||report||benign fractur||neg predict valu||emiss imag||mri||bone marrow-stimul agent||studi||compress fractur||imag||lesion||patholog result||fractur||fdg uptak||fdg-pet||patient||pet imag||histori||uptak||CT find||clinic follow-up||repeat imag||case||benign||acut benign fractur||suv,1||2||3||fig. 2||refer 1||1 sarcoma||2 month||2 mL||patient||2 5 6 9||4 patient||2 breast cancer||1 laryng cancer||studi||6 patient,31046.0||28965.0||17044.0||16970.5||16864.5||15604.0||15281.5||14548.5||13567.0||13448.75||13252.0||12915.667||12720.0||12015.0||11320.5,0.0,0.1,0.13333333333333333
1158,Int_J_Colorectal_Dis-4-1-2386750.txt,laparoscop resect||tcc||colon cancer||differ||number||laparoscop approach||convers||group||oscc||middl colic vessel||studi||splenic flexur||time||middl colic arteri||transvers colon||surgeri||altern||statist differ||patholog outcom||patient||lymph node||proxim resect margin||colon||bloc resect||tumor||long-term analysi||anterior resect||oncolog qualiti||laparoscop surgeri||radial margin||case||hemicolectomi||laparoscopi||local,1||2||3||refer 1||H. 1 1 depart||outcom 1||K. 1||patient||4||82-32-5105816 yslee@catholic.ac.kr 1 2 lee||studi||M. 1 park||T. 1 kim||G. 1 kim||K. 1 cho,31046.0||28965.0||17044.0||16864.5||16568.75||16465.0||16087.5||13567.0||12937.0||12154.0||12015.0||11708.333||11074.333||10942.667||10768.667,0.0,0.1,0.13333333333333333
1159,Ann_Surg_Oncol-4-1-2277445.txt,lymphat||ovarian cancer||squamou cellular cancer||antigen||sentinel node||local recurr||posit||averag||partial right-sid liver resect||blue||immunotherapi||studi||metastas||preoper lymphoscintigraphi||inject||radioact tracer||lymphat vessel||transfus||figur||diseas||increas||surgeri||lymphat map||malign melanoma||patent blue dye||lymphocyt||patient||lymph node||tumor||lymphoscintigraphi||squamou cell carcinoma||tumor homogen||liver||success expans||cell||case||liver metastas||pancreat cancer||node||adopt immunotherapi||expans procedur||superior surfac,1||2||patient 1||patient 2||RT 2 2||3||refer 1||1 1 fig. 1.||MD 1 1 depart||tabl 2||1 48||1 mm||surgic oncolog 2008 1 1 2||1 hour||1 po,31046.0||28965.0||22306.5||21266.0||19413.667||17044.0||16864.5||16801.75||16340.5||16290.5||16186.5||15936.5||15755.5||15666.0||15535.5,0.0,0.0,0.0
1160,J_Med_Internet_Res-7-5-1550689.txt,evidence-bas medicin||number||meta-search engin||pubm||onlin evid retriev method||parallel process||approach||profil||design||evid||diseas||time||system||small peak||meta-search filter||search profil||total search time||standard||paper||intern compon||wrapper||user||sourc||capabl||clinician||filter||search||inform||data||unifi respons languag||technic perform||result||document,1||2||2 1 centr||3||tabl 1 4||1 coiera||tgl 1||figur 2||tgl 2||4||tabl figur 1||tabl 2 system time||3 reliabl||2005||6 0,31046.0||28965.0||20252.667||17044.0||15866.333||15527.0||15524.5||15083.0||14484.0||12937.0||11954.333||10051.5||8759.0||8716.0||7583.5,0.0,0.0,0.0
1161,Diabetologia-4-1-2292423.txt,statist signific||differ||reduct||paee||variabl||total bodi movement||accelerometri||aerob fit||bmi||waist circumfer||bodi size||score||follow-up||measur||associ||type 2 diabet||fit||diabet||particip||metabol syndrom||increas||analys||hdl-cholesterol||metabol risk||activ||baselin||systol blood pressur||height||risk||chang||physic activ||zm||individu||glucos||metabol subcompon||triacylglycerol||data||level||year,1||1 2||2||1 1 fig. 1||2 2 16||result 1||1 year||refer 1||type 2||1 proactiv||1 7 9||19 1 20||1 year outcom||studi||1 year follow-up,31046.0||30005.5||28965.0||24528.5||20627.0||18563.0||17151.0||16864.5||15946.5||15539.5||14478.333||12925.667||12062.0||12015.0||11781.333,0.0,0.0,0.0
1162,Mech_Dev-2-1-2428104.txt,breakpoint||delet||sequenc||human disord||mous chromosom 1||dna||ihh||pattern||express||posterior||embryo||gene||mutant||shh||limb||site||polydactyli||mice||region||anterior||limb bud||result,1||2 4 2 4||fig. 2||fig. 2 fig. 2||1 mm||chromosom 1||patient||4||fig. 1 gli3 fig. 1 dbf||fig. 1 hand2 fig. 1 dbf||studi||fig. 2 dbf||fig. 3||mous chromosom 1||3 day,31046.0||20951.0||16970.5||16970.5||15936.5||15734.0||13567.0||12937.0||12037.0||12034.167||12015.0||11362.0||11010.0||10789.333||9488.5,0.0,0.0,0.06666666666666667
1163,Pflugers_Arch-3-1-2040175.txt,glut||effect||adiponectin||inflamm||product||leptin||differenti||protein||fiaf||normox condit||adipos tissu||present studi||express||hypox condit||obes||white adipos tissu||gene||inflammatori respons||adipokin||hypoxia||mrna||vegf||mif||cell||level||adipocyt||result,1||2 1||2 2||2||2 2 2||2 2 2 4||1 1 fig. 1||32 2 2 2 2||5 2||6 2 2 6||6 2||factor 1||3||refer 1||control 2,31046.0||30005.5||28965.0||28965.0||28965.0||24958.0||24528.5||23610.4||19664.5||19019.5||19019.5||17745.0||17044.0||16864.5||16684.5,0.0,0.0,0.0
1164,Eur_Arch_Otorhinolaryngol-4-1-2279159.txt,intervent||stenosi||subglott||tracheal stenosi||number||sg||tracheoscop||dilat tracheoscopi||progress complaint||present||time||refer group||age||treatment||local diseas||upper airway||institut||patient||femal||subglott stenosi||peakflow||diagnosi,1||2||refer 1||1 26||2 16||2 19||2 21||2 24||1 54||rang 2||patient||31-50-3612540 f.g.dikkers@kno.umcg.nl 1 1 depart||6 2 7 8||studi||fig. 3 patient,31046.0||28965.0||16864.5||16827.0||16458.0||16139.5||16123.0||16120.5||16101.5||15228.5||13567.0||12918.0||12797.5||12015.0||11862.333,0.0,0.0,0.06666666666666667
1165,Intensive_Care_Med-4-1-2244699.txt,increas||intervent||prednisolon||effect||corticosteroid||lp inject||biomark||pct||sepsi intervent strategi||patient stratif method||ct-proavp||dose||studi||sepsi||mr-proanp||human endotoxemia||level||mr-proadm,2||fig. 1||fig. 2||refer 1||2 4 5 7||patient||4||studi||netherland 2 depart||result pharmacokinet data 1||2 giebelen ida||springer-verlag 2008 introduct 1||m.d.dekruif@amc.uva.nl 1 lemair lucienn||2007||5 7 7 15,28965.0||18011.0||16970.5||16864.5||14815.75||13567.0||12937.0||12015.0||11205.0||10567.5||9659.0||8997.25||7768.5||7287.0||7233.75,0.0,0.1,0.06666666666666667
1166,Mcgill_J_Med-11-1-2322926.txt,heal||patellar tendon||dacron prosthesi||carbon fibr||strength||prosthet||review||ligament||techniqu||replac||tissu engin principl||implant||research||reconstruct||tissu||studi||scaffold||anterior cruciat ligament||acl replac||acl||artifici ligament||prosthet replac||surgeri||knee||patient||graft||acl reconstruct graft||tissu engin||signific progress||collagen||biolog tissu autograft reconstruct||cell||prosthesi||lad,1||1 1||2 35 2||1 advantag||1 nau||patient||cell||studi||artifici ligament 1||cell type||4 520 2 711800 13 alexand||2003||2007||cell popul||7,31046.0||31046.0||19975.0||15665.5||15526.0||13567.0||12627.0||12015.0||10496.0||7777.5||7727.667||7651.0||7287.0||7205.0||6997.0,0.0,0.3,0.2
1167,Purinergic_Signal-4-1-2245997.txt,receptor||ligand-bas homolog model||select||adenosin receptor||affin||structure-act relationship||ligand||ligand bind||deriv||antagonist||molecular model||side chain||molecular model studi,1||2||3 1||1 4||5 2||5 2 5 2||3 17 23 1 1||3||refer 1||1 34||6 2 4 4||5 5 5 2||1 6 18 13 7 2||cho cell 2||3 5 3 3 3 model,31046.0||28965.0||24045.0||21991.5||19664.5||19664.5||17141.4||17044.0||16864.5||16417.0||15978.25||15014.25||14045.5||13907.667||13738.5,0.0,0.0,0.0
1168,J_Mol_Med-4-1-2262918.txt,therapeut agent||effect||number||aggreg||polyglutamin aggreg||drug||yfp||toxic||protein||studi||transfect||hsp70||western blot||diseas||hsf1||protect||hsp||treatment||celastrol||polyglutamin toxic||experi||polyglutamin||cell||protect effect||hsp gene||result,1||1 protein||refer 1||2 26||2 27||cell||studi||6 cell||5||2004||10||effect||cell cultur||cell death||stain cell,31046.0||18667.0||16864.5||15786.5||15688.5||12627.0||12015.0||10850.5||10364.0||8077.0||6982.0||6956.0||6891.0||6710.0||6647.0,0.0,0.2,0.2
1169,Diabetologia-4-1-2270360.txt,hyperglycaemia||monogen diabet||molecular genet||syndrom||report||maturity-onset diabet||blood glucos||analysi||diabet||modi||interpret||mutat||children||treatment||test||gene||patient||featur||genet diagnosi||guidelin||molecular genet diagnosi||site||diagnosi||result,1||2||3||type 1||refer 1||T. 1||suppl 1||2 diabet||http://www.hgvs.org/mutnomen 1||sian.ellard@rdeft.nhs.uk 1 2 bellanné-chantelot||patient||studi||type 2 diabet||UK 2 depart||5,31046.0||28965.0||17044.0||16987.0||16864.5||16336.0||15942.0||15728.0||15523.5||15003.25||13567.0||12015.0||11461.333||10778.333||10364.0,0.0,0.0,0.06666666666666667
1170,J_Mol_Evol-3-1-1894752.txt,stramenopil||aua||speci||mechan||argument||small number||stop||mitochondri genet code||translat system||abil||nuclear genom||posit||length||base frequenc||disappear||ucu||pair||delet||estim||origin posit||origin trna-il||reassign||uag||gau||present||ambigu translat||uga||cau||codon reassign||simul||amino acid||asn||mutat||wobbl posit||fact||trna gene||gene||aaa||code||modif||fungi||absent||chang||mitochondri genom||ambigu intermedi mechan||base||show||met||ambigu||trna||cun||case||releas factor||codon,1||2||3||higgsp@mcmaster.ca 1 1 depart||2 S.||stop 1||ser 1||1 burger||thr 1||penicillium 1||gli 1||ala 1||1 sengupta||1 yokobori||1 laforest,31046.0||28965.0||17044.0||16146.75||15813.5||15647.5||15573.0||15548.5||15542.0||15536.5||15536.0||15535.0||15533.0||15527.5||15527.0,0.0,0.0,0.0
1171,Anal_Bioanal_Chem-3-1-1802726.txt,strong band||skin||secondari structur||band||raman||factor analysi||factor||compon||spectral data||corneocyt||solvent||intact tissu||lipid||spectra||structur||vibrat band||epidermi||tissu||keratin||studi||current experi||dmso||imag||singl cell||sampl||imag plane||treatment||II band intens||molecular structur inform||cell||human SC||current work||patholog state||relationship||protein structur,1||1 1||1 2||2||2 4||1 tran 2||compon 2 2||1 12||1 11||1 13||1 11 fig. 2||refer 1||1 region||1 min||1 tran,31046.0||31046.0||30005.5||28965.0||20951.0||20131.333||19597.333||18449.0||18048.5||17654.0||17509.5||16864.5||16313.0||16158.0||15714.5,0.0,0.0,0.0
1172,Purinergic_Signal-3-4-2072927.txt,cell divis||neurotransmiss||receptor||effect||extracellular space||glutam||brain||ntpdase||evid||atp||antagonist||increas||protect||hippocampu||releas||activ||extracellular concentr||ischemia||role||action||stimul||adenosin||cell||rat||data||human mesenchym stem cell||tonic activ||inhibit,1||2||1 1 depart||1 receptor||3||refer 1||1 1 104 105 1 106||1 cipriani||1 traini||84 88 1 2||45 2||patient||1 receptor activ||1 2A 3 receptor||cell,31046.0||28965.0||21528.667||17274.5||17044.0||16864.5||15789.833||15523.5||15523.5||15374.0||15300.0||13567.0||13260.0||12986.0||12627.0,0.0,0.0,0.06666666666666667
1173,Dev_Genes_Evol-3-1-1784541.txt,organ||part||speci||brain||planarian||amput||triclad||acoela||main nerv cord||abil||macrostomorpha||nervou system||free-liv flatworm||organ system||anim||develop||eye||head||neoblast||regener capac||similar||platyhelminth||divers taxa||egger||acoel||ovari||main function||polyclad||postembryon develop||cell||pharynx||flatworm||regener||anterior,1||2||2 M.||suppl 1||2 2006a||4||cell||studi||exp 1 monti||macrostomum 2 2006a||M. lignano fig. 2||3 4 4 2000 2000 2006a||6||2005||2004,31046.0||28965.0||16355.5||15942.0||14529.5||12937.0||12627.0||12015.0||10716.0||9696.0||9434.5||9136.333||9074.0||8716.0||8077.0,0.0,0.1,0.06666666666666667
1174,Eur_J_Health_Econ-3-1-1913175.txt,tiotropium||model||differ||effect||month||spain||scenario analys||ipratropium||cost effect||probabl||prefer option||chronic obstruct pulmonari diseas||cost||clinic trial||perspect||diseas state||spanish healthcar utilis||copd||valu||analys||sever||treatment||patient||scenario||bronchodil||util||ce-plan||similar declin||spanish nation health system||econom evalu||qali||salmeterol||trial||ipratropium group||data||life year||year||gener practition,1||2||1 fig. 1||1 1 17||tabl 1||year 1||3||refer 1||3 1 institut||1 month||tabl 2||year 2||2 year||4.98 1||scenario 2,31046.0||28965.0||22356.0||21891.667||17331.0||17151.0||17044.0||16864.5||16511.0||16322.0||16290.5||16110.5||16110.5||15526.5||14531.5,0.0,0.0,0.0
1175,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-1915597.txt,aitfl imping||joint tissu||anterior inferior tibiofibular ligament||imping||pain||joint||contact||ligament||imping syndrom||talar dome||studi||anterior talofibular ligament||talu||anterior aspect||aitfl||fascicl||arthroscopi||chronic ankl pain||patient||ankl joint||anterior||dorsiflexion||ankl||result,1||2||1 1 4||2 2 4 13||1 24||1 1 22 22||J. 1 1 depart||refer 1||diagnosi 4 2 4 4 2||fascicl 1 4 12 1||24 2||2 24||1 1 4 30 31||type 2||treatment 5 1,31046.0||28965.0||25009.667||18782.25||17161.0||17114.5||17093.75||16864.5||16319.833||16185.8||16120.5||16120.5||16089.8||15946.5||15474.0,0.0,0.0,0.0
1176,Neurosci_Lett-1-5-1885960.txt,tau||p53,1||2||3||fig. 2 waf fig. 2||patient||4||cell||fig. 2 waf||5||6||function studi||2004||7||10||alzheim patient,31046.0||28965.0||17044.0||13578.0||13567.0||12937.0||12627.0||11316.333||10364.0||9074.0||8298.0||8077.0||6997.0||6982.0||6966.0,0.0,0.0,0.0
1177,Histochem_Cell_Biol-4-1-2228382.txt,post-golgi transport||tubular subdomain||apic surfac||motor||molecular motor||precursor||format||cell surfac||process||protein||domain||clem||plasma membran||molecular machineri||fission||membran||target membran||post-golgi carrier||cisterna||transport||golgi complex||tgn||morpholog||carrier||complex||tubular network||type||pgc||golgi||cargo||structur,1||red line 1 2||2003 2003 2005 2004 2005||2003 2003 2003 2003 2004 2004||cell type||2007 2004||2003||2004 2004 2001||cell biolog||1998 2003 2004 2006||2002 2002||cell surfac||conclus 2004 2006 2004 2006||2001 2000 2003 1999 2006||epitheli cell,31046.0||15461.25||8162.2||7793.0||7777.5||7682.0||7651.0||7489.0||7089.5||7083.75||7057.0||6887.0||6817.4||6606.6||6606.5,0.0,0.0,0.06666666666666667
1178,Breast_Cancer_Res_Treat-3-1-2001216.txt,vivo||model||clinic signific||select inhibit||effect||anastrozol||peripher tissu||breast cancer||letrozol||estrogen||breast||postmenopaus women||studi||aminoglutethimid||aromatas||random clinic trial||ai||treatment strategi||patient||tumor||vivo model||trial||human||tamoxifen||complet inhibit,1||2 1||2||3||refer 1||suppl 1||1 77||110 1||2 week||2 109||patient||studi||5||cancer cell||2005,31046.0||30005.5||28965.0||17044.0||16864.5||15942.0||15902.5||15794.0||15100.0||14756.0||13567.0||12015.0||10364.0||9851.5||8716.0,0.0,0.0,0.13333333333333333
1179,J_Muscle_Res_Cell_Motil-3-1-2045119.txt,increas||iso-osmot ringer||valu||conduct veloc||waveform||constant||earli surfac||extracellular osmolar||nerv fibr||local circuit current||conduct||diamet||osmolar||find||membran potenti||skelet muscl,1||2 1 2 2 2||2||1 osm 1 2||2 2 1969 2||2 osm 2||3||latenc 1||chapter 1||1972 2||2 vol||2001 fig. 1||2006 fig. 2||4 5||fig. 3,31046.0||29381.2||28965.0||22769.0||21769.25||19316.333||17044.0||15570.5||15556.5||14577.5||14569.5||14111.667||14104.0||11650.5||11010.0,0.0,0.0,0.0
1180,Int_Arch_Occup_Environ_Health-4-1-2175021.txt,day||effect||durat||posit result||social support||length||short length||conceptu||sick absenc measur||factor||avoid||employe||strategi||behaviour||associ||total number||measur||ucl||day absent||present||health outcom||sampl||frequenc||absenc||sick absenc||cope||problem-solv||role||excess risk||item||emot process||case||sick leav||stress situat||sick||result,1||2||1 year||3||1 tabl 1 demograph||heidelberglaan 1||2 week||2 demograph||4||studi||netherland 2 depart||6 4||1 tamr LK||5||5 5 5,31046.0||28965.0||17151.0||17044.0||16476.75||15530.0||15100.0||14582.0||12937.0||12015.0||11205.0||11005.5||10377.0||10364.0||10364.0,0.0,0.0,0.0
1181,Skeletal_Radiol-4-1-2424184.txt,statist analysi||pain||total||cartilag loss||bone marrow edema||clinic outcom||chart review||review||group||cartilag||follow-up||studi||bme||time||pattern||lesion||age||follow-up period||sever||knee||tka||bone||edema||patient||bandwidth rang||age differ||subject||osteoarthrosi||find||function loss||total knee arthroplasti,1||2||2 5||2 8||2 9||3||fig. 2||refer 1||2 13||1 pattern||patient||4||4 4||studi||5,31046.0||28965.0||19664.5||17559.5||17178.5||17044.0||16970.5||16864.5||16613.5||16147.0||13567.0||12937.0||12937.0||12015.0||10364.0,0.0,0.0,0.13333333333333333
1182,Chiropr_Osteopat-13-_-1151650.txt,date||evidence-bas practic||pain||overweight||osteoarthr||review||bmi||research||associ||studi||evid||bodi mass index||literatur||question||causal factor||obes||definit answer||patient||paper||risk||link||search engin||method||risk factor||problem||search||data||year,1||2||tabl 2||1 4 6 7||patient||4||studi||tabl 1 step||tabl 3 clinic||2004||ebp principl step 1||answer question step 2||2003||14 5||2002,31046.0||28965.0||16290.5||15013.5||13567.0||12937.0||12015.0||11741.0||8506.0||8077.0||7980.25||7679.75||7651.0||7330.5||7057.0,0.2,0.2,0.13333333333333333
1183,Breast_Cancer_Res_Treat-3-1-2001223.txt,respons||cancer||effect||clinic respons||chemotherapi||breast cancer||letrozol||neoadjuv letrozol||neoadjuv therapi||postmenopaus women||letrozole-tr patient||studi||diseas||aromatas inhibitor||surgeri||express||treatment||aromatas||women||patient||tumor||neoadjuv||trial||endocrin therapi||safeti||diseas progress||tamoxifen,1||3||refer 1||2 analysi||1 month||1 aim||2 40||patient popul 1 fig. 1 21||patient||4||studi||2 37 37 35 fig. 2||3 9||2 express statu cancer||38 3 fig. 3,31046.0||17044.0||16864.5||16826.0||16322.0||15826.0||15557.5||14283.167||13567.0||12937.0||12015.0||11409.5||11218.0||10410.25||10164.5,0.0,0.1,0.13333333333333333
1184,Behav_Brain_Res-1-5-2148464.txt,goal arm||effect||dose||side||ventral hippocampu||dorsal||place||perform||drug||guid cannula||studi||correct||arm||infus||lesion||present studi||task||hippocampu||altern||experi||food reward||ventral hpc||spatial memori||trial||rat||ap5||cannula||muscimol||result,1||2||1 fig. 1||2 fig. 1||2 5||fig. 2 2 5||3||fig. 2||experi 1||experi 2||2 mm||4||2001 895 1||york fig. 1||1999 104 1,31046.0||28965.0||22356.0||21662.333||19664.5||18317.5||17044.0||16970.5||16535.0||15494.5||14896.0||12937.0||12465.0||12400.0||12133.0,0.0,0.0,0.0
1185,Pediatr_Radiol-3-1-2077923.txt,fraction anisotropi||roi||brain||dti||white matter||correl||gestat age||infant||diffus tensor||studi||adc||project tract||white-matt tract||imag||direct||age||valu||diffus tensor imag||pyramid tract||standard||patient||week||signific correl||refer valu||diffus||scan||anisotropi,2||age 1||3||refer 1||method 2||2 year||1 overview||2 35||tract 2||patient||studi patient||studi||fig. 2 confirm||13 1 14 17||netherland 2 divis,28965.0||17305.5||17044.0||16864.5||16318.5||16110.5||15645.5||15480.0||14706.0||13567.0||12791.0||12015.0||11505.333||10797.0||10466.667,0.0,0.1,0.13333333333333333
1186,Community_Ment_Health_J-2-2-1705498.txt,current medic model||tradit servic||model||cultur||respond||effect||novin||social support||american indian||SU problem||formal servic||prefer||research||measur||import||higher score||statement||care||mental health||servic||substanc abus||substanc abus servic prefer||commun||reserv||level||adult||health,1||2||1 2004||3||2 valu||patient||4||studi||servic 1 figur 1 perceiv effect||formal servic 1||5||6||patient ’s||2004||7,31046.0||28965.0||19561.5||17044.0||15845.0||13567.0||12937.0||12015.0||11975.833||10821.0||10364.0||9074.0||8305.5||8077.0||6997.0,0.0,0.0,0.0
1187,Neuroradiology-3-1-1786189.txt,injuri||mechan||magnet reson imag||effect||vasogen edema||stroke||leukocyt||reperfus||reperfus injuri||disrupt||clinic outcom||platelet||leukocyt infiltr||rat model||infarct volum||group||temporari mcao||anim||strategi||blood||mri||hyperperfus||brain damag||tissu||studi||cerebr ischemia||complement||increas||bbb||brain cool||hypothermia||patient||secondari deterior||ischem stroke||ischemia||find||rat||blood reperfus||result,1||6 2||refer 1||1 week||2 pile-spellman john 1 1 depart||2 day||phase 1 studi||6 2 20||springer-verlag 2007 introduct 1 2||patient||2 8 9||studi||1 27 32||3 4 5 4 6 7||patient group,31046.0||19019.5||16864.5||16140.5||15633.5||15449.0||14668.333||14152.0||14040.0||13567.0||13503.667||12015.0||11883.333||11558.833||9221.0,0.0,0.1,0.13333333333333333
1188,Int_J_Legal_Med-4-1-2226061.txt,gene express||tissue-specif mrna marker||cotton swab||saliva||signal intens||blood||stabl mrna marker||stain||candid||forens||analysi||rna marker||vagin secret||tissu||candid marker||time||sampl||rna degrad||express||experi||test||gene||identif||mrna||genom express analysi||method||saliva stain,1||2||3||refer 1||tissue-specif marker 1 fig. 1||4||31-10-4089300 m.kayser@erasmusmc.nl 1 1 depart||studi||2 27 28 29 fig. 2||netherland 2 depart||5||real-tim pcr 25 1||human cell||2004||rev 2002 1 607 625 10.1016,31046.0||28965.0||17044.0||16864.5||13562.2||12937.0||12917.6||12015.0||11672.833||11205.0||10364.0||8705.25||8428.0||8077.0||7552.0,0.0,0.0,0.0
1189,Int_J_Med_Sci-4-2-1796947.txt,statist signific||cancer||dna repair gene||effect||ner pathway||dna repair||abil||meta-analysi||popul||larg||dna damag||function||nucleotid excis repair||damag||associ||studi||dna||polymorph||heterogen||nucleotid excis repair pathway||gene||risk||lung cancer||individu||method||dna repair capac||epidemiolog studi||genotyp||multipl gene||human||lung cancer risk||drc||pathway||function effect||genet polymorph||allel,1||2||patient||4||studi||tp53 rb1 2 3 4||1 pharoah PD||5 nucleotid 3||6||xpd 3||3 ercc2||human cell||13 14 15 16 17 2||genet studi||genet polymorph 1. introduct 1,31046.0||28965.0||13567.0||12937.0||12015.0||11799.8||10498.333||9315.333||9074.0||8539.0||8536.5||8428.0||8272.5||7361.0||7139.0,0.2,0.1,0.06666666666666667
1190,Mar_Biotechnol_(NY)-4-1-2263118.txt,gene express||speci||probe||fish speci||suitabl||microarray||signal intens||sequenc||oligonucleotid||design||fragment||studi||dna||dna chip||fish chip||spot||gene||identif||singl target hybridis||dna microarray||method||speci identif||european sea||cross-hybridis||fluoresc signal||oligonucleotid probe,1||2||1 1 centr||1 2 5 2 10 ab108498||3||2 20||1 plane||1 silkenbeum||1 hjörleifsdottir||2 min||2 weber||silico 2||4 2 6 ay359673||tabl 1 number||studi,31046.0||28965.0||20946.333||17720.5||17044.0||16691.0||15625.5||15524.0||15524.0||15117.5||14545.0||14502.5||12744.25||12544.0||12015.0,0.0,0.0,0.06666666666666667
1191,Cancer_Metastasis_Rev-4-1-2362138.txt,respons||tumor suppressor||cancer||atm||effect||major compon||depend||dephosphoryl||dna damag respons||target||dna damag||mef||p53||target protein||phosphoryl||overexpress||import||apoptosi||increas||compound||phosphatas||wip1||activ||homeostat regul||ppm1d||role||tumor||oncogen||amplif||cancer cell line||cell||mice||level||intrins activ||human cancer||result||function,1||2||larryd@bcm.tmc.edu 1 2 3 1 depart||2 checkpoint kinas 1||4||cell||studi||vivo 8 2||3 2 ink4a tabl 3 evid||p53-induc phosphatas 1||dna glycosylas 2||checkpoint kinas 2||cell divis 2006 1 7 10.1186||studi protein||vivo 2 7 9 26,31046.0||28965.0||18432.833||15232.5||12937.0||12627.0||12015.0||11985.0||11370.5||10436.0||10100.667||9961.333||9915.167||9151.5||8959.6,0.0,0.1,0.06666666666666667
1192,Eur_J_Pediatr-4-1-2292482.txt,sun exposur||porphyria||age||diagnosi||children||sever||nose||liver enzym||erythropoiet protoporphyria||cutan manifest||epp||skin lesion||protoporphyrin||symptom||patient||skin symptom||girl||photosensit,1 year||refer 1||M. A. 1 1 depart||patient||4||netherland 2 depart||erythrocyt 2 17||1 kuck-koot veronica||3 day||6||2 22 13 18 23||netherland 3 depart||2002||cultur cell||porphyria patient,17151.0||16864.5||14368.8||13567.0||12937.0||11205.0||10893.667||10350.0||9488.5||9074.0||8665.4||7231.333||7057.0||6891.0||6791.5,0.2,0.1,0.06666666666666667
1193,Arch_Dermatol_Res-3-1-1914293.txt,lesion skin||skin||number||lichen planu||lesion biopsi||skin diseas||remiss||protein||studi||diseas||lichen planu symptom||treatment||relaps||diseas activ||patient||lymphocyt||skin cell||reactiv||plasmacytoid dendrit cell||lichen planu lesion||cell||biopsi,1||2 1||2||fig. 1 2||2 patient||result 1||1 year||3||refer 1||1 month||10 1 3 7 2 19||normal 2||5 11 2||patient||cell,31046.0||30005.5||28965.0||21662.333||21266.0||18563.0||17151.0||17044.0||16864.5||16322.0||15724.667||15414.5||14793.333||13567.0||12627.0,0.0,0.0,0.13333333333333333
1194,Childs_Nerv_Syst-2-2-1705512.txt,organ||oma||specif||probe||nervou system||microarray||nervou system develop||signal||mirna express||analysi||profil||microrna||array result||sampl||express||hybrid||cluster||express profil||cdna||mirna||method||northern blot||human||human chromosom 13||oligonucleotid microarray,1||2||1 1 1 1 fig. 1||1 2 4||refer 1||1 min||1 kb||86-10-62179059 genetic@263.net.cn 1 2 1 depart||nucleotid 2||spinal cord 2 2||human develop 2 fig. 2||studi||microrna 3 fig. 3 2 left||5||microarray fabric 2,31046.0||28965.0||26701.0||24316.0||16864.5||16158.0||15614.0||15592.167||14751.5||14703.75||14177.0||12015.0||11661.5||10364.0||9815.667,0.0,0.0,0.0
1195,World_J_Urol-4-1-2413091.txt,total||gleason score||tumor volum||month||total TV||correl||prognost factor||psa failur||largest tumor||independ predictor||maximum tumor diamet||prostat||follow-up||studi||high risk||index TV||high-risk group||independ prognost factor||median follow-up||signific||largest diamet||bcr||patient||risk||tumor||diamet||mtd||short follow-up||median||patholog stage,1||2 1||2||result 1||3||3 3||refer 1||method 2||springer-verlag 2008 introduct 1 2 3||patient||A. 3 1 depart||4||1 301 22.3 22.0 1||1 241 27.3 26.0 1||tabl 2 associ,31046.0||30005.5||28965.0||18563.0||17044.0||17044.0||16864.5||16318.5||13666.333||13567.0||13524.0||12937.0||12466.4||12465.0||12082.333,0.0,0.1,0.06666666666666667
1196,Pflugers_Arch-3-1-2082653.txt,dynam compon||shortest bcl||arrhythmia||effect||hypokalaemia||anti-arrhythm effect||slope||baselin cycl length||full agreement||analysi||studi||condit||epicardium||bcl||valu||cycl||waveform||frequenc||experi||hypokalaem langendorff-perfus murin heart||endocardium||lidocain||map||alternan||restitut||action potenti||record||restitut curv||arrhythmogen||critic DI||heart,1||2||23 1 1||2 fig. 2||clh11@cam.ac.uk 1 1||3||refer 1||schedul 1||1 khz||1 3 90 fig. 3||2 fig. 7||patient||7 1 3 8 5 10||4||4 5 4,31046.0||28965.0||21693.333||20968.667||20698.667||17044.0||16864.5||15600.0||15551.5||14280.0||13646.0||13567.0||13097.833||12937.0||12079.333,0.0,0.0,0.0
1197,Biotechnol_Lett-4-1-2248218.txt,vivo||express||protein determin protein||purif||recombin protein||exendin-4||bioactiv||result||min,1||1 2 fig. 2||detect 1 fig. 1||3||1 summari||patient||3 fig. 3||fusion protein 1||type 2 diabet||3 time||vivo 3||2006||7||10||effect,31046.0||23488.0||17259.5||17044.0||15734.5||13567.0||13021.333||12530.0||11461.333||10492.5||8940.0||8371.0||6997.0||6982.0||6956.0,0.0,0.0,0.0
1198,Int_J_Biochem_Cell_Biol-1-5-1885942.txt,GS||day||cultur||rt-pcr||medium||rat hepatocyt||epiderm growth factor||kd||pituitari gland extract||dex||hepatocyt||urea product||protein||condit||dexamethason||de-differenti||express||keratinocyt serum-fre medium||liver function||pa||sigma||assay||western||ksfm||differenti properti||car||ugt||transcript factor||liver phenotyp||result,1||2||2 4 3 4 2||2 5||fig. 1||3||fig. 3 2||tabl 2 tabl 2||1 min||1 week||mous 1||rabbit 1||1 kb||2 materi||2005 fig. 2 fig. 2,31046.0||28965.0||20169.6||19664.5||18011.0||17044.0||16995.0||16290.5||16158.0||16140.5||15973.0||15657.5||15614.0||15325.0||15319.6,0.0,0.0,0.0
1199,J_Mol_Evol-3-1-1915622.txt,align||model||secondari structur||potenti||posit||immun studi||slr method||sequenc||select||select pressur||protein||domain||vaccin||hypervari domain||amino acid||immun respons||analys||immun system||local||phylogenet relationship||stretch||recombin||method||site||region||nonsynonym substitut||codon||outer membran protein||structur,2 2||2003 1 2||2005 2||tabl 1||2000 2 2 yang||1 M8||yalelaan 1||2 chong||M. 2 1 netherland institut||4||2 1 fig. 2. H. influenza||netherland 2 depart||5177.30 2.17 2.12 0 1 2||5260.96 1.92 1.91 0 1 2||2005,28965.0||22554.0||18840.5||17331.0||16046.75||15526.0||15525.0||14502.0||13471.2||12937.0||11285.5||11205.0||11027.333||11027.0||8716.0,0.0,0.0,0.0
1200,Behav_Genet-3-1-1914288.txt,adhd index||parent rate||model||differ||genet||sex||scale||parent||correl||varianc||behavior||factor||influenc||estim||twin||analysi||equal||odd||boy||factor structur||children||conner teacher rate scale||adhd||measur invari||sex differ||item||preval differ||teacher rate||data||teacher||MI criteria||environment influenc||girl,1||2||1 1 depart||3||1 promax||2 LL||analys 2 3 1998||2002 1 2001 2001||studi||2002 5 1 6 10.1375||netherland 2 depart||1 4 boomsma dorret||5||age 3||2 hudziak jim,31046.0||28965.0||21528.667||17044.0||15524.0||14563.5||12867.75||12682.25||12015.0||11517.2||11205.0||11017.5||10364.0||10304.5||9667.333,0.0,0.0,0.0
1201,Planta-4-1-2249615.txt,carbon export||chlorophyl level||sucros||plant||function||maiz||mesophyl cell||accumul||tissu||doubl mutant||starch||phenotyp||carbon partit||chlorot||carbon||mutant||sucros export||leav||carbohydr accumul||callos deposit||total chlorophyl||vein||anilin blue||data||carbohydr||leaf||lack||leaf tip,1 1||2||2 2000||3||sxd1-1 1 3||1996 2||1 cm||tdy1-r 1||sxd1-1 1||0.05 2||sxd1-1 4 1||sxd1-1 2||4||1-814-8659131 dbraun@psu.edu 1 1 depart||2 2 famili phenotyp plant,31046.0||28965.0||17434.0||17044.0||16054.333||15996.0||15761.0||15564.0||15559.5||15168.0||14685.333||14519.0||12937.0||12917.6||12557.6,0.0,0.0,0.0
1202,Biochim_Biophys_Acta-2-1-2428106.txt,Na||brush-bord membran||effect||incub||caffein||small intestin||small intestin epithelium||studi||amino acid||activ||uptak||electrochem gradient||monolay||pde||nhe3||exchang||drug transport||cell||inhibit||phosphodiesteras||function,1||2||1 3||4 2 4 2 4 2||2 4||fig. 1||3||fig. 2||figs. 1||2 materi||4||fig. 2 14||cell||studi||fig. 6 3,31046.0||28965.0||24045.0||20951.0||20951.0||18011.0||17044.0||16970.5||15559.5||15325.0||12937.0||12746.0||12627.0||12015.0||10364.667,0.0,0.0,0.13333333333333333
1203,Addiction-1-_-2253702.txt,model||theoret framework||variabl||tpb||target||review||neg expect||belief||behaviour||social facilit||drug||ecstasi||associ||research||measur||studi||attitud||control||effect size||test||evidence-bas intervent||posit outcom||determin||compound construct||subject norm||public||expect||ancestri approach||intent,1||1 2||2||1 4||4 2||1 5||1 2 intens||2 0.01 2||1 8||1 9||2 7||2 8||tabl 1||3||1 0.05,31046.0||30005.5||28965.0||21991.5||20951.0||20705.0||20369.667||19545.0||18600.0||18219.0||17981.0||17559.5||17331.0||17044.0||16208.5,0.0,0.0,0.0
1204,Mol_Genet_Genomics-4-1-2329726.txt,up-regul||strain||hypothet protein||urinari tract||gene express||asymptomat bacteriuria||number||analysi||abu||human||urinari tract infect||transcript||gene||condit||environment condit||gene pool||upec||absent||microarray||genom,1||2||1 analysi||45-45-932809 pkl@bio.dtu.dk 1 1||1 c1968||denmark 2||2 klemm||patient||studi||vivo fig. 2||3794 ygilgh-c3794 4 1||1 fimbria c5391||2 usseri david||1245 sfacb-focaicdfgh 9 1||3 fec,31046.0||28965.0||17866.5||15523.5||15523.5||14536.5||14488.5||13567.0||12015.0||11592.333||10997.0||10351.333||9707.0||9116.25||8523.0,0.0,0.0,0.0
1205,Eur_Radiol-4-1-2373858.txt,initi enhanc||pharmacokinet paramet||magnet reson imag||total||diagnost perform||malign group||evalu||order||multivari analysi||clinic inform||mri||auc||breast||high tempor resolut imag||perform||analysi||follow-up||signific differ||lesion size 14 mm||studi||time||diagnost accuraci||lesion||imag||valu||local imag||malign lesion||wash-out||reader||morpholog characterist||method||tempor resolut||case||benign||imag protocol||divers histolog distribut||result||min,1||2||3 3 3 3||fig. 2||refer 1||tabl 2||1 min||1 tran||2 scar tissu 1||reader 1||2 min||2 cm||2 tran||reader 2||bi-rad 2,31046.0||28965.0||17044.0||16970.5||16864.5||16290.5||16158.0||15714.5||15611.0||15574.0||15117.5||14720.5||14674.0||14533.5||14492.5,0.0,0.0,0.0
1206,Eur_J_Pediatr-3-1-1829442.txt,doppler ultrasound||detect||renal vein||nutcrack group||lrv||flow||hilar portion||PV ratio||hematuria||ratio||asymptomat microscop hematuria||studi||nutcrack syndrom||screen examin||children||doppler angl||gross hematuria||patient||examin||case||data||renal doppler ultrasound||adult||hypercalciuria,1||2||result 1 fig. 1||3||refer 1||glomerulonephr 1||2 SD||NS 2||deaf 2||patient||4||1 januari 2002||studi||7 2 13 16||5,31046.0||28965.0||18287.0||17044.0||16864.5||15545.0||15124.0||14817.0||14552.5||13567.0||12937.0||12744.333||12015.0||11043.75||10364.0,0.0,0.1,0.13333333333333333
1207,Int_J_Biochem_Cell_Biol-1-5-1906734.txt,bind surfac||bind||western analysi||iii||conserv||dnaj||conserv qkraa motif||abil||loop region||prj-b vector||protein||structur||helix IV||leu||domain||vivo assay||bip||similar||mutat||substitut||system||cytosol||hsj1||residu||basic residu||data||region||interact||result||function,1||2||tabl 1||tabl 1 tabl 1||g.blatch@ru.ac.za 1||2 materi||2 mM||2 μM||4||fig. 2 A.||studi||1 botha M.||tabl 1 hennessi||1 mcnamara C.||tabl 1 function analysi,31046.0||28965.0||17331.0||17331.0||15524.0||15325.0||14683.0||14595.5||12937.0||12484.333||12015.0||11599.0||11571.667||11026.0||10982.5,0.0,0.0,0.0
1208,Dev_Biol-2-1-2279743.txt,requir||effect||nkx||mous||combin||zebrafish embryo||heart||zebrafish correl||earli express||evolut||feedback loop||gata activ||zebrafish||loop||phenotyp||express||embryo||absenc||myocardium||network||gene||somit||induct||gata||vertebr||cell||marker||bmp||cardiac marker express||earli role||gata factor||function,2||1 patient roger||figs. 2||patient||4||cell||roger.patient@imm.ox.ac.uk 1 joint||1 gibson abigail||5||2003 med1 2 nkx2.5||6||2005||2006||2004||2003,28965.0||14930.333||14519.0||13567.0||12937.0||12627.0||10543.0||10381.0||10364.0||9162.5||9074.0||8716.0||8371.0||8077.0||7651.0,0.0,0.1,0.06666666666666667
1209,Support_Care_Cancer-3-1-2092408.txt,cancer||spous||differ||correspond||stress respons symptom||distress||chemotherapi||coupl||measur||testicular cancer||studi||social function||time||refer group||qol||children||treatment||mental health||partner||patient||sr||measur time||year||start||level||diagnosi||relationship||physic function||function,1||2||partner 2 2||1 year||3||refer 1||2 sr||patient||4||studi||1 year follow-up||tabl 1 descript||netherland 2 depart||treatment-rel variabl 1||1 hoekstra harald,31046.0||28965.0||19434.333||17151.0||17044.0||16864.5||14499.0||13567.0||12937.0||12015.0||11781.333||11670.667||11205.0||10854.333||10371.333,0.0,0.2,0.13333333333333333
1210,J_Med_Internet_Res-6-2-1550592.txt,organ||qualiti expert||stakehold meet||algorithm||access||tool||project||educ||health servic research||abil||search engin expert||popul||review||factor||onlin search||health inform||engin||pew||criteria||ehealth||research||studi||eysenbach||technolog||particip||web site||qualiti||common reason||rate instrument||conduct||consum search||accur||patient||internet||code||recommend||human mediat||user||search engin||consum||content||search||site||inform||result||health-rel web site||import variabl||health,2||3||1 urac||patient||studi||4 5||25 http://www.pewinternet.org/pdfs/pip_health_report_july_2003.pdf 2||step textbox 1||5||2004||1 202 216 9010||1 202 962 8805||2003||7||effect,28965.0||17044.0||15532.0||13567.0||12015.0||11650.5||10755.667||10536.667||10364.0||8077.0||7855.5||7816.25||7651.0||6997.0||6956.0,0.4,0.2,0.13333333333333333
1211,J_Med_Internet_Res-4-2-1761932.txt,databas||survey||confidenti||technic issu||materi||web||newsgroup||exampl||trial databas||electron public||research||questionnair||peopl||studi||clinic trial||qualit research||inform consent||survey research||e-mail||particip||site visitor||data collect||due emphasi||electron one-to-on interview||patient||internet||ethic||issu||commun||select bia||public||inform||type||type 2 public||result,1||3||type 1||part 1||1 public||Pt 1||1 eysenbach||2 public||patient||box 1 20||studi||type 1 public||4 5||type 2 public||ethic issu 1,31046.0||17044.0||16987.0||16058.5||16020.0||15616.5||15560.0||14979.5||13567.0||12032.333||12015.0||11656.0||11650.5||10962.333||10733.333,0.0,0.1,0.2
1212,Invert_Neurosci-4-1-2257991.txt,receptor||nematod||function||glutamate-g chlorid channel||cys-loop lgic superfamili||glutam acid||ion channel||gaba||cation channel||cys-loop lgic||subunit||group,1||1 2005||1 1 C. elegan C.||ggr-3 group 1 1 2005 C.||2007 3 2002||1999 1999 1 2006 xenopu||mod-1 group 2000 2002 1||haemonchu contortu 2002 1 2005||ggr-1 group 1 2006 C.||2007||note fig. 1 C. elegan C.||protein||result||case studi int||2007 2003 C.,31046.0||19881.0||13250.2||12949.833||10462.667||9864.6||9776.4||9364.6||9262.0||7287.0||6811.333||6288.0||6080.0||5675.0||5651.0,0.0,0.0,0.0
1213,Neuroimage-1-5-1971136.txt,roi||mtr||neuron loss||gray matter||white matter||correl||histopatholog measur||normal||epilepsi||field||volumetr mri data||signal||middl tempor gyru||mri||analysi||measur||field fraction||tissu||studi||vivo mri||imag||valu||resect tempor lobe||neun||paramet||anterior tempor lobe resect||quantit mri||patient||protocol||quantit histopatholog||patholog||neuron densiti||subject||quantit neuropatholog||patholog block||data||mtr valu||region||neuron tissu||visual inspect||focal epilepsi,1||1 2 2 1||1 2||2||2 3||patient 1||1 4||1 6||1 8||1 year||3||fig. 2||tabl 2||registr 1||1 wieser,31046.0||30005.5||30005.5||28965.0||23004.5||22306.5||21991.5||20060.0||18600.0||17151.0||17044.0||16970.5||16290.5||15567.0||15531.0,0.0,0.0,0.0
1214,Virchows_Arch-3-1-1888715.txt,respons||respond||survey||number||chi-squar test||reexcis||criteria||atyp hyperplasia||breast||interobserv variabl||high proport||studi||lesion||adh||invas carcinoma||signific||question||ductal intraepitheli neoplasia||resect margin||patient||manag||hyperplasia||pathologist||duct||partial cribriform prolifer||diagnosi||flat epitheli atypia,1||2||3||refer 1||question 1||1 mm||din 1||question 2||2 mm||patient||4||1-203-7372470 fattaneh.tavassoli@yale.edu 1 1 depart||studi||small din 1||grade 1 din,31046.0||28965.0||17044.0||16864.5||15952.0||15936.5||15530.0||14911.5||14896.0||13567.0||12937.0||12917.6||12015.0||10769.0||10580.333,0.0,0.1,0.13333333333333333
1215,DNA_Repair_(Amst)-1-5-2077361.txt,yeast||strain||nucleas||defect||accumul||dna replic||temperatur||ssdna||activ||dna repair||depend||non-permiss temperatur||checkpoint activ||protein||experi||mrc1||checkpoint pathway||telomer dna||role||telomer,1||2||3||fig. 2||2 materi||cultur 2||cdc13-1 2||4||fig. 1 mrc1||studi||supplement tabl 1 supplement tabl 1||fig. 3||5||3 day||rad50δ supplementari fig. 1,31046.0||28965.0||17044.0||16970.5||15325.0||15060.0||14543.5||12937.0||12026.333||12015.0||11705.333||11010.0||10364.0||9488.5||9204.25,0.0,0.0,0.0
1216,Neuroradiology-3-1-2082067.txt,venou side||shunt||high flow||avm||onyx||liquid embol agent||detach coil||embol agent||flow||pial fistula||AV shunt,patient 1||case 1 1 fig. 1||3 2 4||refer 1||shunt case 2 2 fig. 2||patient||springer-verlag 2007 introduct 1 3||6 month||springer-verlag 2007||2005 147 17 31 10.1007||children||type||control deliveri||41 case||control manner,22306.5||20257.4||19648.667||16864.5||15852.5||13567.0||11655.8||5336.0||4445.5||3717.6||3218.0||2928.0||2362.0||2357.5||2289.5,0.0,0.0,0.0
1217,J_Mol_Med-4-1-2374882.txt,part||receptor||hypertens||bind||renin receptor express||prorenin||angiotensin||renin receptor||develop||intracellular||glomerulosclerosi||proteinuria||hypertens condit||addit||import role||angiotensin II||increas||podocyt||mitogen-activ protein kinas||recent||express||activ||nephropathi||renal angiotensin level||nonproteolyt activ||kidney||rat||anim model||level||region||mrna express||result,2 activ||refer 1||kinas 1||studi||2006 47 1 5 10.1161||kidney 3 4 5 5 6||angiotensin II type 1 gene||2007||cell condit||cell biolog||cell membran||effect||cell surfac||cell speci||vivo studi,17098.0||16864.5||15960.5||12015.0||10259.6||10180.0||8047.4||7287.0||7236.5||7089.5||6961.5||6956.0||6887.0||6740.5||6425.5,0.0,0.0,0.0
1218,J_Med_Internet_Res-5-4-1550579.txt,focu group||apprais skill||difficulti||group||pharmaceut compani||criteria||variabl qualiti||drug||process||health public||medicin||studi||particip||web site||consum search||standard||internet||sourc||issu||consum||method||search||site||inform||result||common convers,1||2||2 3 2 4 5||group 1||group 2||research introduct 1 1||particip 1||tabl 2||1 fox||particip 2||patient||1 year 1 2.2 locat||tabl tabl 1||studi||useless group 1,31046.0||28965.0||19655.0||17960.5||16920.0||16774.5||16518.0||16290.5||15577.5||15477.5||13567.0||13296.4||12759.333||12015.0||11974.333,0.0,0.0,0.06666666666666667
1219,Eur_J_Pediatr-4-1-2254655.txt,pneumomediastinum||group||air leak||lung||tissu||diseas||spontan PM||air||age||cpap||children||sever||stay||respiratori distress syndrom||neonat||patient||week||infect||pneumopericardium||intens care unit||case||subcutan emphysema||mechan ventil,1 1||1||2||2 2||3 1||1 result||2 result||refer 1||38 1||39 1||2 PM||patient||studi||section 2 0 3 day||7 fig. 1 pneumomediastinum,31046.0||31046.0||28965.0||28965.0||24045.0||18563.0||17522.5||16864.5||16320.0||16303.0||14744.5||13567.0||12015.0||10982.2||10763.5,0.0,0.0,0.06666666666666667
1220,Diabetologia-3-1-1781097.txt,vivo||incub||insulin signal||insulin hypersensit||blood sampl||pten||blood||protein||insulin||studi||inject||blood glucos level||haploinsuffici||glucos toler test||key regul||pancreat area||activ||glucos uptak||glucos||insulin sensit||cell||mice||insulin inject||primari myocyt,1||2||1 2 mui||2 2 pten||1-604-8755654 chriso@interchange.ubc.ca 1 2 1||3||3 fig. 2||refer 1||1 mol||4 2 3 3 3 19||2 diabet||1 pten||T. 1 2 kim||day 2||W. 1 2 yau,31046.0||28965.0||20004.667||19357.0||18211.8||17044.0||16995.0||16864.5||16530.0||16058.0||15728.0||15593.5||15547.0||15449.0||15218.0,0.0,0.0,0.0
1221,J_Gastrointest_Surg-3-1-1852378.txt,hepatocellular carcinoma||surgic resect||month||report||fine needl aspir biopsi||oper||follow-up||studi||recurr||hepat aml||angiomyolipoma||imag||conserv treatment||treatment||conserv manag||patient||tumor||hepat angiomyolipoma||year||case||diagnosi||seri,"1||2||1 1 2 c,d||studi 1||follow-up 2 1 2 figur 1||10 1||patholog studi 1 2||clinic data 1 2||3||refer 1||month 1||acknowledg 1||metastasi 1||loss 2 malais 1||patient",31046.0||28965.0||22767.75||21530.5||20377.5||19014.0||18275.5||17459.5||17044.0||16864.5||16322.0||15877.5||15651.5||15253.75||13567.0,0.0,0.0,0.06666666666666667
1222,Purinergic_Signal-3-4-2072922.txt,recent studi||neurotransmiss||receptor||adenosin receptor||receptor-receptor interact||presynapt inhibit||regul||effect||brain||potenti||neuron||channel||studi||atp||antagonist||receptor interact||synapt transmiss||function role||hippocampu||ionotrop receptor||releas||activ||famili||current||role||gpcr||adenosin||nmda||pathophysiolog condit||cell||gaba||interact||result,1||1 2||2 2||2||6 1 1||1 19 1||4 2||1 111 1||1 3 4||2A 3 1 1||2007 1 2A 3 1 1||0 1||12 1||1 receptor||3,31046.0||30005.5||28965.0||28965.0||23722.0||21802.0||20951.0||20852.333||20342.333||19871.75||19636.667||18569.5||18449.0||17274.5||17044.0,0.0,0.0,0.0
1223,Purinergic_Signal-2-2-2254478.txt,ectonucleotidas||ntpdase||liver||vasculatur||nervou tissu||apyras||ecto-atpas||immunolog||platelet||cd39,1||2||entpd 1 1 1||fig. 1||1 receptor||3||refer 1||region 1||2 57 2 1 12 62||1 nomenclatur||ntpdase 1||patient||cell||studi||1 receptor Br,31046.0||28965.0||23285.5||18011.0||17274.5||17044.0||16864.5||16313.0||16125.833||15559.5||15541.0||13567.0||12627.0||12015.0||11850.667,0.0,0.0,0.0
1224,Health_Qual_Life_Outcomes-2-_-395842.txt,rate||old-old patient||scale||mobil||daili live||contact||factor||approach||behaviour||global deterior scale||instrument||measur||nurs||neg affect||qualiti||life||cognit rate scale||well-b||activ||sever dementia||bcr||patient||dementia||item||commun||barthel index||assess||year||physician||life measur,1||2||3||method patient 2||0.001 2||3 4||bcr 2||patient||4||studi||tabl 1 eigenvalu||germani 2 depart||cancer patient||barthel item 2||0.001 3,31046.0||28965.0||17044.0||15401.333||15055.0||14990.5||14522.5||13567.0||12937.0||12015.0||11556.333||10717.333||10321.5||9874.333||9094.5,0.0,0.1,0.06666666666666667
1225,Dig_Dis_Sci-3-1-1914222.txt,day||epitheli homeostasi||dose||stem cell||length||crypt||group||damag||prolifer||dox||differenti||decreas||protein||increas||mucos||express||wnt pathway||treatment||control||mtx||high-dos dox treatment||medium dose||epitheli||cell||tcf4||mice||bmp||level||pathway||morpholog||sever villu atrophi||villi,1||1 1 1 1 1 1||2||villu length 1 1 1||b.dekoning@erasmusmc.nl 1 2 4||protein 2||3||refer 1||day 1||1 week||C. 2 1 depart||1 büller||day 2||2 pieter||4,31046.0||31046.0||28965.0||18746.8||18237.25||17626.5||17044.0||16864.5||16489.5||16140.5||16130.0||15524.0||15449.0||14491.0||12937.0,0.0,0.0,0.0
1226,Eur_J_Appl_Physiol-3-1-1782100.txt,limit||efl||blood||compon||exercis||averag 52||recoveri||control||debt||data||cardiac output||time,1||1 1||2 1||1 2||1 2 2||2 2 2||2 2||2||2 2 2 2||2 kinet 2 2 2||2005a 2 2 2 2||2001 2 2||3 2 2 5||2 fig. 2||2 4,31046.0||31046.0||30005.5||30005.5||29658.667||28965.0||28965.0||28965.0||28965.0||23234.0||23197.0||21414.333||21334.5||20968.667||20951.0,0.0,0.0,0.0
1227,Doc_Ophthalmol-4-1-2244701.txt,parafov ring||high correl||retin dystrophi||rpe||fmm||genotype-phenotyp correl||field||annulu||AF abnorm||high densiti autofluoresc||cone||retin dysfunct||ring||lipofuscin||mutat||visual acuiti||patient||cone-rod dystrophi||autofluoresc||retin pigmentosa||perg||case||data||visual field preserv||function signific,1 1 depart||1 2 guca1a||3||refer 1||3 patient||patient||2 3 moor anthoni||2 3 webster andrew||2 3 fitzk fred||fig. 4||19 patient||2006||fig. 5||2007||62 patient,21528.667||20005.667||17044.0||16864.5||15305.5||13567.0||11569.75||11540.75||11511.0||8956.5||8440.5||8371.0||7670.0||7287.0||7253.5,0.0,0.1,0.06666666666666667
1228,Sleep_Breath-4-1-2276561.txt,hypox climat||effect||hypoxia group||weight loss||group||oxygen||bmi||studi||fat||air||time||room||bodi||hypox condit||low intens physic exercis||moder hypoxia||climat||week||mild||hypoxia||train||normobar hypoxia||subject||weight||simul altitud||level||train period||min,1||1 2||1 2 2 2||2||2 2||springer-verlag 2007 2 2 2 2||3||refer 1||subject 2 3 fig. 2||suppl 1||2 month||period 2||2 max||3 5||patient,31046.0||30005.5||29485.25||28965.0||28965.0||20791.833||17044.0||16864.5||16366.8||15942.0||15281.5||15037.5||14722.0||13704.0||13567.0,0.0,0.0,0.0
1229,Ann_Gen_Hosp_Psychiatry-2-_-162166.txt,respons||auditori deficit||great varieti||attent deficit disord||psychoacoust||evalu||central auditori deficit||mental disord||capd||disord||disabl||test||mental retard||patient||paper||central auditori system||dyslexia||central auditori process disord||electrophysiolog test||auditori cortex||speech stimulu,1||1 iakovides@auth.med.gr 1||2 3 4 6||patient||1 vivian_iliadou@yahoo.gr iakovid||schizophrenia schizophreniaresearch 1997 1||2003||wilkin 1978 2 katz||effect||anorex patient||7 8||9 10||result||2000||differ,31046.0||20697.667||17005.0||13567.0||10350.0||8713.5||7651.0||7373.5||6956.0||6784.0||6575.5||6187.0||6080.0||5903.0||5422.0,0.2,0.1,0.06666666666666667
